Citrus Sinensis ID: 022903
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 290 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.737 | 0.548 | 0.475 | 3e-51 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.851 | 0.269 | 0.372 | 3e-36 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.717 | 0.222 | 0.410 | 2e-32 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.717 | 0.156 | 0.392 | 2e-31 | |
| Q80XI6 | 850 | Mitogen-activated protein | yes | no | 0.693 | 0.236 | 0.378 | 3e-31 | |
| Q16584 | 847 | Mitogen-activated protein | yes | no | 0.693 | 0.237 | 0.378 | 3e-31 | |
| Q66HA1 | 850 | Mitogen-activated protein | yes | no | 0.693 | 0.236 | 0.378 | 3e-31 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.713 | 0.178 | 0.363 | 5e-31 | |
| P11346 | 782 | Raf homolog serine/threon | no | no | 0.696 | 0.258 | 0.384 | 2e-30 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.751 | 0.188 | 0.369 | 3e-30 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 202 bits (514), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 107/225 (47%), Positives = 143/225 (63%), Gaps = 11/225 (4%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDE-RALLEGRFIREVNMMSRVKHD 118
LFIG+K GAH ++Y G Y R VA+K++ + +E RA LE +F EV ++SR+ H
Sbjct: 86 LFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLFHP 145
Query: 119 NLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N+V+F+ ACK P + I+TE + +LR YL P L + L ALDI+R M+ LH+
Sbjct: 146 NIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHS 205
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
G+IHRDLK +NLLL D+ +K+ADFG + ET GTYRWMAPE+
Sbjct: 206 QGVIHRDLKSNNLLLN-DEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMI------ 258
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
++K Y KVDVYSFGIVLWEL T LPF+GM+ +QAA+A A K
Sbjct: 259 --KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 301
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (384), Expect = 3e-36, Method: Composition-based stats.
Identities = 98/263 (37%), Positives = 150/263 (57%), Gaps = 16/263 (6%)
Query: 21 NQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG 80
NQ+ +G++ K S +VV+ S Q + + L I SK+GEG G VY+G +
Sbjct: 626 NQYNNQGNILKNSGSVVEPPS---QQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWR 682
Query: 81 DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL-MVIVTELL 139
VAIK + + + L E F +E+ ++SR++H N+V + AC P + +TE L
Sbjct: 683 GSSVAIKQIKINEDVNNQVLEE--FRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYL 740
Query: 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199
PG SL L S + K+++ + A+ IA+ M+ LH +G+IHRD+K NLLL + ++
Sbjct: 741 PGGSLYDALHS-KKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLD-EHMNV 798
Query: 200 KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259
K+ DFGL++ ++ + MT G+ WM+PEL GE Y KVDVY+FGI+LWE
Sbjct: 799 KICDFGLSKLKSKSTEMTKSIGSPIWMSPELL------MGED--YTEKVDVYAFGIILWE 850
Query: 260 LLTNRLPFEGMSNLQAAYAAAFK 282
L T LP+ G+ ++Q A A K
Sbjct: 851 LGTGELPYSGLDSVQLALAVTTK 873
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 139 bits (351), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 94/229 (41%), Positives = 134/229 (58%), Gaps = 21/229 (9%)
Query: 60 LFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
L I +IG G++G+VY + G + K L++ + AL E F EV +M R++H
Sbjct: 669 LVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSG--AALAE--FRSEVRIMRRLRHP 724
Query: 119 NLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLH 176
N+V FLGA + P + IVTE LP SL Y + RP + +D + ALD+A M+CLH
Sbjct: 725 NVVFFLGAVTRPPNLSIVTEFLPRGSL--YRILHRPKSHIDERRRIKMALDVAMGMNCLH 782
Query: 177 ANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-GTYRWMAPELYST 233
+ I+HRDLK NLL+ + ++K+ DFGL+R + T + + T GT WMAPE+
Sbjct: 783 TSTPTIVHRDLKTPNLLVD-NNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEV--- 838
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
LR + N K DVYSFG++LWEL T RLP+ GM+ +Q A F+
Sbjct: 839 --LR---NEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQ 882
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 136 bits (343), Expect = 2e-31, Method: Composition-based stats.
Identities = 89/227 (39%), Positives = 124/227 (54%), Gaps = 19/227 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
I +IG+G KV +G + + VA+K LN +++ F EV ++ ++H NLV
Sbjct: 1075 IDKEIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQ-EFKAEVELLGSLQHPNLV 1133
Query: 122 KFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN------KLDLHVALNFALDIARAMDCL 175
G +P M IV E LP +L + L+ +P+ KLD + L A DIAR M L
Sbjct: 1134 TCYGYSLNP-MCIVMEFLPSGNLFE-LIHSKPSEQQQSIKLDSTLILAIAFDIARGMQHL 1191
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 235
H IIHRDLK NLL+ ++K+AD G+ARE + T+ MT GT W APE+
Sbjct: 1192 HTRNIIHRDLKSSNLLMD-KHFNIKIADLGIARETSFTQTMTT-IGTVAWTAPEI----- 1244
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
LR + YN K DVYS+ IVL+ELLT P++G+ + A A K
Sbjct: 1245 LRH---ESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASK 1288
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q80XI6|M3K11_MOUSE Mitogen-activated protein kinase kinase kinase 11 OS=Mus musculus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 135 bits (341), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 86/227 (37%), Positives = 120/227 (52%), Gaps = 26/227 (11%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIR-EVNMMSRVKHDNLVKFL 124
IG G GKVY G + +VA+K + DE + +R E + + + H N++
Sbjct: 124 IGIGGFGKVYRGSWRGELVAVKAARQ--DPDEDISVTAESVRQEARLFAMLAHPNIIALK 181
Query: 125 GAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG---I 180
C ++P + +V E G L + L R + HV +N+A+ IAR M LH +
Sbjct: 182 AVCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPV 238
Query: 181 IHRDLKPDN-LLLTP------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
IHRDLK +N LLL P + K+LK+ DFGLARE T M+A GTY WMAPE+
Sbjct: 239 IHRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKA 297
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
T +G DV+SFG++LWELLT +P+ G+ L AY A
Sbjct: 298 STFSKGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVA 336
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q16584|M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 135 bits (340), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 86/227 (37%), Positives = 120/227 (52%), Gaps = 26/227 (11%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIR-EVNMMSRVKHDNLVKFL 124
IG G GKVY G + +VA+K + DE + +R E + + + H N++
Sbjct: 123 IGIGGFGKVYRGSWRGELVAVKAARQ--DPDEDISVTAESVRQEARLFAMLAHPNIIALK 180
Query: 125 GAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG---I 180
C ++P + +V E G L + L R + HV +N+A+ IAR M LH +
Sbjct: 181 AVCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPV 237
Query: 181 IHRDLKPDN-LLLTP------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
IHRDLK +N LLL P + K+LK+ DFGLARE T M+A GTY WMAPE+
Sbjct: 238 IHRDLKSNNILLLQPIESDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKA 296
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
T +G DV+SFG++LWELLT +P+ G+ L AY A
Sbjct: 297 STFSKGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVA 335
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q66HA1|M3K11_RAT Mitogen-activated protein kinase kinase kinase 11 OS=Rattus norvegicus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 135 bits (340), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 86/227 (37%), Positives = 120/227 (52%), Gaps = 26/227 (11%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIR-EVNMMSRVKHDNLVKFL 124
IG G GKVY G + +VA+K + DE + +R E + + + H N++
Sbjct: 124 IGIGGFGKVYRGSWRGELVAVKAARQ--DPDEDISVTAESVRQEARLFAMLAHPNIIALK 181
Query: 125 GAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG---I 180
C ++P + +V E G L + L R + HV +N+A+ IAR M LH +
Sbjct: 182 AVCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYLHCEALVPV 238
Query: 181 IHRDLKPDN-LLLTP------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
IHRDLK +N LLL P + K+LK+ DFGLARE T M+A GTY WMAPE+
Sbjct: 239 IHRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAWMAPEVIKA 297
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
T +G DV+SFG++LWELLT +P+ G+ L AY A
Sbjct: 298 STFSKGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVA 336
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 134 bits (338), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 84/231 (36%), Positives = 121/231 (52%), Gaps = 24/231 (10%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
L I IG G KV+ G Y VAIK+ ++ + D+ + ++E + +KH+N
Sbjct: 142 LDIKEVIGSGGFCKVHRGYYDGEEVAIKIAHQ-TGEDDMQRMRDNVLQEAKLFWALKHEN 200
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ G C + + +V E G SL + L K+ V +N+A+ IAR M+ LH
Sbjct: 201 IAALRGVCLNTKLCLVMEYARGGSLNRILA----GKIPPDVLVNWAIQIARGMNYLHNEA 256
Query: 180 ---IIHRDLKPDNLLLTP-------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 229
IIHRDLK N+L+ QK+LK+ DFGLARE T+ M+A GTY WM PE
Sbjct: 257 PMSIIHRDLKSSNVLIYEAIEGNHLQQKTLKITDFGLAREMYNTQRMSA-AGTYAWMPPE 315
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
+ S T Y+ DV+S+G++LWEL+T P++G L AY A
Sbjct: 316 VISVST--------YSKFSDVWSYGVLLWELITGETPYKGFDPLSVAYGVA 358
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P11346|KRAF1_DROME Raf homolog serine/threonine-protein kinase phl OS=Drosophila melanogaster GN=phl PE=1 SV=5 | Back alignment and function description |
|---|
Score = 133 bits (334), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 83/216 (38%), Positives = 121/216 (56%), Gaps = 14/216 (6%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG +IG G+ G VY + VA+K LN + S A L+ F EV M+ + +H N
Sbjct: 472 ILIGPRIGSGSFGTVYRAHWHGP-VAVKTLNVKTPSP--AQLQA-FKNEVAMLKKTRHCN 527
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
++ F+G P + IVT+ G SL K+ V + K L+ ++ +A+ MD LHA
Sbjct: 528 ILLFMGCVSKPSLAIVTQWCEGSSLYKH-VHVSETKFKLNTLIDIGRQVAQGMDYLHAKN 586
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTL 236
IIHRDLK +N+ L D S+K+ DFGLA +T + TG+ WMAPE+ +
Sbjct: 587 IIHRDLKSNNIFLHED-LSVKIGDFGLATAKTRWSGEKQANQPTGSILWMAPEV-----I 640
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
R E Y+ + DVY+FGIV++ELL LP+ +SN
Sbjct: 641 RMQELNPYSFQSDVYAFGIVMYELLAECLPYGHISN 676
|
Serine/threonine kinase required in the early embryo for the formation of terminal structure. Also required during the proliferation of imaginal cells. May act downstream of ras1 in the sev signal transduction pathway. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 132 bits (331), Expect = 3e-30, Method: Composition-based stats.
Identities = 89/241 (36%), Positives = 127/241 (52%), Gaps = 23/241 (9%)
Query: 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREV 109
+R ++D + K+GEGA +V+EG + VAIK L DE E RFIREV
Sbjct: 843 EREYIIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLK--IIGDEEQFKE-RFIREV 899
Query: 110 NMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN------KLDLHVALN 163
+ + H N+V F+GAC P I+TE + G SL Y + PN K + L
Sbjct: 900 QNLKKGNHQNIVMFIGACYKP-ACIITEYMAGGSL--YNILHNPNSSTPKVKYSFPLVLK 956
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
A D+A + LH+ I+HRDL N+LL + ++K++DFGL+RE++ MT G
Sbjct: 957 MATDMALGLLHLHSITIVHRDLTSQNILLD-ELGNIKISDFGLSREKSREGSMTMTNGGI 1015
Query: 224 ---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
RW PEL + HY+ KVDVY F +V+WE+LT +PF + QA+ A
Sbjct: 1016 CNPRWRPPELTKNL-------GHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVA 1068
Query: 281 F 281
+
Sbjct: 1069 Y 1069
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 290 | ||||||
| 225439671 | 374 | PREDICTED: serine/threonine-protein kina | 0.955 | 0.740 | 0.822 | 1e-136 | |
| 255584255 | 367 | protein kinase atn1, putative [Ricinus c | 0.934 | 0.738 | 0.830 | 1e-133 | |
| 356532165 | 370 | PREDICTED: serine/threonine-protein kina | 0.934 | 0.732 | 0.835 | 1e-130 | |
| 297735553 | 337 | unnamed protein product [Vitis vinifera] | 0.824 | 0.709 | 0.895 | 1e-127 | |
| 449439809 | 373 | PREDICTED: serine/threonine-protein kina | 0.944 | 0.734 | 0.794 | 1e-124 | |
| 449521717 | 373 | PREDICTED: serine/threonine-protein kina | 0.944 | 0.734 | 0.794 | 1e-124 | |
| 357506575 | 363 | Protein kinase, putative [Medicago trunc | 0.858 | 0.685 | 0.86 | 1e-124 | |
| 217074000 | 360 | unknown [Medicago truncatula] | 0.858 | 0.691 | 0.86 | 1e-124 | |
| 388513773 | 360 | unknown [Medicago truncatula] | 0.858 | 0.691 | 0.86 | 1e-123 | |
| 224139346 | 356 | predicted protein [Populus trichocarpa] | 0.862 | 0.702 | 0.830 | 1e-123 |
| >gi|225439671|ref|XP_002270753.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 489 bits (1258), Expect = e-136, Method: Compositional matrix adjust.
Identities = 232/282 (82%), Positives = 259/282 (91%), Gaps = 5/282 (1%)
Query: 1 MSCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLL 60
MSCS S G E+GE E++ ++R SVE + ++ +NGSI APQLTID +LLVDPKL+
Sbjct: 1 MSCSESN---TGGEQGEIEES--IIRNSVEVDPKSFTQNGSIMAPQLTIDENLLVDPKLI 55
Query: 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
FIGSK+GEGAHGKVYEGRYGD+IVAIKVL+RGSTS+ERA LEGRF REVNMMSRVKH+NL
Sbjct: 56 FIGSKVGEGAHGKVYEGRYGDQIVAIKVLHRGSTSEERAALEGRFAREVNMMSRVKHENL 115
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
VKF+GACKDPLMVIVTELLPGMSLRKYL S+RP ++D+HVAL+FALDIARAM+CLHANGI
Sbjct: 116 VKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPKRMDIHVALSFALDIARAMECLHANGI 175
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
IHRDLKPDNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGE
Sbjct: 176 IHRDLKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGE 235
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
KKHYNNKVDVYSFGIV WELLTNR+PFEGMSNLQAAYAAAFK
Sbjct: 236 KKHYNNKVDVYSFGIVFWELLTNRMPFEGMSNLQAAYAAAFK 277
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584255|ref|XP_002532865.1| protein kinase atn1, putative [Ricinus communis] gi|223527377|gb|EEF29519.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 479 bits (1232), Expect = e-133, Method: Compositional matrix adjust.
Identities = 235/283 (83%), Positives = 254/283 (89%), Gaps = 12/283 (4%)
Query: 1 MSCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAP-QLTIDRSLLVDPKL 59
MSCS+ NR GRE EQ SVE ++ + +NGS+TAP QL+ID +LLVDPKL
Sbjct: 1 MSCSSDNNNR-GRENEEQ---------SVEVQT-VITQNGSLTAPHQLSIDENLLVDPKL 49
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
LFIGSKIGEGAHGKVY+GRYGDRIVA+KVLNRGST +ERA LE RF REVNMMSRVKHDN
Sbjct: 50 LFIGSKIGEGAHGKVYQGRYGDRIVAVKVLNRGSTCEERAALENRFAREVNMMSRVKHDN 109
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
LVKF+GACK+PLMVIVTELLPGMSLRKYL+ +RPN+ DL +ALNFALDIARAMDCLHANG
Sbjct: 110 LVKFIGACKEPLMVIVTELLPGMSLRKYLIGIRPNQPDLRLALNFALDIARAMDCLHANG 169
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
IIHRDLKPDNLLLT +QKS+KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG
Sbjct: 170 IIHRDLKPDNLLLTANQKSVKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 229
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK
Sbjct: 230 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 272
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532165|ref|XP_003534644.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 469 bits (1206), Expect = e-130, Method: Compositional matrix adjust.
Identities = 228/273 (83%), Positives = 248/273 (90%), Gaps = 2/273 (0%)
Query: 10 RVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEG 69
R G+ EGE + + + GS E S++V +NGS+ + QLT+D +LLVDPKLLFIGSKIGEG
Sbjct: 4 REGKIEGEDRECEESVLGSTE--SKSVRENGSLASTQLTVDENLLVDPKLLFIGSKIGEG 61
Query: 70 AHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129
AHGKVYEGRYG++IVAIKVL+RGSTS+ERA LE RF REVNMMSRV HDNLVKF+GACKD
Sbjct: 62 AHGKVYEGRYGNKIVAIKVLHRGSTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKD 121
Query: 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189
PLMVIVTELLPGMSLRKYL S+RP LDL VA+NFALDIARAMD LHANGIIHRDLKPDN
Sbjct: 122 PLMVIVTELLPGMSLRKYLTSIRPKLLDLDVAINFALDIARAMDWLHANGIIHRDLKPDN 181
Query: 190 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 249
LLLT DQKS+KLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD
Sbjct: 182 LLLTADQKSVKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 241
Query: 250 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
VYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK
Sbjct: 242 VYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFK 274
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735553|emb|CBI18047.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 460 bits (1183), Expect = e-127, Method: Compositional matrix adjust.
Identities = 214/239 (89%), Positives = 232/239 (97%)
Query: 44 APQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEG 103
APQLTID +LLVDPKL+FIGSK+GEGAHGKVYEGRYGD+IVAIKVL+RGSTS+ERA LEG
Sbjct: 2 APQLTIDENLLVDPKLIFIGSKVGEGAHGKVYEGRYGDQIVAIKVLHRGSTSEERAALEG 61
Query: 104 RFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 163
RF REVNMMSRVKH+NLVKF+GACKDPLMVIVTELLPGMSLRKYL S+RP ++D+HVAL+
Sbjct: 62 RFAREVNMMSRVKHENLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPKRMDIHVALS 121
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
FALDIARAM+CLHANGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTY
Sbjct: 122 FALDIARAMECLHANGIIHRDLKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTY 181
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV WELLTNR+PFEGMSNLQAAYAAAFK
Sbjct: 182 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVFWELLTNRMPFEGMSNLQAAYAAAFK 240
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439809|ref|XP_004137678.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 451 bits (1159), Expect = e-124, Method: Compositional matrix adjust.
Identities = 224/282 (79%), Positives = 248/282 (87%), Gaps = 8/282 (2%)
Query: 1 MSCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLL 60
MSC+ EKNR G + E E VL + + V++NGSITA LTID +LLVDPKLL
Sbjct: 1 MSCN--EKNR-GVNDRETEH--PVL---TKPHQKPVIQNGSITAQHLTIDNNLLVDPKLL 52
Query: 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
FIGSKIGEGAHGKVYEGRY + IVAIKVL+RGST +ERA LE RF REVNMMSRVKH+NL
Sbjct: 53 FIGSKIGEGAHGKVYEGRYRNEIVAIKVLHRGSTPEERAALESRFAREVNMMSRVKHENL 112
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
VKF+GACK+PLMVIVTELLPGMSLRKYL++ R +LD +A+NFALD+ARAMDCLHANGI
Sbjct: 113 VKFIGACKEPLMVIVTELLPGMSLRKYLMNNRKQQLDPRMAINFALDVARAMDCLHANGI 172
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
IHRDLKPDNLLLT +Q+S+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGE
Sbjct: 173 IHRDLKPDNLLLTANQRSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGE 232
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
KKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK
Sbjct: 233 KKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFK 274
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521717|ref|XP_004167876.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 450 bits (1158), Expect = e-124, Method: Compositional matrix adjust.
Identities = 224/282 (79%), Positives = 248/282 (87%), Gaps = 8/282 (2%)
Query: 1 MSCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLL 60
MSC+ EKNR G + E E VL + + V++NGSITA LTID +LLVDPKLL
Sbjct: 1 MSCN--EKNR-GVNDRETEH--PVL---TKPHQKPVIQNGSITAQHLTIDDNLLVDPKLL 52
Query: 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
FIGSKIGEGAHGKVYEGRY + IVAIKVL+RGST +ERA LE RF REVNMMSRVKH+NL
Sbjct: 53 FIGSKIGEGAHGKVYEGRYRNEIVAIKVLHRGSTPEERAALESRFAREVNMMSRVKHENL 112
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
VKF+GACK+PLMVIVTELLPGMSLRKYL++ R +LD +A+NFALD+ARAMDCLHANGI
Sbjct: 113 VKFIGACKEPLMVIVTELLPGMSLRKYLMNNRKQQLDPRMAINFALDVARAMDCLHANGI 172
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
IHRDLKPDNLLLT +Q+S+KLADFGLAREE+VTEMMTAETGTYRWMAPELYSTVTLRQGE
Sbjct: 173 IHRDLKPDNLLLTANQRSVKLADFGLAREESVTEMMTAETGTYRWMAPELYSTVTLRQGE 232
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
KKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK
Sbjct: 233 KKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFK 274
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357506575|ref|XP_003623576.1| Protein kinase, putative [Medicago truncatula] gi|355498591|gb|AES79794.1| Protein kinase, putative [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1154), Expect = e-124, Method: Compositional matrix adjust.
Identities = 215/250 (86%), Positives = 231/250 (92%), Gaps = 1/250 (0%)
Query: 34 RAVVKNGSIT-APQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRG 92
++V NGS+T Q TID +LLVDPKLLFIGSKIGEGAHGKVY+GRY D+IVAIKVL RG
Sbjct: 18 KSVRSNGSLTNTTQFTIDENLLVDPKLLFIGSKIGEGAHGKVYQGRYVDQIVAIKVLQRG 77
Query: 93 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLR 152
+TS+ERA LE RF REVNMMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRKYL S+R
Sbjct: 78 TTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIR 137
Query: 153 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212
P LD+HVA+NFALDIARAMD LH NGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+V
Sbjct: 138 PKPLDIHVAINFALDIARAMDWLHDNGIIHRDLKPDNLLLTANQKSVKLADFGLAREESV 197
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSN
Sbjct: 198 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSN 257
Query: 273 LQAAYAAAFK 282
LQAAYAAAFK
Sbjct: 258 LQAAYAAAFK 267
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217074000|gb|ACJ85360.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 449 bits (1154), Expect = e-124, Method: Compositional matrix adjust.
Identities = 215/250 (86%), Positives = 231/250 (92%), Gaps = 1/250 (0%)
Query: 34 RAVVKNGSIT-APQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRG 92
++V NGS+T Q TID +LLVDPKLLFIGSKIGEGAHGKVY+GRY D+IVAIKVL RG
Sbjct: 18 KSVRSNGSLTNTTQFTIDENLLVDPKLLFIGSKIGEGAHGKVYQGRYVDQIVAIKVLQRG 77
Query: 93 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLR 152
+TS+ERA LE RF REVNMMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRKYL S+R
Sbjct: 78 TTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIR 137
Query: 153 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212
P LD+HVA+NFALDIARAMD LH NGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+V
Sbjct: 138 PKPLDIHVAINFALDIARAMDWLHDNGIIHRDLKPDNLLLTANQKSVKLADFGLAREESV 197
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSN
Sbjct: 198 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSN 257
Query: 273 LQAAYAAAFK 282
LQAAYAAAFK
Sbjct: 258 LQAAYAAAFK 267
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388513773|gb|AFK44948.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1151), Expect = e-123, Method: Compositional matrix adjust.
Identities = 215/250 (86%), Positives = 231/250 (92%), Gaps = 1/250 (0%)
Query: 34 RAVVKNGSIT-APQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRG 92
++V NGS+T Q TID +LLVDPKLLFIGSKIGEGAHGKVY+GRY D+IVAIKVL RG
Sbjct: 18 KSVRSNGSLTNTTQFTIDENLLVDPKLLFIGSKIGEGAHGKVYQGRYVDQIVAIKVLQRG 77
Query: 93 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLR 152
+TS+ERA LE RF REVNMMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRKYL S+R
Sbjct: 78 TTSEERASLENRFAREVNMMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIR 137
Query: 153 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212
P LD+HVA+NFALDIARAMD LH NGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+V
Sbjct: 138 PKPLDIHVAINFALDIARAMDWLHDNGIIHRDLKPDNLLLTANQKSVKLADFGLAREESV 197
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSN
Sbjct: 198 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSN 257
Query: 273 LQAAYAAAFK 282
LQAAYAAAFK
Sbjct: 258 LQAAYAAAFK 267
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139346|ref|XP_002323067.1| predicted protein [Populus trichocarpa] gi|222867697|gb|EEF04828.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 445 bits (1145), Expect = e-123, Method: Compositional matrix adjust.
Identities = 215/259 (83%), Positives = 238/259 (91%), Gaps = 9/259 (3%)
Query: 26 RGSVE--KESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRI 83
RG VE ++ +V +NGSI D++LL+DPKLLFIG+KIGEGAHG+VY+GRYGD I
Sbjct: 7 RGGVEIYEQRTSVEENGSI-------DQNLLIDPKLLFIGNKIGEGAHGEVYKGRYGDLI 59
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMS 143
VAIKVL+ G+TS+ERA LE RF REVNMMSRVKH+NLVKF+GACKDP MVIVTELLPGMS
Sbjct: 60 VAIKVLHPGTTSEERAALEDRFAREVNMMSRVKHENLVKFIGACKDPFMVIVTELLPGMS 119
Query: 144 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203
LRKYLVS+RP +LDL+VA+NFALD+ARAMDCLHANGIIHRDLKPDNLLLT +QKS+KLAD
Sbjct: 120 LRKYLVSIRPKQLDLYVAINFALDVARAMDCLHANGIIHRDLKPDNLLLTANQKSVKLAD 179
Query: 204 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 263
FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN
Sbjct: 180 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 239
Query: 264 RLPFEGMSNLQAAYAAAFK 282
R+PFEGMSNLQAAYAAAFK
Sbjct: 240 RMPFEGMSNLQAAYAAAFK 258
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 290 | ||||||
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.827 | 0.720 | 0.787 | 1.7e-98 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.841 | 0.685 | 0.651 | 1.7e-84 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.806 | 0.662 | 0.670 | 1.5e-83 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.786 | 0.658 | 0.692 | 3.1e-83 | |
| TAIR|locus:2173674 | 405 | AT5G66710 [Arabidopsis thalian | 0.824 | 0.590 | 0.510 | 1.7e-59 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.786 | 0.604 | 0.478 | 8.9e-54 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.741 | 0.523 | 0.451 | 1.8e-46 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.741 | 0.521 | 0.442 | 1.9e-44 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.755 | 0.417 | 0.400 | 1.1e-41 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.741 | 0.373 | 0.427 | 2.3e-39 |
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 978 (349.3 bits), Expect = 1.7e-98, P = 1.7e-98
Identities = 189/240 (78%), Positives = 208/240 (86%)
Query: 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIR 107
TI+ SLLVDPKLLFIGSKIGEGAHGKVY+GRYG +IVAIKV+NRGS D+++ LE RF+R
Sbjct: 6 TIEESLLVDPKLLFIGSKIGEGAHGKVYQGRYGRQIVAIKVVNRGSKPDQQSSLESRFVR 65
Query: 108 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
EVNMMSRV+H NLVKF+GACKDPLMVIVTELLPGMSLRKYL S+RP L L +AL+FALD
Sbjct: 66 EVNMMSRVQHHNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALD 125
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMA 227
IARA+ CLHANGIIHRDLKPDNLLLT + KS+KLADFGLAR YRWMA
Sbjct: 126 IARALHCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMA 185
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESI 287
PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK + +
Sbjct: 186 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPV 245
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 846 (302.9 bits), Expect = 1.7e-84, P = 1.7e-84
Identities = 159/244 (65%), Positives = 196/244 (80%)
Query: 39 NGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDER 98
+G + + +D LVDP+ LF+G KIGEGAH KVYEG+Y ++ VAIK++ RG + +E
Sbjct: 5 SGFYSNEEFELDPKWLVDPRHLFVGPKIGEGAHAKVYEGKYRNQTVAIKIIKRGESPEEI 64
Query: 99 ALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 158
A + RF RE+ M+S+V+H NLVKF+GACK+P+MVIVTELL G +LRKYLVSLRP +LD+
Sbjct: 65 AKRDNRFAREIAMLSKVQHKNLVKFIGACKEPMMVIVTELLLGGTLRKYLVSLRPKRLDI 124
Query: 159 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXX 218
+A+ FALDIARAM+CLH++GIIHRDLKP+NL+L+ D K++KLADFGLAR
Sbjct: 125 RLAVGFALDIARAMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTA 184
Query: 219 XXXXYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
YRWMAPELYSTVTLRQGEKKHYN+KVD YSF IVLWEL+ N+LPFEGMSNLQAAYA
Sbjct: 185 ETGTYRWMAPELYSTVTLRQGEKKHYNHKVDAYSFAIVLWELILNKLPFEGMSNLQAAYA 244
Query: 279 AAFK 282
AAFK
Sbjct: 245 AAFK 248
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 837 (299.7 bits), Expect = 1.5e-83, P = 1.5e-83
Identities = 157/234 (67%), Positives = 191/234 (81%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIRE 108
+D +VDP+ LF+G KIGEGAH K+YEG+Y ++ VAIK++ RG + +E A E RF RE
Sbjct: 15 LDPKWVVDPQHLFVGPKIGEGAHAKIYEGKYKNKTVAIKIVKRGESPEEIAKRESRFARE 74
Query: 109 VNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
V+M+SRV+H NLVKF+GACK+P+MVIVTELL G +LRKYLVSLRP LD+ VA+ +ALDI
Sbjct: 75 VSMLSRVQHKNLVKFIGACKEPIMVIVTELLLGGTLRKYLVSLRPGSLDIRVAVGYALDI 134
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAP 228
ARAM+CLH++G+IHRDLKP++L+LT D K++KLADFGLAR YRWMAP
Sbjct: 135 ARAMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAETGTYRWMAP 194
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
ELYSTVTLR GEKKHYN+KVD YSF IVLWEL+ N+LPFEGMSNLQAAYAAAFK
Sbjct: 195 ELYSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFK 248
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 834 (298.6 bits), Expect = 3.1e-83, P = 3.1e-83
Identities = 158/228 (69%), Positives = 188/228 (82%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
+DP+LLF+G KIGEGAH KVYEG+Y ++ VAIK+++RG T +E A + RF+REV M+SR
Sbjct: 15 IDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGETPEEIAKRDSRFLREVEMLSR 74
Query: 115 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
V+H NLVKF+GACK+P+MVIVTELL G +LRKYL++LRP L+ VA+ FALDIAR M+C
Sbjct: 75 VQHKNLVKFIGACKEPVMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIARGMEC 134
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYSTV 234
LH++GIIHRDLKP+NLLLT D K++KLADFGLAR YRWMAPELYSTV
Sbjct: 135 LHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPELYSTV 194
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
TLR GEKKHYN+KVD YSF IVLWELL N+LPFEGMSNLQAAYAAAFK
Sbjct: 195 TLRLGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFK 242
|
|
| TAIR|locus:2173674 AT5G66710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 610 (219.8 bits), Expect = 1.7e-59, P = 1.7e-59
Identities = 123/241 (51%), Positives = 169/241 (70%)
Query: 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFI 106
TI+ LLVD K + IG IGEG+ VY G + + V++K+ TS +F
Sbjct: 59 TINTELLVDVKDISIGDFIGEGSSSTVYRGLFRRVVPVSVKIFQPKRTSALSIEQRKKFQ 118
Query: 107 REVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
REV ++S+ +H+N+V+F+GAC +P ++I+TEL+ G +L+K+++S+RP LDL ++++FAL
Sbjct: 119 REVLLLSKFRHENIVRFIGACIEPKLMIITELMEGNTLQKFMLSVRPKPLDLKLSISFAL 178
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWM 226
DIAR M+ L+ANGIIHRDLKP N+LLT DQK +KLADFGLAR YRWM
Sbjct: 179 DIARGMEFLNANGIIHRDLKPSNMLLTGDQKHVKLADFGLAREETKGFMTFEAGT-YRWM 237
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQES 286
APEL+S TL GEKKHY++KVDVYSF IV WELLTN+ PF+G +N+ AYAA+ + S
Sbjct: 238 APELFSYDTLEIGEKKHYDHKVDVYSFAIVFWELLTNKTPFKGKNNIFVAYAASKNQRPS 297
Query: 287 I 287
+
Sbjct: 298 V 298
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 8.9e-54, P = 8.9e-54
Identities = 110/230 (47%), Positives = 159/230 (69%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIR 107
I R LL++PK + G IGEG + VY+GR + + VA+K++ G TS + +F +
Sbjct: 37 ISRELLLNPKDIMRGEMIGEGGNSIVYKGRLKNIVPVAVKIVQPGKTSAVSIQDKQQFQK 96
Query: 108 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
EV ++S +KH+N+V+F+GAC +P ++IVTEL+ G +L++++++ RP+ LDL V+L+FALD
Sbjct: 97 EVLVLSSMKHENIVRFVGACIEPQLMIVTELVRGGTLQRFMLNSRPSPLDLKVSLSFALD 156
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMA 227
I+RAM+ LH+ GIIHRDL P N+L+T D K +KLADFGLAR YRWMA
Sbjct: 157 ISRAMEYLHSKGIIHRDLNPRNVLVTGDMKHVKLADFGLAREKTLGGMTCEAGT-YRWMA 215
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
PE+ S LR GEKKHY+ K+DVYSF ++ W LLTN+ PF + ++ Y
Sbjct: 216 PEVCSREPLRIGEKKHYDQKIDVYSFALIFWSLLTNKTPFSEIPSISIPY 265
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 487 (176.5 bits), Expect = 1.8e-46, P = 1.8e-46
Identities = 102/226 (45%), Positives = 145/226 (64%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERA-LLEGRFIREVNMMS 113
+D + L +G +GA GK+Y+G Y VAIK+L R S E+A +E +F +EV+M++
Sbjct: 125 IDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFMEQQFQQEVSMLA 184
Query: 114 RVKHDNLVKFLGACKDPLM-VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+KH N+V+F+GAC+ P++ IVTE G S+R++L + + L +A+ ALD+AR M
Sbjct: 185 NLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVARGM 244
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYS 232
+H IHRDLK DNLL++ D KS+K+ADFG+AR YRWMAPE+
Sbjct: 245 AYVHGRNFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI- 302
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+ + YN KVDVYSFGIVLWEL+T LPF+ M+ +QAA+A
Sbjct: 303 -------QHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFA 341
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 468 (169.8 bits), Expect = 1.9e-44, P = 1.9e-44
Identities = 100/226 (44%), Positives = 143/226 (63%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERA-LLEGRFIREVNMMS 113
+D + L +G +GA GK+Y G Y VAIK+L R ++ E+A LE +F +EV+M++
Sbjct: 126 IDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQALEQQFQQEVSMLA 185
Query: 114 RVKHDNLVKFLGACKDPLM-VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+KH N+V+F+GAC P++ IVTE G S+R++L + + L +A+ ALD+AR M
Sbjct: 186 FLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGM 245
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYS 232
+H IHRDLK DNLL++ D +S+K+ADFG+AR YRWMAPE+
Sbjct: 246 AYVHERNFIHRDLKSDNLLISAD-RSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMI- 303
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+ + Y KVDVYSFGIVLWEL+T LPF+ M+ +QAA+A
Sbjct: 304 -------QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFA 342
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 442 (160.7 bits), Expect = 1.1e-41, P = 1.1e-41
Identities = 93/232 (40%), Positives = 138/232 (59%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERAL---LEGRFIREVNM 111
VD LF G K G + ++Y G+Y D+ VA+K++ D L LE +F +EV +
Sbjct: 202 VDMSKLFFGLKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGCLGARLEKQFTKEVTL 261
Query: 112 MSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+SR+ H N++KF+GA KDP + ++T+ LP SLR +L L L + FA+DIAR
Sbjct: 262 LSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIAR 321
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL 230
M+ +H+ IIHRDLKP+N+L+ ++ LK+ADFG+A YRWMAPE+
Sbjct: 322 GMEYIHSRRIIHRDLKPENVLID-EEFHLKIADFGIACEEEYCDMLADDPGTYRWMAPEM 380
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
++K + K DVYSFG+VLWE++ +P+E M+ +QAA+A K
Sbjct: 381 I--------KRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHK 424
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 420 (152.9 bits), Expect = 2.3e-39, P = 2.3e-39
Identities = 98/229 (42%), Positives = 133/229 (58%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
++ K L G KI G++G +Y+G Y + VAIKVL + LE F +EV +M +
Sbjct: 285 INLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSD---LEKEFAQEVFIMRK 341
Query: 115 VKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
V+H N+V+F+GAC K P + IVTE +PG S+ YL + L A+DI + M
Sbjct: 342 VRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQK-GVFKLPTLFKVAIDICKGMS 400
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPELYST 233
LH N IIHRDLK NLL+ + + +K+ADFG+AR YRWMAPE+
Sbjct: 401 YLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPEVI-- 457
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
E K Y++K DV+S+GIVLWELLT +LP+E M+ LQAA K
Sbjct: 458 ------EHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQK 500
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 290 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-67 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-67 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-66 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-62 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-59 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-46 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-40 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-37 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-36 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-35 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-34 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-34 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-32 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-32 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-32 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-32 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-32 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-31 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-31 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-30 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-30 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-30 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-30 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-29 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-29 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-28 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-27 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-27 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-26 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-26 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-26 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-26 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-26 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-26 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-25 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-24 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-24 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-23 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-23 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-23 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-23 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-22 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-22 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-20 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-20 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-20 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-20 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-19 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-19 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-19 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-18 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-17 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-16 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-16 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-16 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-15 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-13 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-13 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-12 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 9e-09 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 9e-09 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 1e-08 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 7e-05 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 4e-67
Identities = 79/219 (36%), Positives = 117/219 (53%), Gaps = 18/219 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I K+GEG+ GKVY R ++VAIKV+ + +R R +RE+ ++ ++KH N
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE----RILREIKILKKLKHPN 58
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+ +D + +V E G L L +L A + I A++ LH+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG--RLSEDEARFYLRQILSALEYLHSK 116
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
GI+HRDLKP+N+LL D +KLADFGLAR+ E +T GT +MAPE+
Sbjct: 117 GIVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL------ 169
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
K Y VD++S G++L+ELLT + PF G L +
Sbjct: 170 --GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELF 206
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 5e-67
Identities = 84/226 (37%), Positives = 128/226 (56%), Gaps = 23/226 (10%)
Query: 60 LFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
L +G K+GEGA G+VY+G + VA+K L ++ + F+RE +M
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE----FLREARIMR 56
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ H N+VK LG C ++ ++IV E +PG L YL RP +L L L+FAL IAR M
Sbjct: 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG--TYRWMAPEL 230
+ L + IHRDL N L+ + +K++DFGL+R+ + + G RWMAPE
Sbjct: 117 EYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPE- 174
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA 275
+L++G+ + +K DV+SFG++LWE+ T P+ GMSN +
Sbjct: 175 ----SLKEGK---FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV 213
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 5e-66
Identities = 82/229 (35%), Positives = 126/229 (55%), Gaps = 28/229 (12%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRI------VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
L +G K+GEGA G+VY+G+ + VA+K L ++ + F+RE +M
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE----FLREARIMR 56
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALDIAR 170
++ H N+VK LG C ++ + IV E + G L YL RP L ++ L+FAL IAR
Sbjct: 57 KLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQIAR 113
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG--TYRWMAP 228
M+ L + IHRDL N L+ + +K++DFGL+R+ + G RWMAP
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAP 172
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAA 276
E +L++G+ + +K DV+SFG++LWE+ T P+ GMSN +
Sbjct: 173 E-----SLKEGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL 213
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 201 bits (514), Expect = 4e-64
Identities = 82/226 (36%), Positives = 124/226 (54%), Gaps = 27/226 (11%)
Query: 62 IGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV 115
+G K+GEGA G+VY+G + VA+K L G++ +ER F+ E ++M ++
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEERE----EFLEEASIMKKL 58
Query: 116 KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
H N+V+ LG C +PL IVTE +PG L +L KL L L AL IA+ M+
Sbjct: 59 SHPNIVRLLGVCTQGEPLY-IVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGME 116
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPEL 230
L + +HRDL N L+T + +K++DFGL+R+ + G +WMAPE
Sbjct: 117 YLESKNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA 275
L+ G+ + +K DV+SFG++LWE+ T P+ GMSN +
Sbjct: 176 -----LKDGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV 213
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 6e-62
Identities = 70/199 (35%), Positives = 106/199 (53%), Gaps = 16/199 (8%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+GEG G VY R + VAIK++ + +S +RE+ ++ ++ H N+VK
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL----EELLREIEILKKLNHPNIVKL 56
Query: 124 LGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
G +D + +V E G SL+ L KL L L I ++ LH+NGIIH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
RDLKP+N+LL D +KLADFGL++ T ++ GT +MAPE+ K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLL-------GK 168
Query: 242 KHYNNKVDVYSFGIVLWEL 260
+Y+ K D++S G++L+EL
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-59
Identities = 79/212 (37%), Positives = 121/212 (57%), Gaps = 17/212 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ K+G G+ G VY+ ++ +IVA+K+L + E++ + RE+ ++ R+ H N
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK---RSEKSKKDQTARREIRILRRLSHPN 59
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+ + A +D + +V E G L YL P L A AL I R ++ LH+N
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN 117
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLR 237
GIIHRDLKP+N+LL + +K+ADFGLA++ + +T GT +MAPE+ L
Sbjct: 118 GIIHRDLKPENILLDENG-VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV-----LL 171
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
G Y KVDV+S G++L+ELLT + PF G
Sbjct: 172 GG--NGYGPKVDVWSLGVILYELLTGKPPFSG 201
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 2e-59
Identities = 80/228 (35%), Positives = 125/228 (54%), Gaps = 32/228 (14%)
Query: 65 KIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
K+GEGA G+VY+G+ VA+K L ++ +ER F++E +M ++ H N
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD----FLKEARVMKKLGHPN 57
Query: 120 LVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP-------NKLDLHVALNFALDIAR 170
+V+ LG C ++PL +V E + G L YL RP + L L L+FA+ IA+
Sbjct: 58 VVRLLGVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMA 227
M+ L + +HRDL N L+ D +K++DFGL+R+ + +TG RWMA
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
PE +L+ G + +K DV+SFG++LWE+ T P+ G+SN +
Sbjct: 176 PE-----SLKDG---IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 6e-46
Identities = 74/238 (31%), Positives = 113/238 (47%), Gaps = 29/238 (12%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKV--LNRGSTSDERALLEGRFIREVNMMSRVKHD 118
G +G G+ G VY D ++A+K L+ S + AL RE+ ++S ++H
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE-----REIRILSSLQHP 59
Query: 119 NLVKFLGACKDPLMV---IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
N+V++ G+ +D I E + G SL L KL V + I + L
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYL 117
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYS 232
H+NGI+HRD+K N+L+ D +KLADFG A+ + E + GT WMAPE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-- 174
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
+R E Y D++S G + E+ T + P+ S L AA +K+ S P
Sbjct: 175 ---IRGEE---YGRAADIWSLGCTVIEMATGKPPW---SELGNPMAALYKIGSSGEPP 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 1e-43
Identities = 78/221 (35%), Positives = 120/221 (54%), Gaps = 18/221 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-DNL 120
I K+GEG+ G+VY R ++VA+KVL + S + + RF+RE+ +++ + H N+
Sbjct: 4 ILRKLGEGSFGEVYLARD-RKLVALKVLAKKLESKSKEVE--RFLREIQILASLNHPPNI 60
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIARAMDCLHAN 178
VK +D + +V E + G SL L + R L AL I A++ LH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE-------ETVTEMMTAETGTYRWMAPELY 231
GIIHRD+KP+N+LL D + +KL DFGLA+ ++ + + GT +MAPE+
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV- 179
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
L + ++ D++S GI L+ELLT PFEG N
Sbjct: 180 ----LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-40
Identities = 74/211 (35%), Positives = 113/211 (53%), Gaps = 22/211 (10%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I KIG+G G+VY+ R+ + VAIKV+ S + + I E+ ++ + KH N
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI-----INEIQILKKCKHPN 58
Query: 120 LVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL-HVALNFALDIARAMDCLH 176
+VK+ G+ KD L IV E G SL+ L+ L +A ++ + ++ LH
Sbjct: 59 IVKYYGSYLKKDELW-IVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCKELLKGLEYLH 115
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+NGIIHRD+K N+LLT D + +KL DFGL+ + + T+ GT WMAPE+ +
Sbjct: 116 SNGIIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVIN---- 170
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
K Y+ K D++S GI EL + P+
Sbjct: 171 ----GKPYDYKADIWSLGITAIELAEGKPPY 197
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-38
Identities = 75/228 (32%), Positives = 120/228 (52%), Gaps = 23/228 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+DP L ++G G G V+ G++ G VAIK++ G+ S++ FI E +M
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD------FIEEAKVMM 54
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ H NLV+ G C K + IVTE + L YL R KL L+ D+ AM
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDVCEAM 113
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE 229
+ L +NG IHRDL N L+ + +K++DFGLAR + + T+ GT +W PE
Sbjct: 114 EYLESNGFIHRDLAARNCLVG-EDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPE 171
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276
++ +++K DV+SFG+++WE+ + ++P+E SN +
Sbjct: 172 VFD--------YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 70/228 (30%), Positives = 112/228 (49%), Gaps = 23/228 (10%)
Query: 56 DPKLLFI-GSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNM 111
DP+ L+ KIGEGA G+VY+ G VAIK + + E I E+ +
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGKE-VAIKKMRLRKQNKELI------INEILI 68
Query: 112 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
M KH N+V + + + +V E + G SL +++ +++ ++ +
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVLQ 127
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPE 229
++ LH+ +IHRD+K DN+LL+ D S+KLADFG A + T + GT WMAPE
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
+ +K Y KVD++S GI+ E+ P+ L+A +
Sbjct: 187 VIK--------RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-37
Identities = 77/224 (34%), Positives = 121/224 (54%), Gaps = 25/224 (11%)
Query: 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
++ K L +G+ IG+G G V G Y + VA+K L ST+ + F+ E ++M
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQA------FLAEASVM 54
Query: 113 SRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+ ++H NLV+ LG +PL IVTE + SL YL S + L L FALD+
Sbjct: 55 TTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAP 228
M+ L +HRDL N+L++ + K++DFGLA+E + + ++G +W AP
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTAP 168
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271
E LR +K ++ K DV+SFGI+LWE+ + R+P+ +
Sbjct: 169 E-----ALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 5e-37
Identities = 64/235 (27%), Positives = 117/235 (49%), Gaps = 28/235 (11%)
Query: 65 KIGEGAHGKVY--EGRYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+IG+G+ GKVY + ++ +K ++ + ER + EV ++ ++ H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE----DALNEVKILKKLNHPNII 62
Query: 122 KFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIARAMDCLHAN 178
K+ + ++ + IV E G L + + + L++ + + A+ LH+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLR 237
I+HRD+KP N+ LT + +KL DFG+++ + ++ GT +++PEL
Sbjct: 123 KILHRDIKPQNIFLTSNGL-VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC------ 175
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG--MSNLQAAYAAAFKVQESIYAP 290
+ K YN K D++S G VL+EL T + PFEG + L A K+ + Y P
Sbjct: 176 --QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL------ALKILKGQYPP 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-36
Identities = 76/222 (34%), Positives = 113/222 (50%), Gaps = 35/222 (15%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVL-----NRG--STSDERALLEGRFIREVNMMSRV 115
K+GEG +G VY+ R IVA+K + G ST+ +RE++++ +
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA----------LREISLLKEL 55
Query: 116 KHDNLVKFLG-ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
KH N+VK L + + +V E M L+KYL RP L ++ + + R +
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGT--YRWMAPELY 231
H++ I+HRDLKP N+L+ D LKLADFGLAR + T E T YR APE+
Sbjct: 114 CHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTYTHEVVTLWYR--APEIL 170
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
G KHY+ VD++S G + E++T + F G S +
Sbjct: 171 ------LGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 73/243 (30%), Positives = 118/243 (48%), Gaps = 37/243 (15%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI--------VAIKVLNRGSTSDERALLEGRFI 106
+ + + + ++G+G+ G VYEG + VAIK +N ++ ER +E F+
Sbjct: 3 LPREKITLIRELGQGSFGMVYEG-LAKGVVKGEPETRVAIKTVNENASMRER--IE--FL 57
Query: 107 REVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNK--------L 156
E ++M ++V+ LG P +V++ EL+ L+ YL S RP
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSTGQPTLVVM-ELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 157 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216
L + A +IA M L A +HRDL N ++ D ++K+ DFG+ R+ T+
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYY 175
Query: 217 TAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
RWMAPE +L+ G + K DV+SFG+VLWE+ T P++G+SN
Sbjct: 176 RKGGKGLLPVRWMAPE-----SLKDG---VFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
Query: 273 LQA 275
+
Sbjct: 228 EEV 230
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-35
Identities = 79/217 (36%), Positives = 113/217 (52%), Gaps = 28/217 (12%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G G G+V+ G + G VA+K L G+ S E F++E +M +++HD LV+
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA------FLQEAQIMKKLRHDKLVQL 66
Query: 124 LGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
C ++P+ IVTE + SL +L S KL L ++ A IA M L + I
Sbjct: 67 YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYI 125
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYSTVTL 236
HRDL N+L+ + K+ADFGLAR E TA G +W APE Y T+
Sbjct: 126 HRDLAARNILVG-ENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
K DV+SFGI+L E++T R+P+ GM+N
Sbjct: 184 ----------KSDVWSFGILLTEIVTYGRVPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-34
Identities = 71/209 (33%), Positives = 110/209 (52%), Gaps = 19/209 (9%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G+ GKV R D ++ A+KVL + + + + E N++SR+ H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVE--HTLTERNILSRINHPFIVKL 58
Query: 124 LGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
A + + +V E PG L +L + A +A +I A++ LH+ GII+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGE 240
RDLKP+N+LL +KL DFGLA+E +E T GT ++APE V L +G
Sbjct: 117 RDLKPENILLD-ADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLAPE----VLLGKG- 169
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
Y VD +S G++L+E+LT + PF
Sbjct: 170 ---YGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 74/227 (32%), Positives = 121/227 (53%), Gaps = 25/227 (11%)
Query: 57 PKLLF-IGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
P+ F + K+G G G+V+EG + +R+ VAIK+L + L + F +EV + R
Sbjct: 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS-----DDLLKQQDFQKEVQALKR 58
Query: 115 VKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++H +L+ C +P+ I+TEL+ SL +L S L + ++ A +A M
Sbjct: 59 LRHKHLISLFAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGT-YRWMAPE 229
L IHRDL N+L+ + K+ADFGLAR +E V ++++ Y+W APE
Sbjct: 118 AYLEEQNSIHRDLAARNILVG-EDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPE 174
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275
S ++ K DV+SFGI+L+E+ T ++P+ GM+N +
Sbjct: 175 AAS--------HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV 213
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-34
Identities = 79/221 (35%), Positives = 112/221 (50%), Gaps = 28/221 (12%)
Query: 65 KIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
KIG+G G VY+G VA+K D + +F++E ++ + H N+VK
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR----KFLQEAEILKQYDHPNIVKL 57
Query: 124 LGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALDIARAMDCLHANG 179
+G C K P+ IV EL+PG SL +L R K L V L +LD A M+ L +
Sbjct: 58 IGVCVQKQPIY-IVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT----YRWMAPELYSTVT 235
IHRDL N L+ + LK++DFG++REE + T G +W APE
Sbjct: 114 CIHRDLAARNCLVG-ENNVLKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAPE-----A 166
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275
L G Y ++ DV+S+GI+LWE + P+ GMSN Q
Sbjct: 167 LNYGR---YTSESDVWSYGILLWETFSLGDTPYPGMSNQQT 204
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-34
Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 39/218 (17%)
Query: 64 SKIGEGAHGKVYEGRY---GDR---IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++GEG GKV RY GD VA+K LN R+ E RE+ ++ + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE----REIEILRTLDH 65
Query: 118 DNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+N+VK+ G C+ P + ++ E LP SLR YL R ++L L F+ I + MD
Sbjct: 66 ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICKGMDY 124
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----------R 224
L + IHRDL N+L+ + +K++DFGLA+ ++ + Y
Sbjct: 125 LGSQRYIHRDLAARNILVESE-DLVKISDFGLAK------VLPEDKDYYYVKEPGESPIF 177
Query: 225 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
W APE T +++ DV+SFG+ L+EL T
Sbjct: 178 WYAPECLRTSK--------FSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-33
Identities = 78/235 (33%), Positives = 122/235 (51%), Gaps = 34/235 (14%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIR 107
IDR+ + +LL K+G G G+V+EG + + VA+K L G+ + F+
Sbjct: 3 IDRTSI---QLL---RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD------FLA 50
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
E +M +++H L++ C ++P + IVTEL+ SL +YL L L ++ A
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEP-IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA 109
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--- 222
+A M L A IHRDL N+L+ + K+ADFGLAR ++ A G
Sbjct: 110 AQVASGMAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLAR-VIKEDIYEAREGAKFP 167
Query: 223 YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
+W APE LY+ ++ K DV+SFGI+L E++T R+P+ GM+N +
Sbjct: 168 IKWTAPEAALYNRFSI----------KSDVWSFGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-32
Identities = 71/221 (32%), Positives = 116/221 (52%), Gaps = 26/221 (11%)
Query: 60 LFIGSKIGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
L +G GA G VY+G + G+++ VAIKVL + +A E + E +M+
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKE--ILDEAYVMA 64
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
V H ++V+ LG C + ++T+L+P L Y+ + + N + LN+ + IA+ M
Sbjct: 65 SVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMS 123
Query: 174 CLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARE-ETVTEMMTAETGTY--RWMAPE 229
L ++HRDL N+L+ TP +K+ DFGLA+ + + AE G +WMA E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269
++ Y +K DV+S+G+ +WEL+T P+EG
Sbjct: 182 -----SILHRI---YTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-32
Identities = 70/215 (32%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
KIGEG +G VY+ R IVAIK + S+ + +RE+ ++ + H N++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE---GIPKTALREIKLLKELNHPNII 61
Query: 122 KFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
K L + + +V E + L K L+ R L + ++ + + + H++GI
Sbjct: 62 KLLDVFRHKGDLYLVFEFMD-TDLYK-LIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWM-APELYSTVTLRQ 238
+HRDLKP+NLL+ + LKLADFGLAR + T T RW APEL + +
Sbjct: 120 LHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPEL--LLGDKG 175
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
Y+ VD++S G + ELL+ R F G S +
Sbjct: 176 -----YSTPVDIWSVGCIFAELLSRRPLFPGKSEI 205
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-32
Identities = 77/232 (33%), Positives = 118/232 (50%), Gaps = 36/232 (15%)
Query: 66 IGEGAHGKVYEGRYGDRI--------VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
+G GA G+VYEG D + VA+K L +G+T E+ F++E ++MS H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK----EFLKEAHLMSNFNH 58
Query: 118 DNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNK-----LDLHVALNFALDIAR 170
N+VK LG C +P +I+ EL+ G L YL R + L L L+ LD+A+
Sbjct: 59 PNIVKLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKS----LKLADFGLAREETVTEMMTAETG---TY 223
L IHRDL N L++ +K+ DFGLAR+ ++ E
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
RWMAPE +L G+ + + DV+SFG+++WE+LT + P+ ++N +
Sbjct: 178 RWMAPE-----SLLDGK---FTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-32
Identities = 73/229 (31%), Positives = 106/229 (46%), Gaps = 41/229 (17%)
Query: 65 KIGEGAHGKVYEGRY----GDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
K+G+G+ G V G + G I VA+K L SD + F++E +M + H+N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD----IMDDFLKEAAIMHSLDHEN 57
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD---LHVALNFALDIARAMDCLH 176
L++ G +++VTEL P SL L LR + L + ++A+ IA M L
Sbjct: 58 LIRLYGVVLTHPLMMVTELAPLGSL---LDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----------WM 226
+ IHRDL N+LL D K +K+ DFGL R E Y W
Sbjct: 115 SKRFIHRDLAARNILLASDDK-VKIGDFGLMRALPQNEDH------YVMEEHLKVPFAWC 167
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
APE T T +++ DV+ FG+ LWE+ T P+ G+S Q
Sbjct: 168 APESLRTRT--------FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 5e-32
Identities = 69/234 (29%), Positives = 106/234 (45%), Gaps = 20/234 (8%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
G+KIG G GKVY D ++A+K + D E+ ++ +KH NL
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIR---IQDNDPKTIKEIADEMKVLELLKHPNL 61
Query: 121 VKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
VK+ G + I E G +L + L R LD HV + L + + LH++G
Sbjct: 62 VKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVT-EMMTAETGTYRWMAPELYSTV 234
I+HRD+KP N+ L +KL DFG L T E + + GT +MAPE+
Sbjct: 120 IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI--- 175
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKVQESI 287
G+ K + D++S G V+ E+ T + P+ + N Q + + I
Sbjct: 176 --TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-32
Identities = 75/228 (32%), Positives = 116/228 (50%), Gaps = 40/228 (17%)
Query: 65 KIGEGAHGKVYEG---RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
K+G G +G+VYEG +Y VA+K L E + F++E +M +KH NLV
Sbjct: 13 KLGGGQYGEVYEGVWKKY-SLTVAVKTLK------EDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 122 KFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ LG C ++P I+TE + +L YL +++ V L A I+ AM+ L
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--------YRWMAPE--L 230
IHRDL N L+ + +K+ADFGL+R +MT +T T +W APE
Sbjct: 126 IHRDLAARNCLVG-ENHLVKVADFGLSR------LMTGDTYTAHAGAKFPIKWTAPESLA 178
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAY 277
Y+ ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 179 YNK----------FSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVY 215
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 71/217 (32%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 66 IGEGAHGKVYEGR---YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
I +GA+G+V+ + GD I AIKV+ + + + + + E +++S+ + +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGD-IYAIKVIKKADMIRKNQV--DQVLTERDILSQAQSPYVVK 57
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + +V E LPG L L ++ LD VA + +I A++ LH+NGII
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE---------TGTYRWMAPELYS 232
HRDLKPDN+L+ + LKL DFGL++ V + GT ++APE
Sbjct: 116 HRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE--- 171
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
V L QG ++ VD +S G +L+E L PF G
Sbjct: 172 -VILGQG----HSKTVDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 71/234 (30%), Positives = 116/234 (49%), Gaps = 30/234 (12%)
Query: 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY----GDRI-VAIKVLNRGSTSDERALLE 102
I R + +G IGEG G VY+G Y ++I VA+K ++ R
Sbjct: 2 EIQREDIT------LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVRE--- 52
Query: 103 GRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 162
+F++E +M + H ++VK +G + + IV EL P LR YL + LDL +
Sbjct: 53 -KFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLI 110
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETG 221
++ ++ A+ L + +HRD+ N+L+ +PD +KL DFGL+R A G
Sbjct: 111 LYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESYYKASKG 168
Query: 222 TY--RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
+WMAPE ++ R+ + + DV+ FG+ +WE+L PF+G+ N
Sbjct: 169 KLPIKWMAPE---SINFRR-----FTSASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 73/226 (32%), Positives = 117/226 (51%), Gaps = 23/226 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
++P L ++G G G V+ G++ +I VAIK +N G+ S+E FI E +M
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED------FIEEAKVMM 54
Query: 114 RVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
++ H LV+ G C + PL IVTE + L YL R KL + L+ D+
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLY-IVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEG 112
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPE 229
M+ L N IHRDL N L++ +K++DFG+ R E ++ + +W PE
Sbjct: 113 MEYLERNSFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPE 171
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+++ Y++K DV+SFG+++WE+ T ++PFE SN +
Sbjct: 172 VFNF--------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE 209
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 67/241 (27%), Positives = 126/241 (52%), Gaps = 36/241 (14%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD---NL 120
IG GA+G VY G++ R+VA+K++N + D+ + ++ REV ++S+++ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ----REVALLSQLRQSQPPNI 64
Query: 121 VKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIAR----AMDC 174
K+ G+ K P + I+ E G S+R + + + ++++ I R A+
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISV-----IIREVLVALKY 116
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYST 233
+H G+IHRD+K N+L+T +KL DFG+A + + GT WMAPE+ +
Sbjct: 117 IHKVGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT- 174
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY----AAAFKVQESIYA 289
E K+Y+ K D++S GI ++E+ T P+ + +A + +++++ Y+
Sbjct: 175 ------EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYS 228
Query: 290 P 290
Sbjct: 229 K 229
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-30
Identities = 74/207 (35%), Positives = 115/207 (55%), Gaps = 25/207 (12%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125
IG+G G V G Y VA+K + +T+ F+ E ++M++++H NLV+ LG
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-------FLAEASVMTQLRHSNLVQLLG 66
Query: 126 AC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ + IVTE + SL YL S + L L F+LD+ AM+ L AN +HR
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPELYSTVTLRQGEK 241
DL N+L++ D + K++DFGL +E + T+ +TG +W APE LR+
Sbjct: 127 DLAARNVLVSEDNVA-KVSDFGLTKEASSTQ----DTGKLPVKWTAPE-----ALRE--- 173
Query: 242 KHYNNKVDVYSFGIVLWELLT-NRLPF 267
K ++ K DV+SFGI+LWE+ + R+P+
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-30
Identities = 75/214 (35%), Positives = 111/214 (51%), Gaps = 23/214 (10%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G G G+V+ G Y G VAIK L +GS S E F+ E N+M +++H LV+
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA------FLAEANLMKQLQHPRLVRL 66
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ I+TE + SL +L + KL ++ ++ A IA M + IHR
Sbjct: 67 YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPEL--YSTVTLRQG 239
DL+ N+L++ + K+ADFGLAR E E + +W APE Y T T+
Sbjct: 127 DLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI--- 182
Query: 240 EKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
K DV+SFGI+L E++T R+P+ GM+N
Sbjct: 183 -------KSDVWSFGILLTEIVTYGRIPYPGMTN 209
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-30
Identities = 64/229 (27%), Positives = 112/229 (48%), Gaps = 18/229 (7%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG+GA GKV + D ++ A+K +N+ ++ ++ + E ++ + H LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSV--RNVLNERRILQELNHPFLVNL 65
Query: 124 LGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
+ + M +V +LL G LR +L + K + +I A++ LH+ GIIH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIVLALEYLHSKGIIH 123
Query: 183 RDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
RD+KPDN+LL D++ + + DF +A + T + T+ +GT +MAPE+
Sbjct: 124 RDIKPDNILL--DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR-------- 173
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
+ Y+ VD +S G+ +E L + P+ G S A + + P
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP 222
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-29
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 66 IGEGAHGKVYEGRY----GDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
+G G G V +G Y G + VA+K L + + A + F+RE ++M+++ H +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ----EHIAAGKKEFLREASVMAQLDHPCI 58
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
V+ +G CK +++V EL P L KYL R + A +A M L +
Sbjct: 59 VRLIGVCKGEPLMLVMELAPLGPLLKYLKK-RREIPVSDL-KELAHQVAMGMAYLESKHF 116
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETG---TYRWMAPEL--YSTV 234
+HRDL N+LL ++ K++DFG++R ++ A T +W APE Y
Sbjct: 117 VHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK- 174
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275
+++K DV+S+G+ LWE + P+ M +
Sbjct: 175 ---------FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-29
Identities = 75/236 (31%), Positives = 115/236 (48%), Gaps = 27/236 (11%)
Query: 63 GSKIGEGAHGKVYEGRYGDR--IVAIK---VLNRGSTSDER-ALLEGRFIREVNMMSRVK 116
G +G G+ G VYEG D A+K + + G T E LE +E+ ++S+++
Sbjct: 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE----QEIALLSKLQ 60
Query: 117 HDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
H N+V++LG + D L I EL+PG SL K L V + I ++
Sbjct: 61 HPNIVQYLGTEREEDNLY-IFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQILLGLEY 117
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
LH +HRD+K N+L+ + +KLADFG+A++ + G+ WMAPE V
Sbjct: 118 LHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPE----V 172
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
+QG Y D++S G + E+ T + P+ S L+ AA FK+ S P
Sbjct: 173 IAQQGG---YGLAADIWSLGCTVLEMATGKPPW---SQLE-GVAAVFKIGRSKELP 221
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-29
Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG+G+ G+VY+ ++VAIKV++ DE + +E+ +S+ + + K
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDI----QQEIQFLSQCRSPYITK 63
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ G+ K + I+ E G S L +P KLD ++ ++ LH G I
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILREVLLGLEYLHEEGKI 120
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
HRD+K N+LL+ ++ +KLADFG++ + T+++ T GT WMAPE+ ++Q
Sbjct: 121 HRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTF-VGTPFWMAPEV-----IKQS 173
Query: 240 EKKHYNNKVDVYSFGIVLWELLT 262
Y+ K D++S GI EL
Sbjct: 174 G---YDEKADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-29
Identities = 77/234 (32%), Positives = 114/234 (48%), Gaps = 43/234 (18%)
Query: 66 IGEGAHGKVYEGR------YGDR-IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+GEGA GKV+ G D+ +VA+K L +++D R F RE +++ +H+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK----DFEREAELLTNFQHE 68
Query: 119 NLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN------------KLDLHVALNF 164
N+VKF G C DP + +V E + L K+L S P+ +L L L
Sbjct: 69 NIVKFYGVCTEGDPPI-MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY- 223
A+ IA M L + +HRDL N L+ D +K+ DFG++R+ T+ T
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 224 --RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
RWM PE +Y T DV+SFG+VLWE+ T + P+ G+SN
Sbjct: 187 PIRWMPPESIMYRKFTTES----------DVWSFGVVLWEIFTYGKQPWYGLSN 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 74/213 (34%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 63 GSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
G K+GEG + VY+ R RIVAIK + G + + + +RE+ ++ +KH N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 121 VKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALDIARAMDCLHA 177
+ L + +V E + L K + + + L A ++ L R ++ LH+
Sbjct: 65 IGLLDVFGHKSNINLVFEFMET-DLEKVI---KDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWM-APEL-YSTV 234
N I+HRDLKP+NLL+ D LKLADFGLAR + MT + T RW APEL +
Sbjct: 121 NWILHRDLKPNNLLIASDGV-LKLADFGLARSFGSPNRKMTHQVVT-RWYRAPELLFGA- 177
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+HY VD++S G + ELL R+PF
Sbjct: 178 -------RHYGVGVDMWSVGCIFAELL-LRVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 69/221 (31%), Positives = 117/221 (52%), Gaps = 23/221 (10%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
L++ + L +G IGEG G V +G Y + VA+K + T+ F+ E +M+
Sbjct: 2 LLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA-------FLEETAVMT 54
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
++ H NLV+ LG + IV EL+ +L +L + + + L F+LD+A M+
Sbjct: 55 KLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPELY 231
L + ++HRDL N+L++ D + K++DFGLAR M + +W APE
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVA-KVSDFGLAR----VGSMGVDNSKLPVKWTAPE-- 167
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271
L+ + +++K DV+S+G++LWE+ + R P+ MS
Sbjct: 168 ---ALKHKK---FSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 78/246 (31%), Positives = 119/246 (48%), Gaps = 49/246 (19%)
Query: 45 PQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDE 97
P+ + R L +G +GEGA G+V + VA+K+L +T E
Sbjct: 5 PEWELPRDRLT------LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--E 56
Query: 98 RALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP- 153
+ L + + E+ MM + KH N++ LG C + PL V+V E +LR +L + RP
Sbjct: 57 KDLSD--LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPP 113
Query: 154 ----NKLDLHVA---------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
+ D ++FA +AR M+ L + IHRDL N+L+T D +K
Sbjct: 114 GEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMK 172
Query: 201 LADFGLAREETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIV 256
+ADFGLAR+ + T +WMAPE L+ V Y ++ DV+SFG++
Sbjct: 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVL 223
Query: 257 LWELLT 262
LWE+ T
Sbjct: 224 LWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-28
Identities = 74/237 (31%), Positives = 109/237 (45%), Gaps = 42/237 (17%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREV 109
+DP + I IG G G+V GR + VAIK L GS+ +R F+ E
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL----DFLTEA 56
Query: 110 NMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFA 165
++M + H N+++ G P+M I+TE + SL K+L R N V +
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVM-IITEYMENGSLDKFL---RENDGKFTVGQLVGML 112
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-- 223
IA M L +HRDL N+L+ + K++DFGL+R +E TY
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVC-KVSDFGLSRRLEDSE------ATYTT 165
Query: 224 -------RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
RW APE + R + + DV+SFGIV+WE+++ P+ MSN
Sbjct: 166 KGGKIPIRWTAPE---AIAYR-----KFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 5e-28
Identities = 71/224 (31%), Positives = 115/224 (51%), Gaps = 23/224 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ P L + +IG G G V+ G + R VAIK + G+ S+E FI E +M
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED------FIEEAQVMM 54
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ H LV+ G C + + +V E + L YL + R K L LD+ M
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGM 113
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE 229
L ++ +IHRDL N L+ +Q +K++DFG+ R + + T+ TGT +W +PE
Sbjct: 114 AYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE 171
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN 272
++S Y++K DV+SFG+++WE+ + + P+E SN
Sbjct: 172 VFSF--------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN 207
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-28
Identities = 73/235 (31%), Positives = 111/235 (47%), Gaps = 43/235 (18%)
Query: 66 IGEGAHGKVYEG-------RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+GEGA GKVY+G R VAIK L + + F +E +MS ++H
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ----EFRQEAELMSDLQHP 68
Query: 119 NLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK--------------LDLHVALN 163
N+V LG C K+ ++ E L L ++LV P+ LD L+
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAET 220
A+ IA M+ L ++ +HRDL N L+ + ++K++DFGL+R+ + + +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVG-EGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 221 GTYRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSN 272
RWM PE LY T D++SFG+VLWE+ + L P+ G SN
Sbjct: 188 LPVRWMPPEAILYGKFTTES----------DIWSFGVVLWEIFSYGLQPYYGFSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 73/246 (29%), Positives = 112/246 (45%), Gaps = 43/246 (17%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY----GDRI---VAIKVLNRGSTSDERALLEGRFIR 107
V + + +G GA G+VYEG Y GD + VA+K L E F+
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL----PESCSEQDESDFLM 58
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----KLDLHV 160
E +MS+ H N+V+ +G + P I+ EL+ G L+ +L RP L +
Sbjct: 59 EALIMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKD 117
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETVTE---- 214
L A D+A+ L N IHRD+ N LLT + K+ADFG+AR+
Sbjct: 118 LLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 215 ----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269
M+ +WM PE + + +K DV+SFG++LWE+ + +P+ G
Sbjct: 178 GGRAMLPI-----KWMPPEAFLDGI--------FTSKTDVWSFGVLLWEIFSLGYMPYPG 224
Query: 270 MSNLQA 275
+N +
Sbjct: 225 RTNQEV 230
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 20/214 (9%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +IGEGAHG V++ + VA+K + + +RE+ + +H
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN---QALREIKALQACQHPY 60
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VK L V+V E +P L + L L ++ + + + +HAN
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRD-EERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPE-LYSTVT 235
GI+HRDLKP NLL++ D LK+ADFGLAR E + + + T + APE LY
Sbjct: 119 GIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG--- 174
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y+ VD+++ G + ELL F G
Sbjct: 175 -----ARKYDPGVDLWAVGCIFAELLNGSPLFPG 203
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 73/230 (31%), Positives = 114/230 (49%), Gaps = 27/230 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+DPK L ++G G G V G++ G VAIK++ GS S E FI E +M
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS------EDEFIEEAKVMM 54
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ H+ LV+ G C K + IVTE + L YL + L D+ M
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGM 113
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE 229
L + IHRDL N L+ DQ +K++DFGL+R + + T+ G+ RW PE
Sbjct: 114 AYLESKQFIHRDLAARNCLVD-DQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPE 171
Query: 230 --LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276
LYS +++K DV++FG+++WE+ + ++P+E +N +
Sbjct: 172 VLLYSK----------FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV 211
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G+G+ G VY+ R+ +I A+K ++ + R L RE+ + +
Sbjct: 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL----RELKTLRSCESPY 60
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSL---RKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+VK GA + IV E + G SL K + + L A I + +D L
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQILKGLDYL 115
Query: 176 HAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYS 232
H IIHRD+KP NLL+ +K+ADFG+++ E T+ + T GT +M+PE
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFV-GTVTYMSPE--- 170
Query: 233 TVTLR-QGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
R QGE Y+ D++S G+ L E + PF
Sbjct: 171 ----RIQGE--SYSYAADIWSLGLTLLECALGKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-27
Identities = 69/242 (28%), Positives = 117/242 (48%), Gaps = 38/242 (15%)
Query: 62 IGSKIGEGAHGKVYE-GRYGD-RIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHD 118
+ K+G+G++G VY+ R D + A+K ++ GS S ER + E+ +++ V H
Sbjct: 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE----DAVNEIRILASVNHP 59
Query: 119 NLVK----FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAM 172
N++ FL K + IV E P L K + + + + + + R +
Sbjct: 60 NIISYKEAFLDGNK---LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 173 DCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPEL 230
LH I+HRDLK N+LL D +K+ D G+++ + + M + GT +MAPE+
Sbjct: 117 QALHEQKILHRDLKSANILLVANDL--VKIGDLGISK--VLKKNMAKTQIGTPHYMAPEV 172
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG--MSNLQAAYAAAFKVQESIY 288
+ + Y+ K D++S G +L+E+ T PFE M +L+ +KVQ Y
Sbjct: 173 WK--------GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR------YKVQRGKY 218
Query: 289 AP 290
P
Sbjct: 219 PP 220
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G G+ G+V R+ + A+K+L++ + + E ++ ++H LV
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK--QVEHVLNEKRILQSIRHPFLVNL 66
Query: 124 LGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
G+ +D + +V E +PG L +L + + VA +A + A++ LH+ I++
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPVARFYAAQVVLALEYLHSLDIVY 124
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
RDLKP+NLLL +K+ DFG A R + T + GT ++APE + L +G
Sbjct: 125 RDLKPENLLLD-SDGYIKITDFGFAKRVKGRTYTL---CGTPEYLAPE----IILSKG-- 174
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPF 267
Y VD ++ GI+++E+L PF
Sbjct: 175 --YGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 74/235 (31%), Positives = 115/235 (48%), Gaps = 36/235 (15%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRG----STSDERALLEGRFIREVNMMSRVK 116
G +G+GA G+VY D R +A+K + T E LE E+ ++ ++
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC----EIQLLKNLQ 62
Query: 117 HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
H+ +V++ G +D + I E +PG S++ L + L V + I ++ L
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQILEGVEYL 120
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETV---TEMMTAETGTYRWMAPELY 231
H+N I+HRD+K N +L ++KL DFG + R +T+ M + TGT WM+PE+
Sbjct: 121 HSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP---FEGMSNLQAAYAAAFKV 283
S GE Y K DV+S G + E+LT + P FE M AA FK+
Sbjct: 180 S------GEG--YGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKI 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 72/215 (33%), Positives = 113/215 (52%), Gaps = 24/215 (11%)
Query: 65 KIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G G G+V+ G Y + VA+K L G+ S + F+ E N+M ++HD LV+
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA------FLEEANLMKTLQHDKLVRL 66
Query: 124 LGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
K+ + I+TE + SL +L S K+ L ++F+ IA M + IH
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 126
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPEL--YSTVTLRQ 238
RDL+ N+L++ + K+ADFGLAR E E + +W APE + + T+
Sbjct: 127 RDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI-- 183
Query: 239 GEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
K DV+SFGI+L+E++T ++P+ GMSN
Sbjct: 184 --------KSDVWSFGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 71/211 (33%), Positives = 111/211 (52%), Gaps = 16/211 (7%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG +G VY+ R IVA+K + R T DE + IRE++++ + H N+V+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEG--VPSTAIREISLLKELNHPNIVR 62
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L + + +V E L + L+KY+ S LD + ++ + + + H++ ++
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ + +LKLADFGLAR V T E T + APE + L
Sbjct: 122 HRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE----ILLGS-- 174
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
+ Y+ VD++S G + E++ R F G S
Sbjct: 175 -RQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 72/213 (33%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
S++GEGA G V + R I A+K + D L+ + +RE+ + K +V
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPD----LQKQILRELEINKSCKSPYIV 62
Query: 122 KFLGACKDP---LMVIVTELLPGMSLRKYL--VSLRPNKLDLHVALNFALDIARAMDCLH 176
K+ GA D + I E G SL V R ++ V A + + + LH
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+ IIHRD+KP N+LLT + +KL DFG++ E V + TGT +MAPE
Sbjct: 123 SRKIIHRDIKPSNILLT-RKGQVKLCDFGVS-GELVNSLAGTFTGTSFYMAPE------- 173
Query: 237 R-QGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
R QG K Y+ DV+S G+ L E+ NR PF
Sbjct: 174 RIQG--KPYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 79/222 (35%), Positives = 113/222 (50%), Gaps = 30/222 (13%)
Query: 66 IGEGAHGKVY---EGRYGDRIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVKHDNL 120
IG GA G V+ + R G R+ K+ N + S +R RE+ M+ KHDN+
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF------RELKMLCFFKHDNV 61
Query: 121 VKFLGACKDPL------MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+ L + P + +VTEL+ L K +VS +P D HV + F I R +
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSD-HVKV-FLYQILRGLKY 118
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYS 232
LH+ GI+HRD+KP NLL+ + LK+ DFGLAR E E MT E T + APE+
Sbjct: 119 LHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+HY + VD++S G + ELL R+ F+ S +Q
Sbjct: 178 G-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 43/218 (19%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
K+GEG++G VY+ + ++VAIKV+ E I+E++++ + +VK
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE-------IIKEISILKQCDSPYIVK 62
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD---IA-------RA 171
+ G+ K+ + IV E S+ D+ N L IA +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVS-----------DIMKITNKTLTEEEIAAILYQTLKG 111
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
++ LH+N IHRD+K N+LL + KLADFG++ + M T GT WMAPE
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPE 169
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
V G YNNK D++S GI E+ + P+
Sbjct: 170 ----VIQEIG----YNNKADIWSLGITAIEMAEGKPPY 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 77/220 (35%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 60 LFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
L + K+G G G+V+ G + G+ VA+K L G+ S E F+ E +M +++HD
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES------FLEEAQIMKKLRHD 61
Query: 119 NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
LV+ + + IVTE + SL +L L L ++ A +A M +
Sbjct: 62 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE--LYST 233
IHRDL+ N+L+ D K+ADFGLAR E TA G +W APE LY
Sbjct: 122 NYIHRDLRSANILVG-DGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGR 179
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN 272
T+ K DV+SFGI+L EL+T R+P+ GM+N
Sbjct: 180 FTI----------KSDVWSFGILLTELVTKGRVPYPGMNN 209
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 67/229 (29%), Positives = 113/229 (49%), Gaps = 20/229 (8%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G GA G V+ + ++V IK + T DER + E ++ + H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN----ECQVLKLLSHPNIIE 63
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ +D ++IV E PG +L +Y+ + LD L+F + I A+ +H I+
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
HRDLK N+LL + +K+ DFG+++ + GT +++PEL E
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC--------EG 175
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
K YN K D+++ G VL+EL + + FE +NL A K+ +AP
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEA-ANLP---ALVLKIMSGTFAP 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 74/226 (32%), Positives = 115/226 (50%), Gaps = 41/226 (18%)
Query: 66 IGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFL 124
+G+G G+V++G D+ VA+K + L+ +F+ E ++ + H N+VK +
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE----LKIKFLSEARILKQYDHPNIVKLI 58
Query: 125 GAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALDIARAMDCLHANGI 180
G C + P+ IV EL+PG +L LR K +L + FALD A M L +
Sbjct: 59 GVCTQRQPIY-IVMELVPGGD---FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC 114
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----------RWMAPEL 230
IHRDL N L+ + LK++DFG++R+E + G Y +W APE
Sbjct: 115 IHRDLAARNCLVG-ENNVLKISDFGMSRQE--------DDGIYSSSGLKQIPIKWTAPE- 164
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275
L G Y+++ DV+S+GI+LWE + P+ GM+N QA
Sbjct: 165 ----ALNYGR---YSSESDVWSYGILLWETFSLGVCPYPGMTNQQA 203
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 73/228 (32%), Positives = 104/228 (45%), Gaps = 40/228 (17%)
Query: 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDE----RALLEGRFIREVNMMSRVKHDN 119
IG GA+G V R VAIK ++ D R L RE+ ++ ++H+N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-VFDDLIDAKRIL------REIKLLRHLRHEN 60
Query: 120 LVKFLGACKDPL------MVIVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAM 172
++ L + P + IVTEL+ L K + S P L D H+ F I R +
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQY-FLYQILRGL 116
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGT--YRWM 226
LH+ +IHRDLKP N+L+ + LK+ DFGLAR +E +T T YR
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR-- 173
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
APEL Y +D++S G + ELLT + F G +
Sbjct: 174 APELL-------LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 60/239 (25%), Positives = 104/239 (43%), Gaps = 40/239 (16%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HD 118
G IGEG+ V + ++ AIK+L++ E+ E +++R+ H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK--VKYVKIEKEVLTRLNGHP 62
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLH 176
++K +D + V E P L +Y+ R LD +A +I A++ LH
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET---------------- 220
+ GIIHRDLKP+N+LL D +K+ DFG A+ +
Sbjct: 120 SKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 221 -----GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
GT +++PEL + +K D+++ G +++++LT + PF G +
Sbjct: 179 FASFVGTAEYVSPELLN--------EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 75/227 (33%), Positives = 112/227 (49%), Gaps = 30/227 (13%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--- 116
++IGEGA+G VY+ R R VA+K + R S+E L +RE+ ++ +++
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKV-RVPLSEEGIPLS--TLREIALLKQLESFE 59
Query: 117 HDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
H N+V+ L C P + +V E + L YL L + + R
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAP 228
+D LH++ I+HRDLKP N+L+T D + +K+ADFGLAR + +T+ T YR AP
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIYSFEMALTSVVVTLWYR--AP 175
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 274
E V L+ Y VD++S G + EL R P F G S
Sbjct: 176 E----VLLQS----SYATPVDMWSVGCIFAELF-RRRPLFRGTSEAD 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-26
Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 22/214 (10%)
Query: 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
L ++G ++G G G V + + +I+A+K + + + +RE++++ +
Sbjct: 3 LEYLG-ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK----QILRELDILHKCN 57
Query: 117 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+V F GA + + I E + G SL K L ++ ++ + A+ + + + L
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYL 116
Query: 176 HAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
H IIHRD+KP N+L+ + +KL DFG++ + V + GT +MAPE
Sbjct: 117 HEKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQ-LVNSLAKTFVGTSSYMAPE----- 169
Query: 235 TLR-QGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
R QG Y+ K D++S G+ L EL T R P+
Sbjct: 170 --RIQGN--DYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-26
Identities = 70/238 (29%), Positives = 115/238 (48%), Gaps = 22/238 (9%)
Query: 63 GSKIGEGAHGKVYEGR--YGDRIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVKHD 118
G ++G GA Y+ R ++A+K + R ++S++ ++E +E+ +M+R+ H
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE-ALRKEIRLMARLNHP 63
Query: 119 NLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
++++ LGA C+D + E + G S+ L V +N+ + R + LH
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSYLHE 121
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-----TGTYRWMAPELYS 232
N IIHRD+K NLL+ + L++ADFG A E GT +MAPE+
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV-- 179
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
LR GE+ Y DV+S G V+ E+ T + P+ A FK+ + AP
Sbjct: 180 ---LR-GEQ--YGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAP 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 7e-26
Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 27/219 (12%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDER--ALLEGRFIREVNMMSRVKH 117
+ ++G+G G VY R + +VAIK + + S E L E + +R++N +H
Sbjct: 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLN-----EH 57
Query: 118 DNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
N+VK D L V E + G +L + + + V + I + + +
Sbjct: 58 PNIVKLKEVFRENDELY-FVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWM-APELYS 232
H +G HRDLKP+NLL++ + +K+ADFGLARE + T T RW APE
Sbjct: 116 HKHGFFHRDLKPENLLVSGPE-VVKIADFGLARE--IRSRPPYTDYVST-RWYRAPE--- 168
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
+ LR Y++ VD+++ G ++ EL T R F G S
Sbjct: 169 -ILLRST---SYSSPVDIWALGCIMAELYTLRPLFPGSS 203
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-26
Identities = 70/232 (30%), Positives = 118/232 (50%), Gaps = 24/232 (10%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G+GA GKVY+ + A K++ S +E LE F+ E++++S KH N
Sbjct: 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEE---LED-FMVEIDILSECKHPN 63
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVALNFALDIARAMDCLH 176
+V A + + I+ E G +L ++ L R + + L+ A++ LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE---ALNFLH 120
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTV 234
++ +IHRDLK N+LLT D +KLADFG++ + + + +T GT WMAPE+ +
Sbjct: 121 SHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNK-STLQKRDTFIGTPYWMAPEVVACE 178
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQES 286
T + Y+ K D++S GI L EL P ++ ++ K+ +S
Sbjct: 179 TFKD---NPYDYKADIWSLGITLIELAQMEPPHHELNPMR----VLLKILKS 223
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 8e-26
Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLN---RGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG GA VY + VAIK ++ ++ DE +EV MS+ H N
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-------LRKEVQAMSQCNHPN 60
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLHA 177
+VK+ + + +V L G SL + S P LD + ++ + ++ LH+
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAET---GTYRWMAPELYS 232
NG IHRD+K N+LL D S+K+ADFG++ + GT WMAPE+
Sbjct: 121 NGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ Y+ K D++SFGI EL T P+
Sbjct: 180 -------QVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 83/249 (33%), Positives = 124/249 (49%), Gaps = 33/249 (13%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YG----DRI--VAIKVLNRGSTSDERALLEGRFIREVNMM 112
L G +G GA GKV E YG D + VA+K+L + S ER L + E+ +M
Sbjct: 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREAL----MSELKIM 92
Query: 113 SRV-KHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
S + H+N+V LGAC P++VI TE L +L R + L L L+F+ +A
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWM 226
+ M L + IHRDL N+LLT K +K+ DFGLAR+ + +WM
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 227 APE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGM---SNLQAAYAAAF 281
APE +++ V Y + DV+S+GI+LWE+ + P+ GM S +
Sbjct: 211 APESIFNCV---------YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY 261
Query: 282 KVQESIYAP 290
++ + +AP
Sbjct: 262 RMAQPEHAP 270
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+GEGA+G V + R IVAIK S++ ++ +REV ++ +++H+N+V
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKF---KESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 122 KFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
A + + +V E + L L+ P L ++ + +A+ H++ I
Sbjct: 64 NLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWM-APELYSTVTL 236
IHRD+KP+N+L++ LKL DFG AR + + Y RW APEL T
Sbjct: 122 IHRDIKPENILVSESGV-LKLCDFGFAR--ALRARPASPLTDYVATRWYRAPELLVGDT- 177
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
+Y VDV++ G ++ ELL F G S++ Y
Sbjct: 178 ------NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 65/241 (26%), Positives = 111/241 (46%), Gaps = 33/241 (13%)
Query: 65 KIGEGAHGKVYE-GRYGD-RIVAIKVLNRGS-TSDERALLEGRFIREVNMMSRVKHDNLV 121
IG+G+ G V + R D +I+ K ++ G+ T E+ L + EVN++ +KH N+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL----VSEVNILRELKHPNIV 62
Query: 122 KFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH 176
++ D + IV E G L + + + + ++ + A+ H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 177 -----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
N ++HRDLKP N+ L ++KL DFGLA+ + A+T GT +M+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPE 180
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYA 289
+ Y+ K D++S G +++EL PF + LQ A K++E +
Sbjct: 181 QLN--------HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS----KIKEGKFR 228
Query: 290 P 290
Sbjct: 229 R 229
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 75/216 (34%), Positives = 109/216 (50%), Gaps = 27/216 (12%)
Query: 65 KIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G G G+V+ Y VA+K + GS S E F+ E N+M ++HD LVK
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA------FLAEANVMKTLQHDKLVKL 66
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ I+TE + SL +L S +K L ++F+ IA M + IHR
Sbjct: 67 HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 184 DLKPDNLLLTPDQKSL--KLADFGLAREETVTEMMTAETGTY--RWMAPEL--YSTVTLR 237
DL+ N+L++ SL K+ADFGLAR E E + +W APE + + T+
Sbjct: 127 DLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI- 182
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
K DV+SFGI+L E++T R+P+ GMSN
Sbjct: 183 ---------KSDVWSFGILLMEIVTYGRIPYPGMSN 209
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-25
Identities = 67/218 (30%), Positives = 110/218 (50%), Gaps = 35/218 (16%)
Query: 57 PKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
P+ + + +IG G +G VY+ R +VAIKV+ D+ +++ +E++M+
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKL-EPGDDFEIIQ----QEISMLK 55
Query: 114 RVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIA-- 169
+H N+V + G+ + + IV E G SL+ Y V+ P IA
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ---------IAYV 106
Query: 170 -----RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GT 222
+ + LH G IHRD+K N+LLT + +KLADFG++ + T T + ++ GT
Sbjct: 107 CRETLKGLAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTAT-IAKRKSFIGT 164
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260
WMAPE+ + V + G Y+ K D+++ GI EL
Sbjct: 165 PYWMAPEVAA-VERKGG----YDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 68/220 (30%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 54 LVDPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN 110
L DP +F + IGEG +GKVY+ R+ ++VAIK+++ +E E +R+ +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 111 MMSRVKHDNLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVA 161
H N+ F GA D + +V EL G S+ + LR +L
Sbjct: 61 -----NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT-AET 220
+ R + LH N +IHRD+K N+LLT +KL DFG++ + T
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260
GT WMAPE+ + + Y+ + DV+S GI EL
Sbjct: 175 GTPYWMAPEV---IACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-25
Identities = 69/226 (30%), Positives = 112/226 (49%), Gaps = 22/226 (9%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G IG GA G VY+G VAIK ++ E AL ++E++++ +KH N
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISL-EKIKEEALKS--IMQEIDLLKNLKHPN 60
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VK++G+ + + I+ E SLR+ + + + + + + + LH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPELYSTVTLR 237
G+IHRD+K N+L T D +KLADFG+A + V++ + GT WMAPE V
Sbjct: 119 GVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE----VIEM 173
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283
G + D++S G + ELLT P+ +L AA F++
Sbjct: 174 SG----ASTASDIWSLGCTVIELLTGNPPY---YDLNPM-AALFRI 211
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-25
Identities = 71/220 (32%), Positives = 115/220 (52%), Gaps = 27/220 (12%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+IG G G+V+ GR + VA+K D L+ +F++E ++ + H N+V+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPD----LKAKFLQEARILKQYSHPNIVR 57
Query: 123 FLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+G C K P+ IV EL+ G +L + P +L + + + A M+ L +
Sbjct: 58 LIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLESKHC 115
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR-----WMAPELYSTVT 235
IHRDL N L+T ++ LK++DFG++REE + + A TG + W APE
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEE--DGVYASTGGMKQIPVKWTAPE-----A 167
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
L G Y+++ DV+SFGI+LWE + +P+ +SN Q
Sbjct: 168 LNYGR---YSSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 9e-25
Identities = 72/214 (33%), Positives = 107/214 (50%), Gaps = 23/214 (10%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G+G G+V+ G + G VAIK L G+ S E F++E +M +++H+ LV+
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA------FLQEAQVMKKLRHEKLVQL 66
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ + IVTE + SL +L L L ++ A IA M + +HR
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPE--LYSTVTLRQG 239
DL+ N+L+ + K+ADFGLAR E + + +W APE LY T+
Sbjct: 127 DLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI--- 182
Query: 240 EKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN 272
K DV+SFGI+L EL T R+P+ GM N
Sbjct: 183 -------KSDVWSFGILLTELTTKGRVPYPGMVN 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-24
Identities = 71/228 (31%), Positives = 106/228 (46%), Gaps = 52/228 (22%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEG---RFIREVNMMSRVKHDN 119
+IGEG +G+VY+ R +VA+K + +E+ EG IRE+ ++ +++H N
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIR---MENEK---EGFPITAIREIKLLQKLRHPN 59
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLV------SLRPNKLDLHVALNFALD------ 167
+V+ L IVT G S+ Y+V L L + F
Sbjct: 60 IVR--------LKEIVTSKGKG-SI--YMVFEYMDHDL--TGLLDSPEVKFTESQIKCYM 106
Query: 168 --IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGT- 222
+ + LH+NGI+HRD+K N+L+ + LKLADFGLAR T T T
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVITL 165
Query: 223 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
YR PEL G + Y +VD++S G +L EL + F+G
Sbjct: 166 WYR--PPELL------LGATR-YGPEVDMWSVGCILAELFLGKPIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G G G+V + + +R A+K + + + + E ++ H +VK
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG--QQEHIFSEKEILEECNHPFIVKL 58
Query: 124 LGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
KD + ++ E G L L D + A + + A + LH GII+
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIY 116
Query: 183 RDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
RDLKP+NLLL D +KL DFG A++ + GT ++APE+
Sbjct: 117 RDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEII--------LN 166
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEG 269
K Y+ VD +S GI+L+ELLT R PF
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-24
Identities = 74/239 (30%), Positives = 114/239 (47%), Gaps = 52/239 (21%)
Query: 60 LFIGSKIGEGAHGKVYE-------GRYGDRIVAIKVLNRGSTSDE-RALLEGRFIREVNM 111
L +G +GEG GKV + GR G VA+K+L ++S E R LL E N+
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLS-----EFNL 56
Query: 112 MSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRP---------------- 153
+ +V H +++K GAC PL++IV G SLR +L R
Sbjct: 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG-SLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 154 ------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207
L + ++FA I+R M L ++HRDL N+L+ + + +K++DFGL+
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA-EGRKMKISDFGLS 174
Query: 208 R---EETVTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
R EE + +WMA E L+ + Y + DV+SFG++LWE++T
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-24
Identities = 73/213 (34%), Positives = 116/213 (54%), Gaps = 19/213 (8%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG +G VY+GR +IVA+K + R + +E + IRE++++ ++H N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEG--VPSTAIREISLLKELQHPNIVC 63
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLHANGI 180
++ + ++ E L M L+KYL SL + +D + ++ I + + H+ +
Sbjct: 64 LQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122
Query: 181 IHRDLKPDNLLLTPDQKSL-KLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQ 238
+HRDLKP NLL+ D K + KLADFGLAR + + T E T + APE V L
Sbjct: 123 LHRDLKPQNLLI--DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPE----VLL-- 174
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
G + Y+ VD++S G + E+ T + F G S
Sbjct: 175 GSPR-YSTPVDIWSIGTIFAEMATKKPLFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-24
Identities = 74/214 (34%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
K+G+G G+V+ G + G VAIK L G+ E F++E +M +++HD LV
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA------FLQEAQIMKKLRHDKLVPL 66
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ + IVTE + SL +L L L ++ A IA M + IHR
Sbjct: 67 YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPE--LYSTVTLRQG 239
DL+ N+L+ D K+ADFGLAR E + + +W APE LY T+
Sbjct: 127 DLRAANILVG-DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI--- 182
Query: 240 EKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN 272
K DV+SFGI+L EL+T R+P+ GM N
Sbjct: 183 -------KSDVWSFGILLTELVTKGRVPYPGMVN 209
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 4e-24
Identities = 71/226 (31%), Positives = 109/226 (48%), Gaps = 25/226 (11%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G +G VY R +AIK + + + L E E+ + S +KH N+V++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE-----EIALHSYLKHRNIVQY 70
Query: 124 LGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF-ALDIARAMDCLHANGII 181
LG+ ++ I E +PG SL L S D + F I + LH N I+
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 182 HRDLKPDNLLLTPDQKSLKLADFG----LAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
HRD+K DN+L+ +K++DFG LA TE TGT ++MAPE+ +
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYMAPEV-----ID 182
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283
+G + Y D++S G + E+ T + PF + Q AA FKV
Sbjct: 183 KGPRG-YGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKV 224
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 4e-24
Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG +G VY+ R + +A+K + R DE + IRE++++ ++H N+V+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEG--VPSTAIREISLLKEMQHGNIVR 65
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + +V E L + L+K++ S + + + I R + H++ ++
Sbjct: 66 LQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ +LKLADFGLAR + T E T + APE+
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG------- 177
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
+HY+ VD++S G + E++ + F G S +
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 5e-24
Identities = 63/226 (27%), Positives = 110/226 (48%), Gaps = 33/226 (14%)
Query: 66 IGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+G G G+V+ + G+ +V +K L T DE E F RE++M ++ H
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ--KTKDENLQSE--FRRELDMFRKLSHK 68
Query: 119 NLVKFLGAC--KDPLMVIVTELLPGMSLRKYLV-------SLRPNKLDLHVALNFALDIA 169
N+V+ LG C +P ++ E L+++L L+P L + IA
Sbjct: 69 NVVRLLGLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMA 227
MD L +HRDL N L++ Q+ +K++ L+++ +E + RW+A
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN 272
PE +++ + ++ K DV+SFG+++WE+ T LPF G+S+
Sbjct: 187 PE-----AVQEDD---FSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 7e-24
Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 51/247 (20%)
Query: 66 IGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
IG+GA G+V++ R +VA+K+L +++D +A F RE +M+ H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA----DFQREAALMAEFDHP 68
Query: 119 NLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP------------------NKLDL 158
N+VK LG C P+ ++ + G L ++L P N L L
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYG-DLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 159 HVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216
L A +A M L +HRDL N L+ + +K+ADFGL+R +
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIYSADYY 186
Query: 217 TAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGM 270
A RWM PE Y+ Y + DV+++G+VLWE+ + + P+ GM
Sbjct: 187 KASENDAIPIRWMPPESIFYN----------RYTTESDVWAYGVVLWEIFSYGMQPYYGM 236
Query: 271 SNLQAAY 277
++ + Y
Sbjct: 237 AHEEVIY 243
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-23
Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 17/218 (7%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
SKIGEG++G V++ R + +IVAIK + S++ +++ +RE+ M+ ++KH NLV
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIK---KFVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 122 KFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ + + +V E L + + P + H+ +A++ H +
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTVTLRQG 239
IHRD+KP+N+L+T Q +KL DFG AR T + RW APEL T
Sbjct: 122 IHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT---- 176
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
Y VDV++ G V ELLT + + G S++ Y
Sbjct: 177 ---QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-23
Identities = 77/233 (33%), Positives = 116/233 (49%), Gaps = 45/233 (19%)
Query: 60 LFIGSKIGEGAHGKV-------YEGRYGDRI--VAIKVLNRGSTSDERALLEGRFIREVN 110
L +G +GEG G+V + +R+ VA+K+L +T + + L I E+
Sbjct: 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDL----ISEME 75
Query: 111 MMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRP-------------- 153
MM + KH N++ LGAC PL VIV E +LR+YL + RP
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 154 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213
+L ++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLAR+
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHI 193
Query: 214 EMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
+ T +WMAPE L+ + Y ++ DV+SFG++LWE+ T
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-23
Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 21/226 (9%)
Query: 63 GSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIRE-VNMMSRVKHDNL 120
G +G+GA+G VY G +++A+K + +++ A E ++E V+++ +KH N+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 121 VKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V++LG C D + I E +PG S+ L P L V + I + LH N
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNC 122
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLARE-------ETVTEMMTAETGTYRWMAPELYS 232
++HRD+K +N++L P+ +KL DFG AR T + M+ + GT WMAPE+ +
Sbjct: 123 VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+ Y K D++S G ++E+ T + P M L A +
Sbjct: 182 --------ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY 219
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-23
Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 16/213 (7%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG +G VY+ R +VA+K + R T E + IRE++++ + H N+VK
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEG--VPSTAIREISLLKELNHPNIVK 63
Query: 123 FLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L + + +V E L L+K++ + + + L + ++ + + + H++ ++
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ + +KLADFGLAR V T E T + APE+
Sbjct: 123 HRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC------ 175
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
K+Y+ VD++S G + E++T R F G S +
Sbjct: 176 -KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-23
Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 26/240 (10%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFI-----REVNMMSRV 115
G IG+G +G+VY ++A+K + +T R + + E+ + +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 116 KHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
H N+V++LG + I E +PG S+ L + + + F + +
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE----TVTEMMTAETGTYRWMAPEL 230
LH+ GI+HRDLK DNLL+ D K++DFG++++ + M+ + G+ WMAPE+
Sbjct: 124 LHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEV 181
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
+ + Y+ KVD++S G V+ E+ R P+ S+ + A AA FK+ AP
Sbjct: 182 IHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPW---SDEE-AIAAMFKLGNKRSAP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-23
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 24/223 (10%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN-LV 121
KIGEG +GKVY+ R ++VA+K DE + +RE++++ + +V
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGI-PPTALREISLLQMLSESIYIV 64
Query: 122 KFLGA------CKDPLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAM 172
+ L P + +V E L L+K++ S L +F + + +
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELY 231
H +G++HRDLKP NLL+ + LK+AD GL R ++ + T E T + APE+
Sbjct: 124 AHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVL 183
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
T HY+ VD++S G + E+ + F G S LQ
Sbjct: 184 LGST-------HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-23
Identities = 71/216 (32%), Positives = 120/216 (55%), Gaps = 26/216 (12%)
Query: 66 IGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA G VY+G + G+ + VAIK+LN T+ +A +E F+ E +M+ + H +
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNE--TTGPKANVE--FMDEALIMASMDHPH 70
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
LV+ LG C P + +VT+L+P L Y+ + N + + LN+ + IA+ M L
Sbjct: 71 LVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEERR 129
Query: 180 IIHRDLKPDNLLL-TPDQKSLKLADFGLAR-EETVTEMMTAETGTY--RWMAPELYSTVT 235
++HRDL N+L+ +P+ +K+ DFGLAR E + A+ G +WMA E
Sbjct: 130 LVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI---- 183
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270
+ + ++ DV+S+G+ +WEL+T P++G+
Sbjct: 184 ----HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-23
Identities = 68/235 (28%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVKH 117
I +++G+G +G+V+ + D IVA+K + + +E + E ++++ K
Sbjct: 5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVR----HVLTERDILTTTKS 60
Query: 118 DNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+ LVK L A +D + + E +PG R L +L L A + ++ A+D LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH 118
Query: 177 ANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 235
G IHRDLKP+N L+ D +KL DFGL++ + + G+ +MAPE+
Sbjct: 119 ELGYIHRDLKPENFLI--DASGHIKLTDFGLSKG--IVTYANSVVGSPDYMAPEVL---- 170
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
+G+ Y+ VD +S G +L+E L PF G S + +E++ P
Sbjct: 171 --RGKG--YDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRP 220
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-23
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
KIG+G+ G V++ R+ A+K ++ ER I E +++++ ++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE----EAIDEARVLAKLDSSYII 62
Query: 122 KFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
++ + + IV E L K L R L F + I + LH+ I
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI 122
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
+HRD+K NL L ++K+ D G+A+ T GT +++PEL
Sbjct: 123 LHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELC-------- 173
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
E K YN K DV++ G+VL+E T + PF+
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-23
Identities = 83/246 (33%), Positives = 119/246 (48%), Gaps = 51/246 (20%)
Query: 53 LLVDPKL------LFIGSKIGEGAHGKVYE----GRYGDR-----IVAIKVLNRGSTSDE 97
L DPK L +G +GEG G+V G D+ VA+K+L +T +
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD 60
Query: 98 RALLEGRFIREVNMMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPN 154
+ L + E+ MM + KH N++ LGAC PL V+V G +LR+YL + RP
Sbjct: 61 LSDL----VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG-NLREYLRARRPP 115
Query: 155 KLDLHV--------ALNF------ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
+D L F A +AR M+ L + IHRDL N+L+T D +K
Sbjct: 116 GMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN-VMK 174
Query: 201 LADFGLAREETVTEMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIV 256
+ADFGLAR+ + T +WMAPE L+ V Y ++ DV+SFG++
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVL 225
Query: 257 LWELLT 262
LWE+ T
Sbjct: 226 LWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-23
Identities = 79/233 (33%), Positives = 114/233 (48%), Gaps = 45/233 (19%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YG------DRI--VAIKVLNRGSTSDERALLEGRFIREVN 110
L +G +GEG G+V YG D+ VA+K+L +T + A L I E+
Sbjct: 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL----ISEME 69
Query: 111 MMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHV------- 160
+M + KH N++ LG C PL VIV E +LR++L + RP D
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 161 -ALNF------ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213
L+F A +AR M+ L + IHRDL N+L+T D +K+ADFGLAR
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN-VMKIADFGLARGVHDI 187
Query: 214 EMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
+ + +WMAPE L+ V Y ++ DV+SFGI++WE+ T
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 9e-23
Identities = 66/214 (30%), Positives = 109/214 (50%), Gaps = 21/214 (9%)
Query: 66 IGEGAHGK--VYEGRYGDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHDNLVK 122
+G+GA G+ +Y D +V K +N S+ ER + E+ ++S ++H N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA----LNEIVILSLLQHPNIIA 63
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ D ++I E G +L +V + + + L + I A+ +H GI+
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQG 239
HRD+K N+ LT +KL DFG+++ +E AET GT +M+PEL QG
Sbjct: 124 HRDIKTLNIFLTKAG-LIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELC------QG 175
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
K YN K D+++ G VL+ELLT + F+ +N
Sbjct: 176 VK--YNFKSDIWALGCVLYELLTLKRTFDA-TNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-22
Identities = 76/233 (32%), Positives = 116/233 (49%), Gaps = 39/233 (16%)
Query: 65 KIGEGAHGKVYEGRYGDRI-------VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++G+G+ G VYEG + VAIK +N ++ ER F+ E ++M
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI----EFLNEASVMKEFNC 68
Query: 118 DNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLD--------LHVALNFALD 167
++V+ LG P +VI+ EL+ L+ YL SLRP + L + A +
Sbjct: 69 HHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG-----T 222
IA M L+AN +HRDL N ++ D ++K+ DFG+ R+ + E G
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRD--IYETDYYRKGGKGLLP 184
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
RWM+PE +L+ G + DV+SFG+VLWE+ T P++GMSN Q
Sbjct: 185 VRWMSPE-----SLKDGV---FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 75/223 (33%), Positives = 107/223 (47%), Gaps = 38/223 (17%)
Query: 64 SKIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
S IGEGA+G V G + VAIK + + E R +RE+ ++ R KH+N+
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVK-VAIKKI----SPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 121 VKFLGACKDPL------MVIVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMD 173
+ L + P + IV EL+ L K + + L + H+ F I R +
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELME-TDLYKLI---KTQHLSNDHIQY-FLYQILRGLK 120
Query: 174 CLHANGIIHRDLKPDNLLL--TPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWM- 226
+H+ ++HRDLKP NLLL D LK+ DFGLAR E T +T T RW
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLTEYVAT-RWYR 176
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 177 APEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-22
Identities = 73/221 (33%), Positives = 105/221 (47%), Gaps = 42/221 (19%)
Query: 66 IGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
IG+G G VY G D A+K LNR + +E +F++E +M H N+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE----QFLKEGIIMKDFSHPNV 58
Query: 121 VKFLGACKD----PLMVIVTELLPGM---SLRKYLVSLR--PNKLDLHVALNFALDIARA 171
+ LG C PL+V LP M LR ++ S P DL + F L +A+
Sbjct: 59 LSLLGICLPSEGSPLVV-----LPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKG 110
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGT-----YRW 225
M+ L + +HRDL N +L D+ ++K+ADFGLAR+ E + T +W
Sbjct: 111 MEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266
MA E T + K DV+SFG++LWEL+T P
Sbjct: 169 MALESLQTQK--------FTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-22
Identities = 68/211 (32%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 66 IGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+GEG GKV Y +VA+K L R + +E+N++ + H+N
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQ----NTSGWKKEINILKTLYHEN 67
Query: 120 LVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+VK+ G C + + ++ E +P SLR YL +KL+L L FA I M LH
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH 124
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWMAPELY 231
+ IHRDL N+LL D + +K+ DFGLA+ E ++ + W A E
Sbjct: 125 SQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-WYAVECL 182
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
E K DV+SFG+ L+ELLT
Sbjct: 183 K-------ENKFSYAS-DVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-22
Identities = 69/219 (31%), Positives = 112/219 (51%), Gaps = 30/219 (13%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLN----RGSTSDERALLEGRFIREVNMMSRVKHD 118
K+GEG + VY+G R IVA+K ++ G+ S IRE+++M +KH+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA--------IREISLMKELKHE 58
Query: 119 NLVKFLGA--CKDPLMVIVTELLPGMSLRKYL-VSLRPNKLDLHVALNFALDIARAMDCL 175
N+V+ ++ LM +V E + L+KY+ LD + +F + + +
Sbjct: 59 NIVRLHDVIHTENKLM-LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPE-LYST 233
H N ++HRDLKP NLL+ + LKLADFGLAR + + E T + AP+ L +
Sbjct: 117 HENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
T Y+ +D++S G ++ E++T R F G +N
Sbjct: 176 RT--------YSTSIDIWSVGCIMAEMITGRPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-22
Identities = 65/216 (30%), Positives = 111/216 (51%), Gaps = 20/216 (9%)
Query: 65 KIGEGAHGKVY--EGRYGDRIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVKHDNL 120
KIGEG+ GK+Y + + IK ++ + ++ A +EV +++++KH N+
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK-----KEVILLAKMKHPNI 61
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V F + ++ + IV E G L K + R L++ + I+ + +H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
I+HRD+K N+ L+ + KL DFG+AR+ E+ GT +++PE+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC------- 174
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+ + YNNK D++S G VL+EL T + PFEG +NL
Sbjct: 175 -QNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLH 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 72/219 (32%), Positives = 109/219 (49%), Gaps = 29/219 (13%)
Query: 65 KIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
KIGEG+ G V + G R VA+K ++ R LL EV +M +H N+V
Sbjct: 26 KIGEGSTGIVCIATDKSTG-RQVAVKKMDL-RKQQRRELL----FNEVVIMRDYQHPNIV 79
Query: 122 KFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ + D L V V E L G +L + R N+ + L +A+ LHA G
Sbjct: 80 EMYSSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIATVCLAVL---KALSFLHAQG 135
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE---TGTYRWMAPELYSTVTL 236
+IHRD+K D++LLT D + +KL+DFG + V++ + GT WMAPE+ S
Sbjct: 136 VIHRDIKSDSILLTSDGR-VKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPEVIS---- 188
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
+ Y +VD++S GI++ E++ P+ LQA
Sbjct: 189 ----RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 74/237 (31%), Positives = 115/237 (48%), Gaps = 47/237 (19%)
Query: 65 KIGEGAHGKVYEGRYGDRI-------VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++G+G+ G VYEG D I VA+K +N ++ ER F+ E ++M
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI----EFLNEASVMKGFTC 68
Query: 118 DNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD--------LHVALNFALDI 168
++V+ LG K ++V EL+ L+ YL SLRP + L + A +I
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR---- 224
A M L+A +HRDL N ++ D ++K+ DFG+ R+ ET YR
Sbjct: 129 ADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTRD-------IYETDYYRKGGK 180
Query: 225 ------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
WMAPE +L+ G + D++SFG+VLWE+ + P++G+SN Q
Sbjct: 181 GLLPVRWMAPE-----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQPYQGLSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-22
Identities = 71/210 (33%), Positives = 108/210 (51%), Gaps = 27/210 (12%)
Query: 66 IGEGAHGKVYEGRY---GDR---IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+GEG GKV RY GD VA+K L S + A L+ +E+ ++ + H+N
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK----KEIEILRNLYHEN 67
Query: 120 LVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+VK+ G C + + ++ E LP SL++YL NK++L L +A+ I + MD L
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMDYLG 126
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAE---TGTYRWMAPELYS 232
+ +HRDL N+L+ + + +K+ DFGL + ET E T + W APE
Sbjct: 127 SRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
+ K Y DV+SFG+ L+ELLT
Sbjct: 186 -------QSKFYIAS-DVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-22
Identities = 71/218 (32%), Positives = 108/218 (49%), Gaps = 31/218 (14%)
Query: 59 LLFIGSKIGEGAHGKVYEGRY---GD---RIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
L FI ++G+G G V RY D +VA+K L + R F RE+ ++
Sbjct: 6 LKFI-QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-----DFEREIEIL 59
Query: 113 SRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
++HDN+VK+ G C + +V E LP SLR YL R +LD L +A I
Sbjct: 60 KSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQIC 118
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYR 224
+ M+ L + +HRDL N+L+ + + +K+ DFGL + +E E+ +
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPIF- 176
Query: 225 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
W APE + E K ++ DV+SFG+VL+EL T
Sbjct: 177 WYAPESLT-------ESK-FSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-22
Identities = 75/222 (33%), Positives = 111/222 (50%), Gaps = 25/222 (11%)
Query: 65 KIGEGAHGKVY---EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
KIG+GA G VY + G VAIK +N ++ L+ I E+ +M KH N+V
Sbjct: 26 KIGQGASGTVYTAIDVATGQE-VAIKQMNL-QQQPKKELI----INEILVMRENKHPNIV 79
Query: 122 KFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+L + D L V V E L G SL + +D + +A++ LH+N
Sbjct: 80 NYLDSYLVGDELWV-VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ 135
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQ 238
+IHRD+K DN+LL D S+KL DFG + T + + GT WMAPE+ +
Sbjct: 136 VIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT------ 188
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
+K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 189 --RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 4e-22
Identities = 67/222 (30%), Positives = 116/222 (52%), Gaps = 27/222 (12%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+GEG++G V + ++ + +IVAIK + S++ +++ +RE+ M+ +++H+NLV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 123 FLGACK-DPLMVIVTELLPGM---SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+ + + +V E + L KY PN LD + I R ++ H++
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVT 235
IIHRD+KP+N+L++ +KL DFG AR T+ E+ T T + APEL
Sbjct: 120 NIIHRDIKPENILVSQS-GVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLV--- 173
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
G+ K Y VD+++ G ++ E+LT F G S++ Y
Sbjct: 174 ---GDTK-YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 7e-22
Identities = 63/237 (26%), Positives = 117/237 (49%), Gaps = 23/237 (9%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I KIG+G VY+ R+VA+K + D +A ++E++++ ++ H N
Sbjct: 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKA--RQDCLKEIDLLKQLDHPN 63
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH 176
++K+L + ++ + IV EL L + + + K + + + + A++ +H
Sbjct: 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTV 234
+ I+HRD+KP N+ +T +KL D GL R + ++ A + GT +M+PE
Sbjct: 124 SKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI--- 178
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKVQESIYAP 290
+ YN K D++S G +L+E+ + PF G NL Y+ K+++ Y P
Sbjct: 179 -----HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIEKCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 8e-22
Identities = 74/215 (34%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G GA+G+V R VAIK L+R S A R RE+ ++ + H+N++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA---KRTYRELRLLKHMDHENVIGL 79
Query: 124 LGAC--KDPLM-----VIVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCL 175
L L +VT L+ G L + + KL D H+ I R + +
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLM-GADLNNIV---KCQKLSDDHIQF-LVYQILRGLKYI 134
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYSTV 234
H+ GIIHRDLKP N+ + D + LK+ DFGLAR + MT T RW APE +
Sbjct: 135 HSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARH--TDDEMTGYVAT-RWYRAPE----I 186
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
L HYN VD++S G ++ ELLT + F G
Sbjct: 187 ML---NWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 8e-22
Identities = 71/243 (29%), Positives = 106/243 (43%), Gaps = 52/243 (21%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRI-----VAIKVLN-RGSTSDERALLEGRFIREVNMMS 113
L +G +GEG G V EG+ VA+K + T E +E F+ E M
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE---IEE-FLSEAACMK 56
Query: 114 RVKHDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLR----PNKLDLHVAL 162
H N++K +G C K P +++ + L +L+ R P KL L L
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222
F +DIA M+ L IHRDL N +L D + +ADFGL++ +G
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT-VCVADFGLSK--------KIYSGD 167
Query: 223 Y-----------RWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269
Y +W+A E L V Y +K DV++FG+ +WE+ T + P+ G
Sbjct: 168 YYRQGRIAKMPVKWIAIESLADRV---------YTSKSDVWAFGVTMWEIATRGQTPYPG 218
Query: 270 MSN 272
+ N
Sbjct: 219 VEN 221
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 75/233 (32%), Positives = 114/233 (48%), Gaps = 45/233 (19%)
Query: 60 LFIGSKIGEGAHGKVYE----GRYGDR-----IVAIKVLNRGSTSDERALLEGRFIREVN 110
L +G +GEG G+V G D+ VA+K+L +T + + L + E+
Sbjct: 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL----VSEME 72
Query: 111 MMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
MM + KH N++ LGAC PL VIV G +LR+YL + RP ++ + D
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYDIARVPD 131
Query: 168 --------------IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213
+AR M+ L + IHRDL N+L+T + +K+ADFGLAR+
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNI 190
Query: 214 EMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
+ T +WMAPE L+ V Y ++ DV+SFG+++WE+ T
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-21
Identities = 69/238 (28%), Positives = 121/238 (50%), Gaps = 26/238 (10%)
Query: 66 IGEGAHGKVYEGRY---GDRIVAIKVLNR-----GSTSDERALLEGRFIREVNMM-SRVK 116
+G GA G VY+ R G ++A+K +N G ER G + EV ++ +++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 117 HDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMD 173
H N+V++ ++ + IV +L+ G L ++ SL+ K N + + A+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 174 CLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
LH I+HRDL P+N++L D K + + DFGLA+++ +T+ GT + PE+
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFGLAKQKQPESKLTSVVGTILYSCPEIV- 185
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
+ E Y K DV++FG +L+++ T + PF + L + A K+ E++Y P
Sbjct: 186 -----KNEP--YGEKADVWAFGCILYQMCTLQPPFYSTNML----SLATKIVEAVYEP 232
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-21
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG +G V++ + + IVA+K R D+ + +RE+ ++ +KH N+V+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
D + +V E L+KY S +D + +F + + + H++ ++
Sbjct: 64 LYDVLHSDKKLTLVFEYC-DQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVL 121
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ LKLADFGLAR + +AE T + P++ L
Sbjct: 122 HRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL---- 176
Query: 241 KKHYNNKVDVYSFGIVLWEL 260
Y+ +D++S G + EL
Sbjct: 177 ---YSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-21
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 44/216 (20%)
Query: 82 RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLP 140
+VA+KVL ++ + R F++EV ++SR+ N+ + LG C DP + ++ E +
Sbjct: 47 VLVAVKVLRPDASDNARE----DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYME 102
Query: 141 GMSLRKYL-------VSLRPNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLL 191
L ++L L N L + L A IA M L + +HRDL N L
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162
Query: 192 LTPDQKSLKLADFGLAREETVTEMMTAETGTY-----------RWMAPELYSTVTLRQGE 240
+ + +K+ADFG++R + Y RWMA E ++ G+
Sbjct: 163 VGKNYT-IKIADFGMSRN--------LYSSDYYRVQGRAPLPIRWMAWE-----SVLLGK 208
Query: 241 KKHYNNKVDVYSFGIVLWELLT--NRLPFEGMSNLQ 274
+ K DV++FG+ LWE+LT P+E +++ Q
Sbjct: 209 ---FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-21
Identities = 75/238 (31%), Positives = 118/238 (49%), Gaps = 35/238 (14%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR--YGDRIVAIKVLN-RGSTSDERALLEGRFIREVNM 111
DP+ LF +IG G+ G VY R + +VAIK ++ G S+E+ I+EV
Sbjct: 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW---QDIIKEVRF 68
Query: 112 MSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
+ +++H N +++ G C ++ +V E Y + + L++H ++IA
Sbjct: 69 LQQLRHPNTIEYKG-CYLREHTAWLVME---------YCLGSASDILEVHKKPLQEVEIA 118
Query: 170 -------RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222
+ + LH++ IHRD+K N+LLT + ++KLADFG A ++ + GT
Sbjct: 119 AICHGALQGLAYLHSHERIHRDIKAGNILLT-EPGTVKLADFGSA---SLVSPANSFVGT 174
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
WMAPE V L E Y+ KVDV+S GI EL + P M+ + A Y A
Sbjct: 175 PYWMAPE----VILAMDEG-QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-21
Identities = 70/232 (30%), Positives = 120/232 (51%), Gaps = 31/232 (13%)
Query: 63 GSKIGEGAHGKVYEGRYG--DRIVAIK--VLNRGSTSDE---RALLEGRFIREVNMMSRV 115
G+ IG G+ G VY G ++A+K L S S + R++L+ RE+ ++ +
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDA-LAREIALLKEL 63
Query: 116 KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+H+N+V++LG+ D + I E +PG S+ L + + + NF I + ++
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNY 121
Query: 175 LHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYR--------W 225
LH GIIHRD+K N+L+ D K +K++DFG++++ + T T R W
Sbjct: 122 LHNRGIIHRDIKGANILV--DNKGGIKISDFGISKKLEANSLSTK-TNGARPSLQGSVFW 178
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
MAPE+ ++ Y K D++S G ++ E+LT + PF + LQA +
Sbjct: 179 MAPEVV--------KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 7e-21
Identities = 70/227 (30%), Positives = 117/227 (51%), Gaps = 21/227 (9%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DP+ LF KIG+G+ G+V++G ++VAIK+++ DE ++ +E+ ++
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 113 SRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
S+ + K+ G+ KD + I+ E L G S L L P LD +I +
Sbjct: 57 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILREILKG 113
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPEL 230
+D LH+ IHRD+K N+LL+ + +KLADFG+A + T T++ GT WMAPE+
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
++ Y++K D++S GI EL P + ++ +
Sbjct: 173 I--------KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-20
Identities = 68/227 (29%), Positives = 116/227 (51%), Gaps = 21/227 (9%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DP+ LF +IG+G+ G+VY+G +VAIK+++ DE ++ +E+ ++
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 113 SRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
S+ + ++ G+ K + I+ E L G S L L+P L+ +I +
Sbjct: 57 SQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREILKG 113
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGTYRWMAPEL 230
+D LH+ IHRD+K N+LL+ +Q +KLADFG+A + T T++ GT WMAPE+
Sbjct: 114 LDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
++ Y+ K D++S GI EL P + ++ +
Sbjct: 173 I--------KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF 211
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-20
Identities = 73/235 (31%), Positives = 117/235 (49%), Gaps = 32/235 (13%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +G+GA G+VY D R +A+K + S E + E+ ++ + H+
Sbjct: 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65
Query: 120 LVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+V++ G +DP+ + I E +PG S++ L S L +V + I + LH
Sbjct: 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH 123
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETV----TEMMTAETGTYRWMAPELY 231
+N I+HRD+K N +L ++KL DFG ++ +T+ T M + TGT WM+PE+
Sbjct: 124 SNMIVHRDIKGAN-ILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGTPYWMSPEVI 181
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP---FEGMSNLQAAYAAAFKV 283
S GE Y K D++S G + E+LT + P FE M AA FK+
Sbjct: 182 S------GEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 66/215 (30%), Positives = 113/215 (52%), Gaps = 24/215 (11%)
Query: 66 IGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA G VY+G + G+++ VAIK L R +TS + + E +M+ V + +
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPK---ANKEILDEAYVMASVDNPH 70
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ + LG C + ++T+L+P L Y+ + N ++ LN+ + IA+ M+ L
Sbjct: 71 VCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAKGMNYLEERR 129
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTY--RWMAPELYSTVTL 236
++HRDL N+L+ Q +K+ DFGLA+ E AE G +WMA L
Sbjct: 130 LVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMA--------L 180
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270
+ Y ++ DV+S+G+ +WEL+T P++G+
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-20
Identities = 73/232 (31%), Positives = 124/232 (53%), Gaps = 23/232 (9%)
Query: 56 DPKLLFIG-SKIGEGAHGKVY--EGRYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNM 111
DP+ +F+G +IG G+ G VY + + +VA+K ++ G ++E+ I+EV
Sbjct: 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW---QDIIKEVKF 74
Query: 112 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIA 169
+ ++KH N +++ G K+ +V E G + V +P ++++ + AL
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL--- 131
Query: 170 RAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
+ + LH++ +IHRD+K N+LLT P Q +KLADFG A + + + GT WMAP
Sbjct: 132 QGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSA---SKSSPANSFVGTPYWMAP 186
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
E+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A
Sbjct: 187 EV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 233
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-20
Identities = 63/209 (30%), Positives = 90/209 (43%), Gaps = 24/209 (11%)
Query: 66 IGEGAHGKVYEGR---YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
I +GA G VY + GD AIKVL + S + + MM + + + K
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYF-AIKVL-KKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 123 FLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ KD L +V E L G + +L L A + ++ ++ LH GI
Sbjct: 62 LYYSFQSKDYLY-LVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 181 IHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
IHRD+KP+NLL+ DQ LKL DFGL+R GT ++APE
Sbjct: 119 IHRDIKPENLLI--DQTGHLKLTDFGLSR---NGLENKKFVGTPDYLAPETI-------- 165
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
+ D +S G V++E L PF
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSD----ERALLEGRFIREVNMMSRVKHDN 119
+G+G+ GKV D + A+KVL + E + E R + KH
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-----KHPF 57
Query: 120 LVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
L + L +C KD L V E + G L ++ + D A +A +I + LH
Sbjct: 58 LTQ-LHSCFQTKDRLF-FVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH 113
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTV 234
GII+RDLK DN+LL + +K+ADFG+ + E + +T T GT ++APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSE-GHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEIL--- 168
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y VD ++ G++L+E+L + PFEG
Sbjct: 169 ---SYQP--YGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-20
Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 25/222 (11%)
Query: 64 SKIGEGAHGKVYEGR---YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---H 117
++IGEGA+GKV++ R G R VA+K + R T +E L IREV ++ ++ H
Sbjct: 7 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLST--IREVAVLRHLETFEH 63
Query: 118 DNLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
N+V+ C ++ + +V E + L YL + + + + R
Sbjct: 64 PNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 122
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
+D LH++ ++HRDLKP N+L+T + +KLADFGLAR + +T+ T + APE+
Sbjct: 123 LDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMALTSVVVTLWYRAPEV- 180
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
L Q Y VD++S G + E+ + F G S++
Sbjct: 181 ----LLQSS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-20
Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 65 KIGEGAHGKVYEGRYGDRI----VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
+IG G GKV G + V +K L +T DE+ L F++EV + H N+
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL----FLQEVQPYRELNHPNV 57
Query: 121 VKFLGACKD--PLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCL 175
++ LG C + P + +V E P L+ YL S R V A ++A + L
Sbjct: 58 LQCLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTY--RWMAPELYS 232
H IH DL N LT D S+K+ D+GLA E+ + +T + RW+APEL
Sbjct: 117 HQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
K K +++S G+ +WEL T P+ +S+ Q
Sbjct: 176 IRGQDLLPKDQ-TKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-20
Identities = 51/136 (37%), Positives = 75/136 (55%), Gaps = 12/136 (8%)
Query: 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194
V E L G L ++ S + D A +A +I + LH GII+RDLK DN+LL
Sbjct: 74 VMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 195 DQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 253
D +K+ADFG+ +E E + GT ++APE+ +G+K YN VD +SF
Sbjct: 132 DGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL------KGQK--YNESVDWWSF 182
Query: 254 GIVLWELLTNRLPFEG 269
G++L+E+L + PF G
Sbjct: 183 GVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-20
Identities = 75/228 (32%), Positives = 108/228 (47%), Gaps = 44/228 (19%)
Query: 64 SKIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
S +G GA+G V ++ + G R VA+K L+R S A R RE+ ++ +KH+N+
Sbjct: 23 SPVGSGAYGSVCAAFDTKTGLR-VAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENV 78
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRK----YLVS----------LRPNKL-DLHVALNFA 165
+ L P SL + YLV+ ++ KL D HV
Sbjct: 79 IGLLDV-----------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LI 126
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 225
I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR + MT T +
Sbjct: 127 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARH--TDDEMTGYVATRWY 183
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
APE+ HYN VD++S G ++ ELLT R F G ++
Sbjct: 184 RAPEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-20
Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 39/227 (17%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+IGEG +G VY R IVA+K + +ER + +RE+ ++ ++H N+V+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALK---KVRMDNERDGIPISSLREITLLLNLRHPNIVE 70
Query: 123 FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN-------------FALDIA 169
E++ G L + + + DL L+ L +
Sbjct: 71 LK------------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAP 228
R + LH N IIHRDLK NLLLT D+ LK+ADFGLAR + MT + T + AP
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
EL T Y +D+++ G +L ELL ++ G S ++
Sbjct: 178 ELLLGCT-------TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-20
Identities = 69/227 (30%), Positives = 116/227 (51%), Gaps = 21/227 (9%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DP+ LF +IG+G+ G+V++G ++VAIK+++ DE ++ +E+ ++
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ----QEITVL 56
Query: 113 SRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
S+ + K+ G+ K + I+ E L G S L LR D +I +
Sbjct: 57 SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA---LDLLRAGPFDEFQIATMLKEILKG 113
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPEL 230
+D LH+ IHRD+K N+LL+ +Q +KLADFG+A + T T++ GT WMAPE+
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
++ Y++K D++S GI EL P M ++ +
Sbjct: 173 I--------QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 7e-20
Identities = 73/223 (32%), Positives = 112/223 (50%), Gaps = 33/223 (14%)
Query: 64 SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRF----IREVNMMSRVKH 117
++I EG +G VY R IVA+K L E+ EG F +RE+N++ +++H
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEK---EG-FPITSLREINILLKLQH 63
Query: 118 DNLVKF----LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
N+V +G+ D + +V E + L+ + +++ L V L + +
Sbjct: 64 PNIVTVKEVVVGSNLDKIY-MVMEYVE-HDLKSLMETMKQPFLQSEVK-CLMLQLLSGVA 120
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT--YRWMAPEL 230
LH N I+HRDLK NLLL ++ LK+ DFGLARE + + T T YR APEL
Sbjct: 121 HLHDNWILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYR--APEL 177
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
G K+ Y+ +D++S G + ELLT + F G S +
Sbjct: 178 L------LGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 9e-20
Identities = 75/224 (33%), Positives = 101/224 (45%), Gaps = 48/224 (21%)
Query: 66 IGEGAHGKV---YEGRYGDRIVAIKVLNR---GSTSDERALLEGRFIREVNMMSRVKHDN 119
IG GA G V Y+ G VAIK L+R T +RA RE+ +M V H N
Sbjct: 24 IGSGAQGIVCAAYDTVTGQN-VAIKKLSRPFQNVTHAKRAY------RELVLMKLVNHKN 76
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLHVALNFALDIAR----- 170
++ L P SL + YLV + +L + LD R
Sbjct: 77 IIGLLNV-----------FTPQKSLEEFQDVYLV-MELMDANLCQVIQMDLDHERMSYLL 124
Query: 171 -AMDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 225
M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR + MMT T +
Sbjct: 125 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYY 183
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
APE V L G Y VD++S G ++ E++ + F G
Sbjct: 184 RAPE----VILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-19
Identities = 67/236 (28%), Positives = 113/236 (47%), Gaps = 39/236 (16%)
Query: 65 KIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++GEGA GKV+ + +VA+K L S S + F RE +++ ++H
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ-----DFQREAELLTVLQH 66
Query: 118 DNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPN-------------KLDLHVALN 163
++V+F G C + +++V E + L ++L S P+ +L L L
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
A IA M L + +HRDL N L+ +K+ DFG++R+ T+ T
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 224 ---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275
RWM PE ++ R+ + + D++SFG+VLWE+ T + P+ +SN +A
Sbjct: 186 LPIRWMPPE---SILYRK-----FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-19
Identities = 70/217 (32%), Positives = 113/217 (52%), Gaps = 20/217 (9%)
Query: 64 SKIGEGAHGK--VYEGRYGDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHDNL 120
KIGEG+ GK + + + + IK +N S ER E R +EV ++S +KH N+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE--ESR--KEVAVLSNMKHPNI 61
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V++ + ++ + IV + G L K + + R L++ + I A+ +H
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQ 238
I+HRD+K N+ LT D ++KL DFG+AR T E+ GT +++PE+
Sbjct: 122 ILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC------- 173
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEG--MSNL 273
E + YNNK D+++ G VL+E+ T + FE M NL
Sbjct: 174 -ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 70/219 (31%), Positives = 110/219 (50%), Gaps = 24/219 (10%)
Query: 64 SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---HD 118
++IG GA+G VY+ R + VA+K + R T+++ L +REV ++ R++ H
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLST--VREVALLKRLEAFDHP 62
Query: 119 NLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
N+V+ + C ++ + +V E + LR YL + P L + R +
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
D LHAN I+HRDLKP+N+L+T +KLADFGLAR + +T T + APE+
Sbjct: 122 DFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLL 180
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
T Y VD++S G + E+ + F G S
Sbjct: 181 QST--------YATPVDMWSVGCIFAEMFRRKPLFCGNS 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 2e-19
Identities = 70/209 (33%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 66 IGEGAHGKVYEGR--YGDRIVAIK-VLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G GA G V R + VAIK ++ ST +L R RE+ ++ ++H+N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFST----PVLAKRTYRELKLLKHLRHENIIS 73
Query: 123 FLGACKDPLMVI--VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
PL I VTELL G L + L S RP L+ F I R + +H+ G+
Sbjct: 74 LSDIFISPLEDIYFVTELL-GTDLHRLLTS-RP--LEKQFIQYFLYQILRGLKYVHSAGV 129
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
+HRDLKP N+L+ + LK+ DFGLAR + MT T + APE+ T
Sbjct: 130 VHRDLKPSNILIN-ENCDLKICDFGLARIQ--DPQMTGYVSTRYYRAPEIMLTW------ 180
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y+ +VD++S G + E+L + F G
Sbjct: 181 -QKYDVEVDIWSAGCIFAEMLEGKPLFPG 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 39/223 (17%)
Query: 68 EGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
EG G+++ G D V +K + ++ + LL ++E ++ + H N++
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLL----LQESCLLYGLSHQNIL 71
Query: 122 KFLGAC---KDPLMVIVTELLPGMS---LRKYLVSLRPNKLDLHVALN------FALDIA 169
L C +P V L P M+ L+ +L R + + AL+ A+ IA
Sbjct: 72 PILHVCIEDGEPPFV----LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR---WM 226
M LH G+IH+D+ N ++ ++ +K+ D L+R+ + R WM
Sbjct: 128 CGMSYLHKRGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 268
A E +L K Y++ DV+SFG++LWEL+T + P+
Sbjct: 187 ALE-----SL---VNKEYSSASDVWSFGVLLWELMTLGQTPYV 221
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-19
Identities = 76/232 (32%), Positives = 122/232 (52%), Gaps = 23/232 (9%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR--YGDRIVAIKVLN-RGSTSDERALLEGRFIREVNM 111
DP+ LF +IG G+ G VY R + +VAIK ++ G S+E+ I+EV
Sbjct: 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW---QDIIKEVKF 78
Query: 112 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIA 169
+ R+KH N +++ G ++ +V E G + V +P ++++ + AL
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL--- 135
Query: 170 RAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
+ + LH++ +IHRD+K N+LLT P Q +KLADFG A ++ + GT WMAP
Sbjct: 136 QGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSA---SIASPANSFVGTPYWMAP 190
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
E+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A
Sbjct: 191 EV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 237
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-19
Identities = 65/234 (27%), Positives = 116/234 (49%), Gaps = 39/234 (16%)
Query: 65 KIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
++GE A GK+Y+G ++VAIK L + + G F +E ++M+ + H
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQW----GEFQQEASLMAELHHP 67
Query: 119 NLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP---------------NKLDLHVAL 162
N+V LG ++ + ++ E L L ++L+ P + LD L
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222
+ A+ IA M+ L ++ +H+DL N+L+ +Q +K++D GL+RE + + +
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIG-EQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 223 Y---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSN 272
RWM PE + G+ +++ D++SFG+VLWE+ + L P+ G SN
Sbjct: 187 LLPIRWMPPE-----AIMYGK---FSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-19
Identities = 73/242 (30%), Positives = 117/242 (48%), Gaps = 24/242 (9%)
Query: 49 IDRSLLVDPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRF 105
ID S L DP +F + +G G +G+VY+GR+ ++ AIKV++ T DE E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDE----EEEI 59
Query: 106 IREVNMMSRVKHD-NLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLRPNKLD 157
E+NM+ + H N+ + GA D + +V E S+ + + + N L
Sbjct: 60 KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK 119
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEM 215
+I R + LHA+ +IHRD+K N+LLT + +KL DFG++ + TV
Sbjct: 120 EDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRR 178
Query: 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
T GT WMAPE+ + + Y+ + D++S GI E+ P M ++A
Sbjct: 179 NTF-IGTPYWMAPEV---IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234
Query: 276 AY 277
+
Sbjct: 235 LF 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G G G+V+ R + A+KV+ + E E ++ V H +++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ--EQHVHNEKRVLKEVSHPFIIRL 66
Query: 124 LGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
D + ++ E +PG L YL + + L +A +I A++ LH+ I++
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVY 124
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 242
RDLKP+N+LL + +KL DFG A++ + + GT ++APE+ + K
Sbjct: 125 RDLKPENILLDKE-GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVI--------QSK 173
Query: 243 HYNNKVDVYSFGIVLWELLTNRLPFEG 269
+N VD ++ GI+++E+L PF
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 66/225 (29%), Positives = 113/225 (50%), Gaps = 22/225 (9%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
K+GEG++ VY+GR ++VA+K + +E A IRE +++ +KH N+V
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRL--EHEEGAPFTA--IREASLLKDLKHANIVT 67
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ +V E L L++Y+ L +H F + R + H ++
Sbjct: 68 LHDIIHTKKTLTLVFEYLD-TDLKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPE--LYSTVTLRQ 238
HRDLKP NLL++ ++ LKLADFGLAR ++V ++ + E T + P+ L ST
Sbjct: 126 HRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST----- 179
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283
Y+ +D++ G + +E+ T R F G ++++ F+V
Sbjct: 180 ----EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRV 220
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFL--GACKDPLMVIVTELLPG 141
VAIK+L + +E RF RE + +R+ H N+V L G L+ V E +PG
Sbjct: 6 VAIKLLRTDAPEEEH--QRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSL 199
+LR+ L + L L + A+ C H GI+HRDLKP N++++ +
Sbjct: 64 RTLREVLAADGALPAGETGRL--MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 200 KLADFGLAR-----EETVTEMMTAET---GTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 251
K+ DFG+ + +T T GT + APE LR GE N+ D+Y
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-----QLR-GEPVTPNS--DLY 173
Query: 252 SFGIVLWELLTNRLPFEGMSNLQAAY 277
++G++ E LT + +G S + Y
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAEILY 199
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-19
Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 23/216 (10%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG+ G V + ++VA+K ++ R LL EV +M +H+N+V+
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDL-RKQQRRELL----FNEVVIMRDYQHENVVE 81
Query: 123 FLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ D L V++ E L G +L + R N+ + L + +A+ LHA G+
Sbjct: 82 MYNSYLVGDELWVVM-EFLEGGALTDIVTHTRMNEEQIAAV---CLAVLKALSVLHAQGV 137
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
IHRD+K D++LLT D + +KL+DFG A+ + GT WMAPEL S +
Sbjct: 138 IHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP---- 192
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
Y +VD++S GI++ E++ P+ L+A
Sbjct: 193 ----YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-19
Identities = 67/211 (31%), Positives = 112/211 (53%), Gaps = 15/211 (7%)
Query: 55 VDPKLLF-IGSKIGEGAHGKVYEGRYGDR--IVAIKVLNRGSTSDERALLEGRFIREVNM 111
+DP ++ I ++G+GA GKVY+ + + + A KV+ T E L + ++ E+ +
Sbjct: 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELED--YMVEIEI 62
Query: 112 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
++ H +VK LGA D + I+ E PG ++ ++ L + + + +
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLE 121
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPE 229
A+ LH+ IIHRDLK N+LLT D +KLADFG++ + T + + GT WMAPE
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPE 180
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260
+ T++ Y+ K D++S GI L E+
Sbjct: 181 VVMCETMKDTP---YDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 4e-19
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 33/218 (15%)
Query: 66 IGEGAHGKVYE-----GRYGDRIVAIKVL-------NRGSTSDERALLEGRFIREVNMMS 113
+G+G +GKV++ G +I A+KVL N+ T+ +A E N++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA--------ERNILE 55
Query: 114 RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
VKH +V + A + + ++ E L G L +L R A + +I+ A+
Sbjct: 56 AVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLE--REGIFMEDTACFYLSEISLAL 113
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELY 231
+ LH GII+RDLKP+N+LL Q +KL DFGL +E +T GT +MAPE+
Sbjct: 114 EHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
R G + VD +S G +++++LT PF
Sbjct: 173 M----RSG----HGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 5e-19
Identities = 71/234 (30%), Positives = 112/234 (47%), Gaps = 32/234 (13%)
Query: 63 GSKIGEGAHGKV---YEGRYGDRIVAIKVL---NRGSTSDERALLEGRFIREVNMMSRVK 116
G +G+GA G+V Y+ G + A +V TS E + LE E+ ++ ++
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC----EIQLLKNLQ 62
Query: 117 HDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
H+ +V++ G +D + I E +PG S++ L + L V + I M
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMS 120
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPE 229
LH+N I+HRD+K N +L ++KL DFG ++ M + + TGT WM+PE
Sbjct: 121 YLHSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283
+ S GE Y K DV+S G + E+LT + P+ A AA FK+
Sbjct: 180 VIS------GEG--YGRKADVWSLGCTVVEMLTEKPPWAEYE----AMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-19
Identities = 69/205 (33%), Positives = 112/205 (54%), Gaps = 18/205 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGDR--IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G+GA GKVY+ + + + A KV++ T E L + ++ E+++++ H N
Sbjct: 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVID---TKSEEELED--YMVEIDILASCDHPN 63
Query: 120 LVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVALNFALDIARAMDCLH 176
+VK L A + + I+ E G ++ ++ L RP + + V L+ A++ LH
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE---ALNYLH 120
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVT 235
N IIHRDLK N+L T D +KLADFG++ + T T + + GT WMAPE+ V
Sbjct: 121 ENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV---VM 176
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWEL 260
+ + Y+ K DV+S GI L E+
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-19
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 18/209 (8%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
K+GEG + V++GR + +VA+K + +E A IREV+++ +KH N+V
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTA--IREVSLLKNLKHANIVT 67
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + +V E L L++YL + N + +H F + R + H I+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ ++ LKLADFGLAR ++V T+ + E T + P++ T
Sbjct: 126 HRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST----- 179
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
Y+ +D++ G +L+E+ T R F G
Sbjct: 180 --EYSTPIDMWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 8e-19
Identities = 75/231 (32%), Positives = 114/231 (49%), Gaps = 24/231 (10%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DPK + KIG+GA G VY + VAIK +N + + I E+ +M
Sbjct: 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI-----INEILVM 70
Query: 113 SRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
K+ N+V +L + D L V++ E L G SL + ++ + L +
Sbjct: 71 RENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECL---Q 126
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPE 229
A+D LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT WMAPE
Sbjct: 127 ALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 186 VVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 9e-19
Identities = 73/231 (31%), Positives = 114/231 (49%), Gaps = 24/231 (10%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DPK + KIG+GA G VY + VAI+ +N + + I E+ +M
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-----INEILVM 71
Query: 113 SRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
K+ N+V +L + D L V++ E L G SL + ++ + L +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECL---Q 127
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPE 229
A++ LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT WMAPE
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 187 VVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-18
Identities = 73/238 (30%), Positives = 116/238 (48%), Gaps = 38/238 (15%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVL----NRGSTSDERALLEGRFIREVNMMSRV 115
+G +G GA G+VY D R +A+K + + TS E LE E+ ++ +
Sbjct: 6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALEC----EIQLLKNL 61
Query: 116 KHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+HD +V++ G +DP + I E +PG S++ L + L +V + I + +
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGV 119
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAP 228
LH+N I+HRD+K N +L ++KL DFG ++ M + + TGT WM+P
Sbjct: 120 SYLHSNMIVHRDIKGAN-ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP---FEGMSNLQAAYAAAFKV 283
E+ S GE Y K DV+S + E+LT + P +E M AA FK+
Sbjct: 179 EVIS------GEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-18
Identities = 75/232 (32%), Positives = 114/232 (49%), Gaps = 26/232 (11%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR---YGDRIVAIKVLNRGSTSDERALLEGRFIREVNM 111
DPK + KIG+GA G V+ G VAIK +N + + I E+ +
Sbjct: 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQE-VAIKQINLQKQPKKELI-----INEILV 69
Query: 112 MSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
M +K+ N+V FL + D L V++ E L G SL + ++ + L
Sbjct: 70 MKELKNPNIVNFLDSFLVGDELFVVM-EYLAGGSLTDVVTETCMDEAQIAAVCRECL--- 125
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAP 228
+A++ LHAN +IHRD+K DN+LL S+KL DFG + T + + GT WMAP
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
E+ + +K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 185 EVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 41/224 (18%)
Query: 65 KIGEGAHGKVYEGR------YGDR-IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++GEGA GKV+ D+ +VA+K L + + + F RE +++ ++H
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK-----DFQREAELLTNLQH 66
Query: 118 DNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN--------------KLDLHVA 161
+++VKF G C DPL ++V E + L K+L + P+ +L L
Sbjct: 67 EHIVKFYGVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 221
L+ A IA M L + +HRDL N L+ +K+ DFG++R+ T+
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 222 TY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
T RWM PE ++ R+ + + DV+SFG++LWE+ T
Sbjct: 185 TMLPIRWMPPE---SIMYRK-----FTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-18
Identities = 68/215 (31%), Positives = 113/215 (52%), Gaps = 29/215 (13%)
Query: 66 IGEGAHGKVY-----EGRYGDRIVAIKVLNRGSTS-DERALLEGRFIREVNMMSRVKHDN 119
+G+G+ GKV+ G ++ A+KVL + + +R R E ++++ V H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV----RTKMERDILAEVNHPF 59
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYL---VSLRPNKLDLHVALNFALDIARAMDCL 175
+VK A + + ++ + L G L L V + ++A ++A A+D L
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-----ELALALDHL 114
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTV 234
H+ GII+RDLKP+N+LL ++ +KL DFGL++E E GT +MAPE V
Sbjct: 115 HSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE----V 169
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
R+G + D +SFG++++E+LT LPF+G
Sbjct: 170 VNRRG----HTQSADWWSFGVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-18
Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
K+GEG + VY+GR D +VA+K + +E A IREV+++ +KH N+V
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRL--EHEEGAPCTA--IREVSLLKDLKHANIVT 68
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + +V E L L++YL N +++H F + R ++ H ++
Sbjct: 69 LHDIIHTEKSLTLVFEYL-DKDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ ++ LKLADFGLAR +++ T+ + E T + P++ T
Sbjct: 127 HRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST----- 180
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
Y+ ++D++ G + +E+ T R F G
Sbjct: 181 --DYSTQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 38/236 (16%)
Query: 61 FIGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRF---------IREV 109
G+ +GEG +GKV + +IVAIK + S++ +RE+
Sbjct: 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 110 NMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+M+ +KH+N++ + + + +V +++ L+K +V + + V L I
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKK-VVDRKIRLTESQVKC-ILLQI 128
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---------------EETVT 213
++ LH +HRDL P N+ + + K+ADFGLAR
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
E MT++ T + APEL L EK Y+ VD++S G + ELLT + F G
Sbjct: 188 EEMTSKVVTLWYRAPEL-----LMGAEK--YHFAVDMWSVGCIFAELLTGKPLFPG 236
|
Length = 335 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-18
Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 65 KIGEGAHGKV--YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG+ G V ++ + VA+K ++ R LL EV +M H+N+V
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDL-RKQQRRELL----FNEVVIMRDYHHENVVD 83
Query: 123 FLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ D L V V E L G +L + R N+ + L + RA+ LH G+
Sbjct: 84 MYNSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIATV---CLSVLRALSYLHNQGV 139
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
IHRD+K D++LLT D + +KL+DFG A+ + GT WMAPE+ S +
Sbjct: 140 IHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP---- 194
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
Y +VD++S GI++ E++ P+ LQA
Sbjct: 195 ----YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 77/242 (31%), Positives = 113/242 (46%), Gaps = 63/242 (26%)
Query: 62 IGSKIGEGAHGKVYEGRYGDR----IVAIK-VLN--RGSTSDERALLEGRFIREVNMMSR 114
I K+G+GA+G V++ DR +VA+K + + R +T +R E F++E+
Sbjct: 11 ILQKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG---- 64
Query: 115 VKHDNLVKFLG---ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL--NFALDI- 168
H N+VK L A D + +V E + + DLH + N D+
Sbjct: 65 -DHPNIVKLLNVIKAENDKDIYLVFEYM---------------ETDLHAVIRANILEDVH 108
Query: 169 --------ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR------EETVTE 214
+A+ +H+ +IHRDLKP N+LL D + +KLADFGLAR E
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENP 167
Query: 215 MMTAETGTYRWM-APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
++T T RW APE L ST Y VD++S G +L E+L + F G S
Sbjct: 168 VLTDYVAT-RWYRAPEILLGST---------RYTKGVDMWSVGCILGEMLLGKPLFPGTS 217
Query: 272 NL 273
L
Sbjct: 218 TL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 70/232 (30%), Positives = 114/232 (49%), Gaps = 39/232 (16%)
Query: 65 KIGEGAHGKVYEGR------YGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++GEGA GKV+ D+I VA+K L S + + F RE +++ ++H
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK-----DFHREAELLTNLQH 66
Query: 118 DNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----------KLDLHVALNF 164
+++VKF G C DPL ++V E + L K+L + P+ +L L+
Sbjct: 67 EHIVKFYGVCVEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY- 223
A IA M L + +HRDL N L+ + +K+ DFG++R+ T+ T
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 224 --RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
RWM PE ++ R+ + + DV+S G+VLWE+ T + P+ +SN
Sbjct: 185 PIRWMPPE---SIMYRK-----FTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-18
Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G+G++G+V R + IK LN R ++ ER E +E ++S++KH N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAE----QEAQLLSQLKHPNIVA 63
Query: 123 FLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ + + D L+ IV G L L + L + + + + IA A+ LH I
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
+HRDLK N+ LT +K+ D G+AR E +M + GT +M+PEL+S
Sbjct: 124 LHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN------ 176
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPF 267
K YN K DV++ G ++E+ T + F
Sbjct: 177 --KPYNYKSDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-18
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 35/219 (15%)
Query: 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNL 120
KIGEG +V + + + AIK + + S E+ +RE+ + R+ H N+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN----LREIQALRRLSPHPNI 60
Query: 121 VKFLGACKDPL---MVIVTELLPGMSL------RKYLVSLRPNKLDLHVALNFALDIARA 171
++ + D + +V EL+ M+L RK + ++ ++ + ++
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLP--EKRV-----KSYMYQLLKS 112
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APEL 230
+D +H NGI HRD+KP+N+L+ LKLADFG R T T RW APE
Sbjct: 113 LDHMHRNGIFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTEYIST-RWYRAPE- 168
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
L G +Y K+D+++ G V +E+L+ F G
Sbjct: 169 ---CLLTDG---YYGPKMDIWAVGCVFFEILSLFPLFPG 201
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-18
Identities = 71/232 (30%), Positives = 118/232 (50%), Gaps = 23/232 (9%)
Query: 56 DPKLLFIG-SKIGEGAHGKVYEGR--YGDRIVAIKVLN-RGSTSDERALLEGRFIREVNM 111
DP+ LF +IG G+ G VY R +VAIK ++ G S+E+ I+EV
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW---QDIIKEVRF 68
Query: 112 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIA 169
+ +++H N +++ G ++ +V E G + V +P ++++ + AL
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL--- 125
Query: 170 RAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
+ + LH++ +IHRD+K N+LL+ P +KL DFG A ++ GT WMAP
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSA---SIMAPANXFVGTPYWMAP 180
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
E+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A
Sbjct: 181 EV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 73/239 (30%), Positives = 120/239 (50%), Gaps = 29/239 (12%)
Query: 44 APQLTIDRSLLVDPKLL---FIGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDER 98
A ++ +D+ DP+ L +I KIGEG+ G V R + R VA+K+++ R
Sbjct: 9 ALRMVVDQG---DPRSLLENYI--KIGEGSTGIVCIAREKHSGRQVAVKMMDL-RKQQRR 62
Query: 99 ALLEGRFIREVNMMSRVKHDNLVK-FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD 157
LL EV +M +H N+V+ + + ++ E L G +L + R N+
Sbjct: 63 ELL----FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQ 118
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMM 216
+ L +A+ LH+ G+IHRD+K D++LLT D + +KL+DFG A+
Sbjct: 119 IATVCESVL---QALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKR 174
Query: 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
+ GT WMAPE+ S + Y +VD++S GI++ E++ P+ S +QA
Sbjct: 175 KSLVGTPYWMAPEVIS--------RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-18
Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 66 IGEGAHGKVYE--GRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG+G +GKVY+ + + A+K+L+ S DE E ++ + H N+VKF
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP-----NHPNVVKF 84
Query: 124 LGA------CKDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCL 175
G + +V EL G S+ + + L +LD + + L
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTV 234
H N IIHRD+K +N+LLT + +KL DFG++ + T T + GT WMAPE+ +
Sbjct: 145 HNNRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV---I 200
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
Q Y+ + DV+S GI EL P M ++ +
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF 243
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-18
Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 29/220 (13%)
Query: 66 IGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
IG G G+V+ G + VAIK L G T +R F+ E ++M + H N+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ----DFLSEASIMGQFSHHNI 68
Query: 121 VKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV--ALNFALDIARAMDCLHA 177
++ G K +I+TE + +L KYL R + + + IA M L
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTY--RWMAPELYST 233
+HRDL N+L+ K++DFGL+R E+ T G RW APE +
Sbjct: 126 MNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
+ + + DV+SFGIV+WE+++ P+ MSN
Sbjct: 185 --------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-18
Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 39/236 (16%)
Query: 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
L +G +GEG G V EG+ D I+ + V R+ +E F+ E M H
Sbjct: 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED-FLSEAVCMKEFDH 59
Query: 118 DNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFAL 166
N+++ +G C P V++ + L +L+ R P L + + F
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---------REETVTEMMT 217
DIA M+ L + IHRDL N +L + ++ +ADFGL+ R+ + +M
Sbjct: 120 DIASGMEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKM-- 176
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
+W+A E + + Y K DV+SFG+ +WE+ T + P+ G+ N
Sbjct: 177 ----PVKWIAIESLA--------DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 7e-18
Identities = 74/225 (32%), Positives = 108/225 (48%), Gaps = 42/225 (18%)
Query: 66 IGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G GA+G V + R G + VAIK L R S+ L R RE+ ++ +KH+N++
Sbjct: 23 VGSGAYGTVCSALDRRTGAK-VAIKKLYRPFQSE---LFAKRAYRELRLLKHMKHENVIG 78
Query: 123 FLGACKDPLMVIVTELLPGMSLRK----YLVS----------LRPNKLDLHVALNFALDI 168
L P +SL + YLV ++ KL +
Sbjct: 79 LLDV-----------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM 127
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
+ + +HA GIIHRDLKP NL + D + LK+ DFGLAR +T +E MT T + AP
Sbjct: 128 LKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR-QTDSE-MTGYVVTRWYRAP 184
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
E V L HY VD++S G ++ E+LT + F+G +L
Sbjct: 185 E----VILNW---MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-18
Identities = 72/234 (30%), Positives = 109/234 (46%), Gaps = 33/234 (14%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY---GDR--IVAIKVLNRGSTSDERALLEGRFIREV 109
+D + I IG G G+V GR G R VAIK L G T +R F+ E
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR----DFLSEA 56
Query: 110 NMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFA 165
++M + H N++ G P+M I+TE + +L +L R N V +
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVM-IITEFMENGALDSFL---RQNDGQFTVIQLVGML 112
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETG- 221
IA M L +HRDL N+L+ + K++DFGL+R ++T T+ G
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 222 --TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
RW APE + R+ + + DV+S+GIV+WE+++ P+ MSN
Sbjct: 172 KIPIRWTAPE---AIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 7e-18
Identities = 71/237 (29%), Positives = 116/237 (48%), Gaps = 24/237 (10%)
Query: 54 LVDPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN 110
L DP +F + +G G +G+VY+GR+ ++ AIKV++ T DE E +E+N
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDE----EEEIKQEIN 54
Query: 111 MMSRVKHD-NLVKFLGAC--KDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 162
M+ + H N+ + GA K+P + +V E S+ + + + N L
Sbjct: 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 114
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAET 220
+I R + LH + +IHRD+K N+LLT + +KL DFG++ + TV T
Sbjct: 115 YICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTF-I 172
Query: 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
GT WMAPE+ + + Y+ K D++S GI E+ P M ++A +
Sbjct: 173 GTPYWMAPEV---IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 52/139 (37%), Positives = 79/139 (56%), Gaps = 12/139 (8%)
Query: 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 191
+ V E L G L ++ S +K DL A +A +I + LH+ GI++RDLK DN+L
Sbjct: 71 LFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128
Query: 192 LTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 250
L D +K+ADFG+ +E + + T GT ++APE+ G+K YN VD
Sbjct: 129 LDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL------LGQK--YNTSVDW 179
Query: 251 YSFGIVLWELLTNRLPFEG 269
+SFG++L+E+L + PF G
Sbjct: 180 WSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 68/230 (29%), Positives = 107/230 (46%), Gaps = 39/230 (16%)
Query: 66 IGEGAHGKVY-----EGRYGDRIVAIKVLNRGS----------TSDERALLEGRFIREVN 110
+G GA+GKV+ G ++ A+KVL + + T ER +LE +R
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA--VRRCP 65
Query: 111 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
LV A + D + ++ + + G L +L + +I
Sbjct: 66 F--------LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIV 115
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMA 227
A+D LH GII+RD+K +N+LL + + L DFGL++E E A + GT +MA
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQA 275
PE+ +R G H + VD +S G++ +ELLT PF +G N Q+
Sbjct: 175 PEV-----IRGGSGGH-DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 74/230 (32%), Positives = 108/230 (46%), Gaps = 40/230 (17%)
Query: 66 IGEGAHGKVYEG---RYGDRI-VAIKVLNR-GSTSDERALLEGRFIREVNMMSRV-KHDN 119
IGEG G+V + G ++ AIK+L S +D R F E+ ++ ++ H N
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR-----DFAGELEVLCKLGHHPN 64
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--------------LNF 164
++ LGAC++ + I E P +L +L R + D A L F
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 224
A D+A M L IHRDL N+L+ + + K+ADFGL+R E V T R
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVG-ENLASKIADFGLSRGEEVYVKKTMGRLPVR 183
Query: 225 WMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271
WMA E YS Y K DV+SFG++LWE+++ P+ GM+
Sbjct: 184 WMAIESLNYSV----------YTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-17
Identities = 75/233 (32%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY---GDR--IVAIKVLNRGSTSDERALLEGRFIREV 109
+D + I IG G G+V GR G R VAIK L G T +R F+ E
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR----DFLSEA 56
Query: 110 NMMSRVKHDNLVKFLGA---CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNF 164
++M + H N++ G K P+M IVTE + SL +L R + V +
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSK-PVM-IVTEYMENGSLDAFL---RKHDGQFTVIQLVGM 111
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGT 222
IA M L G +HRDL N+L+ + K++DFGL+R E+ T G
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 223 --YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
RW APE + R+ + + DV+S+GIV+WE+++ P+ MSN
Sbjct: 171 IPIRWTAPE---AIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWEMSN 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 68/222 (30%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 65 KIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
IG GA+G V + R G + VAIK + A R +RE+ ++ KHDN++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKK-VAIKKIPHAFDVPTLA---KRTLRELKILRHFKHDNII 67
Query: 122 KFLGACKDPLM--------VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
A +D L V V L L + S +P L F + R +
Sbjct: 68 ----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQP--LTEEHIRYFLYQLLRGLK 121
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-----ETVTEMMTAETGTYRWM-A 227
+H+ +IHRDLKP NLL+ D L++ DFG+AR MT T RW A
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVAT-RWYRA 179
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
PEL ++ Y +D++S G + E+L R F G
Sbjct: 180 PELLLSL-------PEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 18/209 (8%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
K+GEG + V++GR + +VA+K + +E A IREV+++ +KH N+V
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTA--IREVSLLKDLKHANIVT 68
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
D + +V E L L++Y+ N + +H F I R + H ++
Sbjct: 69 LHDIVHTDKSLTLVFEYL-DKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVL 126
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP NLL+ ++ LKLADFGLAR ++V T+ + E T + P+ V L E
Sbjct: 127 HRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPD----VLLGSSE 181
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
Y+ ++D++ G + +E+ + R F G
Sbjct: 182 ---YSTQIDMWGVGCIFFEMASGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-17
Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 34/220 (15%)
Query: 66 IGEGAHGKVYEGRY---GDRI---VAIKVL-NRGSTSDERALLEGRFIREVNMMSRVKHD 118
+G G G V++G + GD I VAIK + +R + + + + M + H
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITD-----HMLAMGSLDHA 69
Query: 119 NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+ LG C + +VT+L P SL ++ R + LD LN+ + IA+ M L +
Sbjct: 70 YIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKGMYYLEEH 128
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLA-------REETVTEMMTAETGTYRWMAPELY 231
++HR+L N+LL D +++ADFG+A ++ +E T +WMA E
Sbjct: 129 RMVHRNLAARNILLKSDSI-VQIADFGVADLLYPDDKKYFYSEHKTP----IKWMALE-- 181
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270
++ + Y ++ DV+S+G+ +WE+++ P+ GM
Sbjct: 182 -SILFGR-----YTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-17
Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 23/211 (10%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGST---SDERALLEGRFIREVNMMSRVKHDNL 120
IG GA G+V R+ ++ A+K+L++ SD E R I M+ + +
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI-----MAHANSEWI 105
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNFALDIARAMDCLHAN 178
V+ A +D + +V E +PG L V+L N + A + ++ A+D +H+
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDL----VNLMSNYDIPEKWARFYTAEVVLALDAIHSM 161
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
G IHRD+KPDN+LL LKLADFG + M+ +T GT +++PE V
Sbjct: 162 GFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE----VLK 216
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
QG +Y + D +S G+ L+E+L PF
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVL--NRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+G GA+G V + R+ I+A+K + S +R L++ +++M S V V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMD----LDISMRS-VDCPYTV 63
Query: 122 KFLGAC-KDPLMVIVTELLPGMSLRKYL--VSLRPNKLDLHVALNFALDIARAMDCLHAN 178
F GA ++ + I E++ SL K+ V + + + A+ I +A++ LH+
Sbjct: 64 TFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122
Query: 179 -GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
+IHRD+KP N+L+ +KL DFG++ + T + G +MAPE +
Sbjct: 123 LSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINP---- 177
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
+ +K Y+ K DV+S GI + EL T R P++
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-17
Identities = 62/217 (28%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEG---RFIREVNMMSRVKHDN 119
K+GEG++ VY+G R ++VA+KV++ + EG IRE +++ +KH N
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTE-------EGVPFTAIREASLLKGLKHAN 64
Query: 120 LVKF--LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+V + K+ L + + L +Y++ P L + F + R + +H
Sbjct: 65 IVLLHDIIHTKETLTFVFEYM--HTDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHG 121
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP NLL++ LKLADFGLAR +++ ++ ++E T + P++ T
Sbjct: 122 QHILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT- 179
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
Y++ +D++ G + E+L + F G+S++
Sbjct: 180 ------DYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-17
Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 66 IGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA G VY+G + G+ + VAIKVL R +TS + + E +M+ V
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKA---NKEILDEAYVMAGVGSPY 70
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ + LG C + +VT+L+P L Y V +++ LN+ + IA+ M L
Sbjct: 71 VCRLLGICLTSTVQLVTQLMPYGCLLDY-VRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 180 IIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETG---TYRWMAPELYSTVT 235
++HRDL N+L+ +P+ +K+ DFGLAR + E G +WMA
Sbjct: 130 LVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWMA-------- 179
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270
L + + ++ DV+S+G+ +WEL+T P++G+
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-17
Identities = 68/232 (29%), Positives = 108/232 (46%), Gaps = 23/232 (9%)
Query: 47 LTID-RSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDE--RALL 101
LTID + D L +IG G G+VY+ R+ ++A+K + R +E R L+
Sbjct: 3 LTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILM 62
Query: 102 EGRFIREVNMMSRVKHD--NLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 158
+ +V + S HD +VK G D + I EL+ L K L ++ +
Sbjct: 63 D----LDVVLKS---HDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQ-GPIPE 113
Query: 159 HVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217
+ + I +A+ L G+IHRD+KP N+LL ++KL DFG++ ++ T
Sbjct: 114 DILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKT 172
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
G +MAPE Y+ + DV+S GI L EL T + P++
Sbjct: 173 RSAGCAAYMAPERIDP----PDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-17
Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 26/227 (11%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
K+GEG++ VY+G+ ++VA+KV+ E IRE +++ +KH N+V
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRL----QEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 123 F--LGACKDPLMVIV----TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+ K+ L ++ T+L M K+ L P + L F + R + +H
Sbjct: 68 LHDIIHTKETLTLVFEYVHTDLCQYMD--KHPGGLHPENVKL-----FLFQLLRGLSYIH 120
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP NLL++ D LKLADFGLAR ++V + W P V L
Sbjct: 121 QRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP---PDVLL 176
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283
E Y+ +D++ G + E++ F GM ++Q F V
Sbjct: 177 GSTE---YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLV 220
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG GA+G V + + VAIK + + A R +RE+ ++ + H+N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAK---RTLREIKLLRHLDHENVI-- 67
Query: 124 LGACKDPLM----------VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
A KD + IV EL+ L + + S + D H F + R +
Sbjct: 68 --AIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDD-HCQY-FLYQLLRGLK 122
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYS 232
+H+ ++HRDLKP NLLL + LK+ DFGLAR + + MT T + APEL
Sbjct: 123 YIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y +DV+S G + ELL + F G
Sbjct: 182 NCS-------EYTTAIDVWSVGCIFAELLGRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-17
Identities = 71/229 (31%), Positives = 109/229 (47%), Gaps = 38/229 (16%)
Query: 66 IGEGAHGKVYEGRY---GDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNL 120
IGEG G+V + R G R+ AIK + ++ D+ G E+ ++ ++ H N+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG----ELEVLCKLGHHPNI 70
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--------------LNFA 165
+ LGAC+ + + E P +L +L R + D A L+FA
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 225
D+AR MD L IHRDL N+L+ + + K+ADFGL+R + V T RW
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVRW 189
Query: 226 MAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271
MA E YS Y DV+S+G++LWE+++ P+ GM+
Sbjct: 190 MAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-17
Identities = 70/234 (29%), Positives = 115/234 (49%), Gaps = 24/234 (10%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGST---SDERALLEGRFIREVNMMSRVKHDNL 120
IG GA G+V R+ ++ A+K+L++ SD E R ++M+ +
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER-----DIMAFANSPWV 105
Query: 121 VKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHAN 178
V+ A +D + +V E +PG L + + P K A + ++ A+D +H+
Sbjct: 106 VQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKW----AKFYTAEVVLALDAIHSM 161
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
G+IHRD+KPDN+LL LKLADFG + T M+ +T GT +++PE+ +
Sbjct: 162 GLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS--- 217
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
QG +Y + D +S G+ L+E+L PF S L Y+ + S+ P
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKIMDHKNSLNFP 269
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 71/242 (29%), Positives = 109/242 (45%), Gaps = 50/242 (20%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I K+GEG G+VY+ R R+VA+K + +E+ +RE+ ++ ++KH N
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILKKLKHPN 68
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRK----YLVS---------LRPN---KLDLHVALN 163
+V + M + P S RK Y+V+ L N KL
Sbjct: 69 VVPLID------MAVER---PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC 119
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETG 221
+ L + ++ LH N I+HRD+K N+L+ +Q LK+ADFGLAR + G
Sbjct: 120 YMLQLLEGINYLHENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 222 T---Y------RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
Y RW PEL GE++ Y VD++ G V E+ T R +G S
Sbjct: 179 GTRKYTNLVVTRWYRPPELLL------GERR-YTTAVDIWGIGCVFAEMFTRRPILQGKS 231
Query: 272 NL 273
++
Sbjct: 232 DI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 64 SKIGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSD----ERALLEGRFIREVNMMSRVKH 117
+ +G G GKV E + + AIK L +G E + E R N +H
Sbjct: 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN---SERH 61
Query: 118 DNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
LV + V V E G L ++ + + A+ +A + + LH
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDL---MMHIHTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVT 235
N I++RDLK DNLLL + +K+ADFGL +E T+ GT ++APE+ +
Sbjct: 119 ENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT--- 174
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y VD + G++++E+L PF G
Sbjct: 175 -----ETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 34/215 (15%)
Query: 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFI---REVNMMSRVKHDNL 120
IG+G+ GKV ++ + A+KVL + + ++ E + I R V ++ VKH L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKK---EQKHIMAERNV-LLKNVKHPFL 58
Query: 121 V--KFLGACKDPLMVIVT-----ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
V + D L ++ EL + + R A +A +IA A+
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR--------ARFYAAEIASALG 110
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYS 232
LH+ II+RDLKP+N+LL Q + L DFGL +E T+ GT ++APE+
Sbjct: 111 YLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV-- 167
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
LR K+ Y+ VD + G VL+E+L PF
Sbjct: 168 ---LR---KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 56/215 (26%), Positives = 108/215 (50%), Gaps = 23/215 (10%)
Query: 65 KIGEGAHGKVYEGRYGDRI----VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
++G G G V +G Y R VAIKVL + R +RE +M ++ + +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD----EMMREAEIMHQLDNPYI 57
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
V+ +G C+ +++V E+ G L K+L + +++ + + ++ M L
Sbjct: 58 VRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWMAPELYSTVTL 236
+HRDL N+LL +Q K++DFGL++ +++ + +A +W APE +
Sbjct: 117 VHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE---CINF 172
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270
R+ ++++ DV+S+GI +WE + + P++ M
Sbjct: 173 RK-----FSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 60/214 (28%), Positives = 109/214 (50%), Gaps = 15/214 (7%)
Query: 62 IGSKIGEGAHGKVY---EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+ S +G G G+V E GD I A+KV+ + + + F E +++S
Sbjct: 5 VKSLVGRGHFGEVQVVREKATGD-IYAMKVMKKSVLLAQETV--SFFEEERDILSISNSP 61
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+ + A +D + +V E PG L L++ ++ D +A + ++ A+ +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 178 NGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAE--TGTYRWMAPELYSTV 234
G +HRD+KP+N+L+ D+ +KLADFG A T +M+ ++ GT ++APE+ +
Sbjct: 121 MGYVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT-- 176
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
T+ K Y + D +S G++ +E++ R PF
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 66 IGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G GA+G V Y+ R + VA+K L+R S A R RE+ ++ +KH+N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK-VAVKKLSRPFQSLIHAR---RTYRELRLLKHMKHENVIG 78
Query: 123 FLGACKDPLMVIVTELLPGMSLRK----YLVS----------LRPNKL-DLHVALNFALD 167
L P S+ YLV+ ++ KL D HV
Sbjct: 79 LLDV-----------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQ 126
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 227
+ R + +H+ GIIHRDLKP N+ + D + L++ DFGLAR+ + MT T + A
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQ--ADDEMTGYVATRWYRA 183
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
PE+ HYN VD++S G ++ ELL + F G
Sbjct: 184 PEIMLNWM-------HYNQTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-16
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 65 KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
++G G G V +G Y ++ VA+K+L + L+ +RE N+M ++ + +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILK---NDNNDPALKDELLREANVMQQLDNPYI 58
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
V+ +G C+ ++V EL L K+L + + ++ M L
Sbjct: 59 VRMIGICEAESWMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNF 116
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT----YRWMAPELYSTVTL 236
+HRDL N+LL Q K++DFGL++ E +W APE +
Sbjct: 117 VHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK- 174
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270
+++K DV+SFG+++WE + + P++GM
Sbjct: 175 -------FSSKSDVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 63/232 (27%)
Query: 64 SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGR---F----IREVNMMSR 114
+KIG+G G+V++ R +IVA+K + L+E F +RE+ ++
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALK----------KVLMENEKEGFPITALREIKILQL 67
Query: 115 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRK--YLV---------SLRPNKLDLHVALN 163
+KH+N+V + C+ T+ P + YLV L NK +
Sbjct: 68 LKHENVVNLIEICR-------TKATPYNRYKGSFYLVFEFCEHDLAGLLSNK-----NVK 115
Query: 164 FAL-DIARAMDCL-------HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EE 210
F L +I + M L H N I+HRD+K N+L+T D LKLADFGLAR +
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKN 174
Query: 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
+ T T + PEL GE + Y +D++ G ++ E+ T
Sbjct: 175 SKPNRYTNRVVTLWYRPPELL------LGE-RDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-16
Identities = 44/116 (37%), Positives = 68/116 (58%), Gaps = 10/116 (8%)
Query: 155 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214
+ DL+ A +A +I + LH+ GII+RDLK DN++L D +K+ADFG+ +E +
Sbjct: 92 RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGD 150
Query: 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ GT ++APE+ QG K Y VD +SFG++L+E+L + PF G
Sbjct: 151 NRASTFCGTPDYIAPEIL------QGLK--YTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-16
Identities = 69/236 (29%), Positives = 113/236 (47%), Gaps = 43/236 (18%)
Query: 65 KIGEGAHGKVYEGR-YG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
++GE GKVY+G +G + VAIK L + E L E F E M SR++H
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLRE-EFKHEAMMRSRLQH 67
Query: 118 DNLVKFLG-ACKDPLMVIVTELLPGMSLRKYLVSLRPN------------KLDLHVA--L 162
N+V LG K+ + ++ L ++LV P+ K L A +
Sbjct: 68 PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAE 219
+ IA M+ L ++ ++H+DL N+L+ D+ ++K++D GL RE + +M
Sbjct: 128 HIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 220 TGTYRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSN 272
RWM+PE +Y ++ D++S+G+VLWE+ + L P+ G SN
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDS----------DIWSYGVVLWEVFSYGLQPYCGYSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 62/262 (23%), Positives = 98/262 (37%), Gaps = 73/262 (27%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG GA G+V+ R ++ A+KVL + ++ +++ H
Sbjct: 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK---------------SDMIKRNQIAHVR 49
Query: 120 LVK-FLGACKDPLMV-------------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
+ L P +V +V E +PG L L+ R + A +
Sbjct: 50 AERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI--RKDVFPEETARFYI 107
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-------------REETV 212
++ A+D +H G IHRD+KPDN+L+ D +KLADFGL +
Sbjct: 108 AELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 213 TEMMTAET-----------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 255
GT ++APE V Y + D +S G+
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE----VLRGTP----YGLECDWWSLGV 218
Query: 256 VLWELLTNRLPFEGMSNLQAAY 277
+L+E+L PF LQ Y
Sbjct: 219 ILYEMLYGFPPFYS-DTLQETY 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-16
Identities = 69/249 (27%), Positives = 117/249 (46%), Gaps = 49/249 (19%)
Query: 60 LFIGSKIGEGAHGKVY----EG----------RYGDR--IVAIKVLNRGSTSDERALLEG 103
L + K+GEG G+V+ EG + + +VA+K+L T R
Sbjct: 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR----N 62
Query: 104 RFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 161
F++E+ +MSR+K+ N+++ LG C DPL ++TE + L ++L S R + A
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPL-CMITEYMENGDLNQFL-SQREIESTFTHA 120
Query: 162 -----------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210
L A+ IA M L + +HRDL N L+ + ++K+ADFG++R
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG-NHYTIKIADFGMSRNL 179
Query: 211 TVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL--LTNRL 265
+ + RWMA + ++ L + + DV++FG+ LWE+ L
Sbjct: 180 YSGDYYRIQGRAVLPIRWMA---WESILLGK-----FTTASDVWAFGVTLWEMFTLCKEQ 231
Query: 266 PFEGMSNLQ 274
P+ +S+ Q
Sbjct: 232 PYSLLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 68/234 (29%), Positives = 112/234 (47%), Gaps = 24/234 (10%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLNRGST---SDERALLEGRFIREVNMMSRVKHDNL 120
IG GA G+V + ++ A+K+L++ SD E R ++M+ +
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER-----DIMAFANSPWV 105
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHAN 178
V+ A +D + +V E +PG L + + P K A + ++ A+D +H+
Sbjct: 106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----ARFYTAEVVLALDAIHSM 161
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
G IHRD+KPDN+LL LKLADFG + M+ +T GT +++PE+ +
Sbjct: 162 GFIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS--- 217
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
QG +Y + D +S G+ L+E+L PF S L Y+ + S+ P
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMNHKNSLTFP 269
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-16
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKV--YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
+ + L S +G G G V + ++A KV++ G+ S R + +RE+ +M
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK----QILRELQIM 57
Query: 113 SRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIA 169
+ +V F GA + + + E + SL + P +++ +A+ +
Sbjct: 58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLT 117
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 229
+ I+HRD+KP N+L+ + +KL DFG++ E + + GT +M+PE
Sbjct: 118 YLYNVHR---IMHRDIKPSNILVN-SRGQIKLCDFGVS-GELINSIADTFVGTSTYMSPE 172
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
QG K Y K DV+S GI + EL + PF
Sbjct: 173 RI------QGGK--YTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-16
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 23/211 (10%)
Query: 66 IGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G GA+G V + R G++ VAIK L+R S+ + R RE+ ++ ++H+N++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEK-VAIKKLSRPFQSE---IFAKRAYRELTLLKHMQHENVIG 78
Query: 123 ----FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
F A ++P M + L + + L + + +H+
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYM--QTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
GIIHRDLKP NL + D + LK+ DFGLAR MT T + APE V L
Sbjct: 137 GIIHRDLKPGNLAVNEDCE-LKILDFGLARHADAE--MTGYVVTRWYRAPE----VILNW 189
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
HYN VD++S G ++ E+LT + F+G
Sbjct: 190 ---MHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-16
Identities = 72/230 (31%), Positives = 108/230 (46%), Gaps = 40/230 (17%)
Query: 66 IGEGAHGKVYEG---RYGDRI-VAIKVLNR-GSTSDERALLEGRFIREVNMMSRV-KHDN 119
IGEG G+V + + G R+ AIK + S D R F E+ ++ ++ H N
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-----DFAGELEVLCKLGHHPN 57
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--------------LNF 164
++ LGAC+ + + E P +L +L R + D A L+F
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 224
A D+AR MD L IHRDL N+L+ + + K+ADFGL+R + V T R
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRLPVR 176
Query: 225 WMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271
WMA E YS Y DV+S+G++LWE+++ P+ GM+
Sbjct: 177 WMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-16
Identities = 61/207 (29%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 65 KIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFL 124
+IG G GKV G +V+ + + +F+ E ++H NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 125 GACKDPL-MVIVTELLPGMSLRKYLVSLRPNKL---DLHVALNFALDIARAMDCLHANGI 180
G C + ++V E P L+ YL S R +L D A +IA + LH N
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF 121
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTV--- 234
IH DL N LLT D ++K+ D+GL+ + + + RW+APEL V
Sbjct: 122 IHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELL 261
L + K N V+S G+ +WEL
Sbjct: 181 LLVVDQTKESN----VWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 6e-16
Identities = 75/221 (33%), Positives = 103/221 (46%), Gaps = 42/221 (19%)
Query: 66 IGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG GA G V Y+ DR VAIK L+R + A R RE+ +M V H N++
Sbjct: 25 IGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVNHKNIIS 80
Query: 123 FLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLHVALNFALDIAR------AM 172
L P SL + YLV + +L + LD R M
Sbjct: 81 LLNV-----------FTPQKSLEEFQDVYLV-MELMDANLCQVIQMELDHERMSYLLYQM 128
Query: 173 DC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR + MMT T + AP
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
E V L G Y VD++S G ++ E++ +++ F G
Sbjct: 188 E----VILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-16
Identities = 70/219 (31%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG GA G V +R VAIK L+R + A R RE+ +M V H N++
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVNHKNIIGL 88
Query: 124 LGACKDPLMVIVTELLPGMSLRKY---LVSLRPNKLDLHVALNFALDIAR------AMDC 174
L P SL ++ + + +L + LD R M C
Sbjct: 89 LNV-----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC 137
Query: 175 ----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 230
LH+ GIIHRDLKP N+++ D +LK+ DFGLAR + MMT T + APE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE- 195
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
V L G Y VD++S G ++ E++ + F G
Sbjct: 196 ---VILGMG----YKENVDIWSVGCIMGEMIKGGVLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-16
Identities = 46/212 (21%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125
I E +Y+G + ++ V I+ + + L++ E+ + R+ +N++K G
Sbjct: 28 IKENDQNSIYKGIFNNKEVIIRTFKKFHK-GHKVLID-ITENEIKNLRRIDSNNILKIYG 85
Query: 126 ACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NG 179
D P + ++ E LR+ L + L L+ A+D + + L+
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
+++L + L+T + K LK+ GL + + Y + ++ + +
Sbjct: 144 KPYKNLTSVSFLVTENYK-LKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIF---- 196
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
Y K D+YS G+VLWE+ T ++PFE ++
Sbjct: 197 --SEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226
|
Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-15
Identities = 70/259 (27%), Positives = 118/259 (45%), Gaps = 64/259 (24%)
Query: 58 KLLFIGSKIGEGAHGKVY----EG--RYGDR------------IVAIKVLNRGSTSDERA 99
K L K+GEG G+V+ EG ++ D+ +VA+K+L + + R
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR- 63
Query: 100 LLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNK-- 155
F++E+ +MSR+K N+++ L C DPL +I TE + L ++L P +
Sbjct: 64 ---NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMI-TEYMENGDLNQFLSRHEPQEAA 119
Query: 156 -------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
+ + A IA M L + +HRDL N L+ + ++K+ADFG++R
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY-TIKIADFGMSR 178
Query: 209 EETVTEMMTAETGTY-----------RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
+G Y RWM+ E ++ L + + DV++FG+ L
Sbjct: 179 --------NLYSGDYYRIQGRAVLPIRWMSWE---SILLGK-----FTTASDVWAFGVTL 222
Query: 258 WELLT--NRLPFEGMSNLQ 274
WE+LT P+ +S+ Q
Sbjct: 223 WEILTLCKEQPYSQLSDEQ 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-15
Identities = 60/235 (25%), Positives = 111/235 (47%), Gaps = 19/235 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I KIG G +VY VA+K + D +A I+E++++ ++ H N
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKA--RADCIKEIDLLKQLNHPN 63
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH 176
++K+ + +D + IV EL L + + + K + + + + A++ +H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVT 235
+ ++HRD+KP N+ +T +KL D GL R + T + GT +M+PE
Sbjct: 124 SRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE------ 176
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
+ + YN K D++S G +L+E+ + PF G + Y+ K+++ Y P
Sbjct: 177 --RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 1e-15
Identities = 52/181 (28%), Positives = 83/181 (45%), Gaps = 27/181 (14%)
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGM 142
V +K+ +G+T L+E ++ VN H ++++ + +V LP
Sbjct: 94 VVLKIGQKGTT-----LIEAMLLQNVN------HPSVIRMKDTLVSGAITCMV---LPHY 139
Query: 143 S--LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
S L YL + R L + AL I + LHA IIHRD+K +N+ + D +
Sbjct: 140 SSDLYTYL-TKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN-DVDQVC 197
Query: 201 LADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260
+ D G A+ V GT APE+ + + YN+K D++S GIVL+E+
Sbjct: 198 IGDLGAAQFPVVAPAFLGLAGTVETNAPEVLA--------RDKYNSKADIWSAGIVLFEM 249
Query: 261 L 261
L
Sbjct: 250 L 250
|
Length = 357 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-15
Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G G+V + ++ A K L++ + E + E ++ +V +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG--EQMALNEKKILEKVSSRFIVSL 58
Query: 124 LGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
A KD L +++T L+ G L+ ++ ++ A+ +A I ++ LH I+
Sbjct: 59 AYAFETKDDLCLVMT-LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
+RDLKP+N+LL D +++++D GLA E + + GT +MAPE+ +
Sbjct: 118 YRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--------QG 168
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPF 267
+ Y+ VD ++ G L+E++ R PF
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-15
Identities = 66/219 (30%), Positives = 113/219 (51%), Gaps = 21/219 (9%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
++G G +G VY+ R + + A+K++ + D+ +L++ +E+ M+ KH N+V
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDFSLIQ----QEIFMVKECKHCNIVA 70
Query: 123 FLGA--CKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ G+ ++ L I E G SL+ Y V+ ++L + L + + LH+ G
Sbjct: 71 YFGSYLSREKLW-ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL---QGLAYLHSKG 126
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQ 238
+HRD+K N+LLT D +KLADFG+A + T T + GT WMAPE+ + V
Sbjct: 127 KMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV-AAVEKNG 184
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
G YN D+++ GI EL + P + ++A +
Sbjct: 185 G----YNQLCDIWAVGITAIELAELQPPMFDLHPMRALF 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 57/184 (30%), Positives = 96/184 (52%), Gaps = 19/184 (10%)
Query: 95 SDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP 153
+DER R E++ ++ H +VK K D ++++ E G L K +
Sbjct: 104 NDERQAAYAR--SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLK 161
Query: 154 NKL---DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210
L + V L F I A+D +H+ ++HRDLK N+ L P +KL DFG +++
Sbjct: 162 EHLPFQEYEVGLLF-YQIVLALDEVHSRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQY 219
Query: 211 TVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ + ++ ++ GT ++APEL+ E+K Y+ K D++S G++L+ELLT PF
Sbjct: 220 SDSVSLDVASSFCGTPYYLAPELW--------ERKRYSKKADMWSLGVILYELLTLHRPF 271
Query: 268 EGMS 271
+G S
Sbjct: 272 KGPS 275
|
Length = 478 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 45/115 (39%), Positives = 62/115 (53%), Gaps = 25/115 (21%)
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---------------EETVTEM 215
A++ LH GI+HRDLKPDNLL+T +KL DFGL++ E+ E
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 216 MTAET-GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ + GT ++APE V LRQG Y VD ++ GI+L+E L +PF G
Sbjct: 172 LDKQVCGTPEYIAPE----VILRQG----YGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 27/215 (12%)
Query: 66 IGEGAHGK--VYEGRYGDRIVAIKVL----NRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+GEG+ G+ + + D+ A+K + + + D R +E +++++KH N
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR--------KEAVLLAKMKHPN 59
Query: 120 LVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V F + + D + IV E G L + + R L + + + + +H
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
++HRD+K N+ LT + K +KL DFG AR T + A T GT ++ PE++
Sbjct: 120 RVLHRDIKSKNIFLTQNGK-VKLGDFGSARLLT-SPGAYACTYVGTPYYVPPEIW----- 172
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
E YNNK D++S G +L+EL T + PF+ S
Sbjct: 173 ---ENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-15
Identities = 71/268 (26%), Positives = 123/268 (45%), Gaps = 24/268 (8%)
Query: 10 RVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEG 69
++ E+E++ + G E E + + + I+RS KL G+ IG G
Sbjct: 30 MNDKKLDEEERSHNNNAGEDEDEEKMIDND---------INRSPNKSYKL---GNIIGNG 77
Query: 70 AHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127
+ G VYE D VAIK + + R LL + + +N++ + F
Sbjct: 78 SFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137
Query: 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN--FALDIARAMDCLHANGIIHRDL 185
K+ + +V E +P ++ KY+ N L + L ++ + RA+ +H+ I HRDL
Sbjct: 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDL 196
Query: 186 KPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 245
KP NLL+ P+ +LKL DFG A+ + + + + APEL T +Y
Sbjct: 197 KPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT-------NYT 249
Query: 246 NKVDVYSFGIVLWELLTNRLPFEGMSNL 273
+D++S G ++ E++ F G S++
Sbjct: 250 THIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 62/221 (28%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVK 122
IG GA G V + + I+A+K + ST DE+ + R + +++ +M +VK
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIR--STVDEKE--QKRLLMDLDVVMRSSDCPYIVK 67
Query: 123 FLGA---------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
F GA C + LM I + KY+ + + + + A+ +A++
Sbjct: 68 FYGALFREGDCWICME-LMDISLDKF-----YKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 174 CLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
L IIHRD+KP N+LL ++KL DFG++ + + T + G +MAPE
Sbjct: 122 YLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 180
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
R G Y+ + DV+S GI L+E+ T + P+ +++
Sbjct: 181 PSA-RDG----YDVRSDVWSLGITLYEVATGKFPYPKWNSV 216
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 42/225 (18%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG G++ KV E + RI A+KV+ + +D+ +++ + KH F
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDE---------DIDWVQTEKH----VF 49
Query: 124 LGACKDPLMV-------------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
A P +V V E + G L ++ R KL A ++ +I+
Sbjct: 50 ETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISL 107
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPE 229
A++ LH GII+RDLK DN+LL + +KL D+G+ +E T+ GT ++APE
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPE 166
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE--GMSN 272
+ LR GE Y VD ++ G++++E++ R PF+ GMS+
Sbjct: 167 I-----LR-GED--YGFSVDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-15
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 38/234 (16%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRG--STSDERALLEGRFIREVNMMSR 114
+G +G+G G V E + + VA+K+L S+SD +E F+RE M
Sbjct: 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD----IE-EFLREAACMKE 57
Query: 115 VKHDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALN 163
H N++K +G + P+ +++ + L +L+ R P L L +
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TAET 220
F +DIA M+ L + IHRDL N +L + ++ +ADFGL+++ + A
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 221 GTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
+W+A E L V Y DV++FG+ +WE++T + P+ G+ N
Sbjct: 177 LPVKWLALESLADNV---------YTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-15
Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 19/218 (8%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+IG G +G VY+ R + + AIKV+ D + + E+ MM KH N+V
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ-----EIIMMKDCKHSNIVA 70
Query: 123 FLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ G+ +D L I E G SL+ P + +A + + + + LH+ G
Sbjct: 71 YFGSYLRRDKLW-ICMEFCGGGSLQDIYHVTGPLS-ESQIAY-VSRETLQGLYYLHSKGK 127
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQG 239
+HRD+K N+LLT D +KLADFG++ + T T + GT WMAPE+ +
Sbjct: 128 MHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV-----E 181
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
K YN D+++ GI EL + P + ++A +
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 5e-15
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 35/223 (15%)
Query: 65 KIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVK-HDNLVK 122
++G+GA+G V R + V + T+ + +L R +RE+ ++ + H N+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 123 FLGACKDPLMVIVT----------ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
M IV E L L + + S +P D H +F I +
Sbjct: 67 LYD------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLT-DAHFQ-SFIYQILCGL 118
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWM- 226
+H+ ++HRDLKP NLL+ D + LK+ DFGLAR MT T RW
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSENPGENAGFMTEYVAT-RWYR 176
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
APE+ + + Y +DV+S G +L ELL + F+G
Sbjct: 177 APEIMLSF-------QSYTKAIDVWSVGCILAELLGRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 39/231 (16%)
Query: 66 IGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G G++G V+ D+ VA+K + +D +++ +RE+ ++ R+ HDN+VK
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHA--LREIKIIRRLDHDNIVKV 67
Query: 124 ---LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN-----------FALDIA 169
LG L V L L + + DL L F +
Sbjct: 68 YEVLGPSGSDLTEDVGSL---TELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL 124
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR------EETVTEMMTAETGTY 223
R + +H+ ++HRDLKP N+ + + LK+ DFGLAR T Y
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWY 184
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
R +P L + +Y +D+++ G + E+LT + F G L+
Sbjct: 185 R--SPRLLLSPN-------NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-15
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G G G VY+ + RI+A+KV+ T + L+ + + E+ ++ + ++ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE----LQKQIMSELEILYKCDSPYIIGF 64
Query: 124 LGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
GA + + I TE + G SL Y K+ HV A+ + + + L + I+H
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILH 118
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 242
RD+KP N+L+ + +KL DFG++ + V + GT +MAPE S GE+
Sbjct: 119 RDVKPSNMLVN-TRGQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERIS------GEQ- 169
Query: 243 HYNNKVDVYSFGIVLWELLTNRLPF 267
Y DV+S GI EL R P+
Sbjct: 170 -YGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-15
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+GEGA+G V + R+ + IVAIK + S+E ++ +RE+ M+ +K +N+V+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIK---KFKDSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 124 LGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
A + + +V E + L L+ PN + ++ + +A+ H N I+H
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123
Query: 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 242
RD+KP+NLL++ + LKL DFG AR ++E A Y +A Y + L G
Sbjct: 124 RDIKPENLLISHND-VLKLCDFGFAR--NLSEGSNANYTEY--VATRWYRSPELLLGAP- 177
Query: 243 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
Y VD++S G +L EL + F G S +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRG----STSDERALLEGRFIREVNMMSRVKHDN 119
+G+G+ GKV R R+ A+KVL + E + E R + ++R H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILS----LAR-NHPF 57
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
L + + P + V E + G L ++ R + D A +A +I A+ LH
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK 115
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLR 237
GII+RDLK DN+LL + KLADFG+ +E T+ GT ++APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHC-KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL------ 168
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
++ Y VD ++ G++L+E+L PFE
Sbjct: 169 --QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 60/241 (24%), Positives = 98/241 (40%), Gaps = 58/241 (24%)
Query: 61 FIGSKIGEGAHGKVYEGR----YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
G IG G +G+VY+ + + AIK ++ + RE+ ++ +K
Sbjct: 4 IEG-CIGRGTYGRVYKAKRKNGKDGKEYAIKKFK--GDKEQYTGISQSACREIALLRELK 60
Query: 117 HDNLVKFLGACKDPLMVIVTELLPGMSL-----------------RKYLVSLRPN--KLD 157
H+N+V + V + + L + VS+ P+ K
Sbjct: 61 HENVVSLVE-------VFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAR------ 208
L LN + LH+N ++HRDLKP N+L+ P++ +K+ D GLAR
Sbjct: 114 LWQILN-------GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
+ T YR APEL +HY +D+++ G + ELLT F+
Sbjct: 167 KPLADLDPVVVTIWYR--APELLLGA-------RHYTKAIDIWAIGCIFAELLTLEPIFK 217
Query: 269 G 269
G
Sbjct: 218 G 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 67/234 (28%), Positives = 106/234 (45%), Gaps = 34/234 (14%)
Query: 62 IGSKIGEGAHGKVYE--GRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I IG+G +GKV++ + A+K+L+ DE E ++ ++ H N
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPN 76
Query: 120 LVKFLG-------ACKDPLMVI--------VTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
+VKF G D L ++ VT+L+ G R R + + L+
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR----GERMEEPIIAYILHE 132
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTY 223
AL + LH N IHRD+K +N+LLT + +KL DFG++ + T T + GT
Sbjct: 133 AL---MGLQHLHVNKTIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
WMAPE+ + Q Y+ + DV+S GI EL P + ++A +
Sbjct: 189 FWMAPEV---IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 40/112 (35%), Positives = 67/112 (59%), Gaps = 12/112 (10%)
Query: 160 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 219
A+ +A +IA + LH+ GII+RDLK DN++L + +K+ADFG+ +E + T
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKEN-IFGGKTTR 159
Query: 220 T--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
T GT ++APE+ + + Y VD ++FG++L+E+L + PF+G
Sbjct: 160 TFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 26/211 (12%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLV- 121
IG+G+ GKV R+ ++ A+KVL + + ++ E + E N ++ VKH LV
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVKHPFLVG 60
Query: 122 -KFLGACKDPLMVIVTELLPG---MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
F D L ++ + G L++ L P A +A +IA A+ LH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR------ARFYAAEIASALGYLHS 114
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTL 236
I++RDLKP+N+LL Q + L DFGL +E T+ GT ++APE+
Sbjct: 115 LNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL----- 168
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
K+ Y+ VD + G VL+E+L PF
Sbjct: 169 ---HKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 67/259 (25%), Positives = 115/259 (44%), Gaps = 60/259 (23%)
Query: 60 LFIGSKIGEGAHGKVY--------------------EGRYGDRIVAIKVLNRGSTSDERA 99
L K+GEG G+V+ +GR +VA+K+L + + R
Sbjct: 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGR--PLLVAVKILRPDANKNARN 64
Query: 100 LLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNK-- 155
F++EV ++SR+K N+++ LG C +DPL ++TE + L ++L S +
Sbjct: 65 ----DFLKEVKILSRLKDPNIIRLLGVCVDEDPL-CMITEYMENGDLNQFLSSHHLDDKE 119
Query: 156 ---------------LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
+ L+ AL IA M L + +HRDL N L+ + ++K
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG-ENLTIK 178
Query: 201 LADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
+ADFG++R + + RWMA E + G+ + DV++FG+ L
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE-----CILMGK---FTTASDVWAFGVTL 230
Query: 258 WELLT--NRLPFEGMSNLQ 274
WE+L P+ +++ Q
Sbjct: 231 WEILMLCKEQPYGELTDEQ 249
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 30/213 (14%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+IG GA G VY+ + R+ A+KV+ G+ D + + RE+ ++ V H N+VK
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDT---VRRQICREIEILRDVNHPNVVK 136
Query: 123 FLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
C D + ++ E + G SL ++ D+ A I + LH
Sbjct: 137 ----CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV------ARQILSGIAYLHR 186
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTV 234
I+HRD+KP NLL+ K++K+ADFG++R + + M + GT +M+PE +T
Sbjct: 187 RHIVHRDIKPSNLLIN-SAKNVKIADFGVSR--ILAQTMDPCNSSVGTIAYMSPERINT- 242
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
L G Y D++S G+ + E R PF
Sbjct: 243 DLNHGAYDGYAG--DIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 65/232 (28%), Positives = 113/232 (48%), Gaps = 43/232 (18%)
Query: 66 IGEGAHGKVY-----EGRYGDRIVAIKVLNRGS----------TSDERALLEGRFIREVN 110
+G GA+GKV+ G ++ A+KVL + + T ER +LE IR+
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE--HIRQSP 65
Query: 111 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS---LRPNKLDLHVALNFALD 167
+ + + D + ++ + + G L +L + ++ ++ +
Sbjct: 66 FLVTLHY-------AFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-----E 113
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRW 225
I A++ LH GII+RD+K +N+LL + + L DFGL++E E E + GT +
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQA 275
MAP++ +R G+ H + VD +S G++++ELLT PF +G N QA
Sbjct: 173 MAPDI-----VRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 61/236 (25%), Positives = 115/236 (48%), Gaps = 21/236 (8%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I KIG G +VY + VA+K + D +A + ++E++++ ++ H N
Sbjct: 6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQD--CVKEIDLLKQLNHPN 63
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH 176
++K+L + +D + IV EL L + + + K + + + + A++ +H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVT 235
+ ++HRD+KP N+ +T +KL D GL R + T + GT +M+PE
Sbjct: 124 SRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE------ 176
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKVQESIYAP 290
+ + YN K D++S G +L+E+ + PF G NL ++ K+++ Y P
Sbjct: 177 --RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLCQKIEQCDYPP 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 39/137 (28%), Positives = 78/137 (56%), Gaps = 9/137 (6%)
Query: 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 191
+ +V L+ G L+ ++ ++ L++ ++++ I + LH+ I++RD+KP+N+L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 192 LTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 251
L DQ + +L+D GLA E + +T GT +MAPE+ +++ Y+ VD +
Sbjct: 128 LD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--------KEEPYSYPVDWF 178
Query: 252 SFGIVLWELLTNRLPFE 268
+ G ++E++ R PF+
Sbjct: 179 AMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSD----ERALLEGRFIREVNMMSRVKHDN 119
+G+G+ GKV E + D + AIKVL + + + E R + ++ KH
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRIL----ALAA-KHPF 57
Query: 120 LVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
L L C KD L V E + G L + R K D + +A ++ A+ LH
Sbjct: 58 LTA-LHCCFQTKDRLF-FVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLH 113
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVT 235
+G+I+RDLK DN+LL + KLADFG+ +E + + T GT ++APE+
Sbjct: 114 RHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEIL---- 168
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
++ Y VD ++ G++++E++ + PFE
Sbjct: 169 ----QELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-14
Identities = 64/228 (28%), Positives = 105/228 (46%), Gaps = 42/228 (18%)
Query: 64 SKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+IGEG +G+VY+ R +VA+K + +E+ IRE+ ++ ++ H N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 122 KFLGACKDPLMVIVTELLPGMSLRK-----YLV---------SLRPNKL----DLHVALN 163
L IVT+ + +K YLV L + L + H+ +
Sbjct: 70 N--------LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-S 120
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETG 221
F + ++ H +HRD+K N+LL ++ +KLADFGLAR + T +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
T + PEL GE++ Y +DV+S G +L EL T + F+
Sbjct: 180 TLWYRPPELL------LGEER-YGPAIDVWSCGCILGELFTKKPIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 41/111 (36%), Positives = 70/111 (63%), Gaps = 12/111 (10%)
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220
A+ +A +IA + LH+ GII+RDLK DN++L + +K+ADFG+ + E + + +T +T
Sbjct: 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCK-ENMWDGVTTKT 160
Query: 221 --GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
GT ++APE+ + + Y VD ++FG++L+E+L + PFEG
Sbjct: 161 FCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-14
Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G G+V + R ++ A K LN+ +R EG + E ++++V +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMV-EKRILAKVHSRFIVSL 58
Query: 124 LGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLHANG 179
A K L +++T ++ G LR ++ ++ A + I ++ LH
Sbjct: 59 AYAFQTKTDLCLVMT-IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQ 238
II+RDLKP+N+LL + +++++D GLA E + T GT +MAPEL Q
Sbjct: 118 IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL------Q 170
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
GE+ Y+ VD ++ G+ L+E++ R PF
Sbjct: 171 GEE--YDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 72/226 (31%), Positives = 102/226 (45%), Gaps = 44/226 (19%)
Query: 66 IGEGAHGKVYEGRYGDRI----VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
IG GA G V D + VA+K L+R + A R RE+ ++ V H N++
Sbjct: 29 IGSGAQGIVCAAF--DTVLGINVAVKKLSRPFQNQTHA---KRAYRELVLLKCVNHKNII 83
Query: 122 KFLGACKDPLMVIVTELLPGMSLRK----YLVSLRPNKLDLHVALNFALDIAR------A 171
L P SL + YLV + +L ++ LD R
Sbjct: 84 SLLNV-----------FTPQKSLEEFQDVYLV-MELMDANLCQVIHMELDHERMSYLLYQ 131
Query: 172 MDC----LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 227
M C LH+ GIIHRDLKP N+++ D +LK+ DFGLAR MMT T + A
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRA 190
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
PE V L G Y VD++S G ++ EL+ + F+G ++
Sbjct: 191 PE----VILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-14
Identities = 36/106 (33%), Positives = 61/106 (57%), Gaps = 12/106 (11%)
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 221
+ +I A+ LH+ +++RDLK +NL+L D +K+ DFGL +E +++ T +T G
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEG-ISDGATMKTFCG 157
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
T ++APE+ E Y VD + G+V++E++ RLPF
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-14
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG+G G+VY+ R D RI A+KVL++ ++ + I E N++ R D F
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEV--AHTIGERNILVRTLLDE-SPF 57
Query: 124 LGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+ K D + +VT+ + G L +L + + A + ++ A++ LH
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
I++RDLKP+N+LL + L DFGL++ +T+ T T GT ++APE V L
Sbjct: 116 DIVYRDLKPENILLDAT-GHIALCDFGLSKAN-LTDNKTTNTFCGTTEYLAPE----VLL 169
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
++K Y VD +S G++++E+ PF
Sbjct: 170 ---DEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 50/217 (23%), Positives = 87/217 (40%), Gaps = 36/217 (16%)
Query: 66 IGEGAHGKVYEGRY--------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH 117
+G+G +Y+G + V+ + SD R L F ++MS++ H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--FFETASLMSQLSH 60
Query: 118 DNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+LVK G C ++V E + L +L N + LH L+ A +A A+ L
Sbjct: 61 KHLVKLYGVCVRDENIMVEEYVKFGPLDVFL-HREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 178 NGIIHRDLKPDNLLLTPD------QKSLKLADFGLAREETVTEMMTAETGTYR-----WM 226
++H ++ N+L+ +KL+D G+ +T + R W+
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--------ITVLSREERVERIPWI 171
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 263
APE + + D +SFG L E+ +N
Sbjct: 172 APECI------RNGQASLTIAADKWSFGTTLLEICSN 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 68/273 (24%), Positives = 109/273 (39%), Gaps = 81/273 (29%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDE-RALLE--------G 103
L +G +G GA GKV + R VA+K+L G+T+ E +AL+ G
Sbjct: 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG 68
Query: 104 RFIREVNMMSRV--------------KHDNLVKFLGA----------------------- 126
+ VN++ K NL +L +
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEG 128
Query: 127 CKDPLMVIV---TELLPGMSLRKYLVSLRPNK---------LDLHVALNFALDIARAMDC 174
K L + + G K L + ++ L L ++++ +AR M+
Sbjct: 129 KKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEF 188
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----WMAPE- 229
L + IHRDL N+LL+ + +K+ DFGLAR+ + G R WMAPE
Sbjct: 189 LASRKCIHRDLAARNILLS-ENNVVKICDFGLARD-IYKDPDYVRKGDARLPLKWMAPES 246
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
++ V Y + DV+SFG++LWE+ +
Sbjct: 247 IFDKV---------YTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 39/106 (36%), Positives = 62/106 (58%), Gaps = 12/106 (11%)
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 221
+ +I A+D LH+ I++RDLK +NL+L D +K+ DFGL + E +T+ T +T G
Sbjct: 100 YGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCK-EGITDAATMKTFCG 157
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
T ++APE+ E Y VD + G+V++E++ RLPF
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 39/111 (35%), Positives = 68/111 (61%), Gaps = 12/111 (10%)
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220
A+ +A +I+ + LH GII+RDLK DN++L + +K+ADFG+ +E V + +T T
Sbjct: 103 AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMV-DGVTTRT 160
Query: 221 --GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
GT ++APE+ + + Y VD +++G++L+E+L + PF+G
Sbjct: 161 FCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 62 IGSKIGEGAHGKVYEGRYGDR--IVAIKVLNRGST----SDERALLEGRFIRE------V 109
+G +G G+ G+V ++ AIK L + + E + E V
Sbjct: 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 110 NMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
NMM + +N V FL E + G L +L + VA + ++
Sbjct: 82 NMMCSFQDENRVYFL-----------LEFVVGGELFTHLRK--AGRFPNDVAKFYHAELV 128
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYRWMAP 228
A + LH+ II+RDLKP+NLLL D K +K+ DFG A++ V + GT ++AP
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLL--DNKGHVKVTDFGFAKK--VPDRTFTLCGTPEYLAP 184
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
E+ + K + VD ++ G++L+E + PF
Sbjct: 185 EVI--------QSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 57/247 (23%), Positives = 105/247 (42%), Gaps = 45/247 (18%)
Query: 65 KIGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G+G G+V+ + ++ A+KVL++ + +E+ ++ + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLPT 65
Query: 123 FLGACKDPLMVI-VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + + V + PG L + L L VA +A ++ A++ LH GI+
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLA----------------------REETVTEMMTAE 219
+RDLKP+N+LL + L+DF L+ +E + E
Sbjct: 126 YRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEE 184
Query: 220 T--------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
GT ++APE+ S + + VD ++ GI+L+E+L PF+G S
Sbjct: 185 PSFRSNSFVGTEEYIAPEVIS--------GDGHGSAVDWWTLGILLYEMLYGTTPFKG-S 235
Query: 272 NLQAAYA 278
N ++
Sbjct: 236 NRDETFS 242
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 44/121 (36%), Positives = 66/121 (54%), Gaps = 17/121 (14%)
Query: 156 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215
LDL L F+ +A+ MD L + IHRD+ N+LLT D + K+ DFGLAR + + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLAR-DIMNDS 266
Query: 216 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269
G R WMAPE ++ V Y + DV+S+GI+LWE+ + + P+ G
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCV---------YTVQSDVWSYGILLWEIFSLGKSPYPG 317
Query: 270 M 270
+
Sbjct: 318 I 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 40/219 (18%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG G++ KV R D+I A+KV+ + D+ +++ + KH F
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE---------DIDWVQTEKH----VF 49
Query: 124 LGACKDPLMV-------------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
A +P +V +V E + G L ++ R KL A +A +I
Sbjct: 50 EQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAEICI 107
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPE 229
A++ LH GII+RDLK DN+LL D +KL D+G+ +E T+ GT ++APE
Sbjct: 108 ALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPE 166
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
+ +GE+ Y VD ++ G++++E++ R PF+
Sbjct: 167 IL------RGEE--YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 43/121 (35%), Positives = 64/121 (52%), Gaps = 17/121 (14%)
Query: 156 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215
LD L+F+ +A+ M L + IHRDL N+LLT + + K+ DFGLAR+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIR-NDS 268
Query: 216 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269
G R WMAPE +++ V Y + DV+S+GI+LWE+ + P+ G
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCV---------YTFESDVWSYGILLWEIFSLGSSPYPG 319
Query: 270 M 270
M
Sbjct: 320 M 320
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG G++ KV R +RI A+KV+ + +D+ + E ++ + + +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDI--DWVQTEKHVFEQASNHPFLVG 60
Query: 124 LGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L +C + + V E + G L ++ R KL A ++ +I+ A++ LH GII
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLALNYLHERGII 118
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGE 240
+RDLK DN+LL + +KL D+G+ +E T+ GT ++APE+ +GE
Sbjct: 119 YRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL------RGE 171
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFE 268
Y VD ++ G++++E++ R PF+
Sbjct: 172 D--YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRG---STSDERALLEGRFIREVNMMSRVKHDNL 120
IG+G+ GKV + R D RI A+K + + S S+ L R ++++V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAER-----TVLAQVNCPFI 55
Query: 121 V--KFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
V KF + L +V + G L +L R + DL A + ++ A++ LH
Sbjct: 56 VPLKFSFQSPEKLY-LVLAFINGGELFHHL--QREGRFDLSRARFYTAELLCALENLHKF 112
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVTLR 237
+I+RDLKP+N+LL Q + L DFGL + + GT ++APEL
Sbjct: 113 NVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-- 169
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
Y VD ++ G++L+E+LT PF
Sbjct: 170 ------YTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-13
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 65 KIGEGAHGKV-----YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+IG G GKV Y R+V +K L ++S E + F+++ + ++H N
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVV-VKELKANASSKE----QNEFLQQGDPYRILQHPN 56
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL--NFALDIARAMDCLH 176
+++ LG C + + ++V E L+ YL + ++ + + L A +IA + +H
Sbjct: 57 ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAPELYST 233
+ +H DL N LT D ++K+ D+G+ + + E RW+APEL
Sbjct: 117 KHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL--- 172
Query: 234 VTLRQG-----EKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
V G E+ +N V++ G+ LWEL N P+ +S+ +
Sbjct: 173 VGEFHGGLITAEQTKPSN---VWALGVTLWELFENAAQPYSHLSDRE 216
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLV- 121
IG+G+ GKV + + + A+KVL + + + + + E N ++ VKH LV
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE--QKHIMAERNVLLKNVKHPFLVG 60
Query: 122 ---KFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
F K + V + + G L +L R A +A +IA A+ LH+
Sbjct: 61 LHYSFQTTEK---LYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLR 237
I++RDLKP+N+LL Q + L DFGL +E ++ T GT ++APE+ +R
Sbjct: 116 NIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV-----IR 169
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
K+ Y+N VD + G VL+E+L PF
Sbjct: 170 ---KQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 47/231 (20%)
Query: 62 IGSKIGEGAHGKV---YEGRYGDRIVAIKVLNR--GSTSDERALLEGRFIREVNMMSRVK 116
I IG+G++G V + G++ VAIK +N SD R +RE+ ++ ++
Sbjct: 4 IQEVIGKGSYGVVCSAIDTHTGEK-VAIKKINDVFEHVSDAT-----RILREIKLLRLLR 57
Query: 117 HDNLVKFLGACKDPLMVIVTELLPG--MSLRKYLVSLRPNKLDLHVALN----------- 163
H ++V+ I +LP + V + DLH +
Sbjct: 58 HPDIVE-----------IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQ 106
Query: 164 -FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAE 219
F + RA+ +H + HRDLKP N+L D K LK+ DFGLAR +T T + +
Sbjct: 107 FFLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTD 165
Query: 220 TGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
RW APEL + + Y +D++S G + E+LT + F G
Sbjct: 166 YVATRWYRAPELCGSFFSK------YTPAIDIWSIGCIFAEVLTGKPLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVK 122
IG+G+ GKV + A+KVL + + ++ + + E N ++ +KH LV
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE--QNHIMAERNVLLKNLKHPFLVG 60
Query: 123 FLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ + + V + + G L +L R A +A ++A A+ LH+ II
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGE 240
+RDLKP+N+LL Q + L DFGL +E E T+ GT ++APE+ LR
Sbjct: 119 YRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV-----LR--- 169
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPF 267
K+ Y+ VD + G VL+E+L PF
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 32/158 (20%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
I GA GKVY GR + ++ A+KV+ + ++ NM+ +V+ +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK------------NMVHQVQAER--DA 57
Query: 124 LGACKDPLMV-------------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
L K P +V +V E L G ++ L D +A+ + ++A
Sbjct: 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVAL 115
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
A+D LH +GIIHRDLKPDN+L++ ++ +KL DFGL++
Sbjct: 116 ALDYLHRHGIIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 35/106 (33%), Positives = 62/106 (58%), Gaps = 12/106 (11%)
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 221
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL + E +++ T +T G
Sbjct: 100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCK-EGISDGATMKTFCG 157
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
T ++APE+ E Y VD + G+V++E++ RLPF
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 41/118 (34%), Positives = 63/118 (53%), Gaps = 23/118 (19%)
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 221
L+F +AR M+ L + +HRDL N+LL K +K+ DFGLAR+ ++
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 222 TY---RWMAPE-----LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270
T+ +WMAPE LY+T++ DV+S+GI+LWE+ + P+ GM
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLS-------------DVWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 38/229 (16%)
Query: 66 IGEGAHGKVY-----EGRYGDRIVAIKVLNRGS----------TSDERALLEGRFIREVN 110
+G GA+GKV+ G ++ A+KVL + + T ER +LE +R+
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE--HVRQSP 65
Query: 111 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+ + + F K + ++ + + G + +L R N + V ++ +I
Sbjct: 66 FLVTLHY----AFQTEAK---LHLILDYVSGGEMFTHLYQ-RDNFSEDEVRF-YSGEIIL 116
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAP 228
A++ LH GI++RD+K +N+LL + + L DFGL++E E + GT +MAP
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQA 275
E+ +G+ H VD +S GI+++ELLT PF EG N Q+
Sbjct: 176 EII------RGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-12
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERAL--LEGRFI-----REVNMMSRV 115
G K+G G +G VY+ + D G E AL +EG I RE+ ++ +
Sbjct: 6 GCKVGRGTYGHVYKAKRKD----------GKDEKEYALKQIEGTGISMSACREIALLREL 55
Query: 116 KHDNLVK----FLGACKDPLMVIVT----ELLPGMSL-RKYLVSLRPNKLDLHVALNFAL 166
KH N++ FL + ++ +L + R + +P +L + +
Sbjct: 56 KHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLY 115
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAREETVTEMMTAETG-- 221
I + LHAN ++HRDLKP N+L+ P++ +K+AD G AR A+
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 222 --TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
T+ + APEL +HY +D+++ G + ELLT+ F
Sbjct: 176 VVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 40/233 (17%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG+G G+VY R VA+K + R S+ LL+ RF+RE + + + H +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN-PLLKKRFLREAKIAADLIHPGIVP 66
Query: 123 FLGACKDPLMVIVT-ELLPGMSLRKYLVSLRPN---KLDLHVA------LNFALDIARAM 172
C D V T + G +L+ L S+ +L L+ I +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 173 DCLHANGIIHRDLKPDNLLL---------------TPDQKSLKLADFGLAREETVTEMMT 217
+ +H+ G++HRDLKPDN+LL + L D + MT
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 218 AE---TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
GT +MAPE L + D+Y+ G++L+++LT P+
Sbjct: 187 IPGKIVGTPDYMAPE-----RLLGVPA---SESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 43/133 (32%), Positives = 70/133 (52%), Gaps = 27/133 (20%)
Query: 140 PGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 197
P + R L++ P + +DL + F+ +A M+ L + +HRDL N+L+ + K
Sbjct: 221 PERTRRDTLINESPALSYMDL---VGFSYQVANGMEFLASKNCVHRDLAARNVLIC-EGK 276
Query: 198 SLKLADFGLAREETVTEMMTAETGTY---RWMAPE-----LYSTVTLRQGEKKHYNNKVD 249
+K+ DFGLAR+ ++ T+ +WMAPE LY+T++ D
Sbjct: 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS-------------D 323
Query: 250 VYSFGIVLWELLT 262
V+SFGI+LWE+ T
Sbjct: 324 VWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-12
Identities = 41/142 (28%), Positives = 75/142 (52%), Gaps = 10/142 (7%)
Query: 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 187
KD L +++T L+ G L+ ++ ++ D A+ +A +I ++ LH I++RDLKP
Sbjct: 72 KDALCLVLT-LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP 130
Query: 188 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 247
+N+LL D ++++D GLA E E + GT +MAPE+ + + Y
Sbjct: 131 ENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV--------KNERYTFS 181
Query: 248 VDVYSFGIVLWELLTNRLPFEG 269
D + G +++E++ + PF
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-12
Identities = 52/208 (25%), Positives = 101/208 (48%), Gaps = 16/208 (7%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G G+V + R ++ A K L + + E + E ++ +V +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKG--ESMALNEKQILEKVNSQFVVNL 65
Query: 124 LGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
A KD L +++T ++ G L+ ++ ++ + AL +A +I ++ LH +
Sbjct: 66 AYAYETKDALCLVLT-IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
+RDLKP+N+LL D ++++D GLA + E + GT +MAPE+ +
Sbjct: 125 YRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-------- 175
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y D + G +++E++ + PF G
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 57/266 (21%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL--V 121
IG GA G+V + D + A+K+L + ++ + R R++ V+ D+L V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI----LVEADSLWVV 64
Query: 122 KFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
K + +D L + ++ E LPG + L ++ + L + + A+D +H G
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLA-------REE-------------TVTEMMT--- 217
IHRD+KPDNLLL + +KL+DFGL R E T M +
Sbjct: 123 IHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 218 AET-------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 264
AET GT ++APE++ ++ G YN D +S G++++E+L
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIGY 233
Query: 265 LPFEGMSNLQAAYAAAFKVQESIYAP 290
PF + Q Y +E++ P
Sbjct: 234 PPFCSETP-QETYKKVMNWKETLIFP 258
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 16/218 (7%)
Query: 62 IGSKIGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ ++G+G+ G VY + + +KVL + + +E ++S++ H
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 120 LVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPN--KLDLHVALNFALDIARAMDCLH 176
+VKF + + I+TE G L L L+ L + + + + + +H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVT 235
I+HRDLK N+ L LK+ DFG++R + ++ T TGT +M+PE
Sbjct: 124 QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK--- 178
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
QG Y++K D++S G +L+E+ FEG + L
Sbjct: 179 -HQG----YDSKSDIWSLGCILYEMCCLAHAFEGQNFL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 62/272 (22%), Positives = 109/272 (40%), Gaps = 39/272 (14%)
Query: 14 EEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLF-IGSKIGEGAHG 72
E G+ + H ++ES + + + T ++ + I S + G+ G
Sbjct: 47 ELGDSDDVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEG 106
Query: 73 KVYE-GRYGD---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128
+V+ ++GD + V +K + G T RE++++ + H ++ + A +
Sbjct: 107 EVFVCTKHGDEQRKKVIVKAVTGGKTPG----------REIDILKTISHRAIINLIHAYR 156
Query: 129 DPLMVIVTELLPGMSLRKYLVSL-----RPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
V M + KY L R L L A+ + A+ LH GIIHR
Sbjct: 157 WKSTVC-------MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR 209
Query: 184 DLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMAPELYSTVTLRQGE 240
D+K +N+ L + ++ L DFG A T +GT +PEL +
Sbjct: 210 DVKTENIFLDEPENAV-LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP----- 263
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
Y K D++S G+VL+E+ + G
Sbjct: 264 ---YCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292
|
Length = 392 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 52/207 (25%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G+G G+V + R ++ A K L + + E + E ++ +V +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--ESMALNEKQILEKVNSRFVVSL 65
Query: 124 LGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
A KD L +++T L+ G L+ ++ + + A+ +A +I ++ LH I+
Sbjct: 66 AYAYETKDALCLVLT-LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
+RDLKP+N+LL D ++++D GLA + + GT +MAPE+ +
Sbjct: 125 YRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--------KN 175
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFE 268
+ Y D ++ G +L+E++ + PF+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-11
Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERAL--LEGRFI-----REVNMMSRV 115
G K+G G +G VY+ + D G + AL +EG I RE+ ++ +
Sbjct: 6 GCKVGRGTYGHVYKAKRKD----------GKDDRDYALKQIEGTGISMSACREIALLREL 55
Query: 116 KHDNLVK----FLGACKDPLMVIVT----ELLPGMSL-RKYLVSLRPNKLDLHVALNFAL 166
KH N++ FL + ++ +L + R + +P +L + +
Sbjct: 56 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 115
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAREETVTEMMTAETG-- 221
I + LHAN ++HRDLKP N+L+ P++ +K+AD G AR A+
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 222 --TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
T+ + APEL +HY +D+++ G + ELLT+ F
Sbjct: 176 VVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 67/274 (24%), Positives = 108/274 (39%), Gaps = 82/274 (29%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YGD------RIVAIKVLNRGST-SDERALLE--------G 103
L +G +G GA GKV E +G VA+K+L G+T S+ +AL+ G
Sbjct: 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG 68
Query: 104 RFIREVNMMSRV--------------KHDNLVKFLGACKDPL------------------ 131
+ VN++ K+ NL FL A ++
Sbjct: 69 NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMV 128
Query: 132 -MVIVTELLPGMSLRKYLVSLRPNK-----------------LDLHVALNFALDIARAMD 173
V + +P+ L + + ++ +AR M+
Sbjct: 129 EQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGME 188
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----WMAPE 229
L + IHRDL N+LL+ + +K+ DFGLAR+ + G+ R WMAPE
Sbjct: 189 FLASRKCIHRDLAARNILLS-ENNVVKICDFGLARD-IYKDPDYVRKGSARLPLKWMAPE 246
Query: 230 -LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
++ V Y + DV+SFG++LWE+ +
Sbjct: 247 SIFDKV---------YTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 54/208 (25%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDER----ALLEGRFIREVNMMSRVKHDN 119
+G+G G+V + R ++ A K L + + AL E R + +VN V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS--- 64
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+ + KD L +++T ++ G L+ ++ ++ D A+ +A ++ ++ L
Sbjct: 65 -LAYAYETKDALCLVLT-IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER 122
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
I++RDLKP+N+LL D+ ++++D GLA + E + GT +MAPE+
Sbjct: 123 IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI------NN 175
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPF 267
EK Y D + G +++E++ + PF
Sbjct: 176 EK--YTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 37/107 (34%), Positives = 61/107 (57%), Gaps = 13/107 (12%)
Query: 164 FALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 220
+ +I A+D LH+ +++RDLK +NL+L D +K+ DFGL +E + + T +T
Sbjct: 100 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKE-GIKDGATMKTFC 157
Query: 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
GT ++APE+ E Y VD + G+V++E++ RLPF
Sbjct: 158 GTPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLN------RGSTS---DERALLEGRFIREVNMMSR 114
IG GA G+V + + ++ A+K+LN R T+ +ER +L R + +
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHY 68
Query: 115 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
D +L V + G L L+S ++L +A + ++ A+D
Sbjct: 69 AFQDENNLYL----------VMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVLAIDS 117
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFG--LAREETVTEMMTAETGTYRWMAPELYS 232
+H G +HRD+KPDN+LL ++LADFG L T GT +++PE+
Sbjct: 118 VHQLGYVHRDIKPDNVLLDK-NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ + K Y + D +S G+ ++E+L PF
Sbjct: 177 AM---EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-11
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 66 IGEGAHGKVYEGRYGDR---IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+G G+ G+V Y + VAIK + ++ + E +++ + H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQV--DHVFSERKILNYINHPFCVN 95
Query: 123 FLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLHANGI 180
G+ KD + +V E + G ++ LR NK V +A I + L + I
Sbjct: 96 LYGSFKDESYLYLVLEFVIG---GEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNI 152
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
++RDLKP+NLLL D +K+ DFG A+ +T T + GT ++APE+ V
Sbjct: 153 VYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTRTYTL---CGTPEYIAPEILLNVG---- 204
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ D ++ GI ++E+L PF
Sbjct: 205 ----HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 7e-11
Identities = 60/241 (24%), Positives = 106/241 (43%), Gaps = 43/241 (17%)
Query: 65 KIGEGAHGKVY---EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
KIG G G+V+ R + + RG E++ L + EVN+M +KH N+V
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQL----VIEVNVMRELKHKNIV 75
Query: 122 K----FLGACKDPLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCL 175
+ FL L +++ E L + + K++ H ++ + A+
Sbjct: 76 RYIDRFLNKANQKLYILM-EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 176 H-----ANG--IIHRDLKPDNLLLTPDQKSL----------------KLADFGLAREETV 212
H NG ++HRDLKP N+ L+ + + K+ DFGL++ +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
M + GT + +PEL E K Y++K D+++ G +++EL + + PF +N
Sbjct: 195 ESMAHSCVGTPYYWSPELLLH------ETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248
Query: 273 L 273
Sbjct: 249 F 249
|
Length = 1021 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 63/251 (25%), Positives = 104/251 (41%), Gaps = 69/251 (27%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLN------RGSTSDERALLEGRFIREVNMMSRVKH 117
IG GA G+V + D I A+K L + + RA E ++++ +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRA--------ERDILAEADN 60
Query: 118 DNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+VK + +D + ++ E LPG + L+ + + + + A+D +H
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETILAIDSIH 118
Query: 177 ANGIIHRDLKPDNLLLTPDQKS-LKLADFGL-----------------------AREETV 212
G IHRD+KPDNLLL D K +KL+DFGL +
Sbjct: 119 KLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 213 TEMMT---AET-------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256
M + AET GT ++APE++ + YN + D +S G++
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL--------QTGYNKECDWWSLGVI 228
Query: 257 LWELLTNRLPF 267
++E+L PF
Sbjct: 229 MYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 58/229 (25%), Positives = 107/229 (46%), Gaps = 11/229 (4%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG GA G+V + + D++ A+K+LN+ R R+V + + + +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
++ L +++ + G L L+S ++L +A + ++ A+D +H +HR
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLT--LLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHR 126
Query: 184 DLKPDNLLLTPDQKSLKLADFG--LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
D+KPDN+L+ + ++LADFG L E T + GT +++PE+ + + K
Sbjct: 127 DIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM---EDGK 182
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
Y + D +S G+ ++E+L PF S L Y +E P
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHKERFQFP 230
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 35/218 (16%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG G G+VY R D ++ A+K L++ ++ E + E M+S V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVS------- 52
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN------------FALDIARA 171
G C P +V ++ +++ L N DLH L+ +A +I
Sbjct: 53 TGDC--PFIVCMSYAFHTPDKLSFILDLM-NGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
++ +H +++RDLKP N+LL + ++++D GLA + + + A GT+ +MAPE+
Sbjct: 110 LEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEV- 166
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
L++G Y++ D +S G +L++LL PF
Sbjct: 167 ----LQKGVA--YDSSADWFSLGCMLFKLLRGHSPFRQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 22/195 (11%)
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGM 142
VAI L R SD++ F+ E + + H N+V+ G + M+IVTE +
Sbjct: 36 VAIHTL-RAGCSDKQRR---GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG 91
Query: 143 SLRKYLVSLRPNKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
+L +L R ++ L + +A M L G +H+ L +L+ D K
Sbjct: 92 ALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCK 147
Query: 201 LADFGLAREETVTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 258
++ F +E+ + T +G W APE ++ H+++ DV+SFGIV+W
Sbjct: 148 ISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE-----AIQYH---HFSSASDVWSFGIVMW 199
Query: 259 ELLT-NRLPFEGMSN 272
E+++ P+ MS
Sbjct: 200 EVMSYGERPYWDMSG 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 67/244 (27%), Positives = 108/244 (44%), Gaps = 58/244 (23%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LV 121
IG GA G+V + D I A+K+L + ++ + R R++ V+ D +V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI----LVEADGAWVV 64
Query: 122 KFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
K + +D + ++ E LPG + L ++ + L + + A+D +H G
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 181 IHRDLKPDNLLLTPDQKS-LKLADFGLA-------REE----------------TVTEMM 216
IHRD+KPDNLLL D K +KL+DFGL R E +
Sbjct: 123 IHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 217 TAET-------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 263
AET GT ++APE++ ++ G YN D +S G++++E+L
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIG 232
Query: 264 RLPF 267
PF
Sbjct: 233 YPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 32/229 (13%)
Query: 61 FIGSKIGEGAHGKV-YEGRYGD-RIVAIKVLN-RGSTSDE--RALLEGRFIREVNMMSRV 115
+I +G GA G V R D A+KV++ G + + RA E + + S V
Sbjct: 35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIV 94
Query: 116 K-HDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVS-LRPNK-LDLHVALNFA 165
K H++ K KDP ++ +V + LR+ + S + N+ H A
Sbjct: 95 KCHEDFAK-----KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGT 222
+ + A+ +H+ +IHRD+K N+LL + +KL DFG ++ T ++ GT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGT 208
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
++APE++ +K Y+ K D++S G++L+ELLT + PF+G +
Sbjct: 209 PYYVAPEIW--------RRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 38/117 (32%), Positives = 60/117 (51%), Gaps = 16/117 (13%)
Query: 151 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210
L L L + ++ +A+ M+ L + IHRDL N+LL+ + +K+ DFGLAR +
Sbjct: 171 LYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLAR-D 228
Query: 211 TVTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
+ G R WMAPE ++ V Y + DV+SFG++LWE+ +
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRV---------YTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 35/216 (16%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG G G+VY R D ++ A+K L++ ++ E + E M+S V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVS------- 52
Query: 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN------------FALDIARA 171
G C P +V +T +++ L N DLH L+ +A +I
Sbjct: 53 TGDC--PFIVCMTYAFHTPDKLCFILDLM-NGGDLHYHLSQHGVFSEKEMRFYATEIILG 109
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
++ +H +++RDLKP N+LL + ++++D GLA + + + A GT+ +MAPE+
Sbjct: 110 LEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEV- 166
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
L++G Y++ D +S G +L++LL PF
Sbjct: 167 ----LQKGTA--YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 66 IGEGAHGKV--YEGRYGDRIVAIKVLN------RGSTS---DERALLEGRFIREVNMMSR 114
IG GA G+V + ++ +RI A+K+LN R T+ +ER +L + + +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 115 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
D + + +V + G L L+S ++L +A + ++ A+
Sbjct: 69 AFQD----------ENYLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYIAEMVLAIHS 117
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFG--LAREETVTEMMTAETGTYRWMAPELYS 232
+H +HRD+KPDN+LL + ++LADFG L + T + GT +++PE+
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ G+ Y + D +S G+ ++E+L PF
Sbjct: 177 AMEDGMGK---YGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 66/257 (25%), Positives = 107/257 (41%), Gaps = 72/257 (28%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIK------VLNRGSTSDERALLEGRFIREVNMMSRV 115
IG GA G+V R D + A+K VL R + +A E ++++
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKA--------ERDILAEA 58
Query: 116 KHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
++ +VK + +D + V + +PG + L+ L + DL A + ++ A++
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL--ARFYIAELTCAIES 116
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGL------------------ARE------E 210
+H G IHRD+KPDN+L+ D +KL DFGL R+ E
Sbjct: 117 VHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 211 TVTEMMTAE--------------------TGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 250
+E+ GT ++APE V LR G Y D
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPE----VLLRTG----YTQLCDW 227
Query: 251 YSFGIVLWELLTNRLPF 267
+S G++L+E+L + PF
Sbjct: 228 WSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
S++G G G V + ++ I+A K+++ + + + + IRE+ ++ +V
Sbjct: 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHL----EIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 122 KFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HANG 179
F GA D + I E + G SL + L + ++ + ++ + R + L +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQ 124
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE QG
Sbjct: 125 IMHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------QG 176
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLP 266
HY+ + D++S G+ L EL R P
Sbjct: 177 --THYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 49/206 (23%), Positives = 86/206 (41%), Gaps = 29/206 (14%)
Query: 83 IVAIKVLNRGSTSDER------ALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVT 136
+V +++ + + ++E ++ F R N+M+ +L +++
Sbjct: 27 LVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW--------VIS 78
Query: 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD- 195
+ S L + P + + N R ++ LH NG IHR++K ++L++ D
Sbjct: 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG 138
Query: 196 -------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 248
L G + + V + T W++PEL LRQ + YN K
Sbjct: 139 LVSLSGLSHLYSLVRNG-QKAKVVYDFPQFSTSVLPWLSPEL-----LRQ-DLYGYNVKS 191
Query: 249 DVYSFGIVLWELLTNRLPFEGMSNLQ 274
D+YS GI EL T R+PF+ M Q
Sbjct: 192 DIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 12/107 (11%)
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE QG
Sbjct: 121 IMHRDVKPSNILVNSRGE-IKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------QG 172
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQES 286
HY + D++S G+ L E+ R P A F S
Sbjct: 173 T--HYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVS 215
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 64 SKIGEGAHGKVYE--GRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
S++G G G V++ + I+A K+++ + + + + IRE+ ++ +V
Sbjct: 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHL----EIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 122 KFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HANG 179
F GA D + I E + G SL + L + ++ + ++ + + + L +
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE QG
Sbjct: 125 IMHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------QG 176
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLP 266
HY+ + D++S G+ L E+ R P
Sbjct: 177 --THYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 21/219 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
IG + + + + + +VA+K +N S S E L +E+ +++H N++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKL---LQQEIITSRQLQHPNIL 62
Query: 122 KFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL-DIARAMDCLHANG 179
++ + + +V+ L+ S L + P L +A+ F L D+ A+D +H+ G
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILKDVLNALDYIHSKG 121
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLA--------REETVTEMMTAETGTYRWMAPELY 231
IHR +K ++LL+ D K L+ + R+ V + + W++PE+
Sbjct: 122 FIHRSVKASHILLSGDGKV-VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV- 179
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270
L+Q + YN K D+YS GI EL +PF+ M
Sbjct: 180 ----LQQ-NLQGYNEKSDIYSVGITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 65/266 (24%), Positives = 112/266 (42%), Gaps = 77/266 (28%)
Query: 60 LFIGSK-IGEGAHGKVYEGRYGDR--IVAIK------VLNRGSTSDERALLEGRFIREVN 110
+F+ K +G GA G+V D + A+K VLNR + +A E +
Sbjct: 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKA--------ERD 53
Query: 111 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
+++ ++ +VK + +D + V + +PG + L+ R +A + ++
Sbjct: 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYIAELT 111
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA------------------REET 211
A++ +H G IHRD+KPDN+L+ D +KL DFGL R+++
Sbjct: 112 LAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170
Query: 212 VT---------------EMMTAE---------------TGTYRWMAPELYSTVTLRQGEK 241
+ + T E GT ++APE V LR+G
Sbjct: 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE----VLLRKG-- 224
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPF 267
Y D +S G++L+E+L + PF
Sbjct: 225 --YTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-09
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 43/238 (18%)
Query: 66 IGEGAHGKVYEG---RYGDRI------VAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
+G+G K+++G GD V +KVL+ R E F +MMS++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLD----KSHRNYSES-FFEAASMMSQLS 57
Query: 117 HDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
H +LV G C + +M V E + SL YL N +++ L A +A A+
Sbjct: 58 HKHLVLNYGVCVCGDESIM--VQEYVKFGSLDTYL-KKNKNLINISWKLEVAKQLAWALH 114
Query: 174 CLHANGIIHRDLKPDNLLLT--PDQKS-----LKLADFGLAREETVTEMMTAETGTYRWM 226
L G+ H ++ N+LL D+K+ +KL+D G++ E++ W+
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---PWV 171
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQ 284
PE ++ + D +SFG LWE+ F G +A + K+Q
Sbjct: 172 PPECIE-------NPQNLSLAADKWSFGTTLWEI------FSGGDKPLSALDSQKKLQ 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 9e-09
Identities = 45/155 (29%), Positives = 65/155 (41%), Gaps = 28/155 (18%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTS------DERALLEGRFIREVNMMSRVKHDN 119
I GA ++Y G + IK R DER + R RE +MSR +
Sbjct: 4 IKRGAEAEIYLGDFLGIKAVIKW--RIPKRYRHPELDER-IRRERTRREARIMSRAR--- 57
Query: 120 LVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
K V IV E + G L+ + S +L+L + +I R +
Sbjct: 58 --KAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELEL------SREIGRLVG 109
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
LH+ GIIH DL N++L+ + + L DFGLA
Sbjct: 110 KLHSAGIIHGDLTTSNMILSGGK--IYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 40/156 (25%), Positives = 60/156 (38%), Gaps = 33/156 (21%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTS------DERALLEGRFIREVNMMSRVKHDN 119
I +GA +Y G + IK R S DER E R E ++SR +
Sbjct: 2 IAKGAEAIIYLGDFLGLKAVIKE--RVPKSYRHPELDERIRRE-RTRNEARLLSRARK-- 56
Query: 120 LVKFLGACK------DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
G DP IV E + G L+ + + + + + +
Sbjct: 57 ----AGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVI-----EEGNDELLREIGRLVGK-- 105
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
LH GI+H DL N+++ D+ L L DFGL +
Sbjct: 106 --LHKAGIVHGDLTTSNIIVRDDK--LYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 35/149 (23%), Positives = 60/149 (40%), Gaps = 17/149 (11%)
Query: 65 KIGEGAHGKVYEGRYGDRIVAIKV----LNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
I +GA +Y + +K R DE+ L R RE ++++ + +
Sbjct: 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEK-LRRERTRREARILAKAREAGV 61
Query: 121 -VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V + +IV E + G L+ L RP+ ++ R + LH G
Sbjct: 62 PVPIVYDVDPDNGLIVMEYIEGELLKDALEEARPD---------LLREVGRLVGKLHKAG 112
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
I+H DL N++L+ + + DFGL
Sbjct: 113 IVHGDLTTSNIILSGGR--IYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 3e-08
Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 11/114 (9%)
Query: 155 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214
KL + A++ LH + IIH D+K +N+L + + L D+GL +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164
Query: 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
GT + +PE + + +Y+ D ++ G++ +ELLT + PF+
Sbjct: 165 CY---DGTLDYFSPE--------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 9/206 (4%)
Query: 65 KIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFL 124
++G+G +G VY+ + V + + DE + I E++++ + +V F
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF--NQIIMELDILHKAVSPYIVDFY 65
Query: 125 GA-CKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAMDCL-HANGII 181
GA + + + E + SL K Y + + V + + + L + II
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
HRD+KP N+L+ +KL DFG++ V + G +MAPE + Q
Sbjct: 126 HRDVKPTNVLVN-GNGQVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGPNQ--N 181
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPF 267
Y + DV+S G+ + E+ R P+
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 69/285 (24%), Positives = 116/285 (40%), Gaps = 83/285 (29%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG+GA G+V + D +I A+K L + + L + R+V ++ +V
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV--LAESDSPWVVSL 66
Query: 124 LGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR--------AMDC 174
+ +D + ++ E LPG L L+ K D F+ D+ R A++
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDT-----FSEDVTRFYMAECVLAIEA 116
Query: 175 LHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLA-------------------------- 207
+H G IHRD+KPDN+L+ D+ +KL+DFGL+
Sbjct: 117 VHKLGFIHRDIKPDNILI--DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 208 ----------------REETVT------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 245
+++ T M + GT ++APE++ L+QG Y
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF----LQQG----YG 226
Query: 246 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
+ D +S G +++E L PF N Y +E++Y P
Sbjct: 227 QECDWWSLGAIMFECLIGWPPFCS-ENSHETYRKIINWRETLYFP 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 51/188 (27%), Positives = 89/188 (47%), Gaps = 40/188 (21%)
Query: 108 EVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL---RPNKLDLHVALN 163
E+ M +++H N+VK +G C+ + ++ E + G +L + L +L R K+
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKI------- 785
Query: 164 FALDIARAMDCLHAN---GIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAE 219
A+ IA+A+ LH ++ +L P+ +++ D+ L+L+ GL +T + +A
Sbjct: 786 -AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA- 843
Query: 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279
++APE E K K D+Y FG++L ELLT + P + A
Sbjct: 844 -----YVAPETR--------ETKDITEKSDIYGFGLILIELLTGKSPAD----------A 880
Query: 280 AFKVQESI 287
F V SI
Sbjct: 881 EFGVHGSI 888
|
Length = 968 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 40/120 (33%), Positives = 57/120 (47%), Gaps = 15/120 (12%)
Query: 144 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLA 202
L YL R L L A + A+D +H GIIHRD+K +N+L+ P+ + L
Sbjct: 246 LYTYL-GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLG 302
Query: 203 DFG---LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259
DFG AR T GT APE+ + G+ Y VD++S G+V++E
Sbjct: 303 DFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA------GDP--YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 64/279 (22%), Positives = 113/279 (40%), Gaps = 71/279 (25%)
Query: 66 IGEGAHGKVYEGRYGDR--IVAIKVLNRGSTSDERALLEGRFIR---EVNMMSRVKHDNL 120
+G GA G+V R D + A+K L + + LL + E ++++ ++ +
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRK-----KDVLLRNQVAHVKAERDILAEADNEWV 63
Query: 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V+ + +D + V + +PG + L+ + DL A + ++ A++ +H G
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL--ARFYIAELTCAVESVHKMG 121
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLA------------------REETVTEMMTAE-- 219
IHRD+KPDN+L+ D +KL DFGL R++++
Sbjct: 122 FIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 220 ----------------------------TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 251
GT ++APE V LR G Y D +
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE----VLLRTG----YTQLCDWW 232
Query: 252 SFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
S G++L+E+L + PF + L+ Q S++ P
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQ-MKVINWQTSLHIP 270
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 18/40 (45%), Positives = 26/40 (65%)
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207
I A+D LH+ GI+HRD+KP N++ + S K+ D G A
Sbjct: 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 11/99 (11%)
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
+A ++ A+D LH GI+ RDL P+N+LL D+ ++L F E V + E
Sbjct: 90 WAAEMVVALDALHREGIVCRDLNPNNILLD-DRGHIQLTYFSRWSE--VEDSCDGEAVEN 146
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
+ APE+ G D +S G +L+ELLT
Sbjct: 147 MYCAPEV--------GGISEETEACDWWSLGAILFELLT 177
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 52/183 (28%), Positives = 78/183 (42%), Gaps = 28/183 (15%)
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLP--G 141
V IK RG T+ E +L R +N H ++++ G + +LP
Sbjct: 120 VVIKAGQRGGTATEAHIL-----RAIN------HPSIIQLKGTFTYNKFTCL--ILPRYK 166
Query: 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201
L YL + R + + L + RA+ LH N IIHRD+K +N+ + + L
Sbjct: 167 TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPGDVCL 223
Query: 202 ADFGLA--REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259
DFG A + GT APEL + + Y VD++S GIVL+E
Sbjct: 224 GDFGAACFPVDINANKYYGWAGTIATNAPELLA--------RDPYGPAVDIWSAGIVLFE 275
Query: 260 LLT 262
+ T
Sbjct: 276 MAT 278
|
Length = 391 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 40/105 (38%), Positives = 54/105 (51%), Gaps = 18/105 (17%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YGD------RIVAIKVLNRGSTSDE-RALLEGRFIREVNM 111
L +G +G GA G+V E +G R VA+K+L G+T E RAL+ E+ +
Sbjct: 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS-----ELKI 63
Query: 112 MSRVKHD-NLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLR 152
+ + H N+V LGAC PLMVIV E +L YL S R
Sbjct: 64 LIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSNYLRSKR 107
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 41/158 (25%), Positives = 68/158 (43%), Gaps = 32/158 (20%)
Query: 125 GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 184
G+ KD +I T + GMS +L +A + +A+D +H G +HR
Sbjct: 84 GSAKD---LICTHFMDGMS-------------ELAIAY-ILQGVLKALDYIHHMGYVHRS 126
Query: 185 LKPDNLLLTPDQK--------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+K ++L++ D K +L + + G R V + W++PE+
Sbjct: 127 VKASHILISVDGKVYLSGLRSNLSMINHG-QRLRVVHDFPKYSVKVLPWLSPEVL----- 180
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
Q + Y+ K D+YS GI EL +PF+ M Q
Sbjct: 181 -QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 41/157 (26%), Positives = 56/157 (35%), Gaps = 30/157 (19%)
Query: 63 GSKIGEGAHGKVYEGRYGDRIVAIKV----LNRGSTSDERALLEGRFIREVNMMSRVKHD 118
IG+GA + +G Y R IK R DER E R E ++S +
Sbjct: 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTE-RTRAEARLLSEARR- 395
Query: 119 NLVKFLGACK------DPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
G DP IV E + G L+ L +
Sbjct: 396 -----AGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVL----------EGNPELVRKVGEI 440
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
+ LH GI+H DL N ++ D+ L L DFGL +
Sbjct: 441 VAKLHKAGIVHGDLTTSNFIVRDDR--LYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 24/66 (36%), Positives = 40/66 (60%), Gaps = 1/66 (1%)
Query: 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201
M+ +K ++ +K D++V + + LH GI+HRD+KP+NLL+T D + +K+
Sbjct: 292 MAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ-VKI 350
Query: 202 ADFGLA 207
DFG A
Sbjct: 351 IDFGAA 356
|
Length = 507 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 33/88 (37%), Positives = 49/88 (55%), Gaps = 15/88 (17%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YG----DRI--VAIKVLNRGSTSDERALLEGRFIREVNMM 112
L G +G GA GKV E +G D + VA+K+L + +DER L + E+ ++
Sbjct: 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREAL----MSELKIL 95
Query: 113 SRV-KHDNLVKFLGACKD--PLMVIVTE 137
S + +H N+V LGAC P++VI TE
Sbjct: 96 SHLGQHKNIVNLLGACTHGGPVLVI-TE 122
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-05
Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 43/197 (21%)
Query: 84 VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGM 142
V +KVL+ A E +MM +V H ++V G C +D ++V E +
Sbjct: 35 VILKVLDPSHRDISLAFFET-----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89
Query: 143 SL-----RKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 197
L RK V P K A +A A+ L ++H ++ N+LL +
Sbjct: 90 PLDLFMHRKSDVLTTPWKF------KVAKQLASALSYLEDKDLVHGNVCTKNILLAREGI 143
Query: 198 S------LKLADFG-----LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN 246
+KL+D G L+R+E V + W+APE + K+ +
Sbjct: 144 DGECGPFIKLSDPGIPITVLSRQECVERI--------PWIAPECVE-------DSKNLSI 188
Query: 247 KVDVYSFGIVLWELLTN 263
D +SFG LWE+ N
Sbjct: 189 AADKWSFGTTLWEICYN 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 19/74 (25%), Positives = 27/74 (36%), Gaps = 10/74 (13%)
Query: 145 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN----------GIIHRDLKPDNLLLTP 194
R L+ L VA +A + L A ++H DL P NLL+ P
Sbjct: 122 RLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPALPLVLVHGDLHPGNLLVDP 181
Query: 195 DQKSLKLADFGLAR 208
+ + DF A
Sbjct: 182 GGRVTGVIDFEDAG 195
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 45/157 (28%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEG-------RYGDRIVAIKVLNRGSTSDER 98
QL D + + L +G +G GA G+V E VA+K+L + S E+
Sbjct: 25 QLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEK 84
Query: 99 ALLEGRFIREVNMMSRV-KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKL 156
L + E+ +MS + H N+V LGAC K + I+TE L Y L NK
Sbjct: 85 QAL----MSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDY---LHRNK- 136
Query: 157 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 193
H L + LD R L + G + ++ L
Sbjct: 137 --HTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLG 171
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 48/185 (25%), Positives = 72/185 (38%), Gaps = 39/185 (21%)
Query: 105 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 163
F ++MS+V H +L G C + ++V E + L V LR K + VA
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD---VCLRKEKGRVPVAWK 119
Query: 164 F--ALDIARAMDCLHANGIIHRDLKPDNLLLT------PDQKSLKLADFG-----LAREE 210
A +A A+ L ++H ++ N+LL +KL+D G L+REE
Sbjct: 120 ITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL-------LTN 263
V + W+APE + D +SFG L E+ L
Sbjct: 180 RVERI--------PWIAPECVPGGN-------SLSTAADKWSFGTTLLEICFDGEVPLKE 224
Query: 264 RLPFE 268
R P E
Sbjct: 225 RTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 40/109 (36%), Positives = 54/109 (49%), Gaps = 13/109 (11%)
Query: 60 LFIGSKIGEGAHGKVYEGR-YG-DRI-----VAIKVLNRGSTSDERALLEGRFIREVNMM 112
L +G +G GA GKV EG YG R VA+K+L + S E+ L + E+ +M
Sbjct: 39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQAL----MSELKIM 94
Query: 113 SRV-KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH 159
+ + H N+V LGAC K + I+TE L YL R N L H
Sbjct: 95 THLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRH 143
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.001
Identities = 27/85 (31%), Positives = 36/85 (42%), Gaps = 15/85 (17%)
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
HR K N+LLT D LKL + + Y +MAPE+ + +
Sbjct: 34 HRQAKSGNILLTWD-GLLKLDGSVAFKTPE-----QSRPDPY-FMAPEVIQGQSYTE--- 83
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLP 266
K D+YS GI L+E L LP
Sbjct: 84 -----KADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 39.0 bits (92), Expect = 0.001
Identities = 40/188 (21%), Positives = 67/188 (35%), Gaps = 56/188 (29%)
Query: 34 RAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNR- 91
+VK G + + +G++IG G VY VA+K +R
Sbjct: 8 HTLVKRGVVES-----------------LGNQIGVGKESDVYLALDPDGNPVALK-FHRL 49
Query: 92 GSTSDERALLEGRFIREVNMMSRVKHDNLV-----------KFLGACKD-------PL-- 131
G TS + + R+ + KH + + L A + P+
Sbjct: 50 GRTSFRKV----KRKRDY--LGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDW 103
Query: 132 --MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189
+V E + G+ L + V P ++ L L + + GIIH DL N
Sbjct: 104 NRHAVVMEYIDGVELYRVRVLEDPEEV-LDEILEEIVKAYKH-------GIIHGDLSEFN 155
Query: 190 LLLTPDQK 197
+L+ D+K
Sbjct: 156 ILVDDDEK 163
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.001
Identities = 28/154 (18%), Positives = 52/154 (33%), Gaps = 23/154 (14%)
Query: 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDN 119
+ G +VY D +K+ REV ++ + +
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKG-------ADREREVAILQLLARKGL 53
Query: 120 LV-KFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
V K L + D ++ E + G +L + + + + +A + LH
Sbjct: 54 PVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAE---------QLAELLAKLHQ 104
Query: 178 ---NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
+ H DL P N+L+ K L + D+ A
Sbjct: 105 LPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 37.8 bits (89), Expect = 0.002
Identities = 33/154 (21%), Positives = 55/154 (35%), Gaps = 21/154 (13%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-RIVAIKV--LNRGSTSDERALLEGRFIREVN-----MMS 113
+G IG G VY GD VA+K+ R S + G + +S
Sbjct: 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLS 60
Query: 114 RVK----HDNLVKFLGA---CKDPLM----VIVTELLPGMSLRKYLVSLRPNKLDLHVAL 162
R+ NL + A P+ V+V E + G + + D
Sbjct: 61 RLWAEKEFRNLKRLYEAGVPVPKPIDLNRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELY 120
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ 196
+ L++ R + G++H DL N+L+ +
Sbjct: 121 DQILELMRKL--YREAGLVHGDLSEYNILVDDGK 152
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 51/176 (28%), Positives = 70/176 (39%), Gaps = 21/176 (11%)
Query: 42 ITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGR-YG------DRIVAIKVLNRGST 94
I QL D L G +G GA GKV E YG VA+K+L +
Sbjct: 19 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78
Query: 95 SDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK--DPLMVIVTELLPG---MSLRKYL 148
ER L + E+ ++S + H N+V LGAC P +VI G LR+
Sbjct: 79 LTEREAL----MSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKR 134
Query: 149 VSLRPNKLDLH--VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202
S K + H AL L R M C N + D+KP + P + + +
Sbjct: 135 DSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYM--DMKPGVSYVVPTKADKRRS 188
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 290 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.84 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.66 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.62 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.61 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.58 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.36 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.35 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.13 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.12 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.05 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.01 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.76 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.71 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.61 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.58 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.41 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.39 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.37 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.31 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.3 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.29 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.19 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.19 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.02 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.0 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.99 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.9 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.89 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.81 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.8 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.66 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.6 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.54 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.5 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.5 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.33 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.32 | |
| PLN02236 | 344 | choline kinase | 97.2 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.16 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.99 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.67 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.38 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.24 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.0 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.87 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.87 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.81 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.79 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.75 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 95.66 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.58 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.5 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.15 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=344.81 Aligned_cols=207 Identities=32% Similarity=0.541 Sum_probs=183.4
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
.+|.+.++||+|+||+||+|++ ++..||||.+.......... +.+..|+.+|+.++|||||.+++++.++ ..++
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~---e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLV---ELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHH---HHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 4588899999999999999987 56899999998876433322 3467999999999999999999999755 7889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--C---CceEEeccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--Q---KSLKLADFGLARE 209 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~---~~~kl~Dfg~~~~ 209 (290)
|||||+||+|.+|++. .+.+++.+++.++.||+.||++||+++||||||||+|||++.. . -.+||+|||+++.
T Consensus 87 VMEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999987 3589999999999999999999999999999999999999753 2 3589999999999
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
........+.+|++.|||||++.. .+|+.++|+||+|+++|+|++|+.||...+..+-..
T Consensus 165 L~~~~~a~tlcGSplYMAPEV~~~--------~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 165 LQPGSMAETLCGSPLYMAPEVIMS--------QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred CCchhHHHHhhCCccccCHHHHHh--------ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 888888888999999999999865 789999999999999999999999999876655544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=341.12 Aligned_cols=215 Identities=32% Similarity=0.482 Sum_probs=187.1
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
...+++|++++.||+|+||+||.++. +++.+|+|++++........ .....+|..+|..++||+||+++..|++.
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e--~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~ 98 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKE--VRHTKAERNILSKIKHPFIVKLIYSFQTEE 98 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhh--HHHHHHHHHHHHhCCCCcEeeeEEecccCC
Confidence 34567899999999999999999965 78999999998876655422 24688999999999999999999999876
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
.+|+|+||+.||.|...++. .+.+++..++.|+.+|+.||.|||++|||||||||+|||+|.+ ++++|+|||+++..
T Consensus 99 kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKED 175 (357)
T ss_pred eEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhc
Confidence 79999999999999999985 6789999999999999999999999999999999999999955 45999999999965
Q ss_pred ccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 211 TVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 211 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
... ......+||+.|||||++.. ..++.++|+||||+++|+|++|.+||.+.+.....-+|..
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil~~--------~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~ 239 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEILLG--------KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK 239 (357)
T ss_pred ccCCCccccccCCccccChHHHhc--------CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc
Confidence 444 34556799999999999976 7899999999999999999999999999765554444443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=342.83 Aligned_cols=227 Identities=27% Similarity=0.395 Sum_probs=190.0
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHH--HHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERA--LLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
-.+.|.+.+.||+|+||.|-+|.. +++.||||++.+........ .....+.+|+++|++|+|||||++++.|..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346688999999999999999954 78999999998876544221 1122467999999999999999999999876
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--CCceEEecccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAR 208 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~~~~kl~Dfg~~~ 208 (290)
..|+||||++||+|.+.+-. .+.+.+.....++.||+.|+.|||++||+||||||+|||+..+ ...+||+|||+++
T Consensus 250 s~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred ceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 55999999999999999986 4678888889999999999999999999999999999999744 2469999999999
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhccccc
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (290)
.......+.+.|||+.|.|||++..-. ...+..++|+|||||+||-+|+|.+||++......+.+.+.+......
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg-----~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKG-----VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred ccccceehhhhcCCccccChhheecCC-----eecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 988888999999999999999997621 122345899999999999999999999998766656666666655555
Q ss_pred C
Q 022903 289 A 289 (290)
Q Consensus 289 ~ 289 (290)
|
T Consensus 403 p 403 (475)
T KOG0615|consen 403 P 403 (475)
T ss_pred C
Confidence 4
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=317.78 Aligned_cols=211 Identities=30% Similarity=0.455 Sum_probs=185.7
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
-.+|..++.||.|+||+|.+++. ++..+|+|++.++......+. +...+|..+|+.+.||+++++++.+.+. .++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQv--eH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQV--EHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHH--HHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 34588899999999999999976 689999999988776665543 4688999999999999999999999876 788
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||.+||.|..+++. .+++++..++.|++||+.||+|||+++|++||+||+|||+|.++ .+||+|||.++.....
T Consensus 121 mvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVSGR 197 (355)
T ss_pred EEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEecCc
Confidence 99999999999999986 67899999999999999999999999999999999999999665 5999999999875433
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~ 283 (290)
+.+.||||.|+|||++.. ..++.++|+||||+++|||+.|.+||-+.+. ..+|+.+.+.
T Consensus 198 --T~TlCGTPeYLAPEii~s--------k~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~ 256 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQS--------KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEG 256 (355)
T ss_pred --EEEecCCccccChHHhhc--------CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhC
Confidence 667899999999999875 8899999999999999999999999999777 4445544443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=338.63 Aligned_cols=229 Identities=47% Similarity=0.772 Sum_probs=199.0
Q ss_pred ccccCCCceeecceeccccceeEEEEEECCce-EEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
...++...+.+.+.||+|+||+||+|.+.+.. ||+|++......... ...|.+|+.+|++++|||||+++|++.++
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES---RKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH---HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 44566667778888999999999999999988 999999887655544 45699999999999999999999999877
Q ss_pred c--eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 131 L--MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 131 ~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g-ivH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
. ..+||||+++|+|.+++.......++...++.++.||++||+|||+++ ||||||||+|+|++.+..++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 4 889999999999999998754678999999999999999999999999 9999999999999966547999999999
Q ss_pred cccccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhccc
Q 022903 208 REETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQES 286 (290)
Q Consensus 208 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~ 286 (290)
+..... .......||+.|||||++... ...++.++||||||++||||+||..||.+....+.++.++.+..+.
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~------~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRGE------KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP 265 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcCC------CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 876544 334446899999999999741 3679999999999999999999999999999999999998776655
Q ss_pred ccC
Q 022903 287 IYA 289 (290)
Q Consensus 287 ~~~ 289 (290)
.+|
T Consensus 266 ~~p 268 (362)
T KOG0192|consen 266 PIP 268 (362)
T ss_pred CCC
Confidence 543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=339.43 Aligned_cols=215 Identities=31% Similarity=0.461 Sum_probs=188.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|..++.||+|+|+.||.+++ +++.||+|++.+........ ..++.+|+++.+.|+|||||+++++|+|. +.|+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~--reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQ--REKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcch--HHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 6699999999999999999976 78999999998865544433 34688999999999999999999999986 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
|.|+|..++|..+++. .+.+++.+++.+++||+.||.|||+++|+|||||..|+|++.+ -+|||+|||+|.....+
T Consensus 96 vLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc-CcEEecccceeeeecCcc
Confidence 9999999999999984 5789999999999999999999999999999999999999944 46999999999986644
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhccc
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQES 286 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~ 286 (290)
+...+.||||.|.|||++.. ...+..+||||+||+||.||.|++||+. .+...+|..+...-+.
T Consensus 173 Erk~TlCGTPNYIAPEVl~k--------~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y~ 236 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNK--------SGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEYS 236 (592)
T ss_pred cccceecCCCcccChhHhcc--------CCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCcc
Confidence 67778899999999999974 6789999999999999999999999998 5556666655554333
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=334.07 Aligned_cols=207 Identities=29% Similarity=0.470 Sum_probs=178.6
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 130 (290)
...+.+|.+++.||.|+|++|++|+. +++.||||++.+.-...+... .-+..|-.+|.+| +||+|++|+..|+|.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~Kv--kYV~~Ek~~l~~L~~hPgivkLy~TFQD~ 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKV--KYVTREKEALTQLSGHPGIVKLYFTFQDE 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhccc--chhhHHHHHHHHhhCCCCeEEEEEEeecc
Confidence 45678899999999999999999965 789999999977655444321 2356788889999 799999999999876
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.+|+|+||+++|+|.+++.. -+.+++..++.++++|+.||+|||++|||||||||+|||+|.+. +++|+|||.++.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K--~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~ 223 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKK--YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKI 223 (604)
T ss_pred cceEEEEEecCCCcHHHHHHH--hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeecccccc
Confidence 78999999999999999987 47899999999999999999999999999999999999999665 599999999885
Q ss_pred cccccc--------------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 210 ETVTEM--------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 210 ~~~~~~--------------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
...... ...++||..|.+||++.. +..++++|+|+||||+|+|+.|.+||.+.+..
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--------~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--------SPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcC--------CCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 322111 144789999999999976 77899999999999999999999999997653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=331.86 Aligned_cols=223 Identities=27% Similarity=0.448 Sum_probs=187.5
Q ss_pred ccCCCceeecceeccccceeEEEEE--ECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
...-++|.++..||+|+||.||+|+ .+|+.+|+|++++.......+. ..++.|-.+|....+|+||+++..|++.
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv--~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQV--EHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhH--HHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 3456779999999999999999995 5899999999988766554443 4578899999998999999999999886
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
.+||||||++||++..++.. .+.+++..++.|+.+++.|++.||+.|+|||||||+|+|||..+ ++||+|||+++..
T Consensus 215 ~LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl 291 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGL 291 (550)
T ss_pred eeEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchh
Confidence 78999999999999999975 57899999999999999999999999999999999999999665 5999999998521
Q ss_pred cc----------------------cc--------------------------cccccCCCccccCccccccccccccccC
Q 022903 211 TV----------------------TE--------------------------MMTAETGTYRWMAPELYSTVTLRQGEKK 242 (290)
Q Consensus 211 ~~----------------------~~--------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~ 242 (290)
.. .. .....+|||.|||||++.+ .
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--------k 363 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--------K 363 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--------C
Confidence 00 00 0112359999999999986 7
Q ss_pred CCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhcccccCC
Q 022903 243 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290 (290)
Q Consensus 243 ~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 290 (290)
.|+..+|+|||||||||||.|.+||.+.++ ...++.+.+|+..|-.|
T Consensus 364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp-~~T~rkI~nwr~~l~fP 410 (550)
T KOG0605|consen 364 GYGKECDWWSLGCIMYEMLVGYPPFCSETP-QETYRKIVNWRETLKFP 410 (550)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhhhccCC
Confidence 799999999999999999999999999554 56677777777665443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=317.94 Aligned_cols=216 Identities=27% Similarity=0.392 Sum_probs=185.5
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCc--e
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL--M 132 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~ 132 (290)
..+++.++.||+|..|+||++++ +++.+|+|++........ +..+.+|+++++.++||+||.+||+|.++. .
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~----~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPAL----QKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHH----HHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 34677889999999999999987 589999999954443332 245889999999999999999999997653 7
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||++|+|.+++.. .+.+++.....++.++++||.|||+ ++||||||||+|+|++.. +.|||||||.+....
T Consensus 154 sI~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVSGILV 230 (364)
T ss_pred EeehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEeccccccHHhh
Confidence 899999999999999986 3789999999999999999999995 899999999999999965 469999999998765
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHhhccc
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM-----SNLQAAYAAAFKVQES 286 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~-----~~~~~~~~~~~~~~~~ 286 (290)
.. ..++..||..|||||.+.+ ..|+.++||||||++++|+..|+.||... ...+..-.|....+..
T Consensus 231 nS-~a~tfvGT~~YMsPERi~g--------~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~ 301 (364)
T KOG0581|consen 231 NS-IANTFVGTSAYMSPERISG--------ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR 301 (364)
T ss_pred hh-hcccccccccccChhhhcC--------CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC
Confidence 55 6678899999999999976 78999999999999999999999999884 5566666666655554
Q ss_pred cc
Q 022903 287 IY 288 (290)
Q Consensus 287 ~~ 288 (290)
++
T Consensus 302 lP 303 (364)
T KOG0581|consen 302 LP 303 (364)
T ss_pred CC
Confidence 43
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=324.95 Aligned_cols=212 Identities=27% Similarity=0.404 Sum_probs=183.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---ce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~ 132 (290)
..|..+++||+|+||.||+|++ +++.||+|.++.+.....-.. -..+||.||++|+||||++|.+...+. .+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~---t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPI---TAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchH---HHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 5588899999999999999987 678999999987764443322 256999999999999999999987543 68
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
|+|+|||+. +|.-++.. ..-.+++.++..|+.||+.||+|||++||+|||||.+||||| +++.+||+|||+++++..
T Consensus 194 YlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID-NNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc-CCCCEEeccccceeeccC
Confidence 999999965 88887764 345799999999999999999999999999999999999999 556799999999996544
Q ss_pred cc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 213 TE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 213 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
.. ..+..+.|+.|.|||++.+ ...|+.++|+||.||||.||+.|++.|.|.+..+.+..|...
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG-------~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl 335 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLG-------ATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL 335 (560)
T ss_pred CCCcccccceEEeeccChHHhcC-------CcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence 43 4567788999999999987 468999999999999999999999999999999999888754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=310.31 Aligned_cols=204 Identities=28% Similarity=0.489 Sum_probs=173.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEe-ee-ecCc-e
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG-AC-KDPL-M 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~-~~~~-~ 132 (290)
.+|++.++||+|+||+||++.+ ++..+|.|.+.-....... ......|+.+|++|+|||||++++ .+ ++.. +
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~---rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKA---RQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHH---HHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 4599999999999999999976 7899999998854443322 245779999999999999999998 34 3444 7
Q ss_pred EEEEEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH--CC--CeeecCCCCCEEEcCCCCceEEecccc
Q 022903 133 VIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHA--NG--IIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~g--ivH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
++|||+|++|+|.+.++..+ ...+++..+++++.|++.||..+|+ .. |+||||||.||+++.+ +.+||.|||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL 174 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGL 174 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-Cceeeccchh
Confidence 89999999999999986543 3569999999999999999999999 45 9999999999999954 5799999999
Q ss_pred cccccccc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 207 AREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 207 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
++...... ...+.+|||.||+||.+.. ..|++++|||||||++|||+.-+.||.|.+-.
T Consensus 175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~--------~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~ 234 (375)
T KOG0591|consen 175 GRFLSSKTTFAHSLVGTPYYMSPERIHE--------SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL 234 (375)
T ss_pred HhHhcchhHHHHhhcCCCcccCHHHHhc--------CCCCcchhHHHHHHHHHHHHhcCCCcccccHH
Confidence 98754443 3456799999999999976 78999999999999999999999999997443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-47 Score=306.42 Aligned_cols=212 Identities=29% Similarity=0.443 Sum_probs=184.6
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
.|..+.++|+|+||.||+.++ +|+.||||.+......... .+-.+||+++|++|+|+|+|.++++|.. ..+.+|
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~V---kKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVV---KKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHH---HHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 477788999999999999975 7899999998765544333 2335799999999999999999999964 578899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc-ccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTE 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~-~~~ 214 (290)
+|||+..-|.++ +. .+.+++...+..|+.|++.|+.|+|++++|||||||+||||+.+ +.+||||||+|+... ++.
T Consensus 80 FE~~dhTvL~eL-e~-~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 80 FEYCDHTVLHEL-ER-YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred eeecchHHHHHH-Hh-ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCcc
Confidence 999988667664 33 47789999999999999999999999999999999999999955 569999999998765 556
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~ 283 (290)
..+.++.|..|.|||++.+ ...|+..+||||+||++.||++|.+-|+|.++.+.+|.|....
T Consensus 157 ~YTDYVATRWYRaPELLvG-------DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktL 218 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVG-------DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTL 218 (396)
T ss_pred hhhhhhhhhhccChhhhcc-------cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHH
Confidence 6677889999999999986 3679999999999999999999999999999999999998764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=321.64 Aligned_cols=216 Identities=32% Similarity=0.545 Sum_probs=182.1
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-c
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-L 131 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~ 131 (290)
....|.+++.||+|+||+|+.|.+ +++.||+|++.+.............+.+|+.+++.++ ||||+++++++... .
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 345699999999999999999976 6799999988775332111122345679999999998 99999999999654 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc-
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE- 210 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~- 210 (290)
.++||||+.||+|.+++.. .+++.+..+..+++||+.|++|||++||+||||||+|+|++.+.+++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred EEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 8899999999999999987 5789999999999999999999999999999999999999976467999999999987
Q ss_pred cccccccccCCCccccCccccccccccccccCC-C-CCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH-Y-NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~-~-~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
.........+||+.|+|||++.+ .. | +.++||||+|++||.|++|..||.+.+. ..++..+.+
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~--------~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-~~l~~ki~~ 237 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSG--------KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-PNLYRKIRK 237 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCC--------CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-HHHHHHHhc
Confidence 56677788899999999999976 22 4 5899999999999999999999999544 334443333
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=326.51 Aligned_cols=212 Identities=27% Similarity=0.448 Sum_probs=182.0
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 130 (290)
...-++|.+++.||+|+||+|+++.. +++.+|||++++...-..++. +..+.|..++...+ ||+++.++.+|+..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~V--e~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEV--ESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccH--HHHHHHHHHHHHhccCCeEeecccccccC
Confidence 45567899999999999999999976 678999999999876655543 24667777777764 99999999999754
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
++|+||||+.||++..+. ....+++..++.|++.++.||.|||++||||||||.+|||+|.+++ +||+|||+++.
T Consensus 442 ~~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh-~kiADFGlcKe 517 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH-VKIADFGLCKE 517 (694)
T ss_pred CeEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc-EEecccccccc
Confidence 789999999999954433 3478999999999999999999999999999999999999997765 99999999997
Q ss_pred cc-ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 210 ET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 210 ~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.. .+..+.+.+|||.|||||++.+ ..|+.++|+|||||+|||||.|+.||.|.+..+.--+|
T Consensus 518 ~m~~g~~TsTfCGTpey~aPEil~e--------~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI 580 (694)
T KOG0694|consen 518 GMGQGDRTSTFCGTPEFLAPEVLTE--------QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI 580 (694)
T ss_pred cCCCCCccccccCChhhcChhhhcc--------CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 54 6667788999999999999976 78999999999999999999999999996665544333
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=319.90 Aligned_cols=216 Identities=36% Similarity=0.614 Sum_probs=187.1
Q ss_pred ccccccCCCceeecceeccccceeEEEEEECCc-eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDR-IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
...+.++++.+++++.||+|-||.||+|++.+. .||+|.++......+ .|.+|+++|++|+|++||+++++|.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~------~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPE------AFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChh------HHHHHHHHHHhCcccCeEEEEEEEe
Confidence 345667778899999999999999999999776 999999988655443 4789999999999999999999998
Q ss_pred cC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 129 DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 129 ~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
.+ ..+|||||+..|+|.+|++......++..+.+.++.||++|++||+++++|||||..+||||+.+ ..+||+|||++
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vKIsDFGLA 350 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVKISDFGLA 350 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEEEcccccc
Confidence 75 48999999999999999998667789999999999999999999999999999999999999944 57999999999
Q ss_pred ccccccccccc--cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 208 REETVTEMMTA--ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 208 ~~~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
+.......... ..-+..|.|||++.. ..++.+|||||||++||||+| |+.||.++++.+.+-.+.
T Consensus 351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~--------~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le 418 (468)
T KOG0197|consen 351 RLIGDDEYTASEGGKFPIKWTAPEALNY--------GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE 418 (468)
T ss_pred cccCCCceeecCCCCCCceecCHHHHhh--------CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh
Confidence 95443333222 233567999999975 779999999999999999999 999999999988776553
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=318.35 Aligned_cols=214 Identities=28% Similarity=0.432 Sum_probs=191.7
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP- 130 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~- 130 (290)
...++|.++++||.|+||.||+|+. +++.||||.+++.....+.- .-+||+..|++|+ ||||+++.+++.|.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~----~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC----MNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH----HHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3446799999999999999999965 67899999999877665443 2459999999999 99999999999664
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.+++||||| ..+|.++++.+ ...+++..++.|+.||+.||+|+|.+|+.|||+||+|||+.. ...+||+|||+|+.
T Consensus 83 ~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~-~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 83 RILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG-NDVIKIADFGLARE 159 (538)
T ss_pred ceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc-cceeEecccccccc
Confidence 588999999 56999999985 789999999999999999999999999999999999999994 44699999999999
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
.......+.++.|..|.|||++.. ...|+.+.||||+||+++|+.+-++-|+|.+..+.+++|..-
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLr-------s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V 225 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLR-------SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV 225 (538)
T ss_pred cccCCCcchhhhcccccchHHhhh-------ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH
Confidence 888888888999999999999875 478999999999999999999999999999999999998753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=307.32 Aligned_cols=211 Identities=28% Similarity=0.465 Sum_probs=189.4
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
..+|.+.+.||+|+||.|-+|.. .|+.||||.++++...++..++ ++++|+++|+.|+||||+.+|++|+.. ..+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlv--hIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLV--HIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHH--HHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 45699999999999999999964 6899999999999888887764 589999999999999999999999754 788
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||..+|.|.+|+.. .+.+++..++.+++||+.|+.|+|.++++|||||.+|||+|.++ ++||+|||++..+...
T Consensus 130 ivMEYaS~GeLYDYiSe--r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISE--RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGLSNLYADK 206 (668)
T ss_pred EEEEecCCccHHHHHHH--hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccchhhhhccc
Confidence 99999999999999987 46899999999999999999999999999999999999999554 5999999999998888
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
....++||++.|.+||+..+ ...-++.+|-||||++||.++.|.+||+|.+.-....+|
T Consensus 207 kfLqTFCGSPLYASPEIvNG-------~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI 265 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNG-------TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI 265 (668)
T ss_pred cHHHHhcCCcccCCccccCC-------CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh
Confidence 88899999999999999876 233478999999999999999999999998765444443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=297.44 Aligned_cols=214 Identities=31% Similarity=0.415 Sum_probs=184.7
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---C
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---P 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~ 130 (290)
.-+.|..+++|++|+||.||+|++ +++.||+|.++.+....--.. --+|||.+|.+++|||||.+..+... +
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI---tsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI---TSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc---hhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 345699999999999999999987 679999999987653332221 24699999999999999999887643 3
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..|+|||||+. +|..++... ..++...++..++.|++.|+.|||.+.|+||||||+|+|++..+ .+||+|||+|+.+
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLAREY 227 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhhhh
Confidence 68999999955 999999874 47899999999999999999999999999999999999999555 5999999999976
Q ss_pred ccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 211 TVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 211 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
..+ ...+..+-|..|.|||++.+ ...|+.+.|+||+|||+.||+++.+-|+|.+..+.+..|+..
T Consensus 228 gsp~k~~T~lVVTLWYRaPELLLG-------~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l 293 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELLLG-------AKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL 293 (419)
T ss_pred cCCcccCcceEEEeeecCHHHhcC-------CcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH
Confidence 554 34556678999999999987 467999999999999999999999999999999999888765
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=303.02 Aligned_cols=206 Identities=28% Similarity=0.425 Sum_probs=180.7
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---C---c
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---P---L 131 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~---~ 131 (290)
|.-.+.+|+|+||.||.|.. +++.||||..-++..-.. +|+++|+.+.|||||++..+|.. . .
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn---------rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN---------RELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc---------HHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 67788999999999999976 568999999877655332 78999999999999999887742 2 3
Q ss_pred eEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..+||||+ ..+|.++++.. ....++...+.-+..||++||.|||+.||+||||||.|+|+|++.+.+||||||.|+.
T Consensus 97 lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 45999999 45898888742 2456888889999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
...++...++..|..|.|||++.+ ...|+.+.||||.||++.||+-|++-|+|.+..+.+..|+.-
T Consensus 176 L~~~epniSYicSRyYRaPELifg-------a~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~ 241 (364)
T KOG0658|consen 176 LVKGEPNISYICSRYYRAPELIFG-------ATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV 241 (364)
T ss_pred eccCCCceeEEEeccccCHHHHcC-------ccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH
Confidence 888888888999999999999987 478999999999999999999999999999998888877653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=303.38 Aligned_cols=214 Identities=28% Similarity=0.470 Sum_probs=176.7
Q ss_pred CCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee--ecC-c
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDP-L 131 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~-~ 131 (290)
..++..++.||+|+||.||++... ++.+|||......... ...+.+|+.+|++++|||||+++|.. .+. .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-----SESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-----HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 344777889999999999999875 6999999987764333 12467999999999999999999963 333 5
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
+.+.|||+.+|+|.+++..... .+++..++.+.+|++.||.|||++|+|||||||+|||++..++.+||+|||+++...
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 7899999999999999987544 799999999999999999999999999999999999999745569999999988644
Q ss_pred c----cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHhh
Q 022903 212 V----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKV 283 (290)
Q Consensus 212 ~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~-~~~~~~~~~~~~~~ 283 (290)
. ........||+.|||||++.. +....+++|||||||++.||+||+.||.+ ....+..+.+.-..
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~-------g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~ 239 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRN-------GEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED 239 (313)
T ss_pred cccccccccccccCCccccCchhhcC-------CCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC
Confidence 2 223345689999999999863 12334699999999999999999999999 56666666665443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=313.27 Aligned_cols=214 Identities=32% Similarity=0.489 Sum_probs=190.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee-ecCceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 134 (290)
..|....+||+|+.|.||.|+. +++.||||.+......... -+.+|+.+|+.++|+|||.+++.| .+..+|.
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~ke-----LilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKE-----LLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchh-----hhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 4577788999999999999976 6788999999877665543 377999999999999999999887 4567999
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||++||+|.+++.. ..+++.+++.++++++.||+|||.+||+|||||.+|||++.++. +||+|||+|.......
T Consensus 348 VMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~-vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS-VKLTDFGFCAQISEEQ 423 (550)
T ss_pred EEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc-EEEeeeeeeecccccc
Confidence 9999999999999976 45999999999999999999999999999999999999997665 9999999998765554
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhccccc
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (290)
...+..||+.|||||+... ..|+++.||||||++++||+-|++||-..+..+++|.|+.+....|-
T Consensus 424 ~KR~TmVGTPYWMAPEVvtr--------k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk 490 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTR--------KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLK 490 (550)
T ss_pred CccccccCCCCccchhhhhh--------cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcC
Confidence 5567799999999999864 88999999999999999999999999999999999999998776653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=315.60 Aligned_cols=202 Identities=31% Similarity=0.508 Sum_probs=180.4
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|++++.||.|+.|.|-+|++ +|+.+|||++.+...-.+.. ...+.+|+.+|+.+.||||+++|+++++. ++|+|.
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~--~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQ--PAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeecccccccccc--ccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 78899999999999999987 89999999998874222211 23578999999999999999999999765 789999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccc
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~ 216 (290)
||++||.|.+++.. .+++++.++.++++||+.|+.|+|..+|+|||+||+|+|+|..+. |||+|||+|.....+...
T Consensus 92 Eyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n-IKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN-IKIADFGMASLEVPGKLL 168 (786)
T ss_pred EecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC-EeeeccceeecccCCccc
Confidence 99999999999986 578999999999999999999999999999999999999997665 999999999998888889
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
.+.||++.|.+||+..+ ....+.++||||.|||||.||+|++||++.+.+
T Consensus 169 eTSCGSPHYA~PEIV~G-------~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir 218 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSG-------RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR 218 (786)
T ss_pred cccCCCcccCCchhhcC-------CCCCCCccccchhHHHHHHHHhCCCCCCCccHH
Confidence 99999999999999987 344589999999999999999999999974443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=282.89 Aligned_cols=211 Identities=29% Similarity=0.418 Sum_probs=181.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
.+|...++||+|.||.||+|++ +++.||||.++.....+..+ ....||++.|+.++|+||+.++++|-. ..+-+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~---~talREIK~Lqel~h~nIi~LiD~F~~~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGIN---RTALREIKLLQELKHPNIIELIDVFPHKSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCcc---HHHHHHHHHHHHccCcchhhhhhhccCCCceEE
Confidence 3577889999999999999987 67999999998765544332 235799999999999999999999954 46779
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
|+||+ ..+|...++. ....++...+..|+.+++.||+|||++.|+||||||.|+||+.+ +.+||+|||+++......
T Consensus 79 VfEfm-~tdLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 79 VFEFM-PTDLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEEec-cccHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccCCCC
Confidence 99999 5599999987 56789999999999999999999999999999999999999955 569999999999765444
Q ss_pred cc-cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 215 MM-TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 215 ~~-~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.. ...+-|..|.|||++.+ ...|+...||||.||++.||+-|.+-|+|.++.+.+-.|.-
T Consensus 156 ~~~~~~V~TRWYRAPELLfG-------sr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~ 216 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFG-------SRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFR 216 (318)
T ss_pred cccccceeeeeccChHHhcc-------chhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHH
Confidence 33 33378899999999987 47899999999999999999999999999999888766653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=284.00 Aligned_cols=215 Identities=31% Similarity=0.481 Sum_probs=187.9
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.++|.+++.||+|-||.||.|+. ++..||+|++.+.+.... ..+..+.+|+++.+.|+||||+++|++|.|. ..|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~--~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKT--QVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHh--cchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 34599999999999999999977 457899999987664332 2334588999999999999999999999876 788
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+++||..+|+|.+.+.......+++..+..++.|++.||.|+|.++||||||||+|+|++..+ .+||+|||.+.... .
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~p-~ 176 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAP-S 176 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCceeecC-C
Confidence 999999999999999977778899999999999999999999999999999999999999655 59999999998765 5
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhc
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQ 284 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~ 284 (290)
....+.+||..|.|||...+ ...+..+|+|++|++.||++.|.+||...+ ...+|+-+.+..
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~--------~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~ 238 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEG--------RGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD 238 (281)
T ss_pred CCceeeecccccCCHhhcCC--------CCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc
Confidence 56677899999999998765 778999999999999999999999999987 667776665544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=312.16 Aligned_cols=209 Identities=34% Similarity=0.538 Sum_probs=180.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
++|.+.+.||+|+||+||+|+. +.+.||+|.+.+.......- ..+.+|+++++.|+||||+.++++|+. ..+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l---~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKEL---KNLRQEVRILRSLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHH---HHHHHHHHHHHhcCCcchhhHHHhhcccceEEE
Confidence 3588889999999999999965 66899999998766554332 357899999999999999999999975 47899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
|.||+.| +|..++.. .+.++++.+..++.+++.||.|||+.+|+|||+||.|||++++ +++|++|||+++.+....
T Consensus 79 Vte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNT 154 (808)
T ss_pred Eehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCc
Confidence 9999977 99999986 6789999999999999999999999999999999999999955 569999999999766554
Q ss_pred c-ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 215 M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 215 ~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
. .....|||.|||||+..+ .+|+..+|+|||||++|||++|++||-..+-.+-...|..
T Consensus 155 ~vltsikGtPlYmAPElv~e--------~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~ 214 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEE--------QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK 214 (808)
T ss_pred eeeeeccCcccccCHHHHcC--------CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc
Confidence 3 345689999999999875 8899999999999999999999999988766655544443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=302.91 Aligned_cols=215 Identities=28% Similarity=0.435 Sum_probs=172.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHH-----H----HHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER-----A----LLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~-----~----~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
..|++++.||+|.||.|-+|+. +++.||||++.+....... . .-.+++.+||.+|++|+|||||+|+++
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 5699999999999999999987 6799999999765432211 0 011368899999999999999999999
Q ss_pred eecC---ceEEEEEecCCCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEe
Q 022903 127 CKDP---LMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 127 ~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~ 202 (290)
..++ .+|+|+|||..|.+...- ..++ +++.++++|+++++.||+|||.+|||||||||+|+|++.+ +++||+
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~-g~VKIs 252 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD-GTVKIS 252 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC-CcEEee
Confidence 8764 689999999988876532 2344 8999999999999999999999999999999999999955 679999
Q ss_pred cccccccc------cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 203 DFGLAREE------TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 203 Dfg~~~~~------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
|||.+... ..........|||.|+|||++..-. .....+.+.||||+||+||.|+.|+.||-+....+.-
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~----~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN----SFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC----CccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 99998753 2222334468999999999886511 1234578999999999999999999999996555443
Q ss_pred HHHH
Q 022903 277 YAAA 280 (290)
Q Consensus 277 ~~~~ 280 (290)
.+|.
T Consensus 329 ~KIv 332 (576)
T KOG0585|consen 329 DKIV 332 (576)
T ss_pred HHHh
Confidence 3433
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=308.10 Aligned_cols=208 Identities=26% Similarity=0.432 Sum_probs=172.4
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|++++.||+|+||+||++++ +++.||+|++......... ....+.+|+.++..++||||+++++.+.+. ..++|
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE--QVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhh--HHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 588899999999999999976 5789999999754322211 123577899999999999999999998765 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCccccccccc
Confidence 999999999999875 4579999999999999999999999999999999999999955 469999999986422110
Q ss_pred -----------------------------------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHH
Q 022903 215 -----------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259 (290)
Q Consensus 215 -----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~ 259 (290)
.....+||+.|+|||++.. ..++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--------TGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--------CCCCCchhhhhhHHHHHH
Confidence 0123479999999999864 568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHH
Q 022903 260 LLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 260 ~l~g~~Pf~~~~~~~~~~~~ 279 (290)
|++|..||.+.+..+....+
T Consensus 229 ll~G~~Pf~~~~~~~~~~~i 248 (363)
T cd05628 229 MLIGYPPFCSETPQETYKKV 248 (363)
T ss_pred HHhCCCCCCCCCHHHHHHHH
Confidence 99999999987765544443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=294.04 Aligned_cols=223 Identities=29% Similarity=0.463 Sum_probs=191.9
Q ss_pred cccccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
..+..+.+.|.+.+.||.|..+.||+|++ +++.||||++.-+.-..+.. .+.+|+..++.++||||++++..|.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld----~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLD----ALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHH----HHHHHHHHhhhcCCCCcceEEEEEE
Confidence 34556788999999999999999999987 67999999998766555432 4789999999999999999999985
Q ss_pred -cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 129 -DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 129 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
+..+|+||.||.+|++.++++......+++..+..|+++++.||.|||.+|.||||||+.||||+.+ +.|||+|||.+
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLadFgvs 173 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLADFGVS 173 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEcCceee
Confidence 5689999999999999999999888889999999999999999999999999999999999999955 56999999976
Q ss_pred ccccccc-----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 208 REETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 208 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
-...... ......||+.|||||++.. ....|+.++||||||++..|+.+|..||..+.++..++....+
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q------~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn 247 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ------QLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN 247 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhh------cccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 5422221 1145689999999999654 3467999999999999999999999999999999988776555
Q ss_pred hc
Q 022903 283 VQ 284 (290)
Q Consensus 283 ~~ 284 (290)
-+
T Consensus 248 ~p 249 (516)
T KOG0582|consen 248 DP 249 (516)
T ss_pred CC
Confidence 43
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=289.52 Aligned_cols=214 Identities=32% Similarity=0.491 Sum_probs=180.9
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC-ceeEEeeeec-C--
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN-LVKFLGACKD-P-- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~-~-- 130 (290)
...|..+++||+|+||+||+|+. +|+.||+|.++-.....-. -....+|+.+++.|+|+| |+.+++++.. .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~---P~taiREisllk~L~~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGV---PSTAIREISLLKRLSHANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCC---CchhhHHHHHHHHhCCCcceEEEEeeeeecccc
Confidence 34577889999999999999976 7899999999876542111 012459999999999999 9999999853 2
Q ss_pred ----ceEEEEEecCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 131 ----LMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 131 ----~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
.+++|+||+ ..+|.+++..... ..++...+..+++||+.||+|||+++|+||||||+|+||++ .+.+||+||
T Consensus 87 ~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~-~G~lKlaDF 164 (323)
T KOG0594|consen 87 RGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS-SGVLKLADF 164 (323)
T ss_pred cccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC-CCcEeeecc
Confidence 577999999 6699999987543 46888899999999999999999999999999999999996 456999999
Q ss_pred cccccccccc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 205 GLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 205 g~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
|++.....+. ......+|..|.|||++.+ ...|+...||||+|||++||+++++-|.|.++.+.+.+|...
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlG-------s~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~ 236 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLG-------STSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL 236 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcC-------CCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence 9998655333 3556688999999999987 246999999999999999999999999999999999888765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=292.23 Aligned_cols=219 Identities=26% Similarity=0.388 Sum_probs=185.9
Q ss_pred cccCCCceeecceeccccceeEEEEEECC--ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
.....+.|++++.||+|.-|+||+++..+ ..+|+|++.+......... .|...|-+||+.++||.++.||..++.+
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl--~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKL--KRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHH--HHHHHHHHHHHhcCCCccchhhheeecc
Confidence 34566779999999999999999998754 8999999988776654433 3566788999999999999999999755
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++|||||.||+|..+++.+..+.+++..++.|+++++.||+|||-.|||+|||||+||||..++ +|.|+||.++..
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-HIMLsDFDLS~~ 228 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-HIMLSDFDLSLR 228 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-cEEeeecccccc
Confidence 678999999999999999988888899999999999999999999999999999999999999555 599999998641
Q ss_pred c----------c------------------------c-c----------------------ccccccCCCccccCccccc
Q 022903 210 E----------T------------------------V-T----------------------EMMTAETGTYRWMAPELYS 232 (290)
Q Consensus 210 ~----------~------------------------~-~----------------------~~~~~~~g~~~y~aPE~~~ 232 (290)
- . . . ......+||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 0 0 0 0 0112346899999999998
Q ss_pred cccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 233 ~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
+ ...+.++|+|+||+.+|||+.|..||.|.++.+....+..+
T Consensus 309 G--------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~ 350 (459)
T KOG0610|consen 309 G--------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ 350 (459)
T ss_pred c--------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC
Confidence 6 56789999999999999999999999999888877776654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.06 Aligned_cols=202 Identities=22% Similarity=0.400 Sum_probs=170.4
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|++.+.||+|+||.||++.+ +++.||+|.+......... ....+.+|+.+++.++|++|+++++.+.+. ..++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhh--hHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 67889999999999999976 6789999998754432221 123477899999999999999999988654 678999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccc
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~ 216 (290)
||+++++|.+++.......+++..+..++.|++.||+|||++|++||||||+|||++.+ +.++|+|||++.........
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCCee
Confidence 99999999988865445578999999999999999999999999999999999999955 46999999998764433333
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
....|+..|+|||++.. ..++.++|||||||++|+|++|+.||.+...
T Consensus 159 ~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 159 RGRVGTVGYMAPEVINN--------EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred cCCCCCCCccCHhhhcC--------CCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 45578999999999864 5688999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=304.52 Aligned_cols=209 Identities=25% Similarity=0.420 Sum_probs=172.3
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.|.+++.||+|+||+||+|++ +++.||+|++.......... ...+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~--~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ--VAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHH--HHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEE
Confidence 488899999999999999977 56899999997644322221 23578999999999999999999998754 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc--
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-- 213 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-- 213 (290)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+ ++++|+|||++......
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 80 MDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCcccccccc
Confidence 999999999999875 3568999999999999999999999999999999999999955 46999999987521100
Q ss_pred ----------------------------------------------ccccccCCCccccCccccccccccccccCCCCCc
Q 022903 214 ----------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 247 (290)
Q Consensus 214 ----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~ 247 (290)
.......||+.|+|||++.. ..++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~ 228 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--------KGYTQL 228 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--------CCCCCc
Confidence 00123468999999998864 568899
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 248 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 248 ~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
+|||||||++|+|++|..||.+.+..+....+.
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~ 261 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 999999999999999999999877665554443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=304.07 Aligned_cols=209 Identities=24% Similarity=0.423 Sum_probs=171.8
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.|.+++.||+|+||.||+|++ +++.||+|++......... ....+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~--~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRN--QVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHH--HHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEE
Confidence 488899999999999999987 5789999998754322211 223578999999999999999999999754 68899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc---
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV--- 212 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~--- 212 (290)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 80 MDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCcccccccc
Confidence 999999999999875 3568999999999999999999999999999999999999955 4699999999742100
Q ss_pred ---------------------------------------------cccccccCCCccccCccccccccccccccCCCCCc
Q 022903 213 ---------------------------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 247 (290)
Q Consensus 213 ---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~ 247 (290)
........||+.|+|||++.. ..++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~ 228 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--------TGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--------CCCCCe
Confidence 000122468999999999864 568899
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 248 VDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 248 ~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
+|||||||++|+|++|+.||.+.+..+....+.
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 261 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI 261 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999999999999999987766555443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=302.94 Aligned_cols=208 Identities=26% Similarity=0.420 Sum_probs=172.0
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+++.||+|+||.||++++ +++.||||++......... ....+.+|+.+++.++||||+++++.+.++ ..++|
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKE--QVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 588999999999999999987 5789999999754322111 123577899999999999999999998765 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.++|+|||++.......
T Consensus 80 ~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceecccccc
Confidence 999999999999875 3568999999999999999999999999999999999999955 459999999986422110
Q ss_pred --------------------------------------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHH
Q 022903 215 --------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256 (290)
Q Consensus 215 --------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~ 256 (290)
......||+.|+|||++.. ..++.++|||||||+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~i 228 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--------TGYNKECDWWSLGVI 228 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--------CCCCCeeeeecchhH
Confidence 0112368999999998864 568899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHH
Q 022903 257 LWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 257 l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
+|+|++|..||.+.+..+....+
T Consensus 229 l~el~~G~~Pf~~~~~~~~~~~i 251 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQETYRKI 251 (364)
T ss_pred HHHhhcCCCCCCCCCHHHHHHHH
Confidence 99999999999998776554443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=304.02 Aligned_cols=204 Identities=25% Similarity=0.425 Sum_probs=168.8
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+++.||+|+||.||+++. +++.||+|++......... ....+.+|+.+++.++||||+++++.+.++ ..++|
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKD--QLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhH--HHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 588899999999999999976 6789999998653322211 124577899999999999999999999765 68899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.+ +.++|+|||+++......
T Consensus 80 ~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeecccccccccccc
Confidence 999999999999875 4578999999999999999999999999999999999999955 469999999985311000
Q ss_pred -----------------------------------------------cccccCCCccccCccccccccccccccCCCCCc
Q 022903 215 -----------------------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 247 (290)
Q Consensus 215 -----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~ 247 (290)
......||+.|+|||++.. ..++.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~ 228 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--------QGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--------CCCCCc
Confidence 0012368999999998864 568899
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 248 VDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 248 ~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
+|||||||++|+|++|..||.+.+..+.
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~ 256 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHET 256 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHH
Confidence 9999999999999999999998766544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=295.68 Aligned_cols=206 Identities=25% Similarity=0.397 Sum_probs=172.9
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
...|.+.+.||+|+||.||+|++ +++.||+|++......... ....+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK--QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhh--hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 45699999999999999999987 5789999998754322111 123578999999999999999999998754 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceEcCCC
Confidence 99999999999999876 4578999999999999999999999999999999999999955 46999999998764322
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
.....|++.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 172 --~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~ 225 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQS--------KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE 225 (329)
T ss_pred --cceecCChhhcCHHHHcC--------CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 234578999999999864 567899999999999999999999999877654433
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=302.54 Aligned_cols=208 Identities=25% Similarity=0.433 Sum_probs=170.5
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.|++++.||+|+||.||++++ +++.||+|++......... ....+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRN--QAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhh--hHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 588999999999999999986 5789999998653321111 123577899999999999999999998754 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc--
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-- 213 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-- 213 (290)
|||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+ +.++|+|||++......
T Consensus 80 ~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccc
Confidence 999999999999875 3568899999999999999999999999999999999999955 46999999997421100
Q ss_pred ------------------------------------------ccccccCCCccccCccccccccccccccCCCCCcchhH
Q 022903 214 ------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 251 (290)
Q Consensus 214 ------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Diw 251 (290)
.......||+.|+|||++.. ..++.++|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Diw 228 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--------TGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--------CCCCcceeee
Confidence 00112468999999999864 5678999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 252 SFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 252 slG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
||||++|+|++|..||.+.+..+....+
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~~~~~i 256 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAETQLKV 256 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHHHHHHH
Confidence 9999999999999999998766554443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=284.57 Aligned_cols=214 Identities=30% Similarity=0.453 Sum_probs=180.9
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec--
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-- 129 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 129 (290)
...+..|..++.||+|+||.|+.+.+ +++.||||.+.......-. ..+..+|+++|+.++|+||+.+.+.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~---akRtlRElklLr~~~HeNIi~l~di~~p~~ 94 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQID---AKRTLRELKLLRHLRHENIIGLLDIFRPPS 94 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHH---HHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence 33455566689999999999999976 6799999998754333322 3478899999999999999999988743
Q ss_pred ----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 130 ----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 130 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
...|+|+|++ +.+|.+.++. +..++...+..++.||++||.|+|+.+|+|||+||.|+|++.+ ..+||+|||
T Consensus 95 ~~~f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFG 170 (359)
T KOG0660|consen 95 RDKFNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFG 170 (359)
T ss_pred ccccceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEecccc
Confidence 3689999999 7799999986 4459999999999999999999999999999999999999955 559999999
Q ss_pred ccccccc---cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 206 LAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 206 ~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
+++.... ...++.++.|..|.|||++.. ...|+.+.||||+||||.||++|++-|.|.+....+..|..
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~-------~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLN-------SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhc-------cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 9987653 445567788999999999865 57899999999999999999999999999888776665543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=301.29 Aligned_cols=207 Identities=29% Similarity=0.383 Sum_probs=181.8
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-C-----CCceeEEeeeec-
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-H-----DNLVKFLGACKD- 129 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~- 129 (290)
+|.+++.||+|+||.|.++.+ +++.||||+++.......+. ..|+.+|..|+ | -|||+++++|..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~------~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQA------QIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHH------HHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 688999999999999999976 67999999998876655443 36888888887 3 489999999965
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc-CCCCceEEecccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~-~~~~~~kl~Dfg~~~ 208 (290)
+++++|+|.+ ..+|.++++.++..+++...++.++.||+.||.+||+.||||+||||+|||+. .+...|||+|||.++
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 4789999999 67999999999999999999999999999999999999999999999999995 334469999999999
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
+...... .+..+..|.|||++.+ .+|+.+.||||||||++||++|.+.|+|.+..+.+..|..-
T Consensus 340 ~~~q~vy--tYiQSRfYRAPEVILG--------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~ 403 (586)
T KOG0667|consen 340 FESQRVY--TYIQSRFYRAPEVILG--------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV 403 (586)
T ss_pred ccCCcce--eeeeccccccchhhcc--------CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence 8554433 6788999999999987 78999999999999999999999999999998888777643
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=299.43 Aligned_cols=216 Identities=28% Similarity=0.431 Sum_probs=174.8
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
.....|++.+.||+|+||.||++++ +++.||+|++.......... ...+.+|+.+++.++||||+++++.+.++ .
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD--SAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhh--HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3456799999999999999999987 56899999986532221111 23467899999999999999999998765 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~ 193 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccceecc
Confidence 7899999999999999865 358899999999999999999999999999999999999955 469999999987643
Q ss_pred cccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 212 VTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 212 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.... .....||+.|+|||++... .....++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~ 260 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhcc----CCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2221 2345799999999998641 112347889999999999999999999999877655544443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=294.89 Aligned_cols=203 Identities=30% Similarity=0.478 Sum_probs=172.0
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.|.+++.||+|+||.||+|++ +++.||+|++......... ....+.+|+.++..++||||+++++.+.+. ..++|
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLN--EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhh--HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 588999999999999999987 5789999998754322211 123577899999999999999999998755 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++..... .
T Consensus 80 ~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 80 MEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCccccc--c
Confidence 999999999999975 3578999999999999999999999999999999999999955 4699999999875433 3
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
.....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 155 ~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 207 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG--------KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW 207 (333)
T ss_pred cCCcccCccccChhHhcC--------CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH
Confidence 345578999999999865 57889999999999999999999999987655443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=290.36 Aligned_cols=205 Identities=27% Similarity=0.425 Sum_probs=171.3
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||+|++ +++.||+|++......... ....+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLK--QEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhH--HHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 588899999999999999987 4789999998654322211 123578999999999999999999988654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.+ +.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 80 MEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhccCC--
Confidence 999999999999976 3578999999999999999999999999999999999999955 46999999998754322
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
.....|++.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 155 ~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~ 209 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS--------KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK 209 (291)
T ss_pred cccccCChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 234578999999998764 5578999999999999999999999998776544333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=302.52 Aligned_cols=212 Identities=37% Similarity=0.672 Sum_probs=183.2
Q ss_pred cccccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
+.+.+..+.+.++.+||+|.||+||+|+|.| .||||+++......+.. +.|++|+.++++-+|-||+-+.|++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~ql---qaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQL---QAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHH---HHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 5666777888999999999999999999866 59999999888777643 4599999999999999999999999988
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
.+.+|..+|+|-+|..++.-. ...++..+...|++|++.|+.|||.++|||||||..|||+..+ .+|||+|||++...
T Consensus 461 ~~AIiTqwCeGsSLY~hlHv~-etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PLAIITQWCEGSSLYTHLHVQ-ETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVK 538 (678)
T ss_pred ceeeeehhccCchhhhhccch-hhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeee
Confidence 889999999999999999763 4679999999999999999999999999999999999999954 67999999998743
Q ss_pred cc---cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 211 TV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 211 ~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
.. ........|...|||||++.. .+..+|++.+||||||+++|||++|.+||......
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRm-----qd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d 599 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRM-----QDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD 599 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhh-----cccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence 22 223344567889999999874 34678999999999999999999999999954433
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=295.36 Aligned_cols=208 Identities=25% Similarity=0.385 Sum_probs=172.6
Q ss_pred cCCCceeecceeccccceeEEEEEEC---CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG---DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
...+.|.+.+.||+|+||.||+|.+. ...||+|++......... ....+.+|+.+++.++||||+++++++.+.
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQK--QVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhh--hHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 34566999999999999999999753 257999998653322211 123577899999999999999999998765
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.++|+|||++...
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEecCCCCeec
Confidence 67899999999999999976 4578999999999999999999999999999999999999955 46999999998764
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+......
T Consensus 182 ~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 238 (340)
T PTZ00426 182 DT--RTYTLCGTPEYIAPEILLN--------VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ 238 (340)
T ss_pred CC--CcceecCChhhcCHHHHhC--------CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH
Confidence 32 2234578999999999864 557899999999999999999999999876654333
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=299.46 Aligned_cols=208 Identities=26% Similarity=0.433 Sum_probs=171.4
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.|.+++.||+|+||.||++++ +++.||+|++......... ....+.+|+.++..++||+|+++++.+.+. ..++|
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKE--QVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhh--hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 588899999999999999977 5789999998753222111 124577899999999999999999998765 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.+ +.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCcccccccc
Confidence 999999999999875 4578999999999999999999999999999999999999955 469999999986321100
Q ss_pred -----------------------------------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHH
Q 022903 215 -----------------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259 (290)
Q Consensus 215 -----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~ 259 (290)
......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilye 228 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--------TGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--------CCCCCcceeccccceeee
Confidence 0123468999999999864 668899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHH
Q 022903 260 LLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 260 ~l~g~~Pf~~~~~~~~~~~~ 279 (290)
|++|..||.+.+.......+
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i 248 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKV 248 (360)
T ss_pred cccCCCCCCCCCHHHHHHHH
Confidence 99999999987765544433
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.87 Aligned_cols=208 Identities=28% Similarity=0.446 Sum_probs=171.1
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec----
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 129 (290)
....|.+++.||+|+||.||+|.+ +++.||||.+..... ...+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---------YKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---------hHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 446799999999999999999976 578999998864322 13479999999999999999887532
Q ss_pred -----CceEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEe
Q 022903 130 -----PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 130 -----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~ 202 (290)
...++||||+. ++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++..+||+
T Consensus 135 ~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeee
Confidence 13568999996 4777776532 345689999999999999999999999999999999999999776679999
Q ss_pred cccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 203 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
|||+++............+|+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+..+...++.
T Consensus 214 DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 214 DFGSAKNLLAGQRSVSYICSRFYRAPELMLG-------ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred ccccchhccCCCCcccCCCCcCccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9999986544444445678999999998754 2457899999999999999999999999988777666654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=292.82 Aligned_cols=208 Identities=32% Similarity=0.589 Sum_probs=167.5
Q ss_pred cCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGA 126 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 126 (290)
+..++|++.+.||+|+||.||+|.+ .++.||+|++......... ..+.+|+.++..+ +||||++++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH----KALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHH----HHHHHHHHHHHHhccCcceeeEEeE
Confidence 4456799999999999999999964 2367999998754433322 3578999999999 89999999998
Q ss_pred eecC--ceEEEEEecCCCCHHHHHHhcC----------------------------------------------------
Q 022903 127 CKDP--LMVIVTELLPGMSLRKYLVSLR---------------------------------------------------- 152 (290)
Q Consensus 127 ~~~~--~~~lv~e~~~~~~L~~~~~~~~---------------------------------------------------- 152 (290)
+... ..+++|||+++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8643 5789999999999999987532
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc---cccccCC
Q 022903 153 --------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETG 221 (290)
Q Consensus 153 --------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g 221 (290)
...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++....... ......+
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCC
Confidence 1247778889999999999999999999999999999999955 469999999987532221 1122345
Q ss_pred CccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022903 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275 (290)
Q Consensus 222 ~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~ 275 (290)
+..|+|||.+.. ..++.++||||||+++|+|++ |..||.+....+.
T Consensus 239 ~~~y~aPE~~~~--------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~ 285 (338)
T cd05102 239 PLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285 (338)
T ss_pred CccccCcHHhhc--------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH
Confidence 678999998864 568899999999999999997 9999998665443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=292.39 Aligned_cols=200 Identities=26% Similarity=0.413 Sum_probs=165.9
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecC
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLP 140 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~ 140 (290)
+.||+|+||.||++++ +++.||+|++.......... ..++.+|+.+++.++||||+++++.+.+. ..++||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE--VAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHH--HHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCC
Confidence 3589999999999976 67899999987543222211 23567899999999999999999988654 6789999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-ccccccc
Q 022903 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAE 219 (290)
Q Consensus 141 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 219 (290)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++..... .......
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 79 GGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccce
Confidence 9999998875 4578999999999999999999999999999999999999955 4599999999875322 2223345
Q ss_pred CCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 220 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
.||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+.....
T Consensus 156 ~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~ 204 (323)
T cd05571 156 CGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204 (323)
T ss_pred ecCccccChhhhcC--------CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH
Confidence 79999999999864 56889999999999999999999999886654433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=296.25 Aligned_cols=214 Identities=27% Similarity=0.410 Sum_probs=173.4
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
...+.|.+.+.||+|+||.||++++ +++.||+|++......... ....+.+|+.+++.++||||+++++.+.+. .
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~--~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS--DSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhH--HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 4456799999999999999999987 5789999998653222111 123467899999999999999999998755 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~ 193 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEEEeCCceeEcC
Confidence 7899999999999999865 458899999999999999999999999999999999999955 469999999987643
Q ss_pred ccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 212 VTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 212 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
... ......||+.|+|||++... .....++.++|||||||++|+|++|..||.+.+.......
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~ 258 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258 (371)
T ss_pred cCCcccccCcccCccccCHHHHhcc----CCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 322 12345799999999998641 1123478899999999999999999999998766544333
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.68 Aligned_cols=211 Identities=32% Similarity=0.501 Sum_probs=184.8
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-c
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-L 131 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~ 131 (290)
....|.+.+.||+|.||.||+++. +++.+|+|++.+........ ...+.+|+.+|+.+. ||||+.+++++++. .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~--~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKED--REDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccccc--HHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 345699999999999999999976 68999999998876644331 124779999999998 99999999999876 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC---CceEEecccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---KSLKLADFGLAR 208 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~---~~~kl~Dfg~~~ 208 (290)
.++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|++||||||+|+|+.... ..++++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 78999999999999999875 399999999999999999999999999999999999996442 369999999999
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
...........+||+.|+|||++.. ..++..+||||+|+++|.|++|..||.+.+.......+
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~--------~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i 250 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGG--------RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI 250 (382)
T ss_pred EccCCceEeeecCCccccCchhhcC--------CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH
Confidence 8777667778899999999999864 67999999999999999999999999998876665544
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=294.65 Aligned_cols=213 Identities=27% Similarity=0.430 Sum_probs=186.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c-eE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L-MV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~-~~ 133 (290)
+.|..++.+|+|+||.+++.++ .+..+++|.+.-........ ....+|+.++++++|||||.+.+.|.++ . .+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r---~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPER---RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhh---HHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 4588899999999999998876 46789999988766544332 1356899999999999999999999644 4 78
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||+||+||+|.+.+...+...+++..+..|+.||+.|+.|||++.|+|||||+.|||+++++. |+|.|||+++.....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~-VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK-VKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc-eeecchhhhhhcCCc
Confidence 9999999999999999877778999999999999999999999999999999999999998776 799999999987777
Q ss_pred c-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 214 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
. ...+..||+.||+||++.+ .+|+.++|||||||++|||++=+++|.+.+...-+.+|.-.
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d--------~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~ 221 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSD--------IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG 221 (426)
T ss_pred hhhhheecCCCcccCHHHhCC--------CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc
Confidence 6 6677899999999999976 78999999999999999999999999998776666655543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=293.94 Aligned_cols=205 Identities=39% Similarity=0.597 Sum_probs=172.8
Q ss_pred ccccCCCceeecceeccccceeEEEEEECC-ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
.+....+.|.-.+.||+|+||.||+|...+ ..||||.+....... . ..|.+|+.++.+++|||+|+|+|+|.+.
T Consensus 69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~----~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 69 ELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-E----REFLNEVEILSRLRHPNLVKLLGYCLEG 143 (361)
T ss_pred HHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-h----hHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence 334455677777899999999999998865 899999887765542 1 1389999999999999999999999765
Q ss_pred c--eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeeecCCCCCEEEcCCCCceEEeccc
Q 022903 131 L--MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG---IIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 131 ~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g---ivH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
. .++|+||+.+|+|.+++.......++|.++.+|+.++|.||+|||+.. ||||||||+|||+| .+...||+|||
T Consensus 144 ~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFG 222 (361)
T KOG1187|consen 144 GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFG 222 (361)
T ss_pred CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCcc
Confidence 3 899999999999999998743228899999999999999999999853 99999999999999 55679999999
Q ss_pred ccccccc-ccccccc-CCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 206 LAREETV-TEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 206 ~~~~~~~-~~~~~~~-~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
+++.... ....... .||.+|+|||.+.. +..+.++||||||++|+|+++|+.|.+..
T Consensus 223 La~~~~~~~~~~~~~~~gt~gY~~PEy~~~--------g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 223 LAKLGPEGDTSVSTTVMGTFGYLAPEYAST--------GKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred CcccCCccccceeeecCCCCccCChhhhcc--------CCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9976544 3322233 89999999998864 67899999999999999999999988864
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=295.52 Aligned_cols=215 Identities=27% Similarity=0.420 Sum_probs=173.5
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
.....|.+.+.||+|+||.||++++ +++.||+|++......... ....+.+|+.+++.++||||+++++++.++ .
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRS--DSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh--hHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3456799999999999999999987 5789999998653221111 113467899999999999999999988765 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~ 193 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEeccceeecc
Confidence 7899999999999998865 458889999999999999999999999999999999999955 469999999987643
Q ss_pred ccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 212 VTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 212 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
... ......||+.|+|||++... .....++.++|||||||++|+|++|..||.+.+.......+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i 259 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccC----CCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH
Confidence 322 12345799999999987541 11245789999999999999999999999987665443333
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.12 Aligned_cols=209 Identities=30% Similarity=0.496 Sum_probs=170.5
Q ss_pred ceeecceeccccceeEEEEEE---CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc---CCCCceeEEeeee----
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACK---- 128 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~---- 128 (290)
+|++.+.||+|+||.||+|++ +++.||+|.+.......... ..+.+|+.+++.+ +||||+++++++.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCch---HHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 588899999999999999976 35789999987544322211 1244666666655 6999999999874
Q ss_pred --cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 129 --DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 129 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
....++||||+. ++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++ .++|+|||+
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~ 156 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGL 156 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccc
Confidence 235789999995 6999998775556789999999999999999999999999999999999999554 599999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
+.............+++.|+|||.+.. ..++.++|||||||++|+|++|.+||.+.+..+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~ 222 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 222 (290)
T ss_pred eEeccCCcccccccccccccChHHHhC--------CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 976544444445578999999998754 567889999999999999999999999988777666554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=289.21 Aligned_cols=203 Identities=26% Similarity=0.409 Sum_probs=166.9
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecC
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLP 140 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~ 140 (290)
+.||+|+||.||++++ +++.||+|++.......... ...+.+|+.+++.++||||+++++.+... ..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE--VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHH--HHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCC
Confidence 3589999999999976 57899999987643222211 23567899999999999999999988654 6889999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-ccccccc
Q 022903 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAE 219 (290)
Q Consensus 141 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 219 (290)
+++|..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++..... .......
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 79 GGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCccccc
Confidence 9999988875 3578999999999999999999999999999999999999955 4699999999875322 2222345
Q ss_pred CCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 220 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.|++.|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 156 ~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~ 207 (323)
T cd05595 156 CGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207 (323)
T ss_pred cCCcCcCCcccccC--------CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 78999999999864 56789999999999999999999999887665444433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=283.48 Aligned_cols=210 Identities=30% Similarity=0.485 Sum_probs=171.6
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.+.|.+.+.||.|+||.||+|++ +++.||+|++......... ..+.+|+.+++.++||||+++++++.+. ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP----CTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcc----hhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 45699999999999999999976 5789999998754332221 2366899999999999999999998654 578
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+.+ +|.+++.. ....+++..+..++.||+.||+|||++|++||||||+|||++.+ +.+||+|||++......
T Consensus 80 lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 80 LVFEYLDS-DLKQYLDN-CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVP 156 (288)
T ss_pred EEEeCCCc-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeeccCC
Confidence 99999965 89998865 33467899999999999999999999999999999999999955 45999999998753222
Q ss_pred c-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
. ......+++.|+|||.+.+ ...++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 217 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLG-------STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217 (288)
T ss_pred CccccCceecccccChHHhcC-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1 2234467899999998753 2457889999999999999999999999987766655443
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=296.52 Aligned_cols=217 Identities=29% Similarity=0.433 Sum_probs=188.7
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
....|+..+.||+|+||.||+|.+ +++.||+|++.-+....+.. .+.+|+.++..++++||.++|+.+..+ .+
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIe----diqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIE----DIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhH----HHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 445578889999999999999977 67999999999887776654 467999999999999999999998654 78
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
+++||||.||++.+.++. ...+++..+..++++++.||.|||+++.+|||||+.|||+..+ +.+||+|||.+.+...
T Consensus 87 wiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeeec
Confidence 899999999999999875 3445888888999999999999999999999999999999966 6699999999876544
Q ss_pred cc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhcccc
Q 022903 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESI 287 (290)
Q Consensus 213 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (290)
.. ...+..||+.|||||++.. ..|+.++||||||++.+||.+|.+||.+..++.+++.|..+.+..|
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~--------~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L 231 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQ--------SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRL 231 (467)
T ss_pred hhhccccccccccccchhhhcc--------ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcc
Confidence 43 3367899999999999975 6899999999999999999999999999999988888777665543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=289.24 Aligned_cols=200 Identities=27% Similarity=0.434 Sum_probs=166.1
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecC
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLP 140 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~ 140 (290)
+.||+|+||.||++++ +++.||+|++.......... ..++.+|+.+++.++||||+++++.+.+. ..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE--VAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH--HHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCC
Confidence 3589999999999976 57899999997643322221 23577899999999999999999988654 6889999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-ccccccc
Q 022903 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAE 219 (290)
Q Consensus 141 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 219 (290)
+++|..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++..... .......
T Consensus 79 ~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 79 GGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCCCcccccccc
Confidence 9999988865 4578999999999999999999999999999999999999955 4599999999875322 2223345
Q ss_pred CCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 220 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
.||+.|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 156 ~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~ 204 (328)
T cd05593 156 CGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 204 (328)
T ss_pred cCCcCccChhhhcC--------CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH
Confidence 78999999999864 56789999999999999999999999887655443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=284.62 Aligned_cols=205 Identities=29% Similarity=0.489 Sum_probs=168.3
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
...+|.+.+.||+|+||.||+|++ +++.||+|++......... ..+.+|+.+++.++||||+++++++.+. ..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP----FTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccc----hhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence 346799999999999999999987 5789999998754432221 2366899999999999999999998654 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+ .++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||++.....
T Consensus 79 ~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 79 TLVFEYV-HTDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKSV 155 (303)
T ss_pred EEEEECC-CcCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceeccC
Confidence 8999999 4688888765 34568999999999999999999999999999999999999955 4599999999865322
Q ss_pred c-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 213 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
. .......+++.|+|||++.+ ...++.++|||||||++|+|++|..||.+..+..
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 211 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLG-------STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211 (303)
T ss_pred CCccCCCCcccCCCCChHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH
Confidence 2 22234567899999998753 2457889999999999999999999999876543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=295.10 Aligned_cols=209 Identities=27% Similarity=0.437 Sum_probs=174.7
Q ss_pred ceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||+|++. ++.||+|++......... ....+.+|+.++..++||||+++++.+.+. ..++|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRN--QIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhcc--HHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 5889999999999999999874 889999998754322211 123577899999999999999999988754 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+.+++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++ .++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCc
Confidence 9999999999999763 6799999999999999999999999999999999999999654 59999999987543322
Q ss_pred -----------------------------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 022903 215 -----------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 265 (290)
Q Consensus 215 -----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~ 265 (290)
......||+.|+|||++.. ..++.++|||||||++|+|++|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--------TPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcC--------CCCCCceeeEecchhhhhhccCCC
Confidence 2234468999999999865 578999999999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 022903 266 PFEGMSNLQAAYAAA 280 (290)
Q Consensus 266 Pf~~~~~~~~~~~~~ 280 (290)
||.+.+..+....+.
T Consensus 229 Pf~~~~~~~~~~~i~ 243 (350)
T cd05573 229 PFYSDTLQETYNKII 243 (350)
T ss_pred CCCCCCHHHHHHHHh
Confidence 999987655544443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=287.10 Aligned_cols=198 Identities=28% Similarity=0.437 Sum_probs=164.6
Q ss_pred eccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecCCC
Q 022903 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGM 142 (290)
Q Consensus 66 lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~~ 142 (290)
||+|+||.||++++ +++.||+|++......... ....+.+|+.+++.++||||+++++.+.+. ..++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRS--EVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCC
Confidence 69999999999987 5688999998753321111 123577899999999999999999988654 688999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccccCC
Q 022903 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETG 221 (290)
Q Consensus 143 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~g 221 (290)
+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .++|+|||++..... ........|
T Consensus 79 ~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 79 ELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred cHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccC
Confidence 99999875 45789999999999999999999999999999999999999554 599999999875322 222334578
Q ss_pred CccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 222 ~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
|+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 156 t~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~ 202 (312)
T cd05585 156 TPEYLAPELLLG--------HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY 202 (312)
T ss_pred CcccCCHHHHcC--------CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH
Confidence 999999998864 56889999999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=280.46 Aligned_cols=204 Identities=24% Similarity=0.400 Sum_probs=171.0
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
.|++.+.||+|+||.||++.+ +++.||+|++......... ....+.+|+.+++.++||||+++++.+.+ ...++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhh--hHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 377889999999999999986 5789999998754432221 12346789999999999999999998865 468899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGET 157 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCCc
Confidence 999999999998876445579999999999999999999999999999999999999955 5699999999876543333
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
.....|++.|+|||.+.. ..++.++||||||+++|+|++|..||.+.+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~ 207 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKN--------ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207 (285)
T ss_pred cccccCCCCccCcHHhcC--------CCCCccccchhHHHHHHHHHHCCCCCCCCchh
Confidence 344578999999998854 56788999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=294.80 Aligned_cols=220 Identities=31% Similarity=0.535 Sum_probs=180.9
Q ss_pred ccccCCCceeecceeccccceeEEEEEEC---C---ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEe
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG---D---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~---~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 125 (290)
.|...-++..+.++||+|+||.||+|+.. + ..||+|..+......... ...+.+|+++|++++|||||++||
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~--~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQ--IKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHH--HHHHHHHHHHHHhCCCCCEEEEEE
Confidence 45556667778899999999999999752 1 238999988633222222 245899999999999999999999
Q ss_pred eeecC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 126 ACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 126 ~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
++.+. .+++|||+|.||+|.++++... ..++..+...++.+++.||+|||++++|||||..+|+|++.+ +.+||+||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISDF 306 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISDF 306 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCcc
Confidence 98655 6789999999999999999743 369999999999999999999999999999999999999954 45899999
Q ss_pred ccccccccccccc-ccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022903 205 GLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 205 g~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~~ 282 (290)
|++.......... ...-+..|+|||.+.. ..++.++|||||||++||+++ |..||.+.+..+....+..+
T Consensus 307 GLs~~~~~~~~~~~~~klPirWLAPEtl~~--------~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~ 378 (474)
T KOG0194|consen 307 GLSRAGSQYVMKKFLKKLPIRWLAPETLNT--------GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN 378 (474)
T ss_pred ccccCCcceeeccccccCcceecChhhhcc--------CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc
Confidence 9988754222222 2235679999999865 689999999999999999999 89999999999888887554
Q ss_pred h
Q 022903 283 V 283 (290)
Q Consensus 283 ~ 283 (290)
.
T Consensus 379 ~ 379 (474)
T KOG0194|consen 379 G 379 (474)
T ss_pred C
Confidence 3
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=285.86 Aligned_cols=208 Identities=26% Similarity=0.404 Sum_probs=168.3
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCC-CceeEEeeeec-CceEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKD-PLMVI 134 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~-~~~~l 134 (290)
+|.+++.||+|+||.||+|++ +++.||+|++.......... ...+..|..++..+.|+ +|+.+++++.+ ...++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDD--VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH--HHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEE
Confidence 378889999999999999977 45789999987643222111 13467888999998764 57788888765 46889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc-cc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VT 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~-~~ 213 (290)
||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.++|+|||++.... ..
T Consensus 79 v~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecCCCC
Confidence 9999999999999875 3568999999999999999999999999999999999999955 469999999986432 22
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213 (324)
T ss_pred CceeeecCCccccChhhhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22334578999999999864 56789999999999999999999999987765544433
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=286.06 Aligned_cols=208 Identities=27% Similarity=0.408 Sum_probs=169.3
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~l 134 (290)
+|.+.+.||+|+||.||+|++ +++.||+|++.......... ...+..|..++..+ +||+|+++++++.+. ..++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD--VECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH--HHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEE
Confidence 377889999999999999977 45799999987643322211 12356677777777 578999999888654 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-c
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-T 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~ 213 (290)
||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++..... .
T Consensus 79 v~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCC
Confidence 9999999999998875 35689999999999999999999999999999999999999554 599999999875332 2
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i 213 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213 (323)
T ss_pred CccccCCCChhhcCHHHhcC--------CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 22334578999999999864 66889999999999999999999999987765554443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=306.47 Aligned_cols=214 Identities=29% Similarity=0.556 Sum_probs=182.4
Q ss_pred cCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
....+....+.||+|+||+||+|+.. ...||||.++.....+.+ ..|.+|++++..|+|||||+|+|+|
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~----~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQAR----QDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHH----HHHHHHHHHHHhccCCCeEEEEEEE
Confidence 45566788899999999999999752 367999999987776544 3699999999999999999999999
Q ss_pred ecC-ceEEEEEecCCCCHHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC
Q 022903 128 KDP-LMVIVTELLPGMSLRKYLVSLRP------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194 (290)
Q Consensus 128 ~~~-~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~ 194 (290)
.++ -+++|+||+..|+|.+|+....+ .+++..+.+.|+.||+.|++||-++.+|||||..+|+||.
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg- 637 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG- 637 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec-
Confidence 765 67899999999999999977432 2277889999999999999999999999999999999999
Q ss_pred CCCceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 022903 195 DQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270 (290)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~ 270 (290)
++..|||+|||+++..-.... .....-..+|||||.+.. ..|+.+|||||+||+|||+++ |..||-+.
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--------~kFTteSDVWs~GVvLWEIFsyG~QPy~gl 709 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--------GKFTTESDVWSFGVVLWEIFSYGKQPYYGL 709 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--------CcccchhhhhhhhhhhhhhhccccCccccc
Confidence 566799999999986322221 223345679999999876 889999999999999999999 99999999
Q ss_pred CHHHHHHHHHH
Q 022903 271 SNLQAAYAAAF 281 (290)
Q Consensus 271 ~~~~~~~~~~~ 281 (290)
++.+++.-+..
T Consensus 710 Sn~EVIe~i~~ 720 (774)
T KOG1026|consen 710 SNQEVIECIRA 720 (774)
T ss_pred chHHHHHHHHc
Confidence 99998877653
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=286.17 Aligned_cols=203 Identities=30% Similarity=0.454 Sum_probs=165.8
Q ss_pred ceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEE
Q 022903 64 SKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTE 137 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e 137 (290)
+.||+|+||.||+++. .++.||+|++.......... ....+.+|+.+++.++||||+++++.+.+. ..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~-~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQK-DTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhh-hHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 5799999999999975 46789999987543221111 123467899999999999999999988654 6789999
Q ss_pred ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-ccc
Q 022903 138 LLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMM 216 (290)
Q Consensus 138 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~~~ 216 (290)
|+.+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++...... ...
T Consensus 81 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 81 YLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred CCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcc
Confidence 9999999999875 4568889999999999999999999999999999999999955 46999999998743222 222
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
....|++.|+|||++.. ..++.++||||||+++|+|++|..||.+.+.......
T Consensus 158 ~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~ 211 (323)
T cd05584 158 HTFCGTIEYMAPEILMR--------SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211 (323)
T ss_pred cccCCCccccChhhccC--------CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 34578999999999864 5578899999999999999999999998776544333
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.47 Aligned_cols=206 Identities=26% Similarity=0.458 Sum_probs=184.2
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
.|.+.+.||+|-|+.|-+|++ +|+.||||++.+....... ...+..|++.|+..+|||||++|++... ..+|+|
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s---t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS---TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh---hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 478889999999999999976 8999999999887665433 3468899999999999999999999864 479999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
.|.-++|+|.+|+-. ...++++..+.+|+.||+.|+.|+|+..+|||||||+||.+-...+.|||+|||++....++..
T Consensus 96 LELGD~GDl~DyImK-He~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMK-HEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEecCCchHHHHHHh-hhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 999999999999976 5678999999999999999999999999999999999999876777899999999998888888
Q ss_pred ccccCCCccccCccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
..+.+|++.|-|||++.+ ..| .+++||||||+|||-+++|++||...++.+.+
T Consensus 175 L~TsCGSLAYSAPEILLG--------DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL 228 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLG--------DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL 228 (864)
T ss_pred hhcccchhhccCchhhhc--------CccCCcchhhhHHHHHHHHHHhCCCccccccchhhh
Confidence 899999999999999986 344 57999999999999999999999998765544
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=285.37 Aligned_cols=207 Identities=27% Similarity=0.425 Sum_probs=167.3
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHH---hhcCCCCceeEEeeeecC-ceE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM---SRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
|++++.||+|+||.||++.+ +++.||||++.......... ...+.+|+.++ +.++||||+++++++.+. ..+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH--HHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 56788999999999999976 57899999997543221111 12455665544 567899999999998754 688
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV- 212 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~- 212 (290)
+||||+++++|..++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 79 lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCC
Confidence 99999999999988754 5699999999999999999999999999999999999999654 599999999875322
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~ 214 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTE--------TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214 (324)
T ss_pred CCcccccccCccccCHhHhcC--------CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 222334578999999998864 567899999999999999999999999877665554443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=277.47 Aligned_cols=203 Identities=27% Similarity=0.418 Sum_probs=177.5
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee-cCce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 132 (290)
...+|..++.||+|.||+|.+++- +++.+|+|+++++......+. +.-..|-++|+..+||++..+.-.|+ ..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEV--AHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEV--AHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHh--hhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 345688899999999999999865 789999999998776555443 34668899999999999999877776 4588
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc-
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET- 211 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~- 211 (290)
++||||..||.|.-.+.. ...+++..++.+..+|+.||.|||+++||+||||.+|+|+|++++ +||+|||+|+...
T Consensus 244 CFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH-IKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH-IKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc-eEeeecccchhccc
Confidence 999999999999888764 678999999999999999999999999999999999999997765 9999999999743
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.+..+.+.+|||.|+|||++.. ..|+.++|+|.+|++||||++|++||-+.+
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleD--------nDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLED--------NDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred ccceeccccCChhhcCchhhcc--------ccccceeehhhhhHHHHHHHhccCcccccc
Confidence 3445678899999999999975 789999999999999999999999998854
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=286.09 Aligned_cols=213 Identities=25% Similarity=0.376 Sum_probs=171.1
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+++.||+|+||.||+++. +++.||+|++......... ....+.+|+.++..++||||+++++++.++ ..++|
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRA--ETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhh--hHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 588999999999999999987 5789999998643221111 123477899999999999999999998754 68899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+.+++|.+++.. ....+++..+..++.||+.||+|||++|++||||||+|||++.+ +.++|+|||++........
T Consensus 80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 80 MDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGT 157 (331)
T ss_pred EecCCCCcHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecCCCCC
Confidence 999999999999975 24578999999999999999999999999999999999999855 4599999999865332221
Q ss_pred --ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 216 --MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 216 --~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
.....||+.|+|||++.... .....++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~ 219 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 219 (331)
T ss_pred ccccceeccccccCHHHHhhcc---ccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH
Confidence 12346899999999875311 0124568899999999999999999999998766544333
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=286.29 Aligned_cols=215 Identities=24% Similarity=0.378 Sum_probs=172.7
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||++++ +++.||+|++......... ....+.+|+.++..++|++|+++++.+.+. ..++|
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA--ETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhh--HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 588899999999999999987 4678999998643221111 123477899999999999999999998755 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+.+++|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.++|+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred EeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecccCCc
Confidence 9999999999999752 3568999999999999999999999999999999999999955 469999999986532221
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
......||+.|+|||++.... .....++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAME---DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (332)
T ss_pred ceecccccCccccCHHHHhccc---cCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 122347899999999875311 012457889999999999999999999999887666555443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=284.89 Aligned_cols=193 Identities=28% Similarity=0.460 Sum_probs=161.3
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||++++ +++.||+|+++......... ...+.+|..++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~--~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDED--IDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH--HHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 3589999999999987 57899999997643322211 23467899999888 699999999998754 678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc-ccccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~-~~~~~~~ 218 (290)
++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++.... .......
T Consensus 79 ~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 79 SGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccccCCCcccc
Confidence 99999998865 3579999999999999999999999999999999999999955 459999999987422 2223344
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
..||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 156 FCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccCCccccCHHHHcC--------CCCCCccceechHHHHHHHHHCCCCccc
Confidence 578999999998864 5678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=287.39 Aligned_cols=226 Identities=32% Similarity=0.489 Sum_probs=178.6
Q ss_pred cCcccccccccccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc
Q 022903 43 TAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV 115 (290)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l 115 (290)
++.++..+..+.....+|.+.+.||+|+||.||+|.+ ++..||||+++........ ..+.+|+.++..+
T Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~----~~~~~Ei~il~~l 95 (375)
T cd05104 20 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTER----EALMSELKVLSYL 95 (375)
T ss_pred cCCCCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHH----HHHHHHHHHHHHh
Confidence 3445555555666677899999999999999999963 3458999999765433322 3577999999999
Q ss_pred -CCCCceeEEeeeecC-ceEEEEEecCCCCHHHHHHhcC-----------------------------------------
Q 022903 116 -KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR----------------------------------------- 152 (290)
Q Consensus 116 -~h~~iv~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~----------------------------------------- 152 (290)
+||||+++++.+.+. ..++||||+++|+|.+++....
T Consensus 96 ~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (375)
T cd05104 96 GNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGV 175 (375)
T ss_pred cCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCc
Confidence 899999999998654 6789999999999999986532
Q ss_pred --------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceE
Q 022903 153 --------------------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200 (290)
Q Consensus 153 --------------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~k 200 (290)
...+++..+..++.||+.||.|||++|++||||||+|||++.+ ..++
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~k 254 (375)
T cd05104 176 SYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITK 254 (375)
T ss_pred ccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEE
Confidence 1246788889999999999999999999999999999999954 5699
Q ss_pred Eeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022903 201 LADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 201 l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~ 276 (290)
|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.......
T Consensus 255 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~ 326 (375)
T cd05104 255 ICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326 (375)
T ss_pred EecCccceeccCcccccccCCCCCCcceeChhHhcC--------CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH
Confidence 999999875432221 112234567999998864 568899999999999999998 99999987665555
Q ss_pred HHHHH
Q 022903 277 YAAAF 281 (290)
Q Consensus 277 ~~~~~ 281 (290)
++...
T Consensus 327 ~~~~~ 331 (375)
T cd05104 327 YKMIK 331 (375)
T ss_pred HHHHH
Confidence 54443
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=286.24 Aligned_cols=214 Identities=25% Similarity=0.374 Sum_probs=172.1
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||++++ +++.||+|++......... ....+.+|..++..++|++|+++++.+.+. ..++|
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRA--ETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 588999999999999999987 5688999998653221111 123477899999999999999999998754 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+.+++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++........
T Consensus 80 ~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 80 MDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDGT 157 (331)
T ss_pred EeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCCc
Confidence 9999999999999763 35789999999999999999999999999999999999999554 599999999875433222
Q ss_pred --ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 216 --MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 216 --~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.....|++.|+|||++.... .....++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i 220 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAME---DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220 (331)
T ss_pred eeeccccCCcccCCHHHHhccc---cCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH
Confidence 12346899999999875421 01135688999999999999999999999987765544433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.10 Aligned_cols=229 Identities=28% Similarity=0.465 Sum_probs=192.1
Q ss_pred ccccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
.+.+..++|.+++.||+|+||.|.++++ +++.||+|++.+-....... .+.|..|-.+|..-+.+.|+++..+|+|
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~--tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAE--TACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchh--HHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4456778899999999999999999977 67899999997733222111 1358888899988889999999999987
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
+ ++|+||||++||+|-.++... ..+++..+++|+..|+.||.-||+.|+|||||||+|||+|..|+ +||+|||.|-
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH-ikLADFGsCl 223 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH-IKLADFGSCL 223 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc-EeeccchhHH
Confidence 6 789999999999999999863 38999999999999999999999999999999999999997654 9999999997
Q ss_pred ccccccc--ccccCCCccccCcccccccccccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhcc
Q 022903 209 EETVTEM--MTAETGTYRWMAPELYSTVTLRQGEK-KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQE 285 (290)
Q Consensus 209 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~ 285 (290)
.+..+.. ....+|||.|++||++... +.. +.|++.+|+||+||++|||+.|..||-. ...-..|..+.+-+.
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~----~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQ----GDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKE 298 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhh----cCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhh
Confidence 7654432 3455899999999998763 334 7899999999999999999999999987 455567777777777
Q ss_pred cccCC
Q 022903 286 SIYAP 290 (290)
Q Consensus 286 ~~~~~ 290 (290)
++-.|
T Consensus 299 ~l~FP 303 (1317)
T KOG0612|consen 299 SLSFP 303 (1317)
T ss_pred hcCCC
Confidence 77655
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.88 Aligned_cols=208 Identities=29% Similarity=0.448 Sum_probs=170.6
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|.+.+.||+|+||.||++++ +++.||+|++........ ....+.+|+.+++.++||||+++++++.+ ...++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEE---VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccccc---chhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 588999999999999999987 468899999876533221 12357789999999999999999998865 467899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||++++.+..+... ...+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCccccccccc
Confidence 999988776654432 4578999999999999999999999999999999999999955 469999999987643221
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~ 214 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLG--------APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQ 214 (287)
T ss_pred ccccccccccccCCcHHHcC--------CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2223468899999998864 567899999999999999999999999987766655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.70 Aligned_cols=208 Identities=29% Similarity=0.538 Sum_probs=179.5
Q ss_pred cccccccccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 47 LTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
...++.|.+..+...-++.||.|+-|-||+|+..++.||||.++... ..+|+-|++|+||||+.|.|+
T Consensus 113 ~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk------------ETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 113 QQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK------------ETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh------------hhhHHHHHhccCcceeeEeee
Confidence 34455666666667778899999999999999999999999875321 146888999999999999999
Q ss_pred ee-cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 127 CK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 127 ~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
|. .+.+++|||||..|.|..+++. ...+.....+.|..+|+.|+.|||.+.|||||||.-||||..++ .|||+|||
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFG 257 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFG 257 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEecccc
Confidence 96 4578899999999999999987 56899999999999999999999999999999999999999554 69999999
Q ss_pred ccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 206 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
.++........-.++||..|||||++.. .+.+.++|||||||+|||||||..||.+..-.-+++
T Consensus 258 TS~e~~~~STkMSFaGTVaWMAPEvIrn--------ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw 321 (904)
T KOG4721|consen 258 TSKELSDKSTKMSFAGTVAWMAPEVIRN--------EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW 321 (904)
T ss_pred chHhhhhhhhhhhhhhhHhhhCHHHhhc--------CCcccccceehhHHHHHHHHhcCCCccccchheeEE
Confidence 9987655555557799999999999975 678999999999999999999999999876654333
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=282.77 Aligned_cols=203 Identities=30% Similarity=0.460 Sum_probs=163.2
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhh-cCCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR-VKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||+|++ +++.||+|+++......... ...+..|..++.. .+||||+++++.+... ..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDD--VECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhh--HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 3589999999999987 46789999987643221111 1124456666654 4799999999998654 678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 218 (290)
++++|..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++..... ......
T Consensus 79 ~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 79 NGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCcccc
Confidence 99999998875 35789999999999999999999999999999999999999554 599999999875322 223344
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i 208 (316)
T cd05592 156 FCGTPDYIAPEILKG--------QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208 (316)
T ss_pred ccCCccccCHHHHcC--------CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 578999999998864 56789999999999999999999999988765554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=286.63 Aligned_cols=199 Identities=27% Similarity=0.428 Sum_probs=164.5
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecC
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLP 140 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~ 140 (290)
+.||+|+||.||++++ +++.||+|++.......... ..++.+|+.+++.++||||+++++.+.+. ..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~--~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE--VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH--HHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 3589999999999976 67899999997643222221 23567899999999999999999988654 6889999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccc
Q 022903 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (290)
Q Consensus 141 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 218 (290)
+++|..++.. ...+++..+..++.||+.||.|||+ +|++||||||+|||++.+ +.+||+|||++..... ......
T Consensus 79 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 79 GGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCccccc
Confidence 9999998865 3578999999999999999999997 799999999999999955 4699999999875322 222334
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
..||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~ 204 (325)
T cd05594 156 FCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 204 (325)
T ss_pred ccCCcccCCHHHHcc--------CCCCCccccccccceeeeeccCCCCCCCCCHHHH
Confidence 579999999998864 5678999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=283.91 Aligned_cols=202 Identities=30% Similarity=0.457 Sum_probs=164.5
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||+|++ +++.||+|++......... ....+..|..++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDD--DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhcc--HHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCC
Confidence 3689999999999987 5689999998754321111 113466788888776 699999999998754 678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 218 (290)
++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.+ +.++|+|||++..... ......
T Consensus 79 ~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 79 NGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred CCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCcccc
Confidence 99999998875 3578999999999999999999999999999999999999955 4699999999875322 222334
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
..||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 207 (320)
T cd05590 156 FCGTPDYIAPEILQE--------MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA 207 (320)
T ss_pred cccCccccCHHHHcC--------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 578999999998864 5678899999999999999999999998776554433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=283.74 Aligned_cols=203 Identities=28% Similarity=0.429 Sum_probs=165.1
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||+|++ +++.||+|++.......... ...+..|..++..+ +||||+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDD--VDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhH--HHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCC
Confidence 3589999999999987 46799999987643222111 12466788888766 799999999999754 678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-ccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 218 (290)
++++|..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .++|+|||++...... .....
T Consensus 79 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 79 NGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCccccc
Confidence 99999998875 45789999999999999999999999999999999999999554 5999999998753222 22334
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..|++.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i 208 (321)
T cd05591 156 FCGTPDYIAPEILQE--------LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208 (321)
T ss_pred cccCccccCHHHHcC--------CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 568999999998764 56889999999999999999999999987765544433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=285.21 Aligned_cols=201 Identities=28% Similarity=0.384 Sum_probs=164.8
Q ss_pred ceeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-c
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-L 131 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~ 131 (290)
+|.+++.||+|+||.||+++. +++.||+|++......... ....++.+|+.+++.+ +||+|+++++.+.+. .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKA-KTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhh-hHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE
Confidence 378899999999999999865 4688999998753322111 1223577899999999 489999999988654 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCcccc
Confidence 7899999999999999875 35689999999999999999999999999999999999999554 69999999987532
Q ss_pred cc--ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 212 VT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 212 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
.. .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRG-------KGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccCCCccccccCCccccCHHHhcC-------CCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 22 12234578999999998754 234678999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=283.26 Aligned_cols=203 Identities=28% Similarity=0.417 Sum_probs=165.2
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec------C
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------P 130 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~ 130 (290)
+|++.+.||+|+||.||+|++ +++.||+|.+......... ..++.+|+.+++.++||||+++++++.. .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 77 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD---ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchh---HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCc
Confidence 478899999999999999986 5789999998753222211 1247799999999999999999988742 2
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++...
T Consensus 78 ~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~ 153 (338)
T cd07859 78 DIYVVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVA 153 (338)
T ss_pred eEEEEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCcccccc
Confidence 378999999 5689998875 3568999999999999999999999999999999999999955 46999999998753
Q ss_pred cccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 211 TVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 211 ~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
.... ......+++.|+|||++... ...++.++|||||||++|+|++|+.||.+.+...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~ 215 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 215 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhcc------ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 2221 11344789999999987531 2467889999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=284.18 Aligned_cols=202 Identities=31% Similarity=0.432 Sum_probs=167.0
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 130 (290)
.++|.+.+.||+|+||.||++.+ +++.||+|++......... ..++.+|+.+++.++||||+++++++...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH---AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhH---HHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 45699999999999999999976 5789999998754332222 23577999999999999999999987532
Q ss_pred ---ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 131 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
..++||||+++ +|.+.+. ..++...+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||++
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a 170 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLA 170 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCCCc
Confidence 36899999965 6666654 248889999999999999999999999999999999999955 46999999999
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
.............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 230 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230 (359)
T ss_pred cccccCccCCCCcccCCCCCchhccC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 76444434445678999999999865 5688899999999999999999999998765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=282.15 Aligned_cols=193 Identities=30% Similarity=0.465 Sum_probs=161.3
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||+++. +++.||+|++.......... ...+.+|+.++.++ +||+|+++++++.+. ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDED--IDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH--HHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 3699999999999976 56899999998654332221 23477899998888 599999999998654 678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc-ccccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~-~~~~~~~ 218 (290)
++++|..++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+|||++.... .......
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 79 NGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceec
Confidence 99999998865 35799999999999999999999999999999999999999554 59999999987522 2223345
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
..||+.|+|||.+.+ ..++.++|||||||++|+|++|..||..
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 156 FCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ccCCcccCCHHHHCC--------CCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 679999999998864 6688999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=282.93 Aligned_cols=202 Identities=29% Similarity=0.440 Sum_probs=162.7
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHH-HHhhcCCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||+|++ +++.||+|++.......... ..++.+|.. +++.++||||+++++.+.+. ..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE--QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhH--HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCC
Confidence 3589999999999987 57899999987543222111 123444544 56788999999999988654 678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 218 (290)
.+++|..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++..... ......
T Consensus 79 ~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 79 NGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCcccc
Confidence 99999998875 45789999999999999999999999999999999999999554 599999999875322 222334
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
..||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 207 (323)
T cd05575 156 FCGTPEYLAPEVLRK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN 207 (323)
T ss_pred ccCChhhcChhhhcC--------CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHH
Confidence 578999999998864 5688999999999999999999999998766544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=286.33 Aligned_cols=218 Identities=32% Similarity=0.521 Sum_probs=173.0
Q ss_pred ccccccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCce
Q 022903 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLV 121 (290)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 121 (290)
...+....++|.+++.||+|+||.||+|.+ ....||+|++......... ..+.+|+.+++.+ +||||+
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~il~~l~~h~nIv 105 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDER----EALMSELKILSHLGQHKNIV 105 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHH----HHHHHHHHHHHhhccCCcee
Confidence 334455667899999999999999999874 1247999999765443322 3577999999999 899999
Q ss_pred eEEeeeecC-ceEEEEEecCCCCHHHHHHhcC------------------------------------------------
Q 022903 122 KFLGACKDP-LMVIVTELLPGMSLRKYLVSLR------------------------------------------------ 152 (290)
Q Consensus 122 ~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~------------------------------------------------ 152 (290)
++++++.+. ..++||||+.+++|.+++....
T Consensus 106 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (374)
T cd05106 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMR 185 (374)
T ss_pred eEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccC
Confidence 999998654 6789999999999999986421
Q ss_pred --------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 153 --------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 153 --------------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
...+++..++.++.||+.||.|||++|++||||||+|||++. +..++|+|||++.....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 186 PVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD-GRVAKICDFGLARDIMN 264 (374)
T ss_pred CccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC-CCeEEEeeceeeeeccC
Confidence 124678889999999999999999999999999999999994 45699999999875432
Q ss_pred ccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 213 TEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
... .....++..|+|||++.. ..++.++||||||+++|+|++ |..||.........+...
T Consensus 265 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~ 328 (374)
T cd05106 265 DSNYVVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV 328 (374)
T ss_pred CcceeeccCCCCccceeCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH
Confidence 221 112234567999998754 568999999999999999997 999998876554444433
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=296.15 Aligned_cols=215 Identities=37% Similarity=0.591 Sum_probs=181.2
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-------C
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-------P 130 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------~ 130 (290)
+...+.||+|+||.||++++ +|+.||||.++........+ ++.+|++++++|+|||||+++++-++ .
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e----~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRE----RWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHH----HHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 44557899999999999986 78999999998876555443 57899999999999999999987543 2
Q ss_pred ceEEEEEecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC---CCceEEecccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD---QKSLKLADFGL 206 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~---~~~~kl~Dfg~ 206 (290)
..+++||||.||+|..+++... ..++++...+.+..++..||.|||++||+||||||.||++-.+ ...-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 4679999999999999997643 3569999999999999999999999999999999999999433 23579999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHh
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN----LQAAYAAAFK 282 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~----~~~~~~~~~~ 282 (290)
|+....+....+..||..|++||++.. ...|+..+|.|||||++|++.||..||..... .+..+.+..+
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~-------q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYER-------QKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhh-------ccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 999888888888999999999999853 37789999999999999999999999976543 4455555555
Q ss_pred hcc
Q 022903 283 VQE 285 (290)
Q Consensus 283 ~~~ 285 (290)
.+.
T Consensus 244 kp~ 246 (732)
T KOG4250|consen 244 KPS 246 (732)
T ss_pred CCC
Confidence 443
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=286.01 Aligned_cols=214 Identities=27% Similarity=0.402 Sum_probs=173.6
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||++++ +++.||+|+++........ ....+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQE--TVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 588899999999999999976 5789999999764332211 223577899999999999999999988654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+++++|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 80 MEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANKM 157 (330)
T ss_pred ECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECCCCCc
Confidence 9999999999999763 3579999999999999999999999999999999999999955 4699999999875433222
Q ss_pred --ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 216 --MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 216 --~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
.....||+.|+|||++..... .....++.++|||||||++|+|++|..||.+.+.......
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 220 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNG--DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN 220 (330)
T ss_pred eeeecccCCccccCHHHhccccc--cccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH
Confidence 223468999999998764211 0134578899999999999999999999998776554443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=273.35 Aligned_cols=209 Identities=22% Similarity=0.389 Sum_probs=172.0
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~ 136 (290)
|+..+.||+|+||+||++.+ +++.||+|.+......... ....+.+|+.+++.++|+||+++.+.+.. +..+++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRK--GESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhh--HHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 66778899999999999987 5789999998654332221 12346789999999999999999988764 4678999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccc
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~ 216 (290)
||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ ..++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecCCCCcc
Confidence 99999999998876545579999999999999999999999999999999999999955 46999999998654333333
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
....|+..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.........+
T Consensus 159 ~~~~g~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~ 213 (285)
T cd05632 159 RGRVGTVGYMAPEVLNN--------QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213 (285)
T ss_pred cCCCCCcCccChHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 44578999999998854 56889999999999999999999999987665443333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=292.96 Aligned_cols=218 Identities=28% Similarity=0.410 Sum_probs=188.3
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee-cCceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 134 (290)
+.|.-++.||+|+||-||-|++ +.+.||||.+.......... +..+.+|+..|++++|||++.+.|+|. +...|+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EK--WqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK--WQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHH--HHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 3477789999999999999987 67899999998655444332 357899999999999999999999985 457889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||| -|+..+++.- ..+++.+..+..|+.+.+.||.|||+.+.||||||..|||++ +.+.|||+|||.+....
T Consensus 104 VMEYC-lGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 104 VMEYC-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS-EPGLVKLADFGSASIMA--- 177 (948)
T ss_pred HHHHH-hccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec-CCCeeeeccccchhhcC---
Confidence 99999 5588887765 357899999999999999999999999999999999999999 55679999999986543
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhccccc
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (290)
..++++|||.|||||++.. .+.+.|+-++||||||++.+|+...++|+-+++.+..+|.|+-+-...|.
T Consensus 178 PAnsFvGTPywMAPEVILA-----MDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq 246 (948)
T KOG0577|consen 178 PANSFVGTPYWMAPEVILA-----MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ 246 (948)
T ss_pred chhcccCCccccchhHhee-----ccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC
Confidence 4567899999999999875 45788999999999999999999999999999999999999987655543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=273.95 Aligned_cols=203 Identities=22% Similarity=0.376 Sum_probs=169.2
Q ss_pred ceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-----CceEEEEEe
Q 022903 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-----PLMVIVTEL 138 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~lv~e~ 138 (290)
..||+|+++.||+|+++++.||+|.+......... ....+.+|+.++++++||||+++++++.+ ...++||||
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKV--LIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHH--HHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 56899999999999999999999999765433322 22457899999999999999999998865 357899999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEeccccccccccccccc
Q 022903 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217 (290)
Q Consensus 139 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~ 217 (290)
+++|+|.+++.. ...+++.....++.+++.||.|||+. +++||||||+||+++.+ +.+||+|||++...... ..
T Consensus 104 ~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~--~~ 178 (283)
T PHA02988 104 CTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSP--PF 178 (283)
T ss_pred CCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-CcEEEcccchHhhhccc--cc
Confidence 999999999976 35788999999999999999999984 99999999999999955 56999999998753322 12
Q ss_pred ccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 218 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
...++..|+|||++... ...++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 179 ~~~~~~~y~aPE~~~~~------~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i 234 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDI------FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234 (283)
T ss_pred cccCcccccCHHHhhhc------cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 34688999999987541 256899999999999999999999999998766554444
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=292.52 Aligned_cols=209 Identities=24% Similarity=0.389 Sum_probs=171.9
Q ss_pred CceeecceeccccceeEEEEEE--C-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--G-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 133 (290)
..|.+.+.||+|+||.||+|.. + ++.||+|.+....... ...+.+|+.+++.++||||+++++.+.+ +..+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~-----~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQ-----AAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHH-----HHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 3499999999999999999965 3 5678888775433221 1246789999999999999999999865 4788
Q ss_pred EEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
+||||+++++|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~ 220 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS 220 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence 999999999999988642 234688999999999999999999999999999999999999554 59999999997643
Q ss_pred ccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 212 VTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 212 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
... .....+||+.|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~ 284 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWER--------KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284 (478)
T ss_pred CccccccccccCCCccccCHhHhCC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 221 2334569999999998864 568899999999999999999999999887766555543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=282.29 Aligned_cols=203 Identities=29% Similarity=0.427 Sum_probs=162.4
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHH-HHHhhcCCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREV-NMMSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||++++ +++.||+|++.......... ...+.+|. .+++.++||||+++++.+.+. ..++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhH--HHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCC
Confidence 3689999999999987 56789999987543221111 12234443 456788999999999988654 678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 218 (290)
.+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .++|+|||++..... ......
T Consensus 79 ~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 79 NGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCccc
Confidence 99999999875 45688899999999999999999999999999999999999554 699999999875322 222344
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 208 (325)
T cd05602 156 FCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208 (325)
T ss_pred ccCCccccCHHHHcC--------CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 579999999998864 56889999999999999999999999987765544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=281.16 Aligned_cols=206 Identities=26% Similarity=0.417 Sum_probs=167.1
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-ceEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~~~lv 135 (290)
|...+.||+|+||.||+|++ +++.||+|++.......... ...+..|..++..+. |++|+++++++.+. ..++|
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDD--VECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH--HHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 66788999999999999977 57899999987543222111 124667888888886 57778888888654 68899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++ .++|+|||++.......
T Consensus 80 ~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 80 MEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCc
Confidence 999999999999875 35799999999999999999999999999999999999999554 59999999987532222
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
......||+.|+|||++.. ..++.++|+|||||++|+|++|..||.+.+.......
T Consensus 157 ~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212 (323)
T ss_pred cccCccCCccccCHHHHcC--------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 2234568999999998864 5678999999999999999999999998776544433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=285.12 Aligned_cols=202 Identities=30% Similarity=0.480 Sum_probs=167.4
Q ss_pred ceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEE
Q 022903 64 SKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTE 137 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e 137 (290)
+.||+|+||.||+++. +++.||+|++......... ..++.+|+.++++++||||+++++.+.++ ..++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRD---RVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhh---HHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 5799999999999864 4689999999754322211 13467899999999999999999998754 6789999
Q ss_pred ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-ccc
Q 022903 138 LLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMM 216 (290)
Q Consensus 138 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~~~ 216 (290)
|+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++...... ...
T Consensus 79 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 79 FLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred CCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCce
Confidence 9999999999865 45689999999999999999999999999999999999999554 5999999998764333 223
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
....|++.|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 156 ~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 156 YSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred ecccCChhhcCHHHHcC--------CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 34578999999998864 55788999999999999999999999987765554443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=281.49 Aligned_cols=199 Identities=29% Similarity=0.427 Sum_probs=161.1
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHH-HHHhhcCCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREV-NMMSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||+|++ +++.||+|++.......... ...+.+|. .+++.++||||+++++.+.+. ..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE--QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhH--HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCC
Confidence 3689999999999987 56899999987543222111 12344554 467888999999999988654 678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 218 (290)
++++|..++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++..... ......
T Consensus 79 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 79 NGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCcccc
Confidence 99999988865 45788999999999999999999999999999999999999654 599999999875322 222334
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
..|++.|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+.
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 204 (321)
T cd05603 156 FCGTPEYLAPEVLRK--------EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM 204 (321)
T ss_pred ccCCcccCCHHHhcC--------CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH
Confidence 578999999998864 5678899999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.39 Aligned_cols=202 Identities=26% Similarity=0.409 Sum_probs=170.8
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 133 (290)
.++|++++.||+|+||.||++++ ++..+|+|++....... ...++.+|+.+++.++||||+++++++.+ +..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPA----IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHH----HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45799999999999999999987 47889999987653322 22458899999999999999999998864 4688
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.+ +.++|+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID 156 (331)
T ss_pred EEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCcccccccc
Confidence 99999999999999976 35689999999999999999999986 69999999999999955 4599999999875432
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......+
T Consensus 157 -~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~ 209 (331)
T cd06649 157 -SMANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209 (331)
T ss_pred -cccccCCCCcCcCCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 22344578999999998864 568899999999999999999999998766544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=281.37 Aligned_cols=192 Identities=29% Similarity=0.480 Sum_probs=159.6
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec-CceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~lv~e~~ 139 (290)
+.||+|+||.||++++ +++.||+|++.......... ...+.+|+.++..+ +||||+++++++.+ ...++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDED--IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhH--HHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 3689999999999987 56899999998653322211 13466888888776 79999999999865 4788999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 218 (290)
++++|..++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++..... ......
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 79 NGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCcccc
Confidence 99999988865 45799999999999999999999999999999999999999654 599999999875322 222334
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 156 FCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccCCccccCHHHHcC--------CCCCCccceecccHHHHHHhhCCCCCc
Confidence 578999999998864 667889999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=266.88 Aligned_cols=218 Identities=27% Similarity=0.387 Sum_probs=179.8
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 133 (290)
.+.|.+-+.||+|.|+.|++..+ +++.+|+|++......... .+.+.+|+.+.+.|+||||+++.+.+.+ ...+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~---~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcccc---HHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 35688889999999999998744 7889999988765443331 1357799999999999999999998864 5789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC--CCCceEEeccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREET 211 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~--~~~~~kl~Dfg~~~~~~ 211 (290)
+|+|+++|++|..-+-.+ .-+++..+-.+++||+++|.|+|.+||||||+||+|+++.. .+..+||+|||++....
T Consensus 87 lvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999998766553 45788889999999999999999999999999999999942 23369999999999877
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhccccc
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (290)
.........|||.|||||++.. .+++..+|||+-|++||-++.|.+||.+.+. ..+|+-+++......
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrk--------dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-~rlye~I~~g~yd~~ 232 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYEQIKAGAYDYP 232 (355)
T ss_pred CccccccccCCCcccCHHHhhc--------CCCCCcchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhccccCCC
Confidence 6666667799999999999864 7899999999999999999999999999544 345555555444443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=279.50 Aligned_cols=213 Identities=28% Similarity=0.425 Sum_probs=177.3
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec-
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD- 129 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~- 129 (290)
.+...+|..+..||+|+||.|.+|.. +++.+|||+++++...+..... .-+.|-++|... +.|.++++..+|+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDve--ctm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVE--CTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCccc--ceehhhhheecCCCCchHHHHHHHhhhh
Confidence 34456688889999999999999965 5689999999987655443321 234566677666 46888889888875
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
+++|+||||+.||+|.-.+++ -+.+.+..+..|+.+|+.||-+||++|||+||||.+||++|.++ ++||+|||+++.
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmcKE 499 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKE 499 (683)
T ss_pred hheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeecccccc
Confidence 489999999999999998886 57899999999999999999999999999999999999999665 599999999997
Q ss_pred ccccc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 210 ETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 210 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..... .+.+.+|||.|+|||++.- .+|+.++|+||+|++||||+.|++||+|.+..+.-.+|
T Consensus 500 ni~~~~TTkTFCGTPdYiAPEIi~Y--------qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI 562 (683)
T KOG0696|consen 500 NIFDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI 562 (683)
T ss_pred cccCCcceeeecCCCcccccceEEe--------cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 54443 4567799999999999876 78999999999999999999999999996655443333
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=279.16 Aligned_cols=200 Identities=28% Similarity=0.445 Sum_probs=162.3
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||+|++ +++.||+|++.......... ...+..|..++..+ +||||+++++.+.+. ..++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDD--VECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcch--HHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCC
Confidence 3689999999999987 56899999987643211111 12355677777654 899999999998654 678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 218 (290)
.+++|..++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++ .++|+|||++..... ......
T Consensus 79 ~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 79 NGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceec
Confidence 99999998875 35789999999999999999999999999999999999999554 699999999874321 222344
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
..||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~ 205 (316)
T cd05620 156 FCGTPDYIAPEILQG--------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF 205 (316)
T ss_pred cCCCcCccCHHHHcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 578999999999864 56889999999999999999999999987665433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=282.91 Aligned_cols=207 Identities=31% Similarity=0.431 Sum_probs=170.3
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec----
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 129 (290)
..++|.+.+.||+|+||.||++.+ .++.||+|.+......... ..++.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 91 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH---AKRAYRELVLMKCVNHKNIISLLNVFTPQKSL 91 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHH---HHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence 346799999999999999999976 5789999998765433222 1357789999999999999999998743
Q ss_pred ---CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 130 ---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 130 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
...++||||+++ +|.+++.. .++...+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+
T Consensus 92 ~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~~kl~Dfg~ 165 (355)
T cd07874 92 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 165 (355)
T ss_pred cccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CCEEEeeCcc
Confidence 246899999965 67776643 58888999999999999999999999999999999999955 4699999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
+.............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV 230 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 986544444445678999999998864 56889999999999999999999999987765554433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=282.76 Aligned_cols=207 Identities=31% Similarity=0.425 Sum_probs=170.8
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec----
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 129 (290)
..++|.+.+.||+|+||.||++.+ .++.||||++......... ..++.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~ 98 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH---AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSL 98 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchh---HHHHHHHHHHHHhcCCCCccccceeecccccc
Confidence 346799999999999999999976 5788999998764332222 1346789999999999999999988743
Q ss_pred ---CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 130 ---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 130 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
...++||||++ ++|.+++.. .++...+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~ 172 (364)
T cd07875 99 EEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGL 172 (364)
T ss_pred cccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCCC
Confidence 24689999995 477777653 47888999999999999999999999999999999999955 4699999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
+.............+|..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 237 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhC--------CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 986544444445678999999999865 56889999999999999999999999998776554444
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=269.40 Aligned_cols=210 Identities=27% Similarity=0.471 Sum_probs=171.7
Q ss_pred CCCceeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 129 (290)
+...|++.+.||+|+||.||+|.+ .+..||+|.++........ ..+.+|+.++..++||||+++++.+..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR----RGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHH----HHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 456799999999999999999965 2468999999875443322 357899999999999999999999865
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++.+ ..++++|||.+..
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~~ 156 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQE 156 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCccccc
Confidence 4788999999999999998763 3578999999999999999999999999999999999999955 4699999998765
Q ss_pred cccccccc--ccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 210 ETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 210 ~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
........ ...++..|+|||.+.. ..++.++|||||||++|++++ |..||.+.+..+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQY--------HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhh--------CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 32222111 2234578999998754 668899999999999999875 99999998776554443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=291.23 Aligned_cols=212 Identities=27% Similarity=0.418 Sum_probs=173.7
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 130 (290)
...+|.+.+.||+|+||.||++++ +++.||||++.......... .++.+|+.++..++|+||+++...+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~---~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADK---NRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHH---HHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 446799999999999999999976 67899999997655433221 3577899999999999999988766321
Q ss_pred ------ceEEEEEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEe
Q 022903 131 ------LMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 131 ------~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~ 202 (290)
..++||||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vkL~ 185 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLG 185 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEEEE
Confidence 2579999999999999986532 3468999999999999999999999999999999999999955 469999
Q ss_pred ccccccccccc---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 203 DFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 203 Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
|||+++..... .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR--------KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99998753321 22234578999999999864 56889999999999999999999999987765544443
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=281.39 Aligned_cols=201 Identities=30% Similarity=0.442 Sum_probs=162.3
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHH-HHhhcCCCCceeEEeeeec-CceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVKFLGACKD-PLMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~-~~~~lv~e~~ 139 (290)
+.||+|+||.||++++ +++.||+|++.......... ...+.+|.. +++.++||||+++++.+.. ...++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE--QKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH--HHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCC
Confidence 3589999999999976 57899999987543222111 123445544 5677899999999998865 4788999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 218 (290)
.+++|..++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .++|+|||++..... ......
T Consensus 79 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 79 NGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCccc
Confidence 99999988875 45789999999999999999999999999999999999999554 599999999875322 222334
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
..|++.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~ 206 (325)
T cd05604 156 FCGTPEYLAPEVIRK--------QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD 206 (325)
T ss_pred ccCChhhCCHHHHcC--------CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH
Confidence 578999999999864 567889999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=278.08 Aligned_cols=203 Identities=31% Similarity=0.475 Sum_probs=163.3
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhh-cCCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR-VKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||+|++ +++.||+|++.......... ...+..|..++.. ++||||+++++.+.+. ..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcch--HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 3689999999999987 46789999987643211111 1235567777765 4899999999998654 678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-ccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 218 (290)
++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++ .++|+|||++...... .....
T Consensus 79 ~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 79 NGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred CCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceee
Confidence 99999999875 35689999999999999999999999999999999999999654 5999999998753221 22334
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 156 ~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i 208 (316)
T cd05619 156 FCGTPDYIAPEILLG--------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208 (316)
T ss_pred ecCCccccCHHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 578999999998864 56889999999999999999999999987765544433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=270.60 Aligned_cols=195 Identities=25% Similarity=0.447 Sum_probs=161.9
Q ss_pred eccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecCCC
Q 022903 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGM 142 (290)
Q Consensus 66 lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~~ 142 (290)
||+|+||.||+++. +++.||+|.+......... ....+..|+++++.++||||+++++.+.+. ..++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~--~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS--GEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcch--hhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCC
Confidence 69999999999976 5789999998653322111 112345799999999999999999988654 678999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccccccCCC
Q 022903 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222 (290)
Q Consensus 143 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~ 222 (290)
+|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.............++
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAGT 157 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCCC
Confidence 99998876555568999999999999999999999999999999999999955 46999999998765443333445789
Q ss_pred ccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 223 ~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
..|+|||++.. ..++.++|+|||||++|+|++|..||.+..
T Consensus 158 ~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 158 NGYMAPEILKE--------EPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CCccCHHHHcc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999998864 558899999999999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=287.64 Aligned_cols=205 Identities=23% Similarity=0.362 Sum_probs=163.5
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC------CCCceeEEeee
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK------HDNLVKFLGAC 127 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~~~~~~ 127 (290)
...+|.+++.||+|+||+||+|.+ +++.||||+++....... ....|+.+++.++ |++++.+++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~------~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTR------DAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHH------HHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 356799999999999999999976 578899999865322111 2345566655554 45688888887
Q ss_pred ec--CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCC-------
Q 022903 128 KD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQK------- 197 (290)
Q Consensus 128 ~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~------- 197 (290)
.. ...++||+++ +++|.+++.. ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence 64 3578999988 7789988875 3579999999999999999999998 59999999999999985432
Q ss_pred --------ceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 198 --------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 198 --------~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
.+||+|||.+.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~--------~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG--------LGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhc--------CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 48999999886432 22345679999999999865 6689999999999999999999999999
Q ss_pred CCHHHHHHHH
Q 022903 270 MSNLQAAYAA 279 (290)
Q Consensus 270 ~~~~~~~~~~ 279 (290)
.+..+....+
T Consensus 348 ~~~~~~~~~i 357 (467)
T PTZ00284 348 HDNLEHLHLM 357 (467)
T ss_pred CChHHHHHHH
Confidence 8776655544
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=275.24 Aligned_cols=205 Identities=28% Similarity=0.532 Sum_probs=169.2
Q ss_pred CCCceeecceeccccceeEEEEEE--CCc----eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
...+|++.+.||+|+||.||+|.+ +++ .||+|++......... .++.+|+.+++.++||||+++++.+..
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN----KEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHH----HHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 445699999999999999999975 333 4899998754333222 357799999999999999999999988
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...+++++|+.+|+|.+++... ...++...+..++.||+.||+|||++|++||||||+|||++.+ ..+||+|||++..
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~~ 158 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAKL 158 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEcccccccc
Confidence 7888999999999999999763 3568889999999999999999999999999999999999855 4599999999986
Q ss_pred ccccccc---cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 210 ETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 210 ~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
....... .....+..|+|||.+.. ..++.++||||||+++|+|++ |..||.+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~ 219 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhcc--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 4332221 12234668999998754 567899999999999999998 999999876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.49 Aligned_cols=208 Identities=32% Similarity=0.488 Sum_probs=166.7
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc---CCCCceeEEeeeec----
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACKD---- 129 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~---- 129 (290)
+|.+.+.||+|+||.||+|++ +++.||+|.+.......... ..+.+|+.+++.+ +||||+++++++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~ 77 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLP---LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTD 77 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCc---hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCC
Confidence 378889999999999999977 57899999987543222111 1234566666555 69999999998753
Q ss_pred --CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 130 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
...+++|||+. ++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++
T Consensus 78 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~ 155 (288)
T cd07863 78 RETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLA 155 (288)
T ss_pred CCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCcc
Confidence 24689999996 589988876555568999999999999999999999999999999999999955 45999999998
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.............++..|+|||++.. ..++.++|||||||++|+|++|.+||.+.+..+....+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 219 (288)
T ss_pred ccccCcccCCCccccccccCchHhhC--------CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH
Confidence 76544333344568899999998864 56889999999999999999999999987766554444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=278.06 Aligned_cols=202 Identities=29% Similarity=0.460 Sum_probs=164.9
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||++++ +++.||+|++.......... ...+.+|..++..+ +||||+++++.+.+. ..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhH--HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCC
Confidence 3689999999999987 56799999987643222111 12466788888887 699999999998654 688999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 218 (290)
.+++|..++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++..... ......
T Consensus 79 ~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 79 NGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCcccc
Confidence 99999998875 35799999999999999999999999999999999999999554 599999999865322 222234
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
..|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....
T Consensus 156 ~~g~~~y~aPE~~~~--------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~ 207 (318)
T cd05570 156 FCGTPDYIAPEILSY--------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS 207 (318)
T ss_pred eecCccccCHHHhcC--------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 468999999999864 5688999999999999999999999998776554433
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=270.90 Aligned_cols=201 Identities=23% Similarity=0.408 Sum_probs=168.4
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~ 136 (290)
|+..+.||+|+||.||++.+ +++.||+|.+......... ....+.+|+.+++.++|++|+++++.+.+ ...++||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchH--HHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 66778899999999999977 5789999998754332221 12346789999999999999999998864 4678999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccc
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~ 216 (290)
||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++.........
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCccc
Confidence 999999999998765555799999999999999999999999999999999999999554 5999999998764433333
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
....|+..|+|||.+.. ..++.++|+||||+++|+|++|..||.+..
T Consensus 159 ~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 159 KGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred cCCCCCccccChHHHcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 34578999999999864 568899999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=274.50 Aligned_cols=209 Identities=28% Similarity=0.477 Sum_probs=170.1
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 133 (290)
.+.|.+.+.||+|+||.||+|++ +++.||+|.+......... ..+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP----CTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcc----hhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 45699999999999999999976 5688999998754433221 236689999999999999999999864 4788
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++ +|.+++... ...++...+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSVP 157 (309)
T ss_pred EEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecCCC
Confidence 99999965 888887653 3458899999999999999999999999999999999999955 46999999998753322
Q ss_pred c-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 214 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
. ......+++.|+|||.+.+ ...++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 217 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLG-------SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217 (309)
T ss_pred ccccccccccccccCCHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 2 2233467889999998754 245788999999999999999999999988766554444
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=281.36 Aligned_cols=221 Identities=34% Similarity=0.520 Sum_probs=176.0
Q ss_pred cccccccccccCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-
Q 022903 45 PQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK- 116 (290)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 116 (290)
.++..+..+..+...|.+++.||+|+||.||+|.+. ...||||++......... ..+.+|+.+++.+.
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~----~~~~~Ei~~l~~l~~ 99 (400)
T cd05105 24 MQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEK----QALMSELKIMTHLGP 99 (400)
T ss_pred ccCCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHH----HHHHHHHHHHHhcCC
Confidence 344555566677888999999999999999999752 246999999765443322 35889999999996
Q ss_pred CCCceeEEeeeecC-ceEEEEEecCCCCHHHHHHhcC-------------------------------------------
Q 022903 117 HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR------------------------------------------- 152 (290)
Q Consensus 117 h~~iv~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~------------------------------------------- 152 (290)
||||+++++++.+. ..++||||+++|+|.+++....
T Consensus 100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (400)
T cd05105 100 HLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMD 179 (400)
T ss_pred CCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccc
Confidence 99999999999754 7889999999999999886521
Q ss_pred ---------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 022903 153 ---------------------------------------------------PNKLDLHVALNFALDIARAMDCLHANGII 181 (290)
Q Consensus 153 ---------------------------------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~giv 181 (290)
...+++..+..++.|++.||.|||++|++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 259 (400)
T cd05105 180 MKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV 259 (400)
T ss_pred cccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 12467788899999999999999999999
Q ss_pred eecCCCCCEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHH
Q 022903 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 258 (290)
Q Consensus 182 H~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~ 258 (290)
||||||+|||++.+ ..+||+|||++....... ......++..|+|||.+.. ..++.++||||||+++|
T Consensus 260 H~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ 330 (400)
T cd05105 260 HRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--------NLYTTLSDVWSYGILLW 330 (400)
T ss_pred CCCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC--------CCCCchhhHHHHHHHHH
Confidence 99999999999954 469999999987532221 1122346678999998754 56789999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHH
Q 022903 259 ELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 259 ~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
+|++ |..||.+.......+.
T Consensus 331 ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 331 EIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred HHHHCCCCCCcccchhHHHHH
Confidence 9997 9999988765444433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=280.45 Aligned_cols=229 Identities=24% Similarity=0.376 Sum_probs=181.5
Q ss_pred cccccCCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeee-
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGAC- 127 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~- 127 (290)
..+.+..+.|++++.||+||.++||++... .+.||+|.+........ ...-|.+|+..|.+|+ |.+||+++++-
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~q---tl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQ---TLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHH---HHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 345578889999999999999999999875 46677776654433332 2246899999999996 89999999986
Q ss_pred ecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 128 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
.++.+|+||||= ..+|..+++... ...+...+..|+.||+.++.++|.+||||.||||.|+|+-. + .+||+|||++
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G-~LKLIDFGIA 506 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-G-RLKLIDFGIA 506 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-e-eEEeeeechh
Confidence 467899999996 679999998743 44444578899999999999999999999999999999983 3 4999999999
Q ss_pred ccccccc---cccccCCCccccCcccccccccc-ccc--cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 208 REETVTE---MMTAETGTYRWMAPELYSTVTLR-QGE--KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 208 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~-~~~--~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.....+. .....+||+.||+||.+....-. ++. .-..++++||||||||||+|+.|+.||....+....+.++.
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 8654432 33456899999999998764321 111 22368899999999999999999999999888777777666
Q ss_pred hhccc
Q 022903 282 KVQES 286 (290)
Q Consensus 282 ~~~~~ 286 (290)
..-.+
T Consensus 587 ~P~~~ 591 (677)
T KOG0596|consen 587 DPNHE 591 (677)
T ss_pred CCCcc
Confidence 55333
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=272.01 Aligned_cols=208 Identities=29% Similarity=0.531 Sum_probs=167.0
Q ss_pred CCceeecceeccccceeEEEEEEC------------------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCC
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG------------------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 118 (290)
...|.+.++||+|+||.||++.+. +..||+|++........ ...+.+|+.++..++||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNA----RNDFLKEVKILSRLKDP 79 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHH----HHHHHHHHHHHhhcCCC
Confidence 346888999999999999999642 23699999876543332 23588999999999999
Q ss_pred CceeEEeeeec-CceEEEEEecCCCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 022903 119 NLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP-----------------NKLDLHVALNFALDIARAMDCLHANGI 180 (290)
Q Consensus 119 ~iv~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~-----------------~~~~~~~~~~i~~qi~~~l~~lH~~gi 180 (290)
||+++++.+.+ ...++||||+.+++|.+++..... ..+++..+..++.||+.||.|||++|+
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999865 467899999999999999865221 236777889999999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHH
Q 022903 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257 (290)
Q Consensus 181 vH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l 257 (290)
+||||||+|||++.+ +.+||+|||++....... ......++..|+|||.+.. ..++.++||||||+++
T Consensus 160 vH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l 230 (304)
T cd05096 160 VHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--------GKFTTASDVWAFGVTL 230 (304)
T ss_pred cccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--------CCCCchhhhHHHHHHH
Confidence 999999999999955 469999999987532221 1223345778999998754 5688999999999999
Q ss_pred HHHHh--CCCCCCCCCHHHHHH
Q 022903 258 WELLT--NRLPFEGMSNLQAAY 277 (290)
Q Consensus 258 ~~~l~--g~~Pf~~~~~~~~~~ 277 (290)
|+|++ +..||.+.+..+...
T Consensus 231 ~el~~~~~~~p~~~~~~~~~~~ 252 (304)
T cd05096 231 WEILMLCKEQPYGELTDEQVIE 252 (304)
T ss_pred HHHHHccCCCCCCcCCHHHHHH
Confidence 99986 778999877655443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=270.69 Aligned_cols=195 Identities=27% Similarity=0.439 Sum_probs=160.6
Q ss_pred eccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecCCC
Q 022903 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGM 142 (290)
Q Consensus 66 lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~~ 142 (290)
||+|+||+||++.+ +++.||+|.+.......... ...+..|+.+++.++||||+++.+++... ..++||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKG--YEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHH--HHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCC
Confidence 69999999999976 57899999987543322211 13467899999999999999999988654 678999999999
Q ss_pred CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-ccccc
Q 022903 143 SLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAE 219 (290)
Q Consensus 143 ~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 219 (290)
+|..++... ....+++..++.++.||+.||.|||++|++||||||+||+++.+ +.++|+|||++....... .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCccceecCCCCcccccc
Confidence 999887532 23468999999999999999999999999999999999999954 569999999987533222 22334
Q ss_pred CCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 220 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.|++.|+|||.+.. ..++.++|+||||+++|+|++|+.||....
T Consensus 158 ~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 158 AGTPGFMAPELLQG--------EEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred CCCcCccCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 78999999999865 567889999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=300.64 Aligned_cols=215 Identities=24% Similarity=0.452 Sum_probs=175.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---Cce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 132 (290)
..|.+++.||+|+||.||++++ .+..||+|++......... ...+..|+.+++.|+||||+++++.|.+ ..+
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~---~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE---KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHH---HHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 4699999999999999999987 5678999998765443322 2357899999999999999999998843 357
Q ss_pred EEEEEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCeeecCCCCCEEEcCC--------
Q 022903 133 VIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHAN-------GIIHRDLKPDNLLLTPD-------- 195 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-------givH~Dikp~Nili~~~-------- 195 (290)
++||||+++++|.+++.... ...+++..++.|+.||+.||.|||+. +||||||||+|||++.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999986532 35699999999999999999999984 49999999999999632
Q ss_pred --------CCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 022903 196 --------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267 (290)
Q Consensus 196 --------~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf 267 (290)
...+||+|||++.............||+.|+|||++.. ....++.++|||||||+||+|++|..||
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g------e~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH------ETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc------cCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 23489999999976544444445679999999998754 1245788999999999999999999999
Q ss_pred CCCCHHHHHHHHHH
Q 022903 268 EGMSNLQAAYAAAF 281 (290)
Q Consensus 268 ~~~~~~~~~~~~~~ 281 (290)
..............
T Consensus 244 ~~~~~~~qli~~lk 257 (1021)
T PTZ00266 244 HKANNFSQLISELK 257 (1021)
T ss_pred CcCCcHHHHHHHHh
Confidence 88776665555443
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=292.46 Aligned_cols=200 Identities=31% Similarity=0.519 Sum_probs=172.0
Q ss_pred eeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecCC
Q 022903 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPG 141 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~ 141 (290)
.||+|+||+||.|++ +....|||.+........+. ++.|+.+.++|+|.|||+++|.+.++ .+-+.||..+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QP-----LhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQP-----LHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhcc-----HHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 589999999999987 55678999987765554443 67899999999999999999998665 45588999999
Q ss_pred CCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc-ccccccccc
Q 022903 142 MSLRKYLVSLRPNKL--DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTA 218 (290)
Q Consensus 142 ~~L~~~~~~~~~~~~--~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~-~~~~~~~~~ 218 (290)
|+|.++++.. -+++ ++.++..|..||++||.|||++.|||||||-+||||+.-.+.+||+|||.++. ......+.+
T Consensus 657 GSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 657 GSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred CcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9999999874 4666 78899999999999999999999999999999999998888999999999986 344555678
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
+.||..|||||++... ...|+.++|||||||++.||.||++||-.+..-+++
T Consensus 736 FTGTLQYMAPEvIDqG------~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA 787 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQG------PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA 787 (1226)
T ss_pred cccchhhhChHhhccC------CcCCCchhhhhhccceeEeeccCCCCeeecCChhHh
Confidence 8999999999998642 256899999999999999999999999887654433
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=279.41 Aligned_cols=206 Identities=26% Similarity=0.421 Sum_probs=179.7
Q ss_pred cCCCceeecceeccccceeEEEE--EECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-Cc
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PL 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 131 (290)
+....|+.-+.||+|+||.||.. +.+|+.+|+|.+.+.......- +..-++|-.+|++++.++||.+--+|+. +.
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g--e~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKG--ETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhh--hHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 45567888899999999999976 5689999999887655433221 2245689999999999999999888764 47
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
+++|+..|.||+|.-++....+..+++..++.|+++|+.||++||+.+||+||+||+|||+| +.++++|+|+|++....
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD-d~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD-DHGHVRISDLGLAVEIP 338 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec-cCCCeEeeccceEEecC
Confidence 89999999999999999887777899999999999999999999999999999999999999 55569999999999888
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.........||.+|||||++.. ..|+.+.|+|||||++|+|+.|+.||....
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~n--------e~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQN--------EVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred CCCccccccCcccccCHHHHcC--------CcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 8877777899999999999975 569999999999999999999999998753
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=283.30 Aligned_cols=191 Identities=26% Similarity=0.351 Sum_probs=160.6
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
....|.+++.||+|+||.||++.+ +++.||+|.... ..+.+|+.+++.++||||+++++.+... ..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 345799999999999999999987 578999996532 1356899999999999999999998654 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++|+|++ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++.....
T Consensus 159 ~lv~e~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVD 234 (391)
T ss_pred EEEEecC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCccccccc
Confidence 8999998 5688888865 35689999999999999999999999999999999999999554 599999999864322
Q ss_pred c--ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 213 T--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 213 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
. .......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLAR--------DPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccccccCccCCCChhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 1 22234579999999998864 5689999999999999999999988754
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=298.81 Aligned_cols=207 Identities=27% Similarity=0.452 Sum_probs=168.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
.+|.+.+.||+|+||.||+|.+ +++.||+|++........ ....++.+|+.+++.++||||+++++.+.+. ..++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e--~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP--LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCH--HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEE
Confidence 4689999999999999999987 578999999876433222 2235688999999999999999999998654 6789
Q ss_pred EEEecCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 135 VTELLPGMSLRKYLVSLR---------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
+|||++|++|.+++.... ....+...+..++.||+.||+|||++|++||||||+||+++.++ .++|+|||
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDFG 158 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDWG 158 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEecC
Confidence 999999999999986421 12345667889999999999999999999999999999999554 59999999
Q ss_pred cccccccc-------------------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 022903 206 LAREETVT-------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266 (290)
Q Consensus 206 ~~~~~~~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~P 266 (290)
++...... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..|
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--------~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--------VPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--------CCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 98754110 01112468999999998764 5678999999999999999999999
Q ss_pred CCCCCHHHH
Q 022903 267 FEGMSNLQA 275 (290)
Q Consensus 267 f~~~~~~~~ 275 (290)
|.+......
T Consensus 231 F~~~~~~ki 239 (932)
T PRK13184 231 YRRKKGRKI 239 (932)
T ss_pred CCCcchhhh
Confidence 988655433
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=263.77 Aligned_cols=213 Identities=29% Similarity=0.462 Sum_probs=174.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|.+.+.||.|++|.||.+.. +++.||+|.+...............+.+|+.++++++||||+++++.+.+. ..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4588899999999999999976 578999999876543322222224578999999999999999999998654 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceeccccc
Confidence 9999999999999876 3568899999999999999999999999999999999999954 469999999987532221
Q ss_pred cc----cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 215 MM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 215 ~~----~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.. ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 221 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 221 (263)
T ss_pred cccccccCCCcCccccCcceecc--------CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc
Confidence 11 23457789999999865 4588999999999999999999999998877666555443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=265.26 Aligned_cols=210 Identities=32% Similarity=0.505 Sum_probs=173.1
Q ss_pred cCCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceE
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 133 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 133 (290)
+...+|++.++||+|+||.||+|++. ...||+|++....... ..+.+|+.+++.++||||+++++.+.+...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~------~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH------HHHHHHHHHHHhCCCCCcceEEEEECCCCcE
Confidence 34567999999999999999999874 3579999987644322 2477899999999999999999988777889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+.+++|.+++.......+++..+..++.|++.||+|||++|++|+||||+||+++.+ +.++|+|||.+......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeecccc
Confidence 99999999999999976444568899999999999999999999999999999999999954 45999999998754332
Q ss_pred ccc--cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 214 EMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 214 ~~~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
... ....++..|+|||.... ..++.++|+||||+++|+|++ |..||.+....+....+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~ 216 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216 (262)
T ss_pred ccccccCCcccceecCHhHhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH
Confidence 221 12345678999998753 567899999999999999999 99999987765544443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=283.72 Aligned_cols=202 Identities=32% Similarity=0.513 Sum_probs=180.2
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee-cCceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 133 (290)
...|.+...||+|.|+.|.+|++ ++..||+|++.+........ .++.+|+++|..|+|||||+++.+.. ...++
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~---~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR---QKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH---HHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34589999999999999999987 78999999998876654332 24789999999999999999999987 45889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+.+|.+.+|+.. .+...+..+..++.|++.|++|||+++|+|||||++|+|++.+ -.+||+|||++.+....
T Consensus 132 lV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN-MNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc-cceeeeccccceeeccc
Confidence 99999999999999987 4667779999999999999999999999999999999999955 45999999999998888
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
....+.+|++.|.|||++.+ ....++.+|+||||+++|.|++|.+||+|.+
T Consensus 209 ~~lqt~cgsppyAaPEl~~g-------~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNG-------KKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred ccccccCCCCCccChHhhcC-------cccCCcceehhhhhhhheeeeecccccCCcc
Confidence 88889999999999999976 2456899999999999999999999999854
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=280.70 Aligned_cols=206 Identities=36% Similarity=0.513 Sum_probs=167.8
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC------c
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP------L 131 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 131 (290)
|.+++.||+|+||.||++.+ +++.||+|.+......... ..++.+|+.+++.++||||+++++++... .
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS---CKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHH---HHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 67789999999999999986 6789999998654322211 23578999999999999999999988643 4
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+. ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++....
T Consensus 79 ~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeecc
Confidence 789999995 688887764 4578999999999999999999999999999999999999955 469999999987543
Q ss_pred ccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 212 VTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 212 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
... ......+++.|+|||.+.+ ...++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 217 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcC-------CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 221 2233467889999998764 245788999999999999999999999988766554443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=264.73 Aligned_cols=212 Identities=30% Similarity=0.493 Sum_probs=170.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---ce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~ 132 (290)
.+|.+.+.||+|+||.||.+.+ +++.||+|.+...............+.+|+.+++.++||||+++++.+.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5688999999999999999976 568999998864332211111123578899999999999999999988653 46
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
+++|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS--YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCcccccccc
Confidence 799999999999999875 2457888999999999999999999999999999999999955 4599999998874321
Q ss_pred c----ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 213 T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 ~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
. .......++..|+|||.+.. ..++.++|+||||+++|+|++|+.||.+........++.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 222 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--------CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh
Confidence 1 11223468889999998754 457889999999999999999999999876665554444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=274.59 Aligned_cols=201 Identities=25% Similarity=0.405 Sum_probs=168.9
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 133 (290)
.++|++.++||.|+||.||++.+ ++..+|+|++........ ...+.+|+++++.++||||+++++++.+ ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAI----RNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHH----HHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 46799999999999999999987 467899998876533222 2357899999999999999999999865 4788
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
+||||+.+++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||||+|||++.++ .+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID 156 (333)
T ss_pred EEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhh
Confidence 99999999999999975 35688999999999999999999985 799999999999999554 599999999865322
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
.......++..|+|||++.+ ..++.++|+|||||++|+|++|+.||......
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 157 -SMANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred -hccccCCCCccccCHHHhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 22234578999999998864 56788999999999999999999999876543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=264.00 Aligned_cols=211 Identities=33% Similarity=0.541 Sum_probs=173.6
Q ss_pred cCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
+..++|+++++||+|+||.||+|.. .+..||+|.+...... ...+.+|+.+++.++||||+++++.+.+. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS------VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4567799999999999999999976 4577999987654322 13578999999999999999999888654 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
+++|||+.+++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVIED 155 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceecCC
Confidence 899999999999999976555678899999999999999999999999999999999999955 4699999999976433
Q ss_pred ccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 213 TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
... .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+....+....+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218 (261)
T ss_pred CceeccCCCccceecCCHHHhcc--------CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence 221 122245678999998754 557889999999999999998 999999877665554443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=259.47 Aligned_cols=209 Identities=24% Similarity=0.408 Sum_probs=175.7
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCC---hhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ce
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGST---SDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~ 132 (290)
|...+.||.|..+.|.+..+ ++..+|+|++..... ......+.+...+|+.+|+++ .||+|+++.+.++.+ ..
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 55667899999999987744 678888888754322 111222334567899999998 599999999999765 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++|+|.+..|.|.+|+.. .-.+++...++|++|++.|++|||.++||||||||+|||+| ++..++|+|||+++....
T Consensus 99 FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld-dn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD-DNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec-cccceEEeccceeeccCC
Confidence 899999999999999986 46799999999999999999999999999999999999999 556699999999999999
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
++.....||||+|+|||.+.+.-.. +...|+...|+||+|+|||.++.|.+||.....+
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e--~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm 234 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYE--NHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM 234 (411)
T ss_pred chhHHHhcCCCcccChhheeeeccc--CCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH
Confidence 9988999999999999988753222 2356888999999999999999999999986544
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=298.18 Aligned_cols=217 Identities=35% Similarity=0.598 Sum_probs=180.7
Q ss_pred cccCCCceeecceeccccceeEEEEEEC---C----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEe
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG---D----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~---~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 125 (290)
..+..+...+.+.||+|.||.||.|... + -.||+|.+++.....+.. .|.+|..+|++++|||||+++|
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~----~Fl~Ea~~m~~f~HpNiv~liG 762 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVS----DFLKEALLMSKFDHPNIVSLIG 762 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHH----HHHHHHHHHhcCCCcceeeEEE
Confidence 3456778899999999999999999762 2 349999998876665543 5999999999999999999999
Q ss_pred eeecC-ceEEEEEecCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCce
Q 022903 126 ACKDP-LMVIVTELLPGMSLRKYLVSLR-----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199 (290)
Q Consensus 126 ~~~~~-~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~ 199 (290)
++-+. ..++++|||+||+|..|+++.+ ...++....+.++.|+++|+.||+++++|||||..+|+|++.. ..+
T Consensus 763 v~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~V 841 (1025)
T KOG1095|consen 763 VCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVV 841 (1025)
T ss_pred eecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcE
Confidence 99655 5679999999999999998853 3458888999999999999999999999999999999999954 679
Q ss_pred EEeccccccccccccc-ccc-c-CCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022903 200 KLADFGLAREETVTEM-MTA-E-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275 (290)
Q Consensus 200 kl~Dfg~~~~~~~~~~-~~~-~-~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~ 275 (290)
||+|||+|+....... ... . .-...|||||.+.. ..++.++|||||||++||++| |..||.+.++.+.
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--------~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v 913 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--------GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV 913 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhh--------cccccccchhhhHHHHHHHHhCCCCCCCCcchHHH
Confidence 9999999984222221 111 1 33468999999975 789999999999999999999 9999999999887
Q ss_pred HHHHHHh
Q 022903 276 AYAAAFK 282 (290)
Q Consensus 276 ~~~~~~~ 282 (290)
..-....
T Consensus 914 ~~~~~~g 920 (1025)
T KOG1095|consen 914 LLDVLEG 920 (1025)
T ss_pred HHHHHhC
Confidence 7644433
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=284.61 Aligned_cols=217 Identities=29% Similarity=0.431 Sum_probs=189.0
Q ss_pred cCCCceeecceeccccceeEEEEEECCce--EEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI--VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~--vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
...+++..+..||-|+||+|=+++...+. +|+|++++....+..+ ++.+..|-.+|..++.|+||++|-.|.+. .
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQ--qeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQ--QEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhH--HHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 34456778889999999999999876544 8999998866555443 34688999999999999999999999876 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.|++||-|-||.|+..+.. .+.++..++..++..+++|++|||++|||+|||||+|+++|.++. +||.|||+++...
T Consensus 495 vYmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy-~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY-LKLVDFGFAKKIG 571 (732)
T ss_pred hhhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc-eEEeehhhHHHhc
Confidence 7899999999999999986 468999999999999999999999999999999999999996655 9999999999999
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhcc
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQE 285 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~ 285 (290)
.+..+.+++|||.|.|||++.. ...+.++|.||||+++||+++|.+||++.+++ .+|.++.+...
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILn--------KGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-ktYn~ILkGid 636 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILN--------KGHDRAVDYWALGILIYELLTGSPPFSGVDPM-KTYNLILKGID 636 (732)
T ss_pred cCCceeeecCCcccccchhhhc--------cCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHhhhh
Confidence 9999999999999999999875 66789999999999999999999999997765 45555555443
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=279.65 Aligned_cols=199 Identities=28% Similarity=0.460 Sum_probs=160.2
Q ss_pred eccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc---CCCCceeEEeeeecC-ceEEEEEec
Q 022903 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 66 lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
||+|+||+||+|++ +++.||+|++........... .....|..++..+ +||||+.+++.+.+. ..++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~--~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEV--AHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHH--HHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 69999999999977 578999999865332222211 2344566666655 699999999998754 688999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-cccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 218 (290)
.+++|..++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++ .++|+|||++..... ......
T Consensus 79 ~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 79 SGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred CCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccC
Confidence 99999998875 46789999999999999999999999999999999999999554 599999999875322 222345
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
..||+.|+|||.+.. ...++.++|||||||++|+|++|..||.+.+..+..
T Consensus 156 ~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~ 206 (330)
T cd05586 156 FCGTTEYLAPEVLLD-------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY 206 (330)
T ss_pred ccCCccccCHHHHcC-------CCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH
Confidence 579999999998753 234788999999999999999999999987655443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=277.21 Aligned_cols=207 Identities=31% Similarity=0.445 Sum_probs=169.0
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--- 129 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 129 (290)
..+++|.+++.||+|+||.||+|.+ +++.||+|++........ ...++.+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLI---HARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhH---HHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 3456799999999999999999976 568899999875432221 12346789999999999999999987742
Q ss_pred ----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 130 ----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 130 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
...+++++++ +++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.+ +.+||+|||
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg 163 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRILDFG 163 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEcCCc
Confidence 2367889988 7899887753 569999999999999999999999999999999999999955 459999999
Q ss_pred ccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 206 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
++..... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+....
T Consensus 164 ~~~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 227 (343)
T cd07878 164 LARQADD--EMTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR 227 (343)
T ss_pred cceecCC--CcCCccccccccCchHhcC-------CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9876432 2334578999999998754 24578899999999999999999999998765554443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=262.83 Aligned_cols=210 Identities=33% Similarity=0.520 Sum_probs=174.0
Q ss_pred CCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceEE
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI 134 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l 134 (290)
..++|++.++||+|+||.||+|.. .+..+|+|.+....... ..+.+|+.++++++|||++++++.+.+...++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~------~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP------ESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH------HHHHHHHHHHHhcCCCceEEEEeEECCCCcEE
Confidence 445689999999999999999976 45679999987654432 24789999999999999999999887778899
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
+|||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||+|+||+++.+ ..++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeeccCcc
Confidence 9999999999999976555568999999999999999999999999999999999999954 569999999987543322
Q ss_pred cc--cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 215 MM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 ~~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
.. ....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 217 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217 (260)
T ss_pred cccccCCCCCccccChHHHhc--------CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 11 12234567999998754 567889999999999999999 999999887766555443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=261.49 Aligned_cols=209 Identities=33% Similarity=0.599 Sum_probs=171.1
Q ss_pred CCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
++++|++.+.||+|+||.||++++. +..+|+|.+....... ..+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE------EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccH------HHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence 4567889999999999999999874 4589999886544322 2477899999999999999999988654 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||+++.+ ..++|+|||.+......
T Consensus 76 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 76 IVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCCC
Confidence 999999999999998753 3468899999999999999999999999999999999999954 56999999998754322
Q ss_pred ccc--cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 214 EMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ~~~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
... ....++..|+|||.+.. ..++.++|+||||+++|+|++ |+.||.+.+..+....+.
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~ 215 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNF--------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215 (256)
T ss_pred ceeccCCCCCchhhCChhhccc--------CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 211 12234568999998754 567889999999999999999 999999887766555543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=264.24 Aligned_cols=206 Identities=29% Similarity=0.546 Sum_probs=169.7
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCc----eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
....+|++.+.||+|+||.||+|++ +++ .||+|++......... ..+.+|+.+++.++||||+++++.+.
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN----KEILDEAYVMAGVGSPYVCRLLGICL 79 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHH----HHHHHHHHHHHhcCCCCCceEEEEEc
Confidence 3456799999999999999999975 333 4899998765443322 35778999999999999999999998
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
....+++++|+++|+|.+++.. ....+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||+++
T Consensus 80 ~~~~~l~~~~~~~g~l~~~l~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~ 157 (279)
T cd05109 80 TSTVQLVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLAR 157 (279)
T ss_pred CCCcEEEEEcCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCcee
Confidence 8788899999999999999875 235689999999999999999999999999999999999998554 59999999987
Q ss_pred cccccccc---cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 209 EETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 209 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
........ ....++..|+|||.... ..++.++|||||||++|+|++ |..||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 219 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILH--------RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 54332221 12234678999998754 568899999999999999998 999998866544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=261.74 Aligned_cols=214 Identities=29% Similarity=0.482 Sum_probs=174.1
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---ce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~ 132 (290)
..|.+.+.||+|+||.||+|.+ +++.||+|.+...............+.+|+.+++.++||||+++++.+.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688999999999999999976 578999998754322211112224688999999999999999999988643 47
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++++||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcccccccccc
Confidence 799999999999999875 3458899999999999999999999999999999999999955 4599999999875322
Q ss_pred c----ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 213 T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 213 ~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+........++...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 224 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--------EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ 224 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC
Confidence 1 11123467889999998864 45788999999999999999999999998777776666544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=289.54 Aligned_cols=214 Identities=23% Similarity=0.382 Sum_probs=175.9
Q ss_pred ccccccccCCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEE
Q 022903 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFL 124 (290)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~ 124 (290)
..+..+.++.-++++.+.|.+|||+.||+|.+. +..||+|++........ ..+++|+.+|++|. |+|||.++
T Consensus 27 ~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L-----~~v~~EI~~MK~L~gh~nIV~yi 101 (738)
T KOG1989|consen 27 FVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEAL-----NAVKREIDIMKLLSGHKNIVSYI 101 (738)
T ss_pred CCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHH-----HHHHHHHHHHHHhcCCCceeeEe
Confidence 334556677888999999999999999999873 38999999876633222 23789999999996 99999999
Q ss_pred eee-e----c---CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCEEEcC
Q 022903 125 GAC-K----D---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTP 194 (290)
Q Consensus 125 ~~~-~----~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g--ivH~Dikp~Nili~~ 194 (290)
+.. . + ...+++||||.||.|-+++..+....+++.++++|+.|+++|+.+||... |||||||-+||||+.
T Consensus 102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~ 181 (738)
T KOG1989|consen 102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA 181 (738)
T ss_pred ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence 943 1 1 14679999999999999999888888999999999999999999999997 999999999999996
Q ss_pred CCCceEEecccccccccccccc----------cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCC
Q 022903 195 DQKSLKLADFGLAREETVTEMM----------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 264 (290)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~----------~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~ 264 (290)
++ ..||||||.++........ -...-|+.|+|||++.-.. +...+.++|||||||+||-|+...
T Consensus 182 ~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys-----g~pI~eKsDIWALGclLYkLCy~t 255 (738)
T KOG1989|consen 182 DG-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS-----GLPIGEKSDIWALGCLLYKLCYFT 255 (738)
T ss_pred CC-CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc-----CCCCcchhHHHHHHHHHHHHHHhC
Confidence 55 5999999999854333211 1123589999999876532 467899999999999999999999
Q ss_pred CCCCCCCH
Q 022903 265 LPFEGMSN 272 (290)
Q Consensus 265 ~Pf~~~~~ 272 (290)
.||.+...
T Consensus 256 ~PFe~sg~ 263 (738)
T KOG1989|consen 256 TPFEESGK 263 (738)
T ss_pred CCcCcCcc
Confidence 99998644
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=273.63 Aligned_cols=208 Identities=33% Similarity=0.576 Sum_probs=167.3
Q ss_pred ccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEe
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLG 125 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 125 (290)
....++|++.+.||+|+||.||+|.. +++.||+|++......... ..+.+|+.++..+ +||||+++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~----~~~~~E~~~~~~l~~h~niv~~~~ 78 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEY----KALMTELKILIHIGHHLNVVNLLG 78 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHH----HHHHHHHHHHHhhccCcchhheee
Confidence 34556799999999999999999964 2368999998755433322 2467899999999 7999999999
Q ss_pred eeec--CceEEEEEecCCCCHHHHHHhcCC--------------------------------------------------
Q 022903 126 ACKD--PLMVIVTELLPGMSLRKYLVSLRP-------------------------------------------------- 153 (290)
Q Consensus 126 ~~~~--~~~~lv~e~~~~~~L~~~~~~~~~-------------------------------------------------- 153 (290)
.+.. ...+++|||+.+++|.+++.....
T Consensus 79 ~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (337)
T cd05054 79 ACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEE 158 (337)
T ss_pred eEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhccc
Confidence 8753 467899999999999999864321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc---cccccCC
Q 022903 154 ---------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETG 221 (290)
Q Consensus 154 ---------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g 221 (290)
..+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++....... ......+
T Consensus 159 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 159 DEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred chhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCC
Confidence 257888999999999999999999999999999999999954 469999999987542221 1122345
Q ss_pred CccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 222 ~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
+..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+
T Consensus 238 ~~~y~aPE~~~~--------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~ 283 (337)
T cd05054 238 PLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE 283 (337)
T ss_pred CccccCcHHhcC--------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH
Confidence 678999998764 668999999999999999998 999998755433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.81 Aligned_cols=210 Identities=32% Similarity=0.564 Sum_probs=170.9
Q ss_pred CceeecceeccccceeEEEEEECC-------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
.+|++.+.||+|+||.||+|...+ ..|++|.+........ ...+.+|+.+++.++||||+++++.+.+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~----~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKV----QQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHH----HHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 468889999999999999997632 5699999875543322 23578999999999999999999998654
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 195 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~ 195 (290)
..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 67899999999999999976321 457888999999999999999999999999999999999955
Q ss_pred CCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 022903 196 QKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271 (290)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~ 271 (290)
+.++|+|||++....... ......+++.|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+
T Consensus 161 -~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 161 -LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--------GKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred -CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc--------CcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 459999999987532221 2233456788999998754 567899999999999999998 999999987
Q ss_pred HHHHHHHHH
Q 022903 272 NLQAAYAAA 280 (290)
Q Consensus 272 ~~~~~~~~~ 280 (290)
..+....+.
T Consensus 232 ~~~~~~~i~ 240 (283)
T cd05048 232 NQEVIEMIR 240 (283)
T ss_pred HHHHHHHHH
Confidence 765544433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.95 Aligned_cols=208 Identities=35% Similarity=0.555 Sum_probs=173.6
Q ss_pred cCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceE
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 133 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 133 (290)
+..+.|+++++||+|+||.||+|.. .++.||+|.+....... ..+.+|+.+++.++||||+++++.+.+...+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP------EAFLAEANLMKQLQHPRLVRLYAVVTQEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH------HHHHHHHHHHHhcCCcCeeeEEEEEccCCcE
Confidence 3456799999999999999999976 56889999987655432 2477999999999999999999988777889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
++|||+.+++|.+++.......+++..+..++.|++.||+|||+.|++||||+|+||+++.+ +.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecCCC
Confidence 99999999999999876555678999999999999999999999999999999999999955 46999999998754322
Q ss_pred cc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022903 214 EM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277 (290)
Q Consensus 214 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~ 277 (290)
.. .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+...
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 214 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214 (260)
T ss_pred CcccccCCcccccccCHHHhcc--------CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH
Confidence 21 122345678999998754 557889999999999999999 999999877654433
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=274.87 Aligned_cols=200 Identities=29% Similarity=0.439 Sum_probs=161.3
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
....|..++.||+|+||.||++++ +++.||||++....... ....+.+|+.+++.++|+||+++++.+.+. ..
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT----VRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHH----HHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 345688889999999999999987 47899999986544322 223578999999999999999999998654 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++++|.+. ...++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++.....
T Consensus 148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQ 220 (353)
T ss_pred EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEcccccceeccc
Confidence 899999999998652 235677788999999999999999999999999999999955 4699999999875432
Q ss_pred c-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 213 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
. .......|+..|+|||.+.... ......+.++|||||||++|+|++|+.||..
T Consensus 221 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 221 TMDPCNSSVGTIAYMSPERINTDL---NHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred ccccccccccCccccCcccccccc---ccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 2 1223457899999999874310 1123345789999999999999999999974
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=261.40 Aligned_cols=207 Identities=35% Similarity=0.590 Sum_probs=171.6
Q ss_pred cCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee--cCce
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK--DPLM 132 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~ 132 (290)
++.+.|.+.+.||+|+||.||++...+..+++|........ ..+.+|+.+++.++|+|++++++.+. +...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~-------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA-------QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchH-------HHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 44567899999999999999999999999999998654321 24779999999999999999998753 3467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
+++|||+++++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASS 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceeccc
Confidence 899999999999999987555568899999999999999999999999999999999999955 4699999999875332
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
.. .....+..|+|||.+.. ..++.++||||||+++|+|++ |..||......+....+
T Consensus 155 ~~--~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~ 212 (256)
T cd05082 155 TQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 212 (256)
T ss_pred cC--CCCccceeecCHHHHcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 22 23345668999998754 567889999999999999997 99999887655444333
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=263.24 Aligned_cols=203 Identities=36% Similarity=0.638 Sum_probs=171.2
Q ss_pred eeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~ 136 (290)
|++++.||+|+||+||+++.. ++.||+|++.......... ....+|+.+++.++||||+++++.+.+ ...+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~---~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEER---EENIREIKILRRLRHPNIVQILDVFQDDNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHH---HHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccccc---chhhhhhhccccccccccccccccccccccccccc
Confidence 678899999999999999884 4689999998876554432 123469999999999999999999864 5788999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc-cccccc
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEM 215 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~-~~~~~~ 215 (290)
+++.+++|.+++.. ...+++..+..++.|++.||.+||++|++|+||||+||+++ +++.++|+|||.+.. ......
T Consensus 78 ~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 78 EYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccccccc--ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccc
Confidence 99999999999983 46789999999999999999999999999999999999999 445699999999875 233344
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
.....++..|+|||.+.. ....+.++|+||||+++|+|++|..||........
T Consensus 155 ~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~ 207 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQ-------GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ 207 (260)
T ss_dssp BSSSSSSGGGSCHHHHTT-------TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH
T ss_pred cccccccccccccccccc-------cccccccccccccccccccccccccccccccchhh
Confidence 456678999999999751 26789999999999999999999999999843333
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=260.18 Aligned_cols=198 Identities=26% Similarity=0.562 Sum_probs=162.6
Q ss_pred eeccccceeEEEEEEC----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceEEEEEecC
Q 022903 65 KIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLP 140 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~ 140 (290)
.||+|+||.||+|.+. +..||+|++........ ...+.+|+.+++.++||||+++++.+.....++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~----~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV----RDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHH----HHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCC
Confidence 3899999999999653 45699999876543222 235889999999999999999999998778899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc----c
Q 022903 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----M 216 (290)
Q Consensus 141 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~----~ 216 (290)
+++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+||+++.+ ..++|+|||++........ .
T Consensus 78 ~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 78 GGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCccccccCCccceecc
Confidence 9999999875 34578999999999999999999999999999999999999955 4699999999875332211 1
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~ 276 (290)
....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+....+..
T Consensus 156 ~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 208 (257)
T cd05115 156 SAGKWPLKWYAPECINF--------RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208 (257)
T ss_pred CCCCCCcccCCHHHHcc--------CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 11233578999998754 557889999999999999996 99999988765544
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=261.26 Aligned_cols=205 Identities=33% Similarity=0.590 Sum_probs=172.5
Q ss_pred CCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceEEE
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIV 135 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 135 (290)
..+.|++.+.||+|+||.||++...++.||+|........ ..+.+|+.+++.++||||+++++.+.....+++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~-------~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v 76 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTA-------QAFLEETAVMTKLHHKNLVRLLGVILHNGLYIV 76 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccCCCceEEEeecCcchH-------HHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEE
Confidence 4466899999999999999999999999999998654321 247799999999999999999999987788999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceecccc--
Confidence 9999999999999875555689999999999999999999999999999999999999554 5999999998753221
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
......+..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+....
T Consensus 154 ~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 209 (254)
T cd05083 154 VDNSKLPVKWTAPEALKH--------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC 209 (254)
T ss_pred CCCCCCCceecCHHHhcc--------CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 122334567999998754 567889999999999999998 9999998876554433
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=259.83 Aligned_cols=201 Identities=27% Similarity=0.547 Sum_probs=164.7
Q ss_pred eeccccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceEEEEEecC
Q 022903 65 KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLP 140 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~ 140 (290)
.||+|+||.||+|.+ ++..+|+|++........ ....+.+|+.+++.++||||+++++.+.+...++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPA---LKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHH---HHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCC
Confidence 589999999999964 467899999875543322 2245789999999999999999999988778899999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc----c
Q 022903 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----M 216 (290)
Q Consensus 141 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~----~ 216 (290)
+++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.+ ..++|+|||++........ .
T Consensus 79 ~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeec
Confidence 9999999875 3568999999999999999999999999999999999999955 4699999999875432221 1
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+....+....+
T Consensus 156 ~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i 211 (257)
T cd05116 156 THGKWPVKWYAPECMNY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211 (257)
T ss_pred CCCCCCccccCHhHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 12234578999998753 557889999999999999998 99999987665544433
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=259.81 Aligned_cols=208 Identities=33% Similarity=0.511 Sum_probs=171.6
Q ss_pred CCceeecceeccccceeEEEEEECC-ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceEEE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIV 135 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 135 (290)
...|.+.+.||+|+||.||++.+.+ ..+|+|.+....... ..+.+|+.+++.++|||++++++.+.+...+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP------EAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccH------HHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEE
Confidence 4568889999999999999998743 579999886544322 247789999999999999999998877788999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ ..++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEccCCcc
Confidence 999999999999976555568899999999999999999999999999999999999954 4699999999875432221
Q ss_pred --ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 216 --MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 216 --~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
.....++..|+|||.... ..++.++|+||||+++|+|++ |..||.+....+....+
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216 (260)
T ss_pred cccCCCccchhhCCHHHhcc--------CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 112345678999997754 567889999999999999999 99999997766554444
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=276.22 Aligned_cols=193 Identities=25% Similarity=0.397 Sum_probs=161.9
Q ss_pred CCceeecceeccccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-Cc
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PL 131 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 131 (290)
...|.+++.||.|+||.||++.. .+..||+|.+.... ...+|+.+++.++||||+++++.+.. ..
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----------~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----------TPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----------cHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 35699999999999999999865 34679999886532 13479999999999999999998865 46
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.+++|+++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++....
T Consensus 161 ~~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~ 236 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLD 236 (392)
T ss_pred EEEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccC
Confidence 78999999 4688888843 46799999999999999999999999999999999999999554 59999999987533
Q ss_pred ccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 212 VTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 212 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+..
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLAL--------DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccccCccCHhHhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 221 1234578999999998864 568899999999999999999999998754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=259.76 Aligned_cols=208 Identities=31% Similarity=0.565 Sum_probs=169.9
Q ss_pred CCCceeecceeccccceeEEEEEECC-ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
+.++|.+++.||+|+||.||++++.+ ..+|+|.+....... ..+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE------DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccH------HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence 45678999999999999999998754 469999887544322 2478999999999999999999998654 578
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
++|||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.+||+|||.+......
T Consensus 76 lv~e~~~~~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 76 IVTEYMSNGCLLNYLREH-GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecCCC
Confidence 999999999999998763 3468999999999999999999999999999999999999954 46999999998754322
Q ss_pred ccc--cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 214 EMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 214 ~~~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
... ....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||......+....+
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLY--------SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214 (256)
T ss_pred ceeecCCCccChhhCCHHHHhc--------CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 211 12234567999998754 557889999999999999998 99999987765444433
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=273.60 Aligned_cols=222 Identities=32% Similarity=0.515 Sum_probs=177.1
Q ss_pred ccccccccccCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-C
Q 022903 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-H 117 (290)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h 117 (290)
++..+..+.+..++|.+++.||+|+||.||+|++. ++.||+|++......... ..+.+|+.++..+. |
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~----~~~~~E~~~l~~l~~H 100 (401)
T cd05107 25 QLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEK----QALMSELKIMSHLGPH 100 (401)
T ss_pred CCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHH----HHHHHHHHHHHhcCCC
Confidence 44455566777788999999999999999999853 257999999765443322 24779999999997 9
Q ss_pred CCceeEEeeeecC-ceEEEEEecCCCCHHHHHHhcCC-------------------------------------------
Q 022903 118 DNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP------------------------------------------- 153 (290)
Q Consensus 118 ~~iv~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------- 153 (290)
|||+++++++... ..++||||+.+|+|.+++.....
T Consensus 101 ~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (401)
T cd05107 101 LNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMD 180 (401)
T ss_pred CCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccc
Confidence 9999999998754 67899999999999999865321
Q ss_pred -----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 022903 154 -----------------------------------------------------NKLDLHVALNFALDIARAMDCLHANGI 180 (290)
Q Consensus 154 -----------------------------------------------------~~~~~~~~~~i~~qi~~~l~~lH~~gi 180 (290)
..+++..++.++.||+.||.|||++|+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i 260 (401)
T cd05107 181 MSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC 260 (401)
T ss_pred cCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCc
Confidence 135667788899999999999999999
Q ss_pred eeecCCCCCEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHH
Q 022903 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257 (290)
Q Consensus 181 vH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l 257 (290)
+||||||+|||++. ...++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++
T Consensus 261 vHrdlkp~NiLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGvil 331 (401)
T cd05107 261 VHRDLAARNVLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--------NLYTTLSDVWSFGILL 331 (401)
T ss_pred CcccCCcceEEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--------CCCCcHhHHHHHHHHH
Confidence 99999999999995 4569999999987532211 1122356788999998864 5678899999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 258 WELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 258 ~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
|+|++ |..||......+......
T Consensus 332 ~e~l~~g~~P~~~~~~~~~~~~~~ 355 (401)
T cd05107 332 WEIFTLGGTPYPELPMNEQFYNAI 355 (401)
T ss_pred HHHHHcCCCCCCCCCchHHHHHHH
Confidence 99998 999998877665554443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=262.82 Aligned_cols=205 Identities=28% Similarity=0.470 Sum_probs=166.7
Q ss_pred CCCceeecceeccccceeEEEEEE--CCc----eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
...+|++++.||+|+||.||+|.+ +++ .+++|.+........ ...+..|+.+++.++||||+++++++.+
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~~~~~l~~l~h~~iv~~~~~~~~ 80 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQT----FQEITDHMLAMGSLDHAYIVRLLGICPG 80 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHH----HHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence 345688899999999999999987 343 478888754332221 1246788889999999999999999877
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...++++||+.+++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+ ..+||+|||++..
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~ 158 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADL 158 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCcccee
Confidence 778899999999999999975 34578999999999999999999999999999999999999954 5699999999875
Q ss_pred cccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 210 ETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 210 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
...... .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 219 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILF--------GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhcc--------CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 322211 122346678999998754 568899999999999999998 999999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=258.20 Aligned_cols=209 Identities=33% Similarity=0.527 Sum_probs=171.4
Q ss_pred CCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
..+.|++.+.||+|+||.||+|.+ .++.||+|.+....... ..+.+|+.++++++||||+++++.+... ..+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP------KDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccH------HHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 456689999999999999999976 45789999987644321 2377899999999999999999988644 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
++|||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKED 156 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccCC
Confidence 999999999999999765445789999999999999999999999999999999999999554 5999999998764422
Q ss_pred cccc--ccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 214 EMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 214 ~~~~--~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
.... ....+..|+|||.+.. ..++.++|+||||+++|+|++ |+.||.+.+.......+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALY--------NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217 (261)
T ss_pred cccccCCCcCceeccCcccccc--------CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 2111 1122457999998754 567889999999999999999 99999988766555444
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=269.76 Aligned_cols=194 Identities=28% Similarity=0.463 Sum_probs=156.2
Q ss_pred cceeccccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---CceEEE
Q 022903 63 GSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMVIV 135 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~lv 135 (290)
+++||+|+||.||+|++ .++.||+|.+....... .+.+|+.+++.++||||+++++.+.+ ...+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISM-------SACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcH-------HHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEE
Confidence 46899999999999975 34789999987654322 25689999999999999999998743 357899
Q ss_pred EEecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc---CCCCceEEeccc
Q 022903 136 TELLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFG 205 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~---~~~~~~kl~Dfg 205 (290)
|||+ +++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|||++ ...+.+||+|||
T Consensus 79 ~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 79 FDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred Eecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 9998 458888875421 23588999999999999999999999999999999999994 234569999999
Q ss_pred ccccccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 206 LAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 206 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
++....... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|++||.+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcC-------CCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 997543221 2234578999999998764 2457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=257.42 Aligned_cols=211 Identities=27% Similarity=0.405 Sum_probs=177.0
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|.+.+.||+|+||.||++.. +++.+|+|.+......... ...+.+|+.+++.++||||+++++.+.. ...++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE---RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHH---HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEE
Confidence 378889999999999999876 6789999998765433322 2357899999999999999999988764 468899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+++++|.+++.......+++..+..++.+++.+|.|||++|++|+||+|+||+++.++..++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999999998755556899999999999999999999999999999999999986666789999999987554444
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+.......+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 214 (256)
T cd08220 158 AYTVVGTPCYISPELCEG--------KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM 214 (256)
T ss_pred ccccccCCcccCchhccC--------CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH
Confidence 445578889999998754 557889999999999999999999999876655444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=250.80 Aligned_cols=210 Identities=23% Similarity=0.329 Sum_probs=174.0
Q ss_pred ccccccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
+..+.++.++|++.+.||.|||+-||+++. +++.||+|.+.-....+. +..++|+...++++|||++++++..
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~-----e~~~rEid~~rkf~s~~vl~l~dh~ 87 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDI-----EEALREIDNHRKFNSPNVLRLVDHQ 87 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHH-----HHHHHHHHHHHhhCCcchHHHHHHH
Confidence 445678899999999999999999999975 789999999987663332 2467999999999999999998765
Q ss_pred e----c--CceEEEEEecCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCEEEcCCCC
Q 022903 128 K----D--PLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQK 197 (290)
Q Consensus 128 ~----~--~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~g--ivH~Dikp~Nili~~~~~ 197 (290)
- | ...|++++|...|+|.+.++.... ..+++.+++.|+.++++||++||+.. +.||||||.|||+.. .+
T Consensus 88 l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~-~~ 166 (302)
T KOG2345|consen 88 LREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD-SG 166 (302)
T ss_pred HHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC-CC
Confidence 2 2 257899999999999999876543 35899999999999999999999998 999999999999995 45
Q ss_pred ceEEecccccccccccccc----------cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 022903 198 SLKLADFGLAREETVTEMM----------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267 (290)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~----------~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf 267 (290)
.++|.|||.++.....-.. .....|..|.|||++.. ..+...+.++|||||||+||.|+.|.-||
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v-----k~~~ti~ertDIWSLGCtLYa~mf~~sPf 241 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV-----KSHCTITERTDIWSLGCTLYAMMFGESPF 241 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheec-----ccCcccccccchhhhhHHHHHHHHcCCcc
Confidence 6999999998764332111 12257899999999865 22456789999999999999999999999
Q ss_pred CCC
Q 022903 268 EGM 270 (290)
Q Consensus 268 ~~~ 270 (290)
+..
T Consensus 242 e~~ 244 (302)
T KOG2345|consen 242 ERI 244 (302)
T ss_pred hHH
Confidence 753
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=269.00 Aligned_cols=210 Identities=30% Similarity=0.445 Sum_probs=183.0
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee-ecCceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv 135 (290)
.|.++.+||.|+||.||+|.+ .|..+|||.++.+..-+ .+.+|+.+++++..|++|++||.+ ....+|+|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQ-------EIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQ-------EIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHH-------HHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 378899999999999999965 78999999987665433 367999999999999999999976 56689999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-c
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~ 214 (290)
||||..|+..+.++. +.+++.+..+..+++..+.||+|||...-||||||..|||++.++ ..||+|||.+-..... .
T Consensus 107 MEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHH
Confidence 999999999999987 568999999999999999999999999999999999999999665 5999999998654322 2
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhcc
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQE 285 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~ 285 (290)
..++..||+.|||||++.. ..|+..+||||||++..||..|++||.+..+++.++-|-.+.+.
T Consensus 185 KRNTVIGTPFWMAPEVI~E--------IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPP 247 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEE--------IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPP 247 (502)
T ss_pred hhCccccCcccccHHHHHH--------hccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCC
Confidence 3456689999999999865 66899999999999999999999999999999888877666544
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=265.04 Aligned_cols=206 Identities=30% Similarity=0.513 Sum_probs=168.6
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.+.|.+.+.||.|+||.||+|++ +++.||+|.+......... ..+.+|+.+++.++||||+++++++.+. ..+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAP----CTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCch----hHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 45699999999999999999976 5789999998754432221 2366899999999999999999998754 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+. ++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++......
T Consensus 81 lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 81 LVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIP 157 (301)
T ss_pred EEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccCCC
Confidence 9999996 5898888753 4568899999999999999999999999999999999999955 45999999998753322
Q ss_pred c-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 214 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
. ......+++.|+|||.+.+ ...++.++||||||+++|+|++|++||.+.+..+..
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~ 214 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214 (301)
T ss_pred CCcccccceeecccCcHHHhC-------CCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2 2223457889999998753 245788999999999999999999999987765443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=260.80 Aligned_cols=208 Identities=34% Similarity=0.577 Sum_probs=166.7
Q ss_pred CCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
..++|++.+.||+|+||.||+|.+. +..||+|.+......... ..+.+|+.+++.++||||+++++.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~----~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRER----IEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHH----HHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4567999999999999999998753 357999998654332222 34789999999999999999999986
Q ss_pred cC-ceEEEEEecCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCce
Q 022903 129 DP-LMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199 (290)
Q Consensus 129 ~~-~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~ 199 (290)
+. ..++||||+.+++|.+++..... ...++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~-~~~ 158 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTV 158 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-CCE
Confidence 54 67899999999999999875321 235677889999999999999999999999999999999955 469
Q ss_pred EEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022903 200 KLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275 (290)
Q Consensus 200 kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~ 275 (290)
+|+|||++........ .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+.
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV 230 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhc--------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999864322111 112345678999998754 567899999999999999999 7999998766543
Q ss_pred H
Q 022903 276 A 276 (290)
Q Consensus 276 ~ 276 (290)
.
T Consensus 231 ~ 231 (277)
T cd05062 231 L 231 (277)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=240.40 Aligned_cols=210 Identities=30% Similarity=0.463 Sum_probs=179.8
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee-cCceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 136 (290)
|.-.++||+|+||+||+|+. +.+.||+|.++-+....-.. ....+|+.+++.++|.|||+++++.. +..+.+|+
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvp---ssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCc---HHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 55568999999999999965 67899999987655443222 23569999999999999999999885 45788999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-c
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~ 215 (290)
||| ..+|..|... .++.++.+.++.++.|+++||.++|+++++|||+||.|+||+.++ .+||+|||+++....+- .
T Consensus 81 e~c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-elkladfglarafgipvrc 157 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRC 157 (292)
T ss_pred HHh-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cEEecccchhhhcCCceEe
Confidence 999 5599999877 568899999999999999999999999999999999999999654 59999999998644433 4
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~~ 282 (290)
......|..|.+|.++.+ .+-|+.+.|+||.||++.|+.. |++.|+|.+-.+.+.+|.+.
T Consensus 158 ysaevvtlwyrppdvlfg-------akly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~ 218 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_pred eeceeeeeeccCcceeee-------eehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH
Confidence 456678999999999987 4678999999999999999997 99999999989999888875
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=263.11 Aligned_cols=215 Identities=33% Similarity=0.522 Sum_probs=173.1
Q ss_pred ccccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeE
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKF 123 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 123 (290)
.+.....+|.+.+.||+|+||.||++.+ .+..||+|++........ ...+.+|+.+++++ +||||+++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE----REALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHH----HHHHHHHHHHHHhccCCCCcceE
Confidence 3445556799999999999999999964 234799999876543322 23578999999999 79999999
Q ss_pred EeeeecC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEe
Q 022903 124 LGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 124 ~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~ 202 (290)
++.+.+. ..+++|||+.+++|.+++.......+++.++..++.|++.||.|||++|++|+||||+||+++.+ ..++|+
T Consensus 105 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~ 183 (302)
T cd05055 105 LGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKIC 183 (302)
T ss_pred EEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-CeEEEC
Confidence 9988654 67899999999999999976444458999999999999999999999999999999999999854 569999
Q ss_pred cccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022903 203 DFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 203 Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+....+....
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~ 255 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhcc--------CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH
Confidence 999987533221 1122345678999998754 567889999999999999998 9999988765544444
Q ss_pred H
Q 022903 279 A 279 (290)
Q Consensus 279 ~ 279 (290)
.
T Consensus 256 ~ 256 (302)
T cd05055 256 L 256 (302)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=256.57 Aligned_cols=208 Identities=26% Similarity=0.425 Sum_probs=172.6
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|.+.+.||+|+||.||++.. +++.|++|.+......... ...+.+|+.+++.++||||+++++.+.+. ..++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE---REEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHH---HHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 67788999999999999976 5789999998754333222 23578999999999999999999988654 688999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-c
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~ 215 (290)
||+++++|.+++.......++...+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccch
Confidence 999999999999875556789999999999999999999999999999999999999654 59999999987543322 2
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.....+++.|+|||.+.. ..++.++|+||||+++|+|++|..||...+.......+
T Consensus 158 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 213 (256)
T cd08529 158 ANTIVGTPYYLSPELCED--------KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI 213 (256)
T ss_pred hhccccCccccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 233467889999998864 55788999999999999999999999987765444433
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=258.54 Aligned_cols=212 Identities=29% Similarity=0.472 Sum_probs=171.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---Cce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 132 (290)
-+|...+.||+|+||.||+|.+ ++..|++|.+...............+.+|+.+++.++||||+++++.+.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3588889999999999999976 57899999987544322222222457899999999999999999998754 357
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++++||+++++|.+++.. ...+++.....++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCcccccc
Confidence 799999999999999875 34588999999999999999999999999999999999999554 599999999864322
Q ss_pred c----ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 213 T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 ~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~ 222 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--------EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA 222 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence 1 11123457889999998754 567889999999999999999999999887666555443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=258.33 Aligned_cols=204 Identities=33% Similarity=0.571 Sum_probs=168.5
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-Cce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 132 (290)
....|.+.+.||+|+||.||+|.+ .++.||+|++....... ..+.+|+.+++.++||||+++++.+.. ...
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------EEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHH------HHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 445688899999999999999976 47889999987543221 247789999999999999999998864 467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
+++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~ 156 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCcccccccc
Confidence 899999999999999977555678999999999999999999999999999999999999855 4699999999876433
Q ss_pred ccccc--ccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 213 TEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 213 ~~~~~--~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
..... ....+..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 213 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213 (263)
T ss_pred ceeeccCCCCCccccCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 22211 1234567999998754 567889999999999999998 999999865543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=262.60 Aligned_cols=201 Identities=29% Similarity=0.476 Sum_probs=170.0
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|++.+.||+|+||.||++.+ .++.||+|++......... ...++.+|++++++++||||+++++.+.+. ..++|
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK--QVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 588899999999999999987 5689999998754332211 124578999999999999999999998754 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRK--SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--
Confidence 999999999999876 3678999999999999999999999999999999999999955 45999999998764433
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
.....+++.|+|||.+.. ...+.++|+||||+++|+|++|..||...+..+
T Consensus 155 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 205 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS--------KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205 (290)
T ss_pred CCCCCCCccccChhhhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 334468899999998754 457889999999999999999999998876443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.65 Aligned_cols=210 Identities=32% Similarity=0.548 Sum_probs=171.3
Q ss_pred CCCceeecceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
++.+|.+.+.||+|+||.||+|.+. ...||+|.+......... ..+.+|+.+++.++||||+++++.+.+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR----LDFLTEASIMGQFDHPNIIRLEGVVTKS 77 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHH----HHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence 3456899999999999999999763 357999998765433322 3578899999999999999999988654
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..+++|||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++..
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~ 155 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRR 155 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhhc
Confidence 678999999999999998763 3478999999999999999999999999999999999999955 4599999999986
Q ss_pred ccccc-c--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 210 ETVTE-M--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 210 ~~~~~-~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
..... . .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+..+....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 221 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221 (266)
T ss_pred ccccccceeccCCCCCccccChhhhcc--------CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence 53111 1 112234578999998764 567899999999999999998 99999887766554444
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=261.56 Aligned_cols=206 Identities=36% Similarity=0.652 Sum_probs=168.2
Q ss_pred eecceeccccceeEEEEEEC------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceE
Q 022903 61 FIGSKIGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 61 ~~~~~lG~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 133 (290)
.+.+.||.|.||.||+|.+. +..|+||.+......... ..+.+|+..+++++||||+++++.+.+ ...+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~----~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEE----EEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHH----HHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccc----eeeeeccccccccccccccccccccccccccc
Confidence 35678999999999999876 578999999664443322 358899999999999999999999974 4678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+|+||+.+++|.+++.......+++..+..++.||+.||.|||+++++|++|+++||+++.+ +.+||+|||++......
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence 99999999999999998646789999999999999999999999999999999999999954 57999999998765221
Q ss_pred ---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 214 ---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 214 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
...........|+|||.+.. ..++.++||||||+++|||++ |+.||.+.+..+....+
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~ 218 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKD--------GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL 218 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHH--------SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH
T ss_pred ccccccccccccccccccccccc--------ccccccccccccccccccccccccccccccccccccccc
Confidence 11223356778999998865 457899999999999999999 78999999777766555
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=258.07 Aligned_cols=207 Identities=27% Similarity=0.404 Sum_probs=171.8
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||.|+||.||++.+ +++.+|+|.++........ ..+.+|+.+++.++||||+++++.+.+. ..+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV----EDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHH----HHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence 377889999999999999976 5789999998654433222 3577899999999999999999998654 78899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||.+.......
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeeccccc
Confidence 999999999999876555678999999999999999999999999999999999999955 459999999987543322
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
......+++.|+|||++.. ..++.++|+||||+++|+|++|..||...+.......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 156 YACTYVGTPYYVPPEIWEN--------MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred ccccccCCccccCHHHHcc--------CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 2233468889999998754 5578899999999999999999999998765544433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=283.27 Aligned_cols=220 Identities=28% Similarity=0.438 Sum_probs=187.9
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee-ecCceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv 135 (290)
.+.|+..||.|+||.||+|.. ++-..|-|++........ ..++-||.||..+.||+||+++++| .++.++++
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEEL-----EDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEEL-----EDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHH-----hhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 356788999999999999965 445677788765544332 3588899999999999999999876 56789999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc-ccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTE 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~-~~~~~ 214 (290)
.|||.||..+.++-.. ...+++.++.-+++|++.||.|||+++|||||||..|||++.++. ++|+|||.+.. .....
T Consensus 108 iEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd-irLADFGVSAKn~~t~q 185 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD-IRLADFGVSAKNKSTRQ 185 (1187)
T ss_pred EeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc-EeeecccccccchhHHh
Confidence 9999999999988774 578999999999999999999999999999999999999997765 99999998754 33334
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhccccc
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (290)
....+.|||.|||||+..+-+ ....+|++++||||||++|++|..+.+|-...+.++++..|+..-+..|-
T Consensus 186 kRDsFIGTPYWMAPEVvmCET---~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl 256 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCET---FKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL 256 (1187)
T ss_pred hhccccCCcccccchheeecc---ccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc
Confidence 556789999999999988744 34578999999999999999999999999999999999999988666554
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=260.59 Aligned_cols=205 Identities=30% Similarity=0.545 Sum_probs=166.7
Q ss_pred CceeecceeccccceeEEEEEE------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
+.|++.+.||+|+||.||+|.. .+..|++|.+......... ..+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQW----GEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHH----HHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4588899999999999999974 3478999999764443321 3477899999999999999999988654
Q ss_pred ceEEEEEecCCCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC
Q 022903 131 LMVIVTELLPGMSLRKYLVSLR---------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 195 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~ 195 (290)
..++||||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 6789999999999999986422 1247888899999999999999999999999999999999955
Q ss_pred CCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 022903 196 QKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271 (290)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~ 271 (290)
..++|+|||+++...... ......++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+
T Consensus 161 -~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 161 -LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--------GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred -CcEEeccccccccccCCcceecccCCCccceecChHHhcc--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 459999999987532221 1223345678999998754 557899999999999999998 999998876
Q ss_pred HHHH
Q 022903 272 NLQA 275 (290)
Q Consensus 272 ~~~~ 275 (290)
....
T Consensus 232 ~~~~ 235 (283)
T cd05090 232 NQEV 235 (283)
T ss_pred HHHH
Confidence 5443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=257.24 Aligned_cols=208 Identities=34% Similarity=0.614 Sum_probs=169.0
Q ss_pred CCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
+..+|++.+.||+|+||.||++++. +..+|+|++....... ..+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE------DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF 75 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH------HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence 3456888999999999999999874 4589999986543322 2367899999999999999999988654 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++......
T Consensus 76 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 76 IVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLDD 153 (256)
T ss_pred EEEecCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceecccc
Confidence 999999999999998763 3468999999999999999999999999999999999999955 46999999998754322
Q ss_pred ccc--cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 214 EMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 214 ~~~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
... ....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.++.+....+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDY--------SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214 (256)
T ss_pred cccccCCCCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 111 11123457999998764 567889999999999999999 89999987776555444
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=262.64 Aligned_cols=205 Identities=33% Similarity=0.488 Sum_probs=171.4
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
.+|.+.+.||+|+||.||+|.+ .++.|++|.+........ ..+.+|+.+++.+.||||+++++.+.+ ...++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~-----~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-----ELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchH-----HHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 5699999999999999999976 578999999876554332 247799999999999999999998864 47889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.......
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred eecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEECccccchhccccc
Confidence 9999999999999864 457899999999999999999999999999999999999855 469999999987533222
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......+++.|+|||.+.. ..++.++|+|||||++|+|++|..||.........+.+
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~ 228 (296)
T cd06654 171 SKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (296)
T ss_pred cccCcccCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH
Confidence 1223468889999998754 55788999999999999999999999887765554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=258.55 Aligned_cols=212 Identities=31% Similarity=0.477 Sum_probs=162.6
Q ss_pred eeccccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEec
Q 022903 65 KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
.||+|+||.||+|.. ....+++|.+........ ...+.+|+.+++.++||||+++++.+.+. ..++||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE----QLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHH----HHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence 589999999999964 235788888765433222 23477899999999999999999988654 688999999
Q ss_pred CCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc--
Q 022903 140 PGMSLRKYLVSLRP---NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-- 214 (290)
Q Consensus 140 ~~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-- 214 (290)
++++|.+++..... ...++..+..++.||+.||+|||++|++||||||+|||++.+ +.+||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEeccccccccccchhe
Confidence 99999999976432 234677888999999999999999999999999999999954 569999999986532221
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~~ 282 (290)
......++..|+|||++..... ......++.++||||||+++|+|++ |..||....+.+........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQ-DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225 (269)
T ss_pred eccCCCCCcccccCHHHHhhccc-cccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc
Confidence 1122345677999998643110 0012456889999999999999999 89999988877665554443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=270.96 Aligned_cols=192 Identities=26% Similarity=0.416 Sum_probs=159.3
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
....|.+++.||+|+||.||+|++ +++.||+|+..... ...|+.+++.++||||+++++.+.+. ..
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-----------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-----------TLIEAMLLQNVNHPSVIRMKDTLVSGAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-----------cHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence 345699999999999999999987 45789999854322 34688999999999999999988654 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||+++ .++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++.....
T Consensus 133 ~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEEEcc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCcccccccc
Confidence 8999999 5688888865 346789999999999999999999999999999999999999554 599999999875443
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCC
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEG 269 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g-~~Pf~~ 269 (290)
........||..|+|||++.. ..++.++|||||||++|+|+++ ..+|.+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLAR--------DKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred CcccccccccccccCCeecCC--------CCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 333345578999999999864 5688999999999999999984 444444
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=256.57 Aligned_cols=208 Identities=34% Similarity=0.539 Sum_probs=171.4
Q ss_pred cCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceE
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 133 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 133 (290)
+..+.|.+.+.||+|+||.||++.. .+..+++|.+...... ...+.+|+.+++.++|+||+++++.+.+...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS------VEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhH------HHHHHHHHHHHHhcCCCCcceEEEEEcCCCeE
Confidence 3456799999999999999999986 4567999988754321 13478899999999999999999998777789
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ ..++|+|||.+......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeeccCC
Confidence 99999999999999977555668888999999999999999999999999999999999955 46999999998653322
Q ss_pred cc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022903 214 EM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277 (290)
Q Consensus 214 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~ 277 (290)
.. .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+...
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214 (260)
T ss_pred CcccccCCcccccccCHhHhcc--------CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 11 112234567999998754 567889999999999999998 999999877655443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.63 Aligned_cols=214 Identities=30% Similarity=0.478 Sum_probs=171.7
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee-cCce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 132 (290)
..+.|++++.||+|+||.||+|++ +++.+++|.+....... ...+.+|+.+++.++||||+++++.+. +...
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYMVEIEILATCNHPYIVKLLGAFYWDGKL 84 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHH-----HHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence 346699999999999999999987 46899999987543222 134778999999999999999999875 4478
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++++|..++... ...+++..+..++.|++.+|.|||++|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVK 162 (292)
T ss_pred EEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccceeccc
Confidence 8999999999999887652 3568999999999999999999999999999999999999854 4699999998764322
Q ss_pred c-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 213 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
. .......+++.|+|||.+.... .....++.++|+||||+++|+|++|..||...+..+....+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 227 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCET---MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 227 (292)
T ss_pred cccccceecCCccccCceeecccc---ccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 1 1123346788999999875311 11245788999999999999999999999887655444333
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=260.65 Aligned_cols=207 Identities=34% Similarity=0.493 Sum_probs=173.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|.+.+.||.|+||.||+|.+ +++.|++|.+........ ..+.+|+.+++.++||||+++++.+.+. ..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKK-----ELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchH-----HHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 4699999999999999999975 678999999875443332 2477899999999999999999988654 6889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
|+||+.+++|..++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 94 VMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhccccc
Confidence 9999999999998864 468999999999999999999999999999999999999955 459999999987533222
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
......++..|+|||.+.. ..++.++|+|||||++|+|++|..||.+.+..+....+..
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~ 229 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 229 (296)
T ss_pred ccCCCcCCCccccCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 1233468889999998754 5578899999999999999999999999887666555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=255.14 Aligned_cols=206 Identities=35% Similarity=0.610 Sum_probs=173.0
Q ss_pred cCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee-cCceE
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMV 133 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 133 (290)
++.+.|.+.+.||.|+||.||+|...++.||+|.+..... ...++.+|+.+++.++|+||+++++.+. ....+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST------AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh------HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 3456788999999999999999999999999999976543 1235789999999999999999999987 44788
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||.+......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEcccccccccccc
Confidence 99999999999999987544578999999999999999999999999999999999999954 45999999998765322
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~ 277 (290)
. .....+..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+..+...
T Consensus 156 ~--~~~~~~~~~~ape~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 210 (256)
T cd05039 156 Q--DSGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 210 (256)
T ss_pred c--ccCCCcccccCchhhcC--------CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 2 12344567999998754 567889999999999999997 999998876554433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=278.94 Aligned_cols=212 Identities=25% Similarity=0.449 Sum_probs=177.3
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
++..-|..++.||-|+||+|.+++. +...||.|.+++...-...+. ..+..|-.||..-..+.||+||..|+|. .
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQv--aHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQV--AHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhh--hhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 5666788899999999999999954 667899999987665444433 3577888999999999999999999865 7
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
+|+||+|+.||++..++-. -+.+.+..++.|++++.+|++++|..|+|||||||+|||||.+++ |||+|||+|+...
T Consensus 704 LYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH-IKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFR 780 (1034)
T ss_pred eEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc-eeeeeccccccce
Confidence 8999999999999999876 357889999999999999999999999999999999999997765 9999999987210
Q ss_pred cc-------------------------------------------ccccccCCCccccCccccccccccccccCCCCCcc
Q 022903 212 VT-------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 248 (290)
Q Consensus 212 ~~-------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~ 248 (290)
.. ......+||+.|+|||++.. ..++..+
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--------~g~~q~c 852 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--------TGYTQLC 852 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--------cCccccc
Confidence 00 00112359999999999975 7789999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 249 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 249 DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
|+||.|||||+|+.|+.||-+.+..+..+++
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv 883 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGETQYKV 883 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCcceeee
Confidence 9999999999999999999998877655544
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.59 Aligned_cols=210 Identities=30% Similarity=0.543 Sum_probs=171.6
Q ss_pred CCCceeecceeccccceeEEEEEECC-----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
...+|.+.+.||+|+||.||+|.+.+ ..|++|........... ..+.+|+.+++.+.||||+++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~----~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR----EKFLQEAYIMRQFDHPHIVKLIGVITEN 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHH----HHHHHHHHHHHhCCCCchhceeEEEcCC
Confidence 34568888999999999999997632 46899988765543322 3578999999999999999999999888
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~ 157 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSRYL 157 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceeeec
Confidence 889999999999999999763 3468999999999999999999999999999999999999954 46999999998754
Q ss_pred cccccc--cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 211 TVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 211 ~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
...... ....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~ 221 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221 (270)
T ss_pred ccccceecCCCCccccccChhhhcc--------CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 332211 12234567999998754 567899999999999999996 99999998776555443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=261.16 Aligned_cols=206 Identities=33% Similarity=0.535 Sum_probs=163.8
Q ss_pred CceeecceeccccceeEEEEEEC--C--ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-c
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYG--D--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-L 131 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~ 131 (290)
++|++.+.||+|+||.||+|... + ..+++|.++........ ..+.+|+.++.++ +||||+++++.+.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDH----RDFAGELEVLCKLGHHPNIINLLGACENRGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHH----HHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence 45888999999999999999763 2 34788887643332221 3578899999999 799999999998654 6
Q ss_pred eEEEEEecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC
Q 022903 132 MVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 197 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~ 197 (290)
.++++||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+|||++.+ .
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~ 156 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-L 156 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-C
Confidence 789999999999999986532 1347888999999999999999999999999999999999854 5
Q ss_pred ceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022903 198 SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~ 276 (290)
.+||+|||++..............+..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~ 228 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY--------SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 699999999864322211122233557999998754 567899999999999999997 99999987765433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.33 Aligned_cols=211 Identities=30% Similarity=0.546 Sum_probs=169.9
Q ss_pred CCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
+...|.+.+.||+|+||.||++.. ++..+|+|.+....... ...+.+|+.++++++||||+++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA-----RKDFHREAELLTNLQHEHIVKFYGVCV 77 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHH-----HHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 345688999999999999999974 23568999886543221 235789999999999999999999986
Q ss_pred c-CceEEEEEecCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC
Q 022903 129 D-PLMVIVTELLPGMSLRKYLVSLR-----------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ 196 (290)
Q Consensus 129 ~-~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~ 196 (290)
+ ...++||||+.+++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++.+
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~- 156 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN- 156 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-
Confidence 5 46789999999999999987532 2348999999999999999999999999999999999999955
Q ss_pred CceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCH
Q 022903 197 KSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272 (290)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~ 272 (290)
+.++|+|||++....... ......++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.....
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 469999999987532221 1122345678999998754 567889999999999999998 9999998876
Q ss_pred HHHHHHHH
Q 022903 273 LQAAYAAA 280 (290)
Q Consensus 273 ~~~~~~~~ 280 (290)
.+....+.
T Consensus 229 ~~~~~~i~ 236 (288)
T cd05093 229 NEVIECIT 236 (288)
T ss_pred HHHHHHHH
Confidence 65544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=254.58 Aligned_cols=208 Identities=29% Similarity=0.432 Sum_probs=171.4
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec--CceEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--PLMVIV 135 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~lv 135 (290)
|++++.||+|++|.||++.+ +++.||+|.+......... ...+.+|+.+++.++|||++++++.+.. ...+++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRE---RKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHH---HHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 78899999999999999976 5688999998754433222 1346789999999999999999988753 357899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-c
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~ 214 (290)
|||+++++|.+++.......+++.++..++.+++.||.+||++|++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEecccCC
Confidence 999999999999987555678999999999999999999999999999999999999955 45999999998754322 2
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+.......+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~ 214 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN--------KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214 (257)
T ss_pred ccccccCCcCccChhHhcC--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 2234467889999998764 56788999999999999999999999987765544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=260.64 Aligned_cols=210 Identities=33% Similarity=0.590 Sum_probs=170.8
Q ss_pred CCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
...|.+.+.||+|+||.||+|+.. ++.||+|.+......... ..+.+|+++++.++||||+++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR----KDFEREAELLTNFQHENIVKFYGVCTE 79 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHH----HHHHHHHHHHHhcCCCCchheeeEEec
Confidence 345888999999999999999652 368999998765443222 358899999999999999999999865
Q ss_pred -CceEEEEEecCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLR------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ 196 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~ 196 (290)
...++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~- 158 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD- 158 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC-
Confidence 46889999999999999997532 2347888999999999999999999999999999999999955
Q ss_pred CceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCH
Q 022903 197 KSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272 (290)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~ 272 (290)
+.++|+|||++....... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+.
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhcc--------CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 569999999987532211 1123345678999998864 668899999999999999998 9999988776
Q ss_pred HHHHHHH
Q 022903 273 LQAAYAA 279 (290)
Q Consensus 273 ~~~~~~~ 279 (290)
.+....+
T Consensus 231 ~~~~~~~ 237 (280)
T cd05049 231 EEVIECI 237 (280)
T ss_pred HHHHHHH
Confidence 6544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=260.88 Aligned_cols=213 Identities=30% Similarity=0.455 Sum_probs=173.3
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|.+.+.||.|+||.||++.+ ++..+|+|++........ ..+.+|+.+++.++||||+++++.+.++ ..++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL-----EDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHH-----HHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 4589999999999999999987 578999999875432221 3477899999999999999999998654 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 80 LIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTL 157 (280)
T ss_pred EeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhcccc
Confidence 99999999999998763 3569999999999999999999999999999999999999955 45999999987653222
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.......+++.|+|||.+..-. .....++.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 221 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACET---FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL 221 (280)
T ss_pred cccceeecchhhcCHHHHhhcc---cCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh
Confidence 1223346888999999875311 112457889999999999999999999999887665554443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=258.83 Aligned_cols=213 Identities=32% Similarity=0.542 Sum_probs=171.0
Q ss_pred cCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
...++|.+.+.||+|+||.||+|.+. +..||+|.+......... ..+.+|+.+++.++||||+++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER----IEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHH----HHHHHHHHHHHhCCCCceeEEEEEE
Confidence 34567899999999999999999763 267999998655433322 3477999999999999999999998
Q ss_pred ecC-ceEEEEEecCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCc
Q 022903 128 KDP-LMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (290)
Q Consensus 128 ~~~-~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~ 198 (290)
.+. ..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +.
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~-~~ 157 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED-LT 157 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-CC
Confidence 654 67899999999999999875322 236788899999999999999999999999999999999955 46
Q ss_pred eEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 199 LKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 199 ~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 229 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE 229 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhc--------CCCCcccchHHHHHHHHHhhccCCCCCccCCHHH
Confidence 9999999987532221 1223356788999998754 567889999999999999998 999999877655
Q ss_pred HHHHHH
Q 022903 275 AAYAAA 280 (290)
Q Consensus 275 ~~~~~~ 280 (290)
....+.
T Consensus 230 ~~~~~~ 235 (277)
T cd05032 230 VLKFVI 235 (277)
T ss_pred HHHHHh
Confidence 444333
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=262.83 Aligned_cols=214 Identities=31% Similarity=0.568 Sum_probs=170.6
Q ss_pred ccccccCCCceeecceeccccceeEEEEEEC---------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCC
Q 022903 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDN 119 (290)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 119 (290)
+..+.....+|.+.+.||+|+||.||++++. ...+|+|.+......... ..+.+|+.+++.+ +|||
T Consensus 4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~E~~~l~~l~~h~~ 79 (314)
T cd05099 4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL----ADLISEMELMKLIGKHKN 79 (314)
T ss_pred cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHH----HHHHHHHHHHHhccCCCC
Confidence 3444556678999999999999999999742 357999998765443322 3477899999999 5999
Q ss_pred ceeEEeeeecC-ceEEEEEecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeec
Q 022903 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRD 184 (290)
Q Consensus 120 iv~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~D 184 (290)
|+++++++.+. ..+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++|||
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 159 (314)
T cd05099 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159 (314)
T ss_pred eeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 99999988654 5789999999999999997632 13478889999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHH
Q 022903 185 LKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 261 (290)
Q Consensus 185 ikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l 261 (290)
|||+||+++.+ +.+||+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|+|+
T Consensus 160 lkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~ 230 (314)
T cd05099 160 LAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGILMWEIF 230 (314)
T ss_pred ccceeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHcc--------CCcCccchhhHHHHHHHHHH
Confidence 99999999955 469999999997543211 1112234567999998754 56789999999999999999
Q ss_pred h-CCCCCCCCCHHHHH
Q 022903 262 T-NRLPFEGMSNLQAA 276 (290)
Q Consensus 262 ~-g~~Pf~~~~~~~~~ 276 (290)
+ |..||.+.+..+..
T Consensus 231 ~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 231 TLGGSPYPGIPVEELF 246 (314)
T ss_pred hCCCCCCCCCCHHHHH
Confidence 9 99999887654433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=255.61 Aligned_cols=211 Identities=34% Similarity=0.552 Sum_probs=174.2
Q ss_pred cCCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-Cce
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 132 (290)
.+.++|.+.+.||+|+||.||+|... +..+|+|.+....... ..+.+|+.+++.++||||+++++.+.+ ...
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP------EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCH------HHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 45567999999999999999999764 4779999987654432 247799999999999999999999875 578
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
+++|||+++++|.+++.......+++..+..++.+++.||.|||++|++|+||+|+||+++.+ ..++|+|||++.....
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLIED 155 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceeccc
Confidence 899999999999999987555678999999999999999999999999999999999999955 4599999999875432
Q ss_pred ccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 213 TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
... ......+..|+|||.+.. ..++.++|+||||+++|+|++ |+.||.+.+.......+.
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANY--------GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218 (261)
T ss_pred hhhhhhhccCCCccccCHHHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 211 112234568999998764 567889999999999999998 999999887665555443
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=263.06 Aligned_cols=205 Identities=32% Similarity=0.550 Sum_probs=163.3
Q ss_pred CCceeecceeccccceeEEEEEE--CCc--eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec-C
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDR--IVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-P 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~ 130 (290)
..+|.+.+.||+|+||.||+|.+ ++. .+++|.+........ ...+.+|+.++.++ +||||+++++.+.+ .
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHH----HHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 35688899999999999999976 333 467777654332222 23577899999999 89999999999865 4
Q ss_pred ceEEEEEecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC
Q 022903 131 LMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ 196 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~ 196 (290)
..++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 6889999999999999987532 12578899999999999999999999999999999999999554
Q ss_pred CceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 197 KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
.++|+|||++..............+..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 162 -~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 231 (303)
T cd05088 162 -VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231 (303)
T ss_pred -cEEeCccccCcccchhhhcccCCCcccccCHHHHhc--------cCCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence 599999999864322222222234567999998754 557889999999999999998 999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=267.78 Aligned_cols=208 Identities=32% Similarity=0.567 Sum_probs=165.5
Q ss_pred cCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGA 126 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 126 (290)
...++|++.+.||+|+||.||+|.+ .++.||||+++........ ..+.+|+.++.++ +||||+++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHH----HHHHHHHHHHHhccCCccHhhhcce
Confidence 3456799999999999999999963 3578999999765433322 2477899999999 68999999998
Q ss_pred eec--CceEEEEEecCCCCHHHHHHhcCC---------------------------------------------------
Q 022903 127 CKD--PLMVIVTELLPGMSLRKYLVSLRP--------------------------------------------------- 153 (290)
Q Consensus 127 ~~~--~~~~lv~e~~~~~~L~~~~~~~~~--------------------------------------------------- 153 (290)
+.. ...+++|||+++++|.+++.....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 753 357899999999999999865221
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc---cc
Q 022903 154 --------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MM 216 (290)
Q Consensus 154 --------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~ 216 (290)
..+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++....... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~ 238 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRK 238 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhc
Confidence 236777888999999999999999999999999999999954 569999999987532211 11
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~ 275 (290)
....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+....+.
T Consensus 239 ~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 290 (343)
T cd05103 239 GDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290 (343)
T ss_pred CCCCCCcceECcHHhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH
Confidence 12234567999998754 567899999999999999997 9999988654433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=274.47 Aligned_cols=211 Identities=28% Similarity=0.500 Sum_probs=177.7
Q ss_pred cCCCceeecceeccccceeEEEEEECC-ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee-cCce
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLM 132 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 132 (290)
...+.+.++++||+|-||.|.+....+ ..||+|+++........ ..|.+|+++|.+|+||||++++|+|. |+.+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r----~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNAR----NDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHH----HHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 455678899999999999999998755 99999999988776654 35999999999999999999999995 5678
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++++||++.|+|.+|+.+.....+......+|+.||+.|++||.+.++|||||.+.|+|+| ++.++||+|||+++..-.
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~-~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD-GEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec-CcccEEecCccccccccc
Confidence 8999999999999999885444456666788999999999999999999999999999999 456799999999984222
Q ss_pred c---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCHHHHHHH
Q 022903 213 T---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 213 ~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~--g~~Pf~~~~~~~~~~~ 278 (290)
. .......-+.+|||+|.+.. ++++.++|+|+||+++||+++ ...||..+++.+..-.
T Consensus 690 g~yy~vqgr~vlpiRwmawEsill--------gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven 752 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN 752 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHh--------ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence 2 22223355789999999875 789999999999999999775 9999999988765443
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=258.08 Aligned_cols=210 Identities=32% Similarity=0.536 Sum_probs=172.8
Q ss_pred CCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
..+|.+++.||.|+||.||+|.+ .++.+++|++........ ..+.+|+.+++.++||||+++++.+.+. ..++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQ-----QDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhH-----HHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34588999999999999999987 468899999876543222 2477899999999999999999988654 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.+ ..++|+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhcCCcc
Confidence 9999999999999987556678999999999999999999999999999999999999955 469999999987543221
Q ss_pred c-ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 215 M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 ~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
. .....++..|+|||.+.. ..++.++|+||||+++|+|++ |+.||.+.+..+....+.
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~--------~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASH--------GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218 (261)
T ss_pred ccccCCCCceEecCHHHHcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 1 123345678999998754 567889999999999999998 899999877655544443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=256.39 Aligned_cols=207 Identities=30% Similarity=0.469 Sum_probs=160.8
Q ss_pred eeccccceeEEEEEEC----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEec
Q 022903 65 KIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
.||+|+||.||+|... ...+|+|.+......... ..+.+|+.+++.++||||+++++.+.+. ..++||||+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQ----MKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHH----HHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 5899999999999753 357999988765543222 2478899999999999999999988654 678999999
Q ss_pred CCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc-
Q 022903 140 PGMSLRKYLVSLRP---NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM- 215 (290)
Q Consensus 140 ~~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~- 215 (290)
++++|.+++..... ...++..+..++.|++.||+|||++|++|+||||+||+++.+ .+++|+|||++........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCccee
Confidence 99999999875322 245677788999999999999999999999999999999954 5699999999865322211
Q ss_pred --ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022903 216 --MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277 (290)
Q Consensus 216 --~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~ 277 (290)
.....++..|+|||++..... ......++.++|+||||+++|+|++ |..||......+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 220 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHG-NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT 220 (269)
T ss_pred ecCCCcCCcccccCHhHhccccc-cccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH
Confidence 122356788999998753110 0001246789999999999999996 999999877665543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=253.93 Aligned_cols=209 Identities=28% Similarity=0.427 Sum_probs=173.0
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|++++.||.|+||.||.++. +++.+++|.+......... ..++.+|+.++++++|+||+++++.+.+. ..+++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKE---RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhH---HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEE
Confidence 478889999999999998876 5688999998655433322 13577999999999999999999998654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+++++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|+||+++.+ ..+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEcccccc
Confidence 999999999999987545678999999999999999999999999999999999999955 459999999987543322
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+....+
T Consensus 157 ~~~~~~~~~~y~ape~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG--------VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI 213 (256)
T ss_pred cccccCCCccccCHhhcCC--------CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 2334568899999998764 45788999999999999999999999987665544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=254.71 Aligned_cols=211 Identities=30% Similarity=0.445 Sum_probs=174.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
++|.+.+.||.|+||.||+|.. +++.+++|++........ ..+.+|+.+++.++||||+++++.+.+ ...++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF-----EIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhH-----HHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence 5688999999999999999986 568899999876544321 347799999999999999999998864 46789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
+|||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 78 VMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATI 155 (262)
T ss_pred EEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhh
Confidence 99999999999998763 35789999999999999999999999999999999999999554 59999999987543322
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
......++..|+|||.+.... ...++.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~-----~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~ 217 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVER-----KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS 217 (262)
T ss_pred hccccccCCccccCchhhcccc-----cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 223446788999999876410 1367889999999999999999999999887666555443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=262.40 Aligned_cols=198 Identities=25% Similarity=0.413 Sum_probs=166.6
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|++.+.||+|+||.||++.+ ++..+|+|.+....... ...++.+|+++++.++||||+++++.+.+ ...++|
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA----IRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 588899999999999999977 56789999887543322 12357799999999999999999999864 478899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.+ +.++|+|||++......
T Consensus 78 ~ey~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 78 MEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred eeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCccccccc-
Confidence 999999999999976 3678999999999999999999998 599999999999999955 45999999998654222
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.
T Consensus 154 ~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 203 (308)
T cd06615 154 MANSFVGTRSYMSPERLQG--------THYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203 (308)
T ss_pred ccccCCCCcCccChhHhcC--------CCCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence 2234578899999998754 5578899999999999999999999987653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=256.89 Aligned_cols=200 Identities=28% Similarity=0.491 Sum_probs=166.1
Q ss_pred cceeccccceeEEEEE--ECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-ceEEEEEe
Q 022903 63 GSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LMVIVTEL 138 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~~~lv~e~ 138 (290)
.+.||+|+|+.|-.+. .++..||||++.+...-. ..++.+|++++.+++ |+||+++++.|+++ .+|+|||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs-----R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS-----RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchH-----HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 3579999999998774 488999999998873322 246889999999996 99999999999865 78899999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC--ceEEeccccccccccc---
Q 022903 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREETVT--- 213 (290)
Q Consensus 139 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~--~~kl~Dfg~~~~~~~~--- 213 (290)
+.||+|...+.. ..-+++.++.++..+|+.||.+||.+||.|||+||+|||...-+. .|||+||.+.......
T Consensus 158 m~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 158 MRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999999999987 357999999999999999999999999999999999999964443 4999999887542111
Q ss_pred -----ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 214 -----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 214 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
....+.+|+..|||||+...+. ++...|+.+.|.||||+++|-||+|.+||.|.-.
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv---~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFV---DQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhc---cccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 1123457899999999764432 2346789999999999999999999999998643
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=253.62 Aligned_cols=201 Identities=31% Similarity=0.596 Sum_probs=162.2
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecC
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLP 140 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~ 140 (290)
+.||+|+||.||+|.+ +++.||+|.......... ...+.+|+.+++.++||||+++++.+.+. ..++||||+.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL----KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHH----HHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeecc
Confidence 3689999999999976 678899998865433222 23578999999999999999999998654 6789999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccccc---
Q 022903 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT--- 217 (290)
Q Consensus 141 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~--- 217 (290)
+++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++..........
T Consensus 77 ~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 77 GGDFLTFLRT-EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCcccccccccccCC
Confidence 9999999875 23468999999999999999999999999999999999999955 459999999987533211111
Q ss_pred ccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022903 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 218 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
....+..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+.......
T Consensus 155 ~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~ 208 (252)
T cd05084 155 MKQIPVKWTAPEALNY--------GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA 208 (252)
T ss_pred CCCCceeecCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH
Confidence 1123456999998754 557889999999999999998 9999988776544333
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=255.82 Aligned_cols=211 Identities=30% Similarity=0.558 Sum_probs=171.6
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhH----HHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-Cce
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDE----RALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 132 (290)
|.+...||.|+||.||+|.+ .++.+|+|.+........ .......+.+|+.++++++||||+++++.+.+ ...
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56778999999999999976 568899998876543321 22233468899999999999999999998865 467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
+++|||+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||+|+||+++.+ ..++|+|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCccccc
Confidence 899999999999999976 3568899999999999999999999999999999999999855 4699999999875432
Q ss_pred cc-------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 213 TE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 213 ~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.. ......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ--------TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc--------CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence 11 1112357889999998764 5678899999999999999999999998877665554433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=260.84 Aligned_cols=209 Identities=28% Similarity=0.478 Sum_probs=168.0
Q ss_pred CCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
...|.+.+.||+|+||.||+|+.. +..||+|++....... ....+.+|+.++..++||||+++++.+.+
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP----LREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHH----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 345888899999999999999763 3679999998654332 22357899999999999999999999865
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~ 194 (290)
. ..+++++|+.+++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 4 6789999999999999985321 234788889999999999999999999999999999999995
Q ss_pred CCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 022903 195 DQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270 (290)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~ 270 (290)
+ ..+||+|||++....... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.
T Consensus 160 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 160 K-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--------GKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred C-CceEecccccccccccchheeeccCccCCccccCHHHHhc--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 4 459999999987532221 1223345778999998754 557889999999999999998 99999987
Q ss_pred CHHHHHHH
Q 022903 271 SNLQAAYA 278 (290)
Q Consensus 271 ~~~~~~~~ 278 (290)
...+....
T Consensus 231 ~~~~~~~~ 238 (283)
T cd05091 231 SNQDVIEM 238 (283)
T ss_pred CHHHHHHH
Confidence 76554443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=263.18 Aligned_cols=211 Identities=27% Similarity=0.428 Sum_probs=174.2
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||++.. +++.||+|.+.......... ...+.+|+++++.++||||+++++.+.+. ..++|
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK--VKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHH--HHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 588899999999999999987 46899999998765443221 23578999999999999999999988654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhccccccc
Confidence 999999999999876555679999999999999999999999999999999999999965 459999999876432111
Q ss_pred -----------------------------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 022903 215 -----------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 265 (290)
Q Consensus 215 -----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~ 265 (290)
......|+..|+|||.+.+ ..++.++||||||+++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Di~slG~ll~~l~~g~~ 230 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--------DGHGSAVDWWTLGILLYEMLYGTT 230 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--------CCCCchHHHHHHHHHHHHHhhCCC
Confidence 1112357888999998864 557889999999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 022903 266 PFEGMSNLQAAYAAA 280 (290)
Q Consensus 266 Pf~~~~~~~~~~~~~ 280 (290)
||.+.+.......+.
T Consensus 231 pf~~~~~~~~~~~~~ 245 (316)
T cd05574 231 PFKGSNRDETFSNIL 245 (316)
T ss_pred CCCCCchHHHHHHHh
Confidence 999887665554443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=259.73 Aligned_cols=209 Identities=32% Similarity=0.504 Sum_probs=168.8
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|.+.+.||.|+||.||+|++ ++..||+|.+......... ...+.+|+.+++.++||||+++++.+.+ ...++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGV---PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCc---hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEE
Confidence 378889999999999999987 5789999998654322211 1246789999999999999999999865 478899
Q ss_pred EEecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
|||+. ++|.+++..... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeecCCCc
Confidence 99996 689888865332 568999999999999999999999999999999999999955 459999999987533222
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......+++.|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+.+.......+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~ 214 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLG-------SPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI 214 (285)
T ss_pred ccccCCcccccccChHHhcC-------CCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 1223356889999998754 234688999999999999999999999988766555544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=257.91 Aligned_cols=212 Identities=30% Similarity=0.464 Sum_probs=171.3
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
.|++.+.||.|+||.||++.+ ++..+++|.+....... ...+.+|+.+++.++||||+++++.+.. ...++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE-----LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHH-----HHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence 367889999999999999987 45788999886543221 1347789999999999999999998864 467899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-c
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~ 214 (290)
+||+.+++|..++.. ....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...... .
T Consensus 81 ~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 81 IEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEcccccccccccccc
Confidence 999999999988764 345789999999999999999999999999999999999999554 5999999998653222 1
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
......+++.|+|||++... ......++.++|+|||||++|+|++|.+||...+..+....+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~---~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 221 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCE---TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221 (282)
T ss_pred ccccccccccccCHhhcccc---CCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh
Confidence 22344688999999987431 1123557889999999999999999999999887766655554
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=258.01 Aligned_cols=212 Identities=28% Similarity=0.463 Sum_probs=171.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec-----
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD----- 129 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----- 129 (290)
..|.+.+.||+|+||.||+|.. +++.||+|++....... ..+.+|+.+++.+ +||||+++++.+..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE------EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccH------HHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4578889999999999999976 56899999987544322 2367899999998 69999999998753
Q ss_pred --CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 130 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
...+++|||+.+++|.+++.......+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~ 158 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVS 158 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCc
Confidence 3478999999999999999875556789999999999999999999999999999999999999554 5999999998
Q ss_pred cccccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 208 REETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 208 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
...... .......|+..|+|||++.... .....++.++|+|||||++|+|++|..||............
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~ 228 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228 (272)
T ss_pred eecccccccCCcccccccccCHhHhcccc---CcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 754322 2223456889999999875311 11245788999999999999999999999877665555443
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=274.87 Aligned_cols=210 Identities=33% Similarity=0.616 Sum_probs=180.4
Q ss_pred cCCCceeecceeccccceeEEEEEECC------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
.......+.+.||.|-||.||+|.++. -.||||..+.+...+..+ .|+.|..+|++++||||++++|+|.
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~te----kflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTE----KFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHH----HHHHHHHHHHhCCCcchhheeeeee
Confidence 344455677899999999999997743 259999999877766543 5999999999999999999999999
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
+...|+|||.+.-|.|..|++.+ ...++......++.||..||.|||++.+|||||..+|||+..... |||+|||+++
T Consensus 462 e~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C-VKLaDFGLSR 539 (974)
T KOG4257|consen 462 EQPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC-VKLADFGLSR 539 (974)
T ss_pred ccceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce-eeecccchhh
Confidence 99999999999999999999874 467999999999999999999999999999999999999996655 9999999999
Q ss_pred cccccccccccCC--CccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022903 209 EETVTEMMTAETG--TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 209 ~~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
.........+..| +.-|||||.+.. ..++.++|||.||++|||+++ |..||.+..+.+.+..
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINf--------RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~ 604 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINF--------RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH 604 (974)
T ss_pred hccccchhhccccccceeecCccccch--------hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE
Confidence 7665554443333 567999999865 678999999999999999998 9999999887766543
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=256.20 Aligned_cols=204 Identities=28% Similarity=0.545 Sum_probs=162.3
Q ss_pred eecceeccccceeEEEEEECC----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-------
Q 022903 61 FIGSKIGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------- 129 (290)
Q Consensus 61 ~~~~~lG~G~~g~V~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 129 (290)
.+++.||+|+||.||+|.+.. ..+|+|.++......... ..+.+|+.+++.++||||+++++.+..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM---EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHH---HHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 456889999999999998633 268999987654333221 357889999999999999999987632
Q ss_pred CceEEEEEecCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSL----RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
...+++|||+.+++|.+++... ....+++..+..++.|++.||.|||++|++||||||+|||++.+ ..++|+|||
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg 157 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFG 157 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCCC
Confidence 2467999999999999987432 22347899999999999999999999999999999999999855 459999999
Q ss_pred cccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022903 206 LAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 206 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~ 276 (290)
++........ .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 224 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLAD--------RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccC--------CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9876433221 122245678999998764 567899999999999999999 89999987665443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=257.92 Aligned_cols=207 Identities=28% Similarity=0.419 Sum_probs=169.2
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-Cce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 132 (290)
..++|++.+.||+|+||.||+|+. +++.||+|++........ ..+.+|+.+++.++||||+++++.+.+ ...
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~-----~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-----SLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchH-----HHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 345699999999999999999986 578899999875433222 236789999999999999999998864 467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++.....
T Consensus 82 ~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~ 158 (267)
T cd06646 82 WICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITA 158 (267)
T ss_pred EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeecc
Confidence 899999999999998865 35789999999999999999999999999999999999998554 599999999875432
Q ss_pred c-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 213 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
. .......++..|+|||.+... ....++.++|+||||+++|+|++|..||......+.
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~ 217 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVE-----KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217 (267)
T ss_pred cccccCccccCccccCHhHcccc-----cCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh
Confidence 2 122344688899999987431 124567899999999999999999999977655443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=264.65 Aligned_cols=205 Identities=20% Similarity=0.328 Sum_probs=163.7
Q ss_pred ecceeccc--cceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEE
Q 022903 62 IGSKIGEG--AHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (290)
Q Consensus 62 ~~~~lG~G--~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~ 136 (290)
+++.||+| +|++||++.. +++.||+|.+......... ...+.+|+.+++.++||||+++++.+.. ...++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEM---VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHH---HHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 45789999 7889999976 6789999998765443322 2346789999999999999999999864 4788999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc--
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-- 214 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-- 214 (290)
||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+|||++.++ .++++||+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhcccccccc
Confidence 999999999999765455689999999999999999999999999999999999999554 59999998653221110
Q ss_pred ------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 215 ------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 215 ------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
......++..|+|||.+.. ....++.++|||||||++|+|++|..||.+.......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 219 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219 (327)
T ss_pred ccccccccccccceecccChHHhhc------ccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 0112246678999998853 1135789999999999999999999999987655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=257.08 Aligned_cols=207 Identities=32% Similarity=0.583 Sum_probs=167.0
Q ss_pred CCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
.+.|.+.+.||+|+||.||+|.+. +..|++|........... ..+.+|+.+++.++|+||+++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDE----SDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHH----HHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 356889999999999999999773 467999988755443322 347889999999999999999998754
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC--CceEE
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKL 201 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~--~~~kl 201 (290)
...++||||+++++|.+++..... ..+++..+..++.||+.||+|||+++++||||||+||+++.++ ..++|
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 467899999999999999876432 2588899999999999999999999999999999999998543 35899
Q ss_pred eccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022903 202 ADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275 (290)
Q Consensus 202 ~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~ 275 (290)
+|||++........ ......+..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~ 230 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD--------GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhc--------CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999875422111 112233567999998864 568999999999999999997 9999998766543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=255.41 Aligned_cols=211 Identities=30% Similarity=0.503 Sum_probs=169.9
Q ss_pred CCCceeecceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 129 (290)
+..+|++.+.||+|+||.||+|.+. +..+|+|.+........ ...+.+|+.+++.++||||+++++.+.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ----RRDFLSEASIMGQFDHPNIIHLEGVVTKS 77 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHH----HHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3456889999999999999999762 23799999876443332 2357899999999999999999998864
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ ..++|+|||++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~~ 155 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSRV 155 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCcccc
Confidence 4678999999999999999763 3568999999999999999999999999999999999999855 4699999999875
Q ss_pred cccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 210 ETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 210 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
...... .....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+.+..+....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~ 223 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE 223 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhcc--------CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh
Confidence 432211 111223567999998854 567899999999999999887 999999887665544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=276.26 Aligned_cols=209 Identities=29% Similarity=0.523 Sum_probs=175.3
Q ss_pred CceeecceeccccceeEEEEEECC--ceEE---EEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC--
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYGD--RIVA---IKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~~--~~va---vK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 130 (290)
..++....||+|+|-+||+|-++. -.|| ||+-........ ..+|..|+.+|+.|+||||+++|..|.+.
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~----leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEE----LERLYSEVHLLKSLKHPNIIRFYDSWVDTDN 115 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHH----HHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence 345667889999999999997743 3343 233222222222 24799999999999999999999999764
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--GIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
...+|.|.+..|+|..|++. .+.++...+..|++||+.||.|||++ .|||||||-+||+|+.+.+.|||.|+|+|
T Consensus 116 ~~in~iTEL~TSGtLr~Y~kk--~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 116 KTINFITELFTSGTLREYRKK--HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred ceeeeeeecccCCcHHHHHHH--hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence 36799999999999999987 56899999999999999999999998 59999999999999988889999999999
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
+........ ...|||.|||||++. ..|+..+||||||.+|+||+|+..||..=++--.+|+....
T Consensus 194 tl~r~s~ak-svIGTPEFMAPEmYE---------E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S 258 (632)
T KOG0584|consen 194 TLLRKSHAK-SVIGTPEFMAPEMYE---------ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS 258 (632)
T ss_pred HHhhccccc-eeccCccccChHHHh---------hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc
Confidence 876555443 368999999999985 57999999999999999999999999998888788877665
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=259.04 Aligned_cols=192 Identities=30% Similarity=0.496 Sum_probs=161.7
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|++.+.||+|+||.||+|.+ +++.||+|++........ ...+.+|+.++++++||||+++++.+.. ...++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVEL----QKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHH----HHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 477889999999999999976 678999999876533222 2357899999999999999999998865 467899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+++++|..+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++...... .
T Consensus 78 ~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 78 TEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS-I 149 (279)
T ss_pred EecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccc-c
Confidence 999999999754 2468888999999999999999999999999999999999654 5999999998754322 2
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||...
T Consensus 150 ~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 150 AKTYVGTNAYMAPERISG--------EQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ccCCCCChhhcCceeecC--------CCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 334578999999998864 56789999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=260.16 Aligned_cols=205 Identities=35% Similarity=0.631 Sum_probs=165.4
Q ss_pred cCCCceeecceeccccceeEEEEEECC---------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEE
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD---------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFL 124 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 124 (290)
...+.|.+.+.||+|+||.||++++.+ ..+|+|.+......... ..+.+|+.+++.+ +||||++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDL----SDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHH----HHHHHHHHHHHHhcCCCCEeeEE
Confidence 344679999999999999999997522 46999999865332221 3477899999999 799999999
Q ss_pred eeeecC-ceEEEEEecCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCC
Q 022903 125 GACKDP-LMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189 (290)
Q Consensus 125 ~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~N 189 (290)
+.+.+. ..++||||+.+++|.+++..... ..+++..++.++.|++.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 998654 67899999999999999976432 247888999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCC
Q 022903 190 LLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 265 (290)
Q Consensus 190 ili~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~ 265 (290)
|+++.+ +.++|+|||++........ .....+++.|+|||.+.. ..++.++|+||||+++|+|++ |..
T Consensus 171 ill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~~~g~~ 241 (307)
T cd05098 171 VLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEIFTLGGS 241 (307)
T ss_pred eEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhcc--------CCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 999965 4699999999875432211 112234568999998754 567899999999999999998 999
Q ss_pred CCCCCCH
Q 022903 266 PFEGMSN 272 (290)
Q Consensus 266 Pf~~~~~ 272 (290)
||.+...
T Consensus 242 p~~~~~~ 248 (307)
T cd05098 242 PYPGVPV 248 (307)
T ss_pred CCCcCCH
Confidence 9987554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=273.30 Aligned_cols=199 Identities=28% Similarity=0.494 Sum_probs=173.2
Q ss_pred cceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEec
Q 022903 63 GSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
.+.||.|.||+||-|++ +|+.||||++.+.......+ ..+++|+.||++++||.||.+...|+.+ +.+.|||.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe---sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE---SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH---HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh
Confidence 46899999999998865 78999999998876655443 3578999999999999999999998765 778999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC--ceEEeccccccccccccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREETVTEMMT 217 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~--~~kl~Dfg~~~~~~~~~~~~ 217 (290)
.|++.+.+-....+++++.....+..||+.||.|||.++|+|+||||+|||+..... .+||||||.++.........
T Consensus 646 -~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr 724 (888)
T KOG4236|consen 646 -HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR 724 (888)
T ss_pred -cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence 556555555556788999999999999999999999999999999999999964322 59999999999988877788
Q ss_pred ccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 218 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
...||+.|+|||++.. +.|..+.|+||.|+|+|--++|..||....+.
T Consensus 725 sVVGTPAYLaPEVLrn--------kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI 772 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRN--------KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI 772 (888)
T ss_pred hhcCCccccCHHHHhh--------ccccccccceeeeEEEEEEecccccCCCccch
Confidence 8899999999999975 78999999999999999999999999876553
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=258.74 Aligned_cols=207 Identities=30% Similarity=0.562 Sum_probs=167.7
Q ss_pred CCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
..+|.+.+.||+|+||.||++++ ....+++|.+........ ..+.+|+.++++++||||+++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR-----KDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHH-----HHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 34588889999999999999974 234688898865443222 247799999999999999999999865
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~ 194 (290)
. ..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++|++||||||+||+++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 4 6789999999999999997532 134788999999999999999999999999999999999995
Q ss_pred CCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 022903 195 DQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270 (290)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~ 270 (290)
+ ..++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||...
T Consensus 159 ~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 159 N-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred C-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 5 469999999987543221 1223346788999998764 567889999999999999998 99999887
Q ss_pred CHHHHHH
Q 022903 271 SNLQAAY 277 (290)
Q Consensus 271 ~~~~~~~ 277 (290)
+..+...
T Consensus 230 ~~~~~~~ 236 (291)
T cd05094 230 SNTEVIE 236 (291)
T ss_pred CHHHHHH
Confidence 7655433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=258.52 Aligned_cols=209 Identities=31% Similarity=0.431 Sum_probs=171.0
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|++.+.||+|+||.||+|++ +++.||+|++......... ...+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVI---KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccc---cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 588899999999999999987 4789999988654322111 12467899999999999999999998654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||++++.|..++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.+ +.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecCCCcc
Confidence 999999888877653 4568999999999999999999999999999999999999955 469999999987643322
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.++.+....+.
T Consensus 156 ~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~ 214 (286)
T cd07847 156 DYTDYVATRWYRAPELLVG-------DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR 214 (286)
T ss_pred cccCcccccccCCHHHHhC-------CCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 2223457788999998753 2446889999999999999999999999988776665543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=257.25 Aligned_cols=210 Identities=31% Similarity=0.550 Sum_probs=168.5
Q ss_pred CCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
+.++|.+.++||+|+||.||++.. .+..+++|.+....... ...+.+|+.+++.++||||+++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-----RQDFQREAELLTVLQHQHIVRFYGVCT 77 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHH-----HHHHHHHHHHHhcCCCCCCceEEEEEe
Confidence 345688889999999999999963 34578999876543222 235889999999999999999999887
Q ss_pred cC-ceEEEEEecCCCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC
Q 022903 129 DP-LMVIVTELLPGMSLRKYLVSLRP-------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194 (290)
Q Consensus 129 ~~-~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~ 194 (290)
+. ..+++|||+.+++|.+++..... ..+++..+..++.|++.||+|||++|++||||||+||+++.
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 54 67899999999999999876332 34788999999999999999999999999999999999995
Q ss_pred CCCceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 022903 195 DQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270 (290)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~ 270 (290)
+ ..++|+|||++........ .....+++.|+|||.+.. ..++.++|||||||++|+|++ |..||...
T Consensus 158 ~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~ 228 (280)
T cd05092 158 G-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228 (280)
T ss_pred C-CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc--------CCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence 4 5699999999865332211 122234678999998764 567899999999999999998 99999887
Q ss_pred CHHHHHHHH
Q 022903 271 SNLQAAYAA 279 (290)
Q Consensus 271 ~~~~~~~~~ 279 (290)
...+....+
T Consensus 229 ~~~~~~~~~ 237 (280)
T cd05092 229 SNTEAIECI 237 (280)
T ss_pred CHHHHHHHH
Confidence 765554443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=254.97 Aligned_cols=205 Identities=30% Similarity=0.559 Sum_probs=164.4
Q ss_pred eeecceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC----
Q 022903 60 LFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 130 (290)
|.+++.||+|+||.||.|... ...||+|.+......... ...+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSE---IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHH---HHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 467789999999999999752 367999998765443322 13578999999999999999999987432
Q ss_pred ---ceEEEEEecCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEec
Q 022903 131 ---LMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (290)
Q Consensus 131 ---~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~D 203 (290)
..++++||+.+++|..++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ ..+||+|
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~d 156 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVAD 156 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECC
Confidence 2689999999999999885432 2358899999999999999999999999999999999999955 4699999
Q ss_pred cccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022903 204 FGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 204 fg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~ 276 (290)
||++........ ......+..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~ 225 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY 225 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhccc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999875432221 112234678999998754 567899999999999999999 99999987765543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=257.58 Aligned_cols=210 Identities=32% Similarity=0.561 Sum_probs=167.5
Q ss_pred ccCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
.++.++|.+.+.||+|+||.||+|... +..||+|.+......... ..+.+|+.+++.++||||+++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~ 77 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER----IEFLNEASVMKGFTCHHVVRLLGV 77 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHH----HHHHHHHHHHHhCCCCCeeeEEEE
Confidence 345678999999999999999998642 347999998755433222 247789999999999999999998
Q ss_pred eecC-ceEEEEEecCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC
Q 022903 127 CKDP-LMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 197 (290)
Q Consensus 127 ~~~~-~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~ 197 (290)
+.+. ..++||||+.+++|.+++..... ...+...+..++.|++.||.|||++|++||||||+||+++.+ +
T Consensus 78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~-~ 156 (288)
T cd05061 78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-F 156 (288)
T ss_pred EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-C
Confidence 8654 67899999999999999975321 234567788999999999999999999999999999999954 5
Q ss_pred ceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHH
Q 022903 198 SLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273 (290)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~ 273 (290)
.++|+|||++........ .....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+..
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~ 228 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhcc--------CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 699999999874322211 122244678999998754 567899999999999999998 89999887765
Q ss_pred HHH
Q 022903 274 QAA 276 (290)
Q Consensus 274 ~~~ 276 (290)
+..
T Consensus 229 ~~~ 231 (288)
T cd05061 229 QVL 231 (288)
T ss_pred HHH
Confidence 533
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=264.07 Aligned_cols=194 Identities=27% Similarity=0.464 Sum_probs=155.0
Q ss_pred cceeccccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee---cCceEEE
Q 022903 63 GSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK---DPLMVIV 135 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~lv 135 (290)
+.+||+|+||.||+|+. ++..||+|.+....... .+.+|+.+++.++||||+++++++. +...++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~-------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISM-------SACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcH-------HHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 35799999999999985 33689999987654322 3568999999999999999999874 3467899
Q ss_pred EEecCCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc---CCCCceEEeccc
Q 022903 136 TELLPGMSLRKYLVSL-------RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFG 205 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~---~~~~~~kl~Dfg 205 (290)
+||+. ++|.+++... ....+++..+..++.||+.||.|||++|++||||||+|||+. ...+.+||+|||
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 99985 5887777532 123578889999999999999999999999999999999994 234569999999
Q ss_pred ccccccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 206 LAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 206 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
++....... ......+|+.|+|||.+.+ ...++.++|||||||++|+|++|.+||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcC-------CCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 997543221 1233467899999998754 2457889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.59 Aligned_cols=207 Identities=30% Similarity=0.444 Sum_probs=169.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
.+|.+.+.||+|+||.||+|++ +++.||+|+++....... ..+.+|+.+++.++||||+++++.+.+ ...++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-----~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF-----AVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHH-----HHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 4688899999999999999976 578999999875533221 236789999999999999999998864 47789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 84 CMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATI 160 (267)
T ss_pred EEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCcc
Confidence 9999999999999875 35789999999999999999999999999999999999999554 5999999998653322
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
.......|+..|+|||.+... ....++.++|+|||||++|+|++|..||..........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~ 219 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVE-----RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF 219 (267)
T ss_pred cccccccCcccccChhhhccc-----cCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH
Confidence 122344788999999986421 12457889999999999999999999997765544433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=261.76 Aligned_cols=203 Identities=34% Similarity=0.496 Sum_probs=169.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|.+++.||+|+||.||++.. .++.||+|.+........ ..+.+|+.+++.++||||+++++.+..+ ..++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK-----ELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchH-----HHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 5689999999999999999976 578999999876544332 2477899999999999999999988654 6889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred eecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEccCCc
Confidence 9999999999999864 458889999999999999999999999999999999999955 469999999987543222
Q ss_pred c-ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 215 M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 215 ~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
. .....+++.|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+.....+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~ 225 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (297)
T ss_pred cCcCcccCCccccCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee
Confidence 1 223467889999998764 567889999999999999999999998766544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=257.22 Aligned_cols=207 Identities=29% Similarity=0.478 Sum_probs=172.4
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|.+.+.||.|+||.||+|++ +++.||+|++......... ..+.+|+.+++.++||||+++++.+.+ ...++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI----EDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHH----HHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 578889999999999999986 5689999998765432222 246789999999999999999998864 467899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-c
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~ 214 (290)
+||+.+++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 78 MEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeeccccc
Confidence 999999999999875 378999999999999999999999999999999999999965 45999999998765433 2
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 154 ~~~~~~~~~~y~~PE~~~~--------~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 212 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQ--------SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK 212 (274)
T ss_pred ccccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh
Confidence 2234467889999998865 4588999999999999999999999988776555444433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=255.90 Aligned_cols=208 Identities=31% Similarity=0.563 Sum_probs=170.0
Q ss_pred cCCCceeecceeccccceeEEEEEE--CC----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
.....|++.+.||+|+||.||+|.+ ++ ..+|+|.......... ...+.+|+.+++.++||||+++++.+.
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA----NKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHH----HHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 3456789999999999999999975 23 2689998876654322 235779999999999999999999998
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
....++||||+.+++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 80 ~~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~~ 157 (279)
T cd05057 80 SSQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAK 157 (279)
T ss_pred cCceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCcccc
Confidence 88889999999999999998763 3468999999999999999999999999999999999999855 459999999987
Q ss_pred cccccccc---cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022903 209 EETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 209 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~ 276 (290)
........ ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 221 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILH--------RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhc--------CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 54322211 11223567999998753 567889999999999999998 99999987665443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=253.85 Aligned_cols=209 Identities=31% Similarity=0.544 Sum_probs=170.6
Q ss_pred eeecceeccccceeEEEEEE-CCceEEEEEcccCCChh-HHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|++.+.||+|+||.||+|.. +++.+|+|.+....... .......++.+|+.+++.++|+||+++++.+.+. ..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 67788999999999999976 67889999987543221 1112224588999999999999999999998654 678999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc----
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV---- 212 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~---- 212 (290)
||+.+++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhhhcccc
Confidence 99999999999975 3468899999999999999999999999999999999999955 4699999998864321
Q ss_pred ---cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 213 ---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 213 ---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
........++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 220 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINE--------SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI 220 (265)
T ss_pred ccccccccccCCCccccChhhhcC--------CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh
Confidence 111223467889999998864 55788999999999999999999999987766555443
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=257.91 Aligned_cols=211 Identities=33% Similarity=0.583 Sum_probs=170.6
Q ss_pred cccccCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCcee
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVK 122 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 122 (290)
..+..+..+|.+.+.||+|+||.||++... ...+|+|.+......... ..+.+|+.++..+ +||||++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~ 80 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL----SDLVSEMEMMKMIGKHKNIIN 80 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHH----HHHHHHHHHHHhhcCCCCeee
Confidence 345566678999999999999999999753 267999998765443322 3477999999999 7999999
Q ss_pred EEeeeecC-ceEEEEEecCCCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCC
Q 022903 123 FLGACKDP-LMVIVTELLPGMSLRKYLVSL--------------RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 187 (290)
Q Consensus 123 ~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp 187 (290)
+++.+.+. ..+++|||+.+++|..++... ....+++..++.++.|++.||.|||++|++||||||
T Consensus 81 ~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp 160 (293)
T cd05053 81 LLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAA 160 (293)
T ss_pred EEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccce
Confidence 99988654 678999999999999998652 234588899999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-C
Q 022903 188 DNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 263 (290)
Q Consensus 188 ~Nili~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g 263 (290)
+||+++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++|||||||++|+|++ |
T Consensus 161 ~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g 231 (293)
T cd05053 161 RNVLVTED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLLWEIFTLG 231 (293)
T ss_pred eeEEEcCC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc--------CCcCcccceeehhhHHHHHhcCC
Confidence 99999954 5699999999875433221 112234567999998754 567899999999999999998 9
Q ss_pred CCCCCCCCHHH
Q 022903 264 RLPFEGMSNLQ 274 (290)
Q Consensus 264 ~~Pf~~~~~~~ 274 (290)
..||.+....+
T Consensus 232 ~~p~~~~~~~~ 242 (293)
T cd05053 232 GSPYPGIPVEE 242 (293)
T ss_pred CCCCCCCCHHH
Confidence 99999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=252.91 Aligned_cols=212 Identities=27% Similarity=0.479 Sum_probs=173.2
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|+..+.||+|+||.||+|.. +++.|++|.+...............+.+|+.+++.++||||+++++.+.+. ..++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 56678899999999999976 578999999876443221111224578999999999999999999988654 678999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccc
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~ 216 (290)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.........
T Consensus 82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 82 ELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccccc
Confidence 99999999999875 34688999999999999999999999999999999999999554 5999999998764443333
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
....++..|+|||.+.. ...++.++|+||||+++|+|++|..||...........+..
T Consensus 159 ~~~~~~~~y~~pe~~~~-------~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 216 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQ-------QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR 216 (258)
T ss_pred cccCCCcceeCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence 45568889999998754 12378899999999999999999999988776665555443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=258.64 Aligned_cols=211 Identities=31% Similarity=0.579 Sum_probs=168.7
Q ss_pred ccCCCceeecceeccccceeEEEEEEC---------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeE
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKF 123 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 123 (290)
.....+|.+.+.||+|+||.||+|++. +..||+|........... ..+.+|+.+++.+ +||||+++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDL----SDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHH----HHHHHHHHHHHhhccCCCchhe
Confidence 345667999999999999999999641 247999998754332222 3577999999999 79999999
Q ss_pred EeeeecC-ceEEEEEecCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q 022903 124 LGACKDP-LMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 188 (290)
Q Consensus 124 ~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~ 188 (290)
++.+.+. ..+++|||+.+++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 9998654 67899999999999999976321 34778889999999999999999999999999999
Q ss_pred CEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CC
Q 022903 189 NLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 264 (290)
Q Consensus 189 Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~ 264 (290)
||+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |.
T Consensus 167 Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~ 237 (304)
T cd05101 167 NVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEIFTLGG 237 (304)
T ss_pred eEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhcc--------CCCCchhhHHHHHHHHHHHHcCCC
Confidence 9999954 569999999987543221 1122345678999998754 567889999999999999998 89
Q ss_pred CCCCCCCHHHHHH
Q 022903 265 LPFEGMSNLQAAY 277 (290)
Q Consensus 265 ~Pf~~~~~~~~~~ 277 (290)
.||.+.+..+...
T Consensus 238 ~p~~~~~~~~~~~ 250 (304)
T cd05101 238 SPYPGIPVEELFK 250 (304)
T ss_pred CCcccCCHHHHHH
Confidence 9998876554433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=246.58 Aligned_cols=208 Identities=24% Similarity=0.420 Sum_probs=183.1
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP- 130 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~- 130 (290)
...++|++.+++|+|.|++||.|.. +.+.++||++++... +++.+|+.+|..|. ||||+.+++...++
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--------kKIkREikIL~nL~gg~NIi~L~DiV~Dp~ 106 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--------KKIKREIKILQNLRGGPNIIKLLDIVKDPE 106 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--------HHHHHHHHHHHhccCCCCeeehhhhhcCcc
Confidence 3557799999999999999999974 678999999976543 35889999999997 99999999999875
Q ss_pred --ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 131 --LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 131 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
...+++||+++.+...+.. .++...++.++.+++.||.|+|++||+|||+||.|++||.....++|+|+|++.
T Consensus 107 SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 107 SKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred ccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 4579999999999887654 477788899999999999999999999999999999999888889999999999
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHh
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF-EGMSNLQAAYAAAFK 282 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf-~~~~~~~~~~~~~~~ 282 (290)
+.......+....+..|--||++.. -..++.+.|+|||||++..|+..+.|| .|.++.+.+.+|+.-
T Consensus 182 FYHp~~eYnVRVASRyfKGPELLVd-------y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV 249 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV 249 (338)
T ss_pred hcCCCceeeeeeehhhcCCchheee-------chhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence 9888888888888989999999986 367899999999999999999977776 567888888888753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=254.98 Aligned_cols=221 Identities=26% Similarity=0.419 Sum_probs=182.4
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeee-cC
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK-DP 130 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~ 130 (290)
..-.+|.++..||+|+|++|..+++ +++.+|+|+++++-..+.... ..+..|-.+...- +||++|-+..+|+ +.
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedi--dwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDI--DWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccc--hhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 4456799999999999999999976 678999999987654443321 1133444454443 7999999999986 45
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
++++|.||..||+|.-.++. ...++++.++.+..+|..||.|||++|||+||||.+|+|+|.++ ++||+|+|+++..
T Consensus 325 rlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdygmcke~ 401 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEG 401 (593)
T ss_pred eEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccchhhcC
Confidence 89999999999999887765 56899999999999999999999999999999999999999665 5999999999974
Q ss_pred c-ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC-------CCCHHHHHHHHHHh
Q 022903 211 T-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE-------GMSNLQAAYAAAFK 282 (290)
Q Consensus 211 ~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~-------~~~~~~~~~~~~~~ 282 (290)
. ....+.+.+|||.|.|||++.+ .+|+.++|+|+||++|+||+.|+.||+ ..++.+.+++++.+
T Consensus 402 l~~gd~tstfcgtpnyiapeilrg--------eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile 473 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE 473 (593)
T ss_pred CCCCcccccccCCCcccchhhhcc--------cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh
Confidence 3 3445667899999999999976 789999999999999999999999996 33566777787777
Q ss_pred hccccc
Q 022903 283 VQESIY 288 (290)
Q Consensus 283 ~~~~~~ 288 (290)
.|-.|+
T Consensus 474 kqirip 479 (593)
T KOG0695|consen 474 KQIRIP 479 (593)
T ss_pred hccccc
Confidence 665443
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=252.13 Aligned_cols=198 Identities=30% Similarity=0.549 Sum_probs=163.2
Q ss_pred ceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceEEEEEe
Q 022903 64 SKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTEL 138 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 138 (290)
++||+|+||.||+|.+. +..+|+|.+........ ...+.+|+.+++.+.||||+++++.+.....++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG----KKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHH----HHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEe
Confidence 36899999999999762 26799999886655421 2357899999999999999999999887788999999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccc--
Q 022903 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-- 216 (290)
Q Consensus 139 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~-- 216 (290)
+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||++.........
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceeecCCcccc
Confidence 9999999999763 378999999999999999999999999999999999999955 45999999998754322211
Q ss_pred --cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022903 217 --TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 217 --~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~ 276 (290)
....++..|+|||.+.. ..++.++||||||+++|+|++ |..||...+..+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~ 208 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--------GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208 (257)
T ss_pred cccCccccccccCHHHhcC--------CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 11123467999998754 567889999999999999998 99999987765443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=257.37 Aligned_cols=202 Identities=31% Similarity=0.577 Sum_probs=163.5
Q ss_pred eeecceeccccceeEEEEEECC-------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-Cc
Q 022903 60 LFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PL 131 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 131 (290)
|++.+.||+|+||.||+|.... ..+++|.+......... ..+.+|+.+++.++||||+++++.+.. ..
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSEL----RDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHH----HHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 6778999999999999997532 56999988765543322 357899999999999999999998864 46
Q ss_pred eEEEEEecCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCC
Q 022903 132 MVIVTELLPGMSLRKYLVSLR----------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~N 189 (290)
.++++||+.+++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 789999999999999986522 1347888999999999999999999999999999999
Q ss_pred EEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCC
Q 022903 190 LLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 265 (290)
Q Consensus 190 ili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~ 265 (290)
|+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..
T Consensus 158 ill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~ 228 (290)
T cd05045 158 VLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--------HIYTTQSDVWSFGVLLWEIVTLGGN 228 (290)
T ss_pred EEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHcc--------CCcchHhHHHHHHHHHHHHHhcCCC
Confidence 999854 569999999987432211 1122245678999998754 567899999999999999998 999
Q ss_pred CCCCCCHHH
Q 022903 266 PFEGMSNLQ 274 (290)
Q Consensus 266 Pf~~~~~~~ 274 (290)
||.+....+
T Consensus 229 p~~~~~~~~ 237 (290)
T cd05045 229 PYPGIAPER 237 (290)
T ss_pred CCCCCCHHH
Confidence 998876543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=253.86 Aligned_cols=208 Identities=30% Similarity=0.504 Sum_probs=167.3
Q ss_pred CceeecceeccccceeEEEEEEC--C---ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYG--D---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
..|++.+.||+|+||.||+|... + ..||+|++......... ..+.+|+.+++.++||||+++++.+.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR----RDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHH----HHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 45888999999999999999763 2 36999998765332222 3588999999999999999999988654 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||+++.+ ..++|+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~ 157 (269)
T cd05065 80 VMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLE 157 (269)
T ss_pred eEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCccccccc
Confidence 78999999999999998763 4568999999999999999999999999999999999999854 469999999886532
Q ss_pred ccccc---cccC---CCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 212 VTEMM---TAET---GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 212 ~~~~~---~~~~---g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
..... .... .+..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i 224 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhcc--------CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 22111 1111 2357999998754 567889999999999999987 99999987766544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=257.21 Aligned_cols=196 Identities=34% Similarity=0.524 Sum_probs=160.9
Q ss_pred ceeecceeccccceeEEEEEE------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--- 129 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 129 (290)
.|.+.+.||+|+||.||++.+ .+..||+|++........ ...+.+|+.+++.++||||+++++.+..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQN----TSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHH----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 358889999999999988653 457899999876543222 2357799999999999999999998753
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...+++|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~ 156 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKA 156 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeecccccc
Confidence 247899999999999999875 459999999999999999999999999999999999999955 5699999999875
Q ss_pred cccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 210 ETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 210 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
...... .....++..|+|||.+.. ..++.++||||||+++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKE--------NKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcc--------cCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 433221 112245667999998754 56789999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=251.99 Aligned_cols=204 Identities=32% Similarity=0.544 Sum_probs=168.7
Q ss_pred ceeccccceeEEEEEEC---C--ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceEEEEEe
Q 022903 64 SKIGEGAHGKVYEGRYG---D--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTEL 138 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 138 (290)
+.||+|++|.||+|.+. + ..||+|.+...... ....++.+|+.++++++||||+++++.+.+...+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS----DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH----HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEe
Confidence 35899999999999762 2 36999999876654 122468899999999999999999999877778899999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc----
Q 022903 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---- 214 (290)
Q Consensus 139 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---- 214 (290)
+++++|.+++.......+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEecccccccccccccccee
Confidence 999999999987443568999999999999999999999999999999999999966 469999999987543321
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 214 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRT--------RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID 214 (257)
T ss_pred cccCCCCCceecCHHHhcc--------cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 1112356778999998754 567889999999999999998 999999887766554443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=248.50 Aligned_cols=225 Identities=25% Similarity=0.444 Sum_probs=185.1
Q ss_pred cccccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeee
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGAC 127 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 127 (290)
+....+.+++..+..||.|+-|.||++++ ++...|||.+.+.....+. .|++..+.++...+ .|.||+.+|+|
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~----kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEEN----KRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHH----HHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 34445667788889999999999999987 5699999999887766544 36788888887776 89999999999
Q ss_pred e-cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 128 K-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 128 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
- +...++.||.+ ...+..++.. ..+++++..+-++...++.||.||-++ ||+|||+||+|||+| +.+.+||||||
T Consensus 161 i~n~dV~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD-e~GniKlCDFG 237 (391)
T KOG0983|consen 161 ITNTDVFICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGNIKLCDFG 237 (391)
T ss_pred eeCchHHHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc-cCCCEEeeccc
Confidence 4 55778899998 5566666655 457899999999999999999999865 899999999999999 55569999999
Q ss_pred ccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhc
Q 022903 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM-SNLQAAYAAAFKVQ 284 (290)
Q Consensus 206 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~-~~~~~~~~~~~~~~ 284 (290)
++-+...........|-+.|||||.+.. .+...|+.++||||||++++|+.||+.||.+- ++.+.+-.+..+-+
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERidp-----~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP 312 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERIDP-----PDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP 312 (391)
T ss_pred ccceeecccccccccCCccccCccccCC-----CCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC
Confidence 9988777766667788999999999865 33577999999999999999999999999995 45666666665555
Q ss_pred ccc
Q 022903 285 ESI 287 (290)
Q Consensus 285 ~~~ 287 (290)
..|
T Consensus 313 P~L 315 (391)
T KOG0983|consen 313 PLL 315 (391)
T ss_pred CCC
Confidence 443
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=254.53 Aligned_cols=216 Identities=30% Similarity=0.471 Sum_probs=175.2
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC---
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP--- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--- 130 (290)
..+|.+.+.||+|+||.||+|++ +++.+++|++....... ..+.+|+.+++++ +||||+++++.+.+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~------~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE------EEIKEEYNILRKYSNHPNIATFYGAFIKKNPP 78 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhH------HHHHHHHHHHHHhcCCCChheEEEEEEecCCC
Confidence 35699999999999999999987 46789999987654321 2477999999999 699999999998543
Q ss_pred ----ceEEEEEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 131 ----LMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 131 ----~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~ 157 (275)
T cd06608 79 GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDF 157 (275)
T ss_pred CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCC
Confidence 3689999999999999987643 4678999999999999999999999999999999999999965 45999999
Q ss_pred ccccccccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 205 GLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 205 g~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
|++...... .......++..|+|||.+.... .....++.++||||||+++|+|++|..||.+.........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 158 GVSAQLDSTLGRRNTFIGTPYWMAPEVIACDE---QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred ccceecccchhhhcCccccccccCHhHhcccc---cccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 998653322 2223446888999999875311 11345788999999999999999999999987776666665543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=249.57 Aligned_cols=201 Identities=32% Similarity=0.588 Sum_probs=163.3
Q ss_pred eeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecCCC
Q 022903 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGM 142 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~~ 142 (290)
.||+|+||.||+|.. .+..+|+|++......... ..+.+|+.+++.++||||+++++.+.+. ..++||||++++
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELK----IKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHH----HHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 589999999999976 4578999998765443222 3578999999999999999999988654 678999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccc--cccC
Q 022903 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM--TAET 220 (290)
Q Consensus 143 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~ 220 (290)
+|.+++... ...+++..+..++.|++.+|.|+|++|++||||+|+||+++.+ +.++|+|||++......... ....
T Consensus 78 ~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 78 DFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceeccccccccCCCCC
Confidence 999998753 3568899999999999999999999999999999999999854 46999999998653222111 1223
Q ss_pred CCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 221 g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
++..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.........+
T Consensus 156 ~~~~y~aPE~~~~--------~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~ 207 (250)
T cd05085 156 IPIKWTAPEALNY--------GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207 (250)
T ss_pred CcccccCHHHhcc--------CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 4567999998754 567889999999999999998 99999988765544433
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=257.09 Aligned_cols=203 Identities=29% Similarity=0.497 Sum_probs=165.2
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
-+.|.+.+.||.|+||.||+|.. +++.||+|.+......... ..+.+|+.+++.++||||+++++++.+. ..+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP----FTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCc----hhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence 35689999999999999999976 5789999998754322211 1356899999999999999999998754 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+.+ +|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 80 lv~e~~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVP 156 (291)
T ss_pred EEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCC
Confidence 99999975 999988753 34789999999999999999999999999999999999999554 5999999998653322
Q ss_pred cc-ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 214 EM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 214 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
.. .....++..|+|||.+.+ ...++.++||||||+++|+|++|..||.+....
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~ 210 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLG-------STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV 210 (291)
T ss_pred CccccccccccccCCcHHhhc-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 11 122346788999998753 244688999999999999999999999877643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=256.80 Aligned_cols=212 Identities=29% Similarity=0.476 Sum_probs=171.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|.+.+.||.|++|.||+|++ +++.||+|.+........ ....+.+|+.+++.++||||+++++.+.+. ..++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEG---VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccccc---chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEE
Confidence 3588999999999999999986 568899999865433221 112467899999999999999999998654 6889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||++ ++|.+++.......+++..+..++.||+.||+|||++|++|+||+|+||+++.++..+||+|||++.......
T Consensus 79 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 79 VFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred EEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 999995 5888887664444568888899999999999999999999999999999998666679999999987543221
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
......+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.+..+...++.
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~ 217 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLG-------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217 (294)
T ss_pred cccccCceeecccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1223456889999998753 2457889999999999999999999999888776666554
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=264.39 Aligned_cols=203 Identities=32% Similarity=0.434 Sum_probs=167.6
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 130 (290)
-.+.|++.+.||+|+||.||+|++ +++.||+|.+.......... ..+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHA---KRAYRELVLMKLVNHKNIIGLLNVFTPQKSL 90 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHH---HHHHHHHHHHHhcCCCCCcceeeeeccCCCc
Confidence 346699999999999999999986 67899999986543222211 2466899999999999999999987432
Q ss_pred ----ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 131 ----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 131 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
..++||||+. ++|.+++.. .++...+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||+
T Consensus 91 ~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~ 164 (353)
T cd07850 91 EEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGL 164 (353)
T ss_pred cccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCcc
Confidence 4689999995 588887764 288899999999999999999999999999999999999654 599999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
+.............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~ 225 (353)
T cd07850 165 ARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225 (353)
T ss_pred ceeCCCCCCCCCCcccccccCHHHHhC--------CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 986544433344567889999998864 5688999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=255.66 Aligned_cols=208 Identities=30% Similarity=0.456 Sum_probs=172.2
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||.|+||.||+|.+ +++.||+|++......... ...+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI---PNQALREIKALQACQHPYVVKLLDVFPHGSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchh---hHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEE
Confidence 378889999999999999986 5789999998765532221 23578999999999999999999998754 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
+||+ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 78 MEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEP 154 (286)
T ss_pred eccc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCC
Confidence 9999 99999998753 3679999999999999999999999999999999999999964 459999999987644332
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......++..|+|||.+.. ...++.++||||||+++|+|++|.+||.+.++......+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 213 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYG-------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213 (286)
T ss_pred CccccccCcccccCceeeec-------cccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH
Confidence 1234468889999998753 245688999999999999999999999887766554443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=253.10 Aligned_cols=198 Identities=33% Similarity=0.581 Sum_probs=157.5
Q ss_pred eeccccceeEEEEEEC--C--ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceEEEEEe
Q 022903 65 KIGEGAHGKVYEGRYG--D--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTEL 138 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~lv~e~ 138 (290)
.||+|+||.||+|+.. + ..+++|.+......... ..+.+|+.++.++ +||||+++++.+... ..+++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH----RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHH----HHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 5899999999999863 2 35788888754333222 2477899999999 799999999998654 67899999
Q ss_pred cCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 139 LPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 139 ~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
+.+++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++.+ ..++|+||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~df 156 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADF 156 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECCC
Confidence 99999999987532 1247889999999999999999999999999999999999955 46999999
Q ss_pred cccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022903 205 GLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275 (290)
Q Consensus 205 g~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~ 275 (290)
|++..............+..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.+..+.
T Consensus 157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~ 220 (270)
T cd05047 157 GLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 220 (270)
T ss_pred CCccccchhhhccCCCCccccCChHHHcc--------CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH
Confidence 99863222211122234567999998754 567889999999999999997 9999988765443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=255.63 Aligned_cols=214 Identities=29% Similarity=0.431 Sum_probs=170.7
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeee---
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK--- 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~--- 128 (290)
...++|.+.+.||+|+||.||++.. +++.+|+|+........ ..+.+|+.+++.+ +||||+++++.+.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~------~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID------EEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchH------HHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3456799999999999999999976 56899999876533221 2366899999999 6999999999873
Q ss_pred ---cCceEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEec
Q 022903 129 ---DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (290)
Q Consensus 129 ---~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~D 203 (290)
+...++||||+++++|.+++... ....+++..+..++.|++.||.|||+++++||||||+||+++.++ .++|+|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~d 167 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVD 167 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEcc
Confidence 23578999999999999987642 235688889999999999999999999999999999999999654 599999
Q ss_pred ccccccccccc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 204 FGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 204 fg~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
||++....... ......+++.|+|||.+.... .....++.++|+|||||++|+|++|+.||.+.........
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 168 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240 (286)
T ss_pred CCceeecccCCCccccccCCCcccChhhhchhh---hccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence 99987543221 223346889999999875310 1124578899999999999999999999998876555444
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=275.14 Aligned_cols=220 Identities=30% Similarity=0.503 Sum_probs=188.4
Q ss_pred ccccccccCCCceeecceeccccceeEEEEEECC-----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCcee
Q 022903 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122 (290)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 122 (290)
..+...++..+.+.+.++||+|+||.|+.|.|+. -.||||.++........ ..|++|+.+|.+|+|||+++
T Consensus 100 ~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~m----ddflrEas~M~~L~H~hliR 175 (1039)
T KOG0199|consen 100 SIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIM----DDFLREASHMLKLQHPHLIR 175 (1039)
T ss_pred CCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhH----HHHHHHHHHHHhccCcceeE
Confidence 3445566777788899999999999999998843 46999999887766422 46999999999999999999
Q ss_pred EEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEe
Q 022903 123 FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 123 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~ 202 (290)
|||+..+...-+|+|.+..|+|.+.+.......+-......|+.||+.||.||.++++|||||..+|+|+-. ..+|||+
T Consensus 176 LyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas-prtVKI~ 254 (1039)
T KOG0199|consen 176 LYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS-PRTVKIC 254 (1039)
T ss_pred EeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc-cceeeee
Confidence 999999888889999999999999998856667888889999999999999999999999999999999985 4579999
Q ss_pred cccccccccccccccc----cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022903 203 DFGLAREETVTEMMTA----ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277 (290)
Q Consensus 203 Dfg~~~~~~~~~~~~~----~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~ 277 (290)
|||+.+-....+.... ..-...|+|||.+.. ..++.++|+|++||++|||++ |..||.|....+++.
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh--------~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~ 326 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH--------RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK 326 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhcc--------ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH
Confidence 9999986544443332 234567999999865 779999999999999999999 999999999888777
Q ss_pred HHH
Q 022903 278 AAA 280 (290)
Q Consensus 278 ~~~ 280 (290)
.+-
T Consensus 327 ~iD 329 (1039)
T KOG0199|consen 327 NID 329 (1039)
T ss_pred hcc
Confidence 664
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=236.75 Aligned_cols=226 Identities=27% Similarity=0.408 Sum_probs=183.0
Q ss_pred cccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeee-
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK- 128 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~- 128 (290)
..+..+.+..+..||+|++|.|=+.++ .|...|+|.+...-..++. .+.++|+.+..+. .+|++|.+||...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q----~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQ----KRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHH----HHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 334555667788999999999866655 7899999999876665443 4677888887766 5899999999864
Q ss_pred cCceEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
+...++.||.+ ..+|..+.... ....+++..+-+|+-.+..||.|||++ .++|||+||+||||+.++ .+|+||||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFG 194 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFG 194 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccc
Confidence 56899999999 66888876442 456799999999999999999999987 899999999999999665 59999999
Q ss_pred ccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHhhc
Q 022903 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKVQ 284 (290)
Q Consensus 206 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~-~~~~~~~~~~~~~~~ 284 (290)
++-.....-..+...|-..|||||.+.. ..+...|+-++||||||++++||.+++.||+. .++.+.+.++.....
T Consensus 195 IsG~L~dSiAkt~daGCkpYmaPEri~~----e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 195 ISGYLVDSIAKTMDAGCKPYMAPERINP----ELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred cceeehhhhHHHHhcCCCccCChhhcCc----ccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 9876544433333567788999999875 22345789999999999999999999999976 588999999988876
Q ss_pred cccc
Q 022903 285 ESIY 288 (290)
Q Consensus 285 ~~~~ 288 (290)
..|.
T Consensus 271 P~Lp 274 (282)
T KOG0984|consen 271 PQLP 274 (282)
T ss_pred CCCc
Confidence 6654
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=253.68 Aligned_cols=202 Identities=28% Similarity=0.495 Sum_probs=167.6
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChh-HHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
|+..+.||+|+||.||+++. +++.||+|++....... ........+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 67778999999999999976 67899999987544221 1222335688999999999999999999998754 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
+||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++..++|+|||.+.......
T Consensus 82 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 82 VEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 999999999999875 35788999999999999999999999999999999999998666679999999987643321
Q ss_pred ----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 215 ----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 215 ----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRG--------EQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cCCccccccccccceeCHhHhcc--------CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1123357889999998754 567889999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=258.16 Aligned_cols=205 Identities=31% Similarity=0.588 Sum_probs=167.0
Q ss_pred CCCceeecceeccccceeEEEEEE--CCc----eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
....|+..+.||+|+||.||+|.+ +++ .||+|.+......... ..+.+|+.+++.++||||+++++.+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN----VEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHH----HHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 345678889999999999999976 343 5789988765443222 247789999999999999999999987
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...+++++|+.+++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+ ..+||+|||++..
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~~~ 158 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHE-HKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLARL 158 (303)
T ss_pred CCceeeehhcCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEcccccccc
Confidence 777899999999999999876 33468899999999999999999999999999999999999854 4599999999975
Q ss_pred cccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 210 ETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 210 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
...... .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~ 219 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHY--------RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhcc--------CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 432221 112345678999998754 567899999999999999997 999998875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=252.28 Aligned_cols=210 Identities=30% Similarity=0.435 Sum_probs=173.1
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
++|++.+.||.|+||+||+|.. ++..+++|++......... ..+.+|+.+++.++|+||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV----DELRKEVQAMSQCNHPNVVKYYTSFVVGDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHH----HHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEE
Confidence 3588899999999999999976 5678999998765443322 347899999999999999999998865 46789
Q ss_pred EEEecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
++|++.+++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADG 155 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccC
Confidence 9999999999999976433 568999999999999999999999999999999999999965 45999999998754332
Q ss_pred cc-----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 214 EM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 214 ~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.. .....++..|+|||.+.. ...++.++|+||||+++|+|++|..||.+.+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 219 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQ-------VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT 219 (267)
T ss_pred ccccccccccccCChhhcChHHHcc-------ccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH
Confidence 21 133468889999998764 136788999999999999999999999987765544443
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=260.59 Aligned_cols=213 Identities=32% Similarity=0.571 Sum_probs=169.2
Q ss_pred ccccCCCceeecceeccccceeEEEEEEC---------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCce
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLV 121 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 121 (290)
.+.....+|++++.||+|+||.||++++. ...||+|.+......... ..+.+|+.+++++ +||||+
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDL----SDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHH----HHHHHHHHHHHhhcCCCCee
Confidence 34455567999999999999999999652 136899988754333222 3477999999999 799999
Q ss_pred eEEeeeecC-ceEEEEEecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCC
Q 022903 122 KFLGACKDP-LMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 186 (290)
Q Consensus 122 ~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dik 186 (290)
++++.+.+. ..++++||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++|||||
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk 161 (334)
T cd05100 82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161 (334)
T ss_pred eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 999998654 6789999999999999987532 1247788889999999999999999999999999
Q ss_pred CCCEEEcCCCCceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-
Q 022903 187 PDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 262 (290)
Q Consensus 187 p~Nili~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~- 262 (290)
|+||+++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|+|++
T Consensus 162 p~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~ 232 (334)
T cd05100 162 ARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLLWEIFTL 232 (334)
T ss_pred cceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhcc--------CCcCchhhhHHHHHHHHHHHhc
Confidence 999999955 4699999999875432211 122234567999998864 567889999999999999998
Q ss_pred CCCCCCCCCHHHHHH
Q 022903 263 NRLPFEGMSNLQAAY 277 (290)
Q Consensus 263 g~~Pf~~~~~~~~~~ 277 (290)
|..||.+.+..+...
T Consensus 233 g~~p~~~~~~~~~~~ 247 (334)
T cd05100 233 GGSPYPGIPVEELFK 247 (334)
T ss_pred CCCCCCCCCHHHHHH
Confidence 999999876554433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=252.12 Aligned_cols=203 Identities=26% Similarity=0.454 Sum_probs=166.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
.+|.+.+.||+|+||.||+|+. +++.||+|.+......... ....+.+|+.+++.++||||+++++.+.+ ...++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK--ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHH--HHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEE
Confidence 4588999999999999999976 6789999987653332222 12357899999999999999999998865 46789
Q ss_pred EEEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~~ 158 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSS 158 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceeccc
Confidence 999999999999886422 34578899999999999999999999999999999999999654 599999999875432
Q ss_pred cc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 213 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.. ......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||....
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred hhHHHhcCCCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 22 1223468889999998754 557889999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=255.89 Aligned_cols=208 Identities=30% Similarity=0.537 Sum_probs=169.3
Q ss_pred CCceeecceeccccceeEEEEEECC------------------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCC
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYGD------------------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 118 (290)
...|.+++.||+|+||.||++...+ ..||+|.+......... ..+.+|+.+++.++||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~----~~~~~e~~~l~~l~~~ 79 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR----EDFLKEVKILSRLSDP 79 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHH----HHHHHHHHHHHhcCCC
Confidence 3568899999999999999987532 45899998766544322 3578999999999999
Q ss_pred CceeEEeeeec-CceEEEEEecCCCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q 022903 119 NLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR---------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 188 (290)
Q Consensus 119 ~iv~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~ 188 (290)
||+++++.+.+ ...+++||++.+++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 99999998865 57889999999999999987632 126889999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh--C
Q 022903 189 NLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--N 263 (290)
Q Consensus 189 Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~--g 263 (290)
||+++.+ ..++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |
T Consensus 160 Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~~~~~ 230 (296)
T cd05051 160 NCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--------GKFTTKSDVWAFGVTLWEILTLCR 230 (296)
T ss_pred ceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--------CCCCccchhhhhHHHHHHHHhcCC
Confidence 9999955 569999999987532221 2223356778999998754 568899999999999999998 8
Q ss_pred CCCCCCCCHHHHHH
Q 022903 264 RLPFEGMSNLQAAY 277 (290)
Q Consensus 264 ~~Pf~~~~~~~~~~ 277 (290)
..||...+..+...
T Consensus 231 ~~p~~~~~~~~~~~ 244 (296)
T cd05051 231 EQPYEHLTDQQVIE 244 (296)
T ss_pred CCCCCCcChHHHHH
Confidence 89998877655433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=254.69 Aligned_cols=201 Identities=30% Similarity=0.479 Sum_probs=170.2
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.|.+.+.||.|+||.||++++ +++.||+|++......... ....+.+|++++++++||||+++++.+.++ ..++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKG--SVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchh--HHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEE
Confidence 378889999999999999987 4789999999764432222 124688999999999999999999888654 68899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
+||+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccCCCcc
Confidence 9999999999998763 578999999999999999999999999999999999999955 4599999999876544333
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+.
T Consensus 156 ~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCR--------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ccccCCChhhcCHHHHcc--------cCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 344568889999998764 4478899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=250.81 Aligned_cols=214 Identities=25% Similarity=0.428 Sum_probs=162.3
Q ss_pred eeccccceeEEEEEE-CC---ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEec
Q 022903 65 KIGEGAHGKVYEGRY-GD---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
.||+|+||.||+++. ++ ..+++|.+........ ...+.+|+.+++.++||||+++++.+.+. ..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE----QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHH----HHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence 589999999999964 22 3466777655443322 23588999999999999999999998754 678999999
Q ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc---c
Q 022903 140 PGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---E 214 (290)
Q Consensus 140 ~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~---~ 214 (290)
++++|.+++.... ....+...+..++.|++.||.|||+++++||||||+|||++.+ +.++|+|||++...... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccccCcchhhh
Confidence 9999999987532 2346677788999999999999999999999999999999955 45999999997542211 1
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhc
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKVQ 284 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~~~~ 284 (290)
......++..|+|||++.... .......++.++||||||+++|+|++ |..||...+..+....+....+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFH-GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ 226 (268)
T ss_pred cccCCcCcccccCchhccccc-CccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc
Confidence 122346788999999874311 00012346789999999999999997 6889988877666655544433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=254.39 Aligned_cols=204 Identities=30% Similarity=0.488 Sum_probs=169.5
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.|+..+.||.|+||.||+|.+ +++.||+|++......... ..+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI----EDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHH----HHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 477889999999999999976 5689999998754433222 3578999999999999999999998654 68899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 81 MEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCcc
Confidence 999999999998864 4688999999999999999999999999999999999999554 59999999986543222
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.........
T Consensus 157 ~~~~~~~~~~y~apE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 212 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQ--------SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL 212 (277)
T ss_pred ccccccCcccccCHhHhcc--------CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh
Confidence 1223457888999998754 5678999999999999999999999998776554443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=253.40 Aligned_cols=207 Identities=23% Similarity=0.453 Sum_probs=169.2
Q ss_pred cCCCceeecceeccccceeEEEEEEC------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
++.++|.+.+.||+|+||.||+|.+. +..|++|.+......... ..+.+|+.+++.++||||+++++.+.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~----~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQV----TLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHH----HHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 35567999999999999999999764 478999998754433322 35779999999999999999999875
Q ss_pred c--CceEEEEEecCCCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceE
Q 022903 129 D--PLMVIVTELLPGMSLRKYLVSLRP------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200 (290)
Q Consensus 129 ~--~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~k 200 (290)
. ...+++++|+.+++|.+++..... ..+++..+..++.|++.||+|||+++++|+||||+||+++.+ ..+|
T Consensus 79 ~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~k 157 (280)
T cd05043 79 EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQVK 157 (280)
T ss_pred cCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcEE
Confidence 4 467899999999999999876432 458899999999999999999999999999999999999855 5699
Q ss_pred Eeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 201 LADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 201 l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
|+|||+++....... .....++..|+|||.+.. ..++.++||||||+++|++++ |+.||.+....+
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 227 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN--------KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc--------CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence 999999875322211 122345678999998754 557899999999999999999 999998876544
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=255.63 Aligned_cols=208 Identities=27% Similarity=0.386 Sum_probs=168.6
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||++.+ .++.|++|.+......... ....+.+|+.+++.++||||+++++.+..+ ..++|
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRN--QIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHH--HHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 588889999999999999977 4688999988754322111 123577899999999999999999988654 57899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccCcCcc
Confidence 999999999999976 3568999999999999999999999999999999999999954 569999999876311100
Q ss_pred ---------------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 ---------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 ---------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+..+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0112356788999998754 56789999999999999999999999987765544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=271.98 Aligned_cols=190 Identities=26% Similarity=0.345 Sum_probs=157.6
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 133 (290)
...|.+.+.||+|+||.||++.+ .++.||||..... .+.+|+.++++++||||+++++++.. ...+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~-----------~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA-----------SSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc-----------CHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 34699999999999999999987 4678999964221 24589999999999999999998754 4678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||+++ .++|..++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||+++.....
T Consensus 237 lv~e~~-~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGS 313 (461)
T ss_pred EEEEcc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceecccc
Confidence 999999 5688888865 335799999999999999999999999999999999999999554 5999999998753222
Q ss_pred c---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 214 E---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 214 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
. ......||..|+|||++.+ ..++.++|||||||++|||++|..|+-
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAG--------DPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccccCCCcCCcCHHHHcC--------CCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 1 1223468999999999865 568899999999999999999876654
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=254.19 Aligned_cols=203 Identities=29% Similarity=0.498 Sum_probs=164.1
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.+.|.+.+.||+|+||.||+|.. +++.||+|++......... ..+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~----~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 79 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP----FTAIREASLLKGLKHANIVLLHDIIHTKETLT 79 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCc----HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence 45699999999999999999976 5789999998754432211 1356899999999999999999998755 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+. ++|.+++.. ....+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 80 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 80 FVFEYMH-TDLAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIP 156 (291)
T ss_pred EEEeccc-CCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCC
Confidence 9999995 678777654 235678888999999999999999999999999999999999554 6999999998653222
Q ss_pred c-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 214 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
. ......+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.+..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~ 210 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLG-------ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210 (291)
T ss_pred CCCCCCccccccccCCceeec-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH
Confidence 1 1223357889999998753 234678899999999999999999999887653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=255.18 Aligned_cols=216 Identities=28% Similarity=0.457 Sum_probs=172.8
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeee----
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK---- 128 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~---- 128 (290)
....|++.+.||.|+||.||+|++ .++.+|+|+........ ..+..|+.+++++ +||||+++++.+.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~------~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE------EEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHH------HHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 345688899999999999999987 56899999986543211 2366888999888 6999999999873
Q ss_pred ---cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 129 ---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 129 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
....+++|||+.+++|.+++.......+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg 166 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFG 166 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCc
Confidence 23578999999999999999876666788999999999999999999999999999999999999554 59999999
Q ss_pred cccccccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 206 LAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 206 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
++...... .......++..|+|||.+..- ......++.++|+||||+++|+|++|..||...........+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 240 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACD---ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcCcc---cCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence 98653321 122345688899999987531 01124578899999999999999999999988776665554433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=249.75 Aligned_cols=204 Identities=36% Similarity=0.651 Sum_probs=170.1
Q ss_pred ceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEEE
Q 022903 64 SKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTE 137 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~e 137 (290)
+.||+|+||.||++... +..|++|++........ ...+.+|+.+++.++|+||+++++.+.+ ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE----RKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhH----HHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 36899999999999774 77899999987655441 2357899999999999999999998865 46789999
Q ss_pred ecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 138 LLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 138 ~~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
|+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~ 155 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDV 155 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEccccccccc
Confidence 999999999998632 3678999999999999999999999999999999999999965 45999999999765
Q ss_pred cccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 211 TVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 211 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
.... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 221 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKD--------GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221 (262)
T ss_pred ccccccccccCCCcCccccCHHHhcc--------CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 4332 2234457889999998764 467899999999999999999 699999987665544443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=254.66 Aligned_cols=196 Identities=26% Similarity=0.429 Sum_probs=162.9
Q ss_pred eccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEEEecCCC
Q 022903 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGM 142 (290)
Q Consensus 66 lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~e~~~~~ 142 (290)
||+|+||+||++.. +++.||+|++......... ....+.+|+.+++.++||||+++++.+.. ...++||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRK--GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhh--hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCC
Confidence 68999999999975 5789999998754322111 12346789999999999999999998865 4688999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccccccCCC
Q 022903 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222 (290)
Q Consensus 143 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~ 222 (290)
+|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.............++
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~ 157 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIKGRAGT 157 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccccccCC
Confidence 999999775555799999999999999999999999999999999999999554 5999999998764433333445678
Q ss_pred ccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 223 ~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
..|+|||.+.. ..++.++|+||||+++|+|++|+.||.....
T Consensus 158 ~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 158 PGYMAPEVLQG--------EVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCcCCHHHhcC--------CCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 89999998754 4478899999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=250.61 Aligned_cols=205 Identities=29% Similarity=0.456 Sum_probs=172.4
Q ss_pred CceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|.+.+.||.|+||.||+++.. ++.+++|.+..... ...+.+|+.+++.++||||+++++.+.+. ..++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 46888999999999999999874 68999999865422 23578999999999999999999988654 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
++||+.+++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 76 ~~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 76 VMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEecCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCc
Confidence 9999999999999875 346789999999999999999999999999999999999999654 59999999987643332
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~ 211 (256)
T cd06612 154 AKRNTVIGTPFWMAPEVIQE--------IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211 (256)
T ss_pred cccccccCCccccCHHHHhc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh
Confidence 2233457889999998764 56788999999999999999999999987766555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=257.48 Aligned_cols=201 Identities=28% Similarity=0.475 Sum_probs=162.0
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||+|++ +++.||+|.++....... ....+.+|+.+++.++||||+++++.+.+. ..+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~---~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc---CccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEE
Confidence 377889999999999999987 578999999875432221 112466899999999999999999998654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
+||++ ++|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++.+ +.++|+|||++.......
T Consensus 78 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 78 FEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVR 154 (284)
T ss_pred EecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccCCCCC
Confidence 99996 5888887652 4568999999999999999999999999999999999999955 459999999987533221
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
......+++.|+|||.+.+ ...++.++|||||||++|+|++|..||....+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~ 205 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGND 205 (284)
T ss_pred CcCCCccccCCcChHHHhC-------CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC
Confidence 1223467889999998754 23468899999999999999998888644433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=257.29 Aligned_cols=207 Identities=34% Similarity=0.482 Sum_probs=169.0
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|.+.+.||.|+||.||+|.+ +++.|++|.+...............+.+|+.+++.++|+||+++++.+.+. ..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 77788999999999999986 578999999976654422222334567899999999999999999998764 678999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-c
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~ 215 (290)
||+ +++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 82 e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 82 EFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred ccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCCCcc
Confidence 999 889999987532 368999999999999999999999999999999999999955 569999999987643322 2
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
.....++..|+|||.+.. ...++.++|+|||||++|+|++|.+||.+.+..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~ 212 (298)
T cd07841 159 MTHQVVTRWYRAPELLFG-------ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212 (298)
T ss_pred ccccccceeeeCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH
Confidence 223356788999998743 245688999999999999999999999887665433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=255.91 Aligned_cols=198 Identities=31% Similarity=0.531 Sum_probs=162.6
Q ss_pred CCceeecceeccccceeEEEEEE------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 129 (290)
.+.|++++.||+|+||.||++++ .+..||+|.+......... ..+.+|+.+++.++||||+++++.+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI----ADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHH----HHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 45688999999999999999874 4678999998765433221 357899999999999999999998865
Q ss_pred --CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 130 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
...++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~~ 156 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLT 156 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCccc
Confidence 3578999999999999998653 3468999999999999999999999999999999999999955 45999999998
Q ss_pred cccccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 208 REETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 208 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
........ .....++..|+|||.+.. ..++.++||||||+++|+|+++..|+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQ--------SKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhcc--------CCCCccccchhhhhhhhhhhcCCCCCc
Confidence 75432221 123456678999998754 567889999999999999999876653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.94 Aligned_cols=209 Identities=29% Similarity=0.504 Sum_probs=167.0
Q ss_pred CCceeecceeccccceeEEEEEECC----------------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYGD----------------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 120 (290)
..+|++.+.||+|+||.||+++..+ ..||+|.+........ ...+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~ei~~l~~l~h~~i 79 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA----RNDFLKEIKIMSRLKNPNI 79 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHH----HHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999986532 3589999976544332 2358899999999999999
Q ss_pred eeEEeeeec-CceEEEEEecCCCCHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCC
Q 022903 121 VKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR----------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189 (290)
Q Consensus 121 v~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~N 189 (290)
+++++.+.. ...++||||+.+++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 999999864 46789999999999999986521 1236788889999999999999999999999999999
Q ss_pred EEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh--CC
Q 022903 190 LLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--NR 264 (290)
Q Consensus 190 ili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~--g~ 264 (290)
|+++.+ +.+||+|||++....... ......++..|+|||.+.. ..++.++|+||||+++|+|++ |.
T Consensus 160 ill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~~l~el~~~~~~ 230 (295)
T cd05097 160 CLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTLWEMFTLCKE 230 (295)
T ss_pred EEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhcc--------CCcCchhhHHHHHHHHHHHHHcCCC
Confidence 999954 469999999986532221 1122344678999998764 567899999999999999988 78
Q ss_pred CCCCCCCHHHHHHH
Q 022903 265 LPFEGMSNLQAAYA 278 (290)
Q Consensus 265 ~Pf~~~~~~~~~~~ 278 (290)
.||...+..+....
T Consensus 231 ~p~~~~~~~~~~~~ 244 (295)
T cd05097 231 QPYSLLSDEQVIEN 244 (295)
T ss_pred CCCcccChHHHHHH
Confidence 89998776654443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=248.40 Aligned_cols=207 Identities=31% Similarity=0.593 Sum_probs=168.9
Q ss_pred CCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
++..|++.+.||.|+||.||++.+. +..+|+|.+....... ..+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE------EDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC 75 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH------HHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence 3456888999999999999999774 7889999987554432 2377899999999999999999998654 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++++|.+++... ...+++..+..++.|++.+|.|||++|++|+||+|+||+++.+ ..++|+|||++......
T Consensus 76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 76 LVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeecccC
Confidence 999999999999998752 3468899999999999999999999999999999999999954 46999999998653222
Q ss_pred cc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022903 214 EM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 214 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
.. .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||......+....
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 213 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSF--------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET 213 (256)
T ss_pred cccccCCCccchhhcCHhHhcc--------CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 11 112234568999998754 557889999999999999998 9999988765544433
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=251.97 Aligned_cols=213 Identities=31% Similarity=0.445 Sum_probs=170.3
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD---- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---- 129 (290)
..+|.+.+.||+|+||.||++.. +++.+|+|++....... ..+.+|+.+++++ +|||++++++.+..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~------~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD------EEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHH------HHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 46699999999999999999977 57899999986543221 2366889999998 79999999998753
Q ss_pred --CceEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 130 --PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 130 --~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
...++||||+++++|.+++... ....+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg 173 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFG 173 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecc
Confidence 2478999999999999988642 245689999999999999999999999999999999999999554 59999999
Q ss_pred ccccccccc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 206 LAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 206 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
++....... ......++..|+|||.+.... .....++.++|+|||||++|+|++|+.||...........+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCC---CcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence 987533222 123346788999999875310 01124688999999999999999999999987766555544
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=252.34 Aligned_cols=202 Identities=26% Similarity=0.457 Sum_probs=166.4
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
.|.+.+.||+|+||.||++.+ +++.+++|.+.......... ...+.+|+.+++.++||||+++++.+.+ ...+++
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~--~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKA--RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHH--HHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 578889999999999999985 67899999886543322221 2457899999999999999999998864 467899
Q ss_pred EEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 136 TELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
|||+.+++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhccccC
Confidence 9999999999988642 23458999999999999999999999999999999999999955 46999999988654322
Q ss_pred c-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 214 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
. ......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+..
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CcccccccCCcCccCHHHhcC--------CCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 2 1223468889999998754 557889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=251.36 Aligned_cols=193 Identities=23% Similarity=0.434 Sum_probs=155.7
Q ss_pred ceeccccceeEEEEEEC--------------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 64 SKIGEGAHGKVYEGRYG--------------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
+.||+|+||.||+|+.. ...|++|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~~~~~~l~~l~hp~iv~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRD-----ISLAFFETASMMRQVSHKHIVLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35899999999999742 235888987654322 12357789999999999999999998865
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC------ceEEe
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK------SLKLA 202 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~------~~kl~ 202 (290)
. ..+++|||+++++|..++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.++. .++++
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 4 67899999999999988765 3456899999999999999999999999999999999999975432 28999
Q ss_pred cccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHH-hCCCCCCCCCH
Q 022903 203 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL-TNRLPFEGMSN 272 (290)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l-~g~~Pf~~~~~ 272 (290)
|||++..... .....++..|+|||.+.. ...++.++||||||+++|+|+ .|..||.+...
T Consensus 155 d~g~~~~~~~---~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 155 DPGIPITVLS---RQECVERIPWIAPECVED-------SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CCCCCccccC---cccccccccccChhhhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 9999865322 123457888999998753 256788999999999999998 59999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=249.31 Aligned_cols=204 Identities=27% Similarity=0.469 Sum_probs=169.5
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---CceE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMV 133 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 133 (290)
+|.+.+.||.|+||.||++.+ +++.||+|++......... ..++.+|+.+++.++||||+++++.+.. ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE---KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHH---HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEE
Confidence 377889999999999999976 5688999998765443322 2357889999999999999999987743 3578
Q ss_pred EEEEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 134 IVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLH-----ANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH-----~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
++|||+++++|.+++.... ...+++..+..++.||+.||.||| +.+++|+||+|+||+++.+ +.++|+|||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~ 156 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGL 156 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEecccc
Confidence 9999999999999986532 356899999999999999999999 8999999999999999954 5699999999
Q ss_pred ccccccccc-ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 207 AREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 207 ~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
+........ .....+++.|+|||.+.. ..++.++|+||||+++|+|++|..||...+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 217 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNH--------MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcC--------CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH
Confidence 886544332 334568899999998864 457889999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.95 Aligned_cols=205 Identities=20% Similarity=0.285 Sum_probs=153.1
Q ss_pred CCCceeecceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHH------HHHHHHHHHHHHhhcCCCCceeEE
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERAL------LEGRFIREVNMMSRVKHDNLVKFL 124 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~ 124 (290)
..+.|.+.+.||+|+||.||+|.+. ...+|+|+..........+. .......++..+..+.|++|++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 3467999999999999999999863 34677776543332211110 011122344556667899999999
Q ss_pred eeeecC-----ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCce
Q 022903 125 GACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199 (290)
Q Consensus 125 ~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~ 199 (290)
+++... ..+++++++ ..++.+.+... ...++..++.++.|++.||.|||+++++||||||+|||++.+ ..+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~~~ 165 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-NRG 165 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CcE
Confidence 876432 235777777 45777766542 346788899999999999999999999999999999999955 459
Q ss_pred EEeccccccccccc--------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 200 KLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 200 kl~Dfg~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
+|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--------~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--------ACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999998753211 11123468999999998764 668999999999999999999999999874
Q ss_pred H
Q 022903 272 N 272 (290)
Q Consensus 272 ~ 272 (290)
.
T Consensus 238 ~ 238 (294)
T PHA02882 238 H 238 (294)
T ss_pred c
Confidence 3
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.04 Aligned_cols=211 Identities=29% Similarity=0.434 Sum_probs=168.6
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-c---
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-L--- 131 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~--- 131 (290)
+|.+.+.||.|+||.||+|.+ +++.||+|.......... ....+.+|+.+++.+. ||||+++++.+... .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG---IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC---CchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 588899999999999999986 578999998765432221 1124678999999995 69999999987543 2
Q ss_pred --eEEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 132 --MVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 132 --~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
.++||||+++ +|.+++.... ...+++..+..++.||+.||.|||++|++||||+|+||+++.+++.++|+|||+
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 6899999975 8888876532 235899999999999999999999999999999999999997466799999999
Q ss_pred ccccccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 207 AREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 207 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
+...... .......+++.|+|||.+.. ...++.++|+||||+++|+|++|..||.+.+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 225 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLG-------STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhC-------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 8753222 12223356788999998753 2457889999999999999999999999988776655543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=251.47 Aligned_cols=189 Identities=29% Similarity=0.433 Sum_probs=163.3
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec-----CceEEE
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-----PLMVIV 135 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-----~~~~lv 135 (290)
+.||-|-.|.|....+ +++.+|+|++..... -++|+++.-.. .|||||.++++|+. ..+.+|
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----------ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----------ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCHH----------HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 5799999999988744 789999999864322 34777765554 59999999999853 246799
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--CCceEEeccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETVT 213 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~~~~kl~Dfg~~~~~~~~ 213 (290)
||.++||.|...++.+....+++.++..|+.||..|+.|||+.+|.||||||+|+|.... +..+||+|||+++.....
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 999999999999999888889999999999999999999999999999999999999633 346999999999987666
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
....+.+-|+.|.|||++.. ..|+...|+||+||+||-|++|.+||=..
T Consensus 218 ~~L~TPc~TPyYvaPevlg~--------eKydkscdmwSlgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_pred ccccCCcccccccCHHHhCc--------hhcCCCCCccchhHHHHHhhcCCCccccc
Confidence 66778899999999999865 66999999999999999999999999644
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=256.87 Aligned_cols=213 Identities=31% Similarity=0.423 Sum_probs=171.5
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 130 (290)
..++|.+.+.||+|+||.||+|.+ +++.||+|.+.......... ..+.+|+.++++++|+||+++++.+.+.
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIP---ISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCc---chhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 345699999999999999999987 57899999987543322111 1255899999999999999999988543
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~ 158 (309)
T cd07845 82 SIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTY 158 (309)
T ss_pred eEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeec
Confidence 5789999996 5898888753 3578999999999999999999999999999999999999955 46999999998764
Q ss_pred cccc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 211 TVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 211 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.... ......+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.+..+....+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLG-------CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred CCccCCCCcccccccccChhhhcC-------CCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3321 2222345778999998753 24578899999999999999999999999887766655543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=250.14 Aligned_cols=214 Identities=27% Similarity=0.482 Sum_probs=171.5
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCCh-----hHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTS-----DERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
.|.+.+.||.|+||.||+|.. +++.+|+|.+...... .........+.+|+.+++.++|||++++++.+...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 377888999999999999975 5789999987543221 11122234578899999999999999999988654
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+.+++|.+++... ..++...+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeeccccccc
Confidence 678999999999999998763 578999999999999999999999999999999999999954 56999999998753
Q ss_pred cccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 211 TVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 211 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.... ......++..|+|||.+.. ....++.++|+||||+++|++++|..||......+....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 226 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN 226 (272)
T ss_pred cccccccccccccCCccccCHHHhcc------ccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc
Confidence 3211 1223467889999998754 113478899999999999999999999988777665555443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=254.10 Aligned_cols=209 Identities=31% Similarity=0.508 Sum_probs=169.7
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|++++.||.|+||.||+|++ +++.||||.+......... ...+.+|+.++++++||||+++++.+.+. ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV---PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccccc---chHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEE
Confidence 378889999999999999987 5789999998754332211 13477899999999999999999988654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+. ++|.+++.......+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR 155 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCcc
Confidence 99995 6899988765556789999999999999999999999999999999999999554 69999999987543221
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.+.+......++
T Consensus 156 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 213 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213 (284)
T ss_pred ccccccccccccCCeEEec-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 1223356788999998754 234578899999999999999999999987766555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=249.11 Aligned_cols=209 Identities=30% Similarity=0.504 Sum_probs=167.8
Q ss_pred CCceeecceeccccceeEEEEEEC--C---ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG--D---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
...|...+.||+|+||.||+|+.. + ..+++|.+......... ..+.+|+.+++.++||||+++.+.+.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR----QDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHH----HHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 346788899999999999999763 2 37999998765433322 3578999999999999999999998654
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+.+++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||||+||+++.+ ..++|+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~ 157 (268)
T cd05063 80 PAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSRVL 157 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccceec
Confidence 67899999999999999876 34578999999999999999999999999999999999999954 46999999998754
Q ss_pred cccccc----cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 211 TVTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 211 ~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
...... .....+..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+..+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i 223 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI 223 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc--------CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 322111 11123457999998754 567899999999999999997 99999887765544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=247.92 Aligned_cols=209 Identities=29% Similarity=0.429 Sum_probs=171.7
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|++.+.||+|+||.||+++. .++.||+|.+......... ...+.+|+.++++++||||+++++.+.+. ..++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKE---REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHH---HHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEE
Confidence 378899999999999999976 5789999998754332221 13578999999999999999999998654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
+||+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchh
Confidence 9999999999998765555689999999999999999999999999999999999999554 599999999875433221
Q ss_pred -ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 216 -MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 216 -~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.....+++.|+|||.+.. ...+.++|+||||+++|+|++|..||......+....+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~ 213 (256)
T cd08218 157 LARTCIGTPYYLSPEICEN--------RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI 213 (256)
T ss_pred hhhhccCCccccCHHHhCC--------CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH
Confidence 223457888999998754 55788999999999999999999999887665554444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=253.88 Aligned_cols=207 Identities=29% Similarity=0.519 Sum_probs=165.3
Q ss_pred CceeecceeccccceeEEEEEEC------------------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYG------------------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 119 (290)
++|++.+.||+|+||.||++++. ...+|+|++........ ...+.+|+.+++.++|||
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~----~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNA----RNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHH----HHHHHHHHHHHHhCCCCC
Confidence 45899999999999999998542 24689999876543322 235789999999999999
Q ss_pred ceeEEeeeec-CceEEEEEecCCCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCC
Q 022903 120 LVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRP---------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189 (290)
Q Consensus 120 iv~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~N 189 (290)
|+++++.+.+ ...+++|||+.+++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 9999998865 467899999999999999875321 236678899999999999999999999999999999
Q ss_pred EEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh--CC
Q 022903 190 LLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--NR 264 (290)
Q Consensus 190 ili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~--g~ 264 (290)
|+++.+ ..++|+|||++....... .......+..|++||.... ..++.++|+|||||++|+|++ |.
T Consensus 161 ili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~DiwSlG~~l~el~~~~~~ 231 (296)
T cd05095 161 CLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--------GKFTTASDVWAFGVTLWEILTLCKE 231 (296)
T ss_pred EEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--------CCccchhhhhHHHHHHHHHHHhCCC
Confidence 999854 469999999987532221 1122234678999997653 568899999999999999998 88
Q ss_pred CCCCCCCHHHHHH
Q 022903 265 LPFEGMSNLQAAY 277 (290)
Q Consensus 265 ~Pf~~~~~~~~~~ 277 (290)
.||...+..+...
T Consensus 232 ~p~~~~~~~~~~~ 244 (296)
T cd05095 232 QPYSQLSDEQVIE 244 (296)
T ss_pred CCccccChHHHHH
Confidence 9998877655443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=252.16 Aligned_cols=204 Identities=31% Similarity=0.536 Sum_probs=168.3
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC---CCCceeEEeeeec-Cce
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGACKD-PLM 132 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~-~~~ 132 (290)
.|.+.+.||+|+||.||+|.+ +++.||+|.+......... ..+.+|+.+++.++ |||++++++.+.+ ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~----~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV----SDIQREVALLSQLRQSQPPNITKYYGSYLKGPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhH----HHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEE
Confidence 377788999999999999986 5789999998765433322 24678999999986 9999999998865 467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecCC
Confidence 899999999999998865 378999999999999999999999999999999999999964 5699999999876433
Q ss_pred cc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 213 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
.. ......++..|+|||.+.. ...++.++|+||||+++|+|++|..||.+........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~ 212 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITE-------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM 212 (277)
T ss_pred CccccccccCCcceeCHHHhcc-------CCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh
Confidence 22 2233468889999998753 2456889999999999999999999998876654443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=277.52 Aligned_cols=216 Identities=30% Similarity=0.509 Sum_probs=184.7
Q ss_pred ccccCCCceeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
...++....++.+.||.|.||+|+.|+. ....||||.++.....+.+. .|+.|+.||-++.||||++|.|+
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekqrr----dFL~EAsIMGQFdHPNIIrLEGV 698 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRR----DFLSEASIMGQFDHPNIIRLEGV 698 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHh----hhhhhhhhcccCCCCcEEEEEEE
Confidence 3446777788999999999999999976 23679999999877766554 59999999999999999999999
Q ss_pred eecCce-EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 127 CKDPLM-VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 127 ~~~~~~-~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
...... .+|.|||++|+|+.+++.+ .+.+...+...+++.|+.|+.||-+.|+|||||..+|||++ .+..+|++|||
T Consensus 699 VTks~PvMIiTEyMENGsLDsFLR~~-DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN-snLvCKVsDFG 776 (996)
T KOG0196|consen 699 VTKSKPVMIITEYMENGSLDSFLRQN-DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN-SNLVCKVSDFG 776 (996)
T ss_pred EecCceeEEEhhhhhCCcHHHHHhhc-CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec-cceEEEecccc
Confidence 987654 4889999999999999985 46799999999999999999999999999999999999999 55679999999
Q ss_pred ccccccccc-cccccCC---CccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 206 LAREETVTE-MMTAETG---TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 206 ~~~~~~~~~-~~~~~~g---~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
+++....+. ...+..| +.+|.|||.+.. ..++.++||||+|++|||.++ |..||.++++.+.+.+|-
T Consensus 777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~--------RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe 848 (996)
T KOG0196|consen 777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE 848 (996)
T ss_pred ceeecccCCCccccccCCccceeecChhHhhh--------cccCchhhccccceEEEEecccCCCcccccchHHHHHHHH
Confidence 998653333 2222222 478999999875 789999999999999999887 999999999998887764
Q ss_pred H
Q 022903 281 F 281 (290)
Q Consensus 281 ~ 281 (290)
.
T Consensus 849 ~ 849 (996)
T KOG0196|consen 849 Q 849 (996)
T ss_pred h
Confidence 4
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=249.34 Aligned_cols=194 Identities=25% Similarity=0.403 Sum_probs=158.9
Q ss_pred ceeccccceeEEEEEECCc------------eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCc
Q 022903 64 SKIGEGAHGKVYEGRYGDR------------IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL 131 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 131 (290)
+.||+|+||.||+|.+.+. .+++|.+...... ...+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD------SLAFFETASLMSQLSHKHLVKLYGVCVRDE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh------HHHHHHHHHHHHcCCCcchhheeeEEecCC
Confidence 3689999999999977432 4778876544322 235789999999999999999999887677
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC------ceEEeccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK------SLKLADFG 205 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~------~~kl~Dfg 205 (290)
.++||||+.+++|.+++... ...++...+..++.||+.||.|||++|++||||||+||+++.++. .++|+|||
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHRE-KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 88999999999999999763 236899999999999999999999999999999999999986541 49999999
Q ss_pred ccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHH
Q 022903 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273 (290)
Q Consensus 206 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~ 273 (290)
++..... .....++..|+|||.+... ...++.++|+||||+++|+|++ |..||...+..
T Consensus 154 ~a~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~ 213 (259)
T cd05037 154 IPITVLS---REERVERIPWIAPECIRNG------QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS 213 (259)
T ss_pred ccccccc---ccccccCCCccChhhhcCC------CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch
Confidence 9876433 2234567789999998641 1367889999999999999999 68999887543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=248.65 Aligned_cols=193 Identities=31% Similarity=0.469 Sum_probs=163.9
Q ss_pred eccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecCCC
Q 022903 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGM 142 (290)
Q Consensus 66 lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~~ 142 (290)
||.|+||.||++++. ++.||+|++......... ....+.+|+.+++.++||||+++++.+.++ ..++++||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG--QQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhh--HHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCC
Confidence 699999999999885 789999999765433222 124688999999999999999999988654 678999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccccccCCC
Q 022903 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222 (290)
Q Consensus 143 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~ 222 (290)
+|.+++.. ...++...+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.............++
T Consensus 79 ~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 79 ELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred cHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccccccCC
Confidence 99999975 34589999999999999999999999999999999999999654 5999999998865444333445788
Q ss_pred ccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 223 ~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
..|+|||.+.. ..++.++|+||||+++|+|++|..||....
T Consensus 156 ~~~~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 156 PEYVAPEIILN--------KGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cCccChhHhcC--------CCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 89999998754 557889999999999999999999998876
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=247.15 Aligned_cols=205 Identities=39% Similarity=0.687 Sum_probs=168.0
Q ss_pred eecceeccccceeEEEEEECC------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceE
Q 022903 61 FIGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 61 ~~~~~lG~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 133 (290)
.+.+.||.|+||.||++++.+ ..||+|++......... ..+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQI----EEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHH----HHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 466889999999999998743 78999999766543222 357899999999999999999999865 4678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
++|||+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceecccc
Confidence 999999999999999764433389999999999999999999999999999999999999554 6999999998764433
Q ss_pred cccc--ccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022903 214 EMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 214 ~~~~--~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
.... ...++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+..+....
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~ 216 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKD--------GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY 216 (258)
T ss_pred cccccccCCCcccccChHHhcc--------CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 2211 1236788999998743 567899999999999999998 8999988666544433
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=256.80 Aligned_cols=203 Identities=31% Similarity=0.475 Sum_probs=166.5
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
.|.....||+|+||.||++.. ++..||||.+....... ...+.+|+.+++.++||||+++++.+.. +..++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR-----RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHH-----HHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence 355567899999999999976 57899999886533221 2347799999999999999999988765 477899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.+ +.++|+|||++.......
T Consensus 98 ~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 98 MEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhcccccc
Confidence 999999999998754 468899999999999999999999999999999999999955 469999999986432211
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+.......
T Consensus 174 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 229 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229 (292)
T ss_pred cCceeecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1233467889999998754 5678899999999999999999999998776654443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=252.73 Aligned_cols=210 Identities=30% Similarity=0.534 Sum_probs=168.3
Q ss_pred CCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
+..+|++.+.||+|+||.||+|++ ++..||+|++........ ...+.+|+.+++.++||||+++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~ei~~l~~l~h~~iv~~~~~~~ 78 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM----QADFQREAALMAEFDHPNIVKLLGVCA 78 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHH----HHHHHHHHHHHHhcCCCchheEEEEEc
Confidence 345688999999999999999975 357899999876543322 235789999999999999999999886
Q ss_pred cC-ceEEEEEecCCCCHHHHHHhcCC--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCC
Q 022903 129 DP-LMVIVTELLPGMSLRKYLVSLRP--------------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 187 (290)
Q Consensus 129 ~~-~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp 187 (290)
+. ..+++|||+.+++|.+++..... ..+++..+..++.|++.||.|||++|++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 54 67899999999999999975321 2467888899999999999999999999999999
Q ss_pred CCEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-C
Q 022903 188 DNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 263 (290)
Q Consensus 188 ~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g 263 (290)
+||+++.+ +.++|+|||++....... .......+..|+|||.+.. ..++.++|+|||||++|+|++ |
T Consensus 159 ~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~~~ 229 (288)
T cd05050 159 RNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIFSYG 229 (288)
T ss_pred hheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc--------CCCCchhHHHHHHHHHHHHHhCC
Confidence 99999855 459999999986432211 1122234667999998754 568899999999999999998 8
Q ss_pred CCCCCCCCHHHHHHH
Q 022903 264 RLPFEGMSNLQAAYA 278 (290)
Q Consensus 264 ~~Pf~~~~~~~~~~~ 278 (290)
..||.+.+..+....
T Consensus 230 ~~p~~~~~~~~~~~~ 244 (288)
T cd05050 230 MQPYYGMAHEEVIYY 244 (288)
T ss_pred CCCCCCCCHHHHHHH
Confidence 899988766554443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=254.93 Aligned_cols=203 Identities=30% Similarity=0.484 Sum_probs=168.0
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.|...+.||+|+||.||+|.+ +++.||+|.+........ ...+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE----IEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHH----HHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 477788999999999999976 567899999875443322 23578999999999999999999988654 68899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 81 MEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEccccccccccCcch
Confidence 999999999998864 568999999999999999999999999999999999999955 469999999987543322
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||..........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQ--------SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF 211 (277)
T ss_pred hhhcccCcccccCHHHhCc--------CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh
Confidence 1223457889999998764 567889999999999999999999998766554443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=248.32 Aligned_cols=203 Identities=27% Similarity=0.467 Sum_probs=167.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
..|.+.+.||.|+||.||+|.. +++.||+|.++........ ...++.+|+.++++++|+||+++++.+.+ ...++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~--~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK--ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchh--hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3588999999999999999977 5789999988753332222 12358899999999999999999998865 46789
Q ss_pred EEEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
||||+++++|.+++.... ...++...+..++.+++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~~ 158 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFSS 158 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeeccC
Confidence 999999999999986532 34578999999999999999999999999999999999999554 599999999875332
Q ss_pred cc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 213 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.. ......++..|+|||.+.. ..++.++|+||||+++|+|++|..||....
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCcccceecCCccccCHHHhcc--------CCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 21 1233467889999998754 567889999999999999999999996643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=251.28 Aligned_cols=202 Identities=30% Similarity=0.472 Sum_probs=160.7
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHH-HhhcCCCCceeEEeeeec-CceEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNM-MSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
+|.+.+.||+|+||.||++.+ +++.||+|.++........ .++..|+.+ ++.++||||+++++.+.. ...++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ----KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH----HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 588899999999999999987 5789999998765433322 234456554 566789999999998864 47889
Q ss_pred EEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 135 VTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
+|||++ ++|.+++... ....+++..+..++.|++.||.|||++ +++||||||+||+++.+ +.+||+|||++....
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~ 155 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLV 155 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecccccccc
Confidence 999995 6888887653 234689999999999999999999997 99999999999999955 469999999987643
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
.........++..|+|||.+.+.. ....++.++|+||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 156 DSVAKTIDAGCKPYMAPERINPEL----NQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred cccccccccCCccccChhhcCCcc----cccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 333333346788999999875411 1245688999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=250.06 Aligned_cols=210 Identities=27% Similarity=0.525 Sum_probs=169.4
Q ss_pred CCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
.++|.++..||.|+||.||+|+. ..+.+++|.+........ ...+.+|+.++++++||||+++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 79 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL----QSEFRRELDMFRKLSHKNVVRLLGLCRE 79 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHH----HHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence 35688899999999999999975 246799998865443211 2357899999999999999999998865
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEE
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRP-------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl 201 (290)
...++||||+++++|.+++..... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l 158 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKV 158 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-cEEE
Confidence 467899999999999999976442 1589999999999999999999999999999999999999654 5999
Q ss_pred ecccccccccccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022903 202 ADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 202 ~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
+|||++....... ......++..|+|||.+.. ...+.++||||||+++|+|++ |..||.+..+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~ 230 (275)
T cd05046 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE--------DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR 230 (275)
T ss_pred cccccccccCcccccccCCceeEEeecChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH
Confidence 9999986432221 1223345677999998754 456789999999999999998 8999988766554444
Q ss_pred H
Q 022903 279 A 279 (290)
Q Consensus 279 ~ 279 (290)
+
T Consensus 231 ~ 231 (275)
T cd05046 231 L 231 (275)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=252.01 Aligned_cols=198 Identities=31% Similarity=0.521 Sum_probs=160.3
Q ss_pred CceeecceeccccceeEEEEEE------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec--
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-- 129 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 129 (290)
..|++.+.||+|+||.||++.. .++.||+|.+........ ..+.+|+.+++.++||||+++++.+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL-----RDFEREIEILKSLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHH-----HHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence 4688899999999999999874 467899999875433221 347799999999999999999987642
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
...++|+||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~ 156 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGLTK 156 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCcccc
Confidence 3578999999999999998753 3468999999999999999999999999999999999999955 459999999987
Q ss_pred ccccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 209 EETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 209 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..|+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~~~~~ 214 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYSDKSCSP 214 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhcc--------CCcChHHHHHHHHHHHHHHhhcCCcCCCc
Confidence 5432211 111223456999998754 56788999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=251.98 Aligned_cols=194 Identities=23% Similarity=0.404 Sum_probs=155.5
Q ss_pred eeccccceeEEEEEEC--------------------------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCC
Q 022903 65 KIGEGAHGKVYEGRYG--------------------------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 118 (290)
.||+|+||.||+|... +..|++|++...... ....+.+|+.+++.++||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~~~~~~~~~l~h~ 76 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRD-----IALAFFETASLMSQVSHI 76 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHH-----HHHHHHHHHHHHhcCCCC
Confidence 5899999999998631 135888988643221 223577899999999999
Q ss_pred CceeEEeeeec-CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC-
Q 022903 119 NLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ- 196 (290)
Q Consensus 119 ~iv~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~- 196 (290)
||+++++++.+ ...++||||+++++|..++.. ....+++..+..++.|++.||+|||++|++||||||+||+++..+
T Consensus 77 niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 77 HLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred CeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 99999999865 467899999999999998865 345789999999999999999999999999999999999997432
Q ss_pred -----CceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHH-hCCCCCCCC
Q 022903 197 -----KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL-TNRLPFEGM 270 (290)
Q Consensus 197 -----~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l-~g~~Pf~~~ 270 (290)
..++++|||++...... ....++..|+|||.+.. ...++.++|+||||+++|+|+ +|..||.+.
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~-------~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 225 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG-------GNSLSTAADKWSFGTTLLEICFDGEVPLKER 225 (274)
T ss_pred ccCccceeeecCCccccccccc---cccccCCcccCchhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 23899999987543211 22356788999998753 245789999999999999995 699999887
Q ss_pred CHHH
Q 022903 271 SNLQ 274 (290)
Q Consensus 271 ~~~~ 274 (290)
+..+
T Consensus 226 ~~~~ 229 (274)
T cd05076 226 TPSE 229 (274)
T ss_pred ChHH
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=252.64 Aligned_cols=212 Identities=30% Similarity=0.435 Sum_probs=171.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|.+.+.||+|+||.||+|+. +++.||+|.+.......... ...+.+|+.+++.++||||+++.+.+.+. ..++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~--~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK--WQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHH--HHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 4588889999999999999976 57899999986543322221 23578999999999999999999998654 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
|+||+. ++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~-~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 93 VMEYCL-GSASDILEV-HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSPA- 168 (307)
T ss_pred EHHhhC-CCHHHHHHH-cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecCCC-
Confidence 999996 577777654 23568999999999999999999999999999999999999955 46999999998654322
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
....++..|+|||.+... ....++.++||||||+++|+|++|..||.+.+.....+.+...
T Consensus 169 --~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~ 229 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229 (307)
T ss_pred --CCccCCccccCceeeecc-----CCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC
Confidence 234678899999987431 1255788999999999999999999999998877766666544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=252.15 Aligned_cols=206 Identities=22% Similarity=0.374 Sum_probs=166.7
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|++++.||+|+||.||++++ .++.||+|.+......... ..+.+|+.+++.++||||+++++.+.. ...++|
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~----~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF----NQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHH----HHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 578899999999999999987 4789999988754332221 357899999999999999999998864 478899
Q ss_pred EEecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
|||+++++|..++.... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.+ +.++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccCC
Confidence 99999999999887521 2368999999999999999999997 599999999999999964 56999999998654222
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
......+++.|+|||.+.... ......++.++|+|||||++|+|++|..||.....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 212 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGG--PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212 (286)
T ss_pred -ccccCCCccCccCcchhcCCC--CCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence 223346788999999875421 11223568899999999999999999999977544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=248.44 Aligned_cols=210 Identities=30% Similarity=0.470 Sum_probs=172.2
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||++.. .+..+|+|.+......... ...+.+|+.+++.++|+||+++++.+.+. ..+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKE---KEASKKEVILLAKMKHPNIVTFFASFQENGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchh---hHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEE
Confidence 377889999999999999977 5688999998664322211 13467899999999999999999988654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
+||+.+++|.+++.......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++..++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999999765555689999999999999999999999999999999999999776667999999887543322
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 158 ~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 214 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN--------RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI 214 (257)
T ss_pred cccccCCCccccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 1223468889999998754 45788999999999999999999999887665544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=249.83 Aligned_cols=193 Identities=26% Similarity=0.407 Sum_probs=154.6
Q ss_pred eeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHH---HHHHhhcCCCCceeEEeeeecC-ceEEEEEe
Q 022903 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIRE---VNMMSRVKHDNLVKFLGACKDP-LMVIVTEL 138 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~ 138 (290)
.||+|+||.||++++ +++.||+|.+........... ..+..| +.+++...||+|+.+++.+.+. ..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH--HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 379999999999976 578999999876543221110 112233 3444556799999999988754 67899999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccccc
Q 022903 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 218 (290)
Q Consensus 139 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~ 218 (290)
+.|++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||+++.+ +.++|+|||++...... ....
T Consensus 79 ~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~~ 154 (278)
T cd05606 79 MNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHA 154 (278)
T ss_pred CCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCcC
Confidence 999999998865 4579999999999999999999999999999999999999955 46999999998753322 2234
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
..|+..|+|||.+.. ...++.++|+||+|+++|+|++|..||.+.
T Consensus 155 ~~~~~~y~aPE~~~~-------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 155 SVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred cCCCcCCcCcHHhcC-------CCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 578999999998753 235788999999999999999999999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=252.55 Aligned_cols=209 Identities=30% Similarity=0.474 Sum_probs=170.7
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||+|.+ +++.|++|.++....... ....+.+|+++++.++|+||+++++.+.+. ..+++
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDED---VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccccc---chhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 588999999999999999987 468999999875433221 123578999999999999999999998654 68899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||++++.+..+... ...++...+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCcc
Confidence 999988767665543 4568999999999999999999999999999999999999954 569999999987644333
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
......++..|+|||.+.. ...++.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 215 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVG-------DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ 215 (288)
T ss_pred ccccCcccccCCcCCchhcC-------CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2234567888999999865 1267889999999999999999999999877665555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=253.75 Aligned_cols=209 Identities=30% Similarity=0.400 Sum_probs=170.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---Cce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 132 (290)
+.|.+.+.||.|+||.||+|.+ +++.+++|.++........ ...+.+|+.+++.++||||+++++.+.+ ...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGF---PITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccc---hhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 4688899999999999999987 4688999998755433211 1246689999999999999999998753 468
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+. ++|.+++... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 82 ~lv~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGS 158 (293)
T ss_pred EEEehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeeccC
Confidence 89999996 4999988763 3468999999999999999999999999999999999999955 4699999999875433
Q ss_pred c-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 213 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
. .......+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.+..+...++
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (293)
T cd07843 159 PLKPYTQLVVTLWYRAPELLLG-------AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219 (293)
T ss_pred CccccccccccccccCchhhcC-------CccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 3 22233457888999998754 234688999999999999999999999988776555443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=253.33 Aligned_cols=209 Identities=29% Similarity=0.468 Sum_probs=170.0
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||++.+ +++.||+|.+........ ....+.+|+.+++.++||||+++++.+.++ ..++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKM---VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcch---hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 588899999999999999987 478999999865443321 123477899999999999999999998654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-c
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~ 214 (290)
+||++++.|..+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 79 ~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCcc
Confidence 999999888887654 3458999999999999999999999999999999999999955 46999999998753222 2
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
......++..|+|||.+.+ ...++.++||||||+++|+|++|.+||.+.+..+....+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 156 VYTDYVATRWYRAPELLVG-------DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred ccCcccceeeccCcHHhcc-------ccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 2233467889999998753 2346789999999999999999999998877655444443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=258.60 Aligned_cols=200 Identities=34% Similarity=0.502 Sum_probs=162.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-----
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 130 (290)
++|.+.+.||+|+||.||+|.+ +++.||+|.+....... ...++.+|+.+++.++||||+++++.+...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT----FCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccch----hHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 5699999999999999999976 57899999986432221 123477899999999999999999876432
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++++||+. ++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 81 ~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~ 155 (336)
T cd07849 81 NDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARI 155 (336)
T ss_pred ceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECcccceee
Confidence 4689999995 588877753 579999999999999999999999999999999999999955 4599999999875
Q ss_pred ccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 210 ETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 210 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
..... ......++..|+|||.+.. ...++.++||||||+++|+|++|+.||.+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~ 216 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 33221 1123467889999997643 245788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=249.69 Aligned_cols=203 Identities=30% Similarity=0.458 Sum_probs=164.6
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeec---CceE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD---PLMV 133 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~---~~~~ 133 (290)
|++.+.||+|+||.||++.+ +++.||+|.+.......... ...+|+.++.++. ||||+++++.+.+ ...+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~----~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV----NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh----hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEE
Confidence 56788999999999999976 57899999987643322221 2457888888885 9999999998864 4678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+. ++|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||+++. +.++|+|||++......
T Consensus 77 lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 77 LVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence 9999996 5888877652 356899999999999999999999999999999999999996 56999999999765443
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
.......++..|+|||.+.. ...++.++|+|||||++|+|++|..||.+.+..+...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~ 209 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLT-------DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIA 209 (282)
T ss_pred CCcCCCCCCcccCChhHhhc-------CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHH
Confidence 33344567889999997643 2456889999999999999999999999877654433
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=253.21 Aligned_cols=203 Identities=34% Similarity=0.501 Sum_probs=168.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
.+|.+.+.||+|+||.||++.. ++..|++|.+........ ..+.+|+.+++.++||||+++++.+.+. ..++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK-----ELIINEILVMRENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHH-----HHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence 5688999999999999999975 568899999864433222 3478999999999999999999988654 6889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
|+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceecccccc
Confidence 9999999999999865 457888999999999999999999999999999999999955 459999999876433222
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
......+++.|+|||.+.. ..++.++|+||||+++|++++|..||...+..+...
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~ 225 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (293)
T ss_pred cccccccCChhhcCchhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee
Confidence 2233467888999998754 567889999999999999999999998876654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=251.59 Aligned_cols=199 Identities=27% Similarity=0.422 Sum_probs=167.0
Q ss_pred CceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
.+|++++.||+|+||.||++.+. ++.||+|++........ ...+.+|+++++.++||||+++++.+.+. ..++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV----RKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchH----HHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 46888999999999999999874 78999998875433221 23578999999999999999999998654 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
||||+++++|.+++.. .+.+++..+..++.+++.+|.|||+ .|++||||+|+||+++.+ +.++|+|||++......
T Consensus 81 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 81 CMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS 157 (284)
T ss_pred EEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccchhhh
Confidence 9999999999998875 3568999999999999999999997 599999999999999954 46999999998643222
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
......++..|+|||.+.. ..++.++|+|||||++|+|++|..||.....
T Consensus 158 -~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQG--------GKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred -ccCccccCcccCCHHHHcc--------CCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 2234478899999998754 4678899999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=245.55 Aligned_cols=202 Identities=30% Similarity=0.475 Sum_probs=166.9
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||++.. +++.|++|.+........ ....+.+|+.+++.++|+||+++++.+.+. ..++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK---TIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchH---HHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEE
Confidence 377889999999999999976 578999999876654311 224588999999999999999999987644 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
+||+++++|.+++.. ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 78 MEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCC
Confidence 999999999999875 3457888999999999999999999999999999999999964 5699999999875432221
Q ss_pred -----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 216 -----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 216 -----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.....++..|+|||.+.... ....+.++||||||+++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~-----~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGK-----GKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred cccccccCCcCCcCccChhhccCCC-----CCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 11346788999999986411 1347889999999999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=254.93 Aligned_cols=203 Identities=31% Similarity=0.462 Sum_probs=166.9
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~ 136 (290)
|.....||+|+||.||++.+ .++.||+|.+........ ..+.+|+.+++.++||||+++++.+.. ...++++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~-----~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR-----ELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchH-----HHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 44556899999999999976 578999999865433221 247789999999999999999998864 4788999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-c
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~ 215 (290)
||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ .++|+|||++....... .
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhccccccc
Confidence 99999999997754 4689999999999999999999999999999999999999554 59999999986432221 2
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+..+....+
T Consensus 174 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 229 (297)
T cd06659 174 RKSLVGTPYWMAPEVISR--------TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 229 (297)
T ss_pred ccceecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 233568899999998864 56788999999999999999999999887765554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=248.69 Aligned_cols=205 Identities=31% Similarity=0.488 Sum_probs=168.7
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.|.+.+.||.|+||.||+|.. .++.||+|+......... ...+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE----IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHH----HHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 377788999999999999976 568999999865443222 23578999999999999999999998654 68899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|||+++++|.+++.. ..+++..+..++.|++.++.|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecccchh
Confidence 999999999998864 468999999999999999999999999999999999999955 459999999886533221
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||...........+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 213 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213 (277)
T ss_pred hhccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH
Confidence 1223467889999998754 56788999999999999999999999887665544443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=247.27 Aligned_cols=198 Identities=29% Similarity=0.473 Sum_probs=161.2
Q ss_pred cceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEec
Q 022903 63 GSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
...||+|+||.||+|++ ++..|++|.+........ ..+.+|+.+++.++|+||+++++.+.++ ..++++||+
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 87 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-----QPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV 87 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHH-----HHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence 35799999999999976 457899998875543322 2477999999999999999999988654 678999999
Q ss_pred CCCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-cc
Q 022903 140 PGMSLRKYLVSLRPNKL--DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MM 216 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~--~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~~ 216 (290)
.+++|.+++.... ..+ +...+..++.|++.||.|||++|++||||||+||+++.+.+.++|+|||++....... ..
T Consensus 88 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 166 (268)
T cd06624 88 PGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166 (268)
T ss_pred CCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence 9999999987532 334 7888899999999999999999999999999999998656679999999986532221 22
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
....+++.|+|||.+.. ....++.++|+||||+++|+|++|..||.....
T Consensus 167 ~~~~~~~~~~aPE~~~~------~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 167 ETFTGTLQYMAPEVIDK------GPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred ccCCCCccccChhhhcc------ccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 23457889999998753 123477899999999999999999999987543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=248.52 Aligned_cols=193 Identities=26% Similarity=0.395 Sum_probs=153.2
Q ss_pred eeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHH---HhhcCCCCceeEEeeeec-CceEEEEEe
Q 022903 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNM---MSRVKHDNLVKFLGACKD-PLMVIVTEL 138 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~---l~~l~h~~iv~~~~~~~~-~~~~lv~e~ 138 (290)
.||+|+||.||+++. +++.+|+|.+........... ..+.+|..+ +...+||+|+.+++.+.. +..++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--TLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH--HHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEec
Confidence 389999999999977 568999999876543222111 123344433 334479999999988864 477899999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccccc
Q 022903 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 218 (290)
Q Consensus 139 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~ 218 (290)
+.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++....... ...
T Consensus 79 ~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~-~~~ 154 (279)
T cd05633 79 MNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHA 154 (279)
T ss_pred CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceeccccC-ccC
Confidence 999999998875 3569999999999999999999999999999999999999955 469999999986543222 223
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
..++..|+|||.+.. +..++.++|+|||||++|+|++|..||...
T Consensus 155 ~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 155 SVGTHGYMAPEVLQK-------GTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred cCCCcCccCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 468999999998742 245788999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=258.30 Aligned_cols=207 Identities=26% Similarity=0.411 Sum_probs=167.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-----
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 130 (290)
.+|.+.+.||.|+||.||+|.. +++.||+|.+........ ..+.+|+.+++.++||||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~-----~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV-----KHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchH-----HHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 5699999999999999999977 578999999876554222 2467899999999999999998766432
Q ss_pred ----------ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceE
Q 022903 131 ----------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200 (290)
Q Consensus 131 ----------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~k 200 (290)
..++||||+. ++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++..++
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEE
Confidence 3679999996 589888754 46899999999999999999999999999999999999986666799
Q ss_pred Eecccccccccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 201 LADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 201 l~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
|+|||.+....... ......++..|+|||.+.. ...++.++|||||||++|+|++|+.||.+....+..
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhC-------ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999986532211 1122356888999997643 245788999999999999999999999988776665
Q ss_pred HHHH
Q 022903 277 YAAA 280 (290)
Q Consensus 277 ~~~~ 280 (290)
..+.
T Consensus 229 ~~~~ 232 (342)
T cd07854 229 QLIL 232 (342)
T ss_pred HHHH
Confidence 5443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=250.51 Aligned_cols=201 Identities=27% Similarity=0.397 Sum_probs=163.2
Q ss_pred eeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ce
Q 022903 60 LFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~ 132 (290)
|++.+.||.|+||.||+++. +++.||+|++........ .....++.+|+.+++.+ +|+||+++++.+..+ ..
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK-AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc-chHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 77889999999999999975 568899999875432111 11223577899999999 589999999888654 56
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+|||++.+ +.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceeccc
Confidence 799999999999999876 3568899999999999999999999999999999999999965 4699999999875433
Q ss_pred cc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 213 TE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 213 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
.. ......++..|+|||.+.. ....++.++|+||||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRG------GDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred ccccccccccCCcccCChhhccC------CCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 22 2223468889999998753 1134678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=249.02 Aligned_cols=201 Identities=37% Similarity=0.636 Sum_probs=161.4
Q ss_pred eeccccceeEEEEEECC--------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 65 KIGEGAHGKVYEGRYGD--------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.||+|+||.||+|+..+ ..+++|.+......... ..+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK----KEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhH----HHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 58999999999997632 57999988654322222 3477899999999999999999988654 67899
Q ss_pred EEecCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC----CceEEecccc
Q 022903 136 TELLPGMSLRKYLVSLR-----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ----KSLKLADFGL 206 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~----~~~kl~Dfg~ 206 (290)
|||+++++|.+++.... ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++ ..++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999999986532 23478899999999999999999999999999999999998654 2599999999
Q ss_pred cccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022903 207 AREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277 (290)
Q Consensus 207 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~ 277 (290)
+....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||...++.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~ 224 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD--------GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ 224 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHcc--------CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH
Confidence 87532221 1122345678999998764 567899999999999999998 999999877655443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=245.49 Aligned_cols=197 Identities=32% Similarity=0.552 Sum_probs=155.7
Q ss_pred ceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee--cCceEEEE
Q 022903 64 SKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK--DPLMVIVT 136 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~lv~ 136 (290)
+.||+|+||.||+|... ...||+|.+......... ..+.+|+.+++.++||||+++++.+. +...+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEV----EQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHH----HHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 35899999999999752 257999988654332222 35778999999999999999999764 34578999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc--
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-- 214 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-- 214 (290)
+|+.+++|.+++... ....+...+..++.|++.||.|||+.+++||||||+|||++.+ +.++|+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 77 PYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCccccccccCCcce
Confidence 999999999998753 3456777888999999999999999999999999999999955 459999999986432211
Q ss_pred ---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 215 ---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 215 ---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
......++..|+|||.+.. ..++.++||||||+++|+|++ |.+||...+..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~ 210 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD 210 (262)
T ss_pred eecccccCcCCccccChhHhcc--------CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 1112245678999998754 567889999999999999999 677887766544
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=293.15 Aligned_cols=203 Identities=28% Similarity=0.414 Sum_probs=168.9
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~ 136 (290)
..-+..||.|.||.||.|.. +|+..|+|-+.-..... .....+.+|+.++..++|||+|+++|+-.+ ...++.|
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~---k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDH---KTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCcccc---ccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 44567899999999999964 78999999987655442 122357799999999999999999998754 4677899
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc---
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT--- 213 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~--- 213 (290)
|||++|+|.+.+.. ....++.....+..|++.|+.|||++|||||||||.||+++.++ .+|+.|||.+......
T Consensus 1314 EyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhc
Confidence 99999999999875 45677888889999999999999999999999999999999655 7999999998753222
Q ss_pred --ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 214 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 214 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
.......||+.|||||++.+.. ......++|||||||+..||+||+.||..+++.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~-----~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTK-----GKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccc-----cCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 2345668999999999998732 344567999999999999999999999988654
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=249.23 Aligned_cols=207 Identities=30% Similarity=0.518 Sum_probs=167.5
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|++.+.||.|++|.||+|++ +++.||+|++......... ..+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP----STAIREISLMKELKHENIVRLHDVIHTENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccch----HHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEE
Confidence 378889999999999999987 5789999998765433221 2366899999999999999999998654 67899
Q ss_pred EEecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
|||+++ +|.+++.... ...+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++.......
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPV 154 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCc
Confidence 999975 8888876532 2458999999999999999999999999999999999999955 469999999986533221
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
......++..|+|||.+.. ...++.++|+||||+++|+|++|..||.+.+..+...+
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 212 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLG-------SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212 (284)
T ss_pred cccccccccccccChHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 1223456888999998754 23468899999999999999999999998776554443
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=252.12 Aligned_cols=207 Identities=27% Similarity=0.427 Sum_probs=165.2
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 130 (290)
..++|.+.+.||+|+||.||+|+. +++.||+|.+.......... ..+.+|+.++++++||||+++++.+...
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCch---hHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 445699999999999999999986 57899999986543322111 2356899999999999999999987532
Q ss_pred ------ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 131 ------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 131 ------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
..++||||+. ++|.+++.. ....+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~df 163 (310)
T cd07865 87 YNRYKGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADF 163 (310)
T ss_pred ccCCCceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEECcC
Confidence 3589999995 588888765 33468999999999999999999999999999999999999955 46999999
Q ss_pred ccccccccccc-----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 205 GLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 205 g~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
|++........ .....++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.+....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~ 232 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcC-------CcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99875432221 123356788999998754 23467899999999999999999999988765433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=248.56 Aligned_cols=198 Identities=33% Similarity=0.486 Sum_probs=165.1
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---CceE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLMV 133 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 133 (290)
.|...++||.|++|.||++.+ +++.+|+|.+........ ..++.+|+++++.++||||+++++.+.+ ...+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL----QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHH----HHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 478889999999999999987 578999999876543321 2357899999999999999999998753 2578
Q ss_pred EEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
+||||+++++|.+++... ....++...+..++.||+.||.|||+.|++|+||+|+||+++.+ ..++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~ 156 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeecccccccc
Confidence 999999999999887542 24568889999999999999999999999999999999999955 459999999986543
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
.... ....++..|+|||.+.. ..++.++|+||||+++|+|++|..||...
T Consensus 157 ~~~~-~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 157 NSLA-GTFTGTSFYMAPERIQG--------KPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccc-ccccCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 2221 23457888999998754 56788999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=242.27 Aligned_cols=201 Identities=35% Similarity=0.620 Sum_probs=163.5
Q ss_pred ceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecCC
Q 022903 64 SKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPG 141 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~ 141 (290)
+.||.|+||.||++.+. ++.|++|.+........ ...+.+|+.+++.++||||+++++.+.+. ..++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL----KRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHH----HHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 36899999999999774 79999999876655422 23588999999999999999999988654 67899999999
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccc---cc
Q 022903 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TA 218 (290)
Q Consensus 142 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~---~~ 218 (290)
++|.+++... ...++...+..++.+++.+|.|||++|++||||+|+||+++.++ .++|+|||++......... ..
T Consensus 77 ~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 77 GSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceecccc
Confidence 9999998753 34688999999999999999999999999999999999999554 5999999998753321111 11
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
...+..|+|||.+.. ..++.++|+||||+++|+|++ |..||.+.........
T Consensus 155 ~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~ 207 (251)
T cd05041 155 KQIPIKWTAPEALNY--------GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER 207 (251)
T ss_pred CcceeccCChHhhcc--------CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH
Confidence 233567999998754 567899999999999999999 8999988775443333
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=249.27 Aligned_cols=208 Identities=32% Similarity=0.519 Sum_probs=168.6
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|++.+.||.|++|.||+|.+ ++..||+|++......... ...+.+|+.+++.++|||++++++.+.+. ..+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGV---PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccc---hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEE
Confidence 46678999999999999976 6789999998765432211 12467899999999999999999988654 678999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc-
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM- 215 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~- 215 (290)
||+ +++|.+++.......+++..+..++.|++.||.|||+++++||||+|+||+++. ++.++|+|||++........
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred ecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC-CCcEEEeecccccccCCCccc
Confidence 999 468999987644457899999999999999999999999999999999999996 45699999999875432221
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|..||.+.+.......+
T Consensus 156 ~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 212 (283)
T cd07835 156 YTHEVVTLWYRAPEILLG-------SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212 (283)
T ss_pred cCccccccCCCCCceeec-------CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 122356788999998753 234688999999999999999999999988776655543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=247.96 Aligned_cols=197 Identities=28% Similarity=0.455 Sum_probs=166.9
Q ss_pred ceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|.+.+.||.|+||.||++.+. ++.+++|.+........ ...+.+|+.+++.++||||+++++.+.. ...+++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI----QKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHH----HHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 4777889999999999999874 78999999877544322 2357899999999999999999988854 467899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
+||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 78 MEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhhHHHH
Confidence 99999999999997632 678999999999999999999999 999999999999999965 459999999986543222
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
. ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 156 ~-~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 A-KTFVGTSSYMAPERIQG--------NDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred h-hcccCChhccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 2 22678889999998764 56789999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=270.43 Aligned_cols=202 Identities=20% Similarity=0.323 Sum_probs=150.0
Q ss_pred CceeecceeccccceeEEEEEEC---CceEEEEEcccCCC------------hhHHHHHHHHHHHHHHHHhhcCCCCcee
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYG---DRIVAIKVLNRGST------------SDERALLEGRFIREVNMMSRVKHDNLVK 122 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~---~~~vavK~~~~~~~------------~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 122 (290)
..|++++.||+|+||+||++... +..+++|.+..... ..........+.+|+.+++.++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 56999999999999999998642 22222221110000 0000112235779999999999999999
Q ss_pred EEeeeecC-ceEEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCc
Q 022903 123 FLGACKDP-LMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (290)
Q Consensus 123 ~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~ 198 (290)
+++++.+. ..+++++++ +++|.+++.... ........+..++.||+.||.|||++||+||||||+|||++.+ +.
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~-~~ 305 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD-GK 305 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CC
Confidence 99998754 678899998 557777764321 1223456778899999999999999999999999999999955 45
Q ss_pred eEEecccccccccccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCC-CCCC
Q 022903 199 LKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEG 269 (290)
Q Consensus 199 ~kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~-Pf~~ 269 (290)
+||+|||++....... ......||..|+|||++.+ ..++.++|||||||++|+|++|.. ||.+
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--------DGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 9999999997643322 2234579999999999865 568899999999999999999875 4443
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=241.23 Aligned_cols=206 Identities=35% Similarity=0.580 Sum_probs=173.0
Q ss_pred eeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~ 136 (290)
|.+.+.||+|++|.||++... ++.+++|++....... ...+.+|+.+++.++||+++++++.+.. ...++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK-----KEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhH-----HHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 677889999999999999874 7889999997755421 1347799999999999999999998865 4678999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccc
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~ 216 (290)
||+++++|.+++... ...+++..+..++.|++.+|.+||++|++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 77 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKAR 154 (253)
T ss_pred ecCCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeeccccccccccccc
Confidence 999999999998763 2578999999999999999999999999999999999999965 45999999998765444323
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
....++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+..+......
T Consensus 155 ~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 210 (253)
T cd05122 155 NTMVGTPYWMAPEVING--------KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA 210 (253)
T ss_pred cceecCCcccCHHHHcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Confidence 45578889999998764 447889999999999999999999999886555544443
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=249.17 Aligned_cols=195 Identities=25% Similarity=0.449 Sum_probs=156.3
Q ss_pred ceeccccceeEEEEEEC---------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceE
Q 022903 64 SKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 133 (290)
+.||+|+||.||+|... ...+++|.+...... ....+.+|+.+++.+.||||+++++.+.. ...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN-----YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHH-----HHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcE
Confidence 35899999999999652 234888877543221 22357789999999999999999999865 5788
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCc-------eEEecccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-------LKLADFGL 206 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~-------~kl~Dfg~ 206 (290)
+||||+++++|.+++... ...+++..++.++.||+.||.|||++|++||||||+||+++.++.. ++++|||+
T Consensus 76 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred EEEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999999998763 3468899999999999999999999999999999999999865432 79999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g-~~Pf~~~~~~~ 274 (290)
+..... .....++..|+|||.+.. ...++.++||||||+++|+|++| ..||...+...
T Consensus 155 ~~~~~~---~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~ 213 (258)
T cd05078 155 SITVLP---KEILLERIPWVPPECIEN-------PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213 (258)
T ss_pred ccccCC---chhccccCCccCchhccC-------CCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence 865432 223467889999998853 23468899999999999999998 57777655543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=243.43 Aligned_cols=198 Identities=30% Similarity=0.456 Sum_probs=168.7
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|.+.+.||.|++|.||+|.+ +++.|++|++....... ....+.+|+..+..++||||+++++.+.. ...+++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE----FRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchH----HHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 478889999999999999977 47899999987765431 12357899999999999999999998865 477899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
+||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 78 LEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTL 154 (264)
T ss_pred EEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceecccCC
Confidence 9999999999999763 678999999999999999999999 999999999999999965 459999999987643333
Q ss_pred cc-cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 215 MM-TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 215 ~~-~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.. ....++..|+|||.+.. ..++.++|+||||+++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQG--------ESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred CcccceeecccccCHhhhCC--------CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 22 23467889999998754 567889999999999999999999998875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=250.69 Aligned_cols=203 Identities=29% Similarity=0.456 Sum_probs=161.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-ceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~~~ 133 (290)
++|...+.||+|+||.||++.+ +++.||+|.+........ ...+.+|+.++.++. ||||+++++.+.++ ..+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~ 79 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE----QKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW 79 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHH----HHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence 3466778899999999999987 568999999876544322 235788999999996 99999999987644 678
Q ss_pred EEEEecCCCCHHHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 134 IVTELLPGMSLRKYL---VSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 134 lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
++|||+. +++.++. .......+++..+..++.|++.||+|||+. |++||||||+||+++.+ +.++|+|||++..
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~ 157 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQ 157 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhHH
Confidence 9999985 4665543 222346789999999999999999999975 99999999999999955 4599999999875
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
...........++..|+|||.+... ....++.++||||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 158 LVDSIAKTRDAGCRPYMAPERIDPS-----ARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred hccCCccccccCccCccCHHHhccc-----cccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 4433333344688899999988641 01367889999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=249.01 Aligned_cols=212 Identities=32% Similarity=0.465 Sum_probs=171.3
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
..|...+.||+|+||.||++++ ++..+|+|.+......... ....+.+|+.+++.++|||++++++.+.+. ..++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE--KWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchH--HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 3477889999999999999986 5689999998754333222 123578999999999999999999988654 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+.+ +|.+++.. ....+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 103 v~e~~~g-~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 103 VMEYCLG-SASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIASP-- 177 (317)
T ss_pred EEeCCCC-CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCccccCC--
Confidence 9999964 78777654 34568999999999999999999999999999999999999855 4599999998865332
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
.....++..|+|||.+... ....++.++|+||||+++|+|++|..||.+.........+...
T Consensus 178 -~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~ 239 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 239 (317)
T ss_pred -cccccCCccccChhhhhcC-----CCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 2344688899999987431 1245788999999999999999999999988777666665543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=254.63 Aligned_cols=208 Identities=33% Similarity=0.455 Sum_probs=167.4
Q ss_pred ccccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
.+....++|.+.+.||+|+||.||++.. +++.||+|++........ ....+.+|+.++++++||||+++++.+..
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhH---HHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3445567899999999999999999975 578999999875432221 12357789999999999999999988743
Q ss_pred -------CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEe
Q 022903 130 -------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 130 -------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~ 202 (290)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~ 162 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKIL 162 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEe
Confidence 2356777776 8899888764 4689999999999999999999999999999999999999654 59999
Q ss_pred cccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 203 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
|||++..... ......++..|+|||.+.. ...++.++|+|||||++|+|++|+.||.+.+.....
T Consensus 163 dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 163 DFGLARHTDD--EMTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred cccccccccc--cccccccCCCccCHHHHhC-------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999875432 2234467889999998743 245788999999999999999999999887654433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=268.19 Aligned_cols=221 Identities=29% Similarity=0.457 Sum_probs=191.2
Q ss_pred CceeecceeccccceeEEEEE--ECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeee------
Q 022903 58 KLLFIGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK------ 128 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~------ 128 (290)
..+.+.+.||.|.+|.||+++ +.++.+|+|+.......++. +..|.++++.+ +|||++.+++++.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deE------iE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEE------IELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHH------HHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 458889999999999999985 47899999999887765543 45778888887 5999999999873
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
++.+|||||||.||+..++++......+.+..+..|++.++.||.+||.+.++|||||=.|||++.+++ |||+|||.+.
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~-VKLvDFGvSa 171 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE-VKLVDFGVSA 171 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc-EEEeeeeeee
Confidence 457999999999999999999888888999999999999999999999999999999999999996665 9999999987
Q ss_pred ccc-ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhcccc
Q 022903 209 EET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESI 287 (290)
Q Consensus 209 ~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~~ 287 (290)
+.. .....++..||+.|||||++.+- +.....|+.++|+||||++..||.-|.+|+.++.++..++.|.-+.+..|
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~---e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL 248 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACD---ESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 248 (953)
T ss_pred eeecccccccCcCCCcccccceeeecc---cCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc
Confidence 533 33455677999999999998772 23346688899999999999999999999999999999999988777665
Q ss_pred c
Q 022903 288 Y 288 (290)
Q Consensus 288 ~ 288 (290)
-
T Consensus 249 k 249 (953)
T KOG0587|consen 249 K 249 (953)
T ss_pred c
Confidence 4
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=246.10 Aligned_cols=208 Identities=32% Similarity=0.484 Sum_probs=172.7
Q ss_pred CceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
+.|.+...||+|+||.||++.+. +..|++|++..... . ...+.+|+.+++.++|+||+++++.+.. ...++
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-N-----KELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-h-----HHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 44788899999999999999874 78999999876544 1 2347789999999999999999998854 47889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
++||+++++|.+++.... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-CCEEECccchhhhhccch
Confidence 999999999999998732 479999999999999999999999999999999999999955 459999999876433221
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.........+..
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~ 230 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKR--------KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT 230 (286)
T ss_pred hhhccccCCcccCCHhHhcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 1223357789999998754 5578999999999999999999999998877665555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=254.78 Aligned_cols=201 Identities=30% Similarity=0.467 Sum_probs=164.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-----
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 130 (290)
..|.+.+.||+|+||.||++++ +++.||+|.+......... ..++.+|+.+++.++||||+++++.+...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID---AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccch---hHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 3588999999999999999986 5789999998754322211 12466899999999999999999877432
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++++||+. ++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCccccc
Confidence 3689999995 689988875 4579999999999999999999999999999999999999955 4599999999876
Q ss_pred cccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 210 ETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 210 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
.... .......++..|+|||.+.. ...++.++|+||||+++|+|++|+.||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLN-------CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred cCCCcccccccccccCccChHHHhc-------CCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 4332 22234467889999998753 13478899999999999999999999988654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=252.32 Aligned_cols=203 Identities=24% Similarity=0.383 Sum_probs=161.6
Q ss_pred ceeccc--cceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEe
Q 022903 64 SKIGEG--AHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTEL 138 (290)
Q Consensus 64 ~~lG~G--~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~ 138 (290)
..||+| +||+||++++ .++.||+|+.......... .+.+.+|+.+++.++||||+++++++..+ ..++|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEH---LKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHH---HHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 346666 9999999987 6899999998765443322 24578999999999999999999999754 67899999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc---
Q 022903 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--- 215 (290)
Q Consensus 139 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~--- 215 (290)
+.+++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.+ +.++++||+.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCcccc
Confidence 999999999987555678999999999999999999999999999999999999955 4599999985432111000
Q ss_pred -----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 216 -----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 216 -----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
.....++..|+|||.+.. ....++.++|||||||++|+|++|..||.+....+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 219 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQ------DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219 (328)
T ss_pred ccccccccccCccCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH
Confidence 011234567999998754 1234688999999999999999999999987655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=245.75 Aligned_cols=202 Identities=31% Similarity=0.474 Sum_probs=165.7
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~ 136 (290)
|...+.||.|++|.||++.+ .++.+++|.+........ ..+.+|+.+++.++||||+++++.+.. ...++++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR-----ELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHH-----HHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 44557899999999999976 568899998864332221 247799999999999999999998764 4788999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-c
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~ 215 (290)
||+.+++|.+++.. ..++...+..++.|++.||+|||++|++||||+|+||+++.+ +.++|+|||.+....... .
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 96 EFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred eccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhccCCcc
Confidence 99999999999875 468899999999999999999999999999999999999955 469999999876432221 2
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+.......
T Consensus 172 ~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~ 226 (285)
T cd06648 172 RKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR 226 (285)
T ss_pred cccccCCccccCHHHhcC--------CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH
Confidence 233468889999998754 5578899999999999999999999988766544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=244.13 Aligned_cols=202 Identities=29% Similarity=0.549 Sum_probs=160.4
Q ss_pred eeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC----
Q 022903 60 LFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 130 (290)
|.+.+.||+|+||.||+|.. ++..||+|++......... ...+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD---IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHH---HHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 45678899999999999975 3578999998765433322 23578999999999999999999987432
Q ss_pred ---ceEEEEEecCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEec
Q 022903 131 ---LMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (290)
Q Consensus 131 ---~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~D 203 (290)
..+++++|+.+++|.+++.... ...++...+..++.|++.||+|||++|++||||||+||+++.+ ..++|+|
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~d 156 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVAD 156 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECc
Confidence 2368889999999998875322 1247888999999999999999999999999999999999854 4599999
Q ss_pred ccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHH
Q 022903 204 FGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273 (290)
Q Consensus 204 fg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~ 273 (290)
||++....... ......+++.|++||.+.. ..++.++||||||+++|+|++ |..||.+....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~ 222 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLAD--------NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhc--------CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH
Confidence 99987543221 1122345678999998754 557889999999999999999 99999886653
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=245.39 Aligned_cols=207 Identities=32% Similarity=0.496 Sum_probs=167.4
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc---CCCCceeEEeeeecC-c--
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACKDP-L-- 131 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~-~-- 131 (290)
|++.+.||+|+||.||+|++ +++.||+|.+......... ...+.+|+.+++.+ +||||+++++.+.+. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 77 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI---PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchh---hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCC
Confidence 56778999999999999987 4789999999754432221 12355677776655 599999999998643 3
Q ss_pred ---eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 132 ---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 132 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
.+++|||+. ++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||.+.
T Consensus 78 ~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~ 155 (287)
T cd07838 78 ELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLAR 155 (287)
T ss_pred CceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcce
Confidence 789999996 489998876444568999999999999999999999999999999999999966 569999999987
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
............++..|+|||.+.. ..++.++|+||||+++|+|++|.+||.+.+..+...++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~ 218 (287)
T cd07838 156 IYSFEMALTSVVVTLWYRAPEVLLQ--------SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218 (287)
T ss_pred eccCCcccccccccccccChHHhcc--------CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence 6544433344457889999998864 55788999999999999999999999998776655444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=251.03 Aligned_cols=208 Identities=23% Similarity=0.351 Sum_probs=166.8
Q ss_pred eeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEe
Q 022903 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTEL 138 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~ 138 (290)
+.+++.+|.|+++.|++++.+++.||+|++......... ..++.+|+.+++.++||||+++++++.+. ..+++|||
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~---~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKED---LKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhH---HHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 345566677777777777778999999999765322222 23588999999999999999999988654 67899999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc----
Q 022903 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---- 214 (290)
Q Consensus 139 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---- 214 (290)
+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||.+.......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeecccccccc
Confidence 999999999987556678999999999999999999999999999999999999954 469999999876432111
Q ss_pred ----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 215 ----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 215 ----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
......++..|+|||.+.. ....++.++|+||||+++|+|++|..||..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~ 220 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQ------NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (314)
T ss_pred ccccccccccccccccCHHHhcC------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 1123346778999998754 12357889999999999999999999999876655443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=248.00 Aligned_cols=214 Identities=28% Similarity=0.375 Sum_probs=171.8
Q ss_pred cccccccccCCCceeecceeccccceeEEEEEEC------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc
Q 022903 47 LTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120 (290)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 120 (290)
...++..+.+...|..+..||+|+||.||+|..+ ...+|+|.++......-.. ..-.+|+.+++.++|||+
T Consensus 13 ~~ser~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS---~SAcREiaL~REl~h~nv 89 (438)
T KOG0666|consen 13 LASERERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS---MSACREIALLRELKHPNV 89 (438)
T ss_pred hhhhhhhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC---HHHHHHHHHHHHhcCCcc
Confidence 3445555566677999999999999999999431 2379999998764322111 124699999999999999
Q ss_pred eeEEeeee--cCceEEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC
Q 022903 121 VKFLGACK--DPLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 195 (290)
Q Consensus 121 v~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~ 195 (290)
+.+..++- +...++++||.+. +|...+...+ ...++...+..|+.||+.|+.|||++=|+||||||.|||+..+
T Consensus 90 i~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgd 168 (438)
T KOG0666|consen 90 ISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGD 168 (438)
T ss_pred hhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEecc
Confidence 99998874 4578899999965 8888875432 3468999999999999999999999999999999999999744
Q ss_pred ---CCceEEecccccccccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 196 ---QKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 196 ---~~~~kl~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
.+.|||+|||+++.....- .....+.|..|.|||++.+ ..+|+.+.|+||.|||+.||++-++-|.
T Consensus 169 gperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG-------a~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 169 GPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG-------ARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred CCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcc-------cccccchhhhHHHHHHHHHHHccCcccc
Confidence 3569999999998643332 1123356889999999987 5789999999999999999999999998
Q ss_pred CCC
Q 022903 269 GMS 271 (290)
Q Consensus 269 ~~~ 271 (290)
+..
T Consensus 242 g~E 244 (438)
T KOG0666|consen 242 GRE 244 (438)
T ss_pred chh
Confidence 853
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=247.04 Aligned_cols=207 Identities=29% Similarity=0.459 Sum_probs=170.0
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-ceEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~~~lv 135 (290)
|.+.+.||+|+||.||+|.. +++.|++|.+......... ....+|+..+++++ ||||+++++.+.+. ..++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~----~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE----CMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhH----HHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEE
Confidence 56778999999999999987 5688999998764432221 12457899999998 99999999988654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+ +++|.+++.......+++..+..++.|++.+|.|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCC
Confidence 9999 8899998877544578999999999999999999999999999999999999954 4599999999976544433
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.....++..|+|||.+.. ...++.++|+||||+++++|++|.+||.+.+..+....+
T Consensus 155 ~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~ 211 (283)
T cd07830 155 YTDYVSTRWYRAPEILLR-------STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI 211 (283)
T ss_pred cCCCCCcccccCceeeec-------CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHH
Confidence 344567889999998753 245788999999999999999999999888766554433
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=240.26 Aligned_cols=204 Identities=30% Similarity=0.531 Sum_probs=170.9
Q ss_pred ceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|.+.+.||.|+||.||++.+. ++.|++|++......... ...+.+|+++++.++|||++++.+.+.+ ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKE---REDALNEVKILKKLNHPNIIKYYESFEEKGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHH---HHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEE
Confidence 3778899999999999999875 789999998765543222 1347789999999999999999998865 467899
Q ss_pred EEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+|++++++|.+++.... ...++...+..++.+++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceeecccC
Confidence 99999999999997643 4679999999999999999999999999999999999999954 45999999998764433
Q ss_pred c-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 214 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
. ......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||...+..+
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 210 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQN--------KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210 (258)
T ss_pred cceecceeeeecccChhHhcc--------CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH
Confidence 2 2334468889999998754 557889999999999999999999998876443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=252.61 Aligned_cols=205 Identities=32% Similarity=0.469 Sum_probs=167.1
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 130 (290)
..++|.+++.||+|+||.||++.. ++..||+|++........ ....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchH---HHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 356699999999999999999976 578999999865332221 223577999999999999999999988532
Q ss_pred ----ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 131 ----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 131 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
..++||+|+ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.+ +.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~ 164 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKILDFGL 164 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeccc
Confidence 357999998 7799988764 568999999999999999999999999999999999999955 4599999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
+...... .....+++.|+|||.+.. ...++.++|+||||+++|+|++|..||.+.+......
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~ 226 (343)
T cd07880 165 ARQTDSE--MTGYVVTRWYRAPEVILN-------WMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM 226 (343)
T ss_pred ccccccC--ccccccCCcccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 8754322 223467889999998753 1347889999999999999999999999876544433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=241.43 Aligned_cols=199 Identities=27% Similarity=0.382 Sum_probs=159.4
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHH-HhhcCCCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNM-MSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||.|+||.||+|.. .++.||+|++........... ..+..|..+ ...++|||++++++.+.+. ..++|+||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQV--TNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHH--HHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 5689999999999977 568999999875433222111 123344444 3445899999999998654 688999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 219 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 219 (290)
++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.++|+|||++..... ....
T Consensus 80 ~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 80 NGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred CCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceeccc---cccC
Confidence 99999999876 3568999999999999999999999999999999999999955 4699999999875332 2334
Q ss_pred CCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 220 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 220 ~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
.++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....
T Consensus 154 ~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 204 (260)
T cd05611 154 VGTPDYLAPETILG--------VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN 204 (260)
T ss_pred CCCcCccChhhhcC--------CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 67889999998764 4478899999999999999999999998776554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=252.92 Aligned_cols=207 Identities=31% Similarity=0.453 Sum_probs=166.3
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC---c
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP---L 131 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~---~ 131 (290)
.+|.+.+.||+|+||.||+|.+ +++.+|+|.+......... ...+.+|+.+++++ +||||+++++++... .
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~---~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD---AQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchh---hhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 4588899999999999999976 5789999988653222211 12466899999999 999999999987532 4
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~ 158 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLS 158 (337)
T ss_pred EEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhccc
Confidence 789999996 599988865 277888899999999999999999999999999999999955 469999999987532
Q ss_pred ccc------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 212 VTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 212 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
... ......++..|+|||.+.. ...++.++|+||||+++|+|++|+.||.+.++.+...++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~ 225 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLG-------STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI 225 (337)
T ss_pred cccccccCcchhcccccccccCceeeec-------cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 221 2223467889999998753 245688999999999999999999999987766554443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=252.08 Aligned_cols=203 Identities=25% Similarity=0.406 Sum_probs=161.0
Q ss_pred eeecceeccccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---ce
Q 022903 60 LFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LM 132 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~ 132 (290)
|.+.+.||+|+||.||+|.. .++.||+|.+......... ....+.+|+.+++.++||||+++++.+.+. ..
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG--ISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccC--ccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 77889999999999999987 4689999999874311110 112366899999999999999999998654 57
Q ss_pred EEEEEecCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC---CCCceEEecccc
Q 022903 133 VIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP---DQKSLKLADFGL 206 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~---~~~~~kl~Dfg~ 206 (290)
++||||+++ +|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++. ..+.+||+|||+
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 899999964 7777765322 236889999999999999999999999999999999999985 145699999999
Q ss_pred ccccccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 207 AREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 207 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
+........ .....++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 875332211 223457888999998753 24578899999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=245.44 Aligned_cols=205 Identities=30% Similarity=0.447 Sum_probs=166.1
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---ceEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LMVI 134 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~l 134 (290)
|.+.+.||.|+||.||+|+. .++.+|+|.+......... ...+.+|+.+++.++|||++++++.+.+. ..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGF---PITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccc---hHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEE
Confidence 56778999999999999987 4589999999876422111 12467899999999999999999998654 6889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
|+||+++ +|.+++... ...+++..+..++.|++.||+|||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 78 v~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 78 VFEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRN 154 (287)
T ss_pred Eeccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCC
Confidence 9999964 898888652 3578999999999999999999999999999999999999954 569999999987644332
Q ss_pred --cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 215 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 215 --~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
......++..|+|||.+.+ ...++.++||||||+++|+|++|..||.+.+......
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~ 212 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLG-------ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212 (287)
T ss_pred cccccccccccccCCceeeEc-------cccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 1223356788999997653 2356889999999999999999999999877544333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=246.86 Aligned_cols=203 Identities=31% Similarity=0.479 Sum_probs=165.6
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~ 136 (290)
|.....||+|+||.||++.. +++.||+|.+....... ...+.+|+.+++.++||||+++++.+.+ ...+++|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR-----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhH-----HHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 33446799999999999976 57899999875433221 2357899999999999999999998865 4788999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-c
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~ 215 (290)
||+++++|.+++.. ..+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~ 172 (292)
T cd06657 97 EFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPR 172 (292)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceeccccccc
Confidence 99999999998754 4688999999999999999999999999999999999999654 59999999876533221 1
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||.+....+....+
T Consensus 173 ~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~ 228 (292)
T cd06657 173 RKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228 (292)
T ss_pred ccccccCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 233467889999998754 55788999999999999999999999987665544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=248.14 Aligned_cols=207 Identities=29% Similarity=0.401 Sum_probs=165.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-----
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 130 (290)
..|.+.+.||.|+||.||+|.+ +++.||+|++......... ...+.+|+.+++.++||||+++++.+.+.
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~---~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF---PITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCc---hHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4588899999999999999987 5689999998754322211 12466899999999999999999887542
Q ss_pred ------ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 131 ------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 131 ------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
..++|+||+++ ++..++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ +.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeCcc
Confidence 57899999975 777777652 4578999999999999999999999999999999999999954 56999999
Q ss_pred cccccccccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 205 GLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 205 g~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
|++....... ......++..|+|||.+.. ...++.++|||||||++|+|++|+.||...+..+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~ 228 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLG-------EERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9987543322 1122345778999998753 2346789999999999999999999998876654443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=260.42 Aligned_cols=207 Identities=32% Similarity=0.558 Sum_probs=177.8
Q ss_pred cccccCCCceeecceeccccceeEEEEEECC--ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
+.|.++..+....++||-|.||.||.|.|+. -.||||.++.+...- ..|++|..+|+.++|||+|+|+|+|.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMev------eEFLkEAAvMKeikHpNLVqLLGVCT 333 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------EEFLKEAAVMKEIKHPNLVQLLGVCT 333 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhH------HHHHHHHHHHHhhcCccHHHHhhhhc
Confidence 5677888889999999999999999998854 579999987654432 35899999999999999999999996
Q ss_pred -cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 129 -DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 129 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
++-+|+|.|||..|+|.+|+++.....++....+.++.||..|++||..+++|||||..+|+|+. +++.||++|||++
T Consensus 334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg-EnhiVKvADFGLs 412 (1157)
T KOG4278|consen 334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG-ENHIVKVADFGLS 412 (1157)
T ss_pred cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc-ccceEEeeccchh
Confidence 55789999999999999999986666688888899999999999999999999999999999999 5567999999999
Q ss_pred cccccccccccc--CCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCH
Q 022903 208 REETVTEMMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272 (290)
Q Consensus 208 ~~~~~~~~~~~~--~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~ 272 (290)
+.+..+..+... .-..-|.|||.+.. ..++.++|||+||++|||+.| |-.||.|.+-
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAy--------NtFSiKSDVWAFGVLLWEIATYGMsPYPGidl 472 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAY--------NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 472 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccc--------cccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence 986554432221 22567999999875 678999999999999999998 9999999653
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=245.52 Aligned_cols=210 Identities=29% Similarity=0.441 Sum_probs=169.7
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|...+.||+|+||.||+|+. +++.|++|++.......... ...+.+|+.+++.++|||++++++.+.+. ..++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEK--WQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHH--HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 55667899999999999976 67899999987654332221 13577899999999999999999998654 678999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccc
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 216 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~ 216 (290)
||+. ++|.+++.. ....+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||++.... ..
T Consensus 101 e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~---~~ 174 (313)
T cd06633 101 EYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS---PA 174 (313)
T ss_pred ecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccC---CC
Confidence 9995 578777764 345689999999999999999999999999999999999999554 59999999986432 22
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
....++..|+|||.+... ....++.++|+||||+++|+|++|..||.+.+.....+.+...
T Consensus 175 ~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~ 235 (313)
T cd06633 175 NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 235 (313)
T ss_pred CCccccccccChhhcccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc
Confidence 345688899999987431 1245788999999999999999999999988777766665543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=242.79 Aligned_cols=211 Identities=28% Similarity=0.509 Sum_probs=168.1
Q ss_pred eeecceeccccceeEEEEEEC---CceEEEEEcccCCChh-----HHHHHHHHHHHHHHHHhh-cCCCCceeEEeeeec-
Q 022903 60 LFIGSKIGEGAHGKVYEGRYG---DRIVAIKVLNRGSTSD-----ERALLEGRFIREVNMMSR-VKHDNLVKFLGACKD- 129 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~---~~~vavK~~~~~~~~~-----~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~- 129 (290)
|++.+.||+|+||.||++.+. ++.+|+|.+....... .......++.+|+.++.+ ++||||+++++.+.+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 778889999999999999873 4789999876432211 111122346688888865 689999999998865
Q ss_pred CceEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
...+++|||+++++|.+++... ....+++..+..++.|++.+|.|||+ .|++|+||+|+||+++.++ .++|+|||.
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~dfg~ 160 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITDFGL 160 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEecccc
Confidence 4788999999999999987542 34568899999999999999999996 7899999999999999554 599999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
+.............++..|+|||.+.. ..++.++|+||||+++|+|++|..||...........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~ 225 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKN--------EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI 225 (269)
T ss_pred eeecccccccccccCcccCcChhhhcC--------CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH
Confidence 976544433345578899999998864 55788999999999999999999999876655444333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=245.61 Aligned_cols=208 Identities=28% Similarity=0.476 Sum_probs=164.7
Q ss_pred ccCCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 130 (290)
..+.+.|.+.+.||+|+||.||+|.+. ++.||||.+......... ..+.+|+.++..+. ||||+++++.+.+.
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~----~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN----KRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHH----HHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 345567899999999999999999885 889999999765433222 23556777666665 99999999998654
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
..+++|||+ +++|.+++... ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.+ +.++|+|||++.
T Consensus 87 ~~~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~dfg~~~ 163 (296)
T cd06618 87 SDVFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDFGISG 163 (296)
T ss_pred CeEEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECccccch
Confidence 688999998 55788877653 3578999999999999999999997 599999999999999954 569999999987
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
............++..|+|||.+.... ....++.++|+||||+++|+|++|+.||.....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 223 (296)
T cd06618 164 RLVDSKAKTRSAGCAAYMAPERIDPPD----PNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223 (296)
T ss_pred hccCCCcccCCCCCccccCHhhcCCCC----CccccccchhHHHHHHHHHHHHhCCCCCCcchh
Confidence 543333333445778999999875411 124578899999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=242.19 Aligned_cols=190 Identities=22% Similarity=0.344 Sum_probs=153.9
Q ss_pred eeecce--eccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceE
Q 022903 60 LFIGSK--IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 60 ~~~~~~--lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~ 133 (290)
|.+.+. ||+|+||.||++.. ++..+|+|+......... |+.....+ +||||+++++.+... ..+
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----------e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----------EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----------hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 444454 59999999999976 568899999865432211 22222222 699999999998654 688
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++..++|+|||++......
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 999999999999999763 478999999999999999999999999999999999999977647999999998754322
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
....++..|+|||.+.. ..++.++|+||||+++|+|++|..||.....
T Consensus 164 ---~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKG--------HNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred ---ccCCCCCcccChhhhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 23468889999998864 5678899999999999999999999986544
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=245.96 Aligned_cols=201 Identities=33% Similarity=0.560 Sum_probs=165.3
Q ss_pred CCceeecceeccccceeEEEEEEC------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 129 (290)
.+.|++.+.||+|+||.||++++. ++.+|+|++....... ....+.+|+.+++.+.||||+++++++.+
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~ 78 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQ----HRSDFEREIEILRTLDHENIVKYKGVCEKP 78 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchH----HHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence 346788899999999999999753 5789999998665541 12358899999999999999999998764
Q ss_pred --CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 130 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
...+++|||+++++|.+++... ...+++..+..++.|++.||+|||++|++|+||||+||+++.+ ..++|+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~ 156 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLA 156 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccccc
Confidence 2578999999999999999763 3468999999999999999999999999999999999999965 56999999998
Q ss_pred cccccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 208 REETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 208 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
........ .....++..|+|||.+.. ..++.++|+||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRT--------SKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHcc--------CCCCcccchHHHhhhhheeeccCCCccccc
Confidence 76442211 112234567999998754 467889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=237.93 Aligned_cols=198 Identities=31% Similarity=0.534 Sum_probs=169.3
Q ss_pred eeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---ceEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---LMVI 134 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~l 134 (290)
|.+.+.||+|++|.||+|... ++.|++|++......... ...+.+|+.++++++||||+++++.+.+. ..++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE---LEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHH---HHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 677789999999999999874 789999998766543221 24578999999999999999999988654 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
++||+.+++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEeccccc
Confidence 99999999999998863 388999999999999999999999999999999999999965 459999999988655443
Q ss_pred c---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 215 M---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 215 ~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
. .....++..|+|||.+.. ...+.++|+||||+++|+|++|..||....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRG--------EEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccccCCCCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 344578889999998764 447899999999999999999999998876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=237.04 Aligned_cols=208 Identities=29% Similarity=0.505 Sum_probs=173.3
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|.+.+.||+|++|.||++.. .++.|++|.+......... ...+.+|++++++++|||++++++.+.+ ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEA---LKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHH---HHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEE
Confidence 377889999999999999976 5688999999876543221 2358899999999999999999988765 467899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|+|+++++|.+++... ..+++..+..++.|++.+|.|||++|++||||+|+||+++.+ +.++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 78 LEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCcc
Confidence 9999999999998763 678999999999999999999999999999999999999964 5699999999876443322
Q ss_pred -ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 216 -MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 216 -~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.....++..|+|||.... ..++.++|+||||+++|+|++|..||...+.........
T Consensus 155 ~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEM--------SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred cccccccchhhcCHhhhcC--------CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 233467889999998754 347889999999999999999999999877665555543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=253.39 Aligned_cols=203 Identities=29% Similarity=0.439 Sum_probs=165.3
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-----C
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-----P 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 130 (290)
.+|.+.+.||.|+||.||++.. +++.||+|++......... ...+.+|+.+++.++||||+++++.+.. .
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL---AKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccc---hHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 5688899999999999999976 5789999998764332211 2346789999999999999999887642 3
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+. ++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++...
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceee
Confidence 5789999995 689988865 3558999999999999999999999999999999999999955 45999999998753
Q ss_pred cccc-----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 211 TVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 211 ~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
.... ......++..|+|||.+.. ...++.++|+||||+++|+|++|+.||.+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~ 219 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLS-------LPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcC-------CcccccccchHHHHHHHHHHHcCCCccCCCChHH
Confidence 3221 1123467889999998753 2457889999999999999999999998876544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=248.80 Aligned_cols=209 Identities=29% Similarity=0.435 Sum_probs=164.8
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 129 (290)
.++|.+.+.||.|+||.||+|.+ +++.+|+|.+.......... ..+.+|+++++.++||||+++++.+.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFP---ITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcc---hhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 35699999999999999999987 56889999986543322111 135689999999999999999887632
Q ss_pred ----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 130 ----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 130 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
...++|++|+.+ +|...+.. ....+++..+..++.|++.||.|||++|++|+||||+||+++.+ +.++|+|||
T Consensus 84 ~~~~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg 160 (311)
T cd07866 84 KRKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFG 160 (311)
T ss_pred cccCceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCc
Confidence 236899999954 77776654 34579999999999999999999999999999999999999955 469999999
Q ss_pred cccccccccc------------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 206 LAREETVTEM------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 206 ~~~~~~~~~~------------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
++........ .....+++.|+|||.+.+ ...++.++||||||+++|+|++|.+||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-------ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhC-------CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9875322211 112245778999998753 245788999999999999999999999987776
Q ss_pred HHHHH
Q 022903 274 QAAYA 278 (290)
Q Consensus 274 ~~~~~ 278 (290)
.....
T Consensus 234 ~~~~~ 238 (311)
T cd07866 234 DQLHL 238 (311)
T ss_pred HHHHH
Confidence 54443
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=250.02 Aligned_cols=198 Identities=31% Similarity=0.576 Sum_probs=162.3
Q ss_pred CceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhh--cCCCCceeEEeeeec-----C
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR--VKHDNLVKFLGACKD-----P 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~-----~ 130 (290)
++..+.+.||+|.||+||+|++.|+.||||++...... .+.+|.++++. |+|+||+.|+++-.. .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~--------SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDER--------SWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccchh--------hhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 45788899999999999999999999999999765432 37788888887 489999999987632 2
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeecCCCCCEEEcCCCCceEEe
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------givH~Dikp~Nili~~~~~~~kl~ 202 (290)
++++|.+|.+.|+|.||+.. ..++....++++..++.||++||.. .|.|||||..||||.++ +++.|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEEe
Confidence 68999999999999999986 6799999999999999999999964 59999999999999955 469999
Q ss_pred ccccccccccc-----ccccccCCCccccCccccccccccccccCCCC--CcchhHHHHHHHHHHHhC----------CC
Q 022903 203 DFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN--NKVDVYSFGIVLWELLTN----------RL 265 (290)
Q Consensus 203 Dfg~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~--~~~DiwslG~~l~~~l~g----------~~ 265 (290)
|+|++...... ...+..+||.+|||||++... .+...+. ..+||||||.++||+... ++
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdet----in~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDET----INMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhh----cChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 99998753322 345667899999999998652 1223332 478999999999999862 47
Q ss_pred CCCCCC
Q 022903 266 PFEGMS 271 (290)
Q Consensus 266 Pf~~~~ 271 (290)
||-+..
T Consensus 435 Pyyd~V 440 (513)
T KOG2052|consen 435 PYYDVV 440 (513)
T ss_pred CcccCC
Confidence 776653
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=249.98 Aligned_cols=208 Identities=29% Similarity=0.433 Sum_probs=164.2
Q ss_pred eecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHH---------HHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 61 FIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERA---------LLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 61 ~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
.+.+.||.|+||.||+|.+ .++.||+|++.......... .....+.+|+.+++.++||||+++++.+..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 3557799999999999976 57899999986543322110 001136789999999999999999998864
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
...++||||+. ++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||++.
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl~dfg~~~ 167 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKIADFGLAR 167 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEECCcccee
Confidence 46789999996 689998865 4568999999999999999999999999999999999999955 469999999986
Q ss_pred ccccc---------------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 209 EETVT---------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 209 ~~~~~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
..... .......+++.|+|||.+.+ ...++.++|+||||+++|+|++|..||.+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-------AEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhccc-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 54311 11122346778999998754 234688999999999999999999999988776
Q ss_pred HHHHHH
Q 022903 274 QAAYAA 279 (290)
Q Consensus 274 ~~~~~~ 279 (290)
+....+
T Consensus 241 ~~~~~i 246 (335)
T PTZ00024 241 DQLGRI 246 (335)
T ss_pred HHHHHH
Confidence 554433
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=239.96 Aligned_cols=205 Identities=28% Similarity=0.477 Sum_probs=169.7
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv 135 (290)
+|.+.+.||.|+||.||++++ +++.+++|.+......... ...+.+|+.+++.++||||+++.+.+.+ ...++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE---REDAVNEIRILASVNHPNIISYKEAFLDGNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHH---HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEE
Confidence 377889999999999999976 5688999998764433222 2356789999999999999999988754 467899
Q ss_pred EEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||+++++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.+ ..++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhhhccC
Confidence 99999999999986522 2468889999999999999999999999999999999999964 45999999998765443
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
......++..|+|||.+.. ..++.++|+||||+++|+|++|+.||...+..+..
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG--------RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210 (256)
T ss_pred -CcccccCCccccCHHHHCC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 3334567889999998754 56788999999999999999999999987765433
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=243.50 Aligned_cols=206 Identities=29% Similarity=0.468 Sum_probs=167.2
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeee-ecC
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC-KDP 130 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~ 130 (290)
....+++-+..||.|+||+|++..+ .++..|||.++......+. .+++.|.....+- +.||||++||+. .++
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq----~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQ----KRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHH----HHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 4556677788999999999999866 6899999999876664433 3677887766554 689999999985 577
Q ss_pred ceEEEEEecCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 131 LMVIVTELLPGMSLRKYLV---SLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
..|+.||.+ ..+|..+.. .-....+++..+-.|.-..+.||.||-.. .|||||+||+|||+|..+ .+||||||+
T Consensus 137 dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGI 214 (361)
T KOG1006|consen 137 DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGI 214 (361)
T ss_pred ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccc
Confidence 899999999 567766543 23346799999999999999999999854 899999999999999655 599999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
+-.....-..+.-.|-..|||||.+.. ....|+-++|+||||++|||+.||..||.+-+.
T Consensus 215 cGqLv~SiAkT~daGCrpYmAPERi~p------~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 215 CGQLVDSIAKTVDAGCRPYMAPERIDP------SDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred hHhHHHHHHhhhccCCccccChhccCC------ccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 976554444455578889999999875 234689999999999999999999999998654
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=240.63 Aligned_cols=200 Identities=33% Similarity=0.510 Sum_probs=164.5
Q ss_pred eccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecCCC
Q 022903 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGM 142 (290)
Q Consensus 66 lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~~ 142 (290)
||.|+||.||++++ +++.+++|++......... ....+.+|+.++++++||||+++++.+... ..++++||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKN--QVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhh--HHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCC
Confidence 68999999999987 4789999998765442211 234578999999999999999999888654 678999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc--------
Q 022903 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-------- 214 (290)
Q Consensus 143 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-------- 214 (290)
+|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 79 ~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 79 DLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccccccccc
Confidence 999998763 4789999999999999999999999999999999999999654 59999999987543321
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
......++..|+|||.... ...+.++|+||||+++|++++|..||......+....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 212 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--------QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN 212 (265)
T ss_pred ccccCcccCccccCHHHhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1223457788999998754 4478899999999999999999999988776554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=250.26 Aligned_cols=204 Identities=33% Similarity=0.491 Sum_probs=168.6
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC------
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP------ 130 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 130 (290)
+|.+.+.||.|+||.||+|+. .++.||+|.+........ ....+.+|+.+++.++||||+++++.+.+.
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~ 77 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI---DAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccch---hhhhHHHHHHHHHhcCCcchhhhhhhhcccCccccc
Confidence 478889999999999999987 468999999876432111 123578999999999999999999988654
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..+++|+|+. ++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.+ +.++|+|||++...
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~ 153 (330)
T cd07834 78 DVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGV 153 (330)
T ss_pred ceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEee
Confidence 5789999996 589888865 3479999999999999999999999999999999999999965 56999999999865
Q ss_pred cccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 211 TVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 211 ~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
.... ......++..|+|||.+.. ...++.++|+||||+++|+|++|..||.+.+..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~ 216 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLS-------SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL 216 (330)
T ss_pred cccccccccccccccccCcCCceeeec-------ccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH
Confidence 4432 2334467889999998865 126789999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=250.67 Aligned_cols=214 Identities=27% Similarity=0.417 Sum_probs=175.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHH--HHHHHHHHHHHHHHhhcCCCCceeEEeeee-c-Cc
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER--ALLEGRFIREVNMMSRVKHDNLVKFLGACK-D-PL 131 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~-~~ 131 (290)
++|.++..||+|+|+.||+|-+ ..+.||||+-.......+. +.......+|..|.+.|.||.||++|+++. | ..
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 5688899999999999999965 5689999997655544332 223445678999999999999999999985 3 36
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CCeeecCCCCCEEEcCCC--CceEEeccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--GIIHRDLKPDNLLLTPDQ--KSLKLADFGLA 207 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--givH~Dikp~Nili~~~~--~~~kl~Dfg~~ 207 (290)
++-|.|||+|.+|+-|++. ...+++..++.|+-||+.||.||.+. .|||-||||.|||+..++ +.+||+|||++
T Consensus 543 FCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 7899999999999999986 56799999999999999999999976 699999999999996332 35999999999
Q ss_pred cccccc--------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 208 REETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 208 ~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
+.+... +.+....||..|+|||++... -.....+.++||||.|||+|+++.|+.||-.....+.+.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg----kePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL 694 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG----KEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL 694 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecC----CCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence 865433 234556799999999998752 123567899999999999999999999998865544443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=247.13 Aligned_cols=202 Identities=29% Similarity=0.432 Sum_probs=160.6
Q ss_pred ceeecceeccccceeEEEEEEC----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec----
Q 022903 59 LLFIGSKIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD---- 129 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---- 129 (290)
.|.+.+.||+|+||.||++++. +..||+|.+........ ....+.+|+.+++++ +||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI---LAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccch---hHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 3778899999999999999874 56899999865332221 123467899999999 59999999886421
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
...+++++++ +++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 78 ~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~ 153 (332)
T cd07857 78 FNELYLYEELM-EADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLAR 153 (332)
T ss_pred CCcEEEEEecc-cCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCce
Confidence 2467888888 4689998864 4578999999999999999999999999999999999999965 459999999987
Q ss_pred cccccc-----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 209 EETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 209 ~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
...... ......++..|+|||.+.. ...++.++|+||||+++|+|++|..||.+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~ 217 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLS-------FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD 217 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH
Confidence 532211 1223468899999997643 2457889999999999999999999998866443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=244.62 Aligned_cols=210 Identities=29% Similarity=0.420 Sum_probs=168.1
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.|...+.||+|+||.||+|+. +++.+++|.+.......... ..++.+|+.+++.++|+|++++++++.+. ..++|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK--WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHH--HHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 477788999999999999987 56789999986533222211 23577899999999999999999988654 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+. ++|.+++.. ....+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 94 MEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP--- 167 (308)
T ss_pred EEccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeecC---
Confidence 99996 588777754 24568999999999999999999999999999999999999955 4699999999865432
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.....++..|+|||.+.... ...++.++|||||||++|+|++|..||.+.+..+..+.+..
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 228 (308)
T cd06634 168 ANXFVGTPYWMAPEVILAMD-----EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228 (308)
T ss_pred cccccCCccccCHHHHhhcc-----cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh
Confidence 23446788999999874311 24567899999999999999999999988776665555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=242.38 Aligned_cols=208 Identities=32% Similarity=0.485 Sum_probs=169.9
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|.+.+.||.|++|.||++.. +++.+++|.+........ ....+.+|+.+++.++||||+++++.+.++ ..++|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG---IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccch---hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEE
Confidence 45678899999999999986 578899999876544321 123577899999999999999999988654 678999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-c
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~ 215 (290)
||+++ +|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+....... .
T Consensus 78 e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 78 EFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred eccCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCccc
Confidence 99965 888887762 3678999999999999999999999999999999999999955 459999999987644332 2
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|+.||.+.+..+....+.
T Consensus 155 ~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 155 YTHYVVTRWYRAPELLLG-------DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred ccCccCcccccCcHHHhc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 223457788999998754 2367899999999999999999999999988766655544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=245.12 Aligned_cols=200 Identities=31% Similarity=0.481 Sum_probs=163.5
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec--Cc
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--PL 131 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 131 (290)
...+|.+.+.||.|+||.||++.+ +++.||+|.+......... ...+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVL---AKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccch---hHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 445699999999999999999976 5788999987653322111 1346789999999999999999998854 36
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++++||+ +++|..++.. ..++...+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||.+....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~ 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQD 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccC
Confidence 78999998 6689888764 468888889999999999999999999999999999999954 569999999987533
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
. ......++..|+|||.+.. ...++.++|+||||+++|+|++|..||.+...
T Consensus 160 ~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 160 P--QMTGYVSTRYYRAPEIMLT-------WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred C--CcCCCcccccccCceeeec-------cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 2233467888999998643 24578899999999999999999999988664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=249.15 Aligned_cols=205 Identities=31% Similarity=0.456 Sum_probs=164.3
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 130 (290)
..+|.+.+.||+|+||.||+|.+ +++.||+|.+........ ....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI---FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccccc---chhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 35688999999999999999976 578999999875432221 112467899999999999999999987532
Q ss_pred ---ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 131 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
..++|++|+. .+|..+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL~dfg~~ 164 (342)
T cd07879 91 EFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKILDFGLA 164 (342)
T ss_pred CCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCCCC
Confidence 3589999995 47776542 468999999999999999999999999999999999999965 45999999998
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..... ......++..|+|||.+.. ...++.++|+||||+++|+|++|+.||.+.+.......+
T Consensus 165 ~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~ 227 (342)
T cd07879 165 RHADA--EMTGYVVTRWYRAPEVILN-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227 (342)
T ss_pred cCCCC--CCCCceeeecccChhhhcC-------ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 75322 2233467888999998753 235788999999999999999999999987765554443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=250.06 Aligned_cols=205 Identities=34% Similarity=0.488 Sum_probs=167.6
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 130 (290)
.++|.+.+.||+|+||.||+|++ +++.||+|++......... ...+.+|+.+++.++||||+++.+.+...
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH---AKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhH---HHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 45699999999999999999987 5689999998654322221 13467899999999999999998876432
Q ss_pred ---ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 131 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
..++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+ +.++|+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~dfg~~ 165 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGLA 165 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEcccccc
Confidence 378999998 6799998864 568999999999999999999999999999999999999955 45999999998
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
...... .....++..|+|||.+.. ...++.++||||||+++|+|++|+.||.+.........
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~ 227 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR 227 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhC-------CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 764332 334467889999998643 23578899999999999999999999998776554443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=241.60 Aligned_cols=204 Identities=29% Similarity=0.493 Sum_probs=168.6
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-ceEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~~~l 134 (290)
+|.+.+.||+|+||.||++.. +++.|++|++.......... ...+.+|..++++++ ||||+++++.+.+. ..++
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK--VKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHH--HHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 588899999999999999977 67899999987643322221 235778999999998 99999999988654 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
|||++++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 80 VLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCcc
Confidence 9999999999999976 34799999999999999999999999999999999999999654 59999999987532221
Q ss_pred ---------------------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 215 ---------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 215 ---------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
......++..|+|||.... ..++.++|+||||++++++++|..||...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--------KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCC--------CCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 1123356789999998754 45788999999999999999999999987754
Q ss_pred HH
Q 022903 274 QA 275 (290)
Q Consensus 274 ~~ 275 (290)
..
T Consensus 229 ~~ 230 (280)
T cd05581 229 LT 230 (280)
T ss_pred HH
Confidence 43
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=239.22 Aligned_cols=210 Identities=26% Similarity=0.413 Sum_probs=163.2
Q ss_pred ceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
+|.+.+.||+|+||.||++++. +..+++|+++..............+.+|+.+++.++||||+++++.+.+. ..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3778899999999999999774 34566666554322111100112356789999999999999999988654 67899
Q ss_pred EEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 136 TELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||+.+++|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+++. + .++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~-~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N-LLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C-CEeecccCceeecCCC
Confidence 9999999999988642 2356899999999999999999999999999999999999984 3 4999999998754322
Q ss_pred -ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 214 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 214 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
.......+++.|+|||.+.. ..++.++|+||||+++|+|++|..||.+.+.......
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~ 216 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKH--------QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR 216 (260)
T ss_pred cccccCCCCCcCccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 22234467889999998753 4567899999999999999999999987665544433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=241.53 Aligned_cols=201 Identities=28% Similarity=0.390 Sum_probs=161.8
Q ss_pred eeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ce
Q 022903 60 LFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~ 132 (290)
|.+.+.||+|+||.||+++. +++.||+|++....... ......++.+|+.++.++ +||||+++++.+... ..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQ-KAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHh-hhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 77889999999999999864 45789999987543221 112234577899999999 599999999888654 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+.+++|.+++.. ...+++..+..++.|++.+|.|||+.|++||||+|+||+++.+ +.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECcccccccc
Confidence 799999999999998865 3568899999999999999999999999999999999999955 4599999999865332
Q ss_pred ccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 213 TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 213 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
... .....++..|+|||.+.. .....+.++|+||||+++|+|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRG------GSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred ccccccccccCCccccCHHHhcC------CCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 221 123457889999998754 1123678999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=270.09 Aligned_cols=193 Identities=34% Similarity=0.537 Sum_probs=152.6
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee----------
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA---------- 126 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~---------- 126 (290)
+|..+..||+||||.||+++. +|+.||||.++... ... .-.++.+|+.++++|+|||||+++.+
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~---~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDK---LYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHH---HHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 477888999999999999975 79999999998766 222 12468899999999999999999721
Q ss_pred ------------------------------------------------e---------e---------------------
Q 022903 127 ------------------------------------------------C---------K--------------------- 128 (290)
Q Consensus 127 ------------------------------------------------~---------~--------------------- 128 (290)
. .
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0 0
Q ss_pred ------------------------c--------CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022903 129 ------------------------D--------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176 (290)
Q Consensus 129 ------------------------~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 176 (290)
+ ..+|+-||||+...|.+++..+.... ....+++++++|++||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 0 02467899998888888877633211 46778899999999999999
Q ss_pred HCCCeeecCCCCCEEEcCCCCceEEeccccccccc-------------------ccccccccCCCccccCcccccccccc
Q 022903 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-------------------VTEMMTAETGTYRWMAPELYSTVTLR 237 (290)
Q Consensus 177 ~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~~~~~ 237 (290)
++|+|||||||.||++|.++ .|||.|||+++... .....+...||..|+|||++....
T Consensus 715 ~~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~-- 791 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS-- 791 (1351)
T ss_pred hCceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc--
Confidence 99999999999999999555 59999999998510 001223457999999999987621
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHh
Q 022903 238 QGEKKHYNNKVDVYSFGIVLWELLT 262 (290)
Q Consensus 238 ~~~~~~~~~~~DiwslG~~l~~~l~ 262 (290)
...|+.++|+||||++|+||+.
T Consensus 792 ---~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 792 ---SNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ---cccccchhhhHHHHHHHHHHhc
Confidence 2479999999999999999986
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=238.40 Aligned_cols=212 Identities=26% Similarity=0.411 Sum_probs=168.9
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec----
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 129 (290)
....|.-..+||+|.||+||+|+. +++.||+|+..-+....--. ..-.+|+.+|..|.|+|++.+++.|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfp---italreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCc---HHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 344577778999999999999976 56778888754321111000 114589999999999999999987731
Q ss_pred -----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 130 -----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 130 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
..+++|+++|+. +|.-++.. ....++..++.+++.+++.||.|+|+..|+|||+||.|+||+.+ +.+||+||
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilklADF 168 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKLADF 168 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEeecc
Confidence 237899999955 88877764 44679999999999999999999999999999999999999955 46999999
Q ss_pred ccccccccc-----ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 205 GLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 205 g~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
|+++..... ......+.|+.|.+||.+.+ ...++++.|||+.||+|.+|++|++-|.+.++.+.+..|
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG-------~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG-------DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhc-------ccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 999642222 12334466999999999987 468999999999999999999999999999888777665
Q ss_pred H
Q 022903 280 A 280 (290)
Q Consensus 280 ~ 280 (290)
-
T Consensus 242 s 242 (376)
T KOG0669|consen 242 S 242 (376)
T ss_pred H
Confidence 3
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=263.42 Aligned_cols=146 Identities=32% Similarity=0.514 Sum_probs=125.7
Q ss_pred CceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
+.|.++++||+|+||.||+|.+. ++.||+|++......... ....+.+|+.++..++||||+++++.+.+ ...++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~--~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKN--MVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHH--HHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 46999999999999999999885 789999999764433222 12357789999999999999999988864 47889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.++|+|||+++
T Consensus 82 VmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 9999999999999875 3568899999999999999999999999999999999999955 469999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=232.58 Aligned_cols=194 Identities=35% Similarity=0.529 Sum_probs=162.7
Q ss_pred eccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecCCC
Q 022903 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGM 142 (290)
Q Consensus 66 lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~~ 142 (290)
||.|+||.||++.+ .++.+++|++.......... ...+.+|+.+++.++||||+++++.+.++ ..+++|||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE--VEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHH--HHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCC
Confidence 69999999999987 47899999987654433221 23578899999999999999999888654 678999999999
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-ccccccCC
Q 022903 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETG 221 (290)
Q Consensus 143 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g 221 (290)
+|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.+ +.++|+|||++...... .......+
T Consensus 79 ~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 79 ELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcC
Confidence 999999763 468999999999999999999999999999999999999955 46999999998764332 22334567
Q ss_pred CccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 222 ~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
+..|+|||.... ...+.++|+||||+++|+|++|..||...+.
T Consensus 156 ~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 198 (250)
T cd05123 156 TPEYLAPEVLLG--------KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR 198 (250)
T ss_pred CccccChHHhCC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 889999998754 4578899999999999999999999987765
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=238.11 Aligned_cols=207 Identities=33% Similarity=0.529 Sum_probs=167.7
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|++.+.||+|+||.||+|+. +++.||+|++......... ...+.+|+.+++.++||||+++++.+.+. ..++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI---PSTALREISLLKELKHPNIVKLLDVIHTERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccc---cHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEe
Confidence 45667899999999999987 4789999998865422111 12467899999999999999999988654 788999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-c
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~ 215 (290)
||+. ++|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.++|+|||.+....... .
T Consensus 78 e~~~-~~l~~~i~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 78 EYCD-MDLKKYLDKR-PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred cCcC-cCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCccc
Confidence 9996 5899999863 2479999999999999999999999999999999999999954 569999999987643332 2
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|..||.+.+.......+
T Consensus 155 ~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 155 YTHEVVTLWYRAPEILLG-------SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred cCccccCcCcCChHHhcC-------CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 223355778999998754 236788999999999999999999999987765554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=245.08 Aligned_cols=195 Identities=34% Similarity=0.537 Sum_probs=156.4
Q ss_pred CCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhh--cCCCCceeEEeeeec-----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR--VKHDNLVKFLGACKD----- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----- 129 (290)
-..+.+.+.+|+|.||.||+|...++.||||+++..... .|.+|-.|.+. +.|+||++|+++-+.
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kq--------s~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQ--------SFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecCHHHHH--------HHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 445777889999999999999999999999999754332 36667666655 579999999987642
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeecCCCCCEEEcCCCCceE
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN---------GIIHRDLKPDNLLLTPDQKSLK 200 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------givH~Dikp~Nili~~~~~~~k 200 (290)
..+++|++|.+.|+|.+|+.. ..+++....+++..+++||+|||+. .|+|||||..||||..| .+..
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D-lTcc 356 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND-LTCC 356 (534)
T ss_pred cceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC-CcEE
Confidence 268899999999999999986 6799999999999999999999974 69999999999999944 5799
Q ss_pred Eeccccccccccccc---ccccCCCccccCccccccc-cccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 022903 201 LADFGLAREETVTEM---MTAETGTYRWMAPELYSTV-TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266 (290)
Q Consensus 201 l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~-~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~P 266 (290)
|+|||++........ ....+||.+|||||++.+- +++. ...-.+.||||+|.+||||++...-
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d---~~Afkr~DvYamgLVLWEi~SRC~~ 423 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD---RDAFKRIDVYAMGLVLWEIASRCTD 423 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc---HHHHHHHHHHHHHHHHHHHHhhccc
Confidence 999999976443322 2235899999999998762 1111 1112478999999999999985433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=250.94 Aligned_cols=202 Identities=28% Similarity=0.410 Sum_probs=166.2
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ce
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~ 132 (290)
...|.+...+|.|+|+.|-.+.+ +++..++|++....... .+|+.++... +||||+++.+++.+. ..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~---------~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDN---------QDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccccc---------ccccchhhhhcCCCcceeecceecCCcee
Confidence 46688888999999999988865 67899999998763222 2566565555 699999999999876 68
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++|||.+.|+-|.+-+.. .+.....+..|+++|+.|+.|||++|+|||||||+|||++.+.++++|+|||.++....
T Consensus 392 ~~v~e~l~g~ell~ri~~---~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRS---KPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeehhccccHHHHHHHh---cchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 899999999998887765 23333778889999999999999999999999999999953555699999999987554
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
. ..+.+-|..|.|||++.. ..+++++||||||++||+||+|+.||.......+++...
T Consensus 469 ~--~~tp~~t~~y~APEvl~~--------~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i 526 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLAI--------QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI 526 (612)
T ss_pred h--hcccchhhcccChhhhcc--------CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence 4 334467889999999864 789999999999999999999999999887765555443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=249.41 Aligned_cols=203 Identities=24% Similarity=0.375 Sum_probs=168.2
Q ss_pred CCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHH---HHHHHHHHHhhcC---CCCceeEEeee
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEG---RFIREVNMMSRVK---HDNLVKFLGAC 127 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~---~~~~e~~~l~~l~---h~~iv~~~~~~ 127 (290)
....|..++.+|.|+||.|+++.++ ...|+||.+.++..--+.+.... .+-.|++||..|+ |+||+++++.|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4456899999999999999999874 46899999987665433321111 1346999999998 99999999999
Q ss_pred ecC-ceEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 128 KDP-LMVIVTELLP-GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 128 ~~~-~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
+++ .++++||... |.+|.+++.. ...+++.++..|+.|++.|+++||+.||||||||-+|+.++.++. +||+|||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~-~klidfg 715 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF-VKLIDFG 715 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe-EEEeecc
Confidence 876 5668888753 5689999985 467999999999999999999999999999999999999996665 9999999
Q ss_pred ccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 206 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
.+.. ..........||..|.|||++.+ ....+..-|||+||++||.++....||=+
T Consensus 716 saa~-~ksgpfd~f~gtv~~aapevl~g-------~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 716 SAAY-TKSGPFDVFVGTVDYAAPEVLGG-------EKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred chhh-hcCCCcceeeeeccccchhhhCC-------CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9865 33455677899999999999976 24457889999999999999999999843
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-32 Score=221.79 Aligned_cols=217 Identities=36% Similarity=0.543 Sum_probs=178.5
Q ss_pred eeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~ 136 (290)
|.+.+.||.|++|.||++... ++.+++|.+....... ....+.+|+..++.++|+|++++++.+.. ...++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEK----QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchH----HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEE
Confidence 456788999999999999874 5899999998765441 12357899999999999999999998764 4778999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc--
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-- 214 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-- 214 (290)
|++.+++|.+++.... ..+++..+..++.+++.++.+||+++++|+||+|.||+++.+ ..++|+|||.+.......
T Consensus 77 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 77 EYCEGGDLFDYLRKKG-GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred eccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccc
Confidence 9999999999987632 128899999999999999999999999999999999999965 569999999987654432
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHhhcccccC
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKVQESIYA 289 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~-~~~~~~~~~~~~~~~~~~~~ 289 (290)
......++..|++||.+.. ...++.++|+|+||+++++|++|+.||.+ ..+....+....+.+..++|
T Consensus 155 ~~~~~~~~~~~~~pe~~~~-------~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLG-------GKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred cccceeccCCcCCHhHhcC-------CCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 2334567788999998731 25677799999999999999999999988 67777777777777666654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=237.73 Aligned_cols=203 Identities=25% Similarity=0.360 Sum_probs=170.8
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC--C----CceeEEeeee
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--D----NLVKFLGACK 128 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~----~iv~~~~~~~ 128 (290)
..+|.++..+|+|+||.|-...+ .+..||||+++....-.+. -+-|+.+++++++ | .++++.++|.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreA------a~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREA------ALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhH------HHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 46799999999999999998866 4689999999765544333 3458899999852 3 2566777774
Q ss_pred -cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC----------C--
Q 022903 129 -DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP----------D-- 195 (290)
Q Consensus 129 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~----------~-- 195 (290)
.++.++|+|.+ |-++.+++..+...+++...++.++.||+.++.+||+.+++|-||||+|||+.. .
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 46789999999 779999999988888999999999999999999999999999999999999941 1
Q ss_pred -------CCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 196 -------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 196 -------~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
...|+++|||.++...... ...+.|..|.|||++.+ -.++..+||||+||||+|+.+|...|.
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg--------LGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG--------LGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec--------cCcCCccCceeeeeEEEEeeccceecc
Confidence 2358999999998754443 45678999999999987 668999999999999999999999999
Q ss_pred CCCHHHHH
Q 022903 269 GMSNLQAA 276 (290)
Q Consensus 269 ~~~~~~~~ 276 (290)
+.++.+.+
T Consensus 311 tHen~EHL 318 (415)
T KOG0671|consen 311 THENLEHL 318 (415)
T ss_pred cCCcHHHH
Confidence 99988766
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=227.98 Aligned_cols=179 Identities=24% Similarity=0.290 Sum_probs=146.3
Q ss_pred ccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecCCCCHH
Q 022903 69 GAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLR 145 (290)
Q Consensus 69 G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~~~L~ 145 (290)
|.||.||++++ +++.||+|.+..... +.+|...+....||||+++++.+.+. ..+++|||+.+++|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHH
Confidence 89999999987 678999999876432 22344444555799999999988654 678999999999999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccccccCCCccc
Q 022903 146 KYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 225 (290)
Q Consensus 146 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y 225 (290)
+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++++|||.+...... .....++..|
T Consensus 74 ~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y 148 (237)
T cd05576 74 SHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMY 148 (237)
T ss_pred HHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCccc
Confidence 998753 4689999999999999999999999999999999999999655 5999999987543322 2233456789
Q ss_pred cCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 226 ~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
+|||.+.. ..++.++|+||+|+++|+|++|..||...
T Consensus 149 ~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 149 CAPEVGGI--------SEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred cCCcccCC--------CCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 99998754 55788999999999999999999887653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=233.83 Aligned_cols=208 Identities=32% Similarity=0.467 Sum_probs=171.6
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC------c
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP------L 131 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 131 (290)
.+..+.||-|+||.||.+.+ .++.|++|.+......- ...+++.+|+++|..++|.|++..++..+-+ .
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L---~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNL---ASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHH---HHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 34457899999999999977 68999999886543222 2345788999999999999999988776532 3
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.|.+.|.+ ..+|.+.+.. +..++...+.-+..||++||.|||+.||+||||||.|+|++ .+..+||||||+++...
T Consensus 132 iYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN-SNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN-SNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec-cCceEEecccccccccc
Confidence 56778888 5688888875 56788889999999999999999999999999999999999 56789999999998755
Q ss_pred cccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 212 VTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 212 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.+.. +.....|..|.|||++.+ ...|+.+.||||.|||+.|++..+..|...++.+.+--|..
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMG-------aRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd 272 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMG-------ARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID 272 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhc-------chhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH
Confidence 4433 344567889999999987 47899999999999999999999999999888776655543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=253.91 Aligned_cols=203 Identities=31% Similarity=0.548 Sum_probs=171.2
Q ss_pred ceeecceeccccceeEEEEEE--CC----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCce
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM 132 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 132 (290)
.++.++.||+|+||+||+|.+ .+ -+||+|++.......... .+++|+-+|.++.|||++++++++.....
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~----e~LdeAl~masldHpnl~RLLgvc~~s~~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASI----ELLDEALRMASLDHPNLLRLLGVCMLSTL 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhH----HHHHHHHHHhcCCCchHHHHhhhcccchH
Confidence 355678999999999999976 33 379999987766554332 47899999999999999999999988778
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
-+|.+|+++|.|.+|++. ....+.....+.|+.||+.||.|||.++++||||..+||||..-+ .+||+|||+++....
T Consensus 773 qlvtq~mP~G~LlDyvr~-hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVRE-HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHhcccchHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchhhccCc
Confidence 899999999999999988 446788889999999999999999999999999999999998554 499999999986544
Q ss_pred cccccc---cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022903 213 TEMMTA---ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275 (290)
Q Consensus 213 ~~~~~~---~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~ 275 (290)
...-.. ....+.|||-|.+.. ..++.++|||||||++||++| |..|+.+.+..++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~--------~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI 909 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRI--------RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI 909 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhc--------cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence 433222 234567999998764 779999999999999999999 9999999887654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=252.58 Aligned_cols=218 Identities=33% Similarity=0.557 Sum_probs=178.1
Q ss_pred cccccccCCCceeecceeccccceeEEEEEEC---------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCC
Q 022903 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHD 118 (290)
Q Consensus 49 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 118 (290)
.+..+..+.+.+.+.+.||.|.||.|++|... ...||||.++......+.. .+..|+++|+.+ .||
T Consensus 287 ~~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~----~~~~El~~m~~~g~H~ 362 (609)
T KOG0200|consen 287 EDPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKK----DLMSELNVLKELGKHP 362 (609)
T ss_pred cCCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHH----HHHHHHHHHHHhcCCc
Confidence 44467777888888889999999999999531 3579999998777664433 588999999999 599
Q ss_pred CceeEEeeeec-CceEEEEEecCCCCHHHHHHhcC------------C--CCCCHHHHHHHHHHHHHHHHHHHHCCCeee
Q 022903 119 NLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR------------P--NKLDLHVALNFALDIARAMDCLHANGIIHR 183 (290)
Q Consensus 119 ~iv~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~------------~--~~~~~~~~~~i~~qi~~~l~~lH~~givH~ 183 (290)
||+.++|++.. ...++|+||+..|+|.++++..+ . ..++....+.++.||+.|++||+++.+|||
T Consensus 363 niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR 442 (609)
T KOG0200|consen 363 NIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR 442 (609)
T ss_pred chhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence 99999999976 57889999999999999998754 0 138888999999999999999999999999
Q ss_pred cCCCCCEEEcCCCCceEEeccccccccccccccc--ccC--CCccccCccccccccccccccCCCCCcchhHHHHHHHHH
Q 022903 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT--AET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259 (290)
Q Consensus 184 Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~--g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~ 259 (290)
||..+|||+..+ ..+||+|||+++......... ... -...|||||.+.. ..|+.++||||+|++|||
T Consensus 443 DLAaRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--------~~ft~kSDVWSfGI~L~E 513 (609)
T KOG0200|consen 443 DLAARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--------RVFTSKSDVWSFGILLWE 513 (609)
T ss_pred hhhhhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--------CcccccchhhHHHHHHHH
Confidence 999999999944 679999999998543332222 122 2456999999865 679999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHH
Q 022903 260 LLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 260 ~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
|++ |..||.+....+..++.
T Consensus 514 ifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 514 IFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred HhhCCCCCCCCCCcHHHHHHH
Confidence 999 99999996644444553
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=249.78 Aligned_cols=206 Identities=23% Similarity=0.341 Sum_probs=141.4
Q ss_pred cCCCceeecceeccccceeEEEEEE--C----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee--
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--G----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA-- 126 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-- 126 (290)
...++|.+.+.||+|+||.||+|++ + +..||+|.+........ ..++ .++...+.++..++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-------~~~e--~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-------WMNE--RVRRACPNSCADFVYGFL 199 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-------HHHH--HHHhhchhhHHHHHHhhh
Confidence 3557899999999999999999987 3 57899998764332111 1111 1111122222222211
Q ss_pred -----eecCceEEEEEecCCCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeee
Q 022903 127 -----CKDPLMVIVTELLPGMSLRKYLVSLRPN------------------KLDLHVALNFALDIARAMDCLHANGIIHR 183 (290)
Q Consensus 127 -----~~~~~~~lv~e~~~~~~L~~~~~~~~~~------------------~~~~~~~~~i~~qi~~~l~~lH~~givH~ 183 (290)
..+...++|+||+.+++|.+++...... ......+..++.||+.||.|||++||+||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 1234688999999999999998752210 01123456799999999999999999999
Q ss_pred cCCCCCEEEcCCCCceEEecccccccccc--cccccccCCCccccCccccccccccccc--------------cCCCCCc
Q 022903 184 DLKPDNLLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGE--------------KKHYNNK 247 (290)
Q Consensus 184 Dikp~Nili~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~--------------~~~~~~~ 247 (290)
||||+|||++.+.+.+||+|||+++.... ........+++.|+|||.+......... ...++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999996556799999999975322 2223455789999999976432111000 0124456
Q ss_pred chhHHHHHHHHHHHhCCCCCCC
Q 022903 248 VDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 248 ~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
+|||||||++|+|+++..|+..
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch
Confidence 7999999999999998776543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=265.16 Aligned_cols=183 Identities=26% Similarity=0.444 Sum_probs=149.8
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
+...+.||+|+||.||+|+. ++..||+|.+....... .+|+.++++++||||+++++++.+. ..++||
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 45567899999999999986 67899999986543221 2467889999999999999999654 678999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH---ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
||+++++|.+++.. +++..+..++.|++.||+||| +.+++||||||+||+++.+. ..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT- 834 (968)
T ss_pred eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence 99999999999853 788999999999999999999 66999999999999999554 35554 555433211
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
.....+++.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 835 --~~~~~~t~~y~aPE~~~~--------~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 --DTKCFISSAYVAPETRET--------KDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred --CCCccccccccCcccccC--------CCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 123367899999998764 6689999999999999999999999954
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-31 Score=238.10 Aligned_cols=215 Identities=23% Similarity=0.321 Sum_probs=150.7
Q ss_pred CCCceeecceeccccceeEEEEEE------------------CCceEEEEEcccCCChhHHHH---------HHHHHHHH
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY------------------GDRIVAIKVLNRGSTSDERAL---------LEGRFIRE 108 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~------------------~~~~vavK~~~~~~~~~~~~~---------~~~~~~~e 108 (290)
..++|.+.++||+|+||.||+|.. .++.||||.+........... .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999853 235799999865432211110 01123346
Q ss_pred HHHHhhcCCCCc-----eeEEeeee---------cCceEEEEEecCCCCHHHHHHhcC----------------------
Q 022903 109 VNMMSRVKHDNL-----VKFLGACK---------DPLMVIVTELLPGMSLRKYLVSLR---------------------- 152 (290)
Q Consensus 109 ~~~l~~l~h~~i-----v~~~~~~~---------~~~~~lv~e~~~~~~L~~~~~~~~---------------------- 152 (290)
+.++.+++|.++ ++++++|. ++..++||||+.+++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 677777766544 55666543 345789999999999999886421
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccccc--cCCCccccCccc
Q 022903 153 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA--ETGTYRWMAPEL 230 (290)
Q Consensus 153 ~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~--~~g~~~y~aPE~ 230 (290)
...+++..+..++.|++.+|.|||+++++||||||+|||++.+ ..++|+|||++........... ..+++.|+|||.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 1124567788999999999999999999999999999999965 4699999999865433222222 234789999998
Q ss_pred cccccccccc--------------cCCCCCcchhHHHHHHHHHHHhCCC-CCCCCC
Q 022903 231 YSTVTLRQGE--------------KKHYNNKVDVYSFGIVLWELLTNRL-PFEGMS 271 (290)
Q Consensus 231 ~~~~~~~~~~--------------~~~~~~~~DiwslG~~l~~~l~g~~-Pf~~~~ 271 (290)
+......+.. ......+.|+||+||++|+|++|.. ||.+..
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~ 437 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIR 437 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchh
Confidence 7541100000 0011235799999999999999886 887643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=238.55 Aligned_cols=204 Identities=25% Similarity=0.399 Sum_probs=171.5
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC------CCceeEEeeee
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH------DNLVKFLGACK 128 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~ 128 (290)
..+|.+....|+|-|++|..|++ .+..||||++.....-. ..=++|+++|++|+. -++++|+-.|.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~------KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH------KTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh------hhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 35677788889999999999987 46799999998654432 234589999999973 37888887774
Q ss_pred -cCceEEEEEecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 129 -DPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 129 -~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
..++|+|+|-+ ..+|.++++... +-++....+..|+.||+.||..|-..||+|.||||+||||+.....+||||||.
T Consensus 505 hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 56899999999 789999997743 345888899999999999999999999999999999999998888899999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
|.+....+. ..+..+..|.|||++.+ ..|+...|+||.||+|||+.||+..|+|.++-+.+
T Consensus 584 A~~~~enei-tPYLVSRFYRaPEIiLG--------~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 584 ASFASENEI-TPYLVSRFYRAPEIILG--------LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred ccccccccc-cHHHHHHhccCcceeec--------CcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 987655443 34566778999999987 77999999999999999999999999999875554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=246.05 Aligned_cols=198 Identities=28% Similarity=0.444 Sum_probs=157.2
Q ss_pred eeecceecccccee-EEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGK-VYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~-V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|...+.+|.|+-|+ ||+|.+.++.||||.+-.... ....+|+..|+.. .|||||++++.-++. ..|+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~--------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFF--------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhH--------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 44556789999987 799999999999998754332 2356899999888 599999999998765 578999
Q ss_pred EecCCCCHHHHHHhc-CCC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC----CCCceEEecccccccc
Q 022903 137 ELLPGMSLRKYLVSL-RPN-KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP----DQKSLKLADFGLAREE 210 (290)
Q Consensus 137 e~~~~~~L~~~~~~~-~~~-~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~----~~~~~kl~Dfg~~~~~ 210 (290)
|.| ..+|.+++... ... .......+.+..|++.||++||+.+||||||||.||||+. ....++|+|||+++..
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 66999999863 111 1111345778999999999999999999999999999975 2246999999999875
Q ss_pred ccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 211 TVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 211 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
..+.. .....||-+|+|||++.. ...+.++|||||||++|+.++ |..||.+...++
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--------~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~ 722 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--------DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ 722 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--------cccCcccchhhcCceEEEEecCCccCCCchHHhh
Confidence 44332 344579999999999875 334669999999999999999 599998866554
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=218.92 Aligned_cols=215 Identities=26% Similarity=0.413 Sum_probs=167.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEee-eec-Cce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGA-CKD-PLM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~-~~~-~~~ 132 (290)
+.|.+.+.||.|.||.+-++++ .+..+++|.++...... ..|.+|..---.| .|.||+.-|++ |+. +.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~------~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQ------ADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhH------HHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 4588999999999999999988 45789999988765543 3578887655555 48999987765 443 366
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEE-cCCCCceEEeccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREET 211 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili-~~~~~~~kl~Dfg~~~~~~ 211 (290)
++++||++.|+|..-+.. .++-+.....++.|++.|+.|+|++++||||||.+|||| +.+...|||||||.....+
T Consensus 98 vF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 799999999999986654 678888899999999999999999999999999999999 4444579999999986533
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhccc
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQES 286 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~ 286 (290)
.--. ....+..|.+||.+.... ...-...+.+|+|.||+++|.+++|.+||....-++..|---.+|+..
T Consensus 175 ~tV~--~~~~~~~y~~pe~~~~~~---ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 175 TTVK--YLEYVNNYHAPELCDTVV---NEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKR 244 (378)
T ss_pred ceeh--hhhhhcccCCcHHHhhcc---ccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcc
Confidence 2211 123455688999765421 123445789999999999999999999999877666666666665544
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=212.90 Aligned_cols=197 Identities=39% Similarity=0.623 Sum_probs=163.7
Q ss_pred cceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEEEecCCCCHHH
Q 022903 70 AHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRK 146 (290)
Q Consensus 70 ~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~e~~~~~~L~~ 146 (290)
+||.||++... ++.+++|++........ ...+.+|+..++.++|+||+++++.+.. ...++++|++.+++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK----RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH----HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHH
Confidence 58999999874 58999999977655432 2357899999999999999999998865 57889999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccccccCCCcccc
Q 022903 147 YLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 226 (290)
Q Consensus 147 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~ 226 (290)
++... ..++...+..++.+++.++.+||+.|++|+||+|+||+++.+ +.++|+|||.+.............++..|+
T Consensus 77 ~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 77 LLKKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCC
Confidence 98763 238999999999999999999999999999999999999965 569999999998755443445567888999
Q ss_pred CccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 227 aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
|||.+.. ..++.++|+||||+++++|++|..||......+.......
T Consensus 154 ~pE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~ 200 (244)
T smart00220 154 APEVLLG--------KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG 200 (244)
T ss_pred CHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh
Confidence 9998753 5678899999999999999999999988555544444443
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=213.97 Aligned_cols=202 Identities=24% Similarity=0.403 Sum_probs=169.0
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 130 (290)
.+..-.|+++++||+|+||..+.|+. +++.||||..+..+.... ++.|....+.|. .++|...|-...++
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQ-------LrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQ-------LRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCCcch-------HHHHHHHHHHHcCCCCCCceeeecccc
Confidence 34456799999999999999999964 899999999887766553 457888888875 68998887666555
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc----CCCCceEEeccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT----PDQKSLKLADFG 205 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~----~~~~~~kl~Dfg 205 (290)
+..+|+|.+ |.+|.++..- ....++..+++.++.|++.-++|+|++.+|+|||||+|+||. ++...|.|+|||
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 557999999 8899997764 678899999999999999999999999999999999999995 344469999999
Q ss_pred cccccccccc--------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 206 LAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 206 ~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
+++.+..+.. ..+..||.+||+-.-.. +.+.+.+.|+.|||-++++.|.|.+||.|+..
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHl--------GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHL--------GREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccc--------cchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 9997654432 34457999999976554 47889999999999999999999999999853
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=218.13 Aligned_cols=208 Identities=31% Similarity=0.441 Sum_probs=171.6
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec--
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-- 129 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 129 (290)
...+.+|.-++.+|.|.- .|..+-+ .++.||+|........... ..+-.+|+.++..++|+||+.++.++.-
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~---akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTH---AKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCcc---chhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 344566888888999998 6666644 6889999988665333222 2456799999999999999999998842
Q ss_pred -----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 130 -----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 130 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
...++|||++ ..+|.+++.. .++..++..++.|+++|+.|||+.||+||||||+||++. ..+++||.||
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~-~~~~lKi~df 162 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN-SDCTLKILDF 162 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec-chhheeeccc
Confidence 2578999999 6699998873 688999999999999999999999999999999999999 4467999999
Q ss_pred cccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 205 GLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 205 g~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
|++......-.++.+..+..|.|||++.+ -.+.+.+||||+||++.||++|..-|.|.+..+.-.++
T Consensus 163 g~ar~e~~~~~mtpyVvtRyyrapevil~--------~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki 229 (369)
T KOG0665|consen 163 GLARTEDTDFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKI 229 (369)
T ss_pred hhhcccCcccccCchhheeeccCchheec--------cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHH
Confidence 99988766656677889999999999986 33899999999999999999999999986655443333
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=206.27 Aligned_cols=211 Identities=24% Similarity=0.339 Sum_probs=168.9
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC-CCceeEEeeeecC-ce
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-DNLVKFLGACKDP-LM 132 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~-~~ 132 (290)
...|+++++||.|+||.+|.|.. .++.||||+......-.. +..|..+.+.|++ ..|..+..+..+. ..
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpq-------L~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQ-------LLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcc-------hhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 34699999999999999999976 689999999876654432 4578888888875 6777776666543 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC--ceEEecccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREE 210 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~--~~kl~Dfg~~~~~ 210 (290)
++||+.+ |.+|.++..- ....++..+++.++-|++.-++|+|.+++|||||||+|+|+.-+.. .+.|+|||+++..
T Consensus 87 vlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 8999999 8899998765 5678999999999999999999999999999999999999974432 5999999999854
Q ss_pred cccc--------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHH
Q 022903 211 TVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAA 280 (290)
Q Consensus 211 ~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~--~~~~~~~~ 280 (290)
.... ......||.+|.+-....+ .+.+.+.|+-|+|++|.++..|.+||.|..+ ....++.+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g--------~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLG--------IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhh--------hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 3221 2234479999999877665 6678999999999999999999999999854 33444444
Q ss_pred Hhhc
Q 022903 281 FKVQ 284 (290)
Q Consensus 281 ~~~~ 284 (290)
.+.+
T Consensus 237 ~EkK 240 (341)
T KOG1163|consen 237 SEKK 240 (341)
T ss_pred HHhh
Confidence 4433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=219.81 Aligned_cols=131 Identities=28% Similarity=0.435 Sum_probs=112.7
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-----C---CCceeEEe
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-----H---DNLVKFLG 125 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~ 125 (290)
...+|.+.++||.|-|++||++.+ ..+.||+|+.+...--.+ .-..||++|++++ | .+||+|++
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtE------aAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTE------AALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHH------HHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 446799999999999999999988 458999999876544333 2458999999885 2 46999999
Q ss_pred eeec-----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEc
Q 022903 126 ACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLT 193 (290)
Q Consensus 126 ~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~ 193 (290)
.|.. .+.++|+|++ |.+|..++.......++...+..|++|++.||.|||.. ||||.||||+|||+.
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9853 3688999999 88999999988888999999999999999999999975 999999999999994
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=217.40 Aligned_cols=203 Identities=28% Similarity=0.398 Sum_probs=163.7
Q ss_pred ceeecceeccccceeEEEEEECC---ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC----CCCceeEEeeee--c
Q 022903 59 LLFIGSKIGEGAHGKVYEGRYGD---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK----HDNLVKFLGACK--D 129 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~~--~ 129 (290)
.|.+.++||+|+||.||++.... ..+|+|+.......... .+..|..++..+. .+++..+++... +
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-----~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-----VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-----cchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 69999999999999999998744 47999998765433211 1456777777776 268888888873 3
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC----CceEEeccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ----KSLKLADFG 205 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~----~~~kl~Dfg 205 (290)
...++||+.+ |.+|.++......+.++..+++.++.|++.+|++||+.|++||||||+|+++.... ..+.|+|||
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 4678999998 99999988765567899999999999999999999999999999999999998553 569999999
Q ss_pred ccc--cccccc------c---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 206 LAR--EETVTE------M---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 206 ~~~--~~~~~~------~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
+++ ...... . .....||..|+++.+..+ .+.+++.|+||+++++.+++.|.+||.+.+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--------~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~ 244 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--------IEQGRRDDLESLFYMLLELLKGSLPWEALEMTD 244 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--------CccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence 998 311111 1 122359999999998765 788999999999999999999999998877543
Q ss_pred H
Q 022903 275 A 275 (290)
Q Consensus 275 ~ 275 (290)
.
T Consensus 245 ~ 245 (322)
T KOG1164|consen 245 L 245 (322)
T ss_pred h
Confidence 3
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=219.94 Aligned_cols=204 Identities=30% Similarity=0.470 Sum_probs=167.6
Q ss_pred CceeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~- 130 (290)
..|.++++||.|+|++||++.+ .++.||+|.+...+... ++.+|+++|..+. +.||+++.+++..+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~-------ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS-------RILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch-------HHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4588899999999999999953 46899999998776654 4779999999995 89999999999654
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
...+|++|++.....++... ++...+..+++.++.||.++|.+|||||||||+|+|.+.....-.|+|||++...
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 67799999999999998764 6788999999999999999999999999999999999988888899999998721
Q ss_pred ccc---------------------------------------------ccccccCCCccccCccccccccccccccCCCC
Q 022903 211 TVT---------------------------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 245 (290)
Q Consensus 211 ~~~---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~ 245 (290)
... .......||++|.|||++..+ +..+
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-------~~Qt 256 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-------PRQT 256 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-------cCcC
Confidence 000 000112489999999998764 3457
Q ss_pred CcchhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHH
Q 022903 246 NKVDVYSFGIVLWELLTNRLPFEGM-SNLQAAYAAA 280 (290)
Q Consensus 246 ~~~DiwslG~~l~~~l~g~~Pf~~~-~~~~~~~~~~ 280 (290)
.++||||.|+|++.++++..||-.. .+.+.+..++
T Consensus 257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~ 292 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIA 292 (418)
T ss_pred CccceeeccceeehhhccccccccCccccchHHHHH
Confidence 8999999999999999999998654 3444444443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=212.13 Aligned_cols=212 Identities=25% Similarity=0.431 Sum_probs=172.1
Q ss_pred cCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
+...++++...+-+|+||+||.|.+. .+.|.+|.++.....-+.. ++..|..++..+.|||+.++.+++
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~----~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVN----LLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHH----HHHHHHHHHhcCcCCCccceeEEE
Confidence 34456778888999999999999552 2567888887766554433 578999999999999999999987
Q ss_pred ec--CceEEEEEecCCCCHHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCce
Q 022903 128 KD--PLMVIVTELLPGMSLRKYLVS------LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199 (290)
Q Consensus 128 ~~--~~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~ 199 (290)
-+ ...+.++.+..-|+|..++.. .....++..+...++.|++.|++|||++|+||.||..+|++|| +...+
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId-d~LqV 435 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID-DQLQV 435 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh-hheeE
Confidence 43 367788999999999999973 2233467778889999999999999999999999999999999 66779
Q ss_pred EEecccccccccc---cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 022903 200 KLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 275 (290)
Q Consensus 200 kl~Dfg~~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~ 275 (290)
||+|=.+++...+ ...-.....+..||+||.+.. .+|+.++|+||||++||||+| |+.|+...++.+.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n--------~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN--------SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhh--------hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 9999999885322 222233456778999999875 889999999999999999999 9999999998776
Q ss_pred HHHH
Q 022903 276 AYAA 279 (290)
Q Consensus 276 ~~~~ 279 (290)
..=+
T Consensus 508 ~~yl 511 (563)
T KOG1024|consen 508 EHYL 511 (563)
T ss_pred HHHH
Confidence 5433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=231.20 Aligned_cols=216 Identities=27% Similarity=0.413 Sum_probs=183.0
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee-ecCc
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPL 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 131 (290)
-...+|.++.++|.|+||.||++++ +++..|+|+++-.....-. -+..|+-+++.++||||+.+++.+ ....
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~-----~iqqei~~~~dc~h~nivay~gsylr~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFS-----GIQQEIGMLRDCRHPNIVAYFGSYLRRDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcccc-----ccccceeeeecCCCcChHHHHhhhhhhcC
Confidence 3446799999999999999999987 6889999999876554432 255899999999999999999988 4568
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
++++||||.||+|.+...- .+++++.++...+++.+.||.|||+.|-+|||||=.||+++.. +.+|++|||.+....
T Consensus 87 lwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQIT 163 (829)
T ss_pred cEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhh
Confidence 9999999999999997654 5789999999999999999999999999999999999999944 459999999986543
Q ss_pred cc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 022903 212 VT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283 (290)
Q Consensus 212 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~ 283 (290)
.. .....+.||+.|||||+... .....|...+|+|++|++..|+-.-++|..+...+++++-.....
T Consensus 164 ati~KrksfiGtpywmapEvaav-----erkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~ 231 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAV-----ERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG 231 (829)
T ss_pred hhhhhhhcccCCccccchhHHHH-----HhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC
Confidence 32 34457799999999998654 234678999999999999999999999999999998888766543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=190.17 Aligned_cols=183 Identities=39% Similarity=0.667 Sum_probs=152.9
Q ss_pred eccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEEEecCCC
Q 022903 66 IGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTELLPGM 142 (290)
Q Consensus 66 lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~e~~~~~ 142 (290)
||.|++|.||++... ++.+++|+........ ....+.+|+..++.+.|++|+++++.+.. ...++++|++.++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS----LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh----HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCC
Confidence 689999999999886 8999999998766542 12357899999999999999999999875 4778999999989
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-cccccCC
Q 022903 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETG 221 (290)
Q Consensus 143 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~g 221 (290)
+|.+++.... ..++...+..++.+++.++.+||+.|++|+||+|.||+++.....++|+|||.+....... ......+
T Consensus 77 ~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (215)
T cd00180 77 SLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155 (215)
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccC
Confidence 9999987632 4689999999999999999999999999999999999999624569999999987643332 1233467
Q ss_pred CccccCccccccccccccccCCCCCcchhHHHHHHHHHH
Q 022903 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260 (290)
Q Consensus 222 ~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~ 260 (290)
...|++||.+.. ....+.++|+|+||+++++|
T Consensus 156 ~~~~~~pe~~~~-------~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 156 TPAYMAPEVLLG-------KGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred CCCccChhHhcc-------cCCCCchhhhHHHHHHHHHH
Confidence 788999998754 12678899999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=205.95 Aligned_cols=164 Identities=21% Similarity=0.213 Sum_probs=122.3
Q ss_pred CCceeecceeccccceeEEEEEE---CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCcee-EEeeeecCce
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK-FLGACKDPLM 132 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~ 132 (290)
...|.+.+.||+|+||+||+|.+ +++.||||++...............+.+|+.+++.++|+|+++ +++. ...
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCc
Confidence 34599999999999999999976 4577899987543210001112245889999999999999985 4432 457
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecC-CCCCEEEcCCCCceEEeccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL-KPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Di-kp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
++||||++|++|.. +.. .. ...++.+++.+|.|||++||+|||| ||+|||++.+ +.++|+|||+++...
T Consensus 94 ~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 94 GLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccceecc
Confidence 89999999999963 211 11 1467899999999999999999999 9999999855 459999999998533
Q ss_pred cccc---------ccccCCCccccCcccccc
Q 022903 212 VTEM---------MTAETGTYRWMAPELYST 233 (290)
Q Consensus 212 ~~~~---------~~~~~g~~~y~aPE~~~~ 233 (290)
.... .....+++.|+|||.+..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 2211 123457788999998865
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-26 Score=183.80 Aligned_cols=174 Identities=16% Similarity=0.185 Sum_probs=131.3
Q ss_pred CCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHH----HHHHHHHHHHhhcCCCCceeEEeeeec---
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLE----GRFIREVNMMSRVKHDNLVKFLGACKD--- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 129 (290)
..+|++.+.||.|+||.||++..++..+|+|++.......+..... ..+.+|+..+.+++||+|..+...+..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 4569999999999999999987777899999998766544332211 115689999999999999988776432
Q ss_pred ------CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEec
Q 022903 130 ------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (290)
Q Consensus 130 ------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~D 203 (290)
...+++|||++|.+|.++.. ++. ....+++.+|..+|+.|++|||++|+||++++++ ++|+|
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liD 177 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIID 177 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEE
Confidence 34789999999999988632 222 3466999999999999999999999999999654 99999
Q ss_pred ccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHH
Q 022903 204 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 261 (290)
Q Consensus 204 fg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l 261 (290)
||........... +.+.. ...+..++|+||||+++....
T Consensus 178 fg~~~~~~e~~a~------------d~~vl-------er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK------------DRIDL-------ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH------------HHHHH-------HhHhcccccccceeEeehHHH
Confidence 9987653221111 11111 134567999999999987653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=220.45 Aligned_cols=143 Identities=22% Similarity=0.352 Sum_probs=109.7
Q ss_pred CCceeEEeee--------ecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCC
Q 022903 118 DNLVKFLGAC--------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189 (290)
Q Consensus 118 ~~iv~~~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~N 189 (290)
+||+.+++.+ .+..+++++|++ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~N 110 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSC 110 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchh
Confidence 4666666655 123466778887 6799999975 24569999999999999999999999999999999999
Q ss_pred EEEcC------------------CCCceEEeccccccccccc-----------------ccccccCCCccccCccccccc
Q 022903 190 LLLTP------------------DQKSLKLADFGLAREETVT-----------------EMMTAETGTYRWMAPELYSTV 234 (290)
Q Consensus 190 ili~~------------------~~~~~kl~Dfg~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~ 234 (290)
||++. ....+|++|||+++..... .......||+.|||||++.+
T Consensus 111 iLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~- 189 (793)
T PLN00181 111 FVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG- 189 (793)
T ss_pred EEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-
Confidence 99953 2234677777776532100 00011357888999999865
Q ss_pred cccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 235 ~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
..++.++|||||||+||||++|.+|+...
T Consensus 190 -------~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 190 -------SSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred -------CCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 56899999999999999999999998753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-23 Score=181.88 Aligned_cols=205 Identities=37% Similarity=0.569 Sum_probs=167.7
Q ss_pred eeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCC-CceeEEeeeecCc-eEEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD-NLVKFLGACKDPL-MVIVTE 137 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~-~~lv~e 137 (290)
|.+.+.||.|+||.||++.+. ..+++|.+........ .....+.+|+.++..+.|+ +|+++++.+.... .+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS--KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch--hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 667788999999999999887 8889999887665543 1123588999999999987 7999999986554 589999
Q ss_pred ecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc--
Q 022903 138 LLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-- 214 (290)
Q Consensus 138 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-- 214 (290)
++.++++.+++..... ..+.......++.|++.++.|+|+.|++|||+||+|++++..+..++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977765221 2688999999999999999999999999999999999999665359999999987433222
Q ss_pred -----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 215 -----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 215 -----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
......++..|++||.+.... ....+...|+||+|++++++++|..||.....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~-----~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLS-----LAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred ccccccccccccccccCCHHHhcCCC-----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 235668999999999875410 13578899999999999999999999888764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-25 Score=175.20 Aligned_cols=142 Identities=19% Similarity=0.178 Sum_probs=107.8
Q ss_pred cceeccccceeEEEEEE-CCceEEEEEcccCCChhHH---------------------HHHHHHHHHHHHHHhhcCCCCc
Q 022903 63 GSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDER---------------------ALLEGRFIREVNMMSRVKHDNL 120 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h~~i 120 (290)
...||+|+||.||+|.. +++.||+|+++........ ........+|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999986 6899999999765321111 1112233469999999987776
Q ss_pred eeEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeecCCCCCEEEcCCCCce
Q 022903 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSL 199 (290)
Q Consensus 121 v~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l-H~~givH~Dikp~Nili~~~~~~~ 199 (290)
....... ....++||||++|+++...... ...++...++.++.|++.+|.++ |+.|++||||||+|||++ + +.+
T Consensus 82 ~~p~~~~-~~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~-~~v 156 (190)
T cd05147 82 PCPEPIL-LKSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-D-GKL 156 (190)
T ss_pred CCCcEEE-ecCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-C-CcE
Confidence 3322222 2234899999988777654332 35788999999999999999999 799999999999999998 3 359
Q ss_pred EEeccccccc
Q 022903 200 KLADFGLARE 209 (290)
Q Consensus 200 kl~Dfg~~~~ 209 (290)
+|+|||++..
T Consensus 157 ~LiDFG~a~~ 166 (190)
T cd05147 157 YIIDVSQSVE 166 (190)
T ss_pred EEEEcccccc
Confidence 9999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=170.99 Aligned_cols=188 Identities=17% Similarity=0.132 Sum_probs=138.9
Q ss_pred ecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecCceEEEEEecC
Q 022903 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDPLMVIVTELLP 140 (290)
Q Consensus 62 ~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~lv~e~~~ 140 (290)
+...|++|+||+||.+...+..++.+.+......... .....+.+|+++|++|. |+++++++++ ...+++|+|+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~-~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRG-VAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhh-HHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeeec
Confidence 4567999999999999888888988777654442221 11225789999999995 5889998886 35689999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecC-CCCCEEEcCCCCceEEecccccccccccccc---
Q 022903 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL-KPDNLLLTPDQKSLKLADFGLAREETVTEMM--- 216 (290)
Q Consensus 141 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Di-kp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~--- 216 (290)
|.+|.+.... ....++.|++.+|.++|++||+|||| ||+|||++.++ .++|+|||++.........
T Consensus 82 G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 82 GAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred CccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHH
Confidence 9998754321 11357889999999999999999999 79999998554 5999999999853322210
Q ss_pred -----------cccCCCccccCccccccccccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 217 -----------TAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 217 -----------~~~~g~~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
.-...++.|++|+....+ ...+ .+.++++.|+-+|.++|+..|+.+.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l-------~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVL-------KRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhh-------ccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 011256677777754331 1223 5678999999999999999887654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=168.48 Aligned_cols=143 Identities=20% Similarity=0.186 Sum_probs=109.0
Q ss_pred cceeccccceeEEEEEE-CCceEEEEEcccCCChh---------------------HHHHHHHHHHHHHHHHhhcCCCCc
Q 022903 63 GSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSD---------------------ERALLEGRFIREVNMMSRVKHDNL 120 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~---------------------~~~~~~~~~~~e~~~l~~l~h~~i 120 (290)
...||+|+||.||+|.+ +++.||||+++...... ........+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987 58999999998753210 111112335688999999999887
Q ss_pred eeEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCce
Q 022903 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSL 199 (290)
Q Consensus 121 v~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~ 199 (290)
......... ..++||||++|+++...... ...++...+..++.|++.++.++|+ +|++||||||+||+++ + +.+
T Consensus 82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-~~~ 156 (190)
T cd05145 82 PVPEPILLK-KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-GKP 156 (190)
T ss_pred CCceEEEec-CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-CCE
Confidence 443332222 34899999988755433222 2467888999999999999999999 9999999999999998 4 459
Q ss_pred EEecccccccc
Q 022903 200 KLADFGLAREE 210 (290)
Q Consensus 200 kl~Dfg~~~~~ 210 (290)
+|+|||++...
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=163.55 Aligned_cols=112 Identities=35% Similarity=0.449 Sum_probs=93.8
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccccccCC
Q 022903 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 221 (290)
Q Consensus 142 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g 221 (290)
|+|.+++.. ....+++..++.++.|++.||.|||+++ ||+|||++.+ +.+++ ||++...... ...|
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeeccc----cCCC
Confidence 689999975 3457999999999999999999999998 9999999955 45887 9998764332 2268
Q ss_pred CccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 222 ~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
++.|||||++.. ..++.++|||||||++|+|++|+.||........
T Consensus 67 ~~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~ 112 (176)
T smart00750 67 DPYFMAPEVIQG--------QSYTEKADIYSLGITLYEALDYELPYNEERELSA 112 (176)
T ss_pred cccccChHHhcC--------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcH
Confidence 899999999865 6688999999999999999999999987654433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-24 Score=170.45 Aligned_cols=228 Identities=27% Similarity=0.439 Sum_probs=177.1
Q ss_pred ccccccccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
++.+..-++-+.+.++-+|.....|+.|+|++.+..++.|++.......... ..|..|.-.|+-+.||||++++++|
T Consensus 180 tlsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~ris---rdfneefp~lrifshpnilpvlgac 256 (448)
T KOG0195|consen 180 TLSRYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARIS---RDFNEEFPALRIFSHPNILPVLGAC 256 (448)
T ss_pred ccccccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhc---chhhhhCcceeeecCCchhhhhhhc
Confidence 4445555666777788899999999999999999999999987655443321 3577888888888999999999999
Q ss_pred ecC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-Cee-ecCCCCCEEEcCCCCceEE--e
Q 022903 128 KDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG-IIH-RDLKPDNLLLTPDQKSLKL--A 202 (290)
Q Consensus 128 ~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g-ivH-~Dikp~Nili~~~~~~~kl--~ 202 (290)
..+ .+.++..|++.++|.+++.....--++..++.+++.++++|+.|||+.. ++- --|....++||.+ -+.+| +
T Consensus 257 nsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided-ltarisma 335 (448)
T KOG0195|consen 257 NSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED-LTARISMA 335 (448)
T ss_pred cCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch-hhhheecc
Confidence 765 7889999999999999998866667899999999999999999999974 333 3678888999844 33443 3
Q ss_pred cccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 203 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
|--++-+ . ......+.||+||.+..-+ ....-.++|+|||++++||+.|...||.+.++++...+++.+
T Consensus 336 d~kfsfq-e-----~gr~y~pawmspealqrkp-----ed~n~raadmwsfaillwel~trevpfadlspmecgmkiale 404 (448)
T KOG0195|consen 336 DTKFSFQ-E-----VGRAYSPAWMSPEALQRKP-----EDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE 404 (448)
T ss_pred cceeeee-c-----cccccCcccCCHHHHhcCc-----hhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc
Confidence 3222211 1 1224567899999886411 112235899999999999999999999999999999999998
Q ss_pred hcccccCC
Q 022903 283 VQESIYAP 290 (290)
Q Consensus 283 ~~~~~~~~ 290 (290)
.-+--+||
T Consensus 405 glrv~ipp 412 (448)
T KOG0195|consen 405 GLRVHIPP 412 (448)
T ss_pred cccccCCC
Confidence 66655554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-24 Score=191.84 Aligned_cols=185 Identities=32% Similarity=0.479 Sum_probs=154.1
Q ss_pred eccccceeEEEEE-----ECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeee-cCceEEEEEe
Q 022903 66 IGEGAHGKVYEGR-----YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTEL 138 (290)
Q Consensus 66 lG~G~~g~V~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~lv~e~ 138 (290)
+|+|+||.|++++ +.+..+|+|+.++......... +...|..++...+ ||.++++.-.++ +...++++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~---~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT---HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc---ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 7999999999763 4567899998877654443322 3456777888886 999999988886 4578899999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccccc
Q 022903 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 218 (290)
Q Consensus 139 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~ 218 (290)
..|+.|...+.. ...+++.....+...++.+++++|+.|++|||+|++||+++.++ ++++.|||+++.....+..
T Consensus 79 ~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhhhc--
Confidence 999999877654 45688888899999999999999999999999999999999665 4999999999875444333
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
+||..|||||+..+ ...++|+||||+++++|++|..||.+
T Consensus 154 -cgt~eymApEI~~g----------h~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -CGTYEYRAPEIING----------HLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -ccchhhhhhHhhhc----------cCCcccchhhhhhHHHHhhCCCCCch
Confidence 89999999999753 57799999999999999999999999
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=191.63 Aligned_cols=206 Identities=26% Similarity=0.372 Sum_probs=162.0
Q ss_pred ccCcccccccccccCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC---C
Q 022903 42 ITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---H 117 (290)
Q Consensus 42 ~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h 117 (290)
...+.+............|.|-+.||+|+||.||+|.. .++.||+|+-++.....-- ==.+++.+|+ -
T Consensus 682 ~~~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfY--------I~~q~~~RLk~~~~ 753 (974)
T KOG1166|consen 682 SRVPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFY--------ICLQVMERLKPQML 753 (974)
T ss_pred ccccccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeee--------ehHHHHHhhchhhh
Confidence 34455666677778888999999999999999999976 5899999999887765422 1224445555 2
Q ss_pred CCceeEEeee-ecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc---
Q 022903 118 DNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--- 193 (290)
Q Consensus 118 ~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~--- 193 (290)
+.|+.+..++ ..+..++|++|.+.|+|.++++. .+.+++..+..+..|++..++.||..+|||+||||+|+|+.
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~ 831 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREI 831 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeeccc
Confidence 3444444433 23456899999999999999984 67899999999999999999999999999999999999994
Q ss_pred ---CCCCceEEeccccccccccc---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 022903 194 ---PDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 265 (290)
Q Consensus 194 ---~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~ 265 (290)
.+...++|+|||.+..+..- .......+|-.+-.+|+..+ ..+++.+|.|.|+.+++-||.|+.
T Consensus 832 ~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g--------rpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 832 CADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG--------RPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC--------CCCchhhhhHHHHHHHHHHHHHHH
Confidence 22335999999998754332 23445577888999998865 789999999999999999999863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=159.45 Aligned_cols=134 Identities=16% Similarity=0.310 Sum_probs=101.6
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-----CCCCceeEEeeeecC----ceE
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-----KHDNLVKFLGACKDP----LMV 133 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~----~~~ 133 (290)
...||+|+||.||....... .+||++........ ..+.+|+.+++.+ .||||++++++++++ ..+
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~~~-----~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDGGD-----KEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEECCCCcC-eEEEEEeccccchH-----HHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46799999999996222333 46898876433222 2478999999999 579999999999765 223
Q ss_pred -EEEEe--cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHHCCCeeecCCCCCEEEcCC---CCceEEecccc
Q 022903 134 -IVTEL--LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM-DCLHANGIIHRDLKPDNLLLTPD---QKSLKLADFGL 206 (290)
Q Consensus 134 -lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l-~~lH~~givH~Dikp~Nili~~~---~~~~kl~Dfg~ 206 (290)
+|+|| +.+++|.+++.. ..+++. ..++.+++.++ +|||+++|+||||||+|||++.. +..++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 447999999965 235555 35678888777 99999999999999999999742 23699999544
Q ss_pred c
Q 022903 207 A 207 (290)
Q Consensus 207 ~ 207 (290)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.4e-22 Score=165.98 Aligned_cols=207 Identities=23% Similarity=0.285 Sum_probs=128.8
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC-----------CCceeEE-
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-----------DNLVKFL- 124 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-----------~~iv~~~- 124 (290)
.+..+..||.|+++.||.+.+ +++.+|+|+........... .+.+.+|.-....+.+ ..++++-
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~--~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANE--YEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTH--HHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHH--HHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 466778999999999999998 46999999987665333222 2345555544443322 1222211
Q ss_pred ee-------e---ec------CceEEEEEecCCCCHHHHHHhc---CCCC--CCHHHHHHHHHHHHHHHHHHHHCCCeee
Q 022903 125 GA-------C---KD------PLMVIVTELLPGMSLRKYLVSL---RPNK--LDLHVALNFALDIARAMDCLHANGIIHR 183 (290)
Q Consensus 125 ~~-------~---~~------~~~~lv~e~~~~~~L~~~~~~~---~~~~--~~~~~~~~i~~qi~~~l~~lH~~givH~ 183 (290)
.. + .+ ...+++|+-+ .++|.+++... .... +.....+.+..|++..+++||+.|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 00 1 11 1346788887 66888886532 1111 1222334566899999999999999999
Q ss_pred cCCCCCEEEcCCCCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC
Q 022903 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 263 (290)
Q Consensus 184 Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g 263 (290)
||+|+|++++.++ .++|.||+.....+..... ...+..|.|||..............++.+.|.|+||+++|.|+||
T Consensus 170 di~~~nfll~~~G-~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 170 DIKPENFLLDQDG-GVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp T-SGGGEEE-TTS--EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ccceeeEEEcCCC-CEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999765 5999999987664443322 344577999997643110000224578899999999999999999
Q ss_pred CCCCCCCC
Q 022903 264 RLPFEGMS 271 (290)
Q Consensus 264 ~~Pf~~~~ 271 (290)
..||...+
T Consensus 247 ~lPf~~~~ 254 (288)
T PF14531_consen 247 RLPFGLSS 254 (288)
T ss_dssp S-STCCCG
T ss_pred cCCCCCCC
Confidence 99998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=161.85 Aligned_cols=147 Identities=22% Similarity=0.283 Sum_probs=111.7
Q ss_pred CCceeecceeccccceeEEEEE-E--CCceEEEEEcccCCCh-------------------hHHHHHHHHHHHHHHHHhh
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGR-Y--GDRIVAIKVLNRGSTS-------------------DERALLEGRFIREVNMMSR 114 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~-~--~~~~vavK~~~~~~~~-------------------~~~~~~~~~~~~e~~~l~~ 114 (290)
...|.+.+.||+|+||.||+|. + +++.||+|+++..... .........+.+|+.++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3457888999999999999998 3 6899999998764321 0111122346789999999
Q ss_pred cCCCC--ceeEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-CeeecCCCCCEE
Q 022903 115 VKHDN--LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG-IIHRDLKPDNLL 191 (290)
Q Consensus 115 l~h~~--iv~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g-ivH~Dikp~Nil 191 (290)
+.+.+ +.+++.. ...++||||++|.+|..+... ........+..++.|++.++.+||+.| ++||||||+||+
T Consensus 107 L~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 107 LYEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HHhcCCCCCeeeEe---cCceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 97533 3444432 345899999999888765422 234566677899999999999999999 999999999999
Q ss_pred EcCCCCceEEecccccccc
Q 022903 192 LTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 192 i~~~~~~~kl~Dfg~~~~~ 210 (290)
++ + +.++|+|||.+...
T Consensus 182 i~-~-~~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-D-GKVVIIDVSQSVEL 198 (237)
T ss_pred EE-C-CCEEEEEChhhhcc
Confidence 98 4 45999999998653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-22 Score=188.18 Aligned_cols=202 Identities=28% Similarity=0.368 Sum_probs=151.4
Q ss_pred eecceeccccceeEEEEEE--CCceEEEEEcccC--CChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 61 FIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRG--STSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 61 ~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.....+|.|++|.|+.... ..+.++.|..... ....+. .....+..|+.+-..+.|||++..+..+.+. ...-.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~-~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESER-KYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHH-HHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 4567899999998887653 2233343433211 122222 2223477888888999999998776655432 23334
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc--
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-- 213 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-- 213 (290)
||||++ +|..++.. ...+....+..++.|++.|+.|+|+.|+.|||+||+|+++..++ .+||+|||.+.....+
T Consensus 400 mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcc
Confidence 999999 99998875 34788888999999999999999999999999999999999554 6999999998743222
Q ss_pred ---ccccccCCCccccCccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 214 ---EMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 214 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
.......|+..|+|||.+.+ ..| ....||||.|++++.|.+|+.||.-....+.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~--------~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTG--------KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccc--------cccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 23345689999999999876 455 4678999999999999999999987765443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.4e-21 Score=154.80 Aligned_cols=138 Identities=28% Similarity=0.374 Sum_probs=111.0
Q ss_pred ceeccccceeEEEEEECCceEEEEEcccCCChh---HHHHHHHHHHHHHHHHhhcCCCCceeEEeee-ecCceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSD---ERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~ 139 (290)
+.||+|++|.||+|.+.+..+++|+........ .......++.+|+.++..+.|++++.....+ .....+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 568999999999999999999999876543221 1122234577899999999998886554443 345678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
+|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.||+++ + +.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 9999999886521 1 7788999999999999999999999999999999 4 4599999999875
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-22 Score=189.49 Aligned_cols=204 Identities=21% Similarity=0.281 Sum_probs=151.6
Q ss_pred ceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVTE 137 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~e 137 (290)
.+...+.||.+.|=+|.+|++.+..|+||++-+....-...-...++ +|++ ...+++||++++..+-.. ...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 57788999999999999999988889999998766443333232233 3444 555689999999776543 34567777
Q ss_pred ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc---
Q 022903 138 LLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--- 214 (290)
Q Consensus 138 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~--- 214 (290)
|. ..+|.|.+.. ..-+...+...|+.||+.||..+|..||.|||||.+||||+.-++ +.|+||...+.--.++
T Consensus 102 yv-khnLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW-~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 102 YV-KHNLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW-LYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HH-hhhhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech-hhhhcccccCCccCCCCCc
Confidence 87 5588888765 234666777889999999999999999999999999999998888 8999998776321111
Q ss_pred -----cccccCCCccccCcccccccc--ccccccCC-CCCcchhHHHHHHHHHHHh-CCCCCC
Q 022903 215 -----MMTAETGTYRWMAPELYSTVT--LRQGEKKH-YNNKVDVYSFGIVLWELLT-NRLPFE 268 (290)
Q Consensus 215 -----~~~~~~g~~~y~aPE~~~~~~--~~~~~~~~-~~~~~DiwslG~~l~~~l~-g~~Pf~ 268 (290)
...+...-..|+|||.+..-. ........ .+++.||||+||+++|+++ |++||.
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 112223445799999987622 11111122 6789999999999999998 899986
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-20 Score=149.03 Aligned_cols=133 Identities=26% Similarity=0.366 Sum_probs=104.7
Q ss_pred eccccceeEEEEEECCceEEEEEcccCCCh---hHHHHHHHHHHHHHHHHhhcCCCCcee--EEeeeecCceEEEEEecC
Q 022903 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTS---DERALLEGRFIREVNMMSRVKHDNLVK--FLGACKDPLMVIVTELLP 140 (290)
Q Consensus 66 lG~G~~g~V~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~--~~~~~~~~~~~lv~e~~~ 140 (290)
||+|+||.||+|.+.+..+++|........ .+......++.+|+.++..+.|+++.. ++.. .+...++||||++
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-DPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-ECCCCEEEEEEEC
Confidence 799999999999998999999996543321 112222356789999999998876533 3333 3446689999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 141 GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 141 ~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
|++|.+++.... . .++.+++.+|.++|+.|++|+|++|.||+++ + +.++++|||++...
T Consensus 81 g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcCC
Confidence 999999875411 1 7899999999999999999999999999998 4 45999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-20 Score=170.25 Aligned_cols=139 Identities=24% Similarity=0.304 Sum_probs=109.5
Q ss_pred eeecceeccccceeEEEEEECCceEEEEEcccCCCh---hHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee-cCceEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTS---DERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIV 135 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 135 (290)
|...+.||+|+||.||++.+.++.+++|+....... ........++.+|+.+++.++|++++.....+. ....++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 456789999999999999987777766654322111 112223356889999999999999887655543 3467899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
|||++|++|.+++. ....++.+++.+|.+||+.|++||||||+|||++ + +.++|+|||++...
T Consensus 415 ~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~-~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D-DRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C-CcEEEEeCcccccC
Confidence 99999999999875 2467899999999999999999999999999995 4 35999999999764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=146.87 Aligned_cols=139 Identities=22% Similarity=0.238 Sum_probs=105.5
Q ss_pred ceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHH-----------------HHHHHHHHHHHHHHhhcCCCC-
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDER-----------------ALLEGRFIREVNMMSRVKHDN- 119 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~-----------------~~~~~~~~~e~~~l~~l~h~~- 119 (290)
.|.+.+.||+|+||.||++.. +++.||||+++........ ........+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 477788999999999999977 6899999987654311100 011123567888999888774
Q ss_pred -ceeEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCc
Q 022903 120 -LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (290)
Q Consensus 120 -iv~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~ 198 (290)
++..++ ....++||||++|++|...... .....++.+++.++.++|+.|++||||+|+||+++.+ +.
T Consensus 96 ~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~ 163 (198)
T cd05144 96 PVPKPID---WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EK 163 (198)
T ss_pred CCCceee---cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-Cc
Confidence 444443 2355899999999998765321 3356788999999999999999999999999999954 56
Q ss_pred eEEeccccccc
Q 022903 199 LKLADFGLARE 209 (290)
Q Consensus 199 ~kl~Dfg~~~~ 209 (290)
++|+|||++..
T Consensus 164 ~~liDfg~~~~ 174 (198)
T cd05144 164 IYIIDWPQMVS 174 (198)
T ss_pred EEEEECCcccc
Confidence 99999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-19 Score=153.15 Aligned_cols=206 Identities=28% Similarity=0.389 Sum_probs=141.0
Q ss_pred CCceeecceeccccceeEEEEEEC---------C----------------------------ceEEEEEcccCCChhHHH
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG---------D----------------------------RIVAIKVLNRGSTSDERA 99 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~---------~----------------------------~~vavK~~~~~~~~~~~~ 99 (290)
.++|.++..||+|+-..||.|+.. + =+.|||++..-...+...
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 356999999999999999987420 0 035777765533333222
Q ss_pred HHHHHHHHHH------HH--------Hhh--------cCCCCceeEEeeeec----------------------------
Q 022903 100 LLEGRFIREV------NM--------MSR--------VKHDNLVKFLGACKD---------------------------- 129 (290)
Q Consensus 100 ~~~~~~~~e~------~~--------l~~--------l~h~~iv~~~~~~~~---------------------------- 129 (290)
.+...+.+|+ .. .+. -+|||||++...|.+
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 2222233332 11 111 249999998765421
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC---ceEEecccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGL 206 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~---~~kl~Dfg~ 206 (290)
..+|+||..+ .-+|..|+-. ...+.....-++.|+++|+.|||.+||.|||+|.+|||+..+.. .++|+|||.
T Consensus 316 ~tlylvMkrY-~~tLr~yl~~---~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 316 KTLYLVMKRY-RQTLREYLWT---RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred ceEEEehhcc-hhhHHHHHhc---CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 2478898888 4599999875 45677788889999999999999999999999999999943322 488999998
Q ss_pred ccccccc------cc-ccccCCCccccCccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 207 AREETVT------EM-MTAETGTYRWMAPELYSTVTLRQGEKKH-YNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 207 ~~~~~~~------~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~-~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
+--.... .. ....-|....||||+....+ +.... .-.++|.|+.|.+.||++....||=+
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P---Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP---GPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCC---CCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 7421111 11 11224566789999976532 11111 22489999999999999999999976
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-18 Score=143.15 Aligned_cols=139 Identities=21% Similarity=0.270 Sum_probs=104.6
Q ss_pred ceec-cccceeEEEEEECCceEEEEEcccCCChhH--------HHHHHHHHHHHHHHHhhcCCCCc--eeEEeeee--cC
Q 022903 64 SKIG-EGAHGKVYEGRYGDRIVAIKVLNRGSTSDE--------RALLEGRFIREVNMMSRVKHDNL--VKFLGACK--DP 130 (290)
Q Consensus 64 ~~lG-~G~~g~V~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~--~~ 130 (290)
..|| .|+.|+||.+...+..++||.+........ ......++.+|+.++..|+|++| +..++... ..
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4687 899999999988899999998864321000 01123467899999999998775 55665532 22
Q ss_pred ---ceEEEEEecCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 131 ---LMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 131 ---~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
..++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||++||+||||||.|||++.++ .++|+|||.
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~ 188 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDR 188 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCC
Confidence 23599999997 689988764 345543 367899999999999999999999999999654 599999999
Q ss_pred cccc
Q 022903 207 AREE 210 (290)
Q Consensus 207 ~~~~ 210 (290)
+...
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 8653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-19 Score=169.19 Aligned_cols=167 Identities=32% Similarity=0.501 Sum_probs=119.4
Q ss_pred CCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceEE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI 134 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l 134 (290)
...|..++.+..|+||.||.++++ .+.+|+|+-++ .. +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l----------ilRn--ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL----------ILRN--ILTFAGNPFVV------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-ch----------hhhc--cccccCCccee-------------
Confidence 356888999999999999999875 67888854321 11 1121 22222233333
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
|+-...++.. +.++. +++.+++|+|+.||+|||+||+|++|..-+ ++|++|||+++.....
T Consensus 136 -------gDc~tllk~~--g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 -------GDCATLLKNI--GPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred -------chhhhhcccC--CCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhc
Confidence 4444444432 23332 227899999999999999999999999555 5999999998631110
Q ss_pred --------------c-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 214 --------------E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 214 --------------~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
+ .....+||+.|.|||++.. ..|+..+|+|++|+|+|+.+.|..||.|.++.+.
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--------qgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhh--------hccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 1 1123379999999999865 7799999999999999999999999999866443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=136.40 Aligned_cols=139 Identities=25% Similarity=0.288 Sum_probs=96.5
Q ss_pred cceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHH-------------------HHHHHHHHHHHhhcCCCC--c
Q 022903 63 GSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALL-------------------EGRFIREVNMMSRVKHDN--L 120 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~-------------------~~~~~~e~~~l~~l~h~~--i 120 (290)
++.||+|+||.||+|.+. ++.||||++............ ......|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999875 899999998764332211100 011235666666665432 3
Q ss_pred eeEEeeeecCceEEEEEecCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCc
Q 022903 121 VKFLGACKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKS 198 (290)
Q Consensus 121 v~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~ 198 (290)
.+.++. ...++||||++++.+.. .+... ... ..+..++.+++.++.++|+ .|++|+||||+||+++ + +.
T Consensus 82 ~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~~ 152 (187)
T cd05119 82 PKPIDL---NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-GK 152 (187)
T ss_pred CceEec---CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-Cc
Confidence 444443 24589999999854321 11110 011 5678899999999999999 9999999999999999 4 45
Q ss_pred eEEecccccccc
Q 022903 199 LKLADFGLAREE 210 (290)
Q Consensus 199 ~kl~Dfg~~~~~ 210 (290)
++|+|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.8e-17 Score=124.67 Aligned_cols=130 Identities=21% Similarity=0.224 Sum_probs=106.7
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC--CCceeEEeeeec-CceEEEEEec
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--DNLVKFLGACKD-PLMVIVTELL 139 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~-~~~~lv~e~~ 139 (290)
++.||.|.++.||++...+..+++|....... ...+.+|+.+++.++| .++++++..... +..+++|||+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc-------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 46799999999999999888999999876543 1247789999999976 588888877653 4678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN---GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.+..+..+ +......++.+++.++.++|.. +++|+|++|.||+++. .+.++++|||.+..
T Consensus 76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 88777653 4556677899999999999985 7999999999999996 45699999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.1e-18 Score=147.77 Aligned_cols=120 Identities=36% Similarity=0.618 Sum_probs=103.8
Q ss_pred ceEEEEEecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.+++.|++|.-.+|.+|+..++ ....+....+.++.|++.|+.| +|.+|+|+||.||+...+ ..+||.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhheee
Confidence 4789999999999999997432 3447788889999999999999 999999999999999844 4699999999887
Q ss_pred ccccc-------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh
Q 022903 210 ETVTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262 (290)
Q Consensus 210 ~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~ 262 (290)
..... ......||+.||+||.+.+ ..|+.++||||||++|+|++.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--------~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG--------QQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh--------hhhhhhcchhhHHHHHHHHHH
Confidence 65554 4456689999999999875 889999999999999999998
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=141.59 Aligned_cols=156 Identities=35% Similarity=0.504 Sum_probs=124.1
Q ss_pred HhhcCCCCceeEEeeeecC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-eeecCCCCC
Q 022903 112 MSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI-IHRDLKPDN 189 (290)
Q Consensus 112 l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~gi-vH~Dikp~N 189 (290)
|+.+.|.|+.+++|.+.++ ..+.|.+||..|+|.+.+.. ....+++.-...+.++|+.||+|+|+..+ .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 4567899999999998654 67899999999999999976 55678888888999999999999998876 999999999
Q ss_pred EEEcCCCCceEEeccccccccccc---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 022903 190 LLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266 (290)
Q Consensus 190 ili~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~P 266 (290)
+++| ..+.+||+|||+....... .......-...|.|||.+..... ....+..+.+.|+||+|++++|+++.+-|
T Consensus 80 Clvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~-~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 80 CLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALS-QSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccc-ccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999 6688999999997654210 11111123456999999876321 11113367889999999999999999999
Q ss_pred CCCC
Q 022903 267 FEGM 270 (290)
Q Consensus 267 f~~~ 270 (290)
|...
T Consensus 158 ~~~~ 161 (484)
T KOG1023|consen 158 FDLR 161 (484)
T ss_pred cccc
Confidence 9874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.3e-18 Score=156.53 Aligned_cols=207 Identities=26% Similarity=0.366 Sum_probs=161.3
Q ss_pred CceeecceeccccceeEEEEEE---CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-ce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~~ 132 (290)
..|.+.+.||+|+|+.|-.... ....+|.|.+......... ..++..|..+-..+. |+|++.+++...++ ..
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~---~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDS---SEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccch---hhhcCccccccccccccccccccCCccCCCccc
Confidence 4477788899999999987743 4466777777655422211 123556888888887 99999999998766 56
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
++..++.+|+++.+.+........+...+-.++.|+..++.|+| ..++.|+|+||+|.+++..+..+++.|||+++...
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 78899999999998773222226777788899999999999999 99999999999999999665269999999998654
Q ss_pred c----cccccccCC-CccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 212 V----TEMMTAETG-TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 212 ~----~~~~~~~~g-~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
. .......+| ++.|+|||.+.. .....+..|+||.|+++.-+++|..||.......
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~-------~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSG-------KAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccc-------hhhcCCCcccccccccccccccCCCCcccccccc
Confidence 4 222344578 999999998864 1355789999999999999999999998765443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-15 Score=117.48 Aligned_cols=127 Identities=22% Similarity=0.239 Sum_probs=95.8
Q ss_pred ceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCce-eEEeeeecCceEEEEEecCCC
Q 022903 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV-KFLGACKDPLMVIVTELLPGM 142 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~lv~e~~~~~ 142 (290)
+.|+.|.++.||+++..++.|++|+........ ..+.+|+.+++.+.+.+++ +++... ....++||||++|.
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~------~~~~~E~~~l~~l~~~~~~P~~~~~~-~~~~~lv~e~i~G~ 76 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTELL------INRENEAENSKLAAEAGIGPKLYYFD-PETGVLITEFIEGS 76 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcccc------cCHHHHHHHHHHHHHhCCCCceEEEe-CCCCeEEEEecCCC
Confidence 568999999999999999999999986553211 1245788888888655544 455443 33458999999998
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI-----IHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 143 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~gi-----vH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
++... . . ....++.+++.+|..||+.++ +|+|++|.||+++ ++ .++++||+.+..
T Consensus 77 ~l~~~--~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTE--D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAGM 136 (170)
T ss_pred ccccc--c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEecccccC
Confidence 87642 0 1 113456789999999999985 9999999999999 44 489999999854
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.2e-14 Score=109.53 Aligned_cols=148 Identities=22% Similarity=0.297 Sum_probs=113.5
Q ss_pred ecceeccccceeEEEEEECCceEEEEEcccCCC---hhHHHHHHHHHHHHHHHHhhcCCCCc--eeEEeeeecCceEEEE
Q 022903 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGST---SDERALLEGRFIREVNMMSRVKHDNL--VKFLGACKDPLMVIVT 136 (290)
Q Consensus 62 ~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~lv~ 136 (290)
.+..|-+|+-++|+++.+.|+.++||.-..... .-+......|..+|++++.+++--.| ..++.+ ......++|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-DTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-ecCCCeEEE
Confidence 356788999999999999999999988655443 23344556788899999999874444 333332 223457999
Q ss_pred EecCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCc--eEEecccccccc
Q 022903 137 ELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLAREE 210 (290)
Q Consensus 137 e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~--~kl~Dfg~~~~~ 210 (290)
||++| .++.+++...............+++++-+.+.-||..+++|+||..+||++.+++.. +.++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99977 478888877665555555557899999999999999999999999999999766554 589999998653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.7e-14 Score=110.36 Aligned_cols=136 Identities=21% Similarity=0.310 Sum_probs=103.6
Q ss_pred ceeccccceeEEEEEECCceEEEEEcccCCC---hhHHHHHHHHHHHHHHHHhhcCCCCc--eeEEeeeecCceEEEEEe
Q 022903 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGST---SDERALLEGRFIREVNMMSRVKHDNL--VKFLGACKDPLMVIVTEL 138 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~lv~e~ 138 (290)
..+++|+-+.+|.+.+-+..+++|.-.+... .-+......+..+|+.++.+++--.| +.++++ ......++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-D~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-DPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-cCCCCEEEEEE
Confidence 3578999999999988887788887655432 22334455678899999999875444 333433 33356799999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 139 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
++|..|.+++... ...++..+-.-+.-||..||+|+||.++|+++..+ . +.++|||++....
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-R-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-c-EEEEECCcccccc
Confidence 9999999998763 14577777788889999999999999999999844 3 8999999997543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.5e-14 Score=128.65 Aligned_cols=142 Identities=23% Similarity=0.293 Sum_probs=95.9
Q ss_pred ceeccccceeEEEEEE-CCceEEEEEcccCCChhHHH-----------------------------------HHHHHHHH
Q 022903 64 SKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERA-----------------------------------LLEGRFIR 107 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~-----------------------------------~~~~~~~~ 107 (290)
+.||.|++|.||+|+. +|+.||||+.++.....-.. ..+-.+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999987 68999999987643211100 00112455
Q ss_pred HHHHHhhcC-----CCCc--eeEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 022903 108 EVNMMSRVK-----HDNL--VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR-AMDCLHANG 179 (290)
Q Consensus 108 e~~~l~~l~-----h~~i--v~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~-~l~~lH~~g 179 (290)
|...+.+++ ++++ .+++..+ ....++||||++|++|.++.... ....+ ...++..++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~-~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALD-EAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHH-hcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 665555552 2332 2223222 23568999999999999876532 11222 2345555555 478899999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 180 ivH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
++|+|++|.||+++.+ +.++++|||++....
T Consensus 278 ~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKD-GKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCC-CcEEEEeCCCeeECC
Confidence 9999999999999855 459999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.2e-14 Score=111.37 Aligned_cols=140 Identities=20% Similarity=0.201 Sum_probs=99.5
Q ss_pred ceeccccceeEEEEEEC--------CceEEEEEcccCCC---------------------hhHHHHHHHHHHHHHHHHhh
Q 022903 64 SKIGEGAHGKVYEGRYG--------DRIVAIKVLNRGST---------------------SDERALLEGRFIREVNMMSR 114 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~--------~~~vavK~~~~~~~---------------------~~~~~~~~~~~~~e~~~l~~ 114 (290)
..||.|--+.||.|... +..+|||+.+.... ..........-.+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754 37899999753221 01111222223489999999
Q ss_pred cCC--CCceeEEeeeecCceEEEEEecCCCCHHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeecCCCCCE
Q 022903 115 VKH--DNLVKFLGACKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAMDCL-HANGIIHRDLKPDNL 190 (290)
Q Consensus 115 l~h--~~iv~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~i~~qi~~~l~~l-H~~givH~Dikp~Ni 190 (290)
+.. -+++..+.. ...++||||+.+..+.. .+. ...++......+..+++.+|..+ |..|++|+||++.||
T Consensus 83 l~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 864 455666654 35689999997654422 122 22455566778889999999999 899999999999999
Q ss_pred EEcCCCCceEEeccccccccc
Q 022903 191 LLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 191 li~~~~~~~kl~Dfg~~~~~~ 211 (290)
+++ ++ .++|+|||.+....
T Consensus 157 L~~-~~-~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DG-KVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CC-cEEEEECCCceeCC
Confidence 998 33 49999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.2e-14 Score=128.92 Aligned_cols=147 Identities=19% Similarity=0.255 Sum_probs=89.7
Q ss_pred eeecceeccccceeEEEEEE-C-CceEEEEEcccCCChh-----------------------------HHHHHH------
Q 022903 60 LFIGSKIGEGAHGKVYEGRY-G-DRIVAIKVLNRGSTSD-----------------------------ERALLE------ 102 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~-~-~~~vavK~~~~~~~~~-----------------------------~~~~~~------ 102 (290)
|.. +.||.|++|.||+|+. + |+.||||+.++..... -.....
T Consensus 122 fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~E 200 (537)
T PRK04750 122 FDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDE 200 (537)
T ss_pred cCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHh
Confidence 444 6899999999999987 3 7999999998653111 000111
Q ss_pred HHHHHHHHHHhhcC----CCCceeEEeeee--cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022903 103 GRFIREVNMMSRVK----HDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176 (290)
Q Consensus 103 ~~~~~e~~~l~~l~----h~~iv~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 176 (290)
-.+.+|+..+.+++ +.+.+.+=.++. ....++||||++|+++.++... .....+.........+ .-+..+.
T Consensus 201 lD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~--~~~~Qif 277 (537)
T PRK04750 201 LDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVE--VFFTQVF 277 (537)
T ss_pred hCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHH--HHHHHHH
Confidence 12444554444442 332232222221 2356899999999999875321 1123332222111111 1133345
Q ss_pred HCCCeeecCCCCCEEEcCCC---CceEEecccccccc
Q 022903 177 ANGIIHRDLKPDNLLLTPDQ---KSLKLADFGLAREE 210 (290)
Q Consensus 177 ~~givH~Dikp~Nili~~~~---~~~kl~Dfg~~~~~ 210 (290)
..|++|+|++|.||+++.++ ..++++|||++...
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 69999999999999998654 26999999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.8e-13 Score=119.55 Aligned_cols=197 Identities=29% Similarity=0.359 Sum_probs=147.8
Q ss_pred ceeecceecc--ccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-
Q 022903 59 LLFIGSKIGE--GAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP- 130 (290)
Q Consensus 59 ~~~~~~~lG~--G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~- 130 (290)
.+.+.+.+|. |.+|.||.++. ....+|+|.-+......... .+=.+|+.-.++++ |++.++.+..+.+.
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~---~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS---KRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc---ccccchhhcccccCccccccccCcccccCC
Confidence 3557788999 99999999865 45778888733322211111 12346777667775 89999988888765
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR----AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~----~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
..++-.|++ +.+|..+... ...-++...+...+.+... ||.++|+.+++|-|+||.|++...+....+++|||+
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred cceeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 455666666 7899998876 3345788888888888888 999999999999999999999997746699999999
Q ss_pred ccccccccccc------ccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 207 AREETVTEMMT------AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 207 ~~~~~~~~~~~------~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
........... ...+...|++||+.. .-++..+|+|+||.++.+..++..+...
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~---------~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN---------GLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc---------cccchHhhhcchhhhhHhhHhhcccccC
Confidence 88654443221 125677899999875 4578899999999999998887666544
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.3e-11 Score=111.90 Aligned_cols=163 Identities=18% Similarity=0.241 Sum_probs=119.3
Q ss_pred EECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee-cCceEEEEEecCCCCHHHHHHhcCCCCC
Q 022903 78 RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKL 156 (290)
Q Consensus 78 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 156 (290)
+..+.+|.|...+.... .. .....+.++-|+.++||||++++..+. ++..|+|.|-+ ..|..+++..
T Consensus 34 k~~~~~vsVF~~~~~~~--~~---~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l----- 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EV---TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL----- 101 (690)
T ss_pred eccCCceEEEEEeCCCc--hh---hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----
Confidence 34567788777766554 11 123567889999999999999999886 45789999998 5788888763
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc-ccccCCCccccCccccccc
Q 022903 157 DLHVALNFALDIARAMDCLH-ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTV 234 (290)
Q Consensus 157 ~~~~~~~i~~qi~~~l~~lH-~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~ 234 (290)
....+..-+.||+.||.||| ..+++|++|.-+.|+|+..+ ..||.+|.++........ .....--..|..|+...
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~-- 178 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEID-- 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcC--
Confidence 36666778899999999998 56899999999999999665 599999988754322211 11111122456666442
Q ss_pred cccccccCCCCCcchhHHHHHHHHHHHhC
Q 022903 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTN 263 (290)
Q Consensus 235 ~~~~~~~~~~~~~~DiwslG~~l~~~l~g 263 (290)
+-+...|.|-|||++++++.|
T Consensus 179 --------~s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 --------PSEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --------ccccchhhhhHHHHHHHHhCc
Confidence 123568999999999999999
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.5e-11 Score=100.50 Aligned_cols=139 Identities=19% Similarity=0.113 Sum_probs=96.7
Q ss_pred ceeEEEEEECCceEEEEEcccCCChhHHHH------HHHHHHHHHHHHhhcCCCCc--eeEEeeee------cCceEEEE
Q 022903 71 HGKVYEGRYGDRIVAIKVLNRGSTSDERAL------LEGRFIREVNMMSRVKHDNL--VKFLGACK------DPLMVIVT 136 (290)
Q Consensus 71 ~g~V~~~~~~~~~vavK~~~~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i--v~~~~~~~------~~~~~lv~ 136 (290)
...|+.....|+.|.||.........-... -.....+|...+..|...+| ++.+++.. ....++|+
T Consensus 35 ~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 35 GRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred CceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 335667777888999997644331110000 00125688888887753333 33333332 12478999
Q ss_pred EecCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC------CCCceEEeccccccc
Q 022903 137 ELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP------DQKSLKLADFGLARE 209 (290)
Q Consensus 137 e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~------~~~~~kl~Dfg~~~~ 209 (290)
|++++. +|.+++........+......++.+++..+..||..|++|+|+++.|||++. +...+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999886 7999886433345666777899999999999999999999999999999984 244699999998854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.33 E-value=2e-11 Score=96.98 Aligned_cols=130 Identities=26% Similarity=0.322 Sum_probs=84.3
Q ss_pred eEEEEEE-CCceEEEEEcccCCCh---------------------hHHHHHHHHHHHHHHHHhhcCCC--CceeEEeeee
Q 022903 73 KVYEGRY-GDRIVAIKVLNRGSTS---------------------DERALLEGRFIREVNMMSRVKHD--NLVKFLGACK 128 (290)
Q Consensus 73 ~V~~~~~-~~~~vavK~~~~~~~~---------------------~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~ 128 (290)
.||.|.. .+..+|+|+.+..... ...........+|.+.|.++... ++++.+...
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4888876 5788999997543211 11223445677899999999865 455666443
Q ss_pred cCceEEEEEecC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 129 DPLMVIVTELLP--GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC-LHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 129 ~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~-lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
..++||||++ |..+..+... .++......++.+++..+.. +|..|++|+|+.+.||+++.+ .+.|+|||
T Consensus 80 --~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 --RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp --TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred --CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence 4579999998 6666654432 22234456677888885555 579999999999999999955 49999999
Q ss_pred cccccc
Q 022903 206 LAREET 211 (290)
Q Consensus 206 ~~~~~~ 211 (290)
.+....
T Consensus 152 qav~~~ 157 (188)
T PF01163_consen 152 QAVDSS 157 (188)
T ss_dssp TEEETT
T ss_pred cceecC
Confidence 986543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-11 Score=100.50 Aligned_cols=139 Identities=23% Similarity=0.356 Sum_probs=99.5
Q ss_pred ceeccccceeEEEEEECC-ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCC--CceeEEeeeec----CceEEEE
Q 022903 64 SKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD--NLVKFLGACKD----PLMVIVT 136 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~----~~~~lv~ 136 (290)
+.|+.|.++.||++...+ +.+++|+......... ...+.+|..+++.+++. ++.+++....+ +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~----~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPS----AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcc----cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 568999999999998765 8999999866443111 12367899999998753 45666666544 2568999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA--------------------------------------- 177 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--------------------------------------- 177 (290)
||++|.++.+.+.. ..++......++.+++.+|.+||+
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99999888764321 235555666666666666666663
Q ss_pred -----------------CCCeeecCCCCCEEEcCC-CCceEEeccccccc
Q 022903 178 -----------------NGIIHRDLKPDNLLLTPD-QKSLKLADFGLARE 209 (290)
Q Consensus 178 -----------------~givH~Dikp~Nili~~~-~~~~kl~Dfg~~~~ 209 (290)
..++|+|+.|.||+++.+ +..+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246999999999999963 34578999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.7e-10 Score=99.72 Aligned_cols=198 Identities=17% Similarity=0.251 Sum_probs=133.1
Q ss_pred eecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCcee--------EEeeeecCc
Q 022903 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVK--------FLGACKDPL 131 (290)
Q Consensus 61 ~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~--------~~~~~~~~~ 131 (290)
..++.||+|+-+.+|..-.-...|| |+..........+. +..|... .||-+-. ++|.-....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~aqk--------~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQAQK--------VAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchhhchhh-eeecCCCchHHHHH--------HHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 3457899999999996533233344 77765554433221 2222222 3553322 222222223
Q ss_pred eEEEEEecCCCC-HHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 132 MVIVTELLPGMS-LRKYLVS----LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 132 ~~lv~e~~~~~~-L~~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
.-++|..+.|.. ..+++.. ......++.-+++.++.|+.+.+.||+.|.+-+|+.++|+|++.+ ..+.|+|=..
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LVdsDs 163 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLVDSDS 163 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEEcccc
Confidence 567888887652 3443322 122347788899999999999999999999999999999999944 4589998655
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCC
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMS 271 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g-~~Pf~~~~ 271 (290)
.....++.......|...|.+||...--. -.+...+...|.|.||+++++++.| +.||+|..
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~s---f~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLPS---FVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhcccc---ccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 44444555556668999999999765211 1234567789999999999999985 99999853
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.4e-11 Score=110.21 Aligned_cols=195 Identities=24% Similarity=0.229 Sum_probs=141.0
Q ss_pred CCCceeecceeccccceeEEEEEE---CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeee-ecC
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGAC-KDP 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~-~~~ 130 (290)
...+|..+..||.|.|+.|+.... ++..|++|............. .-..|+.+...+. |.+++.++..| +..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di---~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI---FSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh---cchhhhhHhhHhhcccccCCCCCCccccc
Confidence 345678889999999999998743 567888888776554443321 1235666666664 88888876665 455
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++--|||+++++...+.. ...+++...+++..|++.++.++|++.++|+|++|+||++..++...++.|||..+..
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 67788999999887765522 3467888889999999999999999999999999999999865456899999988642
Q ss_pred cccccccccCCCccccC-ccccccccccccccCCCCCcchhHHHHHHHHHHHhCC
Q 022903 211 TVTEMMTAETGTYRWMA-PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 264 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~a-PE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~ 264 (290)
... .......-+++| +|.+.. ...+..+.|++|||..+.+..+|.
T Consensus 418 ~~~--~~~~~~~~r~~p~~~~~~e-------~~~~~~~~~~~sl~~~~~e~~~~~ 463 (524)
T KOG0601|consen 418 AFS--SGVFHHIDRLYPIAEILLE-------DYPHLSKADIFSLGLSVDEAITGS 463 (524)
T ss_pred cee--cccccccccccccchhhcc-------ccccccccccccccccccccccCc
Confidence 111 111223334442 444432 256778999999999999888865
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.2e-10 Score=92.37 Aligned_cols=140 Identities=26% Similarity=0.310 Sum_probs=101.1
Q ss_pred ceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHH-----------------HHHHHHHHHHHHHHhhcCCC--
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDER-----------------ALLEGRFIREVNMMSRVKHD-- 118 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~-----------------~~~~~~~~~e~~~l~~l~h~-- 118 (290)
...++..||-|--+.||.|.. .+..+|||.-+....+-.. -.....-.+|.++|..|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356778999999999999987 5899999986543221111 01112245788889888644
Q ss_pred CceeEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCc
Q 022903 119 NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (290)
Q Consensus 119 ~iv~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~ 198 (290)
.+...+++ ++.++|||+++|..|... +++....-.++..|+.-+.-+-..|+||+|+++=||+++.+++
T Consensus 172 ~VP~P~~~---nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~- 240 (304)
T COG0478 172 KVPKPIAW---NRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD- 240 (304)
T ss_pred CCCCcccc---ccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC-
Confidence 55555544 467899999999777652 2234445567777777777777899999999999999996654
Q ss_pred eEEeccccccc
Q 022903 199 LKLADFGLARE 209 (290)
Q Consensus 199 ~kl~Dfg~~~~ 209 (290)
+.++||-.+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999977654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.9e-11 Score=115.45 Aligned_cols=208 Identities=23% Similarity=0.291 Sum_probs=141.2
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee-ecCc
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPL 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~ 131 (290)
...+.+.+.+.+-.|+++.++.++- .+...+.|+............ .....+-.++-.-++|.++...-.+ ....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~--~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDY--ESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccc--cccCCccCccccCCCCceecccCCCCCCCC
Confidence 4556678888999999999998754 333334443322111100000 0111222222222345555544442 2235
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc-
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE- 210 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~- 210 (290)
..++++|..+++|...+.. .+..+..-++.+...+..+++|||+..+.|+|++|.|.++..++ ..++.|||.....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-HRPLTDFGTLSKVG 955 (1205)
T ss_pred cchhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-CcccCccccccccc
Confidence 7899999999999988775 34567777788889999999999999999999999999998555 4899999843210
Q ss_pred ------cc---------------------c----ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHH
Q 022903 211 ------TV---------------------T----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259 (290)
Q Consensus 211 ------~~---------------------~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~ 259 (290)
.. . .......+|+.|.+||.+.+ ......+|+|++|+++++
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--------~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--------RRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--------ccCCCcchhhhhhhhhhh
Confidence 00 0 01123358999999998875 556789999999999999
Q ss_pred HHhCCCCCCCCCHHHH
Q 022903 260 LLTNRLPFEGMSNLQA 275 (290)
Q Consensus 260 ~l~g~~Pf~~~~~~~~ 275 (290)
.++|.+||...+..+.
T Consensus 1028 ~l~g~pp~na~tpq~~ 1043 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQQI 1043 (1205)
T ss_pred hhcCCCCCCCcchhhh
Confidence 9999999999776543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.7e-10 Score=90.24 Aligned_cols=104 Identities=30% Similarity=0.419 Sum_probs=79.8
Q ss_pred HHHHHHHHHhhcCCCCc--eeEEeeeec-----CceEEEEEecCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 022903 104 RFIREVNMMSRVKHDNL--VKFLGACKD-----PLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175 (290)
Q Consensus 104 ~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 175 (290)
+..+|...+..|...+| ++.+++... ...++|+|++++. +|.+++.... ..+......++.+++..+.-|
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHHH
Confidence 46688888877754333 334444332 2457999999884 7999887632 266677788999999999999
Q ss_pred HHCCCeeecCCCCCEEEcCCC--CceEEeccccccc
Q 022903 176 HANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLARE 209 (290)
Q Consensus 176 H~~givH~Dikp~Nili~~~~--~~~kl~Dfg~~~~ 209 (290)
|.+|++|+|++|.|||++.++ ..+.++||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999998665 2599999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.7e-09 Score=85.47 Aligned_cols=143 Identities=15% Similarity=0.151 Sum_probs=99.7
Q ss_pred ccccceeEEEEEECCceEEEEEcccCCChhHH-HHHHHHHHHHHHHHhhcCCCC--ceeEEee--eecC---ceEEEEEe
Q 022903 67 GEGAHGKVYEGRYGDRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDN--LVKFLGA--CKDP---LMVIVTEL 138 (290)
Q Consensus 67 G~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~--iv~~~~~--~~~~---~~~lv~e~ 138 (290)
|+||-+.|+.....|..+-+|.-...-...-. ..-+.-|.+|+..+..|..-+ +++.+.. -..+ ..++|+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 67899999998887777888876421110000 001123789999999886322 4444321 1222 35789997
Q ss_pred cCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC-ceEEeccccccc
Q 022903 139 LPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLARE 209 (290)
Q Consensus 139 ~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~-~~kl~Dfg~~~~ 209 (290)
++| .+|.+++....-.+.+......++.+++..+.-||+.|+.|+|+-+.||+++.++. .+.++||.-+..
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 754 58988886533345577777899999999999999999999999999999984432 499999976643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.9e-09 Score=83.48 Aligned_cols=139 Identities=19% Similarity=0.241 Sum_probs=90.8
Q ss_pred CceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHH----HHHHHHHHHHhhcCC---CCceeEEeeee--
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLE----GRFIREVNMMSRVKH---DNLVKFLGACK-- 128 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~----~~~~~e~~~l~~l~h---~~iv~~~~~~~-- 128 (290)
..|.+.+.+-......|.+-...++.+++|..+......++.... ....+.+..+..++. .....++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk 110 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK 110 (229)
T ss_pred CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence 346666777777777777778889999999987755443332110 001233333333332 22233222221
Q ss_pred ----cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 129 ----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 129 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
....+++|||++|..|.++.. +++ .+...+..++..+|+.|++|+|..|.|++++ +++ ++++||
T Consensus 111 ~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~-~~~-i~iID~ 178 (229)
T PF06176_consen 111 IFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS-NNG-IRIIDT 178 (229)
T ss_pred eccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE-CCc-EEEEEC
Confidence 124568999999998877532 222 2456677889999999999999999999999 444 999999
Q ss_pred cccc
Q 022903 205 GLAR 208 (290)
Q Consensus 205 g~~~ 208 (290)
+...
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 7764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.3e-09 Score=92.19 Aligned_cols=165 Identities=17% Similarity=0.242 Sum_probs=119.3
Q ss_pred ceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee-----cCceEEEEEecCC-C
Q 022903 71 HGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK-----DPLMVIVTELLPG-M 142 (290)
Q Consensus 71 ~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~lv~e~~~~-~ 142 (290)
-.+.|++.. +|..|++|.+......... ....-+++++++.|+|||++.+++. |..+++|++|.++ +
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n-----k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN-----KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcc-----cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 356788854 7889999998433322211 1234578889999999999988764 4467899999876 4
Q ss_pred CHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 143 SLRKYLVSLR-------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 143 ~L~~~~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
+|.++..... +...++..++.|+.||..||.++|+.|+.-+-|.|.+||++.+. +++|..+|+...
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dv 442 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDV 442 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceee
Confidence 5766643321 23467889999999999999999999999999999999999543 589988887643
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 265 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~ 265 (290)
...+. . +-+ +--.+-|.=.||.+++.+.||..
T Consensus 443 l~~d~-----------~--~~l-----------e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDP-----------T--EPL-----------ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecCCC-----------C--cch-----------hHHhhhhHHHHHHHHHHHhhccc
Confidence 22111 0 111 12346799999999999999853
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1e-09 Score=91.94 Aligned_cols=145 Identities=23% Similarity=0.353 Sum_probs=105.3
Q ss_pred HhhcCCCCceeEEeeeec------CceEEEEEecCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC--CCe
Q 022903 112 MSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHAN--GII 181 (290)
Q Consensus 112 l~~l~h~~iv~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~--giv 181 (290)
+-.+-|.|++++..++.+ ++..++.||+..|+|.++++..+. ..+......+|+.||+.||.|||+. -++
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 344568999999888754 356799999999999999977543 3467777889999999999999987 499
Q ss_pred eecCCCCCEEEcCCCCceEEeccccccccccc------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHH
Q 022903 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 255 (290)
Q Consensus 182 H~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~ 255 (290)
|+++..+.+++..++. +|+. .+........ .......+-++|.+||.=.. ...+.++|||++|.
T Consensus 201 hgnlTc~tifiq~ngL-Ikig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--------tn~~~a~dIy~fgm 270 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGL-IKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--------TNTTGASDIYKFGM 270 (458)
T ss_pred cCCcchhheeecCCce-EEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcc--------cccccchhhhhhhH
Confidence 9999999999996543 5443 2221110000 11122346678999996332 44567999999999
Q ss_pred HHHHHHhCCCC
Q 022903 256 VLWELLTNRLP 266 (290)
Q Consensus 256 ~l~~~l~g~~P 266 (290)
+..+|..+..-
T Consensus 271 cAlemailEiq 281 (458)
T KOG1266|consen 271 CALEMAILEIQ 281 (458)
T ss_pred HHHHHHHheec
Confidence 99999887643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.2e-08 Score=79.38 Aligned_cols=143 Identities=22% Similarity=0.217 Sum_probs=95.9
Q ss_pred cceeccccceeEEEEEE-CCceEEEEEcccCCChhH-------------------HHHHHHHHHHHHHHHhhcCCC--Cc
Q 022903 63 GSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDE-------------------RALLEGRFIREVNMMSRVKHD--NL 120 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~-------------------~~~~~~~~~~e~~~l~~l~h~--~i 120 (290)
...|..|--+.||+|.. .+..+|+|+.+....... .........+|..-|.++... .+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 34678888889999976 588999999865443222 122223345677777777533 33
Q ss_pred eeEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCce
Q 022903 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSL 199 (290)
Q Consensus 121 v~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~ 199 (290)
.+-+... ..++||||+... ... -......++....+..+..++++.+.-|-. .|+||+||+.=|||+. ++ .+
T Consensus 133 P~Pi~~~---~nVLvMEfIg~~-g~p-AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~-~p 205 (268)
T COG1718 133 PEPIAFR---NNVLVMEFIGDD-GLP-APRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG-EP 205 (268)
T ss_pred CCceeec---CCeEEEEeccCC-CCC-CCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-eE
Confidence 3444433 457999999543 111 001112233333678888999999988877 8999999999999999 44 48
Q ss_pred EEecccccccccc
Q 022903 200 KLADFGLAREETV 212 (290)
Q Consensus 200 kl~Dfg~~~~~~~ 212 (290)
.|||||.+....+
T Consensus 206 ~iID~~QaV~~~h 218 (268)
T COG1718 206 YIIDVSQAVTIDH 218 (268)
T ss_pred EEEECccccccCC
Confidence 9999999876443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.6e-08 Score=87.37 Aligned_cols=142 Identities=20% Similarity=0.269 Sum_probs=91.6
Q ss_pred ceeccccceeEEEEEEC-CceEEEEEcccCCChhHHH-----------------------------------HHHHHHHH
Q 022903 64 SKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERA-----------------------------------LLEGRFIR 107 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~-----------------------------------~~~~~~~~ 107 (290)
..|+.++-|.||+|+.. |+.||||+.++.-...-.. ..+-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57899999999999885 8999999987654322110 01123445
Q ss_pred HHHHHhhcC-----CCCc--eeEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 022903 108 EVNMMSRVK-----HDNL--VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180 (290)
Q Consensus 108 e~~~l~~l~-----h~~i--v~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~gi 180 (290)
|..-+.+++ .|+| .+++-- .....+++|||++|..+.+.... ...+++...+.....++ -+..+=..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we-~t~~~VLtmE~i~Gi~i~d~~~l-~~~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWE-YTTRRVLTMEWIDGIKISDIAAL-KSAGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehh-ccCCcEEEEEeeCCEecccHHHH-HhcCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 555555543 2332 122211 23466899999999999988533 22556644433322221 1334445899
Q ss_pred eeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 181 vH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
+|.|..|.||+++.+ +.+.+.|||+....
T Consensus 287 fHaDpHpGNi~v~~~-g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSD-GRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecC-CcEEEEcCcceecC
Confidence 999999999999966 45999999998643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.8e-07 Score=72.32 Aligned_cols=132 Identities=24% Similarity=0.335 Sum_probs=95.9
Q ss_pred ceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCcee-EEeeeecCceEEEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK-FLGACKDPLMVIVTE 137 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~lv~e 137 (290)
.....+.|++|++|.||++.+.+..+|+|+-+.++.... +..|+++|..++-.++.+ +|.+..+ ++.||
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~-------l~kEakiLeil~g~~~~p~vy~yg~~---~i~me 92 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRN-------LEKEAKILEILAGEGVTPEVYFYGED---FIRME 92 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCceEEEEEecCCcchhh-------HHHHHHHHHHhhhcCCCceEEEechh---hhhhh
Confidence 345667899999999999999999999999887776543 568999999998776654 6655443 45599
Q ss_pred ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCC-C-CCEEEcCCCCceEEeccccccccc
Q 022903 138 LLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK-P-DNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 138 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dik-p-~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
|++|-+|.+.-.. .+.. -...+++.---|-..||-|+.|. | .||++. ++ .+.|+||..++...
T Consensus 93 ~i~G~~L~~~~~~-----~~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~k~ 157 (201)
T COG2112 93 YIDGRPLGKLEIG-----GDRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATFKK 157 (201)
T ss_pred hhcCcchhhhhhc-----ccHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEec-CC-cEEEEEccchhhcc
Confidence 9999899886442 1222 23345555555677899999886 3 455555 43 48999999987543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.62 E-value=1e-06 Score=72.52 Aligned_cols=135 Identities=17% Similarity=0.227 Sum_probs=79.1
Q ss_pred ceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc--eeEEeeeec-CceEEEEEecC
Q 022903 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL--VKFLGACKD-PLMVIVTELLP 140 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~-~~~~lv~e~~~ 140 (290)
..||+|..+.||+. .+..+++|+........ .+.+|.++++.+..-++ .+.+....+ ....+||++++
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~~~-------~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFDKE-------TIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCCHH-------HHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999984 35567889887544222 25688988888864333 556666544 34568999999
Q ss_pred CCC-HHHHH------------------HhcCC---CCCCHHHH-HHHHHH----------HHH-HHHHHHH----CCCee
Q 022903 141 GMS-LRKYL------------------VSLRP---NKLDLHVA-LNFALD----------IAR-AMDCLHA----NGIIH 182 (290)
Q Consensus 141 ~~~-L~~~~------------------~~~~~---~~~~~~~~-~~i~~q----------i~~-~l~~lH~----~givH 182 (290)
|.+ +...+ ..... ...+.... ..+..+ +.. ...+|.+ ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 21111 11111 11111110 011100 111 1222221 24789
Q ss_pred ecCCCCCEEEcCCCCceEEeccccccc
Q 022903 183 RDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 183 ~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
+|+.|.||+++.+ + +.++||+.+..
T Consensus 158 gD~~~~Nii~~~~-~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGK-G-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCC-C-cEEEechhcCc
Confidence 9999999999954 4 89999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.61 E-value=7.4e-07 Score=73.45 Aligned_cols=140 Identities=20% Similarity=0.293 Sum_probs=81.0
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCC--CceeEEeeee----cCceEEEE
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD--NLVKFLGACK----DPLMVIVT 136 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~----~~~~~lv~ 136 (290)
++.|+.|..+.||+....++.+++|+.... .. ...+.+|..+++.+... .+.+++.... ....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~---~~----~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP---DA----AERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH---HH----HHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC---CC----HHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 357899999999999998889999997654 11 12466888888887533 3455665332 22468999
Q ss_pred EecCCCCHHH----------------HHHh---c--CCCCCCHHH---------HHHH------------HHHHHH-HHH
Q 022903 137 ELLPGMSLRK----------------YLVS---L--RPNKLDLHV---------ALNF------------ALDIAR-AMD 173 (290)
Q Consensus 137 e~~~~~~L~~----------------~~~~---~--~~~~~~~~~---------~~~i------------~~qi~~-~l~ 173 (290)
++++|..+.. .+.. . ......... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988877 1111 1 011111110 0000 011222 233
Q ss_pred HHHH-------CCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 174 CLHA-------NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 174 ~lH~-------~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.+++ ..++|+|+.|.||+++++++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3332 35999999999999995555457999988743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.2e-06 Score=85.37 Aligned_cols=143 Identities=20% Similarity=0.355 Sum_probs=88.5
Q ss_pred cceeccccceeEEEEEECC----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCc--eeEEeeeec----Cc
Q 022903 63 GSKIGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNL--VKFLGACKD----PL 131 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~----~~ 131 (290)
+..|+.|.+..+|+....+ ..+++|+.......... ..+.+|..+++.+. |+++ .+++..+.+ +.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~----~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSA----HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccH----HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 4678999999999987644 46788876554322111 13668999999995 6654 677777765 35
Q ss_pred eEEEEEecCCCCHHH--------------------HHHhcCC---C---------C--CCHHHHHHHHH-----------
Q 022903 132 MVIVTELLPGMSLRK--------------------YLVSLRP---N---------K--LDLHVALNFAL----------- 166 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~--------------------~~~~~~~---~---------~--~~~~~~~~i~~----------- 166 (290)
.|+||||++|..+.+ .+..... . + ....++..+..
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 789999998864321 1111111 0 0 00112222211
Q ss_pred ----HHHHHHHHHHH-----------CCCeeecCCCCCEEEcCCC-CceEEeccccccc
Q 022903 167 ----DIARAMDCLHA-----------NGIIHRDLKPDNLLLTPDQ-KSLKLADFGLARE 209 (290)
Q Consensus 167 ----qi~~~l~~lH~-----------~givH~Dikp~Nili~~~~-~~~kl~Dfg~~~~ 209 (290)
.+...+.+|.. ..++|+|++|.|+++++++ ..+-|+||+++..
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12234556632 2499999999999998643 3357999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.3e-08 Score=90.76 Aligned_cols=186 Identities=18% Similarity=0.161 Sum_probs=131.5
Q ss_pred ceeecceeccccceeEEEEEECC-ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC-ceeEEeeee-cCceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN-LVKFLGACK-DPLMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~-~~~~~lv 135 (290)
.+...+.+++|+++++++.+.+. +....+++... . ...-++++|.+++||| .+..++.++ +...+++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l-----~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----L-----SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----h-----hhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34455678999999999998753 33345555433 1 1346789999999999 666666654 4467799
Q ss_pred EEecCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 136 TELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 136 ~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
++++.++ +-...... ....+...+...+.+.-+++++++|+.--+|+| ||+... + ..+..||+.........
T Consensus 313 ~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~-~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-E-EVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-c-ccccccccCCcccCccc
Confidence 9999876 22111110 111233334556777888999999998778998 888774 3 37999999987655444
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
..+...+++.++|||+... ..+....|.|+++.-..+|--|-+|-..
T Consensus 386 ~~~t~~~~~~~~~pev~~~--------~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQE--------NTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccccCCCCCCCCCchhhcc--------cccccCCCccCCCcchhhcCCCCCCCCC
Confidence 5566789999999998764 6678899999999877788777777554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.41 E-value=5.8e-06 Score=68.96 Aligned_cols=74 Identities=18% Similarity=0.218 Sum_probs=50.5
Q ss_pred eccccc-eeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeec-CceEEEEEecCCC
Q 022903 66 IGEGAH-GKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIVTELLPGM 142 (290)
Q Consensus 66 lG~G~~-g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~lv~e~~~~~ 142 (290)
|-.|.+ ..||+....+..+++|+...... ..+.+|+.+++.+. +-.+.++++.... +..++||++++|.
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~~--------~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGPT--------YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCcc--------cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444555 78999877667899999876531 12457888887774 3335566766654 3578999999998
Q ss_pred CHHHH
Q 022903 143 SLRKY 147 (290)
Q Consensus 143 ~L~~~ 147 (290)
+|...
T Consensus 78 ~l~~~ 82 (244)
T cd05150 78 PAAAL 82 (244)
T ss_pred cHhHh
Confidence 77643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.3e-06 Score=76.99 Aligned_cols=143 Identities=22% Similarity=0.262 Sum_probs=91.7
Q ss_pred ceeccccceeEEEEEE-CCceEEEEEcccCCChhHHH--------------------------H------HHHHHHHHHH
Q 022903 64 SKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERA--------------------------L------LEGRFIREVN 110 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~--------------------------~------~~~~~~~e~~ 110 (290)
+.||.-+.|.|++|+. .|+.||||+-++.-...-.. . .+-.|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5789999999999976 57889999976643322100 0 1112444443
Q ss_pred HHhhc----CCCC------ceeEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 022903 111 MMSRV----KHDN------LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180 (290)
Q Consensus 111 ~l~~l----~h~~------iv~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~gi 180 (290)
-..+. .|-+ |.+++-.+ ....+++|||++|..+.+.-.- ....++...+..-+.++. ++.+=..|+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~--~~qIf~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAY--LEQIFKTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHH--HHHHHhcCC
Confidence 33332 3444 33333333 2356899999999988776433 345666664444333322 233445789
Q ss_pred eeecCCCCCEEEcC---CCCceEEecccccccc
Q 022903 181 IHRDLKPDNLLLTP---DQKSLKLADFGLAREE 210 (290)
Q Consensus 181 vH~Dikp~Nili~~---~~~~~kl~Dfg~~~~~ 210 (290)
+|+|=.|.||++++ .+..+.+-|||+....
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 99999999999984 3567999999998753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.37 E-value=7.2e-06 Score=65.46 Aligned_cols=129 Identities=29% Similarity=0.420 Sum_probs=88.7
Q ss_pred Cceeecceeccccc-eeEEEEEECCceEEEEEccc---CCC-------hhHH------HHHHHHHHHHHHHHhhcC---C
Q 022903 58 KLLFIGSKIGEGAH-GKVYEGRYGDRIVAIKVLNR---GST-------SDER------ALLEGRFIREVNMMSRVK---H 117 (290)
Q Consensus 58 ~~~~~~~~lG~G~~-g~V~~~~~~~~~vavK~~~~---~~~-------~~~~------~~~~~~~~~e~~~l~~l~---h 117 (290)
..++.++.||.|.- |.||+++..++.+|+|++.. ... .... .....-|..|-+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67889999999999 99999999999999999221 111 0000 012234667777777664 4
Q ss_pred CCc--eeEEeeee-c------------------CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022903 118 DNL--VKFLGACK-D------------------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176 (290)
Q Consensus 118 ~~i--v~~~~~~~-~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 176 (290)
.++ ++.+|+.. + +...+|.||..... .+.. .-+.+|++-+..+|
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHHH
Confidence 455 77777751 1 12357777775533 1222 33456777788899
Q ss_pred HCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 177 ~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
..||+-+|+++.|.. + -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-C-----CEEEecccC
Confidence 999999999999987 2 279999864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.7e-08 Score=87.78 Aligned_cols=94 Identities=17% Similarity=0.381 Sum_probs=70.5
Q ss_pred HHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEeccccccccccccc----------ccccCCCccccCccccccccc
Q 022903 168 IARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----------MTAETGTYRWMAPELYSTVTL 236 (290)
Q Consensus 168 i~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~ 236 (290)
.+.|+.|+|.. ++||+.|.|++|.++..+ ..||+.|+.+........ .........|.|||.+..
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~--- 183 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG--- 183 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc---
Confidence 34899999965 899999999999999554 599999998764222110 011124568999999875
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCC
Q 022903 237 RQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 270 (290)
Q Consensus 237 ~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~ 270 (290)
...+.++|+||||+++|.+.. |+.-+.+.
T Consensus 184 -----~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 184 -----TTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred -----ccccccccceeeeeEEEEEecCCcchhhcc
Confidence 567899999999999999994 55555543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.30 E-value=3.2e-06 Score=67.50 Aligned_cols=100 Identities=21% Similarity=0.215 Sum_probs=77.2
Q ss_pred HHHHHHHhhcCC-CCceeEEeeeecCceEEEEEecCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHH---CCC
Q 022903 106 IREVNMMSRVKH-DNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHA---NGI 180 (290)
Q Consensus 106 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~---~gi 180 (290)
..|..+++.+++ +++++++|.|.+ +++.||...+++...... ..-...++..+++++.+++..++++++ ..+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~---~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR---FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC---EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 368888888876 689999999954 788999987655421000 001246899999999999999999997 357
Q ss_pred eeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 181 IHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 181 vH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.-.|++|+|+-++.+ +++|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~-~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDD-GRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCC-CcEEEEechhcch
Confidence 889999999999944 5699999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.1e-06 Score=67.71 Aligned_cols=72 Identities=14% Similarity=0.225 Sum_probs=43.9
Q ss_pred ceeccccce-eEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCC---CceeEEeeeec----CceEEE
Q 022903 64 SKIGEGAHG-KVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD---NLVKFLGACKD----PLMVIV 135 (290)
Q Consensus 64 ~~lG~G~~g-~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~----~~~~lv 135 (290)
+.|+.|+.. .||+. +..+++|+.+..... ..+.+|..++..+... .+.++++.... ...+++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~~~-------~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAGYA-------GQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccchH-------HHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457767766 48875 245778876543221 1366888888877532 23444444332 134789
Q ss_pred EEecCCCCHH
Q 022903 136 TELLPGMSLR 145 (290)
Q Consensus 136 ~e~~~~~~L~ 145 (290)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.4e-05 Score=65.62 Aligned_cols=75 Identities=16% Similarity=0.037 Sum_probs=54.1
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC---CCceeEEeeeec----CceEEE
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH---DNLVKFLGACKD----PLMVIV 135 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~----~~~~lv 135 (290)
.+.||.|..+.||.....+..+++|..+...... .+.+|...++.|.. -.+.++++.+.+ +..++|
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~-------~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARSFSTPG-------VAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecccccch-------HHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 4679999999999998766678888854321211 36688888888853 356778877643 457999
Q ss_pred EEecCCCCH
Q 022903 136 TELLPGMSL 144 (290)
Q Consensus 136 ~e~~~~~~L 144 (290)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.19 E-value=7.6e-05 Score=59.95 Aligned_cols=136 Identities=22% Similarity=0.334 Sum_probs=87.7
Q ss_pred ceeccccceeEEEEEECCceEEEEEcccCCChhHH-----------HHHHHHHHHHHHHHhhcC------CCCceeEEee
Q 022903 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDER-----------ALLEGRFIREVNMMSRVK------HDNLVKFLGA 126 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~------h~~iv~~~~~ 126 (290)
..||+|+.-.||.-- .+...+||+.......... ........+|+.....+. +.+|.+++|.
T Consensus 7 ~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 468999999999743 3345677888776600000 000112445555555544 7788999999
Q ss_pred eecC-ceEEEEEecCC------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC--C
Q 022903 127 CKDP-LMVIVTELLPG------MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--K 197 (290)
Q Consensus 127 ~~~~-~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~--~ 197 (290)
.+.+ ...+|+|.+.+ .+|.+++.. ..++. .+...+-+-..||-+.+|+.+|++|.||++.... .
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 8755 56688887653 368888854 44554 3334444556788899999999999999995332 2
Q ss_pred -ceEEec-cccc
Q 022903 198 -SLKLAD-FGLA 207 (290)
Q Consensus 198 -~~kl~D-fg~~ 207 (290)
.+.|+| ||..
T Consensus 159 ~~lvlIDG~G~~ 170 (199)
T PF10707_consen 159 FRLVLIDGLGEK 170 (199)
T ss_pred eEEEEEeCCCCc
Confidence 577887 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00016 Score=60.69 Aligned_cols=136 Identities=19% Similarity=0.209 Sum_probs=78.6
Q ss_pred eeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc-eeEEeeeecCceEEEEEecCCCC
Q 022903 65 KIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELLPGMS 143 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~lv~e~~~~~~ 143 (290)
.+..|-...+|+....++.+++|+.......... ...+|..+++.+...++ .+++.... .++|++|++|..
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~-----~r~~E~~~l~~l~~~g~~P~~i~~~~---~~~v~e~i~G~~ 74 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGV-----DRQREYQILQALSALGLAPKPILVNE---HWLLVEWLEGEV 74 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccccC-----cHHHHHHHHHHHHhcCCCCceEEEeC---CEEEEEeccCcc
Confidence 3566888899998888888999986543222100 13467888887764333 33444432 368999999866
Q ss_pred HHH--------------HHHhcCCC-----CCCHH-HHHHHHHHH---------HHHHHHHHH--------CCCeeecCC
Q 022903 144 LRK--------------YLVSLRPN-----KLDLH-VALNFALDI---------ARAMDCLHA--------NGIIHRDLK 186 (290)
Q Consensus 144 L~~--------------~~~~~~~~-----~~~~~-~~~~i~~qi---------~~~l~~lH~--------~givH~Dik 186 (290)
+.. .+...... +++.. .+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 532 11111111 11211 112222222 111222222 148999999
Q ss_pred CCCEEEcCCCCceEEecccccccc
Q 022903 187 PDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 187 p~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
|.||+++.+ + +.|+||..+...
T Consensus 155 ~~Nil~~~~-~-~~lIDwE~a~~g 176 (256)
T TIGR02721 155 AYNLVVTPQ-G-LKLIDWEYASDG 176 (256)
T ss_pred cCcEEEeCC-C-CEEEeccccCcC
Confidence 999999954 3 789999988643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=9e-05 Score=61.34 Aligned_cols=72 Identities=17% Similarity=0.240 Sum_probs=47.1
Q ss_pred ceeccccceeEEEEEEC---CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc-eeEEeeeecCceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRYG---DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~lv~e~~ 139 (290)
+.|..|-...+|+.... ++.|++|+........ . ...+|+.+++.+...++ +++++.+. ..++|||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~-----d~~~E~~~~~~l~~~gl~P~v~~~~~---~~~l~e~i 74 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-I-----DRERELRIHKLLSKHGLAPKLYATFQ---NGLIYEFI 74 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-e-----cHHHHHHHHHHHHhCCCCCeEEEEeC---CcEEEEee
Confidence 56788888999998765 5789999876432211 1 12368888888754333 44544433 24799999
Q ss_pred CCCCH
Q 022903 140 PGMSL 144 (290)
Q Consensus 140 ~~~~L 144 (290)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.1e-06 Score=69.65 Aligned_cols=138 Identities=22% Similarity=0.281 Sum_probs=95.4
Q ss_pred ceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHH---------------HHHHHH--HHHHHHHHhhcCCC--
Q 022903 59 LLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDER---------------ALLEGR--FIREVNMMSRVKHD-- 118 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~---------------~~~~~~--~~~e~~~l~~l~h~-- 118 (290)
.+.+++.||-|--+.+|.+-+. |++.++|+-+-...+... ++...+ ..+|...|+.|...
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3567889999999999999874 888888875432221110 111112 34677888877532
Q ss_pred CceeEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCc
Q 022903 119 NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (290)
Q Consensus 119 ~iv~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~ 198 (290)
-++..++. .+.++|||++.|.+|.+.-.- .+ +..+...+...+--|..+|+||+|+.-=||+++.+ +.
T Consensus 173 pVPkpiD~---~RH~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~ 240 (465)
T KOG2268|consen 173 PVPKPIDH---NRHCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD-DK 240 (465)
T ss_pred CCCCcccc---cceeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecC-CC
Confidence 23333433 467899999999998874321 11 23466677777888999999999999999999954 45
Q ss_pred eEEecccccc
Q 022903 199 LKLADFGLAR 208 (290)
Q Consensus 199 ~kl~Dfg~~~ 208 (290)
++++||-.+.
T Consensus 241 i~vIDFPQmv 250 (465)
T KOG2268|consen 241 IVVIDFPQMV 250 (465)
T ss_pred EEEeechHhh
Confidence 9999997654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00015 Score=62.71 Aligned_cols=139 Identities=19% Similarity=0.270 Sum_probs=79.0
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC--ceeEEeee-------ecCceE
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LVKFLGAC-------KDPLMV 133 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~-------~~~~~~ 133 (290)
+..++.|....+|+....+..+++|+......... +..|+.++..|...+ +.+++... .++..+
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~~~~-------i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVKAEE-------LPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCCCHHH-------HHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 45677888889999877666788898765332221 335566666664222 33443321 134568
Q ss_pred EEEEecCCCCHH-----------HHHHhcC--CCCC--------CHH---HH-H-----------HHHHHHHHHHHHHHH
Q 022903 134 IVTELLPGMSLR-----------KYLVSLR--PNKL--------DLH---VA-L-----------NFALDIARAMDCLHA 177 (290)
Q Consensus 134 lv~e~~~~~~L~-----------~~~~~~~--~~~~--------~~~---~~-~-----------~i~~qi~~~l~~lH~ 177 (290)
++++|++|..+. ..+.... ...+ ... .. . .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885431 1111000 0000 000 00 0 001123334555532
Q ss_pred -------CCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 178 -------NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 178 -------~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.+++|+|+.+.|++++.+ +.+.|+||+.+..
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~ 217 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFACT 217 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECC-ceEEEeecccccC
Confidence 589999999999999855 3468999998854
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00011 Score=63.01 Aligned_cols=138 Identities=17% Similarity=0.185 Sum_probs=80.7
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC--ceeEEeee-------ecCceE
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LVKFLGAC-------KDPLMV 133 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~-------~~~~~~ 133 (290)
.+.|..|....+|+....+..+++|+... .... .+..|+.++..+.+.+ +.+++... .++..+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~-~~~~-------~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK-VSAE-------ELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC-CChH-------hccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 45678888889999877777899999865 2111 2456777777774322 34443321 123567
Q ss_pred EEEEecCCCCHHH-----------HHHhc-------CCC-----CCCHHHH----------HHHHHHHHHHHHHHHH---
Q 022903 134 IVTELLPGMSLRK-----------YLVSL-------RPN-----KLDLHVA----------LNFALDIARAMDCLHA--- 177 (290)
Q Consensus 134 lv~e~~~~~~L~~-----------~~~~~-------~~~-----~~~~~~~----------~~i~~qi~~~l~~lH~--- 177 (290)
+|+++++|..+.. .+... ... ...+... ......+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876522 01000 000 0010000 0011112334444443
Q ss_pred ----CCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 178 ----NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 178 ----~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.+++|+|+.|.|++++.+ ..+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence 379999999999999954 4467999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00045 Score=61.47 Aligned_cols=79 Identities=20% Similarity=0.127 Sum_probs=50.9
Q ss_pred ceeccccceeEEEEEECC--ceEEEEEcccCCCh--hHHHHHHHHHHHHHHHHhhcC---CCCceeEEeeeecCceEEEE
Q 022903 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTS--DERALLEGRFIREVNMMSRVK---HDNLVKFLGACKDPLMVIVT 136 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~--~~vavK~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~lv~ 136 (290)
+.||.|.+..||++...+ +.++||...+.... ........+...|.+.|..+. ...+++++.+.. ...++||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~-~~~~lVM 110 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE-ELAVTVM 110 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC-CCCEEEE
Confidence 678999999999998855 48999986532110 100111234566777777763 245566766643 4578999
Q ss_pred EecCCCC
Q 022903 137 ELLPGMS 143 (290)
Q Consensus 137 e~~~~~~ 143 (290)
|++++..
T Consensus 111 E~L~~~~ 117 (401)
T PRK09550 111 EDLSDHK 117 (401)
T ss_pred ecCCCcc
Confidence 9998643
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00024 Score=61.56 Aligned_cols=147 Identities=21% Similarity=0.202 Sum_probs=96.2
Q ss_pred ecceeccccceeEEEEEE-CCceEEEEEcccCCCh---------------------hHHHHHHHHHHHHHHHHhhcCCCC
Q 022903 62 IGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTS---------------------DERALLEGRFIREVNMMSRVKHDN 119 (290)
Q Consensus 62 ~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~---------------------~~~~~~~~~~~~e~~~l~~l~h~~ 119 (290)
+...|..|--+.||.|.- .|..+|||+.+..-.. ..+.+..-.-.+|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 445678888899999865 5677999997542110 011222222346788888887655
Q ss_pred ceeEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeecCCCCCEEEcCCCCc
Q 022903 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKS 198 (290)
Q Consensus 120 iv~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l-H~~givH~Dikp~Nili~~~~~~ 198 (290)
|.--- ...-...+|||+++. .+=+..-. .+...++...+..+-.+++.-+.-| |..++||.||.-=|+|+- ++ .
T Consensus 228 IP~Pe-PIlLk~hVLVM~FlG-rdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG-~ 302 (520)
T KOG2270|consen 228 IPCPE-PILLKNHVLVMEFLG-RDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG-K 302 (520)
T ss_pred CCCCC-ceeeecceEeeeecc-CCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC-E
Confidence 43211 111224689999994 33322111 1234577778888888888877766 567999999999999998 44 4
Q ss_pred eEEeccccccccccc
Q 022903 199 LKLADFGLAREETVT 213 (290)
Q Consensus 199 ~kl~Dfg~~~~~~~~ 213 (290)
+.|+|.+.+.....+
T Consensus 303 lyiIDVSQSVE~DHP 317 (520)
T KOG2270|consen 303 LYIIDVSQSVEHDHP 317 (520)
T ss_pred EEEEEccccccCCCh
Confidence 999999988764443
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00097 Score=57.89 Aligned_cols=31 Identities=35% Similarity=0.525 Sum_probs=25.6
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 178 ~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.+++|+|+.|.||+++. +...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEG-DRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEEC-CceEEEEecccccC
Confidence 38999999999999984 44357999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00014 Score=70.96 Aligned_cols=151 Identities=17% Similarity=0.212 Sum_probs=109.2
Q ss_pred HHHHHHhhcCCCCceeEEeeeecC-----ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 022903 107 REVNMMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181 (290)
Q Consensus 107 ~e~~~l~~l~h~~iv~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~giv 181 (290)
-|+..+.++.|+|++.++.+.... ......+++...++...+.. -..++..+++.+..++..||.|+|+..+.
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 456677778899999998876332 22355688888889888876 46789999999999999999999999777
Q ss_pred eecCCCC---CEEEcCCCCceEEe--cccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHH
Q 022903 182 HRDLKPD---NLLLTPDQKSLKLA--DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256 (290)
Q Consensus 182 H~Dikp~---Nili~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~ 256 (290)
|.-+..+ +..++.+ +.+.+. ||+.+..............+..+.++|.... +....+...|+|.+|..
T Consensus 309 ~v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~------~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE------NTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred eeEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCcccccccccccc------ccchhhhhhHHHHHHHH
Confidence 7666655 4444433 235555 8888877655555445555667778887643 22334456799999999
Q ss_pred HHHHHhCCCC
Q 022903 257 LWELLTNRLP 266 (290)
Q Consensus 257 l~~~l~g~~P 266 (290)
...+..|..+
T Consensus 382 ~~~~~~~~~i 391 (1351)
T KOG1035|consen 382 LLQLSQGEDI 391 (1351)
T ss_pred HhhhhhcCcc
Confidence 9999986654
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00065 Score=58.50 Aligned_cols=73 Identities=26% Similarity=0.342 Sum_probs=46.1
Q ss_pred ceeccccceeEEEEEEC--------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc-eeEEeeeecCceEE
Q 022903 64 SKIGEGAHGKVYEGRYG--------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVI 134 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~l 134 (290)
+.|..|-...||+.... ++.+++|+......... ...+|..++..+...++ .++++.+.+ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~------~r~~E~~~~~~l~~~g~~P~~~~~~~~---~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLI------DRERELVVFARLSERNLGPKLYGIFPN---GR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCccee------chHHHHHHHHHHHhCCCCCceEEEeCC---Cc
Confidence 45666777889988754 37899999765432211 23477778877754333 345555543 35
Q ss_pred EEEecCCCCHH
Q 022903 135 VTELLPGMSLR 145 (290)
Q Consensus 135 v~e~~~~~~L~ 145 (290)
|++|++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 78998887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00056 Score=59.73 Aligned_cols=77 Identities=19% Similarity=0.135 Sum_probs=45.8
Q ss_pred eeccccceeEEEEEECC--ceEEEEEcccCCC--hhHHHHHHHHHHHHHHHHhhcC--CCCceeEEeeeecCceEEEEEe
Q 022903 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGST--SDERALLEGRFIREVNMMSRVK--HDNLVKFLGACKDPLMVIVTEL 138 (290)
Q Consensus 65 ~lG~G~~g~V~~~~~~~--~~vavK~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~lv~e~ 138 (290)
.||.|....||++...+ +.|+||.-.+-.. ......-..|..-|...|+... .|..++-+-.+......+|||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 47999999999998754 5799998543211 0111111224456667776654 3544443334444466799999
Q ss_pred cCC
Q 022903 139 LPG 141 (290)
Q Consensus 139 ~~~ 141 (290)
++.
T Consensus 82 L~~ 84 (370)
T TIGR01767 82 LSH 84 (370)
T ss_pred Ccc
Confidence 854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00081 Score=57.15 Aligned_cols=32 Identities=28% Similarity=0.508 Sum_probs=25.7
Q ss_pred CCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 179 givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
.++|+|+.|.||+++.++...-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 48999999999999954443569999998653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.50 E-value=2.2e-05 Score=78.33 Aligned_cols=155 Identities=12% Similarity=0.028 Sum_probs=110.7
Q ss_pred HHHHHHHHhhcCCCCceeEEeeee---cCceEEEEEecCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC-
Q 022903 105 FIREVNMMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHAN- 178 (290)
Q Consensus 105 ~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~- 178 (290)
...|...++...|+++........ +...+..++|+.+|.+.+.+-.... ...+...+.....+.+....-+|+.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555556667998877665442 3356788999999999998865322 2344444444555546666666654
Q ss_pred ----CCeeecCCCCCEEEcCCCCceEEecccccc-cccccccccccCCCccccCccccccccccccccCCCCCcchhHHH
Q 022903 179 ----GIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 253 (290)
Q Consensus 179 ----givH~Dikp~Nili~~~~~~~kl~Dfg~~~-~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 253 (290)
-.+|+++|+.|.+|..+ ..+++.++|+.+ ............+++.|+.|+.... -.++.++|+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~--------ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE--------IKFTKRSDILRR 1426 (2724)
T ss_pred cCCccchhhhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH--------HhhhhHHHHHHH
Confidence 26899999999999944 459999999998 4333344456678888999997654 567778999999
Q ss_pred HHHHHHHHhCCCCCC
Q 022903 254 GIVLWELLTNRLPFE 268 (290)
Q Consensus 254 G~~l~~~l~g~~Pf~ 268 (290)
++.+|....|..||.
T Consensus 1427 s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHhcccHHHH
Confidence 999998888877764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0034 Score=54.11 Aligned_cols=146 Identities=18% Similarity=0.249 Sum_probs=80.5
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC--CCceeEEeeeec---CceEEEEE
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--DNLVKFLGACKD---PLMVIVTE 137 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~---~~~~lv~e 137 (290)
++.+..|..-.+|....+++.++++ .+......... ....+|..+++.+.. --+...++.|.+ +..|+||+
T Consensus 30 v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~---~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 30 VEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESA---HDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeccCCcccceEEEecCCceEEEe-cCCccccchhh---hHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3444445555567766668888988 44211111111 134578888877753 223344555543 35689999
Q ss_pred ecCCCCHH------------------HHHHhcCC------------CCCCHHHHHHHHHH--------------HHHHHH
Q 022903 138 LLPGMSLR------------------KYLVSLRP------------NKLDLHVALNFALD--------------IARAMD 173 (290)
Q Consensus 138 ~~~~~~L~------------------~~~~~~~~------------~~~~~~~~~~i~~q--------------i~~~l~ 173 (290)
|++|..+. +++...+. ......++..+..+ +.....
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 99883221 11111100 00011111111111 222344
Q ss_pred HHHHC--------CCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 174 CLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 174 ~lH~~--------givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+++.+ .++|+|+.+.|+++++++. +=++||+++....+.
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~-~gVlDwe~~~lGDP~ 232 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP-TGVLDWELATLGDPL 232 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCCe-eEEEeccccccCCcH
Confidence 55443 5899999999999997766 889999998765443
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00092 Score=59.14 Aligned_cols=78 Identities=22% Similarity=0.177 Sum_probs=48.4
Q ss_pred cceeccccceeEEEEEEC--CceEEEEEcccCCC-hhHHHHHHHHHHHHHHHHhhcC--CCCcee-EEeeeecCceEEEE
Q 022903 63 GSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGST-SDERALLEGRFIREVNMMSRVK--HDNLVK-FLGACKDPLMVIVT 136 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~~~~e~~~l~~l~--h~~iv~-~~~~~~~~~~~lv~ 136 (290)
.+.||.|.-..||++... ++.|+||.-.+-.. ......-..|..-|...|+... .|..++ ++.+ ......+||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-D~e~~~~vM 112 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-DSVMNCCVM 112 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-CcHHhhHHH
Confidence 467899999999999874 67899998543211 1111122234556777777664 354444 5544 444567888
Q ss_pred EecCC
Q 022903 137 ELLPG 141 (290)
Q Consensus 137 e~~~~ 141 (290)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 88854
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0031 Score=55.46 Aligned_cols=137 Identities=15% Similarity=0.239 Sum_probs=78.7
Q ss_pred ceeccccceeEEEEEEC------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCce-eEEeeeecCceEEEE
Q 022903 64 SKIGEGAHGKVYEGRYG------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV-KFLGACKDPLMVIVT 136 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~lv~ 136 (290)
..|-.|-.-.+|+.... ++.|++|+........ . . -.+|..+++.+...++. ++++.+..+ .|.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-i----d-R~~E~~~~~~l~~~gl~P~~~~~~~~g---~v~ 112 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-F----D-RDDEIRTFECMSRHGQGPRLLGRFPNG---RVE 112 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-e----c-hHHHHHHHHHHHHcCCCCceEEEECCc---eEE
Confidence 45655888899998642 2679999886543211 0 1 24688888887654443 456665443 578
Q ss_pred EecCCCCHHHH--------------HHhcCCCC------CC-HHHHHHHHHHH-----------------HHHHHHH---
Q 022903 137 ELLPGMSLRKY--------------LVSLRPNK------LD-LHVALNFALDI-----------------ARAMDCL--- 175 (290)
Q Consensus 137 e~~~~~~L~~~--------------~~~~~~~~------~~-~~~~~~i~~qi-----------------~~~l~~l--- 175 (290)
+|+++.+|..- +....... .+ ...+..+..++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99887665321 11111111 11 12222222111 1111112
Q ss_pred -H----HCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 176 -H----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 176 -H----~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
. ...++|+|+++.||+++.+++.+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 125899999999999986555699999998864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.012 Score=52.57 Aligned_cols=78 Identities=15% Similarity=0.077 Sum_probs=50.5
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCC-hhH-HHHHHHHHHHHHHHHhhcC---CCCceeEEeeeecCceEEEEE
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGST-SDE-RALLEGRFIREVNMMSRVK---HDNLVKFLGACKDPLMVIVTE 137 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~-~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~lv~e 137 (290)
.+.||.|....||+....++.++||.-..... ... ...-..|-..|...|+.+. ...+++++.++.+ ..+++||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded-~~vlvME 115 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT-MALIGMR 115 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC-CCEEEEe
Confidence 46789999999999988777899998763221 000 0000122334566665553 3467778888764 4678999
Q ss_pred ecCC
Q 022903 138 LLPG 141 (290)
Q Consensus 138 ~~~~ 141 (290)
++++
T Consensus 116 ~L~~ 119 (418)
T PLN02756 116 YLEP 119 (418)
T ss_pred ecCC
Confidence 9976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.013 Score=51.24 Aligned_cols=137 Identities=17% Similarity=0.221 Sum_probs=76.7
Q ss_pred ceeccccceeEEEEEECC-----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc-eeEEeeeecCceEEEEE
Q 022903 64 SKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTE 137 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~lv~e 137 (290)
+.|..|-.-.+|+....+ ..|++|+........ . .-.+|..+++.+..-++ .++++.+..+ +|.+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-I-----dR~~E~~il~~l~~~gl~P~~l~~~~~G---~i~~ 90 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-I-----DRERELQAIKYLSAAGFGAKLLGVFGNG---MIQS 90 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-e-----chHHHHHHHHHHHhcCCCCceeEEeCCc---Eeeh
Confidence 445558888899886543 378999876533211 0 12367888888765555 3455555332 4788
Q ss_pred ecCCCCHHH--------------HHHhcCCCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 022903 138 LLPGMSLRK--------------YLVSLRPNK------L-DLHVALNFALDI----------------------ARAMDC 174 (290)
Q Consensus 138 ~~~~~~L~~--------------~~~~~~~~~------~-~~~~~~~i~~qi----------------------~~~l~~ 174 (290)
|+++..|.. .+....... . .+..+..+..++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 887765521 111111111 1 122222222221 111111
Q ss_pred H----HHCC----CeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 175 L----HANG----IIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 175 l----H~~g----ivH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
+ .+.+ +.|.|+.+.||+++.+++.++++||..+..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1122 689999999999985555699999998764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.032 Score=48.61 Aligned_cols=136 Identities=25% Similarity=0.347 Sum_probs=79.1
Q ss_pred eccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC---CCcee---EEeee---ecC--ceEE
Q 022903 66 IGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH---DNLVK---FLGAC---KDP--LMVI 134 (290)
Q Consensus 66 lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~---~~~~~---~~~--~~~l 134 (290)
|.. .-..||+....+..+++|+.... ..... +..|+..+..|.. +--++ +-|.. ... +.+-
T Consensus 34 l~s-~eN~~f~~~~~~g~~iLki~~~~-~~~~~------i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~ 105 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRYILKIYRPG-WTRAE------IPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAA 105 (331)
T ss_pred ccc-ccCceEEEEecCCCeEEEEecCC-CCHHH------HHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEE
Confidence 444 45678998887777799999887 32221 4467777777742 21122 22211 123 6778
Q ss_pred EEEecCCCCHHH-H----HHh--------------c---CCC---CCCHH----HH---------HHHHHHHHHHHHHHH
Q 022903 135 VTELLPGMSLRK-Y----LVS--------------L---RPN---KLDLH----VA---------LNFALDIARAMDCLH 176 (290)
Q Consensus 135 v~e~~~~~~L~~-~----~~~--------------~---~~~---~~~~~----~~---------~~i~~qi~~~l~~lH 176 (290)
|++|++|..+.. - +.. . ++. ...+. .. .....++...+..+.
T Consensus 106 lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~ 185 (331)
T COG2334 106 LFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLL 185 (331)
T ss_pred EEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHH
Confidence 999999877762 1 000 0 000 01111 00 012334444555555
Q ss_pred HC--------C--CeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 177 AN--------G--IIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 177 ~~--------g--ivH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
+. + +||+|+.|.||+++.++..+-++||+-+..
T Consensus 186 ~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 186 ARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 43 3 999999999999996643478999998763
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.013 Score=50.00 Aligned_cols=74 Identities=14% Similarity=0.061 Sum_probs=45.0
Q ss_pred eecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC---CCCceeEEeeee-cCceEEEE
Q 022903 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGACK-DPLMVIVT 136 (290)
Q Consensus 61 ~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~-~~~~~lv~ 136 (290)
+-.+.++.|....+|+....++.+.||+-...... .|..|..-|+.|. .-.+++.+++.. +...++|+
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~~--------~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGRD--------MFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGCC--------HHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhhHH--------HHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 34467899999999999988899999998732221 2567777777773 344566777654 33568999
Q ss_pred EecCCC
Q 022903 137 ELLPGM 142 (290)
Q Consensus 137 e~~~~~ 142 (290)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.14 Score=44.23 Aligned_cols=30 Identities=17% Similarity=0.205 Sum_probs=25.9
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 179 givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
+++|+|+.++|++++.++ .+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 799999999999998554 488999988864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.091 Score=43.06 Aligned_cols=75 Identities=17% Similarity=0.197 Sum_probs=52.8
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC---CCCceeEEeeeec-CceEEEEEe
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGACKD-PLMVIVTEL 138 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~-~~~~lv~e~ 138 (290)
.+.+.-|.--..|...++..++.+|+-..... ..|..|+.-|..|. .-.+.+++.+..+ ...|+|+||
T Consensus 21 r~~v~gG~inea~~v~dg~~~~FvK~n~~~~~--------~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~ 92 (286)
T COG3001 21 REEVSGGDINEAWRLRDGTDPFFVKCNQREQL--------SMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY 92 (286)
T ss_pred ccccCCccccceeEeecCCcceEEEecchhhH--------HHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence 34566677778888899999999998644322 23667776666654 4556777777644 478999999
Q ss_pred cCCCCHH
Q 022903 139 LPGMSLR 145 (290)
Q Consensus 139 ~~~~~L~ 145 (290)
++-+.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9886664
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.06 Score=43.87 Aligned_cols=84 Identities=14% Similarity=0.178 Sum_probs=54.6
Q ss_pred HHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CC
Q 022903 104 RFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--GI 180 (290)
Q Consensus 104 ~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--gi 180 (290)
.|.++..++.+++ .|+++..- +. .+-++.|+|-.... .. .-.+.+ =+.+|.-.|+. +.
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~---~N~i~a-gi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NF---SNFITA-GIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------ch---hHHHHH-hHHHHHHhhccCCCe
Confidence 3667888888765 47777633 22 34588898833111 10 111111 14567778843 79
Q ss_pred eeecCCCCCEEEcCCCCceEEeccccc
Q 022903 181 IHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 181 vH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
+|+|-.|+||+-|+.+ .+||.|-+..
T Consensus 165 lHGD~np~NiM~D~~G-~lKlVDP~~L 190 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKFG-YLKLVDPVCL 190 (308)
T ss_pred ecCCCChhheeecCCC-CEEecChhhh
Confidence 9999999999999665 5999998753
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.65 Score=40.49 Aligned_cols=29 Identities=31% Similarity=0.359 Sum_probs=24.5
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 178 ~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.+++|+|+.+.|||++ + + +.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~-~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-G-PHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-C-cEEEeCCCCCC
Confidence 3789999999999996 4 3 78999998864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.16 Score=45.24 Aligned_cols=73 Identities=21% Similarity=0.267 Sum_probs=43.7
Q ss_pred ceeccccceeEEEEEECC---c-----eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc-eeEEeeeecCceEE
Q 022903 64 SKIGEGAHGKVYEGRYGD---R-----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVI 134 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~---~-----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~l 134 (290)
+.|..|-...+|++...+ . .|++++........ . .-.+|+.+++.+...++ .++++.+.. ++
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~-----I-dR~~E~~i~~~Ls~~glgP~l~~~f~~---g~ 126 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLV-----I-DNDLQYNIAKLLGDNNFGPKIIGRFGD---FT 126 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceE-----e-ccHHHHHHHHHHHhCCCCCeEEEecCC---EE
Confidence 456668889999986532 1 24444421111100 0 12368888888876555 446666643 58
Q ss_pred EEEecCCCCHH
Q 022903 135 VTELLPGMSLR 145 (290)
Q Consensus 135 v~e~~~~~~L~ 145 (290)
+.||++|..|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 89999887653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.037 Score=50.47 Aligned_cols=112 Identities=23% Similarity=0.376 Sum_probs=71.5
Q ss_pred HHHHHHHHhhcCCCCceeEEeeeec--CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 022903 105 FIREVNMMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182 (290)
Q Consensus 105 ~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH 182 (290)
+.-...+++.+.|+|...++...+. .+..+|||++ +.+|.+++.... +... +++ .+|+.|
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~-------s~~-------~~~~~~ 90 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDE-------SLL-------AHGVLH 90 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchh-------hhc-------ccccce
Confidence 5567788999999999999887753 3577999999 789999887622 2111 111 122222
Q ss_pred ecCCCCCEEEcCCCCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh
Q 022903 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262 (290)
Q Consensus 183 ~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~ 262 (290)
- | .++.+| -++ |. | | ...++++||||+|.++.++.-
T Consensus 91 ~-----~--------~~~~td-~~~--------------t~-~--~-------------~~~~pKsdVwsl~~i~~el~L 126 (725)
T KOG1093|consen 91 L-----N--------IIYITD-HFL--------------TK-Y--P-------------SPIGPKSDVWSLGFIILELYL 126 (725)
T ss_pred e-----h--------hhhccc-ccc--------------cc-C--C-------------CCCCcchhhhhHHHHHHHHHH
Confidence 1 1 234444 000 00 0 1 112359999999999999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 022903 263 NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 263 g~~Pf~~~~~~~~~~~ 278 (290)
|..-|+.....+....
T Consensus 127 ~~~l~~~~~~s~~l~~ 142 (725)
T KOG1093|consen 127 GISLEAELTESEYLEI 142 (725)
T ss_pred hhHHHHHHHHHHHHHH
Confidence 9988887766555443
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.17 Score=51.02 Aligned_cols=32 Identities=34% Similarity=0.533 Sum_probs=25.7
Q ss_pred CCCeeecCCCCCEEEcCCCC-ceE-Eeccccccc
Q 022903 178 NGIIHRDLKPDNLLLTPDQK-SLK-LADFGLARE 209 (290)
Q Consensus 178 ~givH~Dikp~Nili~~~~~-~~k-l~Dfg~~~~ 209 (290)
.++||+|+.+.|||++.+.. .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 47999999999999996541 344 999998764
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.25 Score=49.68 Aligned_cols=32 Identities=25% Similarity=0.325 Sum_probs=25.7
Q ss_pred CCCeeecCCCCCEEEcCCC----CceEEeccccccc
Q 022903 178 NGIIHRDLKPDNLLLTPDQ----KSLKLADFGLARE 209 (290)
Q Consensus 178 ~givH~Dikp~Nili~~~~----~~~kl~Dfg~~~~ 209 (290)
.|+||+|+.+.||+++.+. ...-|+|||-+..
T Consensus 208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~ 243 (972)
T PRK06149 208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR 243 (972)
T ss_pred ccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence 4899999999999998653 2247999998764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.052 Score=48.17 Aligned_cols=62 Identities=19% Similarity=0.254 Sum_probs=43.4
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCCeeecCCCCCEEEcCC
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HANGIIHRDLKPDNLLLTPD 195 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l-H~~givH~Dikp~Nili~~~ 195 (290)
..+++-+|..|.++..++.. ...++....+++.-.+.|+-.+ --.+++|.|+.|.||++..+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 35677788889999988875 3445555555555445554433 34589999999999999644
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.25 Score=44.95 Aligned_cols=74 Identities=16% Similarity=0.191 Sum_probs=45.7
Q ss_pred ecceeccccceeEEEEEEC----------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCce-eEEeeeecC
Q 022903 62 IGSKIGEGAHGKVYEGRYG----------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV-KFLGACKDP 130 (290)
Q Consensus 62 ~~~~lG~G~~g~V~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~ 130 (290)
-++.|..|-.-.+|+.... ++.|++++.-.....-- .-.+|..+++.+...+|- ++++.+..
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI------dR~~E~~v~~~ls~~gi~P~l~~~f~g- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY------NPISEFEVYKTMSKYRIAPQLLNTFSG- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee------CHHHHHHHHHHHHHCCCCCceEEEeCC-
Confidence 4566777888889988643 45788998755332110 123577777777654553 45665532
Q ss_pred ceEEEEEecCCCCH
Q 022903 131 LMVIVTELLPGMSL 144 (290)
Q Consensus 131 ~~~lv~e~~~~~~L 144 (290)
+.|.+|++|..|
T Consensus 182 --g~I~efi~g~~l 193 (442)
T PTZ00296 182 --GRIEEWLYGDPL 193 (442)
T ss_pred --CEEEEeeCCccC
Confidence 467899987644
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.046 Score=47.17 Aligned_cols=30 Identities=27% Similarity=0.455 Sum_probs=25.3
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 178 ~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.+++|+|+.+.||+++. + .+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECccccc
Confidence 47899999999999985 3 488999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 290 | ||||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-29 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-29 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-29 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-29 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-29 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-28 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-28 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-28 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-28 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-28 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-28 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-28 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-25 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-23 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-23 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-23 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-23 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-23 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-23 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-23 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-23 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-22 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-22 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-21 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-21 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-21 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-21 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-21 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-21 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-20 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-19 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-19 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-19 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-19 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-19 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-19 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-19 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-19 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-19 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-19 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-19 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-19 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-19 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-19 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-19 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-19 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-18 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-18 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-18 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-18 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-18 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-18 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-18 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-18 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-18 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-18 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-18 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-18 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-17 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-17 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-17 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-17 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-17 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-16 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-16 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-16 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-16 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-16 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-16 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-16 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-16 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-16 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-16 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-16 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-16 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-16 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-16 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-16 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-16 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-16 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-16 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-16 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-16 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-16 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-16 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-16 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-16 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-16 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-16 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-16 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-16 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-16 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-16 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-16 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-16 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-16 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-16 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-16 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-16 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-16 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-16 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-16 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-16 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-16 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-16 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-15 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-15 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-15 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-15 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-15 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-14 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-14 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-08 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 6e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 |
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-106
Identities = 72/251 (28%), Positives = 120/251 (47%), Gaps = 20/251 (7%)
Query: 40 GSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDR--IVAIKVLNRGSTSDE 97
G++ + R + + +IG+G G V++GR +VAIK L G + E
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 98 RALLEGR--FIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNK 155
++E F REV +MS + H N+VK G +P +V E +P L L+ + +
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRLLD-KAHP 118
Query: 156 LDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKS----LKLADFGLARE 209
+ V L LDIA ++ + I+HRDL+ N+ L ++ K+ADFGL+++
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
Query: 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
++ G ++WMAPE E++ Y K D YSF ++L+ +LT PF+
Sbjct: 179 SV--HSVSGLLGNFQWMAPETIG------AEEESYTEKADTYSFAMILYTILTGEGPFDE 230
Query: 270 MSNLQAAYAAA 280
S + +
Sbjct: 231 YSYGKIKFINM 241
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = e-104
Identities = 85/255 (33%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 33 SRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRG 92
+ ++ + + L I KIG G+ G V+ + VA+K+L
Sbjct: 12 DYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQ 71
Query: 93 STSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL-VS 150
ER F+REV +M R++H N+V F+GA + P + IVTE L SL + L S
Sbjct: 72 DFHAER---VNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128
Query: 151 LRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
+LD L+ A D+A+ M+ LH I+HR+LK NLL+ + ++K+ DFGL+R
Sbjct: 129 GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSR 187
Query: 209 EETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ T + GT WMAPE+ + N K DVYSFG++LWEL T + P+
Sbjct: 188 LKASTFLSSKSAAGTPEWMAPEVL--------RDEPSNEKSDVYSFGVILWELATLQQPW 239
Query: 268 EGMSNLQAAYAAAFK 282
++ Q A FK
Sbjct: 240 GNLNPAQVVAAVGFK 254
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = e-103
Identities = 82/241 (34%), Positives = 117/241 (48%), Gaps = 24/241 (9%)
Query: 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
L +D L + IG G GKVY + VA+K D +E +E +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIE-NVRQEAKLF 60
Query: 113 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+ +KH N++ G C K+P + +V E G L + L ++ + +N+A+ IAR
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIARG 117
Query: 172 MDCLHANG---IIHRDLKPDNLLLT-------PDQKSLKLADFGLAREETVTEMMTAETG 221
M+ LH IIHRDLK N+L+ K LK+ DFGLARE T M+A G
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AG 176
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281
Y WMAPE+ ++ DV+S+G++LWELLT +PF G+ L AY A
Sbjct: 177 AYAWMAPEVI--------RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 282 K 282
Sbjct: 229 N 229
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-102
Identities = 65/236 (27%), Positives = 114/236 (48%), Gaps = 17/236 (7%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + L IG IG+G G+VY GR+ G+ VAI++++ ++++ F REV
Sbjct: 30 IPFEQLEIGELIGKGRFGQVYHGRWHGE--VAIRLIDIERDNEDQ---LKAFKREVMAYR 84
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+ +H+N+V F+GAC P + I+T L G +L + LD++ A +I + M
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGM 143
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT------EMMTAETGTYRWM 226
LHA GI+H+DLK N+ D + + DFGL V + + + G +
Sbjct: 144 GYLHAKGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHL 201
Query: 227 APELYSTVTL-RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281
APE+ ++ + +K ++ DV++ G + +EL PF+ +
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = e-101
Identities = 78/231 (33%), Positives = 117/231 (50%), Gaps = 22/231 (9%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
++D K + + +G GA G V + ++ + VAIK + S FI E+ +S
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKA-------FIVELRQLS 56
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNFALDIARAM 172
RV H N+VK GAC +P+ +V E G SL L P A+++ L ++ +
Sbjct: 57 RVNHPNIVKLYGACLNPVC-LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 173 DCLHA---NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 229
LH+ +IHRDLKP NLLL LK+ DFG A + + MT G+ WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWMAPE 173
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
++ E +Y+ K DV+S+GI+LWE++T R PF+ + A
Sbjct: 174 VF--------EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA 216
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = e-101
Identities = 57/239 (23%), Positives = 104/239 (43%), Gaps = 18/239 (7%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIRE 108
+++ +D K L +K+ E G++++GR+ + +KVL S F E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR---KSRDFNEE 57
Query: 109 VNMMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
+ H N++ LGAC+ P ++T +P SL L +D A+ FA
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117
Query: 166 LDIARAMDCLHA--NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
LD+AR M LH I L ++++ + + +++ +
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQ----SPGRMYAP 172
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
W+APE L++ + D++SF ++LWEL+T +PF +SN++ A +
Sbjct: 173 AWVAPEA-----LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE 226
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = e-100
Identities = 77/229 (33%), Positives = 127/229 (55%), Gaps = 16/229 (6%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + +G +IG G+ G VY+G++ GD VA+K+LN + + + F EV ++
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ---QLQAFKNEVGVLR 75
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+ +H N++ F+G P + IVT+ G SL +L + K ++ ++ A AR MD
Sbjct: 76 KTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMD 134
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPEL 230
LHA IIHRDLK +N+ L + ++K+ DFGLA E++ +G+ WMAPE+
Sbjct: 135 YLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279
+R + Y+ + DVY+FGIVL+EL+T +LP+ ++N
Sbjct: 194 -----IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM 237
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 2e-80
Identities = 69/246 (28%), Positives = 111/246 (45%), Gaps = 33/246 (13%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
P L G +G+G G+ + + ++ +K L R +R F++EV +M
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT-----FLKEVKVM 61
Query: 113 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
++H N++KF+G KD + +TE + G +LR + S ++ ++FA DIA
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASG 120
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---------------M 216
M LH+ IIHRDL N L+ + K++ +ADFGLAR +
Sbjct: 121 MAYLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276
G WMAPE+ + + Y+ KVDV+SFGIVL E++
Sbjct: 180 YTVVGNPYWMAPEM-----ING---RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231
Query: 277 YAAAFK 282
+ +
Sbjct: 232 FGLNVR 237
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 5e-77
Identities = 66/270 (24%), Positives = 112/270 (41%), Gaps = 39/270 (14%)
Query: 39 NGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDER 98
+GS + L + R K + + +IG+G +G+V+ G++ VA+KV T++E
Sbjct: 21 SGSGSGLPLLVQR---TIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVF---FTTEEA 74
Query: 99 ALLEGRFIRE--VNMMSRVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSL 151
+ + RE + ++H+N++ F+ A + ++T+ SL YL
Sbjct: 75 S-----WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--- 126
Query: 152 RPNKLDLHVALNFALDIARAMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLAD 203
+ LD L A + LH I HRDLK N+L+ + + +AD
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIAD 185
Query: 204 FGLAREE-----TVTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
GLA + V GT R+M PE L ++ + D+YSFG++L
Sbjct: 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ---SYIMADMYSFGLIL 242
Query: 258 WELLTNRLPFEGMSNLQAAYAAAFKVQESI 287
WE+ + + Q Y S
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 2e-75
Identities = 60/251 (23%), Positives = 107/251 (42%), Gaps = 44/251 (17%)
Query: 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIRE--VNMMSRV 115
+ + + +G+G +G+V+ G + VA+K+ S+ DE++ + RE + +
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENVAVKIF---SSRDEKS-----WFRETELYNTVML 59
Query: 116 KHDNLVKFLGAC-----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+H+N++ F+ + + ++T SL YL + LD L L IA
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIAS 116
Query: 171 AMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-----T 217
+ LH I HRDLK N+L+ + +AD GLA + +
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----------NRLPF 267
GT R+MAPE+ Q + +VD+++FG+VLWE+ + PF
Sbjct: 176 PRVGTKRYMAPEVLDETI--QVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 268 EGMSNLQAAYA 278
+ ++
Sbjct: 234 YDVVPNDPSFE 244
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-72
Identities = 58/251 (23%), Positives = 103/251 (41%), Gaps = 32/251 (12%)
Query: 56 DPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV 115
+ + + IG+G G+V+ G++ VA+K+ + S + E E+ +
Sbjct: 40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS--SREERSWFRE----AEIYQTVML 93
Query: 116 KHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+H+N++ F+ A + +V++ SL YL + + + AL A
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTAS 150
Query: 171 AMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-----TVTEMMT 217
+ LH I HRDLK N+L+ + + +AD GLA T+
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 218 AETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276
GT R+MAPE L ++ ++ E + D+Y+ G+V WE+ + Q
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFE---SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
Query: 277 YAAAFKVQESI 287
Y S+
Sbjct: 267 YYDLVPSDPSV 277
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 5e-67
Identities = 72/266 (27%), Positives = 114/266 (42%), Gaps = 44/266 (16%)
Query: 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNM 111
+D L + IG G +G VY+G +R VA+KV + + + FI E N+
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQN--------FINEKNI 58
Query: 112 --MSRVKHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 163
+ ++HDN+ +F+ + ++V E P SL KY L + D +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY---LSLHTSDWVSSCR 115
Query: 164 FALDIARAMDCLHA---------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214
A + R + LH I HRDL N+L+ D + ++DFGL+ T
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNR 174
Query: 215 M---------MTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL--- 261
+ +E GT R+MAPE L V LR E +VD+Y+ G++ WE+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE--SALKQVDMYALGLIYWEIFMRC 232
Query: 262 TNRLPFEGMSNLQAAYAAAFKVQESI 287
T+ P E + Q A+ +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTF 258
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-65
Identities = 59/236 (25%), Positives = 100/236 (42%), Gaps = 31/236 (13%)
Query: 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
L L + G G V++ + + VA+K+ + EV +
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQ------NEYEVYSL 72
Query: 113 SRVKHDNLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
+KH+N+++F+GA K V ++T SL +L + N + + + A
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAET 129
Query: 168 IARAMDCLHAN----------GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTE 214
+AR + LH + I HRD+K N+LL + + +ADFGLA
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAG 188
Query: 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270
+ GT R+MAPE+ Q + ++D+Y+ G+VLWEL + +G
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRD---AFLRIDMYAMGLVLWELASRCTAADGP 241
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-59
Identities = 73/241 (30%), Positives = 119/241 (49%), Gaps = 27/241 (11%)
Query: 40 GSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERA 99
GS+ A ++ K L + IG+G G V G Y VA+K + +T+
Sbjct: 3 GSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-- 60
Query: 100 LLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLD 157
F+ E ++M++++H NLV+ LG + + IVTE + SL YL S + L
Sbjct: 61 -----FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 115
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217
L F+LD+ AM+ L N +HRDL N+L++ + K++DFGL +E + +
Sbjct: 116 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS-----S 169
Query: 218 AETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNL 273
+ +W APE LR+ ++ K DV+SFGI+LWE+ + R+P+ +
Sbjct: 170 TQDTGKLPVKWTAPE-----ALREK---KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 221
Query: 274 Q 274
Sbjct: 222 D 222
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-59
Identities = 73/259 (28%), Positives = 122/259 (47%), Gaps = 27/259 (10%)
Query: 22 QHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD 81
G + + V G++ A ++ K L + IG+G G V G Y
Sbjct: 157 TTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG 216
Query: 82 RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELL 139
VA+K + +T+ F+ E ++M++++H NLV+ LG + + IVTE +
Sbjct: 217 NKVAVKCIKNDATAQA-------FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269
Query: 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199
SL YL S + L L F+LD+ AM+ L N +HRDL N+L++ +
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVA 328
Query: 200 KLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256
K++DFGL +E + + + +W APE +K ++ K DV+SFGI+
Sbjct: 329 KVSDFGLTKEAS-----STQDTGKLPVKWTAPEALR--------EKKFSTKSDVWSFGIL 375
Query: 257 LWELLTN-RLPFEGMSNLQ 274
LWE+ + R+P+ +
Sbjct: 376 LWEIYSFGRVPYPRIPLKD 394
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-59
Identities = 71/229 (31%), Positives = 116/229 (50%), Gaps = 23/229 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
++ + L +G +IG G G+V+ GR + +VA+K D +A +F++E ++
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA----KFLQEARIL 166
Query: 113 SRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+ H N+V+ +G C K P+ IV EL+ G +L + +L + L D A
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAAA 224
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMA 227
M+ L + IHRDL N L+T ++ LK++DFG++REE + +W A
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA 283
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA 275
PE L G Y+++ DV+SFGI+LWE + P+ +SN Q
Sbjct: 284 PE-----ALNYG---RYSSESDVWSFGILLWETFSLGASPYPNLSNQQT 324
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-58
Identities = 78/226 (34%), Positives = 121/226 (53%), Gaps = 23/226 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
V + L + ++G G G+V+ G Y G VA+K L +GS S + F+ E N+M
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA------FLAEANLMK 63
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+++H LV+ ++P+ I+TE + SL +L + KL ++ L+ A IA M
Sbjct: 64 QLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE 229
+ IHRDL+ N+L++ D S K+ADFGLAR E TA G +W APE
Sbjct: 123 AFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 180
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+ G + K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 181 -----AINYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 9e-57
Identities = 73/228 (32%), Positives = 113/228 (49%), Gaps = 25/228 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDR--IVAIKVLNRGSTSDERALLEGRFIREVNMM 112
++ + + K+G G +G+VYEG + VA+K L + E F++E +M
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVM 63
Query: 113 SRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+KH NLV+ LG C + P I+TE + +L YL ++ V L A I+
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMA 227
AM+ L IHRDL N L+ + +K+ADFGL+R T + TA G +W A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTA 180
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
PE +L ++ K DV++FG++LWE+ T P+ G+ Q
Sbjct: 181 PE-----SLAYN---KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 3e-56
Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 13/237 (5%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +G+GA V+ G + + AIKV N S + RE ++ ++ H N
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM----REFEVLKKLNHKN 68
Query: 120 LVKFLGACKDP---LMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIARAMDCL 175
+VK ++ V++ E P SL L L L D+ M+ L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 176 HANGIIHRDLKPDNLLLTP---DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
NGI+HR++KP N++ Q KL DFG ARE E + GT ++ P++Y
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYA 289
LR+ +K Y VD++S G+ + T LPF + +K+ +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-55
Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 29/229 (12%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + + + ++G G G V G++ + VA+K++ GS S++ F +E M
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE------FFQEAQTMM 58
Query: 114 RVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
++ H LVKF G C + P+ IVTE + L YL S L+ L D+
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIY-IVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEG 116
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAP 228
M L ++ IHRDL N L+ +K++DFG+ R + + GT +W AP
Sbjct: 117 MAFLESHQFIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAP 174
Query: 229 E--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
E Y Y++K DV++FGI++WE+ + ++P++ +N +
Sbjct: 175 EVFHYFK----------YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-55
Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 13/237 (5%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +G+GA V+ G + + AIKV N S + RE ++ ++ H N
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM----REFEVLKKLNHKN 68
Query: 120 LVKFLGACKDP---LMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIARAMDCL 175
+VK ++ V++ E P SL L L L D+ M+ L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 176 HANGIIHRDLKPDNLLLTPD---QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
NGI+HR++KP N++ Q KL DFG ARE E + GT ++ P++Y
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYA 289
LR+ +K Y VD++S G+ + T LPF + +K+ +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-55
Identities = 75/261 (28%), Positives = 121/261 (46%), Gaps = 31/261 (11%)
Query: 23 HVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDR 82
L K ++ + S + ++R+ + + K+G G +G+VYEG +
Sbjct: 191 TTLHYPAPKRNKPTIYGVSPNYDKWEMERTDIT------MKHKLGGGQYGEVYEGVWKKY 244
Query: 83 --IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTEL 138
VA+K L + E F++E +M +KH NLV+ LG C + P I+TE
Sbjct: 245 SLTVAVKTLKEDTMEVEE------FLKEAAVMKEIKHPNLVQLLGVCTREPPFY-IITEF 297
Query: 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198
+ +L YL ++ V L A I+ AM+ L IHR+L N L+ +
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG-ENHL 356
Query: 199 LKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 255
+K+ADFGL+R T + TA G +W APE + ++ K DV++FG+
Sbjct: 357 VKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA--------YNKFSIKSDVWAFGV 407
Query: 256 VLWELLTN-RLPFEGMSNLQA 275
+LWE+ T P+ G+ Q
Sbjct: 408 LLWEIATYGMSPYPGIDLSQV 428
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-55
Identities = 60/234 (25%), Positives = 110/234 (47%), Gaps = 30/234 (12%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIR 107
++ +G GA G VY+G + G+++ VAIK L ++ +
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK----EILD 66
Query: 108 EVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
E +M+ V + ++ + LG C + ++T+L+P L Y+ + + LN+ +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCV 124
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---Y 223
IA+ M+ L ++HRDL N+L+ + +K+ DFGLA+ E G
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 224 RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
+WMA E L+ Y ++ DV+S+G+ +WEL+T P++G+ +
Sbjct: 184 KWMALESILHRI----------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-55
Identities = 70/229 (30%), Positives = 118/229 (51%), Gaps = 29/229 (12%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+DPK L ++G G G V G++ + VAIK++ GS S++ FI E +M
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE------FIEEAKVMM 74
Query: 114 RVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+ H+ LV+ G C + P+ I+TE + L YL +R + L D+ A
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIF-IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEA 132
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAP 228
M+ L + +HRDL N L+ DQ +K++DFGL+R E T+ G+ RW P
Sbjct: 133 MEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPP 190
Query: 229 E--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
E +YS +++K D+++FG+++WE+ + ++P+E +N +
Sbjct: 191 EVLMYSK----------FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-55
Identities = 70/230 (30%), Positives = 115/230 (50%), Gaps = 29/230 (12%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+DP L +IG G G V+ G + ++ VAIK + G+ S+E FI E +M
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED------FIEEAEVMM 58
Query: 114 RVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
++ H LV+ G C + P+ +VTE + L YL + + L LD+
Sbjct: 59 KLSHPKLVQLYGVCLEQAPIC-LVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEG 116
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAP 228
M L +IHRDL N L+ + + +K++DFG+ R + T+ TGT +W +P
Sbjct: 117 MAYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASP 174
Query: 229 E--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA 275
E +S Y++K DV+SFG+++WE+ + ++P+E SN +
Sbjct: 175 EVFSFSR----------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 8e-55
Identities = 71/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + L + K+G+G G+V+ G + G VAIK L G+ S E F++E +M
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA------FLQEAQVMK 317
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+++H+ LV+ ++P+ IVTE + SL +L L L ++ A IA M
Sbjct: 318 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPEL 230
+ +HRDL+ N+L+ + K+ADFGLAR E + +W APE
Sbjct: 377 AYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA 275
+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 436 ALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 473
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 9e-55
Identities = 71/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + L + K+G+G G+V+ G + G VAIK L G+ S E F++E +M
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA------FLQEAQVMK 234
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+++H+ LV+ ++P+ IVTE + SL +L L L ++ A IA M
Sbjct: 235 KLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPEL 230
+ +HRDL+ N+L+ + K+ADFGLAR E + +W APE
Sbjct: 294 AYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA 275
+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 353 ALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 390
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-54
Identities = 77/226 (34%), Positives = 114/226 (50%), Gaps = 23/226 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI-VAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + L + K+G G G+V+ Y VA+K + GS S E F+ E N+M
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA------FLAEANVMK 238
Query: 114 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++HD LVK K+P+ I+TE + SL +L S +K L ++F+ IA M
Sbjct: 239 TLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPE 229
+ IHRDL+ N+L++ K+ADFGLAR E TA G +W APE
Sbjct: 298 AFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPE 355
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+ + K DV+SFGI+L E++T R+P+ GMSN +
Sbjct: 356 AIN--------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 393
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-54
Identities = 64/231 (27%), Positives = 111/231 (48%), Gaps = 28/231 (12%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREV 109
+ + + +G IGEG G V++G Y VAIK ++ R +F++E
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE----KFLQEA 67
Query: 110 NMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
M + H ++VK +G ++P+ I+ EL LR +L + LDL + +A +
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLILYAYQL 125
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWM 226
+ A+ L + +HRD+ N+L++ +KL DFGL+R + A G +WM
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 184
Query: 227 APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
APE + + + + DV+ FG+ +WE+L + PF+G+ N
Sbjct: 185 APESINF----------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-54
Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 33/240 (13%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
V K + + +G GA G+VYEG+ VA+K L + + F+
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLM 82
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----KLDLHV 160
E ++S+ H N+V+ +G P I+ EL+ G L+ +L RP L +
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLAREETVTEMMTA 218
L+ A DIA L N IHRD+ N LLT K+ DFG+AR+
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 219 ETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+WM PE +G + +K D +SFG++LWE+ + +P+ SN +
Sbjct: 202 GGCAMLPVKWMPPE-----AFMEG---IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 6e-54
Identities = 71/234 (30%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRY----GDRI-VAIKVLNRGSTSDERALLEGRFIRE 108
L+ K L + K+G+G+ G V G + G + VA+K L S A+ + FIRE
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD--FIRE 71
Query: 109 VNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
VN M + H NL++ G P+ +VTEL P SL L L +A+
Sbjct: 72 VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQ 129
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT---Y 223
+A M L + IHRDL NLLL + +K+ DFGL R + + +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 224 RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
W APE T +++ D + FG+ LWE+ T + P+ G++ Q
Sbjct: 189 AWCAPESLKTRT----------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-53
Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 28/231 (12%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY----GDRI-VAIKVLNRGSTSDERALLEGRFIREV 109
+ + + + +GEG G+VYEG Y G++I VA+K + T D + +F+ E
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE----KFMSEA 64
Query: 110 NMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+M + H ++VK +G ++P I+ EL P L YL + L + + ++L I
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQI 122
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWM 226
+AM L + +HRD+ N+L+ + +KL DFGL+R + A +WM
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 227 APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+PE + + DV+ F + +WE+L+ + PF + N
Sbjct: 182 SPESINFRR----------FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-53
Identities = 66/232 (28%), Positives = 102/232 (43%), Gaps = 27/232 (11%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREV 109
++ + I IG G G+V GR D VAIK L G T +R F+ E
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR----DFLSEA 101
Query: 110 NMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
++M + H N+++ G M IVTE + SL +L + + + +
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAM-IVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRG 159
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---Y 223
+ M L G +HRDL N+L+ K++DFGL+R E + TG
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
RW APE + +++ DV+SFG+V+WE+L P+ M+N
Sbjct: 219 RWTAPE-----AIAFR---TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-53
Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 33/240 (13%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
V K + + +G GA G+VYEG+ VA+K L + + F+
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL----DFLM 123
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----KLDLHV 160
E ++S+ H N+V+ +G P I+ EL+ G L+ +L RP L +
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLAREETVTEMMTA 218
L+ A DIA L N IHRD+ N LLT K+ DFG+AR+
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 219 ETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+WM PE +G + +K D +SFG++LWE+ + +P+ SN +
Sbjct: 243 GGCAMLPVKWMPPE-----AFMEGI---FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-53
Identities = 75/241 (31%), Positives = 117/241 (48%), Gaps = 35/241 (14%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
V + + + ++G+G+ G VYEG + VAIK +N ++ ER F+
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI----EFLN 77
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN--------KLD 157
E ++M ++V+ LG P +VI EL+ L+ YL SLRP
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVI-MELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217
L + A +IA M L+AN +HRDL N ++ D ++K+ DFG+ R+ T+
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYR 195
Query: 218 AETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273
RWM+PE +L+ G + DV+SFG+VLWE+ T P++G+SN
Sbjct: 196 KGGKGLLPVRWMSPE-----SLKDGV---FTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247
Query: 274 Q 274
Q
Sbjct: 248 Q 248
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 6e-53
Identities = 68/235 (28%), Positives = 106/235 (45%), Gaps = 32/235 (13%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIRE 108
+ P + IG G G+VY+G + VAIK L G T +R F+ E
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV----DFLGE 96
Query: 109 VNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
+M + H N+++ G P+M I+TE + +L K+L + + + +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMM-IITEYMENGALDKFLRE-KDGEFSVLQLVGMLR 154
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT--- 222
IA M L +HRDL N+L+ K++DFGL+R E E +G
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 223 YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
RW APE Y + + + DV+SFGIV+WE++T P+ +SN +
Sbjct: 214 IRWTAPEAISY----------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 9e-53
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 26/232 (11%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDR------IVAIKVLNRGSTSDERALLEGRFIR 107
+ L +G G G V++G + V IKV+ S
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ----AVTD 64
Query: 108 EVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
+ + + H ++V+ LG C L +VT+ LP SL ++ R L + LN+ +
Sbjct: 65 HMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGV 122
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---Y 223
IA+ M L +G++HR+L N+LL +++ADFG+A + +
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+WMA E Y ++ DV+S+G+ +WEL+T P+ G+ +
Sbjct: 182 KWMALESIHF--------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-52
Identities = 54/246 (21%), Positives = 96/246 (39%), Gaps = 48/246 (19%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI---------VAIKVLNRGSTSDERALLEGRF 105
+ + L +G+G K+++G + V +KVL++ + + F
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES-----F 59
Query: 106 IREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 163
+MMS++ H +LV G C D + +V E + SL YL + +++ L
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKN-CINILWKLE 117
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL-------KLADFGLAREETVTEMM 216
A +A AM L N +IH ++ N+LL ++ KL+D G++
Sbjct: 118 VAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------- 170
Query: 217 TAETGTY----RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEG 269
W+ PE K+ N D +SFG LWE+ + P
Sbjct: 171 VLPKDILQERIPWVPPECIENP---------KNLNLATDKWSFGTTLWEICSGGDKPLSA 221
Query: 270 MSNLQA 275
+ + +
Sbjct: 222 LDSQRK 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-52
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 60 LFIGSKIGEGAHGKVYEGRYGDRI-----VAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
IG+G G VY G Y D+ AIK L+R + + F+RE +M
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVE----AFLREGLLMRG 78
Query: 115 VKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+ H N++ +G + L ++ + L +++ S + N + ++F L +AR M
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQVARGM 137
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-----RWMA 227
+ L +HRDL N +L + ++K+ADFGLAR+ E + + + +W A
Sbjct: 138 EYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
E +L+ + K DV+SFG++LWELLT P+ +
Sbjct: 197 LE-----SLQTYR---FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-52
Identities = 71/255 (27%), Positives = 117/255 (45%), Gaps = 52/255 (20%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALL 101
I R +V + ++GEGA GKV+ +VA+K L + + +
Sbjct: 12 IKRRDIV------LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD-- 63
Query: 102 EGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN----- 154
F RE +++ ++H+++VKF G C DPL+ +V E + L K+L + P+
Sbjct: 64 ---FQREAELLTNLQHEHIVKFYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 155 ---------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205
+L L L+ A IA M L + +HRDL N L+ +K+ DFG
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFG 178
Query: 206 LAREETVTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260
++R+ T+ T RWM PE +Y + + DV+SFG++LWE+
Sbjct: 179 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK----------FTTESDVWSFGVILWEI 228
Query: 261 LT-NRLPFEGMSNLQ 274
T + P+ +SN +
Sbjct: 229 FTYGKQPWFQLSNTE 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-52
Identities = 65/252 (25%), Positives = 102/252 (40%), Gaps = 50/252 (19%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDR------IVAIKVLNRGSTSDERALLEGRFIRE 108
+ + L ++G+G G V RY +VA+K L + R F RE
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FERE 61
Query: 109 VNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
+ ++ ++HDN+VK+ G C + L ++ E LP SLR YL + ++D L +
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKE-RIDHIKLLQY 119
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT- 222
I + M+ L IHRDL N+L+ ++ +K+ DFGL + E +
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 223 --YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------------- 262
W APE S ++ DV+SFG+VL+EL T
Sbjct: 179 SPIFWYAPESLTESK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
Query: 263 NRLPFEGMSNLQ 274
M
Sbjct: 229 GNDKQGQMIVFH 240
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-52
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 27/232 (11%)
Query: 56 DPKLLFIGSKIGEGAHGKVYEGRYGDR-----IVAIKVLNRGSTSDERALLEGRFIREVN 110
++ IG G G VY G D A+K LNR + E + +F+ E
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGI 78
Query: 111 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+M H N++ LG C + ++V + LR ++ + N + + F L +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 137
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----- 223
A+ M L + +HRDL N +L ++ ++K+ADFGLAR+ E + T
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
+WMA E +L+ + + K DV+SFG++LWEL+T P+ ++
Sbjct: 197 KWMALE-----SLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-52
Identities = 59/234 (25%), Positives = 106/234 (45%), Gaps = 30/234 (12%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDRI------VAIKVLNRGSTSDERALLEGRFIR 107
++ +G GA G VY+G + VAIK L ++ +
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK----EILD 66
Query: 108 EVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
E +M+ V + ++ + LG C + ++T+L+P L Y+ + + LN+ +
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCV 124
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---Y 223
IA+ M+ L ++HRDL N+L+ + +K+ DFGLA+ E G
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 224 RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
+WMA E L+ Y ++ DV+S+G+ +WEL+T P++G+ +
Sbjct: 184 KWMALESILHRI----------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 6e-52
Identities = 64/229 (27%), Positives = 111/229 (48%), Gaps = 24/229 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREV 109
+ + + +G IGEG G V++G Y VAIK ++ R +F++E
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE----KFLQEA 442
Query: 110 NMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
M + H ++VK +G ++P+ I+ EL LR +L + LDL + +A +
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKF-SLDLASLILYAYQL 500
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWM 226
+ A+ L + +HRD+ N+L++ +KL DFGL+R + A G +WM
Sbjct: 501 STALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
APE ++ + + DV+ FG+ +WE+L + PF+G+ N
Sbjct: 560 APE-----SINFR---RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 7e-52
Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 41/247 (16%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
+ + ++GE GKVY+G + VAIK L + R F
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE----EFRH 61
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN----------- 154
E + +R++H N+V LG PL ++ L ++LV P+
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 155 ---KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211
L+ ++ IA M+ L ++ ++H+DL N+L+ D+ ++K++D GL RE
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-DKLNVKISDLGLFREVY 179
Query: 212 VTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 267
+ + RWMAPE + G ++ D++S+G+VLWE+ + P+
Sbjct: 180 AADYYKLLGNSLLPIRWMAPE-----AIMYG---KFSIDSDIWSYGVVLWEVFSYGLQPY 231
Query: 268 EGMSNLQ 274
G SN
Sbjct: 232 CGYSNQD 238
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-51
Identities = 65/252 (25%), Positives = 102/252 (40%), Gaps = 50/252 (19%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDR------IVAIKVLNRGSTSDERALLEGRFIRE 108
+ + L ++G+G G V RY +VA+K L + R F RE
Sbjct: 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD-----FERE 92
Query: 109 VNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
+ ++ ++HDN+VK+ G C + L ++ E LP SLR YL + ++D L +
Sbjct: 93 IEILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKE-RIDHIKLLQY 150
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT- 222
I + M+ L IHRDL N+L+ ++ +K+ DFGL + E +
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209
Query: 223 --YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------------- 262
W APE S ++ DV+SFG+VL+EL T
Sbjct: 210 SPIFWYAPESLTESK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
Query: 263 NRLPFEGMSNLQ 274
M
Sbjct: 260 GNDKQGQMIVFH 271
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-51
Identities = 60/259 (23%), Positives = 112/259 (43%), Gaps = 32/259 (12%)
Query: 36 VVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDR-----IVAIKVLN 90
++ + I+ +L+ + +G +G+G G V E + VA+K+L
Sbjct: 1 MLDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK 60
Query: 91 RGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-------KDPLMVIVTELLPGMS 143
+ F+RE M H ++ K +G + P+ +++ +
Sbjct: 61 ADIIASSDIE---EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117
Query: 144 LRKYLVSLRP----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199
L +L++ R L L + F +DIA M+ L + IHRDL N +L D ++
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTV 176
Query: 200 KLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256
+ADFGL+R+ + + +W+A E +L Y DV++FG+
Sbjct: 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALE-----SLADNL---YTVHSDVWAFGVT 228
Query: 257 LWELLT-NRLPFEGMSNLQ 274
+WE++T + P+ G+ N +
Sbjct: 229 MWEIMTRGQTPYAGIENAE 247
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-51
Identities = 67/251 (26%), Positives = 102/251 (40%), Gaps = 50/251 (19%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDR------IVAIKVLNRGSTSDERALLEGRFIRE 108
+ L +GEG GKV Y +VA+K L + R+ + +E
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS----GWKQE 83
Query: 109 VNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
++++ + H++++K+ G C L +V E +P SLR YL + + L L F
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQ-LVMEYVPLGSLRDYL---PRHSIGLAQLLLF 139
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT- 222
A I M LHA IHRDL N+LL + + +K+ DFGLA+ E
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198
Query: 223 --YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------------N 263
W APE + DV+SFG+ L+ELLT
Sbjct: 199 SPVFWYAPECLKEYK----------FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248
Query: 264 RLPFEGMSNLQ 274
+ M+ L+
Sbjct: 249 GIAQGQMTVLR 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-51
Identities = 68/255 (26%), Positives = 113/255 (44%), Gaps = 49/255 (19%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
K L +G +GEG GKV + G VA+K+L ++ E +
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELR----DLLS 75
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP------------ 153
E N++ +V H +++K GAC PL++IV E SLR +L R
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 154 ----------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203
L + ++FA I++ M L ++HRDL N+L+ + +K++D
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEG-RKMKISD 193
Query: 204 FGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260
FGL+R+ + + +WMA E +L Y + DV+SFG++LWE+
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIE-----SLFDHI---YTTQSDVWSFGVLLWEI 245
Query: 261 LT-NRLPFEGMSNLQ 274
+T P+ G+ +
Sbjct: 246 VTLGGNPYPGIPPER 260
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-51
Identities = 75/262 (28%), Positives = 108/262 (41%), Gaps = 44/262 (16%)
Query: 41 SITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGS 93
I QL D L G +G GA GKV E VA+K+L +
Sbjct: 6 YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65
Query: 94 TSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVS 150
ER + E+ ++S + H N+V LGAC P +VI TE L +L
Sbjct: 66 HLTERE----ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI-TEYCCYGDLLNFLRR 120
Query: 151 LRPNKLDLHVA----------------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194
R + + + L+F+ +A+ M L + IHRDL N+LLT
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180
Query: 195 DQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVY 251
+ K+ DFGLAR+ + +WMAPE ++ Y + DV+
Sbjct: 181 G-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE-----SIFNCV---YTFESDVW 231
Query: 252 SFGIVLWELLT-NRLPFEGMSN 272
S+GI LWEL + P+ GM
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPV 253
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-51
Identities = 72/250 (28%), Positives = 113/250 (45%), Gaps = 44/250 (17%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI---------VAIKVLNRGSTSDERALLEGRF 105
L +G +GEGA G+V VA+K+L +T + +
Sbjct: 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS----DL 87
Query: 106 IREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP--------- 153
+ E+ MM + KH N++ LGAC PL VI E +LR+YL + RP
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 154 -----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
++ ++ +AR M+ L + IHRDL N+L+T + +K+ADFGLAR
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLAR 205
Query: 209 EETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 264
+ + T +WMAPE L Y ++ DV+SFG+++WE+ T
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPE-----ALFDRV---YTHQSDVWSFGVLMWEIFTLGG 257
Query: 265 LPFEGMSNLQ 274
P+ G+ +
Sbjct: 258 SPYPGIPVEE 267
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-51
Identities = 77/275 (28%), Positives = 116/275 (42%), Gaps = 33/275 (12%)
Query: 16 GEQEQNQHVLRGSVEKES-RAVVKNGSITAPQLTIDRSLL-VDPKLLFIGSKIGEGAHGK 73
G E+ H G ++ R V + P T+ +D + I +G G G+
Sbjct: 1 GSDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGE 60
Query: 74 VYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC- 127
V GR + VAIK L G T +R F+ E ++M + H N+++ G
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKVGYTEKQRR----DFLGEASIMGQFDHPNIIRLEGVVT 116
Query: 128 -KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 186
P+M IVTE + SL +L + + + IA M L G +HRDL
Sbjct: 117 KSKPVM-IVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 174
Query: 187 PDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---YRWMAPE--LYSTVTLRQGE 240
N+L+ K++DFGL R E E G RW +PE Y
Sbjct: 175 ARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--------- 224
Query: 241 KKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+ + + DV+S+GIVLWE+++ P+ MSN
Sbjct: 225 -RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-51
Identities = 66/246 (26%), Positives = 112/246 (45%), Gaps = 41/246 (16%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
+ + + + ++GEGA GKV+ +VA+K L S S + F R
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD-----FQR 92
Query: 108 EVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN----------- 154
E +++ ++H ++V+F G C PL+++ E + L ++L S P+
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 155 --KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212
L L L A +A M L +HRDL N L+ +K+ DFG++R+
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYS 210
Query: 213 TEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 268
T+ T RWM PE ++ + + + DV+SFG+VLWE+ T + P+
Sbjct: 211 TDYYRVGGRTMLPIRWMPPE-----SILYRK---FTTESDVWSFGVVLWEIFTYGKQPWY 262
Query: 269 GMSNLQ 274
+SN +
Sbjct: 263 QLSNTE 268
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-51
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY---GDRI---VAIKVLNRGSTSDERALLEGRFIRE 108
+ + L S++G+G G V RY GD VA+K L +R F RE
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD-----FQRE 74
Query: 109 VNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
+ ++ + D +VK+ G + L +V E LP LR +L R +LD L +
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRA-RLDASRLLLY 132
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT- 222
+ I + M+ L + +HRDL N+L+ + +K+ADFGLA+ +
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191
Query: 223 --YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262
W APE + ++ + DV+SFG+VL+EL T
Sbjct: 192 SPIFWYAPESLSDNI----------FSRQSDVWSFGVVLYELFT 225
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-51
Identities = 80/283 (28%), Positives = 122/283 (43%), Gaps = 44/283 (15%)
Query: 22 QHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD 81
H + ++ +L D + L +G +GEGA G+V
Sbjct: 33 HHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIG 92
Query: 82 RI---------VAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KD 129
VA+K+L +T + + I E+ MM + KH N++ LGAC
Sbjct: 93 LDKDKPNRVTKVAVKMLKSDATEKDLS----DLISEMEMMKMIGKHKNIINLLGACTQDG 148
Query: 130 PLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCL 175
PL VI E +LR+YL + RP +L ++ A +AR M+ L
Sbjct: 149 PLYVI-VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYS 232
+ IHRDL N+L+T D +K+ADFGLAR+ + T +WMAPE
Sbjct: 208 ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPE--- 263
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
L Y ++ DV+SFG++LWE+ T P+ G+ +
Sbjct: 264 --ALFDRI---YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 5e-51
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 27/232 (11%)
Query: 56 DPKLLFIGSKIGEGAHGKVYEGRYGDR-----IVAIKVLNRGSTSDERALLEGRFIREVN 110
++ IG G G VY G D A+K LNR + E + +F+ E
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS----QFLTEGI 142
Query: 111 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+M H N++ LG C + ++V + LR ++ + N + + F L +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 201
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----- 223
A+ M L + +HRDL N +L ++ ++K+ADFGLAR+ E + T
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
+WMA E +L+ + + K DV+SFG++LWEL+T P+ ++
Sbjct: 261 KWMALE-----SLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 6e-51
Identities = 71/247 (28%), Positives = 111/247 (44%), Gaps = 46/247 (18%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVN 110
+D + IGEG G+V + R AIK + ++ D+ F E+
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR----DFAGELE 77
Query: 111 MMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA------ 161
++ ++ H N++ LGAC + L + E P +L +L R + D A
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 162 --------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213
L+FA D+AR MD L IHRDL N+L+ + K+ADFGL+R +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQ--- 192
Query: 214 EMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 267
E+ +T RWMA E YS Y DV+S+G++LWE+++ P+
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 268 EGMSNLQ 274
GM+ +
Sbjct: 243 CGMTCAE 249
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 7e-51
Identities = 69/257 (26%), Positives = 108/257 (42%), Gaps = 54/257 (21%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLE 102
++ L +GEG GKV RY VA+K L S + A
Sbjct: 18 FEKRFLK------RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA--- 68
Query: 103 GRFIREVNMMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDL 158
+E+ ++ + H+N+VK+ G C + + ++ E LP SL++YL NK++L
Sbjct: 69 -DLKKEIEILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYLPK-NKNKINL 125
Query: 159 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMT 217
L +A+ I + MD L + +HRDL N+L+ + +K+ DFGL + ET E T
Sbjct: 126 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYT 184
Query: 218 AETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------- 262
+ W APE + S + DV+SFG+ L ELLT
Sbjct: 185 VKDDRDSPVFWYAPECLMQSK----------FYIASDVWSFGVTLHELLTYCDSDSSPMA 234
Query: 263 -----NRLPFEGMSNLQ 274
M+ +
Sbjct: 235 LFLKMIGPTHGQMTVTR 251
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-51
Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 34/242 (14%)
Query: 45 PQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERAL 100
+L + R LL ++G G G V +G Y VAIKVL +G+ +
Sbjct: 2 KKLFLKRD-----NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE- 55
Query: 101 LEGRFIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLH 159
+RE +M ++ + +V+ +G C + LM +V E+ G L K+LV + ++ +
Sbjct: 56 ---EMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVG-KREEIPVS 110
Query: 160 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TA 218
++ M L +HRDL N+LL ++ K++DFGL++ + TA
Sbjct: 111 NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTA 169
Query: 219 ETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN 272
+ +W APE + ++++ DV+S+G+ +WE L+ + P++ M
Sbjct: 170 RSAGKWPLKWYAPECINFRK----------FSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219
Query: 273 LQ 274
+
Sbjct: 220 PE 221
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 9e-51
Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 26/237 (10%)
Query: 55 VDPKLLFI--GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVN 110
+ F+ +IG G+ VY+G + VA L + RF E
Sbjct: 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAE 77
Query: 111 MMSRVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
M+ ++H N+V+F + + + +V+VTEL+ +L+ YL R + + V ++
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWC 135
Query: 166 LDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 223
I + + LH IIHRDLK DN+ +T S+K+ D GLA + + GT
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTP 194
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280
+MAPE+Y ++ Y+ VDVY+FG+ + E+ T+ P+ N Y
Sbjct: 195 EFMAPEMY---------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-50
Identities = 66/239 (27%), Positives = 108/239 (45%), Gaps = 31/239 (12%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDR-----IVAIKVLNRGSTSDERALLEGRFIREV 109
+D LL +G +GEG G V EG VA+K + ++S R + E F+ E
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEE--FLSEA 87
Query: 110 NMMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRP----NKLDLH 159
M H N+++ LG C + P +++ + L YL+ R + L
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 160 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 219
L F +DIA M+ L +HRDL N +L D ++ +ADFGL+++ +
Sbjct: 148 TLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 220 TGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
+W+A E +L Y +K DV++FG+ +WE+ T P+ G+ N +
Sbjct: 207 RIAKMPVKWIAIE-----SLADRV---YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 1e-50
Identities = 60/238 (25%), Positives = 105/238 (44%), Gaps = 34/238 (14%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGR 104
+DR L ++G G G V +G Y + VA+K+L + +
Sbjct: 13 LDRK-----LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL---KDE 64
Query: 105 FIREVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 163
+ E N+M ++ + +V+ +G C + M +V E+ L KYL + + +
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIE 121
Query: 164 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT 222
++ M L + +HRDL N+LL Q K++DFGL++ E A+T
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 223 ---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+W APE Y +++K DV+SFG+++WE + + P+ GM +
Sbjct: 181 KWPVKWYAPECINYYK----------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-50
Identities = 74/267 (27%), Positives = 111/267 (41%), Gaps = 49/267 (18%)
Query: 41 SITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGS 93
+ + D + L G +G GA GKV VA+K+L +
Sbjct: 28 YVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA 87
Query: 94 TSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVS 150
S ER + E+ MM+++ H+N+V LGAC P+ +I E L YL S
Sbjct: 88 DSSERE----ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI-FEYCCYGDLLNYLRS 142
Query: 151 LRPNKLDLHVA---------------------LNFALDIARAMDCLHANGIIHRDLKPDN 189
R + + L FA +A+ M+ L +HRDL N
Sbjct: 143 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202
Query: 190 LLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNN 246
+L+T K +K+ DFGLAR+ +WMAPE +L +G Y
Sbjct: 203 VLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE-----SLFEGI---YTI 253
Query: 247 KVDVYSFGIVLWELLT-NRLPFEGMSN 272
K DV+S+GI+LWE+ + P+ G+
Sbjct: 254 KSDVWSYGILLWEIFSLGVNPYPGIPV 280
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-50
Identities = 71/250 (28%), Positives = 112/250 (44%), Gaps = 44/250 (17%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRI---------VAIKVLNRGSTSDERALLEGRF 105
L +G +GEG G+V VA+K+L +T + +
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS----DL 133
Query: 106 IREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-------- 154
+ E+ MM + KH N++ LGAC PL VI E +LR+YL + RP
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 155 ------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208
++ ++ +AR M+ L + IHRDL N+L+T + +K+ADFGLAR
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLAR 251
Query: 209 EETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 264
+ + T +WMAPE L Y ++ DV+SFG+++WE+ T
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPE-----ALFDRV---YTHQSDVWSFGVLMWEIFTLGG 303
Query: 265 LPFEGMSNLQ 274
P+ G+ +
Sbjct: 304 SPYPGIPVEE 313
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 8e-50
Identities = 71/235 (30%), Positives = 115/235 (48%), Gaps = 23/235 (9%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I K+G G VY + VAIK + E L RF REV+ S++ H N
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLK--RFEREVHNSSQLSHQN 72
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V + ++ +V E + G +L +Y+ S P L + A+NF I + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM 130
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVT 235
I+HRD+KP N+L+ + K+LK+ DFG+A+ E ++T+ GT ++ +PE
Sbjct: 131 RIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHV-LGTVQYFSPE------ 182
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
Q + + + D+YS GIVL+E+L PF G + + A +Q+S+
Sbjct: 183 --QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH---IQDSVPNV 232
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 8e-50
Identities = 72/247 (29%), Positives = 109/247 (44%), Gaps = 43/247 (17%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
L +G +G GA G+V E R VA+K+L G+T E +
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR----ALMS 79
Query: 108 EVNMMSRV-KHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRP---------- 153
E+ ++ + H N+V LGAC PLMVI E +L YL S R
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVI-VEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 154 ----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209
+ L L + ++ +A+ M+ L + IHRDL N+LL+ +K+ DFGLAR+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARD 197
Query: 210 ETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 265
+ +WMAPE T+ Y + DV+SFG++LWE+ +
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPE-----TIFDRV---YTIQSDVWSFGVLLWEIFSLGAS 249
Query: 266 PFEGMSN 272
P+ G+
Sbjct: 250 PYPGVKI 256
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-49
Identities = 71/256 (27%), Positives = 108/256 (42%), Gaps = 39/256 (15%)
Query: 32 ESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIV 84
ES I QL + L G +G GA GKV E V
Sbjct: 20 ESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKV 79
Query: 85 AIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPG 141
A+K+L + +DE+ + E+ +MS + +H+N+V LGAC P++VI TE
Sbjct: 80 AVKMLKSTAHADEKE----ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI-TEYCCY 134
Query: 142 MSLRKYLVSLRP------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189
L +L + L+F+ +A+ M L + IHRD+ N
Sbjct: 135 GDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 194
Query: 190 LLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNN 246
+LLT K+ DFGLAR+ + +WMAPE ++ Y
Sbjct: 195 VLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE-----SIFDCV---YTV 245
Query: 247 KVDVYSFGIVLWELLT 262
+ DV+S+GI+LWE+ +
Sbjct: 246 QSDVWSYGILLWEIFS 261
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-49
Identities = 67/261 (25%), Positives = 112/261 (42%), Gaps = 55/261 (21%)
Query: 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALL 101
R+ + IGEGA G+V++ R +VA+K+L +++D +A
Sbjct: 44 YPRNNIE------YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA-- 95
Query: 102 EGRFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP------ 153
F RE +M+ + N+VK LG C P+ ++ E + L ++L S+ P
Sbjct: 96 --DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSL 152
Query: 154 ----------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 197
L L A +A M L +HRDL N L+ +
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-M 211
Query: 198 SLKLADFGLAREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 254
+K+ADFGL+R + A+ RWM PE ++ Y + DV+++G
Sbjct: 212 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE-----SIFYNR---YTTESDVWAYG 263
Query: 255 IVLWELLT-NRLPFEGMSNLQ 274
+VLWE+ + P+ GM++ +
Sbjct: 264 VVLWEIFSYGLQPYYGMAHEE 284
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 8e-49
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 37/231 (16%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG G G+V++ + + IK + + E+A REV ++++ H N
Sbjct: 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAE------REVKALAKLDHVN 65
Query: 120 LVKFLGA-----------------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVAL 162
+V + G K + I E +L +++ R KLD +AL
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 163 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 222
I + +D +H+ +I+RDLKP N+ L ++ +K+ DFGL T GT
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ-VKIGDFGLVTSLKNDGKRTRSKGT 184
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
R+M+PE + Y +VD+Y+ G++L ELL S
Sbjct: 185 LRYMSPEQI--------SSQDYGKEVDLYALGLILAELLHVCDTAFETSKF 227
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-48
Identities = 54/228 (23%), Positives = 103/228 (45%), Gaps = 18/228 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--D 118
I +IG G KV++ +I AIK +N ++ + E+ +++++ D
Sbjct: 32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSD 88
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+++ + +V E + L +L + +D ++ ++ A+ +H
Sbjct: 89 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ 145
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPEL---Y 231
+GI+H DLKP N L+ LKL DFG+A +T + + ++ GT +M PE
Sbjct: 146 HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279
S+ K + K DV+S G +L+ + + PF+ + N + A
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-48
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 26/224 (11%)
Query: 62 IGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+ ++G G G V + G++ VAIK + + R E+ +M ++ H
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQ-VAIKQCRQELSPKNRERWC----LEIQIMKKLNHP 72
Query: 119 NLVKFL-------GACKDPLMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIAR 170
N+V + L ++ E G LRKYL L DI+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 171 AMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 228
A+ LH N IIHRDLKP+N++L P + K+ D G A+E E+ T GT +++AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
EL E+K Y VD +SFG + +E +T PF
Sbjct: 193 ELL--------EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-48
Identities = 59/240 (24%), Positives = 112/240 (46%), Gaps = 27/240 (11%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALL 101
+L + L LL ++G G G V +G Y VAIKVL +G+ +
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-- 381
Query: 102 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 161
+RE +M ++ + +V+ +G C+ +++V E+ G L K+LV R ++ +
Sbjct: 382 --EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNV 438
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAET 220
++ M L +HR+L N+LL ++ K++DFGL++ + TA +
Sbjct: 439 AELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARS 497
Query: 221 GT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+W APE + ++++ DV+S+G+ +WE L+ + P++ M +
Sbjct: 498 AGKWPLKWYAPECINFRK----------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-48
Identities = 56/239 (23%), Positives = 105/239 (43%), Gaps = 18/239 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--D 118
I +IG G KV++ +I AIK +N ++ + E+ +++++ D
Sbjct: 13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSD 69
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+++ + +V E + L +L + +D ++ ++ A+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ 126
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPEL---Y 231
+GI+H DLKP N L+ LKL DFG+A +T + + ++ GT +M PE
Sbjct: 127 HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
S+ K + K DV+S G +L+ + + PF+ + N + A I P
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 9e-48
Identities = 62/258 (24%), Positives = 107/258 (41%), Gaps = 48/258 (18%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G G G V+E + D AIK + + R + +REV +++++H
Sbjct: 9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE----KVMREVKALAKLEHPG 64
Query: 120 LVKFLGACKD-------------PLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFA 165
+V++ A + + I +L +L+ ++ + + V L+
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-------------EETV 212
L IA A++ LH+ G++HRDLKP N+ T D +K+ DFGL
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
T + GT +M+PE Y++KVD++S G++L+ELL PF
Sbjct: 184 YARHTGQVGTKLYMSPEQI--------HGNSYSHKVDIFSLGLILFELLY---PFSTQME 232
Query: 273 LQAAYAAAFKVQESIYAP 290
V+ + P
Sbjct: 233 RVRTL---TDVRNLKFPP 247
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-47
Identities = 73/240 (30%), Positives = 111/240 (46%), Gaps = 27/240 (11%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +G G +V+ R R VA+KVL D L RF RE + + H
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYL--RFRREAQNAAALNHPA 73
Query: 120 LVKFL-----GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+V PL IV E + G++LR + + P + A+ D +A++
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNF 131
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET----GTYRWMAPEL 230
H NGIIHRD+KP N++++ +K+ DFG+AR + +T GT ++++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE- 189
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
Q + + DVYS G VL+E+LT PF G S + AY V+E P
Sbjct: 190 -------QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ---HVREDPIPP 239
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-47
Identities = 57/282 (20%), Positives = 117/282 (41%), Gaps = 23/282 (8%)
Query: 13 REEGEQEQNQHVLRGSVEKESRAVVKNGSITAP-----QLTIDRSLLVDPKLLFIGSKIG 67
G + + + K R + + + + + + V ++ I +IG
Sbjct: 6 HSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIG 65
Query: 68 EGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--DNLVKFL 124
G KV++ +I AIK +N ++ + E+ +++++ D +++
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 125 GACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 183
+ +V E + L +L + +D ++ ++ A+ +H +GI+H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHS 179
Query: 184 DLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPEL---YSTVTLR 237
DLKP N L+ LKL DFG+A +T + + ++ G +M PE S+
Sbjct: 180 DLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279
K + K DV+S G +L+ + + PF+ + N + A
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 5e-47
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNR-GSTSDERALLEGRFIREVNMMSRV-KH 117
S++G G++G+V++ R + R+ A+K +RA R + EV +V +H
Sbjct: 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA----RKLAEVGSHEKVGQH 116
Query: 118 DNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
V+ A ++ ++ + TEL G SL+++ L + D A+ LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+ G++H D+KP N+ L P + KL DFGL E + G R+MAPEL L
Sbjct: 175 SQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-----L 228
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNR-LPFEG 269
+ Y DV+S G+ + E+ N LP G
Sbjct: 229 QGS----YGTAADVFSLGLTILEVACNMELPHGG 258
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-47
Identities = 69/234 (29%), Positives = 113/234 (48%), Gaps = 22/234 (9%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
KIGEG+ GK + R IK +N +S ER REV +++ +KH
Sbjct: 28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES----RREVAVLANMKHP 83
Query: 119 NLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N+V++ + ++ + IV + G L K + + + L++ + I A+ +H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRD+K N+ LT D +++L DFG+AR + E+ A GT +++PE+
Sbjct: 144 RKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC----- 197
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
E K YNNK D+++ G VL+EL T + FE S K+ + P
Sbjct: 198 ---ENKPYNNKSDIWALGCVLYELCTLKHAFEAGS----MKNLVLKIISGSFPP 244
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-46
Identities = 49/236 (20%), Positives = 95/236 (40%), Gaps = 28/236 (11%)
Query: 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERAL------------LEGRFIREV 109
I + +G K+ ++ A+K + +R F E+
Sbjct: 35 IIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 110 NMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVS------LRPNKLDLHVAL 162
+++ +K++ + G + V I+ E + S+ K+ + + V
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 163 NFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 221
+ + +H I HRD+KP N+L+ + +KL+DFG + ++ + G
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSR-G 212
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
TY +M PE +S E + KVD++S GI L+ + N +PF +L +
Sbjct: 213 TYEFMPPEFFS------NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-46
Identities = 59/235 (25%), Positives = 110/235 (46%), Gaps = 19/235 (8%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I KIG G +VY VA+K + D +A + I+E++++ ++ H N
Sbjct: 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD--CIKEIDLLKQLNHPN 93
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIARAMDCLH 176
++K+ + + + IV EL L + + + K + + + + A++ +H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVT 235
+ ++HRD+KP N+ +T +KL D GL R + T + GT +M+PE
Sbjct: 154 SRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI---- 208
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
+ YN K D++S G +L+E+ + PF G + Y+ K+++ Y P
Sbjct: 209 ----HENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPP 257
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-46
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 48/241 (19%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +G+GA G+V + R R AIK + L EV +++ + H
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL------SEVMLLASLNHQY 63
Query: 120 LVKFLGA--------------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
+V++ A K + I E +L + S
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLF 122
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---------------EE 210
I A+ +H+ GIIHRDLKP N+ + + +K+ DFGLA+
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270
++ +T+ GT ++A E+ HYN K+D+YS GI+ +E++ GM
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLD-------GTGHYNEKIDMYSLGIIFFEMIY--PFSTGM 232
Query: 271 S 271
Sbjct: 233 E 233
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-46
Identities = 66/224 (29%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +G G G VYE +RIVA+K+++ +SD R RE R++ +
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRT--RMQREARTAGRLQEPH 95
Query: 120 LVKF--LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+V G D + + L+ G+ L L P L A+ I A+D HA
Sbjct: 96 VVPIHDFGE-IDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHA 152
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTV 234
G HRD+KP+N+L++ D L DFG+A +E +T++ GT +MAPE
Sbjct: 153 AGATHRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNT-VGTLYYMAPE----- 205
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+ + H + D+Y+ VL+E LT P++G L A
Sbjct: 206 ---RFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGA 245
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 7e-45
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 31/217 (14%)
Query: 62 IGSKIGEGAHGKVYEG---RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+ I G G +Y R V +K L ++ +A + E ++ V H
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQA----MAMAERQFLAEVVHP 139
Query: 119 NLVK------FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++V+ DP+ IV E + G SL+ + KL + A+ + L+I A+
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK----RSKGQKLPVAEAIAYLLEILPAL 195
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
LH+ G+++ DLKP+N++LT +Q LKL D G + GT + APE+
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEEQ--LKLIDLGAVSRINSFGYL---YGTPGFQAPEIVR 250
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
T D+Y+ G L L + G
Sbjct: 251 T---------GPTVATDIYTVGRTLAALTLDLPTRNG 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 1e-44
Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 22/228 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG +G+G G VY R I+A+KVL + +E + REV + S ++H N
Sbjct: 13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPN 70
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ G D V ++ E P ++ + L + +K D + ++A A+ H+
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSK 128
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
+IHRD+KP+NLLL + LK+ADFG + GT ++ PE+
Sbjct: 129 RVIHRDIKPENLLLGSAGE-LKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMI----- 179
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQ 284
E + ++ KVD++S G++ +E L + PFE + Q Y +V+
Sbjct: 180 ---EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVE 223
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 1e-44
Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 18/219 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG +G+G G VY R I+A+KVL + E +E + RE+ + S ++H N
Sbjct: 18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG--VEHQLRREIEIQSHLRHPN 75
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ D + ++ E P L K L + + D + F ++A A+ H
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFMEELADALHYCHER 133
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
+IHRD+KP+NLL+ + LK+ADFG + T GT ++ PE+
Sbjct: 134 KVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM-CGTLDYLPPEMI------- 184
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
E K ++ KVD++ G++ +E L PF+ + +
Sbjct: 185 -EGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETH 221
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-44
Identities = 57/245 (23%), Positives = 95/245 (38%), Gaps = 30/245 (12%)
Query: 62 IGSKIGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
K+GEG V EG + A+K + D RE +M H N
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA-----QREADMHRLFNHPN 87
Query: 120 LVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAM 172
+++ + C ++ +L + L+ L L L I R +
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----------EMMTAETGT 222
+ +HA G HRDLKP N+LL D+ L D G + + + A+ T
Sbjct: 148 EAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282
+ APEL +++ + + DV+S G VL+ ++ P++ + + A A +
Sbjct: 207 ISYRAPEL---FSVQSHCV--IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 283 VQESI 287
Q SI
Sbjct: 262 NQLSI 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-44
Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 24/244 (9%)
Query: 52 SLLVDPKLL---FIGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFI 106
+LVDP+ G +G+G K +E D + A K++ + +
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH--QREKMS 63
Query: 107 REVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
E+++ + H ++V F G +D V +V EL SL + + L A +
Sbjct: 64 MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYL 121
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYR 224
I LH N +IHRDLK NL L + +K+ DFGLA + E E GT
Sbjct: 122 RQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPN 180
Query: 225 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQ 284
++APE+ S KK ++ +VDV+S G +++ LL + PFE S L+ Y +++
Sbjct: 181 YIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYL---RIK 228
Query: 285 ESIY 288
++ Y
Sbjct: 229 KNEY 232
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-44
Identities = 62/231 (26%), Positives = 111/231 (48%), Gaps = 20/231 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G+ +G+G+ VY VAIK++++ + + R EV + ++KH +
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG--MVQRVQNEVKIHCQLKHPS 72
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ +D V +V E+ + +YL + R + A +F I M LH++
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSH 131
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPELYSTVTLR 237
GI+HRDL NLLLT ++K+ADFGLA + + E GT +++PE+ +
Sbjct: 132 GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT----- 185
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288
+ + + DV+S G + + LL R PF+ ++ KV + Y
Sbjct: 186 ---RSAHGLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLN---KVVLADY 229
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-44
Identities = 71/220 (32%), Positives = 106/220 (48%), Gaps = 20/220 (9%)
Query: 56 DPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGR--FIREVNMMS 113
+ + G+K+GEG G VY+G + VA+K L E + F +E+ +M+
Sbjct: 29 ERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVD---ITTEELKQQFDQEIKVMA 85
Query: 114 RVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARA 171
+ +H+NLV+ LG D + +V +P SL L L L H+ A A
Sbjct: 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANG 145
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAP 228
++ LH N IHRD+K N+LL + K++DFGLAR + T M + GT +MAP
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTA-KISDFGLARASEKFAQTVMTSRIVGTTAYMAP 204
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
E G K D+YSFG+VL E++T +
Sbjct: 205 E-ALR-----G---EITPKSDIYSFGVVLLEIITGLPAVD 235
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-44
Identities = 67/233 (28%), Positives = 105/233 (45%), Gaps = 19/233 (8%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
+G+G +G VY GR +AIK + + + L E+ + +KH N+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL-----HEEIALHKHLKHKNI 81
Query: 121 VKFLGACKDPLMV-IVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHAN 178
V++LG+ + + I E +PG SL L S P K + + I + LH N
Sbjct: 82 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLR 237
I+HRD+K DN+L+ LK++DFG ++ + TGT ++MAPE+
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEII------ 195
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
+ Y D++S G + E+ T + PF L AA FKV P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMFKVHP 245
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-44
Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 31/243 (12%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGS-TSDERALLEGRFIREVNMMSRVKHD 118
+ IG G++G+ + R +I+ K L+ GS T E+ +L + EVN++ +KH
Sbjct: 10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML----VSEVNLLRELKHP 65
Query: 119 NLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIARAMD 173
N+V++ D + IV E G L + + L L + A+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 174 CLH-----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMA 227
H + ++HRDLKP N+ L Q ++KL DFGLAR T GT +M+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESI 287
PE + YN K D++S G +L+EL PF S + A K++E
Sbjct: 185 PEQM--------NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG----KIREGK 232
Query: 288 YAP 290
+
Sbjct: 233 FRR 235
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-44
Identities = 70/242 (28%), Positives = 108/242 (44%), Gaps = 21/242 (8%)
Query: 43 TAPQLTIDRSLLVDPKLL---FIGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDE 97
AP +LVDP+ G +G+G K +E D + A K++ +
Sbjct: 23 AAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP 82
Query: 98 RALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKL 156
+ E+++ + H ++V F G +D V +V EL SL + + L
Sbjct: 83 H--QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--AL 138
Query: 157 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEM 215
A + I LH N +IHRDLK NL L + +K+ DFGLA + E E
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGER 197
Query: 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
GT ++APE+ S KK ++ +VDV+S G +++ LL + PFE S L+
Sbjct: 198 KKVLCGTPNYIAPEVLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKE 248
Query: 276 AY 277
Y
Sbjct: 249 TY 250
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-43
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 64 SKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG G GKVY+G D VA+K S+ E F E+ +S +H +LV
Sbjct: 45 FLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE---E--FETEIETLSFCRHPHLVS 99
Query: 123 FLGACKDPL-MVIVTELLPGMSLRKYL--VSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+G C + M+++ + + +L+++L L + L + AR + LH
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159
Query: 180 IIHRDLKPDNLLLTPDQK-SLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVT 235
IIHRD+K N+LL D+ K+ DFG+++ E T + T GT ++ PE +
Sbjct: 160 IIHRDVKSINILL--DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-- 215
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266
K DVYSFG+VL+E+L R
Sbjct: 216 ------GRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-43
Identities = 47/262 (17%), Positives = 93/262 (35%), Gaps = 37/262 (14%)
Query: 45 PQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDE 97
P + + KL+++ +GEGA +VYE GD + +KV + +
Sbjct: 52 PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF 111
Query: 98 RALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNK- 155
+ + + +KF A V+V EL +L + +
Sbjct: 112 YIGT-----QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166
Query: 156 --LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP----------DQKSLKLAD 203
+ + ++FA+ + ++ +H IIH D+KPDN +L L L D
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226
Query: 204 FGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260
G + + + + TA+ T + E+ K +N ++D + ++ +
Sbjct: 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEML--------SNKPWNYQIDYFGVAATVYCM 278
Query: 261 LTNRLPFEGMSNLQAAYAAAFK 282
L + F+
Sbjct: 279 LFGTYMKVKNEGGECKPEGLFR 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-42
Identities = 53/224 (23%), Positives = 91/224 (40%), Gaps = 29/224 (12%)
Query: 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
++G G+ G+V+ + A+K + LE + E+ + + +
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----------LEVFRVEELVACAGLSSPRI 112
Query: 121 VKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V GA ++ V I ELL G SL + + + L AL + ++ LH
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEYLHTRR 170
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVTEMMTAET--GTYRWMAPELYST 233
I+H D+K DN+LL+ D L DFG L + ++T + GT MAPE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE---- 226
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
V + + + KVD++S ++ +L P+
Sbjct: 227 VVMGKP----CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 266
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-41
Identities = 44/238 (18%), Positives = 80/238 (33%), Gaps = 37/238 (15%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHD 118
KIG G G V++ I AIK + E +REV + + +H
Sbjct: 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD---EQNALREVYAHAVLGQHS 71
Query: 119 NLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCL 175
++V++ A +D M+I E G SL + + + L + R + +
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 176 HANGIIHRDLKPDNLLLTPDQKS------------------LKLADFGLAREETVTEMMT 217
H+ ++H D+KP N+ ++ K+ D G T
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQ 188
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
E G R++A E+ E + K D+++ + +
Sbjct: 189 VEEGDSRFLANEVLQ-------ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-41
Identities = 44/310 (14%), Positives = 102/310 (32%), Gaps = 44/310 (14%)
Query: 13 REEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHG 72
+ + ++++ + S ++ G ++ L P+ L G+ +G+
Sbjct: 32 PQANVRTTSEYMQSAADSLVSTSLWNTGQ----PFRVESELGERPRTLVRGTVLGQEDPY 87
Query: 73 KVYEGRYGD--RIVAIKVLNRGSTSDER-----------------------ALLEGRFIR 107
E + + V A + RFI
Sbjct: 88 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147
Query: 108 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGM-----SLRKYLVSL--RPNKLDLHV 160
+++ + +++ +D ++ L P M + + L+S L H
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220
L L + R + LH G++H L+P +++L + L F + +
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHLVRDG---ARVVSS 263
Query: 221 GTYRWMAPEL---YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
+ + PEL +T++ + + D ++ G+V++ + LP
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK-DAALGGS 322
Query: 278 AAAFKVQESI 287
F+ ++I
Sbjct: 323 EWIFRSCKNI 332
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 68/260 (26%), Positives = 116/260 (44%), Gaps = 28/260 (10%)
Query: 29 VEKESRAVVKNGSI-----TAPQLTIDRSLLVDPKLLF---------IGSKIGEGAHGKV 74
V K R + N S + ++ + L VD + ++ + +G GA G+V
Sbjct: 92 VGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEV 151
Query: 75 YEG--RYGDRIVAIKVLNR---GSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129
R + VAI+++++ S A E+ ++ ++ H ++K
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211
Query: 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189
IV EL+ G L +V +L + + A+ LH NGIIHRDLKP+N
Sbjct: 212 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPEN 269
Query: 190 LLLTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 247
+LL+ ++ +K+ DFG ++ T +M GT ++APE+ L YN
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV-----LVSVGTAGYNRA 324
Query: 248 VDVYSFGIVLWELLTNRLPF 267
VD +S G++L+ L+ PF
Sbjct: 325 VDCWSLGVILFICLSGYPPF 344
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-41
Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 27/226 (11%)
Query: 62 IGSKIGEGAHGK-VYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDN 119
+G GA G VY G + +R VA+K + S REV ++ +H N
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--------REVQLLRESDEHPN 79
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++++ KD I EL +L++Y+ + + + LH+
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 179 GIIHRDLKPDNLLLTPDQKS----LKLADFGLAR----EETVTEMMTAETGTYRWMAPEL 230
I+HRDLKP N+L++ ++DFGL + + GT W+APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA 275
L + K++ VD++S G V + +++ PF QA
Sbjct: 198 -----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNR---GSTSDERALLEGRFIREVNMMSRVK 116
+ +G GA G+V R + VAIK++++ S A E+ ++ ++
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 117 HDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
H ++K IV EL+ G L +V +L + + A+ LH
Sbjct: 74 HPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLH 131
Query: 177 ANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
NGIIHRDLKP+N+LL + ++ +K+ DFG ++ T +M GT ++APE+
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV---- 187
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
L YN VD +S G++L+ L+ PF
Sbjct: 188 -LVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 219
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-40
Identities = 42/309 (13%), Positives = 97/309 (31%), Gaps = 43/309 (13%)
Query: 13 REEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHG 72
+ + ++++ + S ++ G ++ L P+ L G+ +G+
Sbjct: 37 PQANVRTTSEYMQSAADSLVSTSLWNTGQ----PFRVESELGERPRTLVRGTVLGQEDPY 92
Query: 73 KVYEGR--YGDRIVAIKVLN-----------------------RGSTSDERALLEGRFIR 107
E + V RG + ++A + RFI
Sbjct: 93 AYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152
Query: 108 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLP-----GMSLRKYLVSL--RPNKLDLHV 160
+++ + +++ +D ++ L P + + L+S L H
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220
L L + R + LH G++H L+P +++L + L F + + +
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGASAVSPIGR 271
Query: 221 --GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
A + Q D ++ G+ ++ + LP
Sbjct: 272 GFAPPETTAERMLPF---GQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSE 327
Query: 279 AAFKVQESI 287
F+ ++I
Sbjct: 328 WIFRSCKNI 336
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 8e-40
Identities = 44/299 (14%), Positives = 83/299 (27%), Gaps = 44/299 (14%)
Query: 11 VGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGA 70
+ REE + AV + T+D L + L + + G
Sbjct: 15 LKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGD 74
Query: 71 HGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--------- 119
V+ R A+KV G+ + L R +R+ ++
Sbjct: 75 RSVVFLVRDVERLEDFALKVFTMGAENSRSEL--ERLHEATFAAARLLGESPEEARDRRR 132
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRK----YLV------------------SLRPNKLD 157
L+ A +L PG L+ +
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217
+ + R L + G++H PDNL + PD L L D +
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGDVSALWKV--GTRGP 249
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276
A + + E + + ++ + G+ ++ + LPF ++
Sbjct: 250 ASSVPVTYAPRE------FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-39
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 20/215 (9%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
K+G GA G V+ R IK +N+ + +E E+ ++ + H N
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE----AEIEVLKSLDHPN 81
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIARAMDCLH 176
++K +D + IV E G L + +VS + L + A+ H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 177 ANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
+ ++H+DLKP+N+L S +K+ DFGLA E T GT +MAPE++
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF--- 198
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
K+ K D++S G+V++ LLT LPF G
Sbjct: 199 ------KRDVTFKCDIWSAGVVMYFLLTGCLPFTG 227
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 71/214 (33%), Positives = 104/214 (48%), Gaps = 24/214 (11%)
Query: 65 KIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTS-DERALLEGRFIREVNMMSRVKHDNLVK 122
+G G GKVY+GR D +VA+K L T E F EV M+S H NL++
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ-----FQTEVEMISMAVHRNLLR 91
Query: 123 FLGACKDPLM-VIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLH--A 177
G C P ++V + S+ L ++ LD AL AR + LH
Sbjct: 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 178 N-GIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTV 234
+ IIHRD+K N+LL + ++ + DFGLA+ + T + TA GT +APE ST
Sbjct: 152 DPKIIHRDVKAANILLDEEFEA-VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST- 209
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268
G + K DV+ +G++L EL+T + F+
Sbjct: 210 ----G---KSSEKTDVFGYGVMLLELITGQRAFD 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 71/279 (25%), Positives = 125/279 (44%), Gaps = 24/279 (8%)
Query: 6 SEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLF-IGS 64
S + + + +++ A + GS+ P + + DP+ LF
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVA-ELFFKDDPEKLFSDLR 60
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+IG G+ G VY R +VAIK ++ + I+EV + +++H N ++
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD--IIKEVRFLQKLRHPNTIQ 118
Query: 123 FLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIARAMDCLHANGI 180
+ G ++ +V E G + L+ + L + +A + + LH++ +
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAYLHSHNM 175
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQ 238
IHRD+K N+LL+ + +KL DFG A + M A + GT WMAPE+ +
Sbjct: 176 IHRDVKAGNILLS-EPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEV-----ILA 224
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
++ Y+ KVDV+S GI EL + P M+ + A Y
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 263
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-39
Identities = 64/230 (27%), Positives = 115/230 (50%), Gaps = 19/230 (8%)
Query: 55 VDPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNM 111
+DP ++ I ++G+GA GKVY+ + + + A KV+ S + +I E+ +
Sbjct: 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-----YIVEIEI 69
Query: 112 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIA 169
++ H +VK LGA D + I+ E PG ++ ++ L + + +
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQML 127
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMA 227
A++ LH+ IIHRDLK N+L+T + ++LADFG++ + T + ++ GT WMA
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWMA 185
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
PE+ V + Y+ K D++S GI L E+ P ++ ++
Sbjct: 186 PEV---VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 232
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-39
Identities = 51/244 (20%), Positives = 101/244 (41%), Gaps = 36/244 (14%)
Query: 58 KLLFIGSKIGEGAHGKV-YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
L+ +G G+ G V ++G + R VA+K + + E+ +++
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD--------IALMEIKLLTESD 66
Query: 117 -HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLV-----SLRPNKLDLHVALNFALDIA 169
H N++++ + + I EL +L+ + + ++ IA
Sbjct: 67 DHPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKS------------LKLADFGLAR-----EETV 212
+ LH+ IIHRDLKP N+L++ + + ++DFGL + + +
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMS 271
+ +GT W APEL Q K+ +D++S G V + +L+ + PF
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQT-KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 272 NLQA 275
+ ++
Sbjct: 245 SRES 248
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-39
Identities = 62/241 (25%), Positives = 97/241 (40%), Gaps = 40/241 (16%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HD 118
+ + EG VYE + R A+K L RA+ I+EV M ++ H
Sbjct: 32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI-----IQEVCFMKKLSGHP 86
Query: 119 NLVKFLGACKDP---------LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDI 168
N+V+F A +++TEL G L ++L + L L
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 169 ARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT------------- 213
RA+ +H IIHRDLK +NLLL+ +Q ++KL DFG A +
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
E T + PE+ + K D+++ G +L+ L + PFE + L
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYS-----NFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259
Query: 274 Q 274
+
Sbjct: 260 R 260
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-39
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 65 KIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG GA V VAIK +N L ++E+ MS+ H N+V
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL----LKEIQAMSQCHHPNIVS 77
Query: 123 FLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN------FALDIARAMDCL 175
+ + + +V +LL G S+ + + L+ ++ ++ L
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVTEMMTAET--GTYRWMAPE 229
H NG IHRD+K N+LL + S+++ADFG LA +T +T GT WMAPE
Sbjct: 138 HKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ + + Y+ K D++SFGI EL T P+
Sbjct: 197 VME-------QVRGYDFKADIWSFGITAIELATGAAPY 227
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-39
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 21/213 (9%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ + IG G+ G+V + A K + + D +E+ +M + H N
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK-----QEIEIMKSLDHPN 67
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ +D + +V EL G L + +V A D+ A+ H
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL 125
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+ HRDLKP+N L T S LKL DFGLA +MM + GT +++P++
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL----- 180
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y + D +S G++++ LL PF
Sbjct: 181 ----EGLYGPECDEWSAGVMMYVLLCGYPPFSA 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-39
Identities = 72/244 (29%), Positives = 119/244 (48%), Gaps = 26/244 (10%)
Query: 48 TIDRSLLVDPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGR 104
ID S L DP +F + +G G +G+VY+GR+ ++ AIKV++ T DE +
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEI--- 67
Query: 105 FIREVNMMSRV-KHDNLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNKL 156
+E+NM+ + H N+ + GA D + +V E S+ + + + N L
Sbjct: 68 -KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 157 D-LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215
+A +I R + LH + +IHRD+K N+LLT + +KL DFG++ + T +
Sbjct: 127 KEEWIAY-ICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRT-V 183
Query: 216 MTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
T GT WMAPE+ + + Y+ K D++S GI E+ P M +
Sbjct: 184 GRRNTFIGTPYWMAPEV---IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240
Query: 274 QAAY 277
+A +
Sbjct: 241 RALF 244
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-39
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
K+G GA+G+V + AIK++ + S S + + EV ++ + H N
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS---NSKLLEEVAVLKLLDHPN 97
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K +D +V E G L ++ K + A + + LH +
Sbjct: 98 IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP+NLLL + ++ + +K+ DFGL+ + M GT ++APE+
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL----- 210
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
+K Y+ K DV+S G++L+ LL PF G ++
Sbjct: 211 ----RKKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-39
Identities = 74/235 (31%), Positives = 117/235 (49%), Gaps = 25/235 (10%)
Query: 43 TAPQLTIDRSLLVDPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERA 99
L ++L DP+ LF KIG+G+ G+V++G ++VAIK+++ DE
Sbjct: 6 VQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE 65
Query: 100 LLEGRFIREVNMMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD- 157
+ +E+ ++S+ + K+ G+ KD + I+ E L G S L P LD
Sbjct: 66 DI----QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDE 118
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 217
+A +I + +D LH+ IHRD+K N+LL+ + +KLADFG+A + T T +
Sbjct: 119 TQIAT-ILREILKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDT-QIK 175
Query: 218 AET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270
T GT WMAPE V + Y++K D++S GI EL P +
Sbjct: 176 RNTFVGTPFWMAPE----VIKQSA----YDSKADIWSLGITAIELARGEPPHSEL 222
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-38
Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +G+G+ G+V + R + A+KV+N+ S ++ +REV ++ ++ H N
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD---TSTILREVELLKKLDHPN 82
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K +D IV EL G L ++ + H A + + +H +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH 140
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP+N+LL + ++ +K+ DFGL+ M GT ++APE+
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL----- 195
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
+ Y+ K DV+S G++L+ LL+ PF G +
Sbjct: 196 ----RGTYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-38
Identities = 62/255 (24%), Positives = 96/255 (37%), Gaps = 53/255 (20%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG+G++G V I AIK++N+ R EV +M ++ H N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHV------------------ 160
+ + +D + +V EL G L L +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 161 --------------------ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-L 199
N I A+ LH GI HRD+KP+N L + ++ +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEI 209
Query: 200 KLADFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 254
KL DFGL++ MT + GT ++APE+ L + Y K D +S G
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV-----LN-TTNESYGPKCDAWSAG 263
Query: 255 IVLWELLTNRLPFEG 269
++L LL +PF G
Sbjct: 264 VLLHLLLMGAVPFPG 278
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-38
Identities = 55/216 (25%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G+G+ G+V + + A+KV+++ + + +REV ++ ++ H N
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDHPN 87
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K +D +V E+ G L ++S + A + + +H N
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN 145
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP+NLLL + + + +++ DFGL+ ++ M + GT ++APE+
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL----- 200
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
Y+ K DV+S G++L+ LL+ PF G +
Sbjct: 201 ----HGTYDEKCDVWSTGVILYILLSGCPPFNGANE 232
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-38
Identities = 49/235 (20%), Positives = 96/235 (40%), Gaps = 26/235 (11%)
Query: 56 DPKLLF-IGSKIGEGAH--GKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVN 110
+ + + IG+G V RY V ++ +N + S+E E++
Sbjct: 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTF---LQGELH 78
Query: 111 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDI 168
+ H N+V + D + +VT + S + + + + ++ L +A +
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-ILQGV 137
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA--------REETVTEMMTAET 220
+A+D +H G +HR +K ++L++ + L+ R+ V +
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275
W++PE+ L+Q + Y+ K D+YS GI EL +PF+ M Q
Sbjct: 197 KVLPWLSPEV-----LQQ-NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-38
Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 24/224 (10%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEG--------RFIREVNM 111
K+G GA+G+V + G AIKV+ + R + E+++
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 112 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+ + H N++K +D +VTE G L + +++ +K D A N I
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILS 157
Query: 171 AMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 228
+ LH + I+HRD+KP+N+LL + +K+ DFGL+ + + GT ++AP
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
E+ KK YN K DV+S G++++ LL PF G ++
Sbjct: 218 EVL---------KKKYNEKCDVWSCGVIMYILLCGYPPFGGQND 252
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 55/255 (21%), Positives = 111/255 (43%), Gaps = 42/255 (16%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNR---------------------GSTSDER 98
+ +IG+G++G V + A+KVL++ +
Sbjct: 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 99 ALLEGRFIREVNMMSRVKHDNLVKF---LGACKDPLMVIVTELLPGMSLRKYLVSLRPNK 155
+ +E+ ++ ++ H N+VK L + + +V EL+ + +
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP---TLKP 133
Query: 156 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215
L A + D+ + ++ LH IIHRD+KP NLL+ + +K+ADFG++ E ++
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDA 192
Query: 216 MTAET-GTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNL 273
+ + T GT +MAPE S +K ++ +DV++ G+ L+ + + PF +
Sbjct: 193 LLSNTVGTPAFMAPESLS------ETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERI 245
Query: 274 QAAYAAAFKVQESIY 288
++ K++
Sbjct: 246 MCLHS---KIKSQAL 257
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 19/213 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +G+G+ G+V + R + A+KV+N+ S ++ +REV ++ ++ H N
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD---TSTILREVELLKKLDHPN 82
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K +D IV EL G L ++ + H A + + +H +
Sbjct: 83 IMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH 140
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
I+HRDLKP+N+LL + ++ +K+ DFGL+ M GT ++APE+
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL----- 195
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y+ K DV+S G++L+ LL+ PF G
Sbjct: 196 ----RGTYDEKCDVWSAGVILYILLSGTPPFYG 224
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 35/224 (15%)
Query: 65 KIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFI-REVNMMSRVKHDNLVK 122
IG G+ G V++ + + VAIK + L + RF RE+ +M VKH N+V
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIK----------KVLQDKRFKNRELQIMRIVKHPNVVD 96
Query: 123 FL------GACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL---HVALNFALDIARAM 172
G KD + + +V E +P ++ + K + + L + + R++
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKL-YMYQLLRSL 154
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE--TGTYRWMAPEL 230
+H+ GI HRD+KP NLLL P LKL DFG A+ E + + YR APEL
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--APEL 212
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
T +Y +D++S G V+ EL+ + F G S +
Sbjct: 213 IFGAT-------NYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-37
Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERAL-LEGRFIREVNMMSRVKHD 118
+G +G G G VY G VAIK + + SD L R EV ++ +V
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 119 --NLVKFLGACKDPLM-VIVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+++ L + P V++ E P L ++ L +A +F + A+
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRH 164
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
H G++HRD+K +N+L+ ++ LKL DFG T + GT + PE
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIR-- 221
Query: 235 TLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEG 269
Y+ V+S GI+L++++ +PFE
Sbjct: 222 ------YHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-36
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 21/218 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERAL-LEGRFIREVNMMSRV--- 115
+G +G+G G V+ G VAIKV+ R L EV ++ +V
Sbjct: 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94
Query: 116 -KHDNLVKFLGACKDPLM-VIVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
H +++ L + ++V E LP L Y+ L + F + A+
Sbjct: 95 GGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAI 152
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
H+ G++HRD+K +N+L+ + KL DFG + GT + PE S
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS 211
Query: 233 TVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEG 269
+ Y+ V+S GI+L++++ +PFE
Sbjct: 212 --------RHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 55/237 (23%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +GEG++GKV E + A+K+L + E +E+ ++ R++H N
Sbjct: 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 120 LVKF---LGACKDPLMVIVTELLPG--MSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+++ L + M +V E + + + + A + + ++
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEY 124
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMAPELY 231
LH+ GI+H+D+KP NLLLT +LK++ G+A + G+ + PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288
+ G KVD++S G+ L+ + T PFEG N+ + + + Y
Sbjct: 184 N------GLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFE---NIGKGSY 230
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 71/229 (31%), Positives = 110/229 (48%), Gaps = 26/229 (11%)
Query: 56 DPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DPK + KIG+GA G VY + VAI+ +N + + I E+ +M
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-----INEILVM 71
Query: 113 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIAR 170
K+ N+V +L + + +V E L G SL + +D +A + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAA-VCRECLQ 127
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAP 228
A++ LH+N +IHRD+K DN+LL S+KL DFG + T T GT WMAP
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAP 185
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
E+ + +K Y KVD++S GI+ E++ P+ + L+A Y
Sbjct: 186 EVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 45/289 (15%)
Query: 1 MSCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLL 60
+ S +E + ++ + K + V G + +
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT------ 59
Query: 61 FIGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFI-REVNMMSRVKH 117
IG G+ G VY+ + D +VAIK + L + RF RE+ +M ++ H
Sbjct: 60 ---KVIGNGSFGVVYQAKLCDSGELVAIK----------KVLQDKRFKNRELQIMRKLDH 106
Query: 118 DNLVKFL------GACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL---HVALNFALD 167
N+V+ G KD + + +V + +P ++ + K L +V L +
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKL-YMYQ 164
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRW 225
+ R++ +H+ GI HRD+KP NLLL PD LKL DFG A++ E + + YR
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR- 223
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
APEL T Y + +DV+S G VL ELL + F G S +
Sbjct: 224 -APELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-36
Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 26/229 (11%)
Query: 56 DPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DP+LL KIGEG+ G V R R VA+K+++ L EV +M
Sbjct: 42 DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL-----FNEVVIM 96
Query: 113 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIAR 170
+H N+V+ + + ++ E L G +L + +L+ +A + +
Sbjct: 97 RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIAT-VCEAVLQ 152
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAP 228
A+ LHA G+IHRD+K D++LLT +KL+DFG + + + ++ GT WMAP
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKD-VPKRKSLVGTPYWMAP 210
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
E+ S + Y +VD++S GI++ E++ P+ S +QA
Sbjct: 211 EVIS--------RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-36
Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +G G GKV G + VA+K+LNR + G+ RE+ + +H +
Sbjct: 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPH 72
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K P +V E + G L Y+ +++ A I A+D H +
Sbjct: 73 IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH 130
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
++HRDLKP+N+LL + K+ADFGL+ + E + G+ + APE+ S
Sbjct: 131 MVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS------ 183
Query: 239 GEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288
+ Y +VD++S G++L+ LL LPF+ ++ + K++ ++
Sbjct: 184 --GRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFK---KIRGGVF 228
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-36
Identities = 52/216 (24%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNR---GSTSDERALLEGRFIREVNMMSRVK 116
S +G GA G V+ + + V +K + + G+ E+ ++SRV+
Sbjct: 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 117 HDNLVKFLGACKDPLMV-IVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
H N++K L ++ +V E G+ L ++ R +LD +A + A+
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGY 145
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
L IIHRD+K +N+++ + ++KL DFG A ++ GT + APE+
Sbjct: 146 LRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM-- 202
Query: 235 TLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEG 269
Y +++++S G+ L+ L+ PF
Sbjct: 203 ------GNPYRGPELEMWSLGVTLYTLVFEENPFCE 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-36
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 18/213 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ ++G+GA V + A K++N S + RE + +++H N
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPN 66
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+ + ++ +V +L+ G L + +V+ A + I ++ H+N
Sbjct: 67 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN 124
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
GI+HR+LKP+NLLL + + + +KLADFGLA E +E GT +++PE+ L
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-----L 179
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ K Y+ VD+++ G++L+ LL PF
Sbjct: 180 K---KDPYSKPVDIWACGVILYILLVGYPPFWD 209
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-36
Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 22/231 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG+G KV R+ R VAIK++++ + + REV +M + H N
Sbjct: 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQKLFREVRIMKILNHPN 75
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VK + + ++ E G + YLV+ ++ A + I A+ H
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
I+HRDLK +NLLL ++K+ADFG + E TV + A G + APEL+
Sbjct: 134 RIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQ------ 186
Query: 239 GEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288
K Y+ +VDV+S G++L+ L++ LPF+G NL+ +V Y
Sbjct: 187 --GKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRE---RVLRGKY 231
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 8e-36
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 17/216 (7%)
Query: 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNM-MSRVKHDNL 120
++G GA+G V + R+ +I+A+K + S E+ R + ++++ M V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK----RLLMDLDISMRTVDCPFT 68
Query: 121 VKFLGAC-KDPLMVIVTELLPGMSLRKYL--VSLRPNKLDLHVALNFALDIARAMDCLHA 177
V F GA ++ + I EL+ SL K+ V + + + A+ I +A++ LH+
Sbjct: 69 VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 178 NG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
+IHRD+KP N+L+ +K+ DFG++ + G +MAPE
Sbjct: 128 KLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE----RIN 182
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
+ +K Y+ K D++S GI + EL R P++
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-36
Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 16/216 (7%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG+G V R + A+K+++ + L RE ++ +KH +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDIARAMDCLH 176
+V+ L M+ +V E + G L +V VA ++ I A+ H
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 177 ANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRWMAPELYST 233
N IIHRD+KP +LL + + + +KL FG+A + + GT +MAPE+
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV--- 204
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
++ ++ Y VDV+ G++L+ LL+ LPF G
Sbjct: 205 --VK---REPYGKPVDVWGCGVILFILLSGCLPFYG 235
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-36
Identities = 68/229 (29%), Positives = 113/229 (49%), Gaps = 26/229 (11%)
Query: 56 DPKLLF-IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
P+ +F + K+GEG++G VY+ + + +IVAIK + S E I+E+++M
Sbjct: 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-------IIKEISIM 78
Query: 113 SRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIAR 170
+ ++VK+ G+ K+ + IV E S+ ++ LR L +A +
Sbjct: 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQSTLK 136
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAP 228
++ LH IHRD+K N+LL + KLADFG+A + T T M T GT WMAP
Sbjct: 137 GLEYLHFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAP 194
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
E+ + YN D++S GI E+ + P+ + ++A +
Sbjct: 195 EVIQ--------EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-35
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +GEGA+G+V VA+K+++ D +E+ + + H+N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHEN 66
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VKF G ++ + + E G L + + A F + + LH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMAPELYSTVT 235
GI HRD+KP+NLLL ++ +LK++DFGLA R ++ GT ++APEL
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--- 180
Query: 236 LRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
++ ++ VDV+S GIVL +L LP++ S+ Y
Sbjct: 181 -----RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 65/216 (30%), Positives = 107/216 (49%), Gaps = 21/216 (9%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
KIGEG++G V++ R D +IVAIK S++ +++ +RE+ M+ ++KH NLV
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLE---SEDDPVIKKIALREIRMLKQLKHPNLVN 66
Query: 123 FLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L + + +V E ++ L + H+ + +A++ H + I
Sbjct: 67 LLEVFRRKRRLHLVFEYCD-HTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQ 238
HRD+KP+N+L+T +KL DFG AR T ++ E T YR +PEL +
Sbjct: 125 HRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELL----VGD 177
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
Y VDV++ G V ELL+ + G S++
Sbjct: 178 ---TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-35
Identities = 76/277 (27%), Positives = 122/277 (44%), Gaps = 23/277 (8%)
Query: 9 NRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLF-IGSKIG 67
+ G +++ S+ + + + P ID S F + S++G
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELG 62
Query: 68 EGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125
GA VY + + A+KVL + T D++ + E+ ++ R+ H N++K
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVR-----TEIGVLLRLSHPNIIKLKE 115
Query: 126 ACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 184
+ P + +V EL+ G L +V A + I A+ LH NGI+HRD
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRD 173
Query: 185 LKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKK 242
LKP+NLL TP + LK+ADFGL++ +M GT + APE+ LR
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI-----LR---GC 225
Query: 243 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279
Y +VD++S GI+ + LL PF Q +
Sbjct: 226 AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR 262
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 13/214 (6%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNR----GSTSDERALLEGRFIREVNMMSRV 115
+G G V + + A+K+++ +++E L ++EV+++ +V
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 116 K-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
H N+++ + +V +L+ L YL L + +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVIC 138
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
LH I+HRDLKP+N+LL D ++KL DFG + + E + GT ++APE+
Sbjct: 139 ALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 197
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
Y +VD++S G++++ LL PF
Sbjct: 198 SM--NDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-35
Identities = 59/234 (25%), Positives = 113/234 (48%), Gaps = 16/234 (6%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEG 103
+++ ++ + L +IG GA+G V + + +I+A+K + E+
Sbjct: 10 KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK---- 65
Query: 104 RFIREVN-MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLR--KYLVSLRPNKLDLH 159
+ + +++ +M +V+F GA ++ I EL+ + KY+ S+ + +
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125
Query: 160 VALNFALDIARAMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 218
+ L +A++ L N IIHRD+KP N+LL ++KL DFG++ + + T
Sbjct: 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTR 184
Query: 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
+ G +MAPE ++ Y+ + DV+S GI L+EL T R P+ ++
Sbjct: 185 DAGCRPYMAPE----RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-35
Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 22/231 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +GEG+ GKV + + VA+K ++R + R RE++ + ++H +
Sbjct: 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSD--MHMRVEREISYLKLLRHPH 70
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K P + +V E G L Y+V + ++ F I A++ H +
Sbjct: 71 IIKLYDVITTPTDIVMVIEYAGG-ELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH 127
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
I+HRDLKP+NLLL D ++K+ADFGL+ T + G+ + APE+ +
Sbjct: 128 KIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN------ 180
Query: 239 GEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288
K Y +VDV+S GIVL+ +L RLPF+ + + KV +Y
Sbjct: 181 --GKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFK---KVNSCVY 225
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-34
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G GA G V+ R A K + SD+ + +E+ MS ++H
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR-----KEIQTMSVLRHPT 215
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
LV A +D MV++ E + G L + + NK+ A+ + + + + +H N
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 179 GIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
+H DLKP+N++ T LKL DFGL + + TGT + APE+
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA------ 328
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
E K D++S G++ + LL+ PF G
Sbjct: 329 --EGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-34
Identities = 70/216 (32%), Positives = 109/216 (50%), Gaps = 21/216 (9%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+GEG++G V + R D RIVAIK SD+ +++ +RE+ ++ +++H+NLV
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLE---SDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 123 FLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L CK +V E + ++ L L PN LD V + I + H++ II
Sbjct: 89 LLEVCKKKKRWYLVFEFVD-HTILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCHSHNII 146
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTVTLRQ 238
HRD+KP+N+L++ +KL DFG AR E+ E T YR APEL
Sbjct: 147 HRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLV------ 197
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
G+ Y VDV++ G ++ E+ F G S++
Sbjct: 198 GD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 22/223 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +GEGA+G+V VA+K+++ D +E+ + + H+N
Sbjct: 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHEN 66
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VKF G ++ + + E G L + + A F + + LH
Sbjct: 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMAPELYSTVT 235
GI HRD+KP+NLLL ++ +LK++DFGLA R ++ GT ++APEL
Sbjct: 125 GITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK--- 180
Query: 236 LRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
++ ++ VDV+S GIVL +L LP++ S+ Y
Sbjct: 181 -----RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 49/218 (22%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLV 121
K+G G + +V+E + V +K+L + + + RE+ ++ ++ N++
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIKREIKILENLRGGPNII 94
Query: 122 KFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
KDP+ +V E + ++ +L D + + +I +A+D H+
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT----DYDIRF-YMYEILKALDYCHSM 149
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTVTLR 237
GI+HRD+KP N+++ + + L+L D+GLA + + R+ PEL
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELLVDY--- 205
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 274
+ Y+ +D++S G +L ++ + P F G N
Sbjct: 206 ----QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA +V+ R ++ A+K + + + +L E+ ++ ++KH+N
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-----NEIAVLKKIKHEN 67
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V + +V +L+ G L ++ A + A+ LH N
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
GI+HRDLKP+NLL TP++ S + + DFGL++ E M TA GT ++APE+
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-CGTPGYVAPEVL----- 179
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+K Y+ VD +S G++ + LL PF
Sbjct: 180 ---AQKPYSKAVDCWSIGVITYILLCGYPPFYE 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLV 121
++G G G+V++ R+ ++A+K + R +E R + +++ ++ +V
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK----RILMDLDVVLKSHDCPYIV 87
Query: 122 KFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NG 179
+ G + + I EL+ + + + + + I +A+ L +G
Sbjct: 88 QCFGTFITNTDVFIAMELMGTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG 145
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 239
+IHRD+KP N+LL ++ +KL DFG++ + G +MAPE +
Sbjct: 146 VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKP 204
Query: 240 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
Y+ + DV+S GI L EL T + P++
Sbjct: 205 ---DYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 18/213 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ ++G+GA V + A K++N S + RE + +++H N
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD---FQKLEREARICRKLQHPN 89
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+ + ++ +V +L+ G L + +V+ A + I ++ H+N
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN 147
Query: 179 GIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
GI+HR+LKP+NLLL + + + +KLADFGLA E +E GT +++PE+ L
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV-----L 202
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ K Y+ VD+++ G++L+ LL PF
Sbjct: 203 K---KDPYSKPVDIWACGVILYILLVGYPPFWD 232
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-34
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG+G+ GKV + D ++ A+K +N+ + + +E+ +M ++H LV
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV--RNVFKELQIMQGLEHPFLVNL 80
Query: 124 LGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 182
+ +D M +V +LL G LR +L + F ++ A+D L IIH
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELVMALDYLQNQRIIH 138
Query: 183 RDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 241
RD+KPDN+LL D+ + + DF +A +T GT +MAPE+ +
Sbjct: 139 RDMKPDNILL--DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEM-----FSSRKG 191
Query: 242 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
Y+ VD +S G+ +ELL R P+ S+
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNR---GSTSDERALLEGRFIREVNMMSRVK 116
IG G V R A+K++ + ++ + RE +++ +V
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 117 -HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
H +++ + + + + +V +L+ L YL L + + A+
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLLEAVSF 215
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE-LYST 233
LHAN I+HRDLKP+N+LL + ++L+DFG + E + GT ++APE L +
Sbjct: 216 LHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
+ Y +VD+++ G++L+ LL PF
Sbjct: 275 MDETH---PGYGKEVDLWACGVILFTLLAGSPPF 305
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
S++G G G V++ + ++A K+++ R + IRE+ ++ +V
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI----IRELQVLHECNSPYIV 94
Query: 122 KFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG- 179
F GA D + I E + G SL + L + ++ + ++ + + + L
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR-Q 238
I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE R Q
Sbjct: 153 IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-------RLQ 203
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPF 267
G HY+ + D++S G+ L E+ R P
Sbjct: 204 GT--HYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 22/221 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG G G R +VA+K + RG A ++ RE+ ++H N
Sbjct: 24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERG------AAIDENVQREIINHRSLRHPN 77
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+F P + I+ E G L + + + + A F + + H+
Sbjct: 78 IVRFKEVILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM 135
Query: 179 GIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
I HRDLK +N LL LK+ DFG ++ + + GT ++APE+
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL----- 190
Query: 238 QGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
++ Y+ DV+S G+ L+ +L PFE Y
Sbjct: 191 ---RQEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPRDY 227
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-34
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRG-------STSDERALLEGRFIREVNMMSRV 115
KIGEG +G V++ + IVA+K + S++ +RE+ ++ +
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----------LREICLLKEL 58
Query: 116 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
KH N+V+ D + +V E L+KY S LD + +F + + +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGF 116
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELY 231
H+ ++HRDLKP NLL+ LKLA+FGLAR + +AE T YR P++
Sbjct: 117 CHSRNVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDV- 172
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 274
L K Y+ +D++S G + EL P F G
Sbjct: 173 ----LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-34
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
IG ++G G V + + A K + R S + R + REV+++ +V H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 119 NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ ++ +V++ EL+ G L +L L A +F I ++ LH
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT 133
Query: 178 NGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
I H DLKP+N++L +KL DFGLA E GT ++APE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI---- 189
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ + + D++S G++ + LL+ PF G
Sbjct: 190 -VNY---EPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
IG ++G G V + + A K + R S + R + REV+++ +V H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 119 NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ ++ +V++ EL+ G L +L L A +F I ++ LH
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHT 133
Query: 178 NGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
I H DLKP+N++L +KL DFGLA E GT ++APE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI---- 189
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ + + D++S G++ + LL+ PF G
Sbjct: 190 -VNY---EPLGLEADMWSIGVITYILLSGASPFLG 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 17/215 (7%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
+G ++G G V + + + A K + R +S R + REVN++ ++H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 119 NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ ++ +V++ EL+ G L +L L A F I + LH+
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHS 126
Query: 178 NGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
I H DLKP+N++L +KL DFG+A + GT ++APE+
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI---- 182
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ + + D++S G++ + LL+ PF G
Sbjct: 183 -VNY---EPLGLEADMWSIGVITYILLSGASPFLG 213
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 21/231 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +G G GKV G++ VA+K+LNR + G+ RE+ + +H +
Sbjct: 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD--VVGKIRREIQNLKLFRHPH 77
Query: 120 LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++K P + +V E + G L Y+ +LD + I +D H +
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRH 135
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
++HRDLKP+N+LL + K+ADFGL+ + E + G+ + APE+ S
Sbjct: 136 MVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS------ 188
Query: 239 GEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288
+ Y +VD++S G++L+ LL LPF+ ++ + K+ + I+
Sbjct: 189 --GRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFK---KICDGIF 233
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G GA G V+ + R+ K +N D+ + E+++M+++ H
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK-----NEISIMNQLHHPK 109
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
L+ A +D MV++ E L G L + + K+ +N+ + +H +
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 179 GIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
I+H D+KP+N++ T S+K+ DFGLA + E++ T T + APE+
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV------ 222
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+++ D+++ G++ + LL+ PF G
Sbjct: 223 --DREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
G ++G G V + + A K + R + S R + REV+++ ++H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 119 NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ ++ ++++ EL+ G L +L L A F I + LH+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHS 132
Query: 178 NGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
I H DLKP+N++L + +K+ DFGLA + GT ++APE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI---- 188
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ + + D++S G++ + LL+ PF G
Sbjct: 189 -VNY---EPLGLEADMWSIGVITYILLSGASPFLG 219
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVN---MMSRVKHDN 119
+IG GA+G VY+ R + VA+K + + L +REV + +H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 120 LVKFL------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+V+ + ++ + +V E + LR YL P L + R +D
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELY 231
LHAN I+HRDLKP+N+L+T ++KLADFGLAR + +T T YR APE+
Sbjct: 135 FLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYR--APEVL 191
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
L Y VD++S G + E+ + F G S
Sbjct: 192 ----L--QST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 67/222 (30%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRG-------STSDERALLEGRFIREVNMMSRVK 116
KIGEG +G VY+ + A+K + ST+ IRE++++ +K
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT----------IREISILKELK 58
Query: 117 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
H N+VK +V+V E L L+K L L+ A +F L + +
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYC 116
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYS 232
H ++HRDLKP NLL+ + LK+ADFGLAR + T E T YR AP++
Sbjct: 117 HDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDV-- 171
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
L K Y+ +D++S G + E++ F G+S
Sbjct: 172 ---LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 34/232 (14%), Positives = 64/232 (27%), Gaps = 44/232 (18%)
Query: 62 IGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ G + ++ DR VA+ ++ + L + +SR+
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVL--QETLSRTLRLSRIDKPG 92
Query: 120 LVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+ + L ++V E + G SL++ + A+ +A A D H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA 148
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
G+ P + ++ D + LA + +
Sbjct: 149 GVALSIDHPSRVRVSID-GDVVLAYPATMPDA------NPQD------------------ 183
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIYAP 290
D+ G L+ LL NR P A P
Sbjct: 184 ----------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEP 225
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-33
Identities = 67/222 (30%), Positives = 106/222 (47%), Gaps = 34/222 (15%)
Query: 65 KIGEGAHGKVYEGRY-GDRIVAIKVLNRG-------STSDERALLEGRFIREVNMMSRVK 116
K+GEG +G VY+ + RIVA+K + ST+ IRE++++ +
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA----------IREISLLKELH 77
Query: 117 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
H N+V + + + +V E + L+K L L + + R +
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYS 232
H + I+HRDLKP NLL+ +LKLADFGLAR + T E T YR AP++
Sbjct: 136 HQHRILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDV-- 190
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
L G K Y+ VD++S G + E++T + F G+++
Sbjct: 191 ---L-MGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-33
Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRF----IREVNMMSRVKHD 118
G+G G V G+ VAIK + + + RF ++ + ++ + H
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIK----------KVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 119 NLVKFL--------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL---HVALNFALD 167
N+V+ +D + +V E +P +L + + ++ + + F
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKV-FLFQ 137
Query: 168 IARAMDCLHAN--GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--Y 223
+ R++ CLH + HRD+KP N+L+ +LKL DFG A++ + +E A + Y
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
R APEL HY VD++S G + E++ F G ++
Sbjct: 198 R--APELIFGNQ-------HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-33
Identities = 59/282 (20%), Positives = 97/282 (34%), Gaps = 82/282 (29%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKV--LNRGSTSDERALLEGR------------- 104
+G G G V+E + D AIK L + E+ + E +
Sbjct: 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 105 --------------------------------------FIREVNMMSRVKHDNLVKFLGA 126
++ M N V L
Sbjct: 70 FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 127 CKDPLMV-IVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 184
+ + I +L +L+ ++ + V L+ + IA A++ LH+ G++HRD
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189
Query: 185 LKPDNLLLTPDQKSLKLADFGLAR-------------EETVTEMMTAETGTYRWMAPELY 231
LKP N+ T D +K+ DFGL T + GT +M+PE
Sbjct: 190 LKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE-- 246
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
Q +Y++KVD++S G++L+ELL F
Sbjct: 247 ------QIHGNNYSHKVDIFSLGLILFELLY---SFSTQMER 279
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 9e-33
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 47/233 (20%)
Query: 65 KIGEGAHGKVYEGR---YGDRIVAIKVLNRGSTSDERALLEGRF----IREVN---MMSR 114
+IGEGA+GKV++ R G R VA+K + + EG IREV +
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE------EG-MPLSTIREVAVLRHLET 70
Query: 115 VKHDNLVKFL------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+H N+V+ ++ + +V E + L YL + + + +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 169 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWM 226
R +D LH++ ++HRDLKP N+L+T +KLADFGLAR + +T+ T YR
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYR-- 186
Query: 227 APEL-----YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
APE+ Y+T VD++S G + E+ + F G S++
Sbjct: 187 APEVLLQSSYAT-------------PVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 62/279 (22%), Positives = 113/279 (40%), Gaps = 25/279 (8%)
Query: 2 SCSNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLF 61
+ + + E E N + K R I AP D ++ +
Sbjct: 26 NSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAV 85
Query: 62 -----IGSK--IGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
+ +G G G+V++ +A K++ D+ + E+++M
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK-----NEISVM 140
Query: 113 SRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+++ H NL++ A + +V+V E + G L ++ L + F I
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEG 199
Query: 172 MDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 230
+ +H I+H DLKP+N+L D K +K+ DFGLAR E + GT ++APE+
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ + D++S G++ + LL+ PF G
Sbjct: 260 VN--------YDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 37/212 (17%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +G G G V+ + K + + + +E+++++ +H N
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISILNIARHRN 62
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++ + + +V++ E + G+ + + + + +L+ +++ + A+ LH++
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 179 GIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
I H D++P+N++ T ++K+ +FG AR+ + + APE+ +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-----HQ 176
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ D++S G +++ LL+ PF
Sbjct: 177 H---DVVSTATDMWSLGTLVYVLLSGINPFLA 205
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 66/226 (29%), Positives = 112/226 (49%), Gaps = 37/226 (16%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRG------STSDERALLEGRFIREVNMMSRVK 116
K+G G + VY+G VA+K + ST+ IRE+++M +K
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA----------IREISLMKELK 61
Query: 117 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL----VSLRPNKLDLHVALNFALDIARA 171
H+N+V+ + + +V E + L+KY+ V P L+L++ F + +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAP 228
+ H N I+HRDLKP NLL+ + LKL DFGLAR + ++E T YR AP
Sbjct: 121 LAFCHENKILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--AP 177
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
++ + G + Y+ +D++S G +L E++T + F G ++ +
Sbjct: 178 DVL----M--GS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKHD 118
+ ++G+GA V + A ++N + ++ + LE RE + +KH
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE----REARICRLLKHP 70
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N+V+ + + ++ +L+ G L + +V+ A + I A+ H
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQ 128
Query: 178 NGIIHRDLKPDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTV 234
G++HR+LKP+NLLL + + + +KLADFGLA E E + GT +++PE+
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV---- 184
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
LR K Y VD+++ G++L+ LL PF
Sbjct: 185 -LR---KDPYGKPVDLWACGVILYILLVGYPPFWD 215
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRF----IREVNMMSRVKHD 118
+GEG VY+ R ++IVAIK + G S+ + +G +RE+ ++ + H
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK---DG-INRTALREIKLLQELSHP 72
Query: 119 NLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ L A + +V + + L + L + L + ++ LH
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFME-TDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYSTV 234
+ I+HRDLKP+NLLL + LKLADFGLA+ T + T YR APEL
Sbjct: 131 HWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYR--APEL---- 183
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
L + Y VD+++ G +L ELL G S+L
Sbjct: 184 -LFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-32
Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 24/235 (10%)
Query: 66 IGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVK 122
+GEGAH +V + A+K++ + R REV M+ + + H N+++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS-----RVFREVEMLYQCQGHRNVLE 75
Query: 123 FLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
+ ++ +V E + G S+ ++ R + A D+A A+D LH GI
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIA 133
Query: 182 HRDLKPDNLLL-TPDQKS-LKLADFGLAR--------EETVTEMMTAETGTYRWMAPELY 231
HRDLKP+N+L P+Q S +K+ DF L T + G+ +MAPE+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV- 192
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQES 286
V E Y+ + D++S G++L+ LL+ PF G +
Sbjct: 193 --VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-32
Identities = 65/222 (29%), Positives = 109/222 (49%), Gaps = 34/222 (15%)
Query: 65 KIGEGAHGKVYEGRYG--DRIVAIKVLNRG------STSDERALLEGRFIREVNMMSRVK 116
K+GEG + VY+G+ D +VA+K + T+ IREV+++ +K
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA----------IREVSLLKDLK 58
Query: 117 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
H N+V + + +V E L L++YL N +++H F + R +
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYC 116
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELYS 232
H ++HRDLKP NLL+ ++ LKLADFGLAR +++ T+ E T YR P++
Sbjct: 117 HRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDI-- 171
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
L Y+ ++D++ G + +E+ T R F G + +
Sbjct: 172 ---LLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRG-------STSDERALLEGRFIREVNMMSRV 115
K+GEG +G+VY+ + VAIK + T+ IREV+++ +
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA----------IREVSLLKEL 90
Query: 116 KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+H N+++ L ++ E L+KY+ + + V +F + ++
Sbjct: 91 QHRNIIELKSVIHHNHRLH-LIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVN 146
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKS----LKLADFGLAREETV-TEMMTAETGT--YRWM 226
H+ +HRDLKP NLLL+ S LK+ DFGLAR + T E T YR
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR-- 204
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
PE+ L G +HY+ VD++S + E+L F G S +
Sbjct: 205 PPEIL----L--GS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID 245
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 47/216 (21%), Positives = 88/216 (40%), Gaps = 19/216 (8%)
Query: 61 FIGSKIGEGAHGKVYEG--RYGDRIVAIKVLN-RGSTSDERALLEGRFIREVNMMSRVKH 117
++G G V + + + A K L R D RA + E+ ++ K
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL----HEIAVLELAKS 87
Query: 118 D-NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
++ ++ ++++ E G + + + + + I + L
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 176 HANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
H N I+H DLKP N+LL + +K+ DFG++R+ + GT ++APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI--- 204
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
L D+++ GI+ + LLT+ PF G
Sbjct: 205 --LNY---DPITTATDMWNIGIIAYMLLTHTSPFVG 235
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 37/219 (16%)
Query: 66 IGEGAHGKVYEGRY--GDRIVAIKVLNRGS---------TSDERALLEGRFIREVNMMSR 114
+GEG+ V R R AIK+L + + ER ++MSR
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER-----------DVMSR 86
Query: 115 VKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+ H VK +D + L KY+ + D + +I A++
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALE 144
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAET--GTYRWMAPEL 230
LH GIIHRDLKP+N+LL + +++ DFG A+ ++ A + GT ++++PEL
Sbjct: 145 YLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+K D+++ G ++++L+ PF
Sbjct: 204 L--------TEKSACKSSDLWALGCIIYQLVAGLPPFRA 234
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 56/234 (23%), Positives = 99/234 (42%), Gaps = 29/234 (12%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLV 121
+G G +GKV E R + A+K+L + +EV+ + ++V
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSP----------KARQEVDHHWQASGGPHIV 85
Query: 122 KFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
L ++ I+ E + G L + A DI A+ LH
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 177 ANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
++ I HRD+KP+NLL + ++ + LKL DFG A+E T + T T ++APE+
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL--- 201
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288
+ Y+ D++S G++++ LL PF + + +++ Y
Sbjct: 202 -----GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQY 250
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-31
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVKHDNLV 121
IG GA G+V + + ++ A+K+LN+ E A F E +++ +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA----CFREERDVLVNGDSKWIT 137
Query: 122 KFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
A +D + +V + G L L+S ++L +A + ++ A+D +H
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY 196
Query: 181 IHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLR 237
+HRD+KPDN+L+ D ++LADFG + + + GT +++PE+ +
Sbjct: 197 VHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI---LQAM 251
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+G K Y + D +S G+ ++E+L PF
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 62/285 (21%), Positives = 103/285 (36%), Gaps = 33/285 (11%)
Query: 4 SNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLF-- 61
SNS+ ++ PQ + L + +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD 62
Query: 62 ---IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV- 115
+G G +GKV + + A+K+L + REV + R
Sbjct: 63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----------KARREVELHWRAS 112
Query: 116 KHDNLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+ ++V+ + ++ IV E L G L + A I
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 171 AMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 228
A+ LH+ I HRD+KP+NLL + + LKL DFG A+E T +T T ++AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
E+ + Y+ D++S G++++ LL PF L
Sbjct: 233 EVL--------GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-31
Identities = 54/237 (22%), Positives = 106/237 (44%), Gaps = 26/237 (10%)
Query: 58 KLLFIGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV 115
L +GEG+ + + ++ A+K++++ ++ + +E+ +
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--------KEITALKLC 62
Query: 116 K-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+ H N+VK D L +V ELL G L + + + A + A+
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVS 120
Query: 174 CLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRWMAPEL 230
+H G++HRDLKP+NLL + +K+ DFG AR + + T + APEL
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESI 287
L + Y+ D++S G++L+ +L+ ++PF+ + +A ++ + I
Sbjct: 181 -----LN---QNGYDESCDLWSLGVILYTMLSGQVPFQS-HDRSLTCTSAVEIMKKI 228
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 24/221 (10%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
IG GA G+V + ++ A+K+L++ +R+ F E ++M+ +V+
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSK-FEMIKRSDSA-FFWEERDIMAFANSPWVVQL 134
Query: 124 LGACKDPLMV-IVTELLPG---MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
A +D + +V E +PG ++L + + A + ++ A+D +H+ G
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNL------MSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 180 IIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTL 236
IHRD+KPDN+LL D+ LKLADFG + M+ +T GT +++PE V
Sbjct: 189 FIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE----VLK 242
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
QG +Y + D +S G+ L+E+L PF +L Y
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTY 282
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 60/257 (23%), Positives = 104/257 (40%), Gaps = 68/257 (26%)
Query: 65 KIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFI-REVNMMSRVKHDNLV 121
+G G+ G V E + + A+K + L + R+ RE+++M + H N++
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALK----------KVLQDPRYKNRELDIMKVLDHVNII 63
Query: 122 K---FLGACKDPLMV------------------------------------IVTELLPGM 142
K + D ++ E +P
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-D 122
Query: 143 SLRKYLVSLRPNKLDL---HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199
+L K L S + + +++ + + RA+ +H+ GI HRD+KP NLL+ +L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 200 KLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
KL DFG A++ +E A + YR APEL T Y +D++S G V
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGAT-------EYTPSIDLWSIGCVF 232
Query: 258 WELLTNRLPFEGMSNLQ 274
EL+ + F G +++
Sbjct: 233 GELILGKPLFSGETSID 249
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 27/226 (11%)
Query: 64 SKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSD------ERALLEGRFIREVNMMSRVK 116
I G++G V G + VAIK + + + L R +RE+ +++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 117 HDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
H N++ +VTEL+ L + + R H+ F I
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY-FMYHILL 145
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAP 228
+ LH G++HRDL P N+LL + + + DF LARE+T T YR AP
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKTHYVTHRWYR--AP 202
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
EL + K + VD++S G V+ E+ + F G +
Sbjct: 203 ELV-------MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-30
Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR-VKHD 118
+ IG G++ + + A+K++++ + + E+ ++ R +H
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-------SKRDPT--EEIEILLRYGQHP 76
Query: 119 NLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ D V +VTEL+ G L ++ + A I + ++ LHA
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHA 134
Query: 178 NGIIHRDLKPDNLLLT---PDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYST 233
G++HRDLKP N+L + +S+++ DFG A++ ++ T ++APE
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE---- 190
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
V RQG Y+ D++S G++L+ +LT PF +
Sbjct: 191 VLERQG----YDAACDIWSLGVLLYTMLTGYTPFANGPD 225
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 59/248 (23%), Positives = 98/248 (39%), Gaps = 42/248 (16%)
Query: 61 FIGSKIGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
+ G K+G G +G VY+ + D + A+K + S RE+ ++ +K
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-------CREIALLRELK 76
Query: 117 HDNLVK----FLGACKDPLMVIVTELLPGMSLRKYLVSLR-------PNKLDLHVALNFA 165
H N++ FL + ++ + L + R P +L + +
Sbjct: 77 HPNVISLQKVFLSHADRKVW-LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS---LKLADFGLAREETV-TEMMTAETG 221
I + LHAN ++HRDLKP N+L+ + +K+AD G AR + +
Sbjct: 135 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 222 T-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276
YR APEL L G +HY +D+++ G + ELLT+ F
Sbjct: 195 VVVTFWYR--APELL----L--GA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245
Query: 277 YAAAFKVQ 284
Q
Sbjct: 246 SNPYHHDQ 253
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVKHDNLV 121
IG GA +V + + ++ A+K++N+ E + F E +++ +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS----CFREERDVLVNGDRRWIT 124
Query: 122 KFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
+ A +D + +V E G L L+S ++ +A + +I A+D +H G
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLL-TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY 183
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQ 238
+HRD+KPDN+LL ++LADFG + + + GT +++PE+ V
Sbjct: 184 VHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
G Y + D ++ G+ +E+ + PF
Sbjct: 243 GTGS-YGPECDWWALGVFAYEMFYGQTPFYA 272
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 40/218 (18%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGS---------TSDERALLEGRFIREVNMMSR 114
+G G+ G+V+ R+ R A+KVL + T+DER M+S
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER-----------LMLSI 62
Query: 115 VKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
V H +++ G +D + ++ + + G L L + + VA +A ++ A++
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLALE 120
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELY 231
LH+ II+RDLKP+N+LL + +K+ DFG A+ T GT ++APE
Sbjct: 121 YLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD----VTYTLCGTPDYIAPE-- 173
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
V + YN +D +SFGI+++E+L PF
Sbjct: 174 --VVSTKP----YNKSIDWWSFGILIYEMLAGYTPFYD 205
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 39/233 (16%)
Query: 64 SKIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSD-ERALLEGRFIREVNMMSRVKHDN 119
+G G +G V + R VAIK + + AL RE+ ++ R+ HDN
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKR-VAIKKIVLTDPQSVKHAL------REIKIIRRLDHDN 69
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRK-YLVS----------LRPNKL-DLHVALNFALD 167
+VK + ++ L Y+V L L + H L F
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQ 128
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGT- 222
+ R + +H+ ++HRDLKP NL + + LK+ DFGLAR + ++ T
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 223 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
YR +P L +Y +D+++ G + E+LT + F G L+
Sbjct: 189 WYR--SPRLL-------LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGS---------TSDERALLEGRFIREVNMMSR 114
+G G+ G+V ++ + A+K+L++ T +E+ ++
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK-----------RILQA 97
Query: 115 VKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
V LVK + KD + +V E + G + +L R + A +A I +
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFE 155
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
LH+ +I+RDLKP+NLL+ DQ+ +++ DFG A+ V GT +APE
Sbjct: 156 YLHSLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPE--- 208
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ L +G YN VD ++ G++++E+ PF
Sbjct: 209 -IILSKG----YNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-28
Identities = 60/296 (20%), Positives = 104/296 (35%), Gaps = 91/296 (30%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
L +G +G GA G+V E R VA+K+L G+T E +
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR----ALMS 74
Query: 108 EVNMMSRV---------------------------KHDNLVKFLGACKDPLMVIVTELLP 140
E+ ++ + K NL +L + ++ + T+
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR 134
Query: 141 GMSLRKYLVS----------------------------------------LRPNKLDLHV 160
+ Y+ + L + L L
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220
+ ++ +A+ M+ L + IHRDL N+LL+ +K+ DFGLAR+ +
Sbjct: 195 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKG 253
Query: 221 GT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN 272
+WMAPE + Y + DV+SFG++LWE+ + P+ G+
Sbjct: 254 DARLPLKWMAPE--------TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-28
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 51/237 (21%)
Query: 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRF----IREVNMMSRVKHD 118
KIG+G G+V++ R + VA+K + + E+ EG F +RE+ ++ +KH+
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EK---EG-FPITALREIKILQLLKHE 76
Query: 119 NLVKFLGACKDPLMVIVTELLPGMSLRK--YLV------------SLRPNKLDLHVALNF 164
N+V + + T+ P + YLV S K L
Sbjct: 77 NVVNLIE-------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 129
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-----ETVTEMMTAE 219
+ + +H N I+HRD+K N+L+T LKLADFGLAR + T
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 220 TGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
T YR PEL L GE + Y +D++ G ++ E+ T +G +
Sbjct: 189 VVTLWYR--PPELL----L--GE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+ +G GA+G V VAIK L+R S+ A R RE+ ++ ++H+N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---RAYRELLLLKHMQHENVI 86
Query: 122 KFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
L + +V + L+K + + + + + +
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM---GLKFSEEKIQY-LVYQMLKGLKY 141
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYST 233
+H+ G++HRDLKP NL + D + LK+ DFGLAR MT T RW APE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLAR--HADAEMTGYVVT-RWYRAPEVI-- 195
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
HYN VD++S G ++ E+LT + F+G L
Sbjct: 196 -----LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 73/220 (33%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G GA+G V VA+K L+R S A R RE+ ++ +KH+N++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHENVIGL 93
Query: 124 LGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCL 175
L + +VT L+ G L + KL D HV I R + +
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQF-LIYQILRGLKYI 148
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYSTV 234
H+ IIHRDLKP NL + D + LK+ DFGLAR + MT T RW APE+
Sbjct: 149 HSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR--HTADEMTGYVAT-RWYRAPEIMLNW 204
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
HYN VD++S G ++ ELLT R F G ++
Sbjct: 205 -------MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 40/220 (18%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
+G+G+ GKV+ E + ++ AIK L + T E+ +L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS----------LA 74
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+H L + K+ L V E L G L ++ +K DL A +A +I
Sbjct: 75 WEHPFLTH-MFCTFQTKENLF-FVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILG 130
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
+ LH+ GI++RDLK DN+LL D +K+ADFG+ +E + T GT ++APE
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKEN-MLGDAKTNTFCGTPDYIAPE 188
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ + YN+ VD +SFG++L+E+L + PF G
Sbjct: 189 IL--------LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
+G+G GKV R R A+K+L + T E +L+
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-----------N 61
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+H L L D L V E G L +L R A + +I A
Sbjct: 62 TRHPFLTA-LKYAFQTHDRLC-FVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSA 117
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
++ LH+ +++RD+K +NL+L D +K+ DFGL +E +++ T +T GT ++APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPE 175
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
V Y VD + G+V++E++ RLPF
Sbjct: 176 ----VLEDND----YGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 73/277 (26%), Positives = 127/277 (45%), Gaps = 47/277 (16%)
Query: 13 REEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSL----LVDPKLLFIGSKIGE 68
EG +E Q R + + ++A + + T + + + L D L + +G+
Sbjct: 295 GSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMV---LGK 351
Query: 69 GAHGKVYEGRY--GDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSRVKH 117
G+ GKV D + A+K+L + T E+ +L K
Sbjct: 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA----------LPGKP 401
Query: 118 DNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
L + L +C D L V E + G L ++ + + A+ +A +IA +
Sbjct: 402 PFLTQ-LHSCFQTMDRLY-FVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYS 232
L + GII+RDLK DN++L + +K+ADFG+ +E + + +T +T GT ++APE
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIAPE--- 512
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Q Y VD ++FG++L+E+L + PFEG
Sbjct: 513 -IIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 63/218 (28%), Positives = 97/218 (44%), Gaps = 32/218 (14%)
Query: 66 IGEGAHG---KVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG GA G Y+ VAIK L+R + A R RE+ +M V H N++
Sbjct: 70 IGSGAQGIVCAAYDAVLDRN-VAIKKLSRPFQNQTHAK---RAYRELVLMKCVNHKNIIS 125
Query: 123 FLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
L + +V EL+ +L + + + ++ + + L
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI---QMELDHERMSY-LLYQMLCGIKHL 180
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYST 233
H+ GIIHRDLKP N+++ D LK+ DFGLAR + MMT T YR APE+
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTRYYR--APEVILG 237
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
Y VD++S G ++ E++ +++ F G
Sbjct: 238 --------MGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 67/233 (28%), Positives = 94/233 (40%), Gaps = 47/233 (20%)
Query: 64 SKIGEGAHGKV---YEGRYGDRIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVKHD 118
S +GEGA+G V G+ VAIK + R L RE+ ++ KH+
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEI-VAIKKIEPFDKPLFALRTL------REIKILKHFKHE 69
Query: 119 NLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARA 171
N++ + I+ EL+ L + + L D H+ F RA
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLSDDHIQY-FIYQTLRA 124
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----------EETVTEMMTAET 220
+ LH + +IHRDLKP NLL+ + LK+ DFGLAR M
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 221 GT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
T YR APE+ Y+ +DV+S G +L EL R F G
Sbjct: 184 ATRWYR--APEVM-------LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 66/220 (30%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKF 123
+G GA+G V G VAIK L R S+ A R RE+ ++ ++H+N++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMRHENVIGL 89
Query: 124 LGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCL 175
L + +V + G L K + + KL + + + + + +
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQF-LVYQMLKGLRYI 144
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTV 234
HA GIIHRDLKP NL + D + LK+ DFGLAR MT T RW APE+
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR--QADSEMTGYVVT-RWYRAPEVI--- 197
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
Y VD++S G ++ E++T + F+G +L
Sbjct: 198 ----LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
IG G++ KV + DRI A+KV+ + E+ + E
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE----------QA 66
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
H LV L +C + L V E + G L ++ R KL A ++ +I+ A
Sbjct: 67 SNHPFLVG-LHSCFQTESRLF-FVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA 122
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
++ LH GII+RDLK DN+LL + +KL D+G+ +E + T T GT ++APE
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE 180
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+ + Y VD ++ G++++E++ R PF+ + +
Sbjct: 181 ----ILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 66/228 (28%), Positives = 93/228 (40%), Gaps = 48/228 (21%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
IG GA G V R VAIK L+R + A R RE+ +M V H N++
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVNHKNII 87
Query: 122 KFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD------- 167
L + IV EL+ +L + LD
Sbjct: 88 GLLNVFTPQKSLEEFQDVYIVMELMDA---------------NLCQVIQMELDHERMSYL 132
Query: 168 ---IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 224
+ + LH+ GIIHRDLKP N+++ D LK+ DFGLAR + MMT T R
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVT-R 190
Query: 225 WM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
+ APE+ Y VD++S G ++ E++ + F G
Sbjct: 191 YYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 65/275 (23%), Positives = 119/275 (43%), Gaps = 27/275 (9%)
Query: 4 SNSEKNRVGREEGEQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIG 63
E G G + + N + A ++ I+ + +LL +
Sbjct: 8 HEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIE-----NFELLKV- 61
Query: 64 SKIGEGAHGKVY-----EGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
+G GA+GKV+ G ++ A+KVL + + + E E ++ ++
Sbjct: 62 --LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE-HTRTERQVLEHIRQS 118
Query: 119 N-LVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
LV A + + ++ + + G L +L + + H + +I A++ LH
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEHLH 176
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTV 234
GII+RD+K +N+LL + + L DFGL++E E A GT +MAP++
Sbjct: 177 KLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV--- 232
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+G ++ VD +S G++++ELLT PF
Sbjct: 233 ---RGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 54/227 (23%), Positives = 94/227 (41%), Gaps = 31/227 (13%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD- 118
+ K+G G V+ + + VA+K++ E A E + ++ VN K D
Sbjct: 23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 82
Query: 119 ----NLVKFL------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
+++K L G + V+V E+L G +L + + L + +
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHV-VMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 169 ARAMDCLHAN-GIIHRDLKPDNLLLTPDQKS-----LKLADFGLAREETVTEMMTAETGT 222
+D +H GIIH D+KP+N+L+ +K+AD G A + +T
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
YR +PE V L + D++S +++EL+T FE
Sbjct: 201 YR--SPE----VLLGAP----WGCGADIWSTACLIFELITGDFLFEP 237
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 51/223 (22%), Positives = 80/223 (35%), Gaps = 49/223 (21%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHD 118
+G G +GKV + + A+K+L R REV + R +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKAR--------REVELHWRASQCP 71
Query: 119 NLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
++V+ + ++ IV E L G L + A I A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 174 CLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
LH+ I HRD+KP+NLL + + LKL DFG A E
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KET- 170
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+ Y+ D++S G++++ LL PF L
Sbjct: 171 --------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
IG G++ KV + DRI A++V+ + E+ + E
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE----------QA 109
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
H LV L +C + L V E + G L ++ R KL A ++ +I+ A
Sbjct: 110 SNHPFLVG-LHSCFQTESRLF-FVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISLA 165
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
++ LH GII+RDLK DN+LL + +KL D+G+ +E + T T GT ++APE
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNYIAPE 223
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+ + Y VD ++ G++++E++ R PF+ + +
Sbjct: 224 ----ILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 71/226 (31%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
IGEGA+G V VAIK ++ T +R L RE+ ++ R +H+N++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL------REIKILLRFRHENII 88
Query: 122 KFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDC 174
+ P + IV +L+ L K L + L + H+ F I R +
Sbjct: 89 GINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT---QHLSNDHICY-FLYQILRGLKY 143
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGT--YRWMAP 228
+H+ ++HRDLKP NLLL LK+ DFGLAR + T +T T YR AP
Sbjct: 144 IHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYR--AP 200
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
E+ K Y +D++S G +L E+L+NR F G L
Sbjct: 201 EIM-------LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVKHDNLV 121
+G+G G+V + ++ A K L + A+ + E ++ +V +V
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA----LNEKQILEKVNSRFVV 247
Query: 122 KFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
L KD L +V L+ G L+ ++ + A+ +A +I ++ LH
Sbjct: 248 S-LAYAYETKDAL-CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
I++RDLKP+N+LL D ++++D GLA + + GT +MAPE V +
Sbjct: 306 RIVYRDLKPENILL-DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE----VVKNE 360
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
Y D ++ G +L+E++ + PF+
Sbjct: 361 R----YTFSPDWWALGCLLYEMIAGQSPFQQ 387
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-26
Identities = 64/220 (29%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
+G+G+ GKV + + A+KVL + T E+ +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS----------LA 80
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
H L + L C D L V E + G L ++ + + D A +A +I A
Sbjct: 81 RNHPFLTQ-LFCCFQTPDRLF-FVMEFVNGGDLMFHIQ--KSRRFDEARARFYAAEIISA 136
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
+ LH GII+RDLK DN+LL + KLADFG+ +E + +T T GT ++APE
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEG-ICNGVTTATFCGTPDYIAPE 194
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y VD ++ G++L+E+L PFE
Sbjct: 195 ----ILQEML----YGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 69/224 (30%), Positives = 103/224 (45%), Gaps = 45/224 (20%)
Query: 66 IGEGAHGKVYEGRYG-----DRIVAIKVLNRG----------STSDERALLEGRFIREVN 110
+G+G +GKV++ R +I A+KVL + T ER +LE
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE-------- 76
Query: 111 MMSRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
VKH +V L L ++ E L G L L R A + +
Sbjct: 77 ---EVKHPFIVD-LIYAFQTGGKL-YLILEYLSGGELFMQLE--REGIFMEDTACFYLAE 129
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 225
I+ A+ LH GII+RDLKP+N++L +KL DFGL +E + + T GT +
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKES-IHDGTVTHTFCGTIEY 187
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
MAPE + +R G +N VD +S G +++++LT PF G
Sbjct: 188 MAPE----ILMRSG----HNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 40/220 (18%)
Query: 66 IGEGAHGKVY--EGRYGDRIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
+G+G+ GKV E + D + A+K+L + T E+ +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA----------LP 77
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
K L + L +C D L V E + G L ++ + + A+ +A +IA
Sbjct: 78 GKPPFLTQ-LHSCFQTMDRLY-FVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIG 133
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
+ L + GII+RDLK DN++L + +K+ADFG+ +E + + +T +T GT ++APE
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEN-IWDGVTTKTFCGTPDYIAPE 191
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Q Y VD ++FG++L+E+L + PFEG
Sbjct: 192 ----IIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 43/222 (19%)
Query: 66 IGEGAHGKVY-----EGRYGDRIVAIKVLNRGS--------TSDERALLEGRFIREVNMM 112
+G+G+ GKV+ G ++ A+KVL + + T ER +L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV---------- 81
Query: 113 SRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 169
V H +VK L + L ++ + L G L L + + ++A
Sbjct: 82 -EVNHPFIVK-LHYAFQTEGKL-YLILDFLRGGDLFTRLS--KEVMFTEEDVKFYLAELA 136
Query: 170 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMA 227
A+D LH+ GII+RDLKP+N+LL + +KL DFGL++E + A + GT +MA
Sbjct: 137 LALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKES-IDHEKKAYSFCGTVEYMA 194
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
PE V R+G + D +SFG++++E+LT LPF+G
Sbjct: 195 PE----VVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQG 228
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVKHDNLV 121
+G G G+V+ + ++ A K LN+ + E ++++V +V
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA----MVEKKILAKVHSRFIV 248
Query: 122 KFLGAC---KDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLH 176
L K L +V ++ G +R ++ ++ A+ + I ++ LH
Sbjct: 249 S-LAYAFETKTDL-CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTV 234
II+RDLKP+N+LL D +++++D GLA E + GT +MAPEL
Sbjct: 307 QRNIIYRDLKPENVLLD-DDGNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELL--- 361
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
+ Y+ VD ++ G+ L+E++ R PF
Sbjct: 362 -----LGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-25
Identities = 68/220 (30%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLN---------RGSTSDERALLEGRFIREVNMMSR 114
IG+G+ GKV R+ A+KVL ER +L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL----------KN 95
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
VKH LV L D L V + + G L +L R A +A +IA A
Sbjct: 96 VKHPFLVG-LHFSFQTADKL-YFVLDYINGGELFYHLQ--RERCFLEPRARFYAAEIASA 151
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPE 229
+ LH+ I++RDLKP+N+LL + L DFGL +E + T T GT ++APE
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKEN-IEHNSTTSTFCGTPEYLAPE 209
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
V +Q Y+ VD + G VL+E+L PF
Sbjct: 210 ----VLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYS 241
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 66/241 (27%), Positives = 103/241 (42%), Gaps = 56/241 (23%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG G++G V E + R+VAIK + R R +RE+ +++R+ HD++VK
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK---RILREIAILNRLNHDHVVK 116
Query: 123 FLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCL 175
L + +V E+ +K + P L +LH+ ++ + +
Sbjct: 117 VLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKT-LLYNLLVGVKYV 172
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--------------------------- 208
H+ GI+HRDLKP N L+ D S+K+ DFGLAR
Sbjct: 173 HSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 209 -EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 265
+ + +T T YR APEL L Q ++Y +DV+S G + ELL
Sbjct: 232 HTKNLKRQLTGHVVTRWYR--APEL----ILLQ---ENYTEAIDVWSIGCIFAELLNMIK 282
Query: 266 P 266
Sbjct: 283 E 283
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
IG G G+VY R D ++ A+K L++ +ER +L ++S
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS--------LVST 248
Query: 115 VKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+V A P + + +L+ G L +L +A +I ++
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLE 306
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
+H +++RDLKP N+LL + ++++D GLA + + + + GT+ +MAPE+
Sbjct: 307 HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEV--- 361
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
L++G Y++ D +S G +L++LL PF
Sbjct: 362 --LQKGVA--YDSSADWFSLGCMLFKLLRGHSPFRQ 393
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 7e-24
Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 42/221 (19%)
Query: 66 IGEGAHGKVYEGRYGD--RIVAIKVLNRG---------STSDERALLEGRFIREVNMMSR 114
+G+G GKV + R A+K+L + T E +L+
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-----------N 204
Query: 115 VKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+H L L D L V E G L +L R A + +I A
Sbjct: 205 SRHPFLTA-LKYSFQTHDRLC-FVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSA 260
Query: 172 MDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAP 228
+D LH+ +++RDLK +NL+L D +K+ DFGL +E + + T +T GT ++AP
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEG-IKDGATMKTFCGTPEYLAP 318
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269
E V Y VD + G+V++E++ RLPF
Sbjct: 319 E----VLEDND----YGRAVDWWGLGVVMYEMMCGRLPFYN 351
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-24
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 27/223 (12%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG+G+ G+V + + VA+K++ +A E R + + + N
Sbjct: 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 120 LVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ L C + ELL M+L + + + L + FA I + +
Sbjct: 161 VIHMLENFTFRNHIC------MTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 173 DCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
D LH N IIH DLKP+N+LL + +K+ DFG + E ++ YR APE
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APE-- 269
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
V L Y +D++S G +L ELLT G
Sbjct: 270 --VILGAR----YGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 9e-24
Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 51/236 (21%)
Query: 65 KIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
IG G++G VY + ++ VAIK +NR R +RE+ +++R+K D +++
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREITILNRLKSDYIIR 89
Query: 123 FLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCL 175
++ IV E+ L+K + P L + H+ ++ + +
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKT--PIFLTEEHIKT-ILYNLLLGENFI 145
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----------------------EETV 212
H +GIIHRDLKP N LL D +K+ DFGLAR + +
Sbjct: 146 HESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 213 TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266
+ +T+ T YR APEL +++Y +D++S G + ELL
Sbjct: 205 KKQLTSHVVTRWYR--APELILL-------QENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 49/239 (20%)
Query: 64 SKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNL 120
K+G+GA+G V++ +VA+K + + A R RE+ +++ + H+N+
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREIMILTELSGHENI 71
Query: 121 VKFLGACKDPLMV---IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAMDCLH 176
V L + +V + + L + + N L +H + + + LH
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA---NILEPVHKQY-VVYQLIKVIKYLH 126
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----------------------EETVTE 214
+ G++HRD+KP N+LL + +K+ADFGL+R +
Sbjct: 127 SGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 215 MMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271
++T T YR APE+ Y +D++S G +L E+L + F G S
Sbjct: 186 ILTDYVATRWYR--APEILLGS-------TKYTKGIDMWSLGCILGEILCGKPIFPGSS 235
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-21
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 29/225 (12%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I S IG+G+ G+V + VAIK++ +A +E R + +N
Sbjct: 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYY 117
Query: 120 LVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+V C +V E+L +L L + + L++ FA + A+
Sbjct: 118 IVHLKRHFMFRNHLC------LVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 173 DCLHAN--GIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 229
L IIH DLKP+N+LL P + ++K+ DFG + + ++ YR +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPE 228
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
V L Y+ +D++S G +L E+ T F G + +
Sbjct: 229 ----VLLGMP----YDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 61/279 (21%), Positives = 98/279 (35%), Gaps = 85/279 (30%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR--VKH 117
+ K+G G V+ G + VA+KV+ E AL E R ++ V
Sbjct: 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 118 DNLVKFLGA-----------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
+ +V+ L C +V E+L G L K+++ L L
Sbjct: 101 EMVVQLLDDFKISGVNGTHIC------MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 167 DIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSL-------------------------- 199
+ + +D LH IIH D+KP+N+LL+ +++ +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 200 ----------------------KLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTVT 235
K+AD G A + TE + T YR + E V
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ--TRQYR--SLE----VL 265
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+ G YN D++S + +EL T FE S +
Sbjct: 266 IGSG----YNTPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 64/244 (26%), Positives = 94/244 (38%), Gaps = 51/244 (20%)
Query: 62 IGSKIGEGAHGKVYEG---RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
I +GEGA GKV E + G R VA+K++ E A E + + +N
Sbjct: 18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTF 77
Query: 119 NLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNK---LDLHVALNFALDI 168
V+ L C IV ELL G+S ++ + N L A I
Sbjct: 78 RCVQMLEWFEHHGHIC------IVFELL-GLSTYDFI---KENGFLPFRLDHIRKMAYQI 127
Query: 169 ARAMDCLHANGIIHRDLKPDNLLL------------------TPDQKSLKLADFGLAREE 210
++++ LH+N + H DLKP+N+L T +K+ DFG A +
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270
T YR APE V L G ++ DV+S G +L E F
Sbjct: 188 DEHHSTLVSTRHYR--APE----VILALG----WSQPCDVWSIGCILIEYYLGFTVFPTH 237
Query: 271 SNLQ 274
+ +
Sbjct: 238 DSKE 241
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 58/241 (24%), Positives = 87/241 (36%), Gaps = 45/241 (18%)
Query: 62 IGSKIGEGAHGKV---YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
I +GEG GKV + G VA+K++ E A LE ++++ +
Sbjct: 23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 119 NLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
V C I ELL G + ++L L + A + A
Sbjct: 83 LCVLMSDWFNFHGHMC------IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 172 MDCLHANGIIHRDLKPDNLLLT------------------PDQKSLKLADFGLAREETVT 213
+ LH N + H DLKP+N+L S+++ADFG A +
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
T YR PE V L G + DV+S G +L+E F+ N
Sbjct: 196 HTTIVATRHYR--PPE----VILELG----WAQPCDVWSIGCILFEYYRGFTLFQTHENR 245
Query: 274 Q 274
+
Sbjct: 246 E 246
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 59/255 (23%), Positives = 99/255 (38%), Gaps = 69/255 (27%)
Query: 62 IGSKIGEGAHGKVYEG--RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD- 118
+ K+G+G G+V + A+KV+ A +E ++++ D
Sbjct: 39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQ-----NDDI 93
Query: 119 ---NLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNK---LDLHVALNFA 165
N+VK+ G C ++ E L G SL + + N + +
Sbjct: 94 NNNNIVKYHGKFMYYDHMC------LIFEPL-GPSLYEII---TRNNYNGFHIEDIKLYC 143
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLL------------------------TPDQKSLKL 201
++I +A++ L + H DLKP+N+LL +KL
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 202 ADFGLA--REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259
DFG A + + ++ T YR APE V L G ++ D++SFG VL E
Sbjct: 204 IDFGCATFKSDYHGSII--NTRQYR--APE----VILNLG----WDVSSDMWSFGCVLAE 251
Query: 260 LLTNRLPFEGMSNLQ 274
L T L F +++
Sbjct: 252 LYTGSLLFRTHEHME 266
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-16
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 37/227 (16%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G KIG G G++ G+ Y + VAIK+ + + LE RF +++ +
Sbjct: 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM-KSRAPQLHLEYRFYKQLGSGDGIPQ-- 69
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V + G C +V ELL G SL + L L L L A+ + M+ +H+
Sbjct: 70 -VYYFGPCGK-YNAMVLELL-GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 180 IIHRDLKPDNLLL----TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMA 227
+I+RD+KP+N L+ Q+ + + DF LA+E ET + E TGT R+M
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM- 184
Query: 228 PELYSTVTLRQGEKKHYNN----KVDVYSFGIVLWELLTNRLPFEGM 270
S T H + D+ + G + L LP++G+
Sbjct: 185 ----SINT-------HLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 35/165 (21%), Positives = 60/165 (36%), Gaps = 20/165 (12%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVN---MMSRVK 116
+G KIG G G +Y + A V+ + E +F + V + +
Sbjct: 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 117 HDNLVKFLG-----------ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 165
+ +LG +V E L G+ L+K L
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLG 157
Query: 166 LDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARE 209
+ + ++ +H N +H D+K NLLL + + LAD+GL+
Sbjct: 158 IRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 30/166 (18%), Positives = 56/166 (33%), Gaps = 19/166 (11%)
Query: 62 IGSKIGEGAHGKVYEGR----------YGDRIVAIKVLNRGSTSDERALLEGRFIREVNM 111
+ S G +YE + ++K+ + R + + +
Sbjct: 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105
Query: 112 MSRVKHDNL-------VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 164
K + G +D +V L G SL+ L + L L
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQV 164
Query: 165 ALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARE 209
A + A++ LH N +H ++ +N+ + DQ + LA +G A
Sbjct: 165 ACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-16
Identities = 34/195 (17%), Positives = 62/195 (31%), Gaps = 35/195 (17%)
Query: 62 IGSKIGEGAHGKVYEGR-------YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
+G IG+G G +Y D +KV + + E +F + +
Sbjct: 39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV---EPSDNGPLFTELKFYQRAAKPEQ 95
Query: 115 VKHDNLVKFLGACKDPLM--------------VIVTELLPGMSLRKYLVSLRPNKLDLHV 160
++ + L P ++ + G L+K +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY-EANAKRFSRKT 153
Query: 161 ALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARE----ETVTEM 215
L +L I ++ +H + +H D+K NLLL + + L D+GLA
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213
Query: 216 MTAE----TGTYRWM 226
GT +
Sbjct: 214 AADPKRCHDGTIEFT 228
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-16
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 37/227 (16%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +IGEG+ G ++EG ++ VAIK + + E R + + + + +
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPN-- 70
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V + G V+V +LL G SL + L+ L K + A + + +H
Sbjct: 71 -VYYFGQEGL-HNVLVIDLL-GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 180 IIHRDLKPDNLLL----TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMA 227
+++RD+KPDN L+ + + + + DFG+ + T + E +GT R+M
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM- 185
Query: 228 PELYSTVTLRQGEKKHYNN----KVDVYSFGIVLWELLTNRLPFEGM 270
S T H + D+ + G V L LP++G+
Sbjct: 186 ----SINT-------HLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 8e-16
Identities = 62/230 (26%), Positives = 93/230 (40%), Gaps = 41/230 (17%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G KIG G+ G +Y G VAIK + L E + ++
Sbjct: 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIK---LECVKTKHPQLH----IESKIYKMMQGGV 65
Query: 120 ---LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
+++ GA D V+V ELL G SL + L + K L L A + ++ +H
Sbjct: 66 GIPTIRWCGAEGD-YNVMVMELL-GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 177 ANGIIHRDLKPDNLLL--TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWM 226
+ IHRD+KPDN L+ + + DFGLA++ T + E TGT R+
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 227 APELYSTVTLRQGEKKHYNN----KVDVYSFGIVLWELLTNRLPFEGMSN 272
S T H + D+ S G VL LP++G+
Sbjct: 183 -----SINT-------HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 35/225 (15%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G KIG G+ G++Y G + VAIK+ N T + L E + R + + + +
Sbjct: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLLYESKIYRILQGGTGIPN-- 67
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
V++ G D V+V +LL G SL + L + KL L L A + ++ +H+
Sbjct: 68 -VRWFGVEGD-YNVLVMDLL-GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 180 IIHRDLKPDNLLL--TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMAPE 229
+HRD+KPDN L+ + + DFGLA++ T + E TGT R+
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA--- 180
Query: 230 LYSTVTLRQGEKKHYNN----KVDVYSFGIVLWELLTNRLPFEGM 270
S T H + D+ S G VL L LP++G+
Sbjct: 181 --SVNT-------HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 3e-12
Identities = 37/193 (19%), Positives = 61/193 (31%), Gaps = 48/193 (24%)
Query: 65 KIGEGAHGKVYEGRYGDRIVAIKVLNRGS---------TSDERALLEGRFIREVNMMS-- 113
KIGEG G+V++ VAIK++ + E L E +E++++S
Sbjct: 27 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 114 -RVKHDNLVKFLGAC-------------------------------KDPLMVIVTELLPG 141
+ + + KD + IV E G
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLK 200
L +R L A + + ++ A+ HRDL N+LL K
Sbjct: 147 GID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK-TSLKK 202
Query: 201 LADFGLAREETVT 213
L + T+
Sbjct: 203 LHYTLNGKSSTIP 215
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 27/168 (16%), Positives = 56/168 (33%), Gaps = 22/168 (13%)
Query: 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTS------DERALLEGR 104
L+ K+ IG +GEG V+ + ++ + ++R +
Sbjct: 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLH 142
Query: 105 FIREVNMMSRVKHDNLVKFLGA-CKDPLM----VIVTELLPGMSLRKYLVSLRPNKLDLH 159
F +R + L K G ++ EL+ L ++ +
Sbjct: 143 FSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELY---------RVRVE 193
Query: 160 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207
I + + GI+H DL N+L++ + + + DF +
Sbjct: 194 NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQS 239
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 36/148 (24%), Positives = 53/148 (35%), Gaps = 19/148 (12%)
Query: 66 IGEGAHGKVYEGRYGDRIVAIKVLN----RGSTSDERALLEGRFIREVNMMSRVKHDNL- 120
IG+GA + Y D V IK R DE R RE ++ VK +
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKS-RTAREARYLALVKDFGIP 402
Query: 121 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 180
++ I+ + G + + L+ A I + LH N +
Sbjct: 403 APYIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDV 452
Query: 181 IHRDLKPDNLLLTPDQKSLKLADFGLAR 208
IH DL N + D L + DFGL +
Sbjct: 453 IHNDLTTSNFIFDKD---LYIIDFGLGK 477
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 2e-04
Identities = 46/269 (17%), Positives = 88/269 (32%), Gaps = 66/269 (24%)
Query: 29 VEKESRAVVKNGS----ITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIV 84
V+ ++++ I + + +L + LL ++ + +V Y +
Sbjct: 38 VQDMPKSILSKEEIDHIIMSKD-AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS 96
Query: 85 AIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSL 144
IK R + +++ +I + + R+ +DN F K V+ L P + L
Sbjct: 97 PIKTEQR-----QPSMMTRMYIEQRD---RLYNDN-QVFA---KYN----VSRLQPYLKL 140
Query: 145 RKYLVSLRPNK-LDLHVALNF-----ALDIARAMD--CLHANGI----IHRDLKPD---- 188
R+ L+ LRP K + + L ALD+ + C I + P+
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 189 ---NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY--STVTLRQGEKKH 243
LL D +D + + + R + + Y + L
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHS---IQAELRRLLKSKPYENCLLVLL------ 251
Query: 244 YNNKVDVYSFGIVLWE--------LLTNR 264
+V + W LLT R
Sbjct: 252 -----NVQNAKA--WNAFNLSCKILLTTR 273
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 2e-04
Identities = 57/345 (16%), Positives = 101/345 (29%), Gaps = 90/345 (26%)
Query: 17 EQEQNQHVLRGSVEKESRAVVKNGSITAPQLTIDRSLLVDP---KLLFIGSKIGEGAHGK 73
+ EQ Q + + E R + N + + + R LL + G
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 74 VYEGRYGDRIVAIKV----------------LNRGSTSDERALLEGRFIREVNMMSRVKH 117
+ G G VA+ V LN + + +LE ++ ++
Sbjct: 159 L--G-SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE----MLQKLLYQIDP 211
Query: 118 DNLVKFLGACKDPLMV--IVTELLPGMSLRKYLVSLRPNKLDL-HV-------ALNFA-- 165
+ + + L + I EL + + Y L L L +V A N +
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL----LVLLNVQNAKAWNAFNLSCK 267
Query: 166 -LDIAR---AMDCLHANGIIHRDLKPDNLLLTPDQ------KSLKLADFGLAREET---- 211
L R D L A H L ++ LTPD+ K L L RE
Sbjct: 268 ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 212 -----VTEMMTAETGTY-RW---MAPELYSTV-----TLRQGE-KKHYNNKVDVYSFGI- 255
+ E + T+ W +L + + L E +K + +
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF------DRLSVF 381
Query: 256 ------------VLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288
++W + ++ L + +ES
Sbjct: 382 PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 3e-04
Identities = 28/201 (13%), Positives = 58/201 (28%), Gaps = 27/201 (13%)
Query: 30 EKESRAVVKNGSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGR----YGDRIVA 85
+ E R + + L L + +G I G V+ +A
Sbjct: 20 DGEERKIYAE-VLDGRTLKTLYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMA 78
Query: 86 IKV--LNRGSTSDERALLEGRFIREVNMMSRVKHDNL-----VKFLGACKDP-------- 130
+K+ + L G ++ +S + + + L K+
Sbjct: 79 VKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPY 138
Query: 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLK 186
V++ E + L + +L D+ + L+ ++H DL
Sbjct: 139 TYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLS 198
Query: 187 PDNLLLTPDQKSLKLADFGLA 207
N++ + D G A
Sbjct: 199 EYNIMYIDK---VYFIDMGQA 216
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 290 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.82 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.28 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.01 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.83 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.68 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.6 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.58 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.51 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.48 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.31 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.1 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.07 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.03 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.83 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.61 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.38 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.3 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.74 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.45 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.79 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.08 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.13 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.42 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.0 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-56 Score=384.44 Aligned_cols=215 Identities=30% Similarity=0.421 Sum_probs=181.0
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
.-++|++++.||+|+||+||+|++ +++.||||++......... ..++.+|+.++++|+|||||++++++.++ ..
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE---REESRREVAVLANMKHPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHH---HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 346799999999999999999987 5799999999876554432 24688999999999999999999999765 68
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
|+|||||+||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCH
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeecC
Confidence 8999999999999999876666789999999999999999999999999999999999999554 699999999987544
Q ss_pred cc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 213 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
.. .....+||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++...
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~--------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~ 240 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICEN--------KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG 240 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred CcccccccCCCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 32 3345689999999999865 67899999999999999999999999998887777766554
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-56 Score=380.05 Aligned_cols=211 Identities=27% Similarity=0.418 Sum_probs=180.2
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
+++|++++.||+|+||+||+|++ +++.||||++.+....... ...++.+|+.+++.|+|||||++++++++. ..|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45799999999999999999987 5789999999753321111 123588999999999999999999999865 688
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV- 212 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~- 212 (290)
+||||++||+|.+++.. .+.+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 109 ivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTT
T ss_pred EEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCC
Confidence 99999999999999986 35799999999999999999999999999999999999999554 599999999986432
Q ss_pred --cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 213 --TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.......+||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++.
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~ 247 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII 247 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHH--------SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcccccCcccCcccCCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 223456789999999999865 678999999999999999999999999977766555544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-55 Score=372.09 Aligned_cols=220 Identities=32% Similarity=0.563 Sum_probs=183.1
Q ss_pred ccccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCc
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL 131 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 131 (290)
.|.++.+++.+.++||+|+||+||+|++.+ .||||+++......+. ...|.+|+.++++++|||||++++++.++.
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~---~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 105 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQ---FQAFRNEVAVLRKTRHVNILLFMGYMTKDN 105 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHH---HHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEECCe
Confidence 456777889999999999999999998765 5999999765544332 246899999999999999999999998888
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+++|+|.+++.. ....+++..++.|+.||+.||+|||+++||||||||+|||++.+ +.+||+|||+++...
T Consensus 106 ~~iVmEy~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKS 183 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCBC--
T ss_pred EEEEEEcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCceecc
Confidence 9999999999999999976 34679999999999999999999999999999999999999944 579999999997543
Q ss_pred c---cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 212 V---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 212 ~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
. .......+||+.|||||++... ....++.++|||||||++|||+||+.||.+.++......+..+
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~-----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~ 252 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQ-----DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR 252 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT
T ss_pred cCCcceeecccccCCCccCHHHhhcc-----CCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 2 2233456899999999998541 1246899999999999999999999999998877666655544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=378.83 Aligned_cols=209 Identities=30% Similarity=0.461 Sum_probs=181.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|+++++||+|+||.||+|++ +++.||||++........ ..+.+|+.+|+.++|||||++++++.+. ..|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~-----~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR-----ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSG-----GGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHH-----HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4599999999999999999988 579999999975443332 2477999999999999999999999754 7889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||++||+|.+++.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 149 vmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSS
T ss_pred EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCC
Confidence 9999999999999975 4699999999999999999999999999999999999999554 6999999999865433
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~ 283 (290)
......+||+.|||||++.. ..|+.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 286 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 286 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred CcccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence 34556799999999999864 678999999999999999999999999988887776665543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-54 Score=366.54 Aligned_cols=210 Identities=31% Similarity=0.536 Sum_probs=178.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-----C
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-----P 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 130 (290)
+.|++.++||+|+||+||+|.+ +++.||+|++......... ..++.+|+.++++|+|||||++++++.+ .
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH---HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH---HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 3457888999999999999987 5789999999765544332 2468899999999999999999999853 2
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g--ivH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
..++||||++||+|.+++.. ...+++..++.|+.||+.||+|||++| |+||||||+|||++..++.+||+|||+++
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 47899999999999999986 357999999999999999999999998 99999999999998545679999999998
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
.... ......+||+.|||||++. ..++.++|||||||++|+|+||+.||.+.++...++.....
T Consensus 181 ~~~~-~~~~~~~GTp~YmAPE~~~---------~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~ 244 (290)
T 3fpq_A 181 LKRA-SFAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp GCCT-TSBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred eCCC-CccCCcccCccccCHHHcC---------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc
Confidence 6433 3445678999999999874 35899999999999999999999999988777766665544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=374.82 Aligned_cols=207 Identities=24% Similarity=0.305 Sum_probs=176.8
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
....|.+.++||+|+||.||+|++ +++.||||+++.... ..+|+.+++.++|||||++++++.++ ..
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----------~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----------RVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 446789999999999999999987 578999999986543 23799999999999999999999764 68
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||++||+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||++.++..+||+|||+++....
T Consensus 126 ~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 8999999999999999863 57999999999999999999999999999999999999997665699999999986433
Q ss_pred ccc------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 213 TEM------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 213 ~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
... ....+||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 271 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMG--------KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE 271 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS
T ss_pred CCcccceecCCccccCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC
Confidence 221 223479999999999865 67899999999999999999999999988766665555544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-54 Score=381.20 Aligned_cols=209 Identities=30% Similarity=0.461 Sum_probs=183.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|+++++||+|+||.||+|++ +++.||||++........ ..+.+|+.+|+.++|||||++++++.+. .+|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~-----~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR-----ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG-----GGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH-----HHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 4699999999999999999987 579999999976554332 2477999999999999999999999754 7889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
|||||+||+|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+|||++.++ .+||+|||+++.....
T Consensus 226 VmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 226 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSC
T ss_pred EEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCC
Confidence 9999999999999975 4699999999999999999999999999999999999999654 5999999999865433
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~ 283 (290)
......+||+.|||||++.. ..|+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 363 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 363 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred ccccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence 34456789999999999865 678999999999999999999999999998888777766553
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-54 Score=361.48 Aligned_cols=207 Identities=32% Similarity=0.500 Sum_probs=161.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
.+|++++.||+|+||+||+|++ +++.||+|++.+....... ...++.+|+.+++.++||||+++++++.++ ..++
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSD--MQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHH--HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3599999999999999999987 5799999999865543322 224688999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+ +|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 91 vmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-CCEEECCSSCC-------
T ss_pred EEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-CCEEEeecCCCeecCCCC
Confidence 99999 6799999976 4679999999999999999999999999999999999999955 469999999998766555
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
.....+||+.|||||++.+ ...++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 167 ~~~~~~GT~~Y~APE~~~~-------~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~ 222 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK 222 (275)
T ss_dssp --------CTTSCHHHHSS-------SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ccCCeeECcccCChhhhcC-------CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 6667799999999999865 1234689999999999999999999999876554433
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=373.99 Aligned_cols=213 Identities=29% Similarity=0.452 Sum_probs=175.0
Q ss_pred cCCCceeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
.++++|++++.||+|+||+||+|++ +++.||+|+++......... .++.+|+.++++++|||||++++++.+
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR---VRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEEC---C------CCCCCCCCTTEECEEEEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHH---HHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 3456799999999999999999976 35789999997643222111 136789999999999999999999975
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
+ ..++||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~ 174 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSK 174 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccce
Confidence 4 78899999999999999986 35799999999999999999999999999999999999999654 59999999998
Q ss_pred cccc-cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 209 EETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 209 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.... .......+||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 175 ~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 240 (304)
T 3ubd_A 175 ESIDHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240 (304)
T ss_dssp C-----CCCCSCCCCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eccCCCccccccccCcccCCHHHhcc--------CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 6432 334456789999999999865 6789999999999999999999999999887766655543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-54 Score=365.44 Aligned_cols=214 Identities=29% Similarity=0.535 Sum_probs=178.4
Q ss_pred cCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
++.++|.+.++||+|+||+||+|++ ++..||||+++...... ...|.+|+.+|++++|||||++++++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA-----RKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHH-----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHH-----HHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 4456799999999999999999976 35789999997643221 24588999999999999999999999
Q ss_pred ecC-ceEEEEEecCCCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC
Q 022903 128 KDP-LMVIVTELLPGMSLRKYLVSLR-----------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 195 (290)
Q Consensus 128 ~~~-~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~ 195 (290)
.++ ..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++|+||||||+|||++.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 764 6889999999999999997632 3569999999999999999999999999999999999999955
Q ss_pred CCceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 022903 196 QKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271 (290)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~ 271 (290)
+.+||+|||+++....... .....||+.|||||++.. ..++.++|||||||++|||+| |+.||.+.+
T Consensus 165 -~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~ 235 (299)
T 4asz_A 165 -LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 235 (299)
T ss_dssp -GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred -CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 5699999999975433222 223468999999999865 679999999999999999998 999999999
Q ss_pred HHHHHHHHHHh
Q 022903 272 NLQAAYAAAFK 282 (290)
Q Consensus 272 ~~~~~~~~~~~ 282 (290)
..+....+...
T Consensus 236 ~~~~~~~i~~~ 246 (299)
T 4asz_A 236 NNEVIECITQG 246 (299)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHcC
Confidence 88776666543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-53 Score=364.00 Aligned_cols=214 Identities=30% Similarity=0.536 Sum_probs=174.6
Q ss_pred cCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
+..++|.+.++||+|+||+||+|++ +++.||||+++...... ...|.+|+.+|++++|||||++++++
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~-----~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-----RQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHH-----HHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHH-----HHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4556789999999999999999986 35789999997543221 24588999999999999999999999
Q ss_pred ecC-ceEEEEEecCCCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc
Q 022903 128 KDP-LMVIVTELLPGMSLRKYLVSLR-------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 193 (290)
Q Consensus 128 ~~~-~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~ 193 (290)
.++ ..++||||+++|+|.+++.... ..++++.+++.|+.|++.||.|||+++||||||||+|||++
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 764 6889999999999999997532 24589999999999999999999999999999999999999
Q ss_pred CCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 022903 194 PDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269 (290)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~ 269 (290)
. +..+||+|||+++...... ......||+.|||||++.. ..++.++|||||||++|||+| |+.||.+
T Consensus 193 ~-~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~ 263 (329)
T 4aoj_A 193 Q-GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263 (329)
T ss_dssp T-TTEEEECCCC----------------CCCCGGGCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred C-CCcEEEcccccceeccCCCcceecCcccccccccChhhhcC--------CCCCccccccchHHHHHHHHcCCCCCCCC
Confidence 5 4579999999998543222 2234579999999999865 678999999999999999999 9999999
Q ss_pred CCHHHHHHHHHHh
Q 022903 270 MSNLQAAYAAAFK 282 (290)
Q Consensus 270 ~~~~~~~~~~~~~ 282 (290)
.+..+....+...
T Consensus 264 ~~~~~~~~~i~~g 276 (329)
T 4aoj_A 264 LSNTEAIDCITQG 276 (329)
T ss_dssp SCHHHHHHHHHHT
T ss_pred CCHHHHHHHHHcC
Confidence 9988776666543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=362.14 Aligned_cols=213 Identities=27% Similarity=0.457 Sum_probs=178.3
Q ss_pred CCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
....++++++||+|+||+||+|++ +++.||||+++........ ..|.+|+.++++++|||||+++|++.
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~----~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLR----EEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CH----HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHH----HHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 445688899999999999999986 3478999999765443322 35889999999999999999999997
Q ss_pred cC-ceEEEEEecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc
Q 022903 129 DP-LMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 193 (290)
Q Consensus 129 ~~-~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~ 193 (290)
++ ..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++||||||||+|||++
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 54 6789999999999999996532 23589999999999999999999999999999999999999
Q ss_pred CCCCceEEeccccccccccc---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 022903 194 PDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269 (290)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~ 269 (290)
.+ +++||+|||+++..... .......||+.|||||++.. ..++.++|||||||+||||+| |..||.+
T Consensus 180 ~~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~~s~ksDVwSfGvvl~El~t~g~~Pf~~ 250 (308)
T 4gt4_A 180 DK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--------GKFSIDSDIWSYGVVLWEVFSYGLQPYCG 250 (308)
T ss_dssp GG-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CC-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--------CCCCccchhhhHHHHHHHHHhCCCCCCCC
Confidence 54 56999999999754322 22344578999999999865 679999999999999999998 9999999
Q ss_pred CCHHHHHHHHHH
Q 022903 270 MSNLQAAYAAAF 281 (290)
Q Consensus 270 ~~~~~~~~~~~~ 281 (290)
.+..+....+..
T Consensus 251 ~~~~~~~~~i~~ 262 (308)
T 4gt4_A 251 YSNQDVVEMIRN 262 (308)
T ss_dssp CCHHHHHHHHHT
T ss_pred CCHHHHHHHHHc
Confidence 998776665544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=359.18 Aligned_cols=218 Identities=30% Similarity=0.515 Sum_probs=182.1
Q ss_pred cccCCCceeecceeccccceeEEEEEECC-------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC-CCceeEE
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-DNLVKFL 124 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~ 124 (290)
+.++.++|++++.||+|+||+||+|++.+ +.||||++......... ..+.+|+.+|.+++| ||||+++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~----~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHH----HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHH----HHHHHHHHHHHHcCCCCcEEEEE
Confidence 55777899999999999999999998632 57999999876655433 358899999999965 9999999
Q ss_pred eeeec--CceEEEEEecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q 022903 125 GACKD--PLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 188 (290)
Q Consensus 125 ~~~~~--~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~ 188 (290)
++|.+ ...++|||||++|+|.+++.... ...+++..++.++.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 99854 35789999999999999997532 245899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CC
Q 022903 189 NLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 264 (290)
Q Consensus 189 Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~ 264 (290)
|||++.+ +.+||+|||+++...... ......||+.|||||++.. ..++.++|||||||++|||+| |.
T Consensus 215 NILl~~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~y~~ksDVwS~Gv~l~El~t~G~ 285 (353)
T 4ase_A 215 NILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGA 285 (353)
T ss_dssp GEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred ceeeCCC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--------CCCCCcccEeehHHHHHHHHhCCC
Confidence 9999955 569999999998643222 2234578999999999875 679999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHHHhh
Q 022903 265 LPFEGMSNLQAAYAAAFKV 283 (290)
Q Consensus 265 ~Pf~~~~~~~~~~~~~~~~ 283 (290)
.||.+.+..+....+..+.
T Consensus 286 ~Pf~~~~~~~~~~~~i~~g 304 (353)
T 4ase_A 286 SPYPGVKIDEEFCRRLKEG 304 (353)
T ss_dssp CSSTTCCCSHHHHHHHHHT
T ss_pred CCCCCCCHHHHHHHHHHcC
Confidence 9999987666665555443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=357.83 Aligned_cols=211 Identities=29% Similarity=0.442 Sum_probs=178.7
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 129 (290)
.++|++++.||+|+||+||+|++ +++.||||+++......... .++.+|+.+|+.|+|||||++++++..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 129 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA---KRTLRELKILKHFKHDNIIAIKDILRPTVPYG 129 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHH---HHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHH---HHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence 35799999999999999999987 58999999997665443322 357899999999999999999998743
Q ss_pred --CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 130 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
...|+||||++ |+|.+++.. .+.+++..+..++.||+.||.|||++|||||||||+|||++.+ +.+||+|||++
T Consensus 130 ~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla 205 (398)
T 4b99_A 130 EFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMA 205 (398)
T ss_dssp TCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred cCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC-CCEEEeeccee
Confidence 35799999995 689999875 4689999999999999999999999999999999999999955 46999999999
Q ss_pred ccccc-----cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 208 REETV-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 208 ~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
+.... .......+||+.|||||++.+ ...++.++|||||||++|+|++|++||.+.+..+....|..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~-------~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLS-------LHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred eecccCccccccccccceeChHhcCHHHhcC-------CCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 75422 223445689999999998765 24579999999999999999999999999988777766643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=347.84 Aligned_cols=196 Identities=31% Similarity=0.528 Sum_probs=156.6
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC------
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP------ 130 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 130 (290)
+|++++.||+|+||+||+|++ +++.||||++........ ..++.+|+.++++|+|||||++++++.+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA----REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHH----HHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 589999999999999999987 578999999976654332 24688999999999999999999988532
Q ss_pred -------ceEEEEEecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEe
Q 022903 131 -------LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 131 -------~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~ 202 (290)
..++||||+++|+|.+++..... ...+...++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~ 160 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVG 160 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEc
Confidence 26899999999999999976322 2245667889999999999999999999999999999999654 69999
Q ss_pred cccccccccccc-------------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 203 DFGLAREETVTE-------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 203 Dfg~~~~~~~~~-------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
|||+++...... .....+||+.|||||++.+ ..++.++|||||||++|||++ ||.+
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--------NSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcC--------CCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999998643322 1233579999999999865 678999999999999999996 8875
Q ss_pred C
Q 022903 270 M 270 (290)
Q Consensus 270 ~ 270 (290)
.
T Consensus 230 ~ 230 (299)
T 4g31_A 230 Q 230 (299)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=344.90 Aligned_cols=199 Identities=26% Similarity=0.431 Sum_probs=158.9
Q ss_pred CceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-----ce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-----LM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 132 (290)
++|.+.++||+|+||+||+|+++++.||||++..... .. ..+..|+..+..++|||||++++++.++ ..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~---~~---~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH---HH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hh---HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4588889999999999999999999999999965321 11 1234577777889999999999998643 46
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeecCCCCCEEEcCCCCceEEecc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
++||||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +++||+||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DF 152 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCC
T ss_pred EEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeC
Confidence 899999999999999976 4699999999999999999999987 99999999999999955 56999999
Q ss_pred cccccccccc-----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 205 GLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 205 g~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
|+++...... .....+||+.|||||++.+.. ......++.++|||||||++|||+||.+||.
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~--~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI--NMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCS--CTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccc--cccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 9997543322 123457999999999986410 0011246779999999999999999977654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=345.56 Aligned_cols=203 Identities=29% Similarity=0.435 Sum_probs=168.1
Q ss_pred CceeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 130 (290)
+.|++.+.||+|+||+||+|++ +++.||+|.+....... ++.+|+.+++.+ +||||+++++++.+.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-------~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPI-------RIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHH-------HHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHH-------HHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 4599999999999999999975 35789999987654322 467899999998 699999999999754
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||++|++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+++..
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 7889999999999999884 48999999999999999999999999999999999999977667999999999743
Q ss_pred ccc-----------------------------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHH
Q 022903 211 TVT-----------------------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 261 (290)
Q Consensus 211 ~~~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l 261 (290)
... ......+||+.|||||++.+ ...++.++||||+||++|+|+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-------CPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHH
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC-------CCCCCCccchhhhHHHHHHHH
Confidence 221 11234579999999998864 245899999999999999999
Q ss_pred hCCCCCCCCC-HHHHHHHH
Q 022903 262 TNRLPFEGMS-NLQAAYAA 279 (290)
Q Consensus 262 ~g~~Pf~~~~-~~~~~~~~ 279 (290)
+|+.||.+.+ +.+.+..|
T Consensus 242 ~G~~Pf~~~~~~~~~l~~I 260 (361)
T 4f9c_A 242 SGRYPFYKASDDLTALAQI 260 (361)
T ss_dssp HTCSSSSCCSSHHHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHH
Confidence 9999996554 44444443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=366.69 Aligned_cols=205 Identities=24% Similarity=0.359 Sum_probs=170.4
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHH-HHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
...++|.+++.||+|+||+||+|++ +++.||||++.+....... ........+++.+++.++|||||++++++++.
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3446799999999999999999987 6799999999653211110 01111233456777888999999999999865
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
.+|+||||++||+|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||++.++ ++||+|||+++..
T Consensus 266 ~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDF 342 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceeeec
Confidence 78899999999999999986 35799999999999999999999999999999999999999655 5999999999865
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
... ...+.+||+.|||||++.. +..|+.++|||||||++|+|++|.+||.+.
T Consensus 343 ~~~-~~~t~~GTp~YmAPEvl~~-------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 343 SKK-KPHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp SSC-CCCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred CCC-CCCCccCCcCccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 433 3456799999999999853 246899999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=363.11 Aligned_cols=209 Identities=27% Similarity=0.412 Sum_probs=183.4
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|.+++.||+|+||.||+|++ +++.||+|++........ ..+.+|+.+|+.|+||||+++++++.+. .+++
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~-----~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK-----ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH-----HHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhH-----HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4699999999999999999987 679999999976543322 3478999999999999999999999765 6889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC-CCceEEeccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVT 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~-~~~~kl~Dfg~~~~~~~~ 213 (290)
||||++||+|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.+ .+.+||+|||+++.....
T Consensus 232 v~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999999865 34679999999999999999999999999999999999999854 356999999999987666
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
......+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 311 ~~~~~~~GT~~y~APEv~~~--------~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~ 369 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CceeeeEECccccCHHHhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 66667799999999999865 678999999999999999999999999988877665554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=315.04 Aligned_cols=208 Identities=32% Similarity=0.500 Sum_probs=178.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
.+|++++.||+|+||.||+|++ +++.||||++......... ..++.+|+.+++.++||||+++++++.+. ..++
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTS---LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 4599999999999999999987 6889999999765443322 23578999999999999999999999754 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCCC
Confidence 99999999999999763 5799999999999999999999999999999999999999554 59999999998766555
Q ss_pred cccccCCCccccCccccccccccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+..+....+
T Consensus 169 ~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 226 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQG--------KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHT--------CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ccccccCCcceeCcccccC--------CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 6667789999999999865 333 57999999999999999999999997765544443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=319.38 Aligned_cols=213 Identities=28% Similarity=0.392 Sum_probs=172.3
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP- 130 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 130 (290)
...++|.+++.||+|+||.||+|++ +++.||+|++......... ....+.+|..+++.+ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~--~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHT--THHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchh--HHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 3456799999999999999999987 5789999999754221111 123467899999988 699999999999765
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||++|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~ 174 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEG 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCS
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceeec
Confidence 678999999999999999763 5799999999999999999999999999999999999999654 5999999999853
Q ss_pred c-ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 211 T-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 211 ~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
. ........+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 175 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 237 (353)
T 3txo_A 175 ICNGVTTATFCGTPDYIAPEILQE--------MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237 (353)
T ss_dssp CC---------CCGGGCCHHHHHH--------HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCCccccccCCCcCeEChhhcCC--------CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3 2333455689999999999865 568899999999999999999999999987765554443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=314.11 Aligned_cols=210 Identities=25% Similarity=0.367 Sum_probs=175.8
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.++|.+++.||+|+||.||++++ +++.||+|++......... ....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhh--HHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45699999999999999999987 5789999998653211110 113477899999999999999999999764 688
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc-c
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-V 212 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~-~ 212 (290)
+||||++|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++... .
T Consensus 82 lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCT
T ss_pred EEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccC
Confidence 99999999999999876 35799999999999999999999999999999999999999654 59999999998632 2
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
.......+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 217 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCcccccccChhhCChhhhcC--------CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 333456689999999999864 56899999999999999999999999987665544333
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=307.07 Aligned_cols=210 Identities=33% Similarity=0.475 Sum_probs=179.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
++|++.+.||+|+||.||+|.+ +++.||+|++......... .+.+|+.+++.++||||+++++++.+ ...++
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHH-----HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHH-----HHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 4699999999999999999976 6789999998765444332 47799999999999999999999865 46889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++.......
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTT
T ss_pred EEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCcc
Confidence 9999999999999976 3689999999999999999999999999999999999999554 59999999987644332
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhc
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQ 284 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~ 284 (290)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+.....
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 233 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHC--------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred cccCCccCCcCccChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 2345579999999999864 6689999999999999999999999999888877776655443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=318.52 Aligned_cols=202 Identities=28% Similarity=0.437 Sum_probs=171.3
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-c
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-L 131 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~ 131 (290)
..++|.+++.||+|+||.||+|++ +++.||+|++++........ ...+.+|..++..+ +||||+++++++.+. .
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~--~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED--IDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC------CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHH--HHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 446799999999999999999987 56899999998654333221 12467888998887 899999999999765 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc-c
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-E 210 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~-~ 210 (290)
.++||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++. .
T Consensus 128 ~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGL 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCC
T ss_pred EEEEEEcCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeecc
Confidence 8899999999999999976 35799999999999999999999999999999999999999654 599999999986 2
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~--------~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred cCCCccccccCCcccCCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 33344556789999999999865 66899999999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=313.11 Aligned_cols=212 Identities=26% Similarity=0.412 Sum_probs=179.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHH-HHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
+.|.+++.||+|+||.||++++ +++.||+|++......... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 4599999999999999999987 5789999999875543210 00012477999999999999999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC---ceEEecccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREE 210 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~---~~kl~Dfg~~~~~ 210 (290)
+||||++|++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++. .+||+|||++...
T Consensus 92 lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 92 LILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 99999999999999975 457999999999999999999999999999999999999985553 6999999999876
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..........||+.|+|||++.. ..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i 230 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCCccccCCCCccEECchHHcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 55555566789999999999864 56899999999999999999999999997766554443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=305.56 Aligned_cols=218 Identities=39% Similarity=0.600 Sum_probs=175.4
Q ss_pred cccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
..+...+|.+.+.||+|+||.||+|++.++.||+|++.......... ..+.+|+.++++++||||+++++++.+. .
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERV---NEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHH---HHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHH---HHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33456679999999999999999999999999999998766544332 3588999999999999999999999754 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~g--ivH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||++| ++||||||+||+++.+ +.+||+|||++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECCCCCCc
Confidence 7899999999999999975221 13899999999999999999999999 9999999999999955 469999999997
Q ss_pred cccccc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 209 EETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 209 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+....+...
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~ 254 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRD--------EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254 (309)
T ss_dssp --------------CCTTSCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS
T ss_pred cccccccccccCCCCccccChhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 543322 2334578999999999865 56789999999999999999999999998887766665443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=316.25 Aligned_cols=206 Identities=30% Similarity=0.445 Sum_probs=175.1
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
+..++|.+++.||+|+||.||++++ +++.||+|++......... ....+.+|+.+++.++||||+++++++.+. .
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~--~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN--EVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 4456799999999999999999987 5688999998653211111 113577999999999999999999999765 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+.|++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeeecc
Confidence 8899999999999999975 45799999999999999999999999999999999999999554 69999999998766
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
........+||+.|+|||++... ....++.++|||||||++|+|++|..||.+.
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSR-----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCC-----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CCCceeccCCCccccCCeeeccC-----CCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 55566677899999999998641 1245789999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=323.34 Aligned_cols=217 Identities=27% Similarity=0.399 Sum_probs=177.0
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
....++|.+++.||+|+||.||+|++ +++.||+|++.+....... ....+.+|+.+++.++||||+++++++.+.
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~--~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS--DSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTC--CCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhH--HHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34567899999999999999999987 5789999998642111000 011367899999999999999999999765
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKM 218 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEee
Confidence 67899999999999999875 4689999999999999999999999999999999999999554 5999999999765
Q ss_pred cccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 211 TVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 211 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.... .....+||+.|+|||++... .....++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 286 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTT----TTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ccCCcccccCCcCCccccCHHHhhcc----CCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence 4332 23456899999999998641 011227889999999999999999999999977665555443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=324.42 Aligned_cols=219 Identities=24% Similarity=0.374 Sum_probs=178.4
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
...++|.+++.||+|+||+||+|++ +++.||+|++.+....... ....+.+|..++..++||||+++++++.+. .
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~--~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA--ETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTT--TTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHH--HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 4557799999999999999999987 4689999998642211110 011367899999999999999999999765 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLM 226 (437)
T ss_dssp EEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred EEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhcc
Confidence 7899999999999999976 346799999999999999999999999999999999999999554 69999999997543
Q ss_pred cccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 212 VTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 212 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.... ....+||+.|+|||++.... .....++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 294 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQAME---GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHHHHH---TSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCCcccccccCCcCeeChHHHhhcc---cCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence 3322 23458999999999885210 012457899999999999999999999999987766655554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=310.92 Aligned_cols=209 Identities=27% Similarity=0.405 Sum_probs=179.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|.+.+.||+|+||.||++.+ +++.||+|++.......... ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF---QKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHH---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHH---HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4699999999999999999987 57899999998765543322 3578999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC--CceEEecccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREETV 212 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~--~~~kl~Dfg~~~~~~~ 212 (290)
||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++.....
T Consensus 106 v~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999999999999875 45789999999999999999999999999999999999998543 3599999999987655
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
........||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i 242 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CcccccCCCCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 554556689999999999864 56899999999999999999999999997766554444
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=309.03 Aligned_cols=201 Identities=28% Similarity=0.439 Sum_probs=172.0
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ce
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~ 132 (290)
..+|.+++.||+|+||.||++++ +++.||+|++.......... ...+.+|..++..+ +||||+++++++.+. ..
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED--IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHH--HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHH--HHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 45699999999999999999987 47899999998654433222 23577899999988 899999999999764 68
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc-
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET- 211 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~- 211 (290)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 86 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLR 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCC
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccccC
Confidence 8999999999999999763 5799999999999999999999999999999999999999554 69999999998532
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
........+||+.|+|||++.. ..++.++|||||||++|+|++|..||...
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred CCCcccccCCCccccCccccCC--------CCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence 2334456689999999999864 56899999999999999999999999763
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=302.58 Aligned_cols=210 Identities=30% Similarity=0.483 Sum_probs=173.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||.||+|++ +++.||+|++.......... ..++.+|+.+++.++||||+++++++.+. ..++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEET--LKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHH--HHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHH--HHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 5699999999999999999987 57899999987654433322 24688999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++.......
T Consensus 89 v~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC----
T ss_pred EEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCcccccccc
Confidence 99999999999999863 5799999999999999999999999999999999999999554 59999999997643332
Q ss_pred --cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 215 --MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 --~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.........
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~ 225 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKG--------EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI 225 (294)
T ss_dssp ---------CCSSCCHHHHHT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH
T ss_pred ccccCccccCccccCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 2234568999999998864 567899999999999999999999999988776655443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=307.46 Aligned_cols=208 Identities=19% Similarity=0.349 Sum_probs=178.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|.+.+.||+|+||.||++.+ +++.||+|++...... . ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~--~----~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--Q----VLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--H----HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc--H----HHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 5699999999999999999987 5789999998754321 1 2477999999999999999999999754 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC-CCceEEeccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVT 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~-~~~~kl~Dfg~~~~~~~~ 213 (290)
||||+++++|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.+ ++.+||+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 79 IFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999999999975 33579999999999999999999999999999999999999853 457999999999876555
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.......+|+.|+|||++.. ..++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 216 (321)
T 1tki_A 158 DNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CccccccCChhhcCcHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 55556679999999999864 457889999999999999999999999987766555443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=310.67 Aligned_cols=213 Identities=29% Similarity=0.472 Sum_probs=175.9
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP- 130 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 130 (290)
...++|.+.+.||+|+||.||+|++ +++.||+|+++........ ....+.+|..++..+ +||||+++++++.+.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhh--hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3456799999999999999999987 5789999999753211100 112466888888877 899999999999765
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||++|++|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++ .+||+|||+++..
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCC
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhhc
Confidence 678999999999999999763 5799999999999999999999999999999999999999655 5999999999763
Q ss_pred cc-cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 211 TV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 211 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 231 (345)
T 1xjd_A 169 MLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231 (345)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCCCcccCCCCCcccCChhhhcC--------CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 32 233456689999999999865 568999999999999999999999999977665544443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=305.78 Aligned_cols=213 Identities=30% Similarity=0.515 Sum_probs=176.4
Q ss_pred cCCCceeecceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
....+|.+.+.||+|+||.||+|++. +..||||++......... ..+.+|+.+++.++||||+++++++.+
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR----RDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHH----HHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHH----HHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45677999999999999999999872 346999999866544332 358899999999999999999999976
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
. ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.++|+|||++.
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~ 199 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSR 199 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCSSCE
T ss_pred CCccEEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-CCEEECCCCccc
Confidence 4 67899999999999999975 34679999999999999999999999999999999999999955 469999999997
Q ss_pred cccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022903 209 EETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 209 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~ 281 (290)
...... ......+|+.|+|||++.. ..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 269 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAF--------RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred ccccCccceeeccCCCCcccccCHhHhcC--------CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 643322 1222346778999999864 567889999999999999999 9999999888766655544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.79 Aligned_cols=213 Identities=29% Similarity=0.411 Sum_probs=170.7
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHH-HhhcCCCCceeEEeeeecC-
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNM-MSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~- 130 (290)
...++|.+++.||+|+||.||++++ +++.||+|++.......... ...+.+|..+ ++.++||||+++++++.+.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~--~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC---------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHH--HHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 3456799999999999999999987 46889999997654332221 1235667666 5678999999999999765
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||++|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGG
T ss_pred EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCcccccc
Confidence 68899999999999999976 35789999999999999999999999999999999999999654 5999999999863
Q ss_pred c-ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 211 T-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 211 ~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
. ........+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 252 (373)
T 2r5t_A 190 IEHNSTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252 (373)
T ss_dssp BCCCCCCCSBSCCCCCCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH
T ss_pred ccCCCccccccCCccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 2 2334456689999999999864 668999999999999999999999999877655544443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=307.16 Aligned_cols=209 Identities=29% Similarity=0.450 Sum_probs=176.2
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.++|.+++.||+|+||.||++++ +++.||+|++......... ....+.+|..+++.++||||+++++++.+. ..+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK--QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhh--HHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 35699999999999999999987 5789999998753211100 113467899999999999999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS-
T ss_pred EEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCC-
Confidence 99999999999999986 45799999999999999999999999999999999999999554 699999999976432
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.....+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 159 -~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 216 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred -ccccccCCccccCHhHhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2345689999999998864 568899999999999999999999999977765554443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=311.29 Aligned_cols=212 Identities=25% Similarity=0.385 Sum_probs=175.8
Q ss_pred CCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-c
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-L 131 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~ 131 (290)
...+|.+++.||+|+||.||+|++. ++.||+|++......... ....+.+|..++..+ +||+|+++++++.+. .
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~--~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTT--CHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcch--HHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 4466999999999999999999884 578999998753211111 113467899999888 799999999999764 7
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENI 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCcccccc
Confidence 88999999999999999863 5699999999999999999999999999999999999999654 59999999998632
Q ss_pred -ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 212 -VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 212 -~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
........+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 234 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTT--------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCcccccccCCccccChhhhcC--------CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 2233456689999999999864 568999999999999999999999999977665544443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=318.87 Aligned_cols=221 Identities=23% Similarity=0.332 Sum_probs=179.1
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
...++|.+++.||+|+||.||++++ +++.||+|++.+....... ....+.+|..++..++||||+++++++.+. .
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~--~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG--EVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHG--GGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHH--HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 4567799999999999999999987 5789999998653211111 112367899999999999999999999765 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||++|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLR 213 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheecc
Confidence 78999999999999999763 34799999999999999999999999999999999999999554 59999999997654
Q ss_pred cccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 212 VTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 212 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.... ....+||+.|+|||++..... ......++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGG-GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHT-CTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCCccccceeccccCcCCHHHHhhccc-CcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3322 234589999999998863100 0012457899999999999999999999999987766555544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=314.20 Aligned_cols=210 Identities=25% Similarity=0.356 Sum_probs=177.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|.+++.||+|+||.||++.+ +++.||+|++.......... ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH---QKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHH---HHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHH---HHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 4599999999999999999987 67899999998766544332 3578999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC--CCCceEEecccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREETV 212 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~--~~~~~kl~Dfg~~~~~~~ 212 (290)
||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++. +++.+||+|||++.....
T Consensus 88 v~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 9999999999999986 357999999999999999999999999999999999999984 235699999999976443
Q ss_pred cc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.. ......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 226 (444)
T 3soa_A 166 EQQAWFGFAGTPGYLSPEVLRK--------DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK 226 (444)
T ss_dssp TCCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCceeecccCCcccCCHHHhcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 32 2345689999999999864 568999999999999999999999999987766555444
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=304.19 Aligned_cols=213 Identities=29% Similarity=0.438 Sum_probs=168.9
Q ss_pred CCCceeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
..+.|.+++.||+|+||.||+++. +++.||+|++.......... ....+.+|+.+++.++||||+++++++.+.
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK-DTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhh-HHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 456799999999999999999986 57899999998754322111 123467899999999999999999999754
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++..
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~ 170 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLER--EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKE 170 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC--
T ss_pred CEEEEEEeCCCCCcHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCcccc
Confidence 78899999999999999976 35689999999999999999999999999999999999999554 699999999875
Q ss_pred cccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 210 ETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 210 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.... .......||+.|+|||++.. ..++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 234 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMR--------SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccCCccccccCCCcCccCHhhCcC--------CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 3322 23345679999999998864 567899999999999999999999999987765554443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=311.09 Aligned_cols=209 Identities=25% Similarity=0.418 Sum_probs=179.1
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|.+++.||+|+||.||+|.+ +++.||+|++........ ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK-----YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH-----HHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhH-----HHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 4699999999999999999987 578999999976543222 2478999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC-CCceEEeccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVT 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~-~~~~kl~Dfg~~~~~~~~ 213 (290)
||||+++++|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.+ .+.+||+|||++......
T Consensus 126 v~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999998875 34579999999999999999999999999999999999999743 356999999999876555
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.......||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~ 263 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 263 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred cceeeeccCCCccCchhccC--------CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 55555689999999998864 567899999999999999999999999987766555443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=305.95 Aligned_cols=211 Identities=30% Similarity=0.500 Sum_probs=175.0
Q ss_pred CCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 130 (290)
...+|.+.+.||+|+||.||+|++. ++.||||++......... ..+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV----DVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCH----HHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchH----HHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence 4567999999999999999999884 789999998764433222 2467999999999999999999998643
Q ss_pred ceEEEEEecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEE----cCCCCceEEeccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQKSLKLADFG 205 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili----~~~~~~~kl~Dfg 205 (290)
..++||||+++++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+|||+ + +...+||+|||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg 161 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTT-SCEEEEECCCT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCC-CCceEEEccCC
Confidence 56899999999999999976432 238999999999999999999999999999999999998 5 34469999999
Q ss_pred ccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 206 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
++.............||+.|+|||++............++.++|||||||++|+|++|..||....
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998765555555668999999999875422222223678899999999999999999999998644
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=307.05 Aligned_cols=214 Identities=31% Similarity=0.564 Sum_probs=176.5
Q ss_pred cccCCCceeecceeccccceeEEEEEEC---------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCcee
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVK 122 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 122 (290)
+....++|.+++.||+|+||.||+|++. +..||+|++......... ..+.+|+.+++.+ +||||++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~~hpnIv~ 151 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL----SDLVSEMEMMKMIGKHKNIIN 151 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHH----HHHHHHHHHHHHSCCCTTBCC
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHH----HHHHHHHHHHHHhcCCCCEee
Confidence 3445678999999999999999999762 246999999876443322 3588999999999 8999999
Q ss_pred EEeeeecC-ceEEEEEecCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCC
Q 022903 123 FLGACKDP-LMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 187 (290)
Q Consensus 123 ~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp 187 (290)
+++++.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|++||||||
T Consensus 152 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 231 (370)
T 2psq_A 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 231 (370)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 99998654 68899999999999999987432 3578999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-C
Q 022903 188 DNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 263 (290)
Q Consensus 188 ~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g 263 (290)
+|||++.+ +.+||+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |
T Consensus 232 ~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~ellt~g 302 (370)
T 2psq_A 232 RNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEIFTLG 302 (370)
T ss_dssp GGEEECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred hhEEECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcC--------CCCCcHHHHHHHHHHHHHHHcCC
Confidence 99999955 469999999997543322 2233456789999998864 668999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHH
Q 022903 264 RLPFEGMSNLQAAYAA 279 (290)
Q Consensus 264 ~~Pf~~~~~~~~~~~~ 279 (290)
..||.+....+....+
T Consensus 303 ~~p~~~~~~~~~~~~~ 318 (370)
T 2psq_A 303 GSPYPGIPVEELFKLL 318 (370)
T ss_dssp CCSSTTCCGGGHHHHH
T ss_pred CCCCCCCCHHHHHHHH
Confidence 9999997765544433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=301.97 Aligned_cols=212 Identities=25% Similarity=0.396 Sum_probs=178.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHH-HHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
+.|.+.+.||+|+||.||++++ +++.||+|++......... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4599999999999999999987 4789999999765432110 00012477999999999999999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC---ceEEecccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREE 210 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~---~~kl~Dfg~~~~~ 210 (290)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++. .+||+|||++...
T Consensus 91 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 99999999999999975 467999999999999999999999999999999999999985542 6999999999876
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..........||+.|+|||++.. ..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 229 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 229 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CCCCccccccCCcCcCCceeecC--------CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 55545556689999999998854 56899999999999999999999999988766555444
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=308.87 Aligned_cols=209 Identities=24% Similarity=0.344 Sum_probs=176.1
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.++|.+++.||+|+||.||++++ +++.||+|++......... ....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK--QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 35699999999999999999987 5789999998653221111 113577899999999999999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC
T ss_pred EEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccCC
Confidence 999999999999999863 5699999999999999999999999999999999999999554 5999999999864332
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
....+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 195 --~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 251 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251 (350)
T ss_dssp --BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred --cccccCCccccCHHHhcC--------CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH
Confidence 345579999999999864 568899999999999999999999999977665544443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=308.42 Aligned_cols=206 Identities=26% Similarity=0.409 Sum_probs=170.5
Q ss_pred eecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEE
Q 022903 61 FIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTE 137 (290)
Q Consensus 61 ~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e 137 (290)
...+.||+|+||.||+|.+ +++.||+|++........ ..+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~-----~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK-----EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHH-----HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccH-----HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3467899999999999987 578999999987543222 3578999999999999999999999764 6789999
Q ss_pred ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc-CCCCceEEecccccccccccccc
Q 022903 138 LLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMM 216 (290)
Q Consensus 138 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~-~~~~~~kl~Dfg~~~~~~~~~~~ 216 (290)
|+++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++ .+.+.+||+|||++.........
T Consensus 167 ~~~~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 167 YVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp CCTTCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred CCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 9999999998875 335689999999999999999999999999999999999994 24457999999999876555555
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
....||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 246 ~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 301 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNY--------DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301 (373)
T ss_dssp CCCCSSCTTCCHHHHTT--------CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ccccCCCcEeChhhccC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 56679999999998754 567889999999999999999999999988776655544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=307.91 Aligned_cols=207 Identities=23% Similarity=0.348 Sum_probs=171.6
Q ss_pred cccccccccCCCceeecceeccccceeEEEEE-------ECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC---
Q 022903 47 LTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGR-------YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--- 116 (290)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--- 116 (290)
+..........+.|.+.+.||+|+||.||+|. ..++.||+|++...... .+.+|+.+++.++
T Consensus 54 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~e~~~~~~l~~~~ 125 (365)
T 3e7e_A 54 IKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW--------EFYIGTQLMERLKPSM 125 (365)
T ss_dssp CCSSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH--------HHHHHHHHHHHSCGGG
T ss_pred cccceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh--------HHHHHHHHHHHhhhhh
Confidence 33445566778899999999999999999993 26789999999765321 2556777777776
Q ss_pred CCCceeEEeeeec-CceEEEEEecCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEE
Q 022903 117 HDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSL---RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 192 (290)
Q Consensus 117 h~~iv~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili 192 (290)
|+||+.+++++.. ...++||||+++++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 126 ~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll 205 (365)
T 3e7e_A 126 QHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFIL 205 (365)
T ss_dssp GGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE
T ss_pred hhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEe
Confidence 9999999999865 4788999999999999999753 24569999999999999999999999999999999999999
Q ss_pred cCC----------CCceEEecccccccc---cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHH
Q 022903 193 TPD----------QKSLKLADFGLAREE---TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259 (290)
Q Consensus 193 ~~~----------~~~~kl~Dfg~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~ 259 (290)
+.+ .+.+||+|||++... ..........||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 206 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~e 277 (365)
T 3e7e_A 206 GNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--------KPWNYQIDYFGVAATVYC 277 (365)
T ss_dssp CGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--------CCBSTHHHHHHHHHHHHH
T ss_pred cccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--------CCCCccccHHHHHHHHHH
Confidence 851 456999999999643 22334455689999999999865 568999999999999999
Q ss_pred HHhCCCCCCC
Q 022903 260 LLTNRLPFEG 269 (290)
Q Consensus 260 ~l~g~~Pf~~ 269 (290)
|++|+.||..
T Consensus 278 lltg~~pf~~ 287 (365)
T 3e7e_A 278 MLFGTYMKVK 287 (365)
T ss_dssp HHHSSCCCEE
T ss_pred HHhCCCcccc
Confidence 9999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=300.51 Aligned_cols=211 Identities=29% Similarity=0.470 Sum_probs=172.5
Q ss_pred CCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
.++|++++.||+|+||.||+|++ +++.||+|++........ ....+.+|+.+++.++||||+++++++.+. ..++
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG---IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------C---HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccch---hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 35699999999999999999988 678999999976543221 123577999999999999999999999755 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||+++ +|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++......
T Consensus 97 v~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCceecCCCc
Confidence 9999975 88888876 345699999999999999999999999999999999999999554 5999999999764322
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 233 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMG-------SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF 233 (311)
T ss_dssp C---CCCCCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH
T ss_pred ccccCCcccCCcCCHHHhcC-------CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 23344578999999998754 2457899999999999999999999999887766555543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=302.70 Aligned_cols=215 Identities=31% Similarity=0.445 Sum_probs=174.8
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc---CCCCceeEEeeeecC-
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACKDP- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~- 130 (290)
..+|++++.||+|+||.||+|++ +++.||+|++...............+.+|+.+++.+ +||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 45799999999999999999985 678999999874332110000001244666666665 499999999998643
Q ss_pred -----ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 131 -----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 131 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
..++||||+. ++|.+++.......+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg 165 (308)
T 3g33_A 88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLADFG 165 (308)
T ss_dssp SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT-SCEEECSCS
T ss_pred CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEEeeCc
Confidence 3689999996 599999987655569999999999999999999999999999999999999955 469999999
Q ss_pred ccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 206 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
++.............||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHT--------SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred cccccCCCcccCCccccccccCchHHcC--------CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9987655555566789999999999864 5689999999999999999999999999888777666654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=323.87 Aligned_cols=217 Identities=22% Similarity=0.368 Sum_probs=180.9
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
....+|.+.+.||+|+||.||+|++ +++.||+|++......... ....+.+|+.+++.++||||+++++++.+. .
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~--~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK--GEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhH--HHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 4567799999999999999999987 5789999998653211111 113477999999999999999999999764 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~~ 337 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHVP 337 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceecc
Confidence 88999999999999999875555699999999999999999999999999999999999999554 69999999998765
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHh
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS---NLQAAYAAAFK 282 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~---~~~~~~~~~~~ 282 (290)
........+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+ ...........
T Consensus 338 ~~~~~~~~~GT~~Y~APEvl~~--------~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~ 403 (576)
T 2acx_A 338 EGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403 (576)
T ss_dssp TTCCEECCCSCGGGCCHHHHTT--------CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH
T ss_pred cCccccccCCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc
Confidence 5555556689999999999864 568899999999999999999999998864 23444444433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=298.46 Aligned_cols=201 Identities=33% Similarity=0.519 Sum_probs=170.4
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
...++|.+++.||+|+||.||+|.+ +++.||+|++....... ...+.+|+.+++.++||||+++++++.+. .
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 81 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-----QRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR 81 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHH-----HHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHH-----HHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence 4567799999999999999999987 47899999886543222 23588999999999999999999998654 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-KNVVVADFGLARLMV 159 (310)
T ss_dssp EEEEEECCTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-SCEEECCCTTCEECC
T ss_pred eEEEEEecCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-CCEEEeecccceecc
Confidence 7899999999999999986 35679999999999999999999999999999999999999955 459999999997543
Q ss_pred ccccc---------------cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 212 VTEMM---------------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 212 ~~~~~---------------~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
..... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--------RSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 22211 14579999999999864 67899999999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=292.27 Aligned_cols=214 Identities=30% Similarity=0.571 Sum_probs=180.6
Q ss_pred ccccCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
.+.++.++|++.+.||+|+||.||+|++ .++.||+|++.......+ .+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------~~~~E~~~l~~l~h~~i~~~~~~~~~~ 77 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE------DFIEEAEVMMKLSHPKLVQLYGVCLEQ 77 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHH------HHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHH------HHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3456778899999999999999999988 678899999987654432 377999999999999999999999764
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRF 155 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGGGG
T ss_pred CceEEEEEeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEecccccccc
Confidence 67899999999999999976 34569999999999999999999999999999999999999855 4699999999976
Q ss_pred ccccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022903 210 ETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 210 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~ 281 (290)
..... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~ 222 (269)
T 4hcu_A 156 VLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 222 (269)
T ss_dssp BCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred ccccccccccCcccccccCCHHHhcC--------CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Confidence 43332 2233456788999998864 568899999999999999999 9999999887665555443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=307.47 Aligned_cols=203 Identities=28% Similarity=0.441 Sum_probs=161.7
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
.....+|.+++.||+|+||.||++++ +++.||+|++........ .+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE------NVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCH------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccH------HHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 44567899999999999999999988 578999999986554332 367999999999999999999999754
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC-CceEEeccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ-KSLKLADFGLARE 209 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~-~~~kl~Dfg~~~~ 209 (290)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ ..+||+|||+++.
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 67899999999999999876 35799999999999999999999999999999999999998543 2499999999976
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
...........||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+...
T Consensus 168 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 168 SVLHSQPKSTVGTPAYIAPEVLLR--------QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp -------------CTTSCHHHHHC--------SSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred ccccCCCCCCcCCCCcCChhhhcC--------CCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 544444556689999999999864 3443 458999999999999999999988644
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=307.27 Aligned_cols=208 Identities=26% Similarity=0.445 Sum_probs=165.3
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC---c
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP---L 131 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~---~ 131 (290)
++|.+++.||+|+||.||+|.+ +++.||||++.......... .++.+|+.+++.+. ||||+++++++... .
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~---~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA---QRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHH---HHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHH---HHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4699999999999999999987 57899999987654333222 35779999999997 99999999998632 5
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||++ ++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 86 ~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEESS
T ss_pred EEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC-CCEEecCCccccccc
Confidence 799999996 589999876 478999999999999999999999999999999999999955 469999999997532
Q ss_pred c----------------------cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 212 V----------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 212 ~----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
. .......+||+.|+|||++.+ ...++.++|||||||++|+|++|++||.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-------STKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-------CCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 112334579999999998864 25689999999999999999999999999
Q ss_pred CCHHHHHHHHH
Q 022903 270 MSNLQAAYAAA 280 (290)
Q Consensus 270 ~~~~~~~~~~~ 280 (290)
.+..+....+.
T Consensus 234 ~~~~~~~~~i~ 244 (388)
T 3oz6_A 234 SSTMNQLERII 244 (388)
T ss_dssp SSHHHHHHHHH
T ss_pred CCHHHHHHHHH
Confidence 98877776665
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=315.81 Aligned_cols=209 Identities=31% Similarity=0.420 Sum_probs=170.8
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 130 (290)
..++|++++.||+|+||.||+|.+ +++.||||++......... ..++.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH---AKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHH---HHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHH---HHHHHHHHHHHHhCCCCCCCcEEEEEccCCcc
Confidence 346799999999999999999987 5789999999765322222 24678999999999999999999998543
Q ss_pred ----ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 131 ----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 131 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~ 210 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGL 210 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEe
Confidence 46899999965 57666643 489999999999999999999999999999999999999554 699999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
+.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~ 277 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeecCCCcccCCCcccccccCHHHHcC--------CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 987665555566789999999999865 5689999999999999999999999999888777666554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.21 Aligned_cols=209 Identities=30% Similarity=0.458 Sum_probs=162.6
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.+.|.+.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++||||+++++++.+. ..+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-------KIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhH-------HHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 35699999999999999999988 4678999999764321 2467899999999999999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC--CCCceEEeccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREET 211 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~--~~~~~kl~Dfg~~~~~~ 211 (290)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++. +++.+||+|||++....
T Consensus 125 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999999875 456899999999999999999999999999999999999974 24569999999998655
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+..+....+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~ 265 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRG--------CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265 (349)
T ss_dssp ----------CGGGSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT
T ss_pred cccccccccCCCCccCHHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh
Confidence 4444456679999999998864 56899999999999999999999999987766655554444
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=301.60 Aligned_cols=212 Identities=31% Similarity=0.469 Sum_probs=172.1
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 130 (290)
.++|++.+.||+|+||.||+|++ +++.||+|++.......... ..++.+|+.+++.++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSF--YLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHH--HHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHH--HHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 35699999999999999999986 67899999998765443322 24688999999999999999999988543
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~ 165 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC--
T ss_pred cccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCccc
Confidence 248999999999999999763 5799999999999999999999999999999999999999554 599999999975
Q ss_pred ccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 210 ETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 210 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
..... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+.......
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 233 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233 (311)
T ss_dssp ----------------CCTTCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccccccCcCcccCCHHHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc
Confidence 43221 2233468999999998864 5688999999999999999999999999887766655543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=307.78 Aligned_cols=217 Identities=20% Similarity=0.320 Sum_probs=180.8
Q ss_pred cccCCCceeecceeccc--cceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 53 LLVDPKLLFIGSKIGEG--AHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G--~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
......+|++++.||+| +||.||+|++ +++.||||++......... ...+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEM---VTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHH---HHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 44566789999999999 9999999988 4789999999875544332 245789999999999999999999986
Q ss_pred cC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 129 DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 129 ~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
+. ..++||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||.+
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~ 175 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSN 175 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGGC
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccccc
Confidence 54 678999999999999999876567799999999999999999999999999999999999999554 6999999987
Q ss_pred cccccc--------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 208 REETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 208 ~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
...... .......||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 249 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK 249 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHST------TSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred eeeccccccccccccccccccccccccCHHHHhc------cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 642211 11223478999999998864 1246889999999999999999999999987766555443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=312.63 Aligned_cols=210 Identities=34% Similarity=0.577 Sum_probs=178.5
Q ss_pred ccccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
.+.+..+.|.+.+.||+|+||.||+|.+.++.||||+++..... ..+.+|+.++++++||||+++++++.+.
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA-------QAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTS-------HHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHH-------HHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 45567788999999999999999999999999999999875422 2478999999999999999999997543
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++||||+++++|.+++.......++...++.++.||+.||.|||++|++||||||+|||++.+ +.+||+|||+++.
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKE 338 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-SCEEECCCTTCEE
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-CCEEEeeCCCccc
Confidence 68899999999999999987655558999999999999999999999999999999999999955 4699999999975
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
.... .....++..|+|||++.. ..++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus 339 ~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i 399 (450)
T 1k9a_A 339 ASST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399 (450)
T ss_dssp CC--------CCCTTTSCHHHHHS--------SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH
T ss_pred cccc--ccCCCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 4322 223367889999999864 668999999999999999998 99999998766555444
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=306.09 Aligned_cols=201 Identities=32% Similarity=0.502 Sum_probs=170.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
..|.+.+.||+|+||.||+|.+ +++.||+|++........ ....++.+|+.+++.++||||+++++++.++ ..++
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS--DMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT--TCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccch--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4599999999999999999987 678999999864321111 0113577999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+ +++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-CCEEEEEeccceeccCCc
Confidence 99999 78999988763 579999999999999999999999999999999999999955 469999999998766666
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.....+||+.|+|||++.+ ....+.++||||||+++|+|++|..||.+..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVING-------KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCC-------SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred ccccccCCcCcCCHHHHcC-------CCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 6667789999999999864 1223789999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=294.10 Aligned_cols=214 Identities=29% Similarity=0.509 Sum_probs=169.5
Q ss_pred cccCCCceeecceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
......+|++.+.||+|+||.||+|.+. +..||+|++........ ...+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV----REKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHH----HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHH----HHHHHHHHHHHHhCCCCccceEEEEE
Confidence 3455678999999999999999999873 35699999876544332 23588999999999999999999999
Q ss_pred ecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 128 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
.+...++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~ 163 (281)
T 1mp8_A 86 TENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLS 163 (281)
T ss_dssp CSSSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC----
T ss_pred ccCccEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECccccc
Confidence 88888999999999999999976 34579999999999999999999999999999999999999955 56999999999
Q ss_pred cccccccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 208 REETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 208 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
........ .....+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~ 231 (281)
T 1mp8_A 164 RYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231 (281)
T ss_dssp ---------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred cccCcccccccccCCCcccccChhhccc--------CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH
Confidence 76433322 223356788999998864 568899999999999999997 999999987765554443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=296.56 Aligned_cols=211 Identities=29% Similarity=0.442 Sum_probs=172.5
Q ss_pred CceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
++|++++.||+|+||.||+|++ .++.||+|++......... ...+.+|+.+++.++||||+++++++.+. ..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI---PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC---CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccccc---chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 4699999999999999999987 4789999998765432211 12467999999999999999999999754 68899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-c
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~ 214 (290)
|||+++ +|.+++.. ....+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EECCSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---
T ss_pred EEecCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCcccc
Confidence 999965 99998875 346799999999999999999999999999999999999999554 5999999998754322 2
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
......+|+.|+|||++.+ ...++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 215 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (288)
T ss_dssp ------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccccCchheeC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2334578999999998754 24578999999999999999999999999887776666543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=313.80 Aligned_cols=216 Identities=33% Similarity=0.513 Sum_probs=183.2
Q ss_pred cccccCCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
..+.+..++|.+.+.||+|+||.||+|.+. +..||||+++...... ..+.+|+.+++.++||||+++++++.+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~iv~l~~~~~~ 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV------EAFLAEANVMKTLQHDKLVKLHAVVTK 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCH------HHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccH------HHHHHHHHHHhhCCCCCEeeEEEEEeC
Confidence 445677788999999999999999999884 6789999998654332 247899999999999999999999988
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...++||||+.+++|.+++.......++...+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||+++.
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARV 333 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CCEEECSTTGGGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-CcEEEeeCCCceE
Confidence 889999999999999999976444468899999999999999999999999999999999999955 4699999999986
Q ss_pred cccccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022903 210 ETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 210 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~ 281 (290)
...... .....++..|+|||++.. ..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~ 400 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH
T ss_pred cCCCceeccCCCcccccccCHHHhcc--------CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 433221 223356788999999864 568999999999999999999 9999999888776655543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=296.02 Aligned_cols=225 Identities=33% Similarity=0.504 Sum_probs=184.4
Q ss_pred cccccccccccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-C
Q 022903 45 PQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-K 116 (290)
Q Consensus 45 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~ 116 (290)
.++..+..+.....+|.+.+.||+|+||.||+|++ +++.||+|++......... ..+.+|+.+++.+ +
T Consensus 10 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~~ 85 (313)
T 1t46_A 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER----EALMSELKVLSYLGN 85 (313)
T ss_dssp TTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHH----HHHHHHHHHHHHHCC
T ss_pred ccCCCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHH----HHHHHHHHHHhhccc
Confidence 33444555667778899999999999999999975 3478999999876554332 3588999999999 8
Q ss_pred CCCceeEEeeeecC-ceEEEEEecCCCCHHHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHHCC
Q 022903 117 HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN----------------KLDLHVALNFALDIARAMDCLHANG 179 (290)
Q Consensus 117 h~~iv~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~----------------~~~~~~~~~i~~qi~~~l~~lH~~g 179 (290)
||||+++++++.+. ..++||||+++++|.+++...... .+++..++.++.||+.||.|||++|
T Consensus 86 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 165 (313)
T 1t46_A 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165 (313)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999998654 678999999999999999874322 4899999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHH
Q 022903 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256 (290)
Q Consensus 180 ivH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~ 256 (290)
++||||||+||+++.+ +.+||+|||++........ .....+|+.|+|||.+.. ..++.++||||||++
T Consensus 166 i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 236 (313)
T 1t46_A 166 CIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIF 236 (313)
T ss_dssp CCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHH
T ss_pred eecCCCccceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcC--------CCCChHHHHHHHHHH
Confidence 9999999999999954 5699999999976443322 223346788999998864 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022903 257 LWELLT-NRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 257 l~~~l~-g~~Pf~~~~~~~~~~~~~~~ 282 (290)
+|+|++ |..||.+.............
T Consensus 237 l~ellt~g~~p~~~~~~~~~~~~~~~~ 263 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPVDSKFYKMIKE 263 (313)
T ss_dssp HHHHHTTTCCSSTTCCSSHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcccchhHHHHHhcc
Confidence 999999 99999998765555555443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=303.82 Aligned_cols=216 Identities=31% Similarity=0.503 Sum_probs=178.2
Q ss_pred ccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
....++|.+++.||+|+||.||+|++ +++.||||++......... ..+.+|+.+++.++||||++++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----LDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHH----HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhH----HHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34567899999999999999999984 3468999999765544433 257899999999999999999999
Q ss_pred eecC-ceEEEEEecCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC--Cc
Q 022903 127 CKDP-LMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KS 198 (290)
Q Consensus 127 ~~~~-~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~--~~ 198 (290)
+.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ..
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 9754 67899999999999999987432 3589999999999999999999999999999999999998432 35
Q ss_pred eEEeccccccccccc---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 199 LKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 199 ~kl~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
+||+|||+++..... .......+|+.|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~ 294 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 294 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999743221 22233467889999998865 668999999999999999998 999999987766
Q ss_pred HHHHHHH
Q 022903 275 AAYAAAF 281 (290)
Q Consensus 275 ~~~~~~~ 281 (290)
....+..
T Consensus 295 ~~~~i~~ 301 (367)
T 3l9p_A 295 VLEFVTS 301 (367)
T ss_dssp HHHHHHT
T ss_pred HHHHHHc
Confidence 5554443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=302.57 Aligned_cols=207 Identities=29% Similarity=0.444 Sum_probs=170.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||.||+|++ +++.||+|++......... ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP----ENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchH----HHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 5699999999999999999987 5789999998765443322 2477999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 83 FLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETT
T ss_pred EEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCC
Confidence 9999999999998864 45699999999999999999999999999999999999999554 5999999999753222
Q ss_pred --ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 214 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 214 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
.......||+.|+|||++.. ....+.++||||||+++|+|++|..||.+.+.....+.
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 219 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHC-------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH
T ss_pred cccccCCCccCcCccCcHHhcc-------CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 22345679999999999864 12347789999999999999999999988765433333
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=302.09 Aligned_cols=216 Identities=33% Similarity=0.567 Sum_probs=179.7
Q ss_pred cccccCCCceeecceeccccceeEEEEEECC---------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCc
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD---------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNL 120 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 120 (290)
..+....++|.+++.||+|+||.||+|++.+ ..||+|++......... .++.+|+.+++.+ +||||
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~~hpnI 137 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL----SDLISEMEMMKMIGKHKNI 137 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHH----HHHHHHHHHHHHHCCCTTB
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHH----HHHHHHHHHHHHhcCCchh
Confidence 3445666789999999999999999998622 57999999876554432 3578999999999 89999
Q ss_pred eeEEeeeecC-ceEEEEEecCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecC
Q 022903 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDL 185 (290)
Q Consensus 121 v~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Di 185 (290)
+++++++.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|++||||
T Consensus 138 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 217 (382)
T 3tt0_A 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 217 (382)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred hhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 9999999754 67899999999999999987442 35899999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccccccccccc---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh
Q 022903 186 KPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262 (290)
Q Consensus 186 kp~Nili~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~ 262 (290)
||+|||++.+ +.+||+|||++...... .......+|+.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 218 kp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~ellt 288 (382)
T 3tt0_A 218 AARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEIFT 288 (382)
T ss_dssp CGGGEEECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--------CCCCchhHHHHHHHHHHHHHh
Confidence 9999999955 46999999999764332 22234467889999998864 668999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHH
Q 022903 263 -NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 263 -g~~Pf~~~~~~~~~~~~ 279 (290)
|..||.+.+..+....+
T Consensus 289 ~g~~p~~~~~~~~~~~~~ 306 (382)
T 3tt0_A 289 LGGSPYPGVPVEELFKLL 306 (382)
T ss_dssp TSCCSSTTCCHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHH
Confidence 99999998766544433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=293.96 Aligned_cols=218 Identities=34% Similarity=0.626 Sum_probs=171.6
Q ss_pred ccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceE
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMV 133 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 133 (290)
.+...+|++.+.||+|+||.||+|++.+ .||+|++.......... ..+.+|+.+++.++||||++++++..+...+
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 95 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGYSTAPQLA 95 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHH---HHHHHHHHHHTTCCCTTBCCEEEEECSSSCE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHH---HHHHHHHHHHHhCCCCcEEEEEeeccCCccE
Confidence 3556779999999999999999998765 59999997665443322 3588999999999999999999988778889
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV- 212 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~- 212 (290)
+||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC--------
T ss_pred EEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CCEEEccceeccccccc
Confidence 99999999999999865 34679999999999999999999999999999999999999955 4699999999875332
Q ss_pred --cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 213 --TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 213 --~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
........||+.|+|||.+... ....++.++||||||+++|+|++|..||.+....+........
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 240 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQ-----DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240 (289)
T ss_dssp ----------CCCTTCCHHHHC---------CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH
T ss_pred cccccccccCCCccccCchhhccc-----CCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc
Confidence 2222345789999999987521 1356788999999999999999999999998777666655543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=298.52 Aligned_cols=211 Identities=29% Similarity=0.495 Sum_probs=162.0
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
..+|++++.||+|+||.||+|.+ +++.||+|++......... ..+.+|+.+++.++||||+++++++.+. ..+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTP----STAIREISLMKELKHENIVRLYDVIHTENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSC----HHHHHHHHHHTTCCBTTBCCEEEEECCTTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccH----HHHHHHHHHHHhcCCCCcceEEEEEEECCeEE
Confidence 45699999999999999999976 5789999999765432221 2367899999999999999999999754 678
Q ss_pred EEEEecCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
+||||++ ++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++..
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARA 157 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence 9999997 59999986532 24589999999999999999999999999999999999999554 599999999976
Q ss_pred cccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 210 ETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 210 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 222 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMG-------SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cCCCcccCCCCcccccccCchHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 4322 22344578999999998754 2457899999999999999999999999988776665554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=317.97 Aligned_cols=206 Identities=25% Similarity=0.421 Sum_probs=173.9
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
...+.|.+.+.||+|+||.||++++ +++.||+|++......... ....+.+|+.+++.++||||+++++++.+. .
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~--~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK--GYQGAMVEKKILAKVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhH--HHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence 4557799999999999999999987 5789999998653221111 113477899999999999999999998765 6
Q ss_pred eEEEEEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.++||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~ 338 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVE 338 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeee
Confidence 889999999999999987643 34699999999999999999999999999999999999999654 599999999986
Q ss_pred cccccc-ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 210 ETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 210 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLG--------EEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred ccCCCcccccccCCccccChhhhcC--------CCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 543332 334589999999999865 568999999999999999999999998863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=312.62 Aligned_cols=202 Identities=33% Similarity=0.467 Sum_probs=155.9
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec----
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 129 (290)
-.++|.+++.||+|+||.||+|++ +++.||||++......... ..++.+|+.+++.++||||+++++++..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID---CKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHH---HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHH---HHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence 346799999999999999999976 5789999998765443322 2468899999999999999999999842
Q ss_pred --CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 130 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
...++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 128 ~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-~~~kl~DFGla 203 (458)
T 3rp9_A 128 KFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLA 203 (458)
T ss_dssp TCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTC
T ss_pred cCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC-CCEeecccccc
Confidence 3578999998 6799999875 4679999999999999999999999999999999999999955 46999999999
Q ss_pred ccccccc----------------------------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHH
Q 022903 208 REETVTE----------------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259 (290)
Q Consensus 208 ~~~~~~~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~ 259 (290)
+...... .....+||+.|+|||++.. ...++.++|||||||++||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-------QENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHH
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC-------CCCCCcHhHHHHHHHHHHH
Confidence 7643211 2234578999999997643 2568999999999999999
Q ss_pred HHh-----------CCCCCCCCC
Q 022903 260 LLT-----------NRLPFEGMS 271 (290)
Q Consensus 260 ~l~-----------g~~Pf~~~~ 271 (290)
|++ |.+||.+.+
T Consensus 277 lltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 277 LLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp HHTTSTTTCSSGGGCCCSCC---
T ss_pred HHHhccccccccccccccCCCCc
Confidence 998 788888765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=306.20 Aligned_cols=205 Identities=27% Similarity=0.431 Sum_probs=168.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|++.+.||+|+||.||+|.+ +++.||||++...............+.+|+.+++.++||||+++++++.+. ..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4699999999999999999987 578999999854211100000012478999999999999999999998754 6789
Q ss_pred EEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC--CceEEecccccccc
Q 022903 135 VTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREE 210 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~--~~~kl~Dfg~~~~~ 210 (290)
||||+++++|.+++... ....+++..+..++.||+.||.|||++|++||||||+|||++.++ ..+||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999998887653 234589999999999999999999999999999999999997543 34999999999765
Q ss_pred ccccc-ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 211 TVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 211 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
..... .....||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKR--------EPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCCCeeecCCcCCcCccCHHHHcC--------CCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 43332 345579999999999864 56789999999999999999999999885
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=290.00 Aligned_cols=215 Identities=35% Similarity=0.625 Sum_probs=170.3
Q ss_pred cCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.+..+|.+.+.||+|+||.||+|.+.++.||+|++.......... ....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQ-TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHH-HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 355679999999999999999999999999999987654333211 123578999999999999999999998654 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CeeecCCCCCEEEcCC-------CCceEEec
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG---IIHRDLKPDNLLLTPD-------QKSLKLAD 203 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g---ivH~Dikp~Nili~~~-------~~~~kl~D 203 (290)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||++| ++||||||+||+++.. .+.++|+|
T Consensus 83 lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999998853 57999999999999999999999999 8999999999999852 45699999
Q ss_pred ccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 204 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 204 fg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
||++....... .....|++.|+|||.+.. ..++.++||||||+++|+|++|+.||.+.+.......+...
T Consensus 160 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (271)
T 3dtc_A 160 FGLAREWHRTT-KMSAAGAYAWMAPEVIRA--------SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229 (271)
T ss_dssp CCC--------------CCGGGSCHHHHHH--------CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred CCccccccccc-ccCCCCccceeCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence 99997644332 234578999999998864 56889999999999999999999999998887776665544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=289.16 Aligned_cols=217 Identities=26% Similarity=0.423 Sum_probs=180.6
Q ss_pred ccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---C
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---P 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~ 130 (290)
.+..++|.+.+.||+|+||.||+|++.++.||+|++.......... ..+.+|+.+++.++||||+++++++.+ .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKS---RDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHH---HHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHH---HHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 3455679999999999999999999999999999998765444332 358899999999999999999999865 3
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g--ivH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
..++||||+++++|.+++.......+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.++|+|||+..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~ 161 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKF 161 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCC
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEecccee
Confidence 6789999999999999998754446999999999999999999999999 9999999999999955 458999888765
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~ 283 (290)
... .....+|+.|+|||.+.... ...++.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 162 ~~~----~~~~~~t~~y~aPE~~~~~~-----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 227 (271)
T 3kmu_A 162 SFQ----SPGRMYAPAWVAPEALQKKP-----EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG 227 (271)
T ss_dssp TTS----CTTCBSCGGGSCHHHHHSCG-----GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC
T ss_pred eec----ccCccCCccccChhhhccCC-----CCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC
Confidence 422 23447899999999986411 1233448999999999999999999999998877766665543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=299.30 Aligned_cols=214 Identities=30% Similarity=0.529 Sum_probs=178.1
Q ss_pred ccCCCceeecceeccccceeEEEEEECC-------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
....++|.+++.||+|+||.||+|++.+ +.||+|++........ ...+.+|+.+++.++||||++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM----QADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHH----HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHH----HHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3456789999999999999999998743 7899999987654332 2358899999999999999999999
Q ss_pred eecC-ceEEEEEecCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeee
Q 022903 127 CKDP-LMVIVTELLPGMSLRKYLVSLRP----------------------NKLDLHVALNFALDIARAMDCLHANGIIHR 183 (290)
Q Consensus 127 ~~~~-~~~lv~e~~~~~~L~~~~~~~~~----------------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~ 183 (290)
+.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|++||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 8654 67899999999999999986421 568999999999999999999999999999
Q ss_pred cCCCCCEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHH
Q 022903 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260 (290)
Q Consensus 184 Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~ 260 (290)
||||+|||++.+ +.+||+|||++....... ......+|+.|+|||.+.. ..++.++||||||+++|+|
T Consensus 199 Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 269 (343)
T 1luf_A 199 DLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEI 269 (343)
T ss_dssp CCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred CCCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc--------CCcCcccccHHHHHHHHHH
Confidence 999999999955 469999999987533221 2234467889999998864 5688999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHH
Q 022903 261 LT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 261 l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
++ |..||.+.+..+....+.
T Consensus 270 ~t~g~~p~~~~~~~~~~~~~~ 290 (343)
T 1luf_A 270 FSYGLQPYYGMAHEEVIYYVR 290 (343)
T ss_dssp HTTTCCTTTTSCHHHHHHHHH
T ss_pred HhcCCCcCCCCChHHHHHHHh
Confidence 99 999999988766555443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=290.21 Aligned_cols=213 Identities=32% Similarity=0.569 Sum_probs=175.5
Q ss_pred cccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHH--HHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALL--EGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
.....++|.+.+.||+|+||.||+|++ +++.||+|++............ ...+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 345667899999999999999999988 5789999998765543322111 135789999999999999999999987
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCEEEcCCCC----ceEEe
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQK----SLKLA 202 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g--ivH~Dikp~Nili~~~~~----~~kl~ 202 (290)
+.. ++||||+++++|.+++.. ....+++..+..++.|++.||.|||++| ++||||||+||+++.++. .+||+
T Consensus 94 ~~~-~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP-RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT-EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC-eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 654 699999999999998865 3467999999999999999999999999 999999999999985432 39999
Q ss_pred cccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 203 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
|||++..... ......+|+.|+|||.+.. ....++.++||||||+++|+|++|..||.+.+....
T Consensus 172 Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 172 DFGLSQQSVH--SVSGLLGNFQWMAPETIGA------EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp CCTTCBCCSS--CEECCCCCCTTSCGGGSSC------SSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred CCCccccccc--cccccCCCccccCchhhcc------CCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 9999975433 3345679999999998743 124568899999999999999999999988765443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=314.72 Aligned_cols=212 Identities=25% Similarity=0.365 Sum_probs=168.7
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
...+|.+++.||+|+||.||+|++ +++.||+|++......... ....+.+|+.+++.++||||+++++++.+. ..
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC---------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhH--HHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 446799999999999999999987 5789999998753211111 113467899999999999999999998754 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||++....
T Consensus 224 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGI 300 (446)
T ss_dssp EEEECCCSSCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTTC
T ss_pred EEEEeeCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceecc
Confidence 899999999999999976 3579999999999999999999998 9999999999999999654 69999999997632
Q ss_pred -ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 212 -VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 212 -~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.........||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 362 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCcccccccCCccccCHhhcCC--------CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 2233455689999999999864 678999999999999999999999999987665544443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=295.06 Aligned_cols=205 Identities=31% Similarity=0.441 Sum_probs=174.8
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~lv~ 136 (290)
|...+.||+|+||.||+|++ +++.||||++........ ..+.+|+.+++.++||||+++++++.. ...++||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 121 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR-----ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM 121 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSH-----HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHH-----HHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 67778999999999999987 578999999976554432 247799999999999999999999865 4788999
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-c
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M 215 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-~ 215 (290)
||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++....... .
T Consensus 122 e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 122 EFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp CCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCC
T ss_pred ecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCccc
Confidence 99999999998864 5699999999999999999999999999999999999999554 69999999987643322 2
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.....||+.|+|||++.. ..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 198 ~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 255 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISR--------SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD 255 (321)
T ss_dssp BCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred cccccCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 345579999999998864 5688999999999999999999999999887666555443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=290.76 Aligned_cols=214 Identities=30% Similarity=0.576 Sum_probs=177.1
Q ss_pred ccccCCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
.+.+..++|++++.||+|+||.||++++. +..||+|++........ .+.+|+.+++.++||||+++++++.+.
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED------EFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHH------HHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHH------HHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 44567788999999999999999999885 46899999987654432 377999999999999999999999764
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~ 169 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRY 169 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-SCEEECSTTGGGG
T ss_pred CCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-CCEEEcccccccc
Confidence 678999999999999999763 3569999999999999999999999999999999999999955 4699999999976
Q ss_pred cccccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022903 210 ETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 210 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~ 281 (290)
...... .....+|+.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~ 236 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred ccccccccccCCccCcccCCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc
Confidence 433322 223356788999999864 568899999999999999998 9999999887766555443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=300.21 Aligned_cols=198 Identities=26% Similarity=0.376 Sum_probs=168.9
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ce
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~ 132 (290)
..+|.+.+.||+|+||.||+|++ +++.||||++....... .+.+|+.+++.+ +||||+++++++.+. ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-------QLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSC-------CHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchH-------HHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 46799999999999999999986 67899999987654332 367899999999 899999999998754 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC----ceEEecccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK----SLKLADFGLAR 208 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~----~~kl~Dfg~~~ 208 (290)
++||||+ +++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++. .+||+|||++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 8999999 99999999863 467999999999999999999999999999999999999985432 29999999998
Q ss_pred ccccccc--------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 209 EETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 209 ~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
....... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLG--------KEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcC--------CCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 5433221 235579999999999865 668999999999999999999999999854
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=306.61 Aligned_cols=215 Identities=31% Similarity=0.574 Sum_probs=178.5
Q ss_pred cccccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
..+..+.++|.+.+.||+|+||.||+|++ +++.||||++......... ..+.+|+.+++.++||||+++++++.
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~ 182 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK----AKFLQEARILKQYSHPNIVRLIGVCT 182 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHH----TTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHH----HHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34566778999999999999999999988 4789999999765433222 35789999999999999999999997
Q ss_pred cC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 129 DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 129 ~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
+. ..++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||++
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~s 260 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGMS 260 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGC
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-CcEEECcCCCc
Confidence 54 678999999999999999763 3468999999999999999999999999999999999999955 46999999999
Q ss_pred cccccccccc---ccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 208 REETVTEMMT---AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 208 ~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
.......... ...+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~ 328 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNY--------GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 7543322111 1234678999998864 557889999999999999998 99999998876654433
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=288.22 Aligned_cols=212 Identities=29% Similarity=0.546 Sum_probs=178.0
Q ss_pred ccCCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
....++|++++.||+|+||.||+|++. +..||+|++........ .+.+|+.+++.++||||+++++++.+. .
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED------EFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHH------HHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHH------HHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 345677999999999999999999885 45899999987654432 377999999999999999999999765 6
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~ 155 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVL 155 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECC
T ss_pred eEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecc
Confidence 78999999999999999763 34699999999999999999999999999999999999999554 69999999997643
Q ss_pred cccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022903 212 VTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 212 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~ 281 (290)
.... .....+|+.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 220 (268)
T 3sxs_A 156 DDQYVSSVGTKFPVKWSAPEVFHY--------FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220 (268)
T ss_dssp TTCEEECCSCCCCGGGCCHHHHHH--------SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred hhhhhcccCCCcCcccCCHHHHhc--------cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc
Confidence 3322 223356778999998864 557889999999999999999 9999999887766555443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=302.74 Aligned_cols=207 Identities=28% Similarity=0.418 Sum_probs=170.9
Q ss_pred cccccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
..+.....+|++++.||+|+||.||+|++.++.||||++....... ....+|+.+++.++||||+++++++.+.
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS------WQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHH------HHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecCchHH------HHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 3555677889999999999999999999999999999996543211 2345689999999999999999998653
Q ss_pred -----ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CCeeecCCCCCEEEcCC
Q 022903 131 -----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN----------GIIHRDLKPDNLLLTPD 195 (290)
Q Consensus 131 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----------givH~Dikp~Nili~~~ 195 (290)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. |++||||||+|||++.+
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~ 167 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence 36899999999999999976 4599999999999999999999999 99999999999999955
Q ss_pred CCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 196 QKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
+.+||+|||++....... ......||+.|+|||++.+.. .....++.++|||||||++|+|++|..||.+.
T Consensus 168 -~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 168 -LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAI---NFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp -CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCC---CCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred -CeEEEccCCcccccccccCccccccCccCccccCHhhccccc---ccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 469999999997543322 223357899999999886411 00123556889999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=307.66 Aligned_cols=207 Identities=29% Similarity=0.395 Sum_probs=173.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec------
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------ 129 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 129 (290)
..|.+.+.||+|+||.||+|++ +++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---------HHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 3599999999999999999988 5789999998764322 2379999999999999999988732
Q ss_pred -CceEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
...++||||+++ +|.+++.. .....+++..+..++.||+.||.|||++||+||||||+|||++.++..+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 136799999965 66665543 23467999999999999999999999999999999999999997767789999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
++............+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 204 a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~ 271 (420)
T 1j1b_A 204 AKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271 (420)
T ss_dssp CEECCTTCCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred hhhcccCCCceeeeeCCCcCCHHHHcC-------CCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 987555555556789999999998754 24689999999999999999999999999988777776654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=303.67 Aligned_cols=209 Identities=27% Similarity=0.412 Sum_probs=175.9
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 130 (290)
...+|.+++.||+|+||.||+|++ +++.||+|++...... ..+|+.+++.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 456799999999999999999987 6789999998765332 23799999999999999999987321
Q ss_pred ------------------------------------ceEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHH
Q 022903 131 ------------------------------------LMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAM 172 (290)
Q Consensus 131 ------------------------------------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~~l 172 (290)
..++||||++ ++|.+++.. .....+++..+..++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 3779999997 587777653 2356799999999999999999
Q ss_pred HHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHH
Q 022903 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 252 (290)
Q Consensus 173 ~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Diws 252 (290)
.|||++|++||||||+|||++..++.+||+|||++.............+|+.|+|||++.+ ...++.++||||
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Diws 227 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG-------ATEYTPSIDLWS 227 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT-------CSSCCTHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC-------CCCCCcchhhhh
Confidence 9999999999999999999986566799999999987655555566788999999998764 245899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 253 FGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 253 lG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
|||++|+|++|+.||.+.+..+....+..
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~ 256 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQ 256 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999999999999999988887777654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=290.56 Aligned_cols=214 Identities=27% Similarity=0.551 Sum_probs=178.9
Q ss_pred ccccCCCceeecc-eeccccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 52 SLLVDPKLLFIGS-KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 52 ~~~~~~~~~~~~~-~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
.+....++|.+.+ .||+|+||.||+|.+ ++..||+|++......... ..+.+|+.+++.++||||++++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~ 78 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT----EEMMREAQIMHQLDNPYIVRLIGV 78 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHH----HHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHH----HHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4556667788887 999999999999975 4678999999876543332 357899999999999999999999
Q ss_pred eecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 127 CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 127 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
+.+...++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~ 156 (287)
T 1u59_A 79 CQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGL 156 (287)
T ss_dssp EESSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTT
T ss_pred ecCCCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcccc
Confidence 988889999999999999999975 34679999999999999999999999999999999999999954 5699999999
Q ss_pred ccccccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 207 AREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 207 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
+........ .....+|+.|+|||++.. ..++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i 226 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred eeeeccCcceeeccccccccccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 976433221 223356889999998854 557889999999999999998 99999998766554443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=313.17 Aligned_cols=208 Identities=28% Similarity=0.431 Sum_probs=164.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCCh---hHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTS---DERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 132 (290)
+.|.+.+.||+|+||.||+|.+ +++.||+|++...... .........+.+|+.++++++||||+++++++.....
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 214 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 214 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSEE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCce
Confidence 5699999999999999999987 5689999998754311 1111111247799999999999999999999988888
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC--CceEEecccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREE 210 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~--~~~kl~Dfg~~~~~ 210 (290)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ ..+||+|||+++..
T Consensus 215 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred EEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 999999999999998764 46799999999999999999999999999999999999997433 35999999999876
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
..........||+.|+|||++... ....++.++||||||+++|+|++|..||.+...
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp C-----------CTTCCTTTTC---------CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred CCCccccccCCCCCccCceeeecC-----CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 655555667899999999987531 124578899999999999999999999987644
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=290.09 Aligned_cols=209 Identities=28% Similarity=0.462 Sum_probs=170.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||+||+|++ +++.||+|++.......... ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHH---HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcc---hHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEE
Confidence 4699999999999999999988 57899999998655433221 3477999999999999999999999654 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||+++ +|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++......
T Consensus 79 v~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 79 VFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCC
T ss_pred EEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcc
Confidence 9999965 66666654 346799999999999999999999999999999999999999554 5999999999764322
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCC-CCCCCHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQAAYAA 279 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~P-f~~~~~~~~~~~~ 279 (290)
.......+|+.|+|||++.+ ...++.++||||||+++|+|++|..| |.+.+..+....+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i 215 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred ccccCCccccCCcChHHHcC-------CCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence 23345578999999998864 23479999999999999999987777 5554544444433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=302.29 Aligned_cols=218 Identities=31% Similarity=0.537 Sum_probs=178.0
Q ss_pred ccccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeE
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKF 123 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 123 (290)
.+....++|.+++.||+|+||.||+|++ +++.||||++......... ..+.+|+.++..+ +||||+++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHH----HHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHH----HHHHHHHHHHHhhcCCcceeee
Confidence 3445667899999999999999999974 3378999999876554432 3578999999999 79999999
Q ss_pred EeeeecC--ceEEEEEecCCCCHHHHHHhcCC------------------------------------------------
Q 022903 124 LGACKDP--LMVIVTELLPGMSLRKYLVSLRP------------------------------------------------ 153 (290)
Q Consensus 124 ~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------ 153 (290)
++++.+. ..++||||+++++|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 9998653 47899999999999999976432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc---
Q 022903 154 ----------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--- 214 (290)
Q Consensus 154 ----------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~--- 214 (290)
..+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCE
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecccccch
Confidence 128899999999999999999999999999999999999955 469999999997542221
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~~ 282 (290)
......+|+.|+|||++.. ..++.++||||||+++|+|++ |..||.+....+........
T Consensus 251 ~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 311 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311 (359)
T ss_dssp EC--CEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH
T ss_pred hccccCCCceeEChhhhcC--------CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc
Confidence 2234467889999998864 668899999999999999998 99999998765555544443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=300.42 Aligned_cols=208 Identities=27% Similarity=0.534 Sum_probs=168.6
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCc----eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
....+|++.+.||+|+||.||+|++ +++ .||+|.+........ ...+.+|+.+++.++||||+++++++.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------C----HHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHH----HHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 4456799999999999999999987 333 368888765432222 235889999999999999999999999
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
+...++|++|+.+++|.+++.. ....+++..++.++.||+.||.|||++|++||||||+|||++.+ +.+||+|||+++
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~ 165 (327)
T 3poz_A 88 TSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAK 165 (327)
T ss_dssp SSSEEEEEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTHHH
T ss_pred cCCeEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCccee
Confidence 8888999999999999999986 34679999999999999999999999999999999999999954 469999999997
Q ss_pred ccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022903 209 EETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 209 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~ 276 (290)
....... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 229 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred EccCCcccccccCCCccccccChHHhcc--------CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH
Confidence 5433222 223356789999999865 678999999999999999999 99999987765443
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=287.91 Aligned_cols=212 Identities=26% Similarity=0.393 Sum_probs=180.6
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.++|.+.+.||+|+||.||+|.+ +++.||+|++.......... ..+.+|+.+++.++||||+++++++.+. ..+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF---QKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHH---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHH---HHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 35699999999999999999987 47899999997655433322 3578999999999999999999999765 578
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC--CceEEeccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREET 211 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~--~~~kl~Dfg~~~~~~ 211 (290)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ ..+||+|||++....
T Consensus 82 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 999999999999988763 5699999999999999999999999999999999999997543 349999999998766
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.........+|+.|+|||.+.. ..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 221 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCccccCCCCCcCCcCchhhcC--------CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh
Confidence 5555556789999999999864 5678999999999999999999999999877665555443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=294.45 Aligned_cols=212 Identities=26% Similarity=0.411 Sum_probs=178.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHH-HHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
+.|.+.+.||+|+||.||+|++ +++.||+|++......... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4599999999999999999987 5789999999765432210 00012477999999999999999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC---ceEEecccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREE 210 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~---~~kl~Dfg~~~~~ 210 (290)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++. .++|+|||++...
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999999975 457899999999999999999999999999999999999986653 6999999999876
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..........||+.|+|||++.. ..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 230 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred CccccccccCCCCCccCcccccC--------CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 55544456679999999998864 56889999999999999999999999998766555443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=310.97 Aligned_cols=215 Identities=32% Similarity=0.490 Sum_probs=178.2
Q ss_pred cccccCCCceeecceeccccceeEEEEEECC-ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
..+.+..+.|++.+.||+|+||.||+|.+.+ ..||||+++...... ..+.+|+.++++++||||+++++++.+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCH------HHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3455677889999999999999999999854 679999998755432 247899999999999999999999988
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...++||||+++++|.+++.......+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++..
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARL 329 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC-
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CCEEECCCcccee
Confidence 888999999999999999976444568999999999999999999999999999999999999854 4699999999976
Q ss_pred cccccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 210 ETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 210 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
...... .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~ 395 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395 (452)
T ss_dssp -------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred cCCCceecccCCcccccccCHhHHhc--------CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 433221 223356788999998864 568999999999999999999 999999988876665543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=292.72 Aligned_cols=211 Identities=29% Similarity=0.412 Sum_probs=173.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||.||+|++ +++.||+|++......... ...+.+|+.+++.++||||+++++++.+. ..++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI---KKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHH---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHH---HHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 4699999999999999999988 4789999998766544332 24578999999999999999999999754 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++......
T Consensus 80 v~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 80 VFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC---
T ss_pred EEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCcc
Confidence 9999999999998765 4679999999999999999999999999999999999999955 46999999999764422
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.......+|+.|+|||++.+ ...++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 217 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVG-------DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK 217 (311)
T ss_dssp ---------GGGCCHHHHHT-------CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccCCCcCCccccChHHHhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 22345578999999998754 25678999999999999999999999999888777666544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=302.63 Aligned_cols=207 Identities=20% Similarity=0.310 Sum_probs=166.0
Q ss_pred cCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHH------HHHHHHHHHHHHhhcCCCCce
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERAL------LEGRFIREVNMMSRVKHDNLV 121 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv 121 (290)
.....|.+++.||+|+||.||+|.+. ++.||||++.........+. ....+..|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 34568999999999999999999873 47899999876543221110 011244566777888999999
Q ss_pred eEEeeeec-----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC-C
Q 022903 122 KFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP-D 195 (290)
Q Consensus 122 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~-~ 195 (290)
++++++.+ ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 99998854 2478999999 9999999986 3467999999999999999999999999999999999999982 2
Q ss_pred CCceEEecccccccccccccc--------cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 022903 196 QKSLKLADFGLAREETVTEMM--------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 267 (290)
Q Consensus 196 ~~~~kl~Dfg~~~~~~~~~~~--------~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf 267 (290)
.+.+||+|||+++........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~Pf 261 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--------VAPSRRGDLEILGYCMIQWLTGHLPW 261 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--------CCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 346999999999754332211 23359999999998865 56899999999999999999999999
Q ss_pred CCCC
Q 022903 268 EGMS 271 (290)
Q Consensus 268 ~~~~ 271 (290)
.+..
T Consensus 262 ~~~~ 265 (364)
T 3op5_A 262 EDNL 265 (364)
T ss_dssp GGGT
T ss_pred cccc
Confidence 9743
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=298.61 Aligned_cols=207 Identities=25% Similarity=0.392 Sum_probs=175.1
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-----CCCceeEEeeeec
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-----HDNLVKFLGACKD 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~ 129 (290)
.++|.+++.||+|+||.||+|++ +++.||||++...... ...+..|+.+++.+. ||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY------TRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHH------HHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhh------hhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 35699999999999999999988 6789999998743211 123567889998886 9999999999865
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC--------------
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP-------------- 194 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~-------------- 194 (290)
...++||||+ +++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 4678999999 999999998866667999999999999999999999999999999999999974
Q ss_pred ----------CCCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCC
Q 022903 195 ----------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 264 (290)
Q Consensus 195 ----------~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~ 264 (290)
....+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN--------LGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC--------CCCCCccchHHHHHHHHHHHHCC
Confidence 245699999999976432 2345678999999999865 56899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 022903 265 LPFEGMSNLQAAYAAA 280 (290)
Q Consensus 265 ~Pf~~~~~~~~~~~~~ 280 (290)
.||.+.+..+....+.
T Consensus 257 ~pf~~~~~~~~~~~~~ 272 (360)
T 3llt_A 257 LLFRTHEHMEHLAMME 272 (360)
T ss_dssp CSCCCSSHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHH
Confidence 9999987766555443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=294.11 Aligned_cols=214 Identities=30% Similarity=0.543 Sum_probs=177.3
Q ss_pred ccccccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCcee
Q 022903 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122 (290)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 122 (290)
+..+....++|.+.+.||+|+||.||+|.+ +++.||+|++......... ..+.+|+.+++.++||||++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~ 90 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL----RDLLSEFNVLKQVNHPHVIK 90 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHH----HHHHHHHHHHTTCCCTTBCC
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHH----HHHHHHHHHHhhCCCCceee
Confidence 344556678899999999999999999976 2378999999865543332 35789999999999999999
Q ss_pred EEeeeecC-ceEEEEEecCCCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 022903 123 FLGACKDP-LMVIVTELLPGMSLRKYLVSLRP----------------------NKLDLHVALNFALDIARAMDCLHANG 179 (290)
Q Consensus 123 ~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~----------------------~~~~~~~~~~i~~qi~~~l~~lH~~g 179 (290)
+++++.+. ..++||||+++++|.+++..... ..+++..+..++.||+.||.|||++|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 170 (314)
T 2ivs_A 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK 170 (314)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99998654 68899999999999999987432 23889999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHH
Q 022903 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256 (290)
Q Consensus 180 ivH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~ 256 (290)
++||||||+||+++.+ +.+||+|||++....... ......+++.|+|||.+.. ..++.++||||||++
T Consensus 171 ivH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~i 241 (314)
T 2ivs_A 171 LVHRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--------HIYTTQSDVWSFGVL 241 (314)
T ss_dssp EECCCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--------CEECHHHHHHHHHHH
T ss_pred CcccccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC--------CCcCchhhHHHHHHH
Confidence 9999999999999954 569999999987543322 1233456788999998864 557899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHH
Q 022903 257 LWELLT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 257 l~~~l~-g~~Pf~~~~~~~~~ 276 (290)
+|+|++ |..||.+....+..
T Consensus 242 l~el~t~g~~p~~~~~~~~~~ 262 (314)
T 2ivs_A 242 LWEIVTLGGNPYPGIPPERLF 262 (314)
T ss_dssp HHHHHTTSCCSSTTCCGGGHH
T ss_pred HHHHHhCCCCCCCCCCHHHHH
Confidence 999999 99999987765443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=296.67 Aligned_cols=213 Identities=29% Similarity=0.420 Sum_probs=178.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
+.|.+++.||+|+||.||+|++ +++.||||++.......... ...+.+|+.+++.++||||+++++++.+ ...++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK--WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHH--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHH--HHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 4589999999999999999986 67899999998655433322 2458899999999999999999999865 46789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+. |+|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||++.....
T Consensus 132 v~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS--
T ss_pred EEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEeeccCceecCC--
Confidence 999996 5888887653 4679999999999999999999999999999999999999954 5699999999976432
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~ 283 (290)
.....||+.|+|||++... ....++.++||||||+++|+|++|..||.+.+.......+....
T Consensus 207 -~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 269 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTT-----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred -CCcccCCcceeCHhhhccc-----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Confidence 2345799999999987531 12567899999999999999999999999988887777665543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=313.81 Aligned_cols=209 Identities=29% Similarity=0.478 Sum_probs=176.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
..|.+++.||+|+||.||+|++ +++.||||++........ ....++.+|+.+++.++||||+++++++.+. ..++
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSL--DVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHT--TTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4599999999999999999987 589999999865322111 1123578999999999999999999999754 6889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++.......
T Consensus 94 v~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 94 VMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCTTC
T ss_pred EEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhccccc
Confidence 9999999999999875 46799999999999999999999999999999999999999554 59999999998765555
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
.....+||+.|+|||++.+ ....+.++|||||||++|+|++|..||.+.+.......
T Consensus 171 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 227 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK 227 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH
T ss_pred cccccCCCcCeEChhhccC-------CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 5566789999999999864 12346899999999999999999999998765544333
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=293.00 Aligned_cols=213 Identities=25% Similarity=0.384 Sum_probs=168.3
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHH---------------------HHHHHHHHHHHHHHhh
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER---------------------ALLEGRFIREVNMMSR 114 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~---------------------~~~~~~~~~e~~~l~~ 114 (290)
.+|.+.+.||+|+||.||+|++ +++.||+|++......... ......+.+|+.+++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 4699999999999999999987 5789999999765432211 0112357899999999
Q ss_pred cCCCCceeEEeeeec---CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEE
Q 022903 115 VKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 191 (290)
Q Consensus 115 l~h~~iv~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nil 191 (290)
++||||+++++++.+ ...++||||+++++|.+++. ...+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 999999999999874 36789999999999988643 357999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccccccccccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 192 LTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 192 i~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
++.++ .+||+|||++...... .......||+.|+|||.+.... ....+.++||||||+++|+|++|..||.+.
T Consensus 170 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 170 VGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR-----KIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp ECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC-----CCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCC-----CCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99554 5999999999764332 2234557999999999886410 011367899999999999999999999987
Q ss_pred CHHHHHHHH
Q 022903 271 SNLQAAYAA 279 (290)
Q Consensus 271 ~~~~~~~~~ 279 (290)
........+
T Consensus 244 ~~~~~~~~~ 252 (298)
T 2zv2_A 244 RIMCLHSKI 252 (298)
T ss_dssp SHHHHHHHH
T ss_pred cHHHHHHHH
Confidence 765444333
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=290.62 Aligned_cols=214 Identities=33% Similarity=0.528 Sum_probs=179.7
Q ss_pred cccccCCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
+.+.+..++|++++.||+|+||.||+|++. ++.||+|++....... ..+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP------DAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccH------HHHHHHHHHHHhCCCcCcceEEEEEcC
Confidence 455667788999999999999999999885 4689999997655432 247799999999999999999999988
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++..
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARL 158 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEE
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CCEEECCCccccc
Confidence 889999999999999999875333368999999999999999999999999999999999999954 4699999999976
Q ss_pred cccccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 210 ETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 210 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
...... .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 223 (279)
T 1qpc_A 159 IEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (279)
T ss_dssp CSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred ccCcccccccCCCCccCccChhhhcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 443322 223356788999998864 557889999999999999999 99999998776554443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=287.49 Aligned_cols=207 Identities=26% Similarity=0.395 Sum_probs=177.3
Q ss_pred CceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|.+.+.||+|+||.||+|.+. +..||+|++........ .++.+|+.+++.++||||+++++++.+. ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV-----DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCH-----HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchH-----HHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 45999999999999999999874 56899999876544332 2477999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEE---cCCCCceEEeccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREET 211 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili---~~~~~~~kl~Dfg~~~~~~ 211 (290)
||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++ + .++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 84 VMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS-PDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEECCCTTCEECC
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC-CCCcEEEEecccceecc
Confidence 99999999999998763 568999999999999999999999999999999999999 4 34569999999998766
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.........+|+.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEG---------LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTT---------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CccchhccCCCCCccChHHhcc---------cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 5555566789999999998753 478999999999999999999999999887766555443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=298.65 Aligned_cols=219 Identities=33% Similarity=0.502 Sum_probs=176.4
Q ss_pred ccccccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCce
Q 022903 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLV 121 (290)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 121 (290)
+..+....++|.+.+.||+|+||.||+|++ .+..||+|++........ ...+.+|+.+++.+ +||||+
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE----REALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC----------CHHHHHHHHHHHHHCCCTTBC
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHH----HHHHHHHHHHHHhhcCCCCee
Confidence 334556778899999999999999999986 346799999975433222 23578999999999 899999
Q ss_pred eEEeeeecC-ceEEEEEecCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 022903 122 KFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP---------------------NKLDLHVALNFALDIARAMDCLHANG 179 (290)
Q Consensus 122 ~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~i~~qi~~~l~~lH~~g 179 (290)
++++++.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|
T Consensus 113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999998754 68899999999999999976432 23789999999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHH
Q 022903 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 256 (290)
Q Consensus 180 ivH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~ 256 (290)
++||||||+|||++.+ +.+||+|||++........ .....+|+.|+|||.+.. ..++.++||||||++
T Consensus 193 ivH~Dikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~i 263 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSYGIL 263 (344)
T ss_dssp EEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHH
T ss_pred cccCCCChhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--------CCCChhHhHHHHHHH
Confidence 9999999999999955 5699999999975433221 223356788999998864 568899999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022903 257 LWELLT-NRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 257 l~~~l~-g~~Pf~~~~~~~~~~~~~~ 281 (290)
+|+|++ |..||.+............
T Consensus 264 l~el~t~g~~p~~~~~~~~~~~~~~~ 289 (344)
T 1rjb_A 264 LWEIFSLGVNPYPGIPVDANFYKLIQ 289 (344)
T ss_dssp HHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred HHHHHcCCCCCcccCCcHHHHHHHHh
Confidence 999998 9999999876555554443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=299.57 Aligned_cols=208 Identities=30% Similarity=0.430 Sum_probs=170.8
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 130 (290)
-.+.|.+++.||+|+||.||+|.+ +++.||||++........ ...++.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 99 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 99 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHH---HHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHH---HHHHHHHHHHHHHhCCCcCCCCceeeEecCCcc
Confidence 346799999999999999999987 578999999976543332 224688999999999999999999998643
Q ss_pred ----ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 131 ----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 131 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~ 174 (367)
T 1cm8_A 100 DDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGL 174 (367)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTT
T ss_pred ccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC-CCEEEEeeec
Confidence 358999999 8899999876 468999999999999999999999999999999999999955 4699999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
+..... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 175 a~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 239 (367)
T 1cm8_A 175 ARQADS--EMTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239 (367)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccc--ccCcCcCCCCcCCHHHHhC-------CCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 986432 2345678999999998754 2468999999999999999999999999988776665554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=312.79 Aligned_cols=209 Identities=29% Similarity=0.450 Sum_probs=173.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|++++.||+|+||.||+|++ ++..||+|++......... ...+.+|+.+++.++||||+++++++.+. ..++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS---NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT---THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH---HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3599999999999999999988 5789999999765432211 13477999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--CCceEEecccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETV 212 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~~~~kl~Dfg~~~~~~~ 212 (290)
||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.. ...+||+|||++.....
T Consensus 114 v~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999999999988763 569999999999999999999999999999999999999753 33599999999987665
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
........||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLR---------KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CccccccCCCcCeeCHHHHc---------ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 55556678999999999874 458899999999999999999999999988766655544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=305.63 Aligned_cols=197 Identities=28% Similarity=0.423 Sum_probs=158.0
Q ss_pred Cceeec-ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhh-cCCCCceeEEeeeec----
Q 022903 58 KLLFIG-SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR-VKHDNLVKFLGACKD---- 129 (290)
Q Consensus 58 ~~~~~~-~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~---- 129 (290)
+.|.+. +.||+|+||.||++.+ +++.||||++... ..+.+|+.++.+ .+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 346665 6899999999999987 5789999998632 125578887744 479999999998753
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--CCceEEecccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGL 206 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~~~~kl~Dfg~ 206 (290)
...++||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.+ ++.+||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 357899999999999999987544569999999999999999999999999999999999999853 45699999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
++...........+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+...
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp CEECC-----------CTTCCGGGSCC--------CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCC--------CCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 987555444556689999999999864 6789999999999999999999999987643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=296.99 Aligned_cols=213 Identities=27% Similarity=0.439 Sum_probs=170.4
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
..+|++++.||+|+||.||+|++ +++.||+|++......... ...+.+|+.+++.++||||+++++++.+. ..+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV---PGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-----------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccccc---chhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34699999999999999999976 6789999999765543322 23467999999999999999999999754 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC----CCCceEEeccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP----DQKSLKLADFGLARE 209 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~----~~~~~kl~Dfg~~~~ 209 (290)
+||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++. +...+||+|||++..
T Consensus 110 lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999997 499999986 356999999999999999999999999999999999999953 333599999999975
Q ss_pred cccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 210 ETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 210 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
.... .......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLG-------SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp HC-----------CCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cCCcccccCCCcCCccccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 4322 22344578999999998864 245799999999999999999999999999888777776543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=324.15 Aligned_cols=213 Identities=25% Similarity=0.385 Sum_probs=176.4
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP- 130 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 130 (290)
....+|.+++.||+|+||.||+|++ +++.||||++......... ....+..|..++..+ +||+|+++++++.+.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~--~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTT--TTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHH--HHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 3456799999999999999999987 5678999998753211111 112466888999887 699999999999764
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+++++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~ 492 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEEC
T ss_pred EEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeecc
Confidence 678999999999999999863 5799999999999999999999999999999999999999654 6999999999853
Q ss_pred c-ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 211 T-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 211 ~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
. ........+||+.|+|||++.. ..++.++||||||+++|||++|..||.+.+..+....+.
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 555 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTC--------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCCcccccccCCCcccCHhhhcC--------CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 2 2334456689999999999864 678999999999999999999999999977765554443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=313.15 Aligned_cols=209 Identities=28% Similarity=0.496 Sum_probs=174.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|.+++.||+|+||.||++++ +++.||||++......... ...+.+|+.+++.++||||+++++++.+. ..++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD---TSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH---HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 4599999999999999999987 5789999998642211100 12477999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--CCceEEecccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETV 212 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~~~~kl~Dfg~~~~~~~ 212 (290)
||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.. ...+||+|||++.....
T Consensus 99 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999988763 579999999999999999999999999999999999999632 34699999999987655
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
........||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 177 ~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 235 (486)
T 3mwu_A 177 NTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (486)
T ss_dssp C----CCTTGGGGCCGGGGG---------SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCccCCCcCCCCCCCHHHhC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 55556678999999999875 348899999999999999999999999988776655544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=287.62 Aligned_cols=212 Identities=32% Similarity=0.547 Sum_probs=177.2
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec----
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 129 (290)
+...|.+.+.||+|+||.||+|.+ ++..||+|++......... ...+.+|+.+++.++||||+++++++.+
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHH---HHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 455689999999999999999987 4678999998765544332 2458899999999999999999998753
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCEEEcCCCCceEEecccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g--ivH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
...++||||+++++|.+++... ..+++..+..++.||+.||.|||++| ++||||||+||+++.+.+.++|+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred CceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 3478999999999999999763 56899999999999999999999999 999999999999985556799999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
+...... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+.............
T Consensus 179 ~~~~~~~-~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (290)
T 1t4h_A 179 ATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp GGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred ccccccc-ccccccCCcCcCCHHHHh---------ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc
Confidence 9754332 234457899999999874 34889999999999999999999999987766665554443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=309.83 Aligned_cols=213 Identities=29% Similarity=0.477 Sum_probs=176.5
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhH--------HHHHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDE--------RALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
.+.|.+++.||+|+||+||+|++ +++.||+|++........ .......+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 35699999999999999999987 568999999976543221 00112357899999999999999999999
Q ss_pred eecC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC--ceEEec
Q 022903 127 CKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLAD 203 (290)
Q Consensus 127 ~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~--~~kl~D 203 (290)
+.+. ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++. .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 9765 678999999999999998763 57999999999999999999999999999999999999986543 599999
Q ss_pred ccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 204 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 204 fg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
||++.............||+.|+|||++. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 260 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK---------KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhc---------cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99998766555556678999999999874 357899999999999999999999999988766655544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=288.13 Aligned_cols=211 Identities=28% Similarity=0.518 Sum_probs=174.6
Q ss_pred ccCCCceeecceeccccceeEEEEEECC-----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
....++|.+.+.||+|+||.||+|++.+ ..||+|++......... .++.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK----EKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHH----HHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHH----HHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 3456779999999999999999997632 35999999876544332 35889999999999999999999998
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
+...++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++.
T Consensus 84 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 84 EEPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLSR 161 (281)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCCCGGG
T ss_pred CCCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCccCCCc
Confidence 88889999999999999999763 4568999999999999999999999999999999999999955 469999999987
Q ss_pred ccccccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022903 209 EETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 209 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
....... .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||......+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~ 226 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINF--------RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV 226 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH
T ss_pred ccccccccccccCCCCcceeCchhhcc--------CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH
Confidence 6433321 233456789999998854 568899999999999999998 9999987766554433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=289.68 Aligned_cols=211 Identities=29% Similarity=0.457 Sum_probs=172.1
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|.+.+.||+|+||.||++++ ++..||+|++......... ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM----EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCH----HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhH----HHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence 4599999999999999999987 4789999998765433222 2477999999999999999999999764 6789
Q ss_pred EEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--CCceEEecccccccc
Q 022903 135 VTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREE 210 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~~~~kl~Dfg~~~~~ 210 (290)
||||+++++|.+++... ....+++..+..++.||+.||.|||++|++||||||+||+++.+ .+.+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999999988543 23679999999999999999999999999999999999999532 346999999999865
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
..........+|+.|+|||++. ..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~ 239 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFK---------RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239 (285)
T ss_dssp ---------CTTGGGCCHHHHT---------TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcccCcCcccccCcCChHHhc---------cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc
Confidence 5555555668999999999874 4578899999999999999999999999877665554443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=300.97 Aligned_cols=212 Identities=30% Similarity=0.517 Sum_probs=166.5
Q ss_pred cCCCceeecceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
.....|.+.+.||+|+||.||+|++. +..||||++......... ..+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR----RDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHH----HHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHH----HHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 45567999999999999999999763 567999999765543322 358899999999999999999999975
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
. ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++.
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~ 195 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFGLGR 195 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC----
T ss_pred CCceEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-CCEEECcCcccc
Confidence 4 67899999999999999976 34579999999999999999999999999999999999999955 469999999997
Q ss_pred ccccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 209 EETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 209 ~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
....... .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~ 264 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264 (373)
T ss_dssp ------------------CTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH
T ss_pred ccccCCccceeccCCCcCCCccChhhhcc--------CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 6433221 112245678999998864 668999999999999999998 999999988766554443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=312.71 Aligned_cols=211 Identities=26% Similarity=0.463 Sum_probs=179.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++.+.||+|+||.||++++ +++.||||++.......... ...+.+|+.+++.++||||+++++++.+. ..++
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD--KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC--HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH--HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5699999999999999999987 57899999987654321111 12478999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC--CCCceEEecccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREETV 212 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~--~~~~~kl~Dfg~~~~~~~ 212 (290)
||||+.+++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++. ..+.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999999875 467999999999999999999999999999999999999952 345699999999987655
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
........||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 241 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLH---------GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHH---------TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccccCCCCccccCceeec---------CCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 55555668999999999874 3588999999999999999999999999887766655543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=298.52 Aligned_cols=207 Identities=31% Similarity=0.429 Sum_probs=164.9
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 130 (290)
.++|.+++.||+|+||.||+|.+ +++.||||++......... ..++.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH---AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHH---HHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHH---HHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 35699999999999999999987 5789999999865443322 23578999999999999999999998543
Q ss_pred ---ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 131 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a 174 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLA 174 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC-
T ss_pred cccceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEEEeecc
Confidence 46899999964 7888875 358999999999999999999999999999999999999955 46999999999
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 239 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239 (371)
T ss_dssp ---------------CTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccccccCCceecCCccCHHHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 87554444455689999999999865 568899999999999999999999999988776655543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.21 Aligned_cols=198 Identities=29% Similarity=0.494 Sum_probs=162.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-----
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 130 (290)
++|.+++.||+|+||.||+|++ +++.||||++......... ..+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR----EKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHH----HHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHH----HHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 3589999999999999999988 5789999999765543322 3578999999999999999999987432
Q ss_pred -----------------------------------------------------ceEEEEEecCCCCHHHHHHhcCC-CCC
Q 022903 131 -----------------------------------------------------LMVIVTELLPGMSLRKYLVSLRP-NKL 156 (290)
Q Consensus 131 -----------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~-~~~ 156 (290)
..++||||+++++|.+++..... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 26899999999999999986332 224
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-------------cccccCCCc
Q 022903 157 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-------------MMTAETGTY 223 (290)
Q Consensus 157 ~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~-------------~~~~~~g~~ 223 (290)
++..++.++.||+.||.|||++|++||||||+|||++.++ .+||+|||++....... ......||+
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 5667899999999999999999999999999999999554 69999999998644331 223347999
Q ss_pred cccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 224 ~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
.|+|||.+.+ ..++.++||||||+++|+|++|..|+.
T Consensus 241 ~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 241 LYMSPEQIHG--------NNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGSCHHHHHC--------CCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CccChHHhcC--------CCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999999864 568999999999999999999887753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=298.08 Aligned_cols=211 Identities=27% Similarity=0.464 Sum_probs=171.4
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCce----EEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRI----VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
....+|++++.||+|+||.||+|++ +++. ||+|.+......... ..+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF----QAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCB----CSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHH----HHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 4556799999999999999999987 3333 788887544322211 13568999999999999999999998
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
+...++||||+.+++|.+++... ...+++..++.++.||+.||.|||++|++||||||+|||++.++ .+||+|||++.
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~ 163 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVAD 163 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCccc
Confidence 88899999999999999999752 35789999999999999999999999999999999999998554 59999999998
Q ss_pred cccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 209 EETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 209 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
...... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+....+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 230 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHF--------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH
T ss_pred ccCcccccccccCCCCcccccChHHhcc--------CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence 643322 2234467789999999864 568999999999999999999 99999987765544433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=298.07 Aligned_cols=194 Identities=25% Similarity=0.465 Sum_probs=165.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~ 133 (290)
+.|.+.+.||+|+||.||++.+ +++.||+|++...... ..+|+.++.++ +||||+++++++.+. ..+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 4599999999999999999987 5789999999765432 23677888887 799999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC---ceEEecccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREE 210 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~---~~kl~Dfg~~~~~ 210 (290)
+||||++|++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||+..+++ .+||+|||++...
T Consensus 93 lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 93 VVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999999875 457999999999999999999999999999999999999854432 4999999999864
Q ss_pred ccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 211 TVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 211 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
... ......++|+.|+|||++.. ..++.++|||||||++|+|++|..||.+.
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLER--------QGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHH--------HHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred cCCCCceeccCCCccccCHHHhcC--------CCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 332 23345688999999999864 44778999999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=290.53 Aligned_cols=210 Identities=34% Similarity=0.575 Sum_probs=170.4
Q ss_pred ccccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec--
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-- 129 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 129 (290)
.+....++|++.+.||+|+||.||++++.++.||+|++...... ..+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA-------QAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHH-------HHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34456678999999999999999999999999999999765421 247799999999999999999998743
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++..
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~ 166 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE 166 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC---
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeecccccc
Confidence 3678999999999999999764333488999999999999999999999999999999999999554 699999999875
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
.... .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 227 (278)
T 1byg_A 167 ASST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227 (278)
T ss_dssp -----------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred cccc--ccCCCccccccCHHHhCC--------CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 4332 223467889999998864 568899999999999999998 99999987665444333
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.53 Aligned_cols=210 Identities=30% Similarity=0.502 Sum_probs=172.3
Q ss_pred CCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 130 (290)
...+|.+.+.||+|+||.||+|++. ++.||||++......... ..+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV----DVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCH----HHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchH----HHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 3567999999999999999999884 789999999764432222 2467999999999999999999998643
Q ss_pred ceEEEEEecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEE----cCCCCceEEeccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL----TPDQKSLKLADFG 205 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili----~~~~~~~kl~Dfg 205 (290)
..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ + +...+||+|||
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG 161 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTT-SCEEEEECCGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCC-CceeEEEecCC
Confidence 56899999999999999875322 239999999999999999999999999999999999998 4 34469999999
Q ss_pred ccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 206 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
++.............||+.|+|||++............++.++|||||||++|+|++|..||.+.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99876655555567899999999987542111111235678999999999999999999999754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=294.16 Aligned_cols=226 Identities=30% Similarity=0.473 Sum_probs=183.2
Q ss_pred CcccccccccccCCCceeecceeccccceeEEEEEECC-------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-
Q 022903 44 APQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV- 115 (290)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l- 115 (290)
+.++.....+....+.|.+.+.||+|+||.||+|.+.+ ..||+|++......... ..+.+|+.+++.+
T Consensus 32 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~ 107 (333)
T 2i1m_A 32 PTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEK----EALMSELKIMSHLG 107 (333)
T ss_dssp TTSSCCCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHH----HHHHHHHHHHHHHC
T ss_pred CccccccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHH----HHHHHHHHHHHhhc
Confidence 34444455667788899999999999999999998732 47999999876544332 3578999999999
Q ss_pred CCCCceeEEeeeecC-ceEEEEEecCCCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 022903 116 KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR------------PNKLDLHVALNFALDIARAMDCLHANGIIH 182 (290)
Q Consensus 116 ~h~~iv~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH 182 (290)
+||||+++++++.+. ..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++|++|
T Consensus 108 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 187 (333)
T 2i1m_A 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIH 187 (333)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 899999999999754 6889999999999999987532 346899999999999999999999999999
Q ss_pred ecCCCCCEEEcCCCCceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHH
Q 022903 183 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259 (290)
Q Consensus 183 ~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~ 259 (290)
|||||+|||++.+ +.+||+|||++........ .....+|+.|+|||.+.. ..++.++||||||+++|+
T Consensus 188 ~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~e 258 (333)
T 2i1m_A 188 RDVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILLWE 258 (333)
T ss_dssp SCCSGGGCEEEGG-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred CCcccceEEECCC-CeEEECccccccccccccceeecCCCCCCccccCHHHhcc--------CCCChHHHHHHHHHHHHH
Confidence 9999999999954 5699999999975432221 223346778999998864 568899999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHHHh
Q 022903 260 LLT-NRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 260 ~l~-g~~Pf~~~~~~~~~~~~~~~ 282 (290)
|++ |..||.+.........+...
T Consensus 259 l~t~g~~p~~~~~~~~~~~~~~~~ 282 (333)
T 2i1m_A 259 IFSLGLNPYPGILVNSKFYKLVKD 282 (333)
T ss_dssp HTTTSCCSSTTCCSSHHHHHHHHH
T ss_pred HHcCCCCCCcccchhHHHHHHHhc
Confidence 998 99999987765555544433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=297.55 Aligned_cols=215 Identities=29% Similarity=0.401 Sum_probs=170.9
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.++|.+++.||+|+||.||+|++ +++.||+|++...............+.+|+.+++.++||||+++++++.+. ..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 45699999999999999999987 478999999976543332222223577999999999999999999998654 788
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++ +|.+++.. ....+++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||++......
T Consensus 89 lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSC
T ss_pred EEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-CCEEEEecccceeccCC
Confidence 99999976 89888875 34568999999999999999999999999999999999999955 46999999999764332
Q ss_pred -ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 214 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 214 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.......+|+.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~ 227 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 227 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccCCcccccccccCchHhhC-------CCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 23345578999999998754 24578899999999999999999999999888777666554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=292.68 Aligned_cols=216 Identities=30% Similarity=0.480 Sum_probs=176.8
Q ss_pred cccCCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
.....++|++++.||+|+||.||+|++. ++.||+|++......... ...+.+|+.+++.++||||+++++++.+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 96 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV---KKIAMREIKLLKQLRHENLVNLLEVCKKK 96 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHH---HHHHHHHHHHHhhCCCCCEeeEEEEeecC
Confidence 3345567999999999999999999884 789999998766544332 23577999999999999999999999754
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++||||+++++|.++... ...+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++..
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~ 173 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFART 173 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC--
T ss_pred CEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCcee
Confidence 67899999999989887654 45799999999999999999999999999999999999999554 699999999975
Q ss_pred cccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 210 ETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 210 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.... .......+++.|+|||.+.+ ...++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 174 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 239 (331)
T 4aaa_A 174 LAAPGEVYDDEVATRWYRAPELLVG-------DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239 (331)
T ss_dssp ----------CCCCCTTCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ecCCccccCCCcCCccccCcccccC-------CCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 4332 23345578999999998754 23678999999999999999999999999988777766553
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=296.66 Aligned_cols=210 Identities=29% Similarity=0.480 Sum_probs=167.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|.+++.||+|+||.||+|++ +++.||+|++......... ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAP----CTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------C----CCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccc----hhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEE
Confidence 4699999999999999999987 5789999998754432211 1245799999999999999999999754 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||++ ++|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++......
T Consensus 78 v~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPT 154 (324)
T ss_dssp EEECCS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC----
T ss_pred Eecccc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCc
Confidence 999996 599998876 345799999999999999999999999999999999999999554 5999999998754332
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.......+|+.|+|||++.+ ...++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp --------CGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccCcccccChhhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 22334578999999998754 24578999999999999999999999999887766655543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=299.59 Aligned_cols=220 Identities=30% Similarity=0.440 Sum_probs=173.0
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.++|.+++.||+|+||.||+|.+ +++.||+|++...............+.+|+.+++.++||||+++++++.+. ..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 45699999999999999999987 567899999865321110111123588999999999999999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 022903 134 IVTELLPGMSLRKYLVSLR--------------------------------------PNKLDLHVALNFALDIARAMDCL 175 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~--------------------------------------~~~~~~~~~~~i~~qi~~~l~~l 175 (290)
+||||+++++|.+++.... ...+++..+..++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999885210 11235677889999999999999
Q ss_pred HHCCCeeecCCCCCEEEcCCCC-ceEEecccccccccccc-----cccccCCCccccCccccccccccccccCCCCCcch
Q 022903 176 HANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVD 249 (290)
Q Consensus 176 H~~givH~Dikp~Nili~~~~~-~~kl~Dfg~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~D 249 (290)
|++|++||||||+||+++.++. .+||+|||++....... ......||+.|+|||++.. ....++.++|
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~D 258 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT------TNESYGPKCD 258 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC------SSSCCCTHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc------CCCCCCcHHH
Confidence 9999999999999999985542 69999999997532211 2345579999999998854 1256889999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 250 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 250 iwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
|||||+++|+|++|..||.+.+..+....+...
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 291 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK 291 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 999999999999999999998887776665543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=290.54 Aligned_cols=217 Identities=32% Similarity=0.526 Sum_probs=178.9
Q ss_pred ccccccCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCcee
Q 022903 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122 (290)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 122 (290)
...+....++|.+.+.||+|+||.||+|.+. ++.||+|++......... ..+.+|+.+++.++||||++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER----IEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHH----HHHHHHHHHGGGCCCTTBCC
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHH----HHHHHHHHHHHhcCCCCEee
Confidence 3455566788999999999999999999753 578999999866544332 35789999999999999999
Q ss_pred EEeeeecC-ceEEEEEecCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc
Q 022903 123 FLGACKDP-LMVIVTELLPGMSLRKYLVSLR--------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 193 (290)
Q Consensus 123 ~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~ 193 (290)
+++++.+. ..++||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA 172 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc
Confidence 99998754 6789999999999999987532 14578999999999999999999999999999999999999
Q ss_pred CCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCC
Q 022903 194 PDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 269 (290)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~ 269 (290)
.+ +.+||+|||++....... ......+|+.|+|||.+.. ..++.++||||||+++|+|++ |..||.+
T Consensus 173 ~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 173 ED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp TT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CC-CeEEECcCccccccccccccccccCCCCCCCccChhhhcc--------CCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 55 469999999987543322 1223356889999998764 568899999999999999999 9999999
Q ss_pred CCHHHHHHHH
Q 022903 270 MSNLQAAYAA 279 (290)
Q Consensus 270 ~~~~~~~~~~ 279 (290)
.+..+....+
T Consensus 244 ~~~~~~~~~~ 253 (322)
T 1p4o_A 244 LSNEQVLRFV 253 (322)
T ss_dssp SCHHHHHHHH
T ss_pred CCHHHHHHHH
Confidence 8766554443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=283.26 Aligned_cols=212 Identities=31% Similarity=0.580 Sum_probs=178.9
Q ss_pred cccCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
+.++.++|.+.+.||+|+||.||++++ +++.||+|++....... ..+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 76 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE------EDFIEEAEVMMKLSHPKLVQLYGVCLEQA 76 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH------HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH------HHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 456678899999999999999999988 56789999998765443 2477999999999999999999998654
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++...
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFV 154 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-GCEEECCTTGGGGB
T ss_pred CeEEEEeCCCCCcHHHHHhh-CcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-CCEEEccccccccc
Confidence 68899999999999999976 34568999999999999999999999999999999999999855 45999999998764
Q ss_pred cccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 211 TVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 211 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
.... ......+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~ 219 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred ccccccccccccccccccChhhhcC--------CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh
Confidence 3322 2233457788999999864 567899999999999999999 999999987766554443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=294.17 Aligned_cols=213 Identities=25% Similarity=0.452 Sum_probs=168.4
Q ss_pred cccCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC--CCceeEEeeeec
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--DNLVKFLGACKD 129 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~ 129 (290)
+....+.|.+++.||+|+||.||++.+ +++.||||++......... ...+.+|+.+++.++| |||+++++++.+
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHH---HHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHH---HHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 345677899999999999999999977 5678999999866544332 2357899999999976 999999999875
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
. ..++|||+ .+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ + +.+||+|||++.
T Consensus 81 ~~~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~-~~~kl~DFG~a~ 155 (343)
T 3dbq_A 81 DQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIAN 155 (343)
T ss_dssp SSEEEEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T-TEEEECCCSSSC
T ss_pred CCEEEEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-C-CcEEEeeccccc
Confidence 4 67899995 58899999986 45799999999999999999999999999999999999998 4 359999999997
Q ss_pred cccccc---cccccCCCccccCcccccccccccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 209 EETVTE---MMTAETGTYRWMAPELYSTVTLRQG---EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 209 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~---~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
...... ......||+.|+|||++........ ....++.++|||||||++|+|++|..||.+....
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 226 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence 643332 2234579999999998754211100 1256788999999999999999999999886543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=310.20 Aligned_cols=210 Identities=31% Similarity=0.532 Sum_probs=178.2
Q ss_pred ccccCCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
.+.+....|.+.+.||+|+||.||+|.+. +..||||++....... ..+.+|+.++++++||||+++++++.+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~hpniv~l~~~~~~ 287 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------EEFLKEAAVMKEIKHPNLVQLLGVCTR 287 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccch------HHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34566778999999999999999999884 6899999998655432 247899999999999999999999975
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
. ..++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~ 366 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSR 366 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCEE
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-CcEEEeecccce
Confidence 4 68899999999999999987656679999999999999999999999999999999999999854 469999999998
Q ss_pred ccccccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022903 209 EETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 209 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~ 276 (290)
....... .....++..|+|||++.. ..++.++||||||+++|+|++ |..||.+.+..+..
T Consensus 367 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~ 429 (495)
T 1opk_A 367 LMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429 (495)
T ss_dssp CCTTCCEECCTTCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred eccCCceeecCCCcCCcceeCHhHHhc--------CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 6433221 223346788999999864 567899999999999999999 99999998765443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=293.31 Aligned_cols=216 Identities=27% Similarity=0.490 Sum_probs=163.4
Q ss_pred cccCCCceeecceeccccceeEEEEEECC--c---eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGD--R---IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~--~---~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
.....++|.+++.||+|+||.||+|++.. + .||+|++......... ..++.+|+.+++.++||||+++++++
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD---IEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHH---HHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHH---HHHHHHHHHHHHHCCCCceehhhcee
Confidence 34566789999999999999999997632 2 7999999765433322 23588999999999999999999998
Q ss_pred ecCc-------eEEEEEecCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC
Q 022903 128 KDPL-------MVIVTELLPGMSLRKYLVSLRP----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ 196 (290)
Q Consensus 128 ~~~~-------~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~ 196 (290)
.+.. .++||||+++++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~- 173 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED- 173 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC-
Confidence 6542 2899999999999999865321 258999999999999999999999999999999999999955
Q ss_pred CceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCH
Q 022903 197 KSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272 (290)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~ 272 (290)
+.+||+|||++........ .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 245 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD--------NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcC--------CCCCCccchhhHHHHHHHHHhCCCCCccccCh
Confidence 4699999999976433322 123356788999999865 568899999999999999999 9999999877
Q ss_pred HHHHHHHH
Q 022903 273 LQAAYAAA 280 (290)
Q Consensus 273 ~~~~~~~~ 280 (290)
.+....+.
T Consensus 246 ~~~~~~~~ 253 (323)
T 3qup_A 246 AEIYNYLI 253 (323)
T ss_dssp GGHHHHHH
T ss_pred HHHHHHHh
Confidence 65554443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=291.70 Aligned_cols=216 Identities=31% Similarity=0.561 Sum_probs=177.4
Q ss_pred cccccCCCceeecceeccccceeEEEEEEC---------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCc
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNL 120 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 120 (290)
..+....++|.+++.||+|+||.||+|++. +..||+|++......... ..+.+|+.+++.+ +||||
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL----SDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHH----HHHHHHHHHHHHHCCCTTB
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHH----HHHHHHHHHHHHhhcCCCE
Confidence 344566778999999999999999999863 467999999876544332 3578999999999 89999
Q ss_pred eeEEeeeecC-ceEEEEEecCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecC
Q 022903 121 VKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDL 185 (290)
Q Consensus 121 v~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Di 185 (290)
+++++++.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|++||||
T Consensus 104 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 183 (334)
T 2pvf_A 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183 (334)
T ss_dssp CCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 9999998654 67899999999999999986432 24889999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh
Q 022903 186 KPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262 (290)
Q Consensus 186 kp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~ 262 (290)
||+||+++.+ +.+||+|||++....... ......+++.|+|||++.. ..++.++||||||+++|+|++
T Consensus 184 kp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt 254 (334)
T 2pvf_A 184 AARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSFGVLMWEIFT 254 (334)
T ss_dssp SGGGEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHT
T ss_pred ccceEEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcC--------CCcChHHHHHHHHHHHHHHHh
Confidence 9999999955 469999999997643322 2233456788999998864 557889999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHH
Q 022903 263 -NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 263 -g~~Pf~~~~~~~~~~~~ 279 (290)
|..||.+.+..+....+
T Consensus 255 ~g~~p~~~~~~~~~~~~~ 272 (334)
T 2pvf_A 255 LGGSPYPGIPVEELFKLL 272 (334)
T ss_dssp TSCCSSTTCCHHHHHHHH
T ss_pred CCCCCcCcCCHHHHHHHH
Confidence 99999998765544333
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=290.49 Aligned_cols=201 Identities=30% Similarity=0.524 Sum_probs=166.1
Q ss_pred cCCCceeecceeccccceeEEEEEE------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
...++|++++.||+|+||.||++++ +++.||+|++....... ...+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-----LRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHH-----HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3456799999999999999999984 56899999987543222 135789999999999999999999985
Q ss_pred c---CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 129 D---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 129 ~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
+ ...++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg 159 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFG 159 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEccCc
Confidence 3 3578999999999999999763 3469999999999999999999999999999999999999955 569999999
Q ss_pred ccccccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 206 LAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 206 ~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
++....... ......++..|+|||.+.. ..++.++||||||+++|+|++|..||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcC--------CCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 997643322 2223456778999998865 56899999999999999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=296.47 Aligned_cols=208 Identities=28% Similarity=0.433 Sum_probs=170.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChh---HHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSD---ERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 132 (290)
++|.+.+.||+|+||.||+|.+ +++.||||++....... ........+.+|+.+++.++||||+++++++.....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 89 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY 89 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCce
Confidence 4599999999999999999987 56899999987643211 011112347799999999999999999999988889
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC--ceEEecccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREE 210 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~--~~kl~Dfg~~~~~ 210 (290)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++. .+||+|||++...
T Consensus 90 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 90 YIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp EEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 999999999999998865 467999999999999999999999999999999999999985432 5999999999875
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
..........||+.|+|||++... ....++.++||||||+++|+|++|..||.+...
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHT-----TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred ccccccccccCCcCccCchhhccC-----CCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 544444455789999999987421 125678999999999999999999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=290.18 Aligned_cols=199 Identities=38% Similarity=0.662 Sum_probs=164.7
Q ss_pred cCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCceEE
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLMVI 134 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~l 134 (290)
++.++|.+.+.||+|+||.||++++.++.||+|++..... ...+.+|+.++++++||||+++++++.+ ..++
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~l 76 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE-------RKAFIVELRQLSRVNHPNIVKLYGACLN-PVCL 76 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTH-------HHHHHHHHHHHHHCCCTTBCCEEEBCTT-TTEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChhH-------HHHHHHHHHHHhcCCCCCcCeEEEEEcC-CcEE
Confidence 4567799999999999999999999999999999865321 1347899999999999999999999875 4789
Q ss_pred EEEecCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHA---NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
||||+++++|.+++..... ..++...++.++.|++.||.|||+ +|++||||||+||+++.++..+||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 9999999999999976322 247888999999999999999999 899999999999999866655899999998754
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 157 QTH--MTNNKGSAAWMAPEVFEG--------SNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ----------CCTTSSCHHHHTC--------CCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ccc--cccCCCCCceEChhhhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 322 234468999999998864 568999999999999999999999998654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.86 Aligned_cols=215 Identities=32% Similarity=0.490 Sum_probs=182.4
Q ss_pred cccccCCCceeecceeccccceeEEEEEECC-ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
..+.+..+.|++.+.||+|+||.||+|.+.+ ..||||++....... ..+.+|+.+++.++||||+++++++.+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~ 333 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSE 333 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCH------HHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3455677889999999999999999999854 679999998755432 247899999999999999999999988
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++..
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARL 412 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCTTSTTT
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-CcEEEccccccee
Confidence 889999999999999999976444568999999999999999999999999999999999999854 4699999999976
Q ss_pred cccccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 210 ETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 210 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
...... .....++..|+|||++.. ..++.++||||||++||+|++ |..||.+....+....+.
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~ 478 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH
T ss_pred cCCCceecccCCcCcccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 443221 223356788999998864 568999999999999999999 999999988876655543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=300.40 Aligned_cols=208 Identities=27% Similarity=0.377 Sum_probs=171.2
Q ss_pred CceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC------
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP------ 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 130 (290)
.+|.+.+.||+|+||.||+|++ .+..||+|.+...... ..+|+.+++.++||||+++++++...
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 4599999999999999999988 4456888887654332 23789999999999999999988421
Q ss_pred -ceEEEEEecCCCCHHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLV-SLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
..++||||++++.+..... ......+++..+..++.||+.||.|||++||+||||||+|||++..++.+||+|||+++
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 2679999997654433322 11346799999999999999999999999999999999999999556679999999998
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
............+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 191 ILIAGEPNVSYICSRYYRAPELIFG-------ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp ECCTTCCCCSSCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccCCCCCcccccCcCccCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 7655555566789999999998754 24589999999999999999999999999988877776654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=303.09 Aligned_cols=193 Identities=32% Similarity=0.465 Sum_probs=160.3
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 129 (290)
.++|.+++.||+|+||.||+|++ +++.||||++......... ..++.+|+.+++.++||||+++++++..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLID---CKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHH---HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHH---HHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 46799999999999999999987 5789999999765443322 2468899999999999999999999854
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
...++||||++ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~kL~DFGla~ 177 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSVKVCDFGLAR 177 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred CCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCEEEccCCCcc
Confidence 35789999995 599999875 4579999999999999999999999999999999999999955 469999999998
Q ss_pred cccccc-----------------------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC
Q 022903 209 EETVTE-----------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 263 (290)
Q Consensus 209 ~~~~~~-----------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g 263 (290)
...... ......||+.|+|||++.. ...++.++|||||||++|+|++|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-------QENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc-------CCCCCcccccchHHHHHHHHHhc
Confidence 643321 2355689999999998643 25689999999999999999983
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=297.66 Aligned_cols=213 Identities=24% Similarity=0.447 Sum_probs=168.9
Q ss_pred cccCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC--CCCceeEEeeeec
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--HDNLVKFLGACKD 129 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~ 129 (290)
.....+.|.+++.||+|+||.||++.+ .++.||||++......... ...+.+|+.+++.++ ||||+++++++..
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHH---HHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHH---HHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 344566799999999999999999987 4788999999876543322 245889999999996 5999999998865
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
. ..++||| +.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ + +.+||+|||++.
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~-~~~kl~DFG~a~ 202 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIAN 202 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-S-SCEEECCCSSSC
T ss_pred CCEEEEEEe-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-C-CeEEEEecCccc
Confidence 4 6789999 568899999986 35789999999999999999999999999999999999997 4 459999999998
Q ss_pred cccccc---cccccCCCccccCccccccccccc---cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 209 EETVTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 209 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~---~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
...... ......||+.|+|||++....... .....++.++|||||||++|+|++|..||.+....
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 273 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence 643322 234557999999999885421000 01135889999999999999999999999986543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=314.20 Aligned_cols=214 Identities=26% Similarity=0.547 Sum_probs=173.9
Q ss_pred cccCCCceeecc-eeccccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 53 LLVDPKLLFIGS-KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 53 ~~~~~~~~~~~~-~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
+......+.+.+ .||+|+||.||+|.+ ++..||||+++........ ..+.+|+.+++.++||||+++++++
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~ 405 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT----EEMMREAQIMHQLDNPYIVRLIGVC 405 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTH----HHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHH----HHHHHHHHHHHhCCCCCEeeEEEEe
Confidence 344555666666 899999999999976 3467999999875433222 2478999999999999999999999
Q ss_pred ecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 128 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
.+...++||||+.+++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 406 ~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkL~DFGla 483 (613)
T 2ozo_A 406 QAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISDFGLS 483 (613)
T ss_dssp ESSSEEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCSTT
T ss_pred ccCCeEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-CcEEEeeccCc
Confidence 88889999999999999999975 34679999999999999999999999999999999999999954 56999999999
Q ss_pred cccccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 208 REETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 208 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
+....... .....+++.|+|||++.. ..++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 553 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 86433221 122345688999999864 678999999999999999998 999999988776554443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=293.41 Aligned_cols=210 Identities=27% Similarity=0.525 Sum_probs=169.0
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCce----EEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRI----VAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~----vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
....+|++++.||+|+||.||+|++ +++. ||+|.+......... ..+.+|+.+++.++||||+++++++.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~ 87 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN----KEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCH----HHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHH----HHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence 4556799999999999999999987 3443 577777654333222 24789999999999999999999999
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
+...++|++|+.+++|.+++.. ....+++..++.++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++.
T Consensus 88 ~~~~~~v~~~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a~ 165 (327)
T 3lzb_A 88 TSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAK 165 (327)
T ss_dssp SSSEEEEECCCSSCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC--
T ss_pred cCCceEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCccee
Confidence 8888999999999999999986 34679999999999999999999999999999999999999854 469999999997
Q ss_pred ccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022903 209 EETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 209 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
....... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.+..+....
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 231 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231 (327)
T ss_dssp --------------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred EccCccccccccCCCccccccCHHHHcC--------CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Confidence 6433222 223356788999998865 668999999999999999999 9999999776554433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=289.07 Aligned_cols=199 Identities=29% Similarity=0.404 Sum_probs=162.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~ 133 (290)
+.|.++++||+|+||+||+|++ +++.||||++.......... .+...|+..+..+ +||||+++++++.+. ..+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR---ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH---HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 5699999999999999999988 57899999987654443322 2345566666555 899999999999754 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 134 lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEECCCTTCEECC--
T ss_pred EEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEccceeeeecccC
Confidence 999999 77999988764 4579999999999999999999999999999999999999855 46999999999876555
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.......||+.|+|||++. ..++.++||||||+++|+|++|..||.+..
T Consensus 211 ~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~el~~g~~~~~~~~ 259 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQ---------GSYGTAADVFSLGLTILEVACNMELPHGGE 259 (311)
T ss_dssp ----CCCCCGGGCCGGGGG---------TCCSTHHHHHHHHHHHHHHHHTCCCCSSHH
T ss_pred CCCcccCCCccccCHhHhc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 5555667999999999874 357899999999999999999977766543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=287.31 Aligned_cols=211 Identities=32% Similarity=0.529 Sum_probs=178.2
Q ss_pred cccCCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
+.+...+|.+.+.||+|+||.||+|.+. +..||+|++....... ..+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------EEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHH------HHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHH------HHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4456778999999999999999999884 7899999997654432 2477999999999999999999999754
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++..
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRL 160 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence 678999999999999999876667799999999999999999999999999999999999998554 599999999976
Q ss_pred cccccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 022903 210 ETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 278 (290)
Q Consensus 210 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~ 278 (290)
...... .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~ 224 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 224 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred ccCCccccccCCccccCcCChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 443322 223346778999998864 568899999999999999999 9999998776544433
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=298.22 Aligned_cols=208 Identities=33% Similarity=0.448 Sum_probs=158.3
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec----
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 129 (290)
-.++|.+++.||+|+||.||+|.+ +++.||||++......... ..++.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH---AKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHH---HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHH---HHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 346799999999999999999986 5789999999765433222 2457899999999999999999998853
Q ss_pred ---CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 130 ---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 130 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
...++|++++ +++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||+
T Consensus 104 ~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kL~DFG~ 178 (367)
T 2fst_X 104 EEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGL 178 (367)
T ss_dssp GGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECC---
T ss_pred ccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC-CCEEEeeccc
Confidence 3468999999 7899998864 579999999999999999999999999999999999999955 4699999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
+..... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 179 a~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 243 (367)
T 2fst_X 179 ARHTAD--EMTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243 (367)
T ss_dssp --------------CCCTTCCHHHHTT-------CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccc--cCCCcCcCcCccChHHHcC-------CcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 976432 2345678999999998754 2468899999999999999999999999988776665554
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=289.95 Aligned_cols=202 Identities=22% Similarity=0.393 Sum_probs=172.4
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeec---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD--- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--- 129 (290)
..++|++++.||+|+||.||+|++ +++.||+|++..... ..+.+|+.+++.++ ||||+++++++.+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--------KKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH--------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch--------HHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 446799999999999999999977 678999999875432 24779999999997 9999999999975
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...++||||+.+++|.+++.. +++..+..++.||+.||.|||++|++||||||+|||++.++..+||+|||++..
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 357899999999999998753 889999999999999999999999999999999999997766799999999987
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM-SNLQAAY 277 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~-~~~~~~~ 277 (290)
...........+++.|+|||.+.. ...++.++|||||||++|+|++|..||... ...+...
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~ 242 (330)
T 3nsz_A 181 YHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242 (330)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred cCCCCccccccccccccChhhhcC-------CCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence 655555566689999999998754 256889999999999999999999999554 4433333
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=293.89 Aligned_cols=190 Identities=26% Similarity=0.493 Sum_probs=145.7
Q ss_pred ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-ceEEEEEec
Q 022903 64 SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
+.||+|+||.||++.+ +++.||||++..... ..+.+|+.+++.+. ||||+++++++.+. ..++||||+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~ 88 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME--------ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELL 88 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGH--------HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhhh--------hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEcc
Confidence 6899999999999987 478999999965321 23668999999997 99999999999765 678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC--ceEEeccccccccccc-ccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREETVT-EMM 216 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~--~~kl~Dfg~~~~~~~~-~~~ 216 (290)
++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++. .+||+|||++...... ...
T Consensus 89 ~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 89 NGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp CSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 99999999986 467999999999999999999999999999999999999985442 6999999999754332 233
Q ss_pred cccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 217 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
....+|+.|+|||++.. ..++.++||||||+++|+|++|..||.+..
T Consensus 167 ~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQ--------NGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp -------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cccCCCcCccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 45578999999999864 668999999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=293.19 Aligned_cols=203 Identities=29% Similarity=0.467 Sum_probs=170.7
Q ss_pred cCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
....+|.+.+.||+|+||.||+|++ +++.||+|++........ ..+.+|+.+++.++||||+++++++.+. ..
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGI-----EEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHH-----HHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHH-----HHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 3456799999999999999999987 478999999877654332 2478999999999999999999998654 68
Q ss_pred EEEEEecCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
++||||+++++|.+++..... ..+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGISKKG 189 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT-CCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC-CCEEEeeccccccc
Confidence 899999999999998865322 358999999999999999999999999999999999999955 46999999998753
Q ss_pred ccc---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 211 TVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 211 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
... .......||+.|+|||.+.. ..++.++||||||+++|+|++|+.||.+..
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~p~~~~~ 245 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIK--------GRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHH--------CBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred ccccccccccccCCCccccCHHHhcC--------CCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence 222 12233458999999998864 568899999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=294.45 Aligned_cols=211 Identities=26% Similarity=0.385 Sum_probs=173.1
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 129 (290)
..+|++++.||+|+||.||+|++ +++.||+|++.......... ..+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP---ITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSC---HHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccch---HHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 35699999999999999999987 57899999986654332211 236789999999999999999998854
Q ss_pred ----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 130 ----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 130 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
...++||||+++ +|.+.+.. ....+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg 169 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFG 169 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred ccCCceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccch
Confidence 247899999965 77777765 345799999999999999999999999999999999999999554 69999999
Q ss_pred ccccccc-----cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 206 LAREETV-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 206 ~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
++..... ........||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcC-------CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9875432 222344578999999998754 2457899999999999999999999999987766555544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=286.91 Aligned_cols=214 Identities=27% Similarity=0.527 Sum_probs=174.0
Q ss_pred ccccCCCceeecc-eeccccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 52 SLLVDPKLLFIGS-KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 52 ~~~~~~~~~~~~~-~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
....+.++|.+.+ .||+|+||.||+|.+ .++.||||++........ ....+.+|+.+++.++||||++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA---LKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH---HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHH---HHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445667899988 999999999999954 357899999976543322 12458899999999999999999999
Q ss_pred eecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 127 CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 127 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
+.+...++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.+ +.++|+|||+
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~ 163 (291)
T 1xbb_A 87 CEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGL 163 (291)
T ss_dssp EESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTT
T ss_pred ECCCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCCc
Confidence 988888999999999999999986 3569999999999999999999999999999999999999955 4699999999
Q ss_pred ccccccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 207 AREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 207 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
+........ .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 233 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhcc--------CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 876433221 122346788999998864 457889999999999999999 99999998776554443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=293.12 Aligned_cols=217 Identities=24% Similarity=0.387 Sum_probs=179.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCC---hhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGST---SDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 130 (290)
..|.+.+.||+|+||.||+|++ +++.||||++..... ..........+.+|+.+++.+ +||||+++++++...
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 4689999999999999999987 478999999876542 222233345688999999999 799999999998754
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.+ +.++|+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEecCccccc
Confidence 678999999999999999763 579999999999999999999999999999999999999955 46999999999876
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..........||+.|+|||++.+.. ......++.++||||||+++|+|++|..||.+.+.......+
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSM--DETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTT--CTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcccccCCCCCCccChhhccccc--cccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 5555555678999999999875411 001235788999999999999999999999987765544433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=282.82 Aligned_cols=212 Identities=25% Similarity=0.424 Sum_probs=173.3
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHH-HHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
++|.+.+.||+|+||.||++++ +++.||+|++......... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4599999999999999999988 4789999998765432110 00012478999999999999999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC---ceEEecccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREE 210 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~---~~kl~Dfg~~~~~ 210 (290)
+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++. .++|+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 99999999999999976 357899999999999999999999999999999999999985542 6999999999875
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..........+++.|+|||++.. ..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 223 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 223 (283)
T ss_dssp C--------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cCCCcccccCCCcCccCcceecC--------CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh
Confidence 55444455679999999998764 56889999999999999999999999998766554443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.93 Aligned_cols=209 Identities=32% Similarity=0.437 Sum_probs=175.1
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--- 130 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 130 (290)
...+|++++.||+|+||.||+|++ +++.||+|++......... .++.+|+.+++.++||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC----QRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHH----HHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHH----HHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 346799999999999999999987 5789999999765443322 3578999999999999999999988543
Q ss_pred ---ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 131 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
..++||||++ ++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||++
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a 175 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLA 175 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred ccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcce
Confidence 4789999996 599998875 4699999999999999999999999999999999999999554 5999999999
Q ss_pred cccccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 208 REETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 208 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
........ .....||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 245 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHT-------BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcC-------CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 76443322 234578999999998653 2457899999999999999999999999988766665554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=284.16 Aligned_cols=208 Identities=28% Similarity=0.393 Sum_probs=157.8
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
+..++|++++.||+|+||.||++++ +++.||+|++.......... ..+.++...++.++||||+++++++.+. .
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK---RLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHH---HHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHH---HHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 4556799999999999999999988 68899999998765444332 2344555668888999999999998754 6
Q ss_pred eEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
.++||||++ ++|.+++... ....+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++.
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~ 158 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISG 158 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC----
T ss_pred EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcc
Confidence 889999996 4888877542 346799999999999999999999998 999999999999999554 69999999998
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
............||+.|+|||.+... .....++.++||||||+++|+|++|..||....
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERINPE----LNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217 (290)
T ss_dssp -----------CCCCCCSCHHHHSCC----TTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred cccccccccccCCCccccChhhcChh----hcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence 75555555556799999999986320 013567899999999999999999999998743
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=287.83 Aligned_cols=218 Identities=28% Similarity=0.448 Sum_probs=173.5
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec--
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-- 129 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-- 129 (290)
.....|.+++.||+|+||.||+|++ +++.||+|++........ .+.+|+.+++.+ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE------EIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTH------HHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHH------HHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3456799999999999999999998 678999999976544332 367899999999 79999999999853
Q ss_pred -----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 130 -----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 130 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
...++||||+++++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.+ +.++|+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~kl~Df 173 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDF 173 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECCC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC-CCEEEeeC
Confidence 467899999999999999987555679999999999999999999999999999999999999955 45999999
Q ss_pred ccccccccc-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 205 GLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 205 g~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
|++...... .......+++.|+|||++.... .....++.++||||||+++|+|++|..||.+.........+...
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp TTTC-------------CCGGGCCHHHHC-----------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred cCceecCcCccccccccCCccccChhhhcccc---ccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 998764322 2233457899999999875311 11356789999999999999999999999998877766655443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.65 Aligned_cols=211 Identities=27% Similarity=0.387 Sum_probs=177.1
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
...+|.+.+.||+|+||.||++++ +++.||+|++.......... ...+.+|+.+++.++||||+++++++.+. ..
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHH--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHH--HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 456799999999999999999987 46899999987654332221 23578999999999999999999999765 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus 117 ~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-CCEEEeeccCceeccc
Confidence 8999999999999998763 579999999999999999999999999999999999999955 4599999999976432
Q ss_pred c-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 213 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
. .......|++.|+|||++.. ..++.++||||||+++|+|++|..||.+....+....+
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 253 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred CcccccccCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 2 22344578999999998864 56789999999999999999999999987765554443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=283.47 Aligned_cols=211 Identities=27% Similarity=0.387 Sum_probs=176.7
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
..++|.+.+.||+|+||.||++++ +++.||+|++.......... ...+.+|+.+++.++||||+++++++.+. ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ--REKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHH--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHH--HHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 346799999999999999999988 46899999987654332221 23578999999999999999999999765 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-CCEEEEeccCceeccc
Confidence 8999999999999998763 578999999999999999999999999999999999999955 4599999999976432
Q ss_pred c-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 213 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
. .......+++.|+|||.+.. ..++.++||||||+++|+|++|..||.+....+....+
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 227 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 227 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred CccccccccCCCCcCCcchhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2 22344578999999998864 56788999999999999999999999987765544433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=292.81 Aligned_cols=211 Identities=20% Similarity=0.368 Sum_probs=172.0
Q ss_pred ceeec-ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC-ceE
Q 022903 59 LLFIG-SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 59 ~~~~~-~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~-~~~ 133 (290)
.|.+. +.||+|+||.||+|.+ +++.||+|++......... ...+.+|+.+++.+. ||||+++++++.+. ..+
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC---RAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEEC---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHH---HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 46665 8899999999999987 4789999998764433221 124779999999995 69999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC--CCCceEEeccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREET 211 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~--~~~~~kl~Dfg~~~~~~ 211 (290)
+||||+.+++|.+++.......+++..++.++.||+.||.|||++|++||||||+|||++. ..+.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999999999986655577999999999999999999999999999999999999985 24569999999998765
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.........||+.|+|||++.. ..++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 186 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 246 (327)
T 3lm5_A 186 HACELREIMGTPEYLAPEILNY--------DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246 (327)
T ss_dssp --------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CccccccccCCcCccCCeeecC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 5555556689999999998864 668899999999999999999999999988766655544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=284.13 Aligned_cols=210 Identities=30% Similarity=0.500 Sum_probs=171.8
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
..++|.+.+.||+|+||.||+|++ +++.||+|++........ .....+.+|+.+++.++||||+++++++.+. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA--GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHH--TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchh--hHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 345699999999999999999987 457899999865332211 1224578999999999999999999999765 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC--
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCc
Confidence 8999999999999999763 5699999999999999999999999999999999999999554 599999999865433
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
. ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 219 (279)
T 3fdn_A 162 S-RRTDLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219 (279)
T ss_dssp -------CCCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred c-cccccCCCCCccCHhHhcc--------CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence 2 2344578999999998864 56788999999999999999999999987765544433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=294.08 Aligned_cols=203 Identities=25% Similarity=0.394 Sum_probs=169.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHH---HHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER---ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L 131 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~ 131 (290)
++|.+++.||+|+||.||+|++ +++.||||++......... .....++.+|+.+++.++||||+++++++.+. .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 4699999999999999999976 6789999999875432110 00001356899999999999999999999765 6
Q ss_pred eEEEEEecCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 132 MVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 132 ~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
.++||||+.++ +|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-CcEEEeecccceEC
Confidence 78999998766 99999875 4579999999999999999999999999999999999999955 46999999999876
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
..........||+.|+|||++.+ ....+.++||||||+++|+|++|..||.+.
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMG-------NPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCCCceeccCCCccccChhhhcC-------CCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 55555556689999999998864 122378999999999999999999999764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=290.56 Aligned_cols=203 Identities=32% Similarity=0.523 Sum_probs=170.0
Q ss_pred ccccCCCceeecceeccccceeEEEEEE------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEe
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG 125 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 125 (290)
......+.|++++.||+|+||.||++.+ +++.||||++......... ..+.+|+.+++.++||||+++++
T Consensus 25 ~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~ 100 (318)
T 3lxp_A 25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR----SGWKQEIDILRTLYHEHIIKYKG 100 (318)
T ss_dssp CCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHH----HHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHH----HHHHHHHHHHHhCCCcchhhEEE
Confidence 3445556679999999999999988864 5688999999876544332 35789999999999999999999
Q ss_pred eeec---CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEe
Q 022903 126 ACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 126 ~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~ 202 (290)
++.+ ...++||||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.+ +.++|+
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~-~~~kl~ 176 (318)
T 3lxp_A 101 CCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-RLVKIG 176 (318)
T ss_dssp EEEETTTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEEC
T ss_pred EEecCCCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC-CCEEEC
Confidence 9865 357899999999999999875 359999999999999999999999999999999999999955 469999
Q ss_pred cccccccccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 203 DFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 203 Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++|..||...
T Consensus 177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE--------YKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred CccccccccccccccccccCCCCCceeeChHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 999998654332 2234467888999998865 45778999999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.36 Aligned_cols=207 Identities=25% Similarity=0.345 Sum_probs=173.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc------CCCCceeEEeeeec
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV------KHDNLVKFLGACKD 129 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~ 129 (290)
.+|.+++.||+|+||.||+|.+ +++.||||++....... ..+.+|+.+++.+ +|+||+++++.+..
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~------~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH------RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHH------HHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchH------HHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 4699999999999999999987 46899999997542211 2355777777766 57799999999865
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC-ceEEeccccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLA 207 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~-~~kl~Dfg~~ 207 (290)
...++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||++
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 47789999995 69999998866667999999999999999999999999999999999999996543 3999999999
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 250 ~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~ 313 (429)
T 3kvw_A 250 CYEHQ--RVYTYIQSRFYRAPEVILG--------ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313 (429)
T ss_dssp EETTC--CCCSSCSCGGGCCHHHHHT--------BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eecCC--cccccCCCCCccChHHHhC--------CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 75432 2345689999999999865 5689999999999999999999999999888776665553
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=288.38 Aligned_cols=213 Identities=31% Similarity=0.506 Sum_probs=171.6
Q ss_pred ccCCCceeecceeccccceeEEEEEECC------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
.+....|.+.+.||+|+||.||+|.+.. ..||+|++......... ..+.+|+.+++.++||||+++++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR----VDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHH----HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHH----HHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3566789999999999999999997632 35999999865543322 3578999999999999999999999
Q ss_pred ecC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 128 KDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 128 ~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
.+. ..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++|++||||||+||+++.+ +.+||+|||+
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~ 193 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGL 193 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-CcEEECCCCc
Confidence 754 67899999999999999976 34679999999999999999999999999999999999999955 4699999999
Q ss_pred ccccccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 207 AREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 207 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
+........ .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 264 (333)
T 1mqb_A 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264 (333)
T ss_dssp -----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred chhhccccccccccCCCCccccccCchhccc--------CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 976433211 122345788999998854 568899999999999999999 999999987765554443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=280.70 Aligned_cols=218 Identities=23% Similarity=0.380 Sum_probs=180.5
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCC----ChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeec
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGS----TSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 129 (290)
.++|.+.+.||+|+||.||+|.+ +++.||+|++.... ...........+.+|+.+++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 45699999999999999999988 56899999997654 22222333456889999999995 9999999999976
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
. ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccchh
Confidence 5 678999999999999999863 5789999999999999999999999999999999999999554 59999999998
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
............+++.|+|||++.... ......++.++||||||+++|+|++|..||.+.+.......+
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 241 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSM--NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHH--CTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred hcCCCcccccccCCccccCHHHhcccc--ccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH
Confidence 765555555668999999999875311 011245788999999999999999999999987766554443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=285.54 Aligned_cols=198 Identities=24% Similarity=0.359 Sum_probs=168.3
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ce
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~ 132 (290)
.++|.+.+.||+|+||.||+|++ +++.||+|++....... .+.+|+.+++.+ +|+|++++++++.+. ..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-------CHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccH-------HHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 45699999999999999999985 68999999987654332 256899999999 799999999988654 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC----ceEEecccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK----SLKLADFGLAR 208 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~----~~kl~Dfg~~~ 208 (290)
++||||+ +++|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++.++. .+||+|||++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 8999999 99999999863 456999999999999999999999999999999999999975432 39999999997
Q ss_pred cccccc--------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 209 EETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 209 ~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
...... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcC--------CCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 543322 1234578999999998864 568999999999999999999999999853
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=283.82 Aligned_cols=209 Identities=30% Similarity=0.477 Sum_probs=177.5
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 133 (290)
.+.|.+++.||+|+||.||+|.+ +++.||+|++......... ..+.+|+.+++.++||||+++++.+.+ ...+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 96 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI----EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW 96 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTH----HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHH----HHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence 35599999999999999999987 5789999999766543322 247899999999999999999999865 4678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 97 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTT
T ss_pred EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCcc
Confidence 99999999999999864 5799999999999999999999999999999999999999554 5999999999764333
Q ss_pred c-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 214 E-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 214 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
. ......+++.|+|||.+.. ..++.++||||||+++|+|++|..||.+....+....+..
T Consensus 173 ~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 233 (303)
T 3a7i_A 173 QIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK 233 (303)
T ss_dssp BCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ccccCccCCCcCccCHHHHhc--------CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc
Confidence 2 2344578999999999864 5678899999999999999999999999887766655543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=285.02 Aligned_cols=206 Identities=26% Similarity=0.453 Sum_probs=171.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|.+.+.||+|+||.||++++ +++.||+|++........ ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD-----SSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccch-----HHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 4599999999999999999987 578999999986543222 2477999999999999999999998765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc--CCCCceEEecccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLAREETV 212 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~--~~~~~~kl~Dfg~~~~~~~ 212 (290)
||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++. .+++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 84 VMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999999998763 5689999999999999999999999999999999999992 2445699999999875433
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
. ......|++.|+|||.+.. ..++.++||||||+++|+|++|..||.+.+.......+
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 219 (304)
T 2jam_A 162 G-IMSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219 (304)
T ss_dssp B-TTHHHHSCCCBCCTTTBSS--------CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred C-ccccccCCCCccChHHhcc--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 2 2234468999999999864 56889999999999999999999999987765544443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=313.40 Aligned_cols=212 Identities=27% Similarity=0.521 Sum_probs=171.5
Q ss_pred cCCCceeec-ceeccccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 55 VDPKLLFIG-SKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 55 ~~~~~~~~~-~~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
.+.+.+.+. +.||+|+||.||+|.+ .++.||||+++........ ...+.+|+.+++.++||||+++++++.+
T Consensus 365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL---KDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGG---HHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 344445543 4799999999999965 3478999999764332211 2358899999999999999999999988
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 442 ~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~ 518 (635)
T 4fl3_A 442 ESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKA 518 (635)
T ss_dssp SSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTTHHHH
T ss_pred CCEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcCCccc
Confidence 888999999999999999976 4579999999999999999999999999999999999999955 5699999999975
Q ss_pred ccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 210 ETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 210 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
..... ......+|+.|+|||++.. ..++.++||||||+++|+|++ |+.||.+.+..+....+.
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 586 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586 (635)
T ss_dssp TTC-------------CGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred cccCccccccccCCCCceeeeChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 43322 1223356788999999864 678999999999999999998 999999988776554443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=288.16 Aligned_cols=216 Identities=31% Similarity=0.500 Sum_probs=173.9
Q ss_pred ccccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEE
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFL 124 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 124 (290)
......++|.+++.||+|+||.||+|++ +++.||+|++......... .++.+|+.+++.++||||++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE----LDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHH----HHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhH----HHHHHHHHHHhhCCCCCCCeEE
Confidence 3345667899999999999999999973 4568999999765444332 3578999999999999999999
Q ss_pred eeeecC-ceEEEEEecCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--C
Q 022903 125 GACKDP-LMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--Q 196 (290)
Q Consensus 125 ~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~ 196 (290)
+++.+. ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||++|++||||||+|||++.+ +
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~ 179 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTT
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCc
Confidence 999754 67899999999999999987432 348899999999999999999999999999999999999843 3
Q ss_pred CceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCH
Q 022903 197 KSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272 (290)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~ 272 (290)
..++|+|||++....... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+...
T Consensus 180 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 180 RVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp CCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEECccccccccccccccccCCCcCCCcceeCHhHhcC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 359999999987432221 2223467889999998864 568899999999999999998 9999998876
Q ss_pred HHHHHHH
Q 022903 273 LQAAYAA 279 (290)
Q Consensus 273 ~~~~~~~ 279 (290)
.+....+
T Consensus 252 ~~~~~~~ 258 (327)
T 2yfx_A 252 QEVLEFV 258 (327)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 6554443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=289.59 Aligned_cols=212 Identities=32% Similarity=0.533 Sum_probs=171.2
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCce--EEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRI--VAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD 129 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~--vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 129 (290)
.+.++|.+.+.||+|+||.||+|++ ++.. +|+|.+......... .++.+|+.+++++ +||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~----~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH----RDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHH----HHHHHHHHHHHhccCCCchhhhceeeee
Confidence 4556799999999999999999976 4554 599998754333222 3578999999999 89999999999865
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~ 194 (290)
. ..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++|++||||||+||+++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 4 6789999999999999997632 246899999999999999999999999999999999999985
Q ss_pred CCCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHH
Q 022903 195 DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273 (290)
Q Consensus 195 ~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~ 273 (290)
+ +.+||+|||++.............+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..
T Consensus 178 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 178 N-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp G-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred C-CeEEEcccCcCccccccccccCCCCCccccChhhhcc--------ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 5 4699999999976444444444567889999998854 557889999999999999998 99999998766
Q ss_pred HHHHHH
Q 022903 274 QAAYAA 279 (290)
Q Consensus 274 ~~~~~~ 279 (290)
+....+
T Consensus 249 ~~~~~~ 254 (327)
T 1fvr_A 249 ELYEKL 254 (327)
T ss_dssp HHHHHG
T ss_pred HHHHHh
Confidence 544433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=283.41 Aligned_cols=204 Identities=28% Similarity=0.461 Sum_probs=152.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|.+.+.||+|+||.||+|++ +++.||+|++........ ....++.+|+.+++.++||||+++++++.+. ..++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKA--GMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT--TCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhh--hHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 5699999999999999999987 678999999864321111 1123578999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCCC
Confidence 9999999999999976 346799999999999999999999999999999999999999554 5999999998764322
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
.......+++.|+|||.+.. ..++.++||||||+++|+|++|..||...+..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 218 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATR--------SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK 218 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC
T ss_pred CcceeccCCCCcCCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCChhHH
Confidence 22234578999999998864 56788999999999999999999999876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=288.51 Aligned_cols=214 Identities=31% Similarity=0.551 Sum_probs=175.4
Q ss_pred ccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEe
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLG 125 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 125 (290)
....++|++.+.||+|+||.||+|++ +++.||+|++......... ..+.+|+.++..+ +||||+++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHH----HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHH----HHHHHHHHHHHhcccCCCeeeEEE
Confidence 34567899999999999999999974 3478999999876554332 3578999999999 6999999999
Q ss_pred eeecC--ceEEEEEecCCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCC
Q 022903 126 ACKDP--LMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189 (290)
Q Consensus 126 ~~~~~--~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~N 189 (290)
++.+. ..++||||+++++|.+++..... ..+++..+..++.||+.||.|||++|++||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 98653 48899999999999999986432 128899999999999999999999999999999999
Q ss_pred EEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCC
Q 022903 190 LLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 265 (290)
Q Consensus 190 ili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~ 265 (290)
|+++.+ +.+||+|||++....... ......+|+.|+|||++.. ..++.++||||||+++|+|++ |..
T Consensus 179 il~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 179 ILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp EEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred EEECCC-CCEEECCCccccccccCccceeccCCCcceeecCchhhcc--------ccccchhHHHHHHHHHHHHHhCCCC
Confidence 999855 459999999997543222 1223456889999998864 668899999999999999998 999
Q ss_pred CCCCCCHHHHHHHHH
Q 022903 266 PFEGMSNLQAAYAAA 280 (290)
Q Consensus 266 Pf~~~~~~~~~~~~~ 280 (290)
||.+....+......
T Consensus 250 p~~~~~~~~~~~~~~ 264 (316)
T 2xir_A 250 PYPGVKIDEEFCRRL 264 (316)
T ss_dssp SSTTCCCSHHHHHHH
T ss_pred CCcccchhHHHHHHh
Confidence 999877555444433
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.63 Aligned_cols=205 Identities=24% Similarity=0.402 Sum_probs=173.3
Q ss_pred CCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
..++|.+++.||+|+||.||++++. ++.||+|++......... ..+.+|+.+++.++||||+++++++.+. ..
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHH----HHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHH----HHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 3456999999999999999999884 789999999876543322 3588999999999999999999998654 67
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++....
T Consensus 107 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI 183 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHH
T ss_pred EEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcccc
Confidence 8999999999999999763 4689999999999999999999996 999999999999999654 59999999986532
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
. .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+..
T Consensus 184 ~-~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 239 (360)
T 3eqc_A 184 D-SMANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239 (360)
T ss_dssp H-HC----CCCCTTCCHHHHTT--------CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred c-ccccCCCCCCCeECHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 2 22344578999999999864 56889999999999999999999999987765543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=293.83 Aligned_cols=204 Identities=34% Similarity=0.500 Sum_probs=169.8
Q ss_pred ccccCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
......++|.+.+.||+|+||.||+|++ +++.||+|++......... ..+.+|+.+++.++||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE----LQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CC----CHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHH----HHHHHHHHHHHhccCCCccceEEEEecC
Confidence 3445667899999999999999999986 5789999999765432221 1477999999999999999999998654
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeeecCCCCCEEEcCCCCceEEecc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHAN---GIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++ |++||||||+|||++.+ +.+||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~kl~Df 178 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDF 178 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEEECCC
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEEeccC
Confidence 67899999999999999976432 3489999999999999999999999 99999999999999955 46999999
Q ss_pred ccccccccc--ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 205 GLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 205 g~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
|++...... .......||+.|+|||++.. ..++.++||||||+++|+|++|..||.
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHH--------SEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred ccccccCcccccccccccCCcCccCHHHhcc--------CCCCccccchhHHHHHHHHHhCCCccc
Confidence 999764322 22334469999999998864 557899999999999999999999996
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=283.60 Aligned_cols=210 Identities=29% Similarity=0.423 Sum_probs=172.8
Q ss_pred CCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-Cce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 132 (290)
..+.|.+.+.||+|+||.||+|.+. ++.||+|++....... .+.+|+.+++.++||||+++++++.+ ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-------EIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCH-------HHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHH-------HHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 3456999999999999999999874 7899999998654322 36799999999999999999999865 467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 100 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBT
T ss_pred EEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhh
Confidence 899999999999999874 346799999999999999999999999999999999999999554 599999999975433
Q ss_pred cc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 213 TE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 213 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
.. ......+++.|+|||.+.. ..++.++||||||+++|+|++|..||.+.........+...
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 240 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQE--------IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN 240 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSS--------SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred hccccCccCCCCCccChhhcCC--------CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence 22 2334578999999998864 56789999999999999999999999998877666655443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=283.76 Aligned_cols=204 Identities=30% Similarity=0.459 Sum_probs=163.6
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 133 (290)
.+.|.+.+.||+|+||.||++.+ +++.||+|++......... ....+.+|+.+++.++||||+++++++.+ ...+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPV--FRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHH--HHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 35699999999999999999987 5789999999765433322 23458899999999999999999999865 4678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 111 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC-------
T ss_pred EEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCcccccc
Confidence 999999999999999863 5699999999999999999999999999999999999999554 6999999998764332
Q ss_pred c--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 214 E--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 214 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
. ......+++.|+|||.+.. ..++.++||||||+++|+|++|..||.+.+..
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSE--------SHATYRADIYALTCVLYECLTGSPPYQGDQLS 241 (309)
T ss_dssp ---------CCGGGCCGGGTCC------------CCCHHHHHHHHHHHHHHSSCSSCSCHHH
T ss_pred ccccccccCCCcCccCHHHHcC--------CCCCchHhHHHHHHHHHHHHHCCCCCCCchHH
Confidence 2 2234578999999998864 56788999999999999999999999986554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=284.71 Aligned_cols=217 Identities=29% Similarity=0.467 Sum_probs=173.8
Q ss_pred CCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
..+.|++++.||+|+||.||+|++. ++.||+|++........ ..+.+|+.+++.++||||+++++++.+. ..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL-----EDYIVEIEILATCDHPYIVKLLGAYYHDGKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCH-----HHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHH-----HHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence 3456999999999999999999884 78999999876543322 2477999999999999999999998654 78
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++++|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 92 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLK 169 (302)
T ss_dssp EEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHH
T ss_pred EEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCccccc
Confidence 8999999999999998763 45799999999999999999999999999999999999999554 599999998754221
Q ss_pred c-ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 213 T-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 213 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
. .......+++.|+|||++.... .....++.++||||||+++|+|++|..||.+.+.......+...
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCET---MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 237 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHH---TTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred cccccccccCChhhcCCeeecccc---CCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc
Confidence 1 2223457899999999874210 01356789999999999999999999999998887766655544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=288.61 Aligned_cols=200 Identities=28% Similarity=0.488 Sum_probs=160.9
Q ss_pred CCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhh--cCCCCceeEEeeeec-----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR--VKHDNLVKFLGACKD----- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----- 129 (290)
.++|.+.+.||+|+||.||+|+++++.||||++..... ..+.+|.+++.. ++||||+++++.+.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~--------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE--------KSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGH--------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccc--------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 45699999999999999999999999999999865321 124456666665 789999999998643
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeecCCCCCEEEcCCCCceEE
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH--------ANGIIHRDLKPDNLLLTPDQKSLKL 201 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~givH~Dikp~Nili~~~~~~~kl 201 (290)
...++||||+++++|.+++.. ..+++..+..++.|++.||.||| ++|++||||||+|||++.+ +.+||
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~kl 154 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCI 154 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT-SCEEE
T ss_pred ceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC-CCEEE
Confidence 247899999999999999964 57999999999999999999999 9999999999999999955 46999
Q ss_pred eccccccccccccc-----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC----------CCC
Q 022903 202 ADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN----------RLP 266 (290)
Q Consensus 202 ~Dfg~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g----------~~P 266 (290)
+|||++........ .....||+.|+|||++..... .....++.++||||||+++|+|++| ..|
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ--VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCC--TTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCC--CCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 99999875332221 223479999999998864110 0000345789999999999999999 899
Q ss_pred CCCC
Q 022903 267 FEGM 270 (290)
Q Consensus 267 f~~~ 270 (290)
|.+.
T Consensus 233 f~~~ 236 (301)
T 3q4u_A 233 FYDV 236 (301)
T ss_dssp TTTT
T ss_pred cccc
Confidence 9764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=287.40 Aligned_cols=211 Identities=30% Similarity=0.493 Sum_probs=174.4
Q ss_pred CCceeecceeccccceeEEEEEE---CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc---CCCCceeEEeeee--
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACK-- 128 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-- 128 (290)
.++|++++.||+|+||.||+|++ +++.||+|++.......... ..+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC---chhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 45699999999999999999987 36789999987543221100 1244677666665 8999999999875
Q ss_pred ----cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 129 ----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 129 ----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
....++||||+. ++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Df 164 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADF 164 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecC
Confidence 235789999997 6999999876656799999999999999999999999999999999999999554 6999999
Q ss_pred cccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 205 GLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 205 g~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
|++.............+++.|+|||++.. ..++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccCCCCccccccccceeCHHHHhc--------CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 99987655555556688999999998864 568899999999999999999999999988776665554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=281.21 Aligned_cols=208 Identities=29% Similarity=0.472 Sum_probs=164.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
.+|.+++.||+|+||.||+|++ +++.||+|++........ ....++.+|+.+++.++||||+++++++.+. ..++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSL--DVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT--TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccch--hHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4699999999999999999987 478999999865321110 1123578999999999999999999998754 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC--
T ss_pred EEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccCCCc
Confidence 99999999999999763 4689999999999999999999999999999999999999554 59999999998765544
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
......+++.|+|||.+.. ....+.++||||||+++|+|++|..||.+....+...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 221 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK 221 (276)
T ss_dssp -----------CCTGGGTT-------SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ceecccCCccccCHHHHcC-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 4455678999999998864 1223679999999999999999999999876654433
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=284.17 Aligned_cols=215 Identities=29% Similarity=0.541 Sum_probs=167.5
Q ss_pred cccCCCceeecceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
...+.++|.+.+.||+|+||.||+|++. +..||+|++......... ...+.+|+.+++.++||||+++++++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE---IEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHH---HHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhH---HHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 4456678999999999999999999762 347999999866544332 23588999999999999999999998
Q ss_pred ecC------ceEEEEEecCCCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC
Q 022903 128 KDP------LMVIVTELLPGMSLRKYLVSL----RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 197 (290)
Q Consensus 128 ~~~------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~ 197 (290)
.+. ..++||||+++++|.+++... ....+++..++.++.||+.||.|||++|++||||||+||+++.+ +
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~ 184 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-M 184 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT-S
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-C
Confidence 643 358999999999999998542 23569999999999999999999999999999999999999955 4
Q ss_pred ceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHH
Q 022903 198 SLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273 (290)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~ 273 (290)
.+||+|||++....... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+....
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHS--------SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcC--------CCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 59999999987543322 1223356789999998864 668899999999999999999 99999987765
Q ss_pred HHHHHH
Q 022903 274 QAAYAA 279 (290)
Q Consensus 274 ~~~~~~ 279 (290)
+....+
T Consensus 257 ~~~~~~ 262 (313)
T 3brb_A 257 EMYDYL 262 (313)
T ss_dssp GHHHHH
T ss_pred HHHHHH
Confidence 544433
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.04 Aligned_cols=203 Identities=27% Similarity=0.447 Sum_probs=166.6
Q ss_pred CCCceeecceeccccceeEEEEEEC--C-------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG--D-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~--~-------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
..++|.+.+.||+|+||.||+|++. + ..||+|++........ ..+.+|+.+++.++||||++++++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS-----ESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGH-----HHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHH-----HHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4567999999999999999999763 2 4699999865443322 347899999999999999999999
Q ss_pred eecC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCc-------
Q 022903 127 CKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS------- 198 (290)
Q Consensus 127 ~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~------- 198 (290)
+.++ ..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.++..
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 8754 67899999999999999986 33459999999999999999999999999999999999999855432
Q ss_pred eEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022903 199 LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274 (290)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~ 274 (290)
+||+|||++...... ....+++.|+|||++.. ...++.++||||||+++|+|++ |.+||.......
T Consensus 160 ~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~ 226 (289)
T 4fvq_A 160 IKLSDPGISITVLPK---DILQERIPWVPPECIEN-------PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226 (289)
T ss_dssp EEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHC-------GGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred eeeccCcccccccCc---cccCCcCcccCHHHhCC-------CCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH
Confidence 999999998754332 22357888999998753 2457899999999999999999 566666655443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.11 Aligned_cols=205 Identities=26% Similarity=0.385 Sum_probs=166.2
Q ss_pred CCCceeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 129 (290)
...+|.+++.||+|+||.||++++ +++.||||+++......... ....+.+|+.+++.+ +||||+++++++.+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK-TTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES-SGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhh-HHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 446799999999999999999987 67899999986532110000 001356789999999 69999999999865
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
. ..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~ 207 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSK 207 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEE
T ss_pred CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCCe
Confidence 4 678999999999999999863 4699999999999999999999999999999999999999554 69999999997
Q ss_pred ccccc--ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 209 EETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 209 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
..... .......||+.|+|||++.+ ....++.++|||||||++|+|++|..||...
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 265 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred ecccCCCCcccCcccCcCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence 54322 22334579999999999864 1244788999999999999999999999754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=281.61 Aligned_cols=208 Identities=30% Similarity=0.525 Sum_probs=169.3
Q ss_pred CceeecceeccccceeEEEEEECC-----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee--cC
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK--DP 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~ 130 (290)
..|.+.+.||+|+||.||+|.+.+ ..||+|.+......... ..+.+|+.++++++||||+++++++. +.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV----SQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHH----HHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHH----HHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 458899999999999999998632 35899998875544432 35789999999999999999999864 34
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++...
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDM 178 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSCGGGCCC
T ss_pred ceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-CCEEECcccccccc
Confidence 67899999999999999975 34668999999999999999999999999999999999999955 46999999999754
Q ss_pred ccccc-----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 211 TVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 211 ~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
..... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++ |.+||.+.+..+....+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH
T ss_pred cccchhccccccCCCCCccccChHHhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 33221 223356788999998864 568899999999999999999 77888877655444333
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=282.19 Aligned_cols=209 Identities=29% Similarity=0.469 Sum_probs=174.3
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
.++|.+.+.||+|+||.||+|++ +++.||+|++........ .....+.+|+.+++.++||||+++++++.+. ..+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE--GVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT--TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchH--HHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 35699999999999999999987 467899999865321111 1123578999999999999999999999764 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSSS
T ss_pred EEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCccc
Confidence 999999999999999863 4689999999999999999999999999999999999999554 5999999998654332
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......+++.|+|||.+.. ..++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 168 -~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 224 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEG--------KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI 224 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred -ccccccCCCCcCCHHHhcc--------CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH
Confidence 2345578999999998864 56789999999999999999999999987766554443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=280.87 Aligned_cols=202 Identities=30% Similarity=0.444 Sum_probs=169.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||.||+|.+ +++.||+|++......... ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP----ENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHH----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhh----HHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 4589999999999999999987 4789999998755443322 3478999999999999999999998754 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 83 FLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETT
T ss_pred EEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCc
Confidence 9999999999998864 45699999999999999999999999999999999999999554 5999999998754322
Q ss_pred --ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 214 --EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 214 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
.......+++.|+|||.+.. ....+.++||||||+++|+|++|..||.+....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 214 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTC-------SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT
T ss_pred chhcccCCccccCccChHHHhc-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Confidence 22345578999999998864 122467899999999999999999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=284.29 Aligned_cols=208 Identities=26% Similarity=0.405 Sum_probs=166.7
Q ss_pred CCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee------
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK------ 128 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------ 128 (290)
..+|.+++.||+|+||.||+|.+. ++.||+|++....... ...+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS-----VKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHH-----HHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHH-----HHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 356999999999999999999884 7899999987543221 235789999999999999999998863
Q ss_pred ---------cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCce
Q 022903 129 ---------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL 199 (290)
Q Consensus 129 ---------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~ 199 (290)
....++||||++ ++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++..+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 235789999997 599998864 5789999999999999999999999999999999999998666679
Q ss_pred EEeccccccccccc----ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 200 KLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 200 kl~Dfg~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
||+|||++...... .......++..|+|||.+.. ...++.++||||||+++|+|++|+.||.+.+..+.
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 233 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-------TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcC-------cccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999764322 12233457889999998753 24678999999999999999999999999887666
Q ss_pred HHHHH
Q 022903 276 AYAAA 280 (290)
Q Consensus 276 ~~~~~ 280 (290)
...+.
T Consensus 234 ~~~~~ 238 (320)
T 2i6l_A 234 MQLIL 238 (320)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=291.87 Aligned_cols=205 Identities=21% Similarity=0.304 Sum_probs=162.8
Q ss_pred cCCCceeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHH------HHHHHHHHHHHHhhcCCCCceeE
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERAL------LEGRFIREVNMMSRVKHDNLVKF 123 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~ 123 (290)
...++|.+.+.||+|+||.||+|.+ .+..||+|+..........+. ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 3457899999999999999999988 457899999987654322111 11236678899999999999999
Q ss_pred Eeeeec-----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC-C
Q 022903 124 LGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ-K 197 (290)
Q Consensus 124 ~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~-~ 197 (290)
++++.+ ...++||||+ +++|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence 998854 3678999999 99999998763 3799999999999999999999999999999999999998554 2
Q ss_pred ceEEecccccccccccc--------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 198 SLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--------VALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 69999999997543221 1234578999999998864 5689999999999999999999999965
Q ss_pred C
Q 022903 270 M 270 (290)
Q Consensus 270 ~ 270 (290)
.
T Consensus 263 ~ 263 (345)
T 2v62_A 263 N 263 (345)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=307.98 Aligned_cols=216 Identities=28% Similarity=0.498 Sum_probs=178.3
Q ss_pred ccccCCCceeecceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
.......+|.+++.||+|+||.||+|.+. +..||+|.+........ ...+.+|+.+++.++||||++++++
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV----REKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHH----HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34455678999999999999999999873 35799999876544332 2358899999999999999999999
Q ss_pred eecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 127 CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 127 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
+.++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||+
T Consensus 460 ~~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~vkL~DFG~ 537 (656)
T 2j0j_A 460 ITENPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGL 537 (656)
T ss_dssp ECSSSCEEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCC
T ss_pred EecCceEEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CCEEEEecCC
Confidence 988889999999999999999986 34568999999999999999999999999999999999999955 5699999999
Q ss_pred ccccccccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022903 207 AREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 207 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~ 281 (290)
+........ .....+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~ 607 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcC--------CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc
Confidence 986433322 223356789999998864 568899999999999999997 9999999887766655544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=289.85 Aligned_cols=216 Identities=25% Similarity=0.360 Sum_probs=168.2
Q ss_pred CCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChh------HHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSD------ERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
-.+.|.+.+.||+|+||.||+|.+ .++.||||++....... .......++.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 346699999999999999999976 57899999986543321 11122346889999999999999999999873
Q ss_pred c------CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEe
Q 022903 129 D------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 129 ~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~ 202 (290)
. ...++||||+. ++|.+++.. ....+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~ 176 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITIC 176 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEE
Confidence 2 14689999996 688888875 345799999999999999999999999999999999999999554 59999
Q ss_pred cccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 203 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
|||++.............+|+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 248 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQ-------FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVE 248 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ecCcccccccccccceecccceecCcHHhcC-------CCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999986555555556688999999998754 24578999999999999999999999999887766665543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=286.05 Aligned_cols=208 Identities=30% Similarity=0.419 Sum_probs=171.8
Q ss_pred CCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec----
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 129 (290)
-.++|.+.+.||+|+||.||+|++. ++.||||++........ ..++.+|+.+++.++||||+++++++..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF----ALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHH----HHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchH----HHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 3467999999999999999999874 78999999975443332 2357799999999999999999998753
Q ss_pred --CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 130 --PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 130 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
...++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.+ +.+||+|||++
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a 159 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLA 159 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTC
T ss_pred ccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC-CcEEEEecccc
Confidence 45789999996 599998876 469999999999999999999999999999999999999955 45999999998
Q ss_pred ccccccc-----------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 208 REETVTE-----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 208 ~~~~~~~-----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
....... ......||+.|+|||++.. ...++.++||||||+++|+|++|..||.+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 232 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-------SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHS-------CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeecc-------CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 7543221 1223468999999998643 256789999999999999999999999998876655
Q ss_pred HHH
Q 022903 277 YAA 279 (290)
Q Consensus 277 ~~~ 279 (290)
..+
T Consensus 233 ~~~ 235 (353)
T 2b9h_A 233 LLI 235 (353)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=280.72 Aligned_cols=198 Identities=27% Similarity=0.384 Sum_probs=166.1
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee-e-cCce
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-K-DPLM 132 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~-~~~~ 132 (290)
.++|++.+.||+|+||.||+|++ +++.||+|++....... .+.+|+.+++.++|++++..+..+ . +...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC-------HHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh-------HHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 45699999999999999999986 67899999987655433 367899999999998877766655 3 3467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc--CCCCceEEecccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLAREE 210 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~--~~~~~~kl~Dfg~~~~~ 210 (290)
++||||+ +++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+|||++ .+++.+||+|||++...
T Consensus 81 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 8999999 9999999975 346799999999999999999999999999999999999994 24456999999999764
Q ss_pred ccccc--------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 211 TVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 211 ~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
..... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccccccCChhhhcC--------CCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 33321 234578999999999865 568899999999999999999999998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=280.81 Aligned_cols=212 Identities=29% Similarity=0.435 Sum_probs=173.9
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee---cCc
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK---DPL 131 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~ 131 (290)
.++|++++.||+|+||.||++++ +++.||+|++......... ...+.+|+.+++.++||||+++++++. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE---KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHH---HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHH---HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 35699999999999999999987 5789999999876544332 245889999999999999999999874 346
Q ss_pred eEEEEEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeecCCCCCEEEcCCCCceEEecc
Q 022903 132 MVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANG-----IIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~g-----ivH~Dikp~Nili~~~~~~~kl~Df 204 (290)
.++||||+++++|.+++.... ...+++..+..++.|++.||.|||++| ++||||||+||+++.+ +.+||+||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~df 160 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDF 160 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecC
Confidence 789999999999999987532 345899999999999999999999999 9999999999999955 46999999
Q ss_pred cccccccccc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 205 GLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 205 g~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
|++....... ......+++.|+|||.+.. ..++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~ 229 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR 229 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHC--------C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred chheeeccccccccccCCCccccChHHhcc--------CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh
Confidence 9987643322 1234468999999998864 567899999999999999999999999987765544443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=289.28 Aligned_cols=206 Identities=30% Similarity=0.458 Sum_probs=170.1
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCc---
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPL--- 131 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 131 (290)
.++|.+.+.||+|+||.||+|.+ +++.||||++......... ..++.+|+.+++.++||||+++++++....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF---AKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHH---HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhH---HHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 46799999999999999999987 5789999999865544322 246789999999999999999999986532
Q ss_pred ----eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 132 ----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 132 ----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
.++||||+. ++|.+++. ..+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a 191 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLA 191 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECSTTCC
T ss_pred cceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC-CCEEEEecCcc
Confidence 389999996 68887663 459999999999999999999999999999999999999955 45999999999
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
..... ......+|+.|+|||++.+ ...++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 255 (371)
T 4exu_A 192 RHADA--EMTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 255 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccc--CcCCcccCccccCHHHhcC-------CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 75432 2345578999999998754 2568899999999999999999999999988777666654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.90 Aligned_cols=209 Identities=18% Similarity=0.283 Sum_probs=158.1
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHH---HHHhhcCCCCceeEE-----
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREV---NMMSRVKHDNLVKFL----- 124 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~~~----- 124 (290)
...+.|.+.+.||+|+||.||+|++ +++.||||++.......... ...+.+|+ .+++.++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA--IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTH--HHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHH--HHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 3457899999999999999999985 58999999997543222111 13577999 555566799999988
Q ss_pred --eeeecC------------------ceEEEEEecCCCCHHHHHHhcCCCCCC-------HHHHHHHHHHHHHHHHHHHH
Q 022903 125 --GACKDP------------------LMVIVTELLPGMSLRKYLVSLRPNKLD-------LHVALNFALDIARAMDCLHA 177 (290)
Q Consensus 125 --~~~~~~------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~-------~~~~~~i~~qi~~~l~~lH~ 177 (290)
+++.++ ..++||||+ +|+|.+++... ..++ +..+..++.||+.||.|||+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~--~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL--LSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH--HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc--cccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 444433 278999999 67999999763 2233 47788899999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEecccccccccccccccccCCCccccCcccccccc---ccccccCCCCCcchhHHHH
Q 022903 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT---LRQGEKKHYNNKVDVYSFG 254 (290)
Q Consensus 178 ~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~~~~~~~DiwslG 254 (290)
+||+||||||+|||++.+ +.+||+|||++..... ......| +.|+|||++.... ........++.++||||||
T Consensus 225 ~~ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp TTEECSCCCGGGEEECTT-CCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred CCeecCCCCHHHEEEcCC-CCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 999999999999999965 4699999999986332 3345567 9999999986510 0000012689999999999
Q ss_pred HHHHHHHhCCCCCCCCCH
Q 022903 255 IVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 255 ~~l~~~l~g~~Pf~~~~~ 272 (290)
|++|+|++|..||.+.+.
T Consensus 301 ~il~elltg~~Pf~~~~~ 318 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAA 318 (377)
T ss_dssp HHHHHHHHSSCCC-----
T ss_pred HHHHHHHHCCCCCccccc
Confidence 999999999999987543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=288.42 Aligned_cols=211 Identities=25% Similarity=0.369 Sum_probs=163.2
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 130 (290)
.++|.+.+.||+|+||.||+|++ +++.||||++........ +..+++..+..++||||+++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN------RELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCC------HHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccH------HHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 35699999999999999999987 478999999866543332 245778888889999999999988431
Q ss_pred ----ceEEEEEecCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeeecCCCCCEEEcCCCCceEEe
Q 022903 131 ----LMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLH--ANGIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 131 ----~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH--~~givH~Dikp~Nili~~~~~~~kl~ 202 (290)
..++||||+++ +|...+.. .....+++..+..++.|++.||.||| ++|++||||||+|||++..++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 26799999976 55544432 23567899999999999999999999 99999999999999999646679999
Q ss_pred cccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 203 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
|||++.............||+.|+|||++.+ ...++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~ 246 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFG-------NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR 246 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence 9999987665555556688999999998754 24579999999999999999999999999887776666543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=284.84 Aligned_cols=204 Identities=27% Similarity=0.471 Sum_probs=163.4
Q ss_pred Cceeec-ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ce
Q 022903 58 KLLFIG-SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 58 ~~~~~~-~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~ 132 (290)
+.|.+. +.||+|+||.||+|++ +++.||||++........ .++.+|+.++.++ +||||+++++++.+. ..
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR-----SRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCH-----HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhH-----HHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 457775 7899999999999986 678999999976543322 2477999999885 799999999998654 68
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC--ceEEecccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREE 210 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~--~~kl~Dfg~~~~~ 210 (290)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++. .+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 8999999999999999863 56899999999999999999999999999999999999986543 3999999998753
Q ss_pred ccc--------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 211 TVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 211 ~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
... .......||+.|+|||++..... ....++.++||||||+++|+|++|..||.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE---EASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSH---HHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccc---cccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 221 11223469999999998753110 01346889999999999999999999998864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=280.92 Aligned_cols=194 Identities=29% Similarity=0.471 Sum_probs=168.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec------
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------ 129 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 129 (290)
.+|.+++.||+|+||.||+|++ +++.||+|++..... .+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---------KAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG---------GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH---------HHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 4589999999999999999988 478999999976542 25689999999999999999998743
Q ss_pred -----------CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCc
Q 022903 130 -----------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS 198 (290)
Q Consensus 130 -----------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~ 198 (290)
...++||||+++++|.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.+ +.
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~ 160 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-KQ 160 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-CC
Confidence 247899999999999999987656789999999999999999999999999999999999999954 46
Q ss_pred eEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 199 LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 199 ~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
++|+|||++.............+++.|+|||.+.. ..++.++||||||+++|+|++|..||..
T Consensus 161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS--------QDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC--------SCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred EEECcchhheeccccccccccCCcccccChhhhcc--------CCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 99999999987655544455679999999998864 5678999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=285.37 Aligned_cols=214 Identities=28% Similarity=0.430 Sum_probs=159.2
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
.+..++|.+.+.||+|+||.||+|.+ +++.||+|++........ ...+.+|+.+++.++||||+++++++.+.
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------CCCCCCCTTBCCEEEEEESSS
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchh----HHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 35567899999999999999999976 678999999875443222 23577999999999999999999998654
Q ss_pred ceEEEEEecCCCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 131 LMVIVTELLPGMSLRKYLVSL------RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
..++||||+++++|.+++... ....+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~df 165 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADF 165 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEec
Confidence 688999999999999998742 245689999999999999999999999999999999999999554 5999999
Q ss_pred ccccccccc------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 205 GLAREETVT------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 205 g~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
|++...... .......+|+.|+|||++.. ...++.++||||||+++|+|++|..||.+.........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 238 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ-------VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHH-------HHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhcc-------ccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH
Confidence 998653322 11234468999999998753 13578999999999999999999999998776655544
Q ss_pred H
Q 022903 279 A 279 (290)
Q Consensus 279 ~ 279 (290)
.
T Consensus 239 ~ 239 (303)
T 2vwi_A 239 T 239 (303)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=283.89 Aligned_cols=216 Identities=33% Similarity=0.523 Sum_probs=168.0
Q ss_pred ccCCCceeecceeccccceeEEEEEEC---C--ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG---D--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
....++|++.+.||+|+||.||+|++. + ..||+|++......... ....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE--AMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CH--HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHH--HHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 345678999999999999999999752 2 26899998765432211 1245889999999999999999999998
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
+...++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.
T Consensus 92 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~ 169 (291)
T 1u46_A 92 TPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMR 169 (291)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCE
T ss_pred cCCceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEccccccc
Confidence 88889999999999999999763 3568999999999999999999999999999999999999855 469999999987
Q ss_pred cccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022903 209 EETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 209 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~ 281 (290)
...... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.+.+..+....+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 239 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred cccccccchhhhccCCCCceeeCchhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc
Confidence 643322 1223457788999998864 457889999999999999999 9999999887766555543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=293.29 Aligned_cols=206 Identities=31% Similarity=0.540 Sum_probs=161.6
Q ss_pred CceeecceeccccceeEEEEEE--CC---ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee--cC
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GD---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK--DP 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~ 130 (290)
..|.+.+.||+|+||.||+|++ .+ ..||+|.+......... .++.+|+.++++++||||+++++++. +.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV----SQFLTEGIIMKDFSHPNVLSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHH----HHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHH----HHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence 3478889999999999999976 22 36899998765443332 35889999999999999999999864 34
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.+ +.+||+|||++...
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDM 242 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC------
T ss_pred CeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-CCEEEeeccccccc
Confidence 67899999999999999975 34568899999999999999999999999999999999999955 46999999999754
Q ss_pred cccc-----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022903 211 TVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277 (290)
Q Consensus 211 ~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~ 277 (290)
.... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |.+||.+.+..+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~ 307 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 307 (373)
T ss_dssp ---------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH
T ss_pred cccccccccccCCCCCcccccChHHhcC--------CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH
Confidence 3221 1123356788999998864 668999999999999999999 889998876554443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=288.91 Aligned_cols=203 Identities=30% Similarity=0.493 Sum_probs=170.2
Q ss_pred ccCCCceeecceeccccceeEEEEEE------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
+.+.++|++++.||+|+||.||++++ +++.||+|++........ ..+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~E~~~l~~l~h~~i~~~~~~~ 93 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ-----RDFQREIQILKALHSDFIVKYRGVS 93 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHH-----HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHH-----HHHHHHHHHHHhcCCCceeEEEEEE
Confidence 35567899999999999999999984 568899999976543222 3578999999999999999999987
Q ss_pred e---cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 128 K---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 128 ~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
. ....++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.+ +.+||+||
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~kl~Df 171 (327)
T 3lxl_A 94 YGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADF 171 (327)
T ss_dssp ECSSSCEEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCG
T ss_pred ecCCCceEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEEEccc
Confidence 5 23578999999999999999763 3469999999999999999999999999999999999999855 46999999
Q ss_pred cccccccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 205 GLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 205 g~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
|++....... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--------NIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhcc--------CCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 9997643322 2233467888999998864 557889999999999999999999997643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=291.04 Aligned_cols=198 Identities=26% Similarity=0.413 Sum_probs=166.5
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC--------CCCceeEEee
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--------HDNLVKFLGA 126 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~ 126 (290)
..+|.+.+.||+|+||.||+|++ +++.||||++..... ....+.+|+.+++.++ ||||+++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH------YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH------HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc------chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 35699999999999999999987 578999999974321 1235778999999885 7889999998
Q ss_pred ee----c-CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCC----
Q 022903 127 CK----D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQ---- 196 (290)
Q Consensus 127 ~~----~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~---- 196 (290)
+. + ...++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence 85 2 3678999999 66777777665556799999999999999999999999 999999999999998654
Q ss_pred --------------------------------------------CceEEecccccccccccccccccCCCccccCccccc
Q 022903 197 --------------------------------------------KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232 (290)
Q Consensus 197 --------------------------------------------~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~ 232 (290)
..+||+|||++...... .....||+.|+|||++.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhc
Confidence 26999999999764432 34557899999999986
Q ss_pred cccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 233 ~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 267 ~--------~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 267 G--------SGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp T--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred C--------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 5 568999999999999999999999998765
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=290.50 Aligned_cols=196 Identities=20% Similarity=0.301 Sum_probs=165.0
Q ss_pred CCceeecceeccccceeEEEEEEC----------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCcee----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG----------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK---- 122 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~---- 122 (290)
.++|.+.+.||+|+||.||+|++. ++.||+|++.... .+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~----------~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG----------RLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS----------THHHHHHHHHHHCCHHHHHHHHH
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc----------hHHHHHHHHHHhcccchhhhhhh
Confidence 467999999999999999999873 6799999997652 3668999999999999987
Q ss_pred -----------EEeeee--cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCC
Q 022903 123 -----------FLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 189 (290)
Q Consensus 123 -----------~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~N 189 (290)
+++.+. +...++||||+ +++|.+++.......+++..++.++.||+.||.|||++|++||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 445553 45788999999 9999999987444679999999999999999999999999999999999
Q ss_pred EEEcCCC-CceEEeccccccccccccc--------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHH
Q 022903 190 LLLTPDQ-KSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260 (290)
Q Consensus 190 ili~~~~-~~~kl~Dfg~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~ 260 (290)
||++.++ ..+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 261 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--------CGPSRRSDLQSLGYCMLKW 261 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--------CCCCchhhHHHHHHHHHHH
Confidence 9999654 1699999999976433221 133478999999998864 5689999999999999999
Q ss_pred HhCCCCCCCCC
Q 022903 261 LTNRLPFEGMS 271 (290)
Q Consensus 261 l~g~~Pf~~~~ 271 (290)
++|..||.+..
T Consensus 262 ~~g~~pf~~~~ 272 (352)
T 2jii_A 262 LYGFLPWTNCL 272 (352)
T ss_dssp HHSCCTTGGGT
T ss_pred HhCCCCcccCC
Confidence 99999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=280.49 Aligned_cols=200 Identities=31% Similarity=0.534 Sum_probs=165.8
Q ss_pred CCCceeecceeccccceeEEEEEE------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
..+.|++++.||+|+||.||+|++ +++.||+|++......... ..+.+|+.+++.++||||+++++++.+
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI----ADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCH----HHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhH----HHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 446699999999999999999984 5789999999765432221 347899999999999999999999865
Q ss_pred ---CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccc
Q 022903 130 ---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 130 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
...++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||+
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~ 172 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGL 172 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECcccc
Confidence 3578999999999999999653 4569999999999999999999999999999999999999855 4699999999
Q ss_pred cccccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 207 AREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 207 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
+....... ......+|..|+|||.+.. ..++.++||||||+++|+|++|..||..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--------SKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecC--------CCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 97644332 2234467888999998865 5577899999999999999999998643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.86 Aligned_cols=202 Identities=34% Similarity=0.511 Sum_probs=167.4
Q ss_pred eeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEe
Q 022903 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTEL 138 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~ 138 (290)
|..++.||+|+||.||+|++.++.||+|++......... .....+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE-ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTT-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchH-HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence 455689999999999999999999999998764321111 1123588999999999999999999999754 67899999
Q ss_pred cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc---
Q 022903 139 LPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--- 214 (290)
Q Consensus 139 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~--- 214 (290)
+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.++|+|||++.......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCSCSSCE
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-CcEEEeecccccccccccccc
Confidence 99999999987532 3468999999999999999999999999999999999999955 469999999987543221
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+...
T Consensus 191 ~~~~~~g~~~y~aPE~~~~---------~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRG---------EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTT---------EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred cccccCCCcCcCChHHhcC---------CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 2234578999999998743 368899999999999999999999987643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=280.73 Aligned_cols=208 Identities=28% Similarity=0.500 Sum_probs=173.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||.||+|++ +++.||+|++......... ...+.+|+.++++++||||+++++++.+. ..++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD---TSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHH---HHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 4699999999999999999988 5789999998654322111 12477999999999999999999998765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCC--CceEEecccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLAREETV 212 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~--~~~kl~Dfg~~~~~~~ 212 (290)
||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++ ..+||+|||++.....
T Consensus 99 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999999999988763 4689999999999999999999999999999999999997543 3699999999876544
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
........+++.|+|||.+.+ .++.++||||||+++|+|++|..||.+.+..+....+
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~---------~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (287)
T 2wei_A 177 NTKMKDRIGTAYYIAPEVLRG---------TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV 234 (287)
T ss_dssp CSSCSCHHHHHTTCCHHHHTT---------CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCccccccCcccccChHHhcC---------CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 443344467889999998753 4789999999999999999999999998776554443
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=283.26 Aligned_cols=208 Identities=25% Similarity=0.382 Sum_probs=168.5
Q ss_pred cccccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
+...++.++|.+++.||+|+||.||++++ +++.||+|++....... ...+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (317)
T 2buj_A 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD-----REEAQREADMHRLFNHPNILRLVAYCL 96 (317)
T ss_dssp EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHH-----HHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHH-----HHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence 34556778899999999999999999986 67899999986643222 235789999999999999999999885
Q ss_pred c-----CceEEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEE
Q 022903 129 D-----PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201 (290)
Q Consensus 129 ~-----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl 201 (290)
. ...++||||+.+++|.+++... ....+++..++.++.||+.||.|||++|++||||||+||+++.++ .++|
T Consensus 97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl 175 (317)
T 2buj_A 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVL 175 (317)
T ss_dssp EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEE
T ss_pred eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEE
Confidence 2 2678999999999999998763 345699999999999999999999999999999999999998554 5999
Q ss_pred eccccccccccccc----------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 202 ADFGLAREETVTEM----------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 202 ~Dfg~~~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
+|||++........ .....||+.|+|||.+... ....++.++||||||+++|+|++|..||..
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ-----SHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC-----SEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccC-----CCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 99998875432111 1233579999999987541 112368899999999999999999999964
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=285.29 Aligned_cols=210 Identities=28% Similarity=0.406 Sum_probs=153.9
Q ss_pred ccccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeee
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACK 128 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 128 (290)
.+.....+|++.+.||+|+||.||+|++ +++.||+|++........ ..+.+|+.++.++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN-----RAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHH-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHH-----HHHHHHHHHHHHhccCCChhhcccccc
Confidence 4445667899999999999999999998 678999999865533222 34789999999996 999999999883
Q ss_pred --------c-CceEEEEEecCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCEEEcCCC
Q 022903 129 --------D-PLMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQ 196 (290)
Q Consensus 129 --------~-~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~g--ivH~Dikp~Nili~~~~ 196 (290)
+ ...++||||+. ++|.+++... ....+++..++.++.||+.||.|||++| ++||||||+|||++.++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence 1 24689999995 6998888652 3456999999999999999999999999 99999999999999554
Q ss_pred CceEEeccccccccccccc-------------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC
Q 022903 197 KSLKLADFGLAREETVTEM-------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 263 (290)
Q Consensus 197 ~~~kl~Dfg~~~~~~~~~~-------------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g 263 (290)
.+||+|||++........ .....+|+.|+|||++... ....++.++||||||+++|+|++|
T Consensus 176 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~~~Dv~slG~il~el~~g 249 (337)
T 3ll6_A 176 -TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-----SNFPIGEKQDIWALGCILYLLCFR 249 (337)
T ss_dssp -CEEBCCCTTCBCCSSCC-------------------------------CC-----TTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred -CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-----ccCCCChHHhHHHHHHHHHHHHhC
Confidence 699999999976433211 1134589999999987321 135678899999999999999999
Q ss_pred CCCCCCCCHH
Q 022903 264 RLPFEGMSNL 273 (290)
Q Consensus 264 ~~Pf~~~~~~ 273 (290)
..||.+....
T Consensus 250 ~~p~~~~~~~ 259 (337)
T 3ll6_A 250 QHPFEDGAKL 259 (337)
T ss_dssp SCCC------
T ss_pred CCCCcchhHH
Confidence 9999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=283.62 Aligned_cols=205 Identities=26% Similarity=0.358 Sum_probs=171.3
Q ss_pred CCceeecceeccccceeEEEEEE---CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCC------CceeEEeee
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD------NLVKFLGAC 127 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~ 127 (290)
.++|++.+.||+|+||.||+|.+ +++.||+|++..... ....+.+|+.+++.++|+ +++++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~ 86 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR------YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF 86 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH------HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc------hhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence 35699999999999999999976 568999999864321 123467899998888765 489999988
Q ss_pred ec-CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC-----------
Q 022903 128 KD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD----------- 195 (290)
Q Consensus 128 ~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~----------- 195 (290)
.+ ...++||||+ +++|.+++.......+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence 65 4788999999 8899999987655678999999999999999999999999999999999999853
Q ss_pred -------CCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 196 -------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 196 -------~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
+..+||+|||++..... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA--------LGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT--------SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC--------CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 34599999999976432 2345578999999999864 568999999999999999999999999
Q ss_pred CCCHHHHHHH
Q 022903 269 GMSNLQAAYA 278 (290)
Q Consensus 269 ~~~~~~~~~~ 278 (290)
+.+..+....
T Consensus 236 ~~~~~~~~~~ 245 (339)
T 1z57_A 236 THDSKEHLAM 245 (339)
T ss_dssp CSCHHHHHHH
T ss_pred CCChHHHHHH
Confidence 9877654433
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=278.93 Aligned_cols=202 Identities=20% Similarity=0.293 Sum_probs=167.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec-CceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD-PLMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~ 133 (290)
.+|.+++.||+|+||.||+|.+ +++.||+|++.......... ..+.+|+..+..+ +||||+++++++.+ ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDE---QNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHH---HHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHH---HHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 4599999999999999999988 58999999998754433322 3577899999999 89999999999865 4678
Q ss_pred EEEEecCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC----------------
Q 022903 134 IVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD---------------- 195 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~---------------- 195 (290)
+||||+++++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999999997632 2568999999999999999999999999999999999999843
Q ss_pred --CCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 196 --QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 196 --~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
...++|+|||.+...... ....+|+.|+|||.+.. ...++.++||||||+++|+|++|.+|+.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQE-------NYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTT-------CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred CCceEEEEcccccccccCCc---cccCCCccccChhHhcC-------CCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 235999999998765432 23468999999998864 23556799999999999999999988766543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.97 Aligned_cols=199 Identities=28% Similarity=0.463 Sum_probs=151.2
Q ss_pred ceee-cceeccccceeEEEEEEC----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee---cC
Q 022903 59 LLFI-GSKIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK---DP 130 (290)
Q Consensus 59 ~~~~-~~~lG~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~ 130 (290)
.|.+ +++||+|+||.||+|++. ++.||+|++....... .+.+|+.+++.++||||+++++++. +.
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM-------SACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH-------HHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH-------HHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3555 568999999999999853 6789999998665443 3668999999999999999999984 34
Q ss_pred ceEEEEEecCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc---CCCCceE
Q 022903 131 LMVIVTELLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLK 200 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~---~~~~~~k 200 (290)
..++||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+. ...+.+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 6789999995 58888775321 22489999999999999999999999999999999999993 2445699
Q ss_pred Eeccccccccccc----ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 201 LADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 201 l~Dfg~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
|+|||++...... .......||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTT-------CCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcC-------CCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999764322 22334578999999998864 24588999999999999999999999987654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=282.29 Aligned_cols=197 Identities=27% Similarity=0.386 Sum_probs=161.9
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee-e-cCce
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC-K-DPLM 132 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~-~~~~ 132 (290)
.++|.+.+.||+|+||.||+|++ +++.||+|++....... .+.+|+.+++.++|++++..+..+ . ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC-------CHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch-------HHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 35699999999999999999986 67899999876544332 266899999999988877766655 3 3467
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEE---cCCCCceEEeccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL---TPDQKSLKLADFGLARE 209 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili---~~~~~~~kl~Dfg~~~~ 209 (290)
++||||+ +++|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||+ + +++.+||+|||++..
T Consensus 81 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEECC-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGG-GTTCEEECCCTTCEE
T ss_pred EEEEEcc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccC-CCCeEEEecCcccee
Confidence 8999999 9999999975 34579999999999999999999999999999999999999 5 445699999999975
Q ss_pred ccccc--------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 210 ETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 210 ~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
..... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--------CCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 43322 1234578999999999865 568899999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=276.97 Aligned_cols=205 Identities=30% Similarity=0.496 Sum_probs=167.1
Q ss_pred ceeecceeccccceeEEEEEE--CC---ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC--c
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GD---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP--L 131 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 131 (290)
.|.+.+.||+|+||.||+|++ ++ ..||+|++......... ..+.+|+.+++.++||||+++++++.+. .
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV----EAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHH----HHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHH----HHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 367789999999999999976 22 37999999765544332 3578999999999999999999998643 3
Q ss_pred eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 132 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 132 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
.++||||+.+++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||++....
T Consensus 98 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-FTVKVADFGLARDIL 175 (298)
T ss_dssp CEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECCTTSSCTTT
T ss_pred cEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEeCcCCCccccc
Confidence 4899999999999999976 35678999999999999999999999999999999999999955 469999999997543
Q ss_pred ccc-----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 022903 212 VTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 277 (290)
Q Consensus 212 ~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~ 277 (290)
... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||.+.+..+...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~ 239 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQT--------YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH
T ss_pred CCcccccccCcCCCCCccccChhhhcc--------CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH
Confidence 222 2233467889999999864 568899999999999999999 556666655544433
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=292.71 Aligned_cols=204 Identities=16% Similarity=0.236 Sum_probs=151.7
Q ss_pred cCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc--CCCCceeEE------
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV--KHDNLVKFL------ 124 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~------ 124 (290)
.....|.+.+.||+|+||.||+|++ +++.||+|++.......... ...+.+|+.+++.| +||||++++
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE--LERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHH--HHHHHHHHHHHHHHHC----------CBCCC
T ss_pred CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccH--HHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 3445699999999999999999987 57899999998876533322 23577885555544 699988855
Q ss_pred -eeeec------------------CceEEEEEecCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHHCC
Q 022903 125 -GACKD------------------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA------LNFALDIARAMDCLHANG 179 (290)
Q Consensus 125 -~~~~~------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~------~~i~~qi~~~l~~lH~~g 179 (290)
+++.. ...++||||++ ++|.+++.... ..+..... ..++.||+.||.|||++|
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ 214 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG 214 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC
Confidence 33321 23689999998 89999998632 23444444 677799999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHH
Q 022903 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 259 (290)
Q Consensus 180 ivH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~ 259 (290)
|+||||||+|||++.++ .+||+|||++....... ....+|+.|+|||++.. ....++.++|||||||++|+
T Consensus 215 ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~~~~--~~~~~t~~y~aPE~~~~------~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDG-RLMLGDVSALWKVGTRG--PASSVPVTYAPREFLNA------STATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp EEETTCSGGGEEECTTS-CEEECCGGGEEETTCEE--EGGGSCGGGCCHHHHTC------SEEECCHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEECCCC-CEEEEecceeeecCCCc--cCccCCcCCcChhhccC------CCCCcCccccHHHHHHHHHH
Confidence 99999999999999554 69999999998654322 24466799999999853 12467999999999999999
Q ss_pred HHhCCCCCCCCC
Q 022903 260 LLTNRLPFEGMS 271 (290)
Q Consensus 260 ~l~g~~Pf~~~~ 271 (290)
|++|+.||.+..
T Consensus 286 lltg~~Pf~~~~ 297 (371)
T 3q60_A 286 VWCLFLPFGLVT 297 (371)
T ss_dssp HHHSSCSTTBCC
T ss_pred HHhCCCCCCCcC
Confidence 999999998873
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=284.58 Aligned_cols=206 Identities=30% Similarity=0.465 Sum_probs=168.9
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 130 (290)
.++|.+.+.||+|+||.||+|.+ +++.||||++........ ...++.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI---FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHH---HHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchH---HHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 35699999999999999999987 578999999976544332 224578999999999999999999998653
Q ss_pred ---ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 131 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
..++||||+. ++|.+++. ..+++..+..++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~ 173 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLA 173 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-CCEEECSTTCT
T ss_pred cceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC-CcEEEeecccc
Confidence 2489999996 58887664 359999999999999999999999999999999999999955 46999999999
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
..... ......+|+.|+|||++.. ...++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 174 ~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~ 237 (353)
T 3coi_A 174 RHADA--EMTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237 (353)
T ss_dssp TC----------CCSBCCSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH
T ss_pred cCCCC--CccccccCcCcCCHHHHhC-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 76432 2334578999999998753 2467899999999999999999999999988766555543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=276.31 Aligned_cols=205 Identities=26% Similarity=0.446 Sum_probs=159.1
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-Cce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 132 (290)
...+|++.+.||+|+||.||+|.+ +++.||+|++.......... ...+.+|+.+++.++||||+++++.+.+ ...
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKA--RADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHH--HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHH--HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 345699999999999999999986 57899999997644332221 2457899999999999999999999865 477
Q ss_pred EEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
++||||+++++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEeccceeee
Confidence 8999999999999998652 345689999999999999999999999999999999999999554 6999999998754
Q ss_pred cccc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 211 TVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 211 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.... ......+++.|+|||.+.. ..++.++||||||+++|+|++|..||.+..
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp ------------CCSSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cCCCccccccCCCeeEeChHHhCC--------CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 3322 2234568999999998764 567899999999999999999999998753
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=288.53 Aligned_cols=212 Identities=24% Similarity=0.402 Sum_probs=173.6
Q ss_pred CceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHH------------HHHHHHHHHHHHHhhcCCCCceeEEe
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERA------------LLEGRFIREVNMMSRVKHDNLVKFLG 125 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 125 (290)
.+|.+++.||+|+||.||+|+++++.||+|++.......... .....+.+|+.+++.++||||+++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred CceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 569999999999999999999999999999986432111000 00024789999999999999999999
Q ss_pred eeecC-ceEEEEEecCCCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCC
Q 022903 126 ACKDP-LMVIVTELLPGMSLRKY------LVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQK 197 (290)
Q Consensus 126 ~~~~~-~~~lv~e~~~~~~L~~~------~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~ 197 (290)
++.+. ..++||||+++++|.++ +.......+++..+..++.|++.||.|||+ +|++||||||+||+++.++
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~- 189 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG- 189 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS-
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC-
Confidence 98765 67899999999999998 554335779999999999999999999999 9999999999999999554
Q ss_pred ceEEecccccccccccccccccCCCccccCccccccccccccccCCCCC-cchhHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022903 198 SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN-KVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276 (290)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~-~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~ 276 (290)
.++|+|||++...... ......+++.|+|||++.. ...++. ++||||||+++|+|++|..||.+.+.....
T Consensus 190 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 190 RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN-------ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS-------CCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred cEEEeccccccccccc-cccCCCCCcCccCchhhcC-------CCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 6999999999764333 3345679999999999864 124444 999999999999999999999987763333
Q ss_pred HH
Q 022903 277 YA 278 (290)
Q Consensus 277 ~~ 278 (290)
..
T Consensus 262 ~~ 263 (348)
T 2pml_X 262 FN 263 (348)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=286.13 Aligned_cols=208 Identities=25% Similarity=0.336 Sum_probs=171.8
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CC-----CceeEEeeee
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HD-----NLVKFLGACK 128 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~ 128 (290)
..+|.+.+.||+|+||.||+|++ +++.||||++...... ...+.+|+.+++.++ |+ +|+++++.+.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF------LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHH------HHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHH------HHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 35799999999999999999987 4789999999753211 124567888887775 44 4899999886
Q ss_pred c-CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCCeeecCCCCCEEEcC-CCCceEEecc
Q 022903 129 D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH--ANGIIHRDLKPDNLLLTP-DQKSLKLADF 204 (290)
Q Consensus 129 ~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~givH~Dikp~Nili~~-~~~~~kl~Df 204 (290)
. ...++||||+. ++|.+++.......+++..+..++.|++.||.||| +.||+||||||+|||++. +.+.+||+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 4 57889999995 59999998765567999999999999999999999 579999999999999963 3456999999
Q ss_pred cccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 205 GLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 205 g~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
|++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 206 G~a~~~~~--~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 206 GSSCQLGQ--RIYQYIQSRFYRSPEVLLG--------MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp TTCEETTC--CCCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCceeccc--ccccccCCccccChHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99976532 2345688999999999865 5689999999999999999999999999888776666554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=280.95 Aligned_cols=212 Identities=27% Similarity=0.426 Sum_probs=151.7
Q ss_pred cccccCCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHH-HHhhcCCCCceeEEeee
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVN-MMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~ 127 (290)
..+....++|.+++.||+|+||.||+|.+. ++.||||++.......... .+.+|+. +++.++||||+++++++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~----~~~~e~~~~~~~~~h~niv~~~~~~ 90 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK----QLLMDLDVVMRSSDCPYIVQFYGAL 90 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHH----HHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHH----HHHHHHHHHHHcCCCCcEeeeeeEE
Confidence 345566788999999999999999999884 7899999998765443322 3445555 77778999999999998
Q ss_pred ecC-ceEEEEEecCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEe
Q 022903 128 KDP-LMVIVTELLPGMSLRKYLVS---LRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 128 ~~~-~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~ 202 (290)
.+. ..++||||+++ +|.+++.. .....+++..+..++.|++.||.|||++ |++||||||+||+++.+ +.+||+
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~-~~~kl~ 168 (327)
T 3aln_A 91 FREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLC 168 (327)
T ss_dssp ECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-TEEEEC
T ss_pred EeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-CCEEEc
Confidence 754 67899999975 88877753 2356799999999999999999999999 99999999999999955 569999
Q ss_pred cccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 203 DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 203 Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
|||++.............||+.|+|||++... .....++.++||||||+++|+|++|..||.+...
T Consensus 169 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 234 (327)
T 3aln_A 169 DFGISGQLVDSIAKTRDAGCRPYMAPERIDPS----ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234 (327)
T ss_dssp CCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--
T ss_pred cCCCceecccccccccCCCCccccCceeeccc----cCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 99999765544444445799999999987421 0125678999999999999999999999987543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=280.01 Aligned_cols=211 Identities=25% Similarity=0.412 Sum_probs=170.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---Cce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 132 (290)
.+|.+++.||+|+||.||++.+ +++.||+|++........ ......+.+|+.+++.++||||+++++++.+ ...
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI-PNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc-chhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4699999999999999999987 568999999865322110 0112358899999999999999999998842 367
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||++++ |.+++.......+++..+..++.||+.||.|||++|++||||||+||+++.+ +.++|+|||++.....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECCT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC-CcEEeeccccccccCc
Confidence 8999999776 8888877666789999999999999999999999999999999999999955 4699999999975432
Q ss_pred ---cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 213 ---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 213 ---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
........+++.|+|||++.+. ....+.++||||||+++|+|++|..||.+.+..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 223 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGL------DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE 223 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCC------SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccCCCCCCCcChhhccCc------ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH
Confidence 2222345789999999987541 1234679999999999999999999999876654433
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=275.67 Aligned_cols=203 Identities=29% Similarity=0.453 Sum_probs=165.4
Q ss_pred eeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVT 136 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~ 136 (290)
|.....||+|+||.||+|.+ +++.||+|++........ ..+.+|+.+++.++||||+++++++.+. ..++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS-----QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC--------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHH-----HHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 33445899999999999987 568999999976544322 2477999999999999999999999654 678999
Q ss_pred EecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-c
Q 022903 137 ELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~ 214 (290)
||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++..++.++|+|||++...... .
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999999997642 2346788899999999999999999999999999999999964567999999999764332 2
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
......|++.|+|||++... ...++.++||||||+++|+|++|..||.+....
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKG------PRGYGKAADIWSLGCTIIEMATGKPPFYELGEP 231 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHG------GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH
T ss_pred cccccCCCccccChhhhcCC------CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch
Confidence 23445789999999988541 133788999999999999999999999876443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=282.35 Aligned_cols=193 Identities=31% Similarity=0.544 Sum_probs=157.4
Q ss_pred CceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhh--cCCCCceeEEeeeec-----C
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR--VKHDNLVKFLGACKD-----P 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~-----~ 130 (290)
++|++.+.||+|+||.||+|++.++.||||++...... .+.+|.+++.. ++||||+++++++.+ .
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~--------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA--------SWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHH--------HHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccc--------hhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 46999999999999999999999999999998643211 23345555544 489999999998854 3
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeecCCCCCEEEcCCCCceEEe
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--------givH~Dikp~Nili~~~~~~~kl~ 202 (290)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||++ |++||||||+|||++.+ +.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCEEEE
Confidence 57899999999999999976 4699999999999999999999999 99999999999999955 469999
Q ss_pred ccccccccccccc-----ccccCCCccccCccccccccccccccCCCCC------cchhHHHHHHHHHHHhC--------
Q 022903 203 DFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNN------KVDVYSFGIVLWELLTN-------- 263 (290)
Q Consensus 203 Dfg~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~------~~DiwslG~~l~~~l~g-------- 263 (290)
|||++........ .....||+.|+|||++.. ...+. ++|||||||++|+|++|
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--------SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTT--------CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhccc--------ccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 9999975433221 124579999999999864 23333 48999999999999999
Q ss_pred --CCCCCCC
Q 022903 264 --RLPFEGM 270 (290)
Q Consensus 264 --~~Pf~~~ 270 (290)
..||...
T Consensus 257 ~~~~p~~~~ 265 (337)
T 3mdy_A 257 EYQLPYHDL 265 (337)
T ss_dssp CCCCTTTTT
T ss_pred cccccHhhh
Confidence 7888764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=294.71 Aligned_cols=198 Identities=27% Similarity=0.408 Sum_probs=163.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCce-eEEeeee-cCceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV-KFLGACK-DPLMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~-~~~~~ 133 (290)
++|.+++.||+|+||.||+|++ +++.||||++....... .+.+|+.+++.++|++++ .+..++. ....+
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-------CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-------HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 5699999999999999999987 57899999987655433 256899999999875444 4444443 34678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc--CCCCceEEeccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLAREET 211 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~--~~~~~~kl~Dfg~~~~~~ 211 (290)
+||||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .+.+.+||+|||+++...
T Consensus 80 lvme~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEECC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999999 9999999975 346799999999999999999999999999999999999994 244569999999997643
Q ss_pred cccc--------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 212 VTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 212 ~~~~--------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
.... .....||+.|+|||.+.+ ..++.++|||||||+||+|++|+.||.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCccccccccccccccCCCccccCHHHhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 3221 225579999999999865 6689999999999999999999999998643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=281.46 Aligned_cols=200 Identities=30% Similarity=0.527 Sum_probs=168.4
Q ss_pred cCCCceeecceeccccceeEEEEEE------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
...+.|++++.||+|+||.||++++ +++.||+|++........ ..+.+|+.+++.++||||+++++++.
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL-----RDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHH-----HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHH-----HHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 4556799999999999999999984 578999999987543322 34789999999999999999999875
Q ss_pred cC---ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 129 DP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 129 ~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
.. ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.+ +.++|+|||
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kL~Dfg 190 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFG 190 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCT
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC-CcEEEecCc
Confidence 42 578999999999999999863 4569999999999999999999999999999999999999954 469999999
Q ss_pred cccccccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 206 LAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 206 ~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
++........ .....++..|+|||.+.. ..++.++||||||+++|+|++|..||..
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred chhhccccccccccccCCCCceeEECchhhcC--------CCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 9976433321 223456778999998864 4578899999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=285.35 Aligned_cols=203 Identities=29% Similarity=0.455 Sum_probs=157.4
Q ss_pred cCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-----
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 129 (290)
...++|++++.||+|+||.||+|+++++.||||++........ ....|+..+..++||||+++++.+..
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~------~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNF------INEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHH------HHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred cChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhH------HHHHHHHHHHhccCcchhhheecccccccCC
Confidence 4556799999999999999999999999999999865332111 12244444556899999999975431
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeecCCCCCEEEcCCCCce
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN---------GIIHRDLKPDNLLLTPDQKSL 199 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------givH~Dikp~Nili~~~~~~~ 199 (290)
...++||||+++++|.+++.. ...++..+..++.||+.||.|||++ |++||||||+|||++.+ +.+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~ 159 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTC 159 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-SCE
T ss_pred CceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-CcE
Confidence 246799999999999999976 3468899999999999999999999 99999999999999955 469
Q ss_pred EEeccccccccccc---------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 200 KLADFGLAREETVT---------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 200 kl~Dfg~~~~~~~~---------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
||+|||++...... .......||+.|+|||++.+... ......++.++|||||||++|+|++|..||.
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN-LRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCC-GGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcc-cccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 99999999754321 12224469999999998864110 0001245678999999999999999976654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=280.82 Aligned_cols=206 Identities=26% Similarity=0.334 Sum_probs=169.3
Q ss_pred CCceeecceeccccceeEEEEEEC--C-ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC------ceeEEeee
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG--D-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN------LVKFLGAC 127 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~--~-~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~ 127 (290)
.++|.+.+.||+|+||.||+|.+. + +.||+|++..... . ...+.+|+.+++.++|++ ++.+++.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK--Y----REAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH--H----HHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc--c----hhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 357999999999999999999873 3 6899999975321 1 234678999998887655 88888887
Q ss_pred ec-CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC------------
Q 022903 128 KD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP------------ 194 (290)
Q Consensus 128 ~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~------------ 194 (290)
.. ...++||||+ +++|.+++.......+++..+..++.||+.||.|||++|++||||||+|||++.
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 64 4788999999 678888887755567999999999999999999999999999999999999942
Q ss_pred ------CCCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 195 ------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 195 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
....+||+|||++..... ......||+.|+|||++.. ..++.++||||||+++|+|++|..||.
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE--------LGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeec--------CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 345699999999976432 2345579999999999864 568999999999999999999999999
Q ss_pred CCCHHHHHHHH
Q 022903 269 GMSNLQAAYAA 279 (290)
Q Consensus 269 ~~~~~~~~~~~ 279 (290)
+.+..+....+
T Consensus 241 ~~~~~~~~~~~ 251 (355)
T 2eu9_A 241 THENREHLVMM 251 (355)
T ss_dssp CSSHHHHHHHH
T ss_pred CCCHHHHHHHH
Confidence 98876655444
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=283.62 Aligned_cols=225 Identities=28% Similarity=0.506 Sum_probs=176.4
Q ss_pred cccccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 51 RSLLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 51 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
+.+.+..++|.+.+.||+|+||.||+|++.+ .+|+|++.......... ..+.+|+.+++.++||||+++++++.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQL---KAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCC---CCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHH---HHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 3455677889999999999999999999866 49999987543222110 1366899999999999999999998754
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++||||+++++|.+++.. ....+++..+..++.||+.||.|||++|++||||||+||+++ ++ .++|+|||++..
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFSI 178 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC-
T ss_pred CceEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCccc
Confidence 68899999999999999875 345699999999999999999999999999999999999998 43 599999999764
Q ss_pred ccc------cccccccCCCccccCccccccccccc-cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 210 ETV------TEMMTAETGTYRWMAPELYSTVTLRQ-GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 210 ~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
... ........|++.|+|||++....... .....++.++||||||+++|+|++|..||.+.+.......+...
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 258 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTT
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccC
Confidence 321 11223346889999999886421100 01245788999999999999999999999998877666555443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=284.93 Aligned_cols=199 Identities=23% Similarity=0.366 Sum_probs=165.2
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-----------CCCcee
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-----------HDNLVK 122 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~ 122 (290)
...+|.+++.||+|+||.||+|++ +++.||||++...... ...+.+|+.+++.++ ||||++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY------TEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH------HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc------hhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 446799999999999999999987 6789999999753221 134678888888876 899999
Q ss_pred EEeeeecC-----ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcC--
Q 022903 123 FLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTP-- 194 (290)
Q Consensus 123 ~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~-- 194 (290)
+++++... ..++|||++ +++|.+++.......+++..+..++.||+.||.|||++ |++||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 99988642 578999999 89999999876667799999999999999999999998 9999999999999953
Q ss_pred ---CCCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 195 ---DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 195 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
+...+||+|||++..... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhC--------CCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 223699999999976433 2344578999999999865 568999999999999999999999998764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=275.18 Aligned_cols=215 Identities=24% Similarity=0.392 Sum_probs=155.0
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP- 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 130 (290)
....++|.+++.||+|+||.||+|++ +++.||||++.......... ..+.++..+++.++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK---RILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHH---HHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHH---HHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 34556799999999999999999988 57899999998765544322 2344555677888999999999998754
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++||||+ ++.+..+... ....+++..+..++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++..
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~ 174 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGR 174 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC--
T ss_pred cEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCchh
Confidence 678999999 5566665544 346799999999999999999999995 999999999999999554 599999999976
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
...........+++.|+|||++.... .....++.++||||||+++|+|++|..||.+........
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 239 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPD---PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239 (318)
T ss_dssp ------------CCTTCCHHHHC-----------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccCCccccccCCCccccChhhccccc---ccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHH
Confidence 55444445567899999999985311 113567899999999999999999999999854443333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=283.00 Aligned_cols=199 Identities=27% Similarity=0.520 Sum_probs=164.0
Q ss_pred CceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhh--cCCCCceeEEeeeecC-----
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR--VKHDNLVKFLGACKDP----- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~----- 130 (290)
++|.+.+.||+|+||.||+|+++++.||||++.... . ..+.+|.+++.. ++||||+++++++.+.
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~-----~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---E-----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG---H-----HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh---H-----HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 469999999999999999999999999999986432 1 236678888877 7899999999998654
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeecCCCCCEEEcCCCCceEEe
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH--------ANGIIHRDLKPDNLLLTPDQKSLKLA 202 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--------~~givH~Dikp~Nili~~~~~~~kl~ 202 (290)
..++||||+++++|.+++.. ..+++..++.++.|++.||.||| ++|++||||||+|||++.++ .+||+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 189 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIA 189 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEEC
T ss_pred eeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEE
Confidence 57899999999999999976 46999999999999999999999 89999999999999999554 69999
Q ss_pred cccccccccccc-----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC----------CCCC
Q 022903 203 DFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN----------RLPF 267 (290)
Q Consensus 203 Dfg~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g----------~~Pf 267 (290)
|||++....... ......||+.|+|||++...... ....++.++||||||+++|+|++| ..||
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM--KHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT--TCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccc--cccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 999987543322 22445799999999988641100 000233689999999999999999 8899
Q ss_pred CCC
Q 022903 268 EGM 270 (290)
Q Consensus 268 ~~~ 270 (290)
.+.
T Consensus 268 ~~~ 270 (342)
T 1b6c_B 268 YDL 270 (342)
T ss_dssp TTT
T ss_pred ccc
Confidence 875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=274.51 Aligned_cols=195 Identities=28% Similarity=0.484 Sum_probs=157.3
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec------
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------ 129 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 129 (290)
++|.+++.||+|+||.||+|++ +++.||+|++.... . ....+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--E----KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--H----HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--H----HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 4589999999999999999987 57899999986421 1 12357899999999999999999998743
Q ss_pred --------CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEE
Q 022903 130 --------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 201 (290)
Q Consensus 130 --------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl 201 (290)
...++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl 157 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKI 157 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEE
Confidence 357899999999999999986 345678899999999999999999999999999999999999554 5999
Q ss_pred eccccccccccc---------------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 022903 202 ADFGLAREETVT---------------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 266 (290)
Q Consensus 202 ~Dfg~~~~~~~~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~P 266 (290)
+|||++...... .......+++.|+|||++.+ ...++.++||||||+++|+|++ |
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~---p 227 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-------TGHYNEKIDMYSLGIIFFEMIY---P 227 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTS-------CSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC-------CCCCcchhhHHHHHHHHHHHHh---c
Confidence 999998754321 12234468999999998754 2467899999999999999998 6
Q ss_pred CCCC
Q 022903 267 FEGM 270 (290)
Q Consensus 267 f~~~ 270 (290)
|...
T Consensus 228 ~~~~ 231 (303)
T 1zy4_A 228 FSTG 231 (303)
T ss_dssp CSSH
T ss_pred cCCc
Confidence 6543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=273.17 Aligned_cols=214 Identities=25% Similarity=0.451 Sum_probs=167.6
Q ss_pred ccccCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC--CCCceeEEeeee
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--HDNLVKFLGACK 128 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~ 128 (290)
......+.|.+++.||+|+||.||++.+ +++.||+|++......... ...+.+|+.+++.++ ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT---LDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHH---HHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccc---hHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 3445677899999999999999999987 4688999999765543322 235889999999997 599999999986
Q ss_pred cC-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 129 DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 129 ~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
+. ..++||| +.+++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++ + +.+||+|||++
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIA 173 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T-TEEEECCCSSS
T ss_pred cCCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-C-CeEEEeecccc
Confidence 54 6789999 558899999986 35789999999999999999999999999999999999997 3 46999999999
Q ss_pred ccccccc---cccccCCCccccCccccccccccc---cccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 208 REETVTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 208 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~---~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
....... ......|++.|+|||.+....... .....++.++||||||+++|+|++|..||.+....
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence 7643322 123447899999999876421100 01136788999999999999999999999887543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=288.91 Aligned_cols=205 Identities=27% Similarity=0.424 Sum_probs=160.2
Q ss_pred ccCCCceeecceeccccceeE-EEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-
Q 022903 54 LVDPKLLFIGSKIGEGAHGKV-YEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP- 130 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V-~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 130 (290)
.+....|.+.+.||+|+||+| |.+..+++.||||++....... +.+|+.+++.+ +||||+++++++.+.
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~--------~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF--------ADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEE--------CHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHH--------HHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 345567999999999999995 5556789999999997654332 45799999999 799999999998765
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC----CCceEEecccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD----QKSLKLADFGL 206 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~----~~~~kl~Dfg~ 206 (290)
..++||||+. ++|.+++... ........+..++.||+.||.|||++||+||||||+|||++.+ ...+||+|||+
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEEEEEECCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 6789999995 5999999763 3345555678899999999999999999999999999999532 22588999999
Q ss_pred ccccccc----ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHH
Q 022903 207 AREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273 (290)
Q Consensus 207 ~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~ 273 (290)
++..... .......||+.|+|||++... ....++.++|||||||++|+|++ |..||......
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~ 236 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED-----CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC--------CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcc-----cccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH
Confidence 9764433 223345799999999998631 12456789999999999999999 99999765443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=280.61 Aligned_cols=198 Identities=26% Similarity=0.391 Sum_probs=142.2
Q ss_pred Cceeecc-eeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-----
Q 022903 58 KLLFIGS-KIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (290)
Q Consensus 58 ~~~~~~~-~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 129 (290)
++|.+.+ .||+|+||.||+|++. ++.||||++..... . ..+....++.++||||+++++++..
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~-------~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK--A-------RQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH--H-------HHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH--H-------HHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 4588855 6999999999999884 78999999865311 1 1122334566689999999998853
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--CCceEEeccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLA 207 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~~~~kl~Dfg~~ 207 (290)
...++||||+++++|.+++.......+++..++.++.||+.||.|||++|++||||||+|||++.+ ...+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 247899999999999999987555679999999999999999999999999999999999999853 345999999999
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~ 273 (290)
...... ......+|+.|+|||++.. ..++.++||||||+++|+|++|..||.+....
T Consensus 179 ~~~~~~-~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 179 KETTQN-ALQTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp EEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred eecccc-ccccCCCCcCccChhhhCC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 764432 2344578999999998854 55788999999999999999999999876543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=297.75 Aligned_cols=201 Identities=32% Similarity=0.461 Sum_probs=171.0
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec------
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------ 129 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 129 (290)
.+|.+.+.||+|+||.||+|.+ +++.||||++......... .++.+|+.+++.++||||+++++++.+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~----~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR----ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHH----HHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHH----HHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 5699999999999999999976 5789999999876544332 358899999999999999999998643
Q ss_pred -CceEEEEEecCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC--ceEEeccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFG 205 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~--~~kl~Dfg 205 (290)
...++||||+++++|.+++.... ...+++..++.++.|++.||.|||++|++||||||+||+++.++. .++|+|||
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 35789999999999999998633 235899999999999999999999999999999999999986543 48999999
Q ss_pred ccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 206 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
++.............||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.
T Consensus 170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 170 YAKELDQGELCTEFVGTLQYLAPELLEQ--------KKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCBTTSCCCCCCCCSCCTTCSSCSSCC--------SCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccccccccccCCcccCChHHhcc--------CCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 9987665555566789999999999864 67899999999999999999999999764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=277.05 Aligned_cols=208 Identities=26% Similarity=0.393 Sum_probs=168.1
Q ss_pred cccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHH-HHHHHHHHHHHHHhhcC--CCCceeEEeee
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERA-LLEGRFIREVNMMSRVK--HDNLVKFLGAC 127 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~--h~~iv~~~~~~ 127 (290)
...-..+|++.+.||+|+||.||+|++ +++.||||++.......... ....++.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 334456799999999999999999987 67899999987643221000 00013567899999996 59999999999
Q ss_pred ecC-ceEEEEEecCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 128 KDP-LMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 128 ~~~-~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
.+. ..++|||++.+ ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.+++.+||+|||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 765 67899999976 899999986 35789999999999999999999999999999999999998655679999999
Q ss_pred ccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 206 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 206 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
++...... ......||+.|+|||++.. ....+.++||||||+++|+|++|..||.+.
T Consensus 196 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 196 SGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccc-cccCCCCCccCCChHHhcc-------CCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 98765432 2344578999999998754 123467899999999999999999999764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=301.30 Aligned_cols=190 Identities=27% Similarity=0.364 Sum_probs=161.2
Q ss_pred CceeecceeccccceeEEEEEE---CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-c--
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-L-- 131 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~-- 131 (290)
.+|++.+.||+|+||.||+|.+ +++.||||++......... ..+.+|+.+++.++||||+++++++.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQ----AMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHH----HHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHH----HHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 6799999999999999999987 4689999998765443322 3578999999999999999999998643 2
Q ss_pred ---eEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 132 ---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 132 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
.++||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~ 229 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVS 229 (681)
T ss_dssp CEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred CceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccch
Confidence 5899999999999987653 69999999999999999999999999999999999999954 59999999997
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
..... ....||+.|+|||++.. .++.++|||||||++|+|++|..||.+
T Consensus 230 ~~~~~---~~~~gt~~y~aPE~~~~---------~~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 230 RINSF---GYLYGTPGFQAPEIVRT---------GPTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp ETTCC---SCCCCCTTTSCTTHHHH---------CSCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred hcccC---CccCCCccccCHHHHcC---------CCCCceehhhhHHHHHHHHhCCCCCcc
Confidence 65432 44579999999998753 248899999999999999999999875
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=275.43 Aligned_cols=204 Identities=26% Similarity=0.374 Sum_probs=162.6
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHH-HHHHHHHHHHHHHhhc----CCCCceeEEeeeec
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERA-LLEGRFIREVNMMSRV----KHDNLVKFLGACKD 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l----~h~~iv~~~~~~~~ 129 (290)
.++|++.+.||+|+||.||+|++ +++.||+|++.......... .....+.+|+.++.++ +||||+++++++.+
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 45699999999999999999987 57899999997654432111 0112355789999888 89999999999865
Q ss_pred -CceEEEEEe-cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 130 -PLMVIVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 130 -~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
...++|||+ +.+++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.+++.++|+|||++
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 467899999 7899999999863 469999999999999999999999999999999999999955567999999998
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
...... ......++..|+|||++.. ....+.++||||||+++|+|++|+.||.+.
T Consensus 188 ~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 188 ALLHDE-PYTDFDGTRVYSPPEWISR-------HQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp EECCSS-CBCCCCSCTTTSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred hhcccC-cccccCCcccccCceeeec-------CCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 765433 2345578999999998754 122345899999999999999999999763
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=276.66 Aligned_cols=199 Identities=18% Similarity=0.192 Sum_probs=156.8
Q ss_pred CCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhH---HHHHHHHHHHHHHHHhhcC---------CCCceeE
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDE---RALLEGRFIREVNMMSRVK---------HDNLVKF 123 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~---------h~~iv~~ 123 (290)
..++|.+++.||+|+||.||+|+++++.||||++........ .......+.+|+.+++.++ ||||+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 346699999999999999999999999999999987543200 0000123567777777775 7777776
Q ss_pred Eeee-----------------e--------------cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q 022903 124 LGAC-----------------K--------------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172 (290)
Q Consensus 124 ~~~~-----------------~--------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l 172 (290)
.+++ . +...++||||+++|++.+.+.. ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 6653 2 4578999999999976665532 5689999999999999999
Q ss_pred HHHH-HCCCeeecCCCCCEEEcCCC-------------------CceEEecccccccccccccccccCCCccccCccccc
Q 022903 173 DCLH-ANGIIHRDLKPDNLLLTPDQ-------------------KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232 (290)
Q Consensus 173 ~~lH-~~givH~Dikp~Nili~~~~-------------------~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~ 232 (290)
.||| ++||+||||||+|||++.++ ..+||+|||+++..... ...||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 99999999999999998654 16999999999864322 347999999999986
Q ss_pred cccccccccCCCCCcchhHHHHHH-HHHHHhCCCCCCCC
Q 022903 233 TVTLRQGEKKHYNNKVDVYSFGIV-LWELLTNRLPFEGM 270 (290)
Q Consensus 233 ~~~~~~~~~~~~~~~~DiwslG~~-l~~~l~g~~Pf~~~ 270 (290)
+ . .+.++|||||+++ .+++++|..||.+.
T Consensus 251 g--------~-~~~~~Diwsl~~~~~~~~~~g~~p~~~~ 280 (336)
T 2vuw_A 251 G--------D-GDYQFDIYRLMKKENNNRWGEYHPYSNV 280 (336)
T ss_dssp C--------C-SSHHHHHHHHHHHHHTTCTTSCCTHHHH
T ss_pred C--------C-CccceehhhhhCCCCcccccccCCCcch
Confidence 4 2 2789999998777 77888999999653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=280.68 Aligned_cols=206 Identities=24% Similarity=0.421 Sum_probs=154.4
Q ss_pred CceeecceeccccceeEEEE-EECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEG-RYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|.+.+.||+|+||+||.+ ..+++.||||++..... ..+.+|+.+++.+ +||||+++++.+.+. ..++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~--------~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--------DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGH--------HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHH--------HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 45667789999999999754 55789999999865321 1356899999887 899999999998765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCC-----CHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC------------CC
Q 022903 135 VTELLPGMSLRKYLVSLRPNKL-----DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD------------QK 197 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~-----~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~------------~~ 197 (290)
||||+. ++|.+++........ ++..++.++.||+.||.|||++||+||||||+|||++.+ ..
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999995 699999976322111 223457799999999999999999999999999999743 34
Q ss_pred ceEEeccccccccccccc-----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 022903 198 SLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 271 (290)
Q Consensus 198 ~~kl~Dfg~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~ 271 (290)
.+||+|||++........ .....||+.|+|||++.+... ......++.++|||||||++|+|++ |..||.+..
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNN-LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCT-TSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccc-cccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 699999999986543321 234579999999998854210 0012568899999999999999999 999998764
Q ss_pred HH
Q 022903 272 NL 273 (290)
Q Consensus 272 ~~ 273 (290)
..
T Consensus 245 ~~ 246 (434)
T 2rio_A 245 SR 246 (434)
T ss_dssp TH
T ss_pred hh
Confidence 43
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=259.99 Aligned_cols=174 Identities=19% Similarity=0.180 Sum_probs=147.4
Q ss_pred CceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
.+|++.+.||+|+||.||+|++. ++.||||++.......... ..++.+|+.++..++||||+++++++.+. ..++
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDV--LQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHH--HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHH--HHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 46999999999999999999884 7999999998765543321 24588999999999999999999998654 7889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||++|++|.+++.. ......+..++.|++.||.|||++|++||||||+|||++.++ .+||++++
T Consensus 109 v~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~--------- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPA--------- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCC---------
T ss_pred EEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecc---------
Confidence 9999999999999854 245667889999999999999999999999999999999554 58887443
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
|++| ++.++||||||+++|+|++|+.||.+.+.
T Consensus 175 ----------~~~~---------------~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ----------TMPD---------------ANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ----------CCTT---------------CCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ----------ccCC---------------CCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3332 47799999999999999999999998654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.20 Aligned_cols=211 Identities=16% Similarity=0.224 Sum_probs=154.8
Q ss_pred cCCCceeecceeccccceeEEEEEEC--CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC-CCcee---------
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-DNLVK--------- 122 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~--------- 122 (290)
.....|...+.||+|+||.||+|.+. ++.||||++.......... ...+.+|+.+++.++| +|...
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~--~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA--IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----C--CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHH--HHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 44566889999999999999999974 8999999988544433211 2357899999999977 32111
Q ss_pred ------------EEeeee------cCceEEEEEecCCCCHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 022903 123 ------------FLGACK------DPLMVIVTELLPGMSLRKYLVSL-----RPNKLDLHVALNFALDIARAMDCLHANG 179 (290)
Q Consensus 123 ------------~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~~g 179 (290)
+...+. ....+++|+++ +++|.+++... ....+++..++.++.||+.||.|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 111111 11345667766 78999998521 2345778888999999999999999999
Q ss_pred CeeecCCCCCEEEcCCCCceEEecccccccccccccccccCCCccccCcccccccc--ccccccCCCCCcchhHHHHHHH
Q 022903 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNNKVDVYSFGIVL 257 (290)
Q Consensus 180 ivH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~~~~~~~~~DiwslG~~l 257 (290)
|+||||||+|||++.++ .+||+|||+++..... .....| +.|+|||++.... ..+.....++.++|||||||++
T Consensus 232 iiHrDiKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp EECSCCCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999665 4999999998764433 345567 9999999884210 0000234578899999999999
Q ss_pred HHHHhCCCCCCCCCH
Q 022903 258 WELLTNRLPFEGMSN 272 (290)
Q Consensus 258 ~~~l~g~~Pf~~~~~ 272 (290)
|+|++|+.||.+.+.
T Consensus 308 ~elltg~~Pf~~~~~ 322 (413)
T 3dzo_A 308 YWIWCADLPNTDDAA 322 (413)
T ss_dssp HHHHHSSCCCCTTGG
T ss_pred HHHHHCCCCCCCcch
Confidence 999999999988644
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=256.42 Aligned_cols=175 Identities=29% Similarity=0.438 Sum_probs=146.4
Q ss_pred ceeec-ceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHH-hhcCCCCceeEEeeeec-----
Q 022903 59 LLFIG-SKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM-SRVKHDNLVKFLGACKD----- 129 (290)
Q Consensus 59 ~~~~~-~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----- 129 (290)
.|.+. +.||+|+||.||++.+ +++.||+|++.... .+.+|+.++ +.++||||+++++++.+
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----------KARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH----------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH----------HHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 36666 7899999999999987 57899999986421 255788887 55589999999998854
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--CCceEEeccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLA 207 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~~~~kl~Dfg~~ 207 (290)
...++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.+ ++.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 357899999999999999988655679999999999999999999999999999999999999863 456999999998
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
.... ...++.++||||||+++|+|++|..||.+...
T Consensus 168 ~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 168 KETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp EECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred cccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 5421 12356799999999999999999999977544
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=267.79 Aligned_cols=185 Identities=17% Similarity=0.172 Sum_probs=126.7
Q ss_pred eeccccceeEEEEE--ECCceEEEEEcccCCC-----hhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeecC-ceEEE
Q 022903 65 KIGEGAHGKVYEGR--YGDRIVAIKVLNRGST-----SDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 65 ~lG~G~~g~V~~~~--~~~~~vavK~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~lv 135 (290)
.++.|++|.+..++ +.++.|++|++..... ....+.....+.+|+++|+++ .|+||++++++++++ ..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666553 4788999999976532 222333345689999999999 699999999999765 78999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-c
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-E 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~ 214 (290)
|||++|++|.+++.. .++++.. .|+.||+.||+|+|++|||||||||+|||++.++ .+||+|||+++..... .
T Consensus 321 MEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp EECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---C
T ss_pred EecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCCc
Confidence 999999999999986 3566654 5889999999999999999999999999999654 6999999999764332 2
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCC
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 264 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~ 264 (290)
.....+||+.|||||++.+ .+..++|+||+|++++++.++.
T Consensus 395 ~~~t~vGTp~YmAPE~l~g---------~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAE---------NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp CSHHHHHHHHHHHHHHC--------------------------CCCCTTH
T ss_pred cccCceechhhccHHHhCC---------CCCCcccccccccchhhhcccc
Confidence 3345679999999999853 3567899999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=245.19 Aligned_cols=188 Identities=22% Similarity=0.285 Sum_probs=145.0
Q ss_pred eecceeccccceeEEEEEECCceEEEEEcccCCChh---HHHHHHHHHHHHHHHHhhcCCCCce--eEEeeeecCceEEE
Q 022903 61 FIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSD---ERALLEGRFIREVNMMSRVKHDNLV--KFLGACKDPLMVIV 135 (290)
Q Consensus 61 ~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv--~~~~~~~~~~~~lv 135 (290)
...+.||+|+||.||++...++.+++|......... .......++.+|+.++++++||||+ .+++. .....++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-DLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-ETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-eCCccEEE
Confidence 345689999999999998889999999876543321 2222345688999999999999999 55555 34467999
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+++++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCccc
Confidence 999999999998864 5689999999999999999999999999999995 699999999987554322
Q ss_pred --------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 216 --------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 216 --------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
.....||+.|||||++.... ..|+..+|+||..+-..+.+.++-+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~------~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFL------EGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHH------HHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHH------HHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 23557999999999986421 346778899999999888888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=196.41 Aligned_cols=149 Identities=19% Similarity=0.179 Sum_probs=114.1
Q ss_pred CceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhH-----HH--------HHHHHHHHHHHHHhhcCCCCceeE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDE-----RA--------LLEGRFIREVNMMSRVKHDNLVKF 123 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~-----~~--------~~~~~~~~e~~~l~~l~h~~iv~~ 123 (290)
..|.+++.||+|+||.||+|.+ +++.||+|+++....... .. .....+.+|+.+++.++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3455669999999999999988 578999999965432111 00 12245889999999998 4 556
Q ss_pred EeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEec
Q 022903 124 LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 203 (290)
Q Consensus 124 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~D 203 (290)
.+.+.....++||||++|++|.+ +.. .....++.|++.||.|||++|++||||||+|||++ + +.+||+|
T Consensus 167 ~~~~~~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~D 235 (282)
T 1zar_A 167 PKVYAWEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWIID 235 (282)
T ss_dssp CCEEEEETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEECC
T ss_pred CeEEeccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEEE
Confidence 55555567799999999999988 321 22457999999999999999999999999999999 4 5699999
Q ss_pred ccccccccccccccccCCCccccCccccc
Q 022903 204 FGLAREETVTEMMTAETGTYRWMAPELYS 232 (290)
Q Consensus 204 fg~~~~~~~~~~~~~~~g~~~y~aPE~~~ 232 (290)
||++.. +..++|||.+.
T Consensus 236 FG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE------------TTSTTHHHHHH
T ss_pred CCCCeE------------CCCCCHHHHHH
Confidence 999863 23467888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=176.37 Aligned_cols=142 Identities=15% Similarity=0.157 Sum_probs=107.8
Q ss_pred CceeecceeccccceeEEEEEE--CCce--EEEEEcccCCChhH-------------------HHHHHHHHHHHHHHHhh
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRI--VAIKVLNRGSTSDE-------------------RALLEGRFIREVNMMSR 114 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~--vavK~~~~~~~~~~-------------------~~~~~~~~~~e~~~l~~ 114 (290)
..|.+.+.||+|+||.||+|.+ +++. ||||+++....... .......+.+|+.++..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 4478889999999999999987 7888 99999755421110 11223357899999999
Q ss_pred cCCCCc--eeEEeeeecCceEEEEEecCC-C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeecCC
Q 022903 115 VKHDNL--VKFLGACKDPLMVIVTELLPG-M----SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGIIHRDLK 186 (290)
Q Consensus 115 l~h~~i--v~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~givH~Dik 186 (290)
++|+++ +.++.. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.|++|||||
T Consensus 127 l~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HHhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 988764 334432 356899999942 3 67765432 234567889999999999999 9999999999
Q ss_pred CCCEEEcCCCCceEEecccccccc
Q 022903 187 PDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 187 p~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
|+|||++. .++|+|||++...
T Consensus 199 p~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS---SEEECCCTTCEET
T ss_pred HHHEEEcC---cEEEEECcccccC
Confidence 99999995 5999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=163.88 Aligned_cols=144 Identities=17% Similarity=0.238 Sum_probs=102.4
Q ss_pred CCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCC---------------hhHH--HHHHHHHHHHHHHHhhcCC
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGST---------------SDER--ALLEGRFIREVNMMSRVKH 117 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~---------------~~~~--~~~~~~~~~e~~~l~~l~h 117 (290)
....|.++..||.|+||.||+|.+ .|+.||||+++.... .... ........+|...|.++.+
T Consensus 93 rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 93 RKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 344589999999999999999987 678999999754211 0001 1111112357777777765
Q ss_pred CCce--eEEeeeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC
Q 022903 118 DNLV--KFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 195 (290)
Q Consensus 118 ~~iv--~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~ 195 (290)
+++. ..++. ...++||||++|.+|..+.. ...+..++.||+.+|.+||++|||||||||.|||++.+
T Consensus 173 ~gv~vp~p~~~---~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 173 EGFPVPEPIAQ---SRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp TTCSCCCEEEE---ETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred cCCCCCeeeec---cCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 5442 22222 24579999999988875421 12346788999999999999999999999999999855
Q ss_pred CC---------ceEEecccccccc
Q 022903 196 QK---------SLKLADFGLAREE 210 (290)
Q Consensus 196 ~~---------~~kl~Dfg~~~~~ 210 (290)
+. .+.|+||+.+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 42 3899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=2.2e-13 Score=113.70 Aligned_cols=137 Identities=15% Similarity=0.083 Sum_probs=104.6
Q ss_pred eeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeec-CceEEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIVTE 137 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~lv~e 137 (290)
|.+...++.|+.+.||++...++.+++|+......... ..+.+|+.+++.+. +..+.++++.+.+ +..++|||
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~-----~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT-----YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST-----TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH-----HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 66777788899999999988889999999875221111 12668999998885 5667788887754 46789999
Q ss_pred ecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 022903 138 LLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA---------------------------------------- 177 (290)
Q Consensus 138 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---------------------------------------- 177 (290)
+++|.+|.+... +......++.+++.+|..||+
T Consensus 91 ~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999987521 112234688899999999998
Q ss_pred -------------------CCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 178 -------------------NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 178 -------------------~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++|+|++|.||+++. +..+.|+||+.+..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhccc
Confidence 34899999999999984 44456999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.1e-12 Score=112.77 Aligned_cols=139 Identities=16% Similarity=0.257 Sum_probs=104.5
Q ss_pred cceeccccceeEEEEEECCceEEEEEcc--cCCChhHHHHHHHHHHHHHHHHhhcCC--CCceeEEeeeecC----ceEE
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLN--RGSTSDERALLEGRFIREVNMMSRVKH--DNLVKFLGACKDP----LMVI 134 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~----~~~l 134 (290)
++.|+.|.++.||+....+..+++|+.. ........ ..+.+|..+++.|.. ..+++++..+.+. ..++
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~----~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSA----HAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC--------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcH----HHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 4678999999999998888889999886 33221111 246789999999873 4567788877654 4789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA------------------------------------- 177 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~------------------------------------- 177 (290)
||||++|..+.+. ....++......++.+++..|..||+
T Consensus 119 vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999999887541 12346788888999999999999997
Q ss_pred ---------------------CCCeeecCCCCCEEEcCCCC-ceEEeccccccc
Q 022903 178 ---------------------NGIIHRDLKPDNLLLTPDQK-SLKLADFGLARE 209 (290)
Q Consensus 178 ---------------------~givH~Dikp~Nili~~~~~-~~kl~Dfg~~~~ 209 (290)
..++|+|++|.||+++.++. .+.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999996653 358999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.30 E-value=1e-11 Score=103.02 Aligned_cols=124 Identities=16% Similarity=0.131 Sum_probs=88.4
Q ss_pred ccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC--ceeEEeeeec-CceEEEEEecCCC
Q 022903 67 GEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LVKFLGACKD-PLMVIVTELLPGM 142 (290)
Q Consensus 67 G~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~-~~~~lv~e~~~~~ 142 (290)
+.|..+.||++... ++.+++|+....... .+.+|+.+++.+.+.+ +.++++...+ +..++||||++|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~--------~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~ 100 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGALN--------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 100 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCTTS--------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcccch--------hhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCc
Confidence 45666999999764 567999997654221 2568888888886444 4557777654 3678999999998
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-------------------------------------------
Q 022903 143 SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG------------------------------------------- 179 (290)
Q Consensus 143 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g------------------------------------------- 179 (290)
+|. .. ..+ ...++.+++..|..||+..
T Consensus 101 ~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 101 DLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp ETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 884 11 111 1256677777777777643
Q ss_pred ---------------CeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 180 ---------------IIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 180 ---------------ivH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
++|+|++|.||+++. +..+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhccc
Confidence 999999999999984 44456999999754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.28 E-value=8.1e-12 Score=106.49 Aligned_cols=191 Identities=19% Similarity=0.228 Sum_probs=119.1
Q ss_pred ceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCC--ceeEEeeeecC----ceEEEE
Q 022903 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDN--LVKFLGACKDP----LMVIVT 136 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~----~~~lv~ 136 (290)
+.++.|.+..||+.. ..+++|+.... . ...++.+|..+++.+. +.. +.+++....+. ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~---~----~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS---R----GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH---H----HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc---c----hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 568999999999864 56889986532 1 1235778999998884 332 33444443322 347899
Q ss_pred EecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 022903 137 ELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA--------------------------------------- 177 (290)
Q Consensus 137 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--------------------------------------- 177 (290)
++++|.+|..... ..++..+...++.+++..|..||+
T Consensus 96 ~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999988875433 246777777888888888888886
Q ss_pred -------------------CCCeeecCCCCCEEEcCC-CCceEEecccccccccccccccccCCCccccCcccccc----
Q 022903 178 -------------------NGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST---- 233 (290)
Q Consensus 178 -------------------~givH~Dikp~Nili~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~---- 233 (290)
..++|+|++|.||+++.+ +..+.|+||+.+.................-..|+....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 136999999999999964 44578999998865322111100000000011211110
Q ss_pred ccccc--cccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 022903 234 VTLRQ--GEKKHYNNKVDVYSFGIVLWELLTNRLPFE 268 (290)
Q Consensus 234 ~~~~~--~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~ 268 (290)
..... ..........+.|+++.++|.+.+|..||-
T Consensus 252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00000 000001223689999999999999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=3.1e-08 Score=84.29 Aligned_cols=133 Identities=20% Similarity=0.204 Sum_probs=89.0
Q ss_pred ceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCC---CceeEEeeee--cCceEEEEEe
Q 022903 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD---NLVKFLGACK--DPLMVIVTEL 138 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~--~~~~~lv~e~ 138 (290)
+.++.|....||+. +..+++|+... .. ...++.+|..+++.+.+. .+.+.+.... ++..++||++
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~~---~~----~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPKS---QQ----GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEESS---HH----HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE---CCEEEEEecCC---ch----HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 45788999999988 67788898532 11 123577999999999742 2445555553 3457899999
Q ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------
Q 022903 139 LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN---------------------------------------- 178 (290)
Q Consensus 139 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---------------------------------------- 178 (290)
++|.++....- ..++......++.++...|..||+.
T Consensus 95 i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 95 VQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred cCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 99988876321 1234444444455555555544432
Q ss_pred --------------------CCeeecCCCCCEEEcC---CCCceEEecccccccc
Q 022903 179 --------------------GIIHRDLKPDNLLLTP---DQKSLKLADFGLAREE 210 (290)
Q Consensus 179 --------------------givH~Dikp~Nili~~---~~~~~kl~Dfg~~~~~ 210 (290)
.++|+|++|.||+++. ++..+.|+||+.+...
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999986 2444589999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=4.1e-07 Score=75.69 Aligned_cols=130 Identities=17% Similarity=0.142 Sum_probs=86.3
Q ss_pred eeccccce-eEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeec-CceEEEEEec
Q 022903 65 KIGEGAHG-KVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD-PLMVIVTELL 139 (290)
Q Consensus 65 ~lG~G~~g-~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~lv~e~~ 139 (290)
.+..|..+ .||+... .+..+++|+..... . ..+.+|...|+.+. +-.+.+++..+.+ +..++||+++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~---~-----~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV---A-----NDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH---H-----HHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC---H-----hHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 34455555 6887654 45678999865321 1 23668888888885 3235667777654 4678999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN----------------------------------------- 178 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----------------------------------------- 178 (290)
+|.++.+..... ......++.++...|..||+.
T Consensus 103 ~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 998887765431 112234455555555555531
Q ss_pred -----------------CCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 179 -----------------GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 179 -----------------givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.++|+|+.|.||+++. ++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEEECccccc
Confidence 2689999999999984 44466999998854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=2.1e-07 Score=80.77 Aligned_cols=79 Identities=8% Similarity=0.016 Sum_probs=52.5
Q ss_pred eccee-ccccceeEEEEEEC--------CceEEEEEcccCC---ChhHHHHHHHHHHHHHHHHhhcC-C--CCceeEEee
Q 022903 62 IGSKI-GEGAHGKVYEGRYG--------DRIVAIKVLNRGS---TSDERALLEGRFIREVNMMSRVK-H--DNLVKFLGA 126 (290)
Q Consensus 62 ~~~~l-G~G~~g~V~~~~~~--------~~~vavK~~~~~~---~~~~~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~ 126 (290)
..+.| +.|....+|+.... ++.+++|+..... .... ..+.+|..+++.|. + -.+.+++..
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~-----~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT-----YRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC-----CCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch-----hHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 34677 88989999988654 6789999876432 1000 12457777777774 2 245667777
Q ss_pred eecC----ceEEEEEecCCCCHH
Q 022903 127 CKDP----LMVIVTELLPGMSLR 145 (290)
Q Consensus 127 ~~~~----~~~lv~e~~~~~~L~ 145 (290)
+.+. ..++|||+++|..+.
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCCC
T ss_pred ccCCCccCCceEEEEecCCCChh
Confidence 6543 468999999886653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=3e-07 Score=81.06 Aligned_cols=79 Identities=23% Similarity=0.198 Sum_probs=47.9
Q ss_pred cceeccccceeEEEEEE--CCceEEEEEcccCCC-hhHH-HHHHHHHHHHHHHHhhcCC--CCc-eeEEeeeecCceEEE
Q 022903 63 GSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGST-SDER-ALLEGRFIREVNMMSRVKH--DNL-VKFLGACKDPLMVIV 135 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~-~~~~~~~~~e~~~l~~l~h--~~i-v~~~~~~~~~~~~lv 135 (290)
.+.||.|.++.||++.. .++.+++|....... .... .....++..|..+++.+.. |.. .+++.. .....++|
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~lv 113 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV 113 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEEE
Confidence 46789999999999954 568899998654221 0000 0001235678888887742 433 345544 34456899
Q ss_pred EEecCCC
Q 022903 136 TELLPGM 142 (290)
Q Consensus 136 ~e~~~~~ 142 (290)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.31 E-value=1.5e-05 Score=68.33 Aligned_cols=72 Identities=11% Similarity=0.171 Sum_probs=40.4
Q ss_pred ceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-----CCCceeEE-e--e-eecCceEE
Q 022903 64 SKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-----HDNLVKFL-G--A-CKDPLMVI 134 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~-~--~-~~~~~~~l 134 (290)
+.|+.|..+.||+....+..+++|+.... . . ++..|..+++.|. .|.++... + . ..++..++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~--~-~------~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP--E-K------KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC--H-H------HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC--H-H------HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 45666788999999887777999998752 1 1 1223444444442 24443311 1 0 12446789
Q ss_pred EEEecCCCCH
Q 022903 135 VTELLPGMSL 144 (290)
Q Consensus 135 v~e~~~~~~L 144 (290)
+|+|++|..+
T Consensus 109 l~~~i~G~~~ 118 (346)
T 2q83_A 109 VYDWIEGRPF 118 (346)
T ss_dssp EEECCCCBCC
T ss_pred EEEeecCccC
Confidence 9999998653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.9e-05 Score=70.11 Aligned_cols=32 Identities=25% Similarity=0.387 Sum_probs=27.1
Q ss_pred HCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 177 ~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
...++|+|++|.||+++.+ + +.++||+.+...
T Consensus 231 ~~~liHGDl~~~Nil~~~~-~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQD-S-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSS-C-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCC-C-CEEEeCcccccC
Confidence 4579999999999999854 3 899999988753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.07 E-value=1.7e-05 Score=66.50 Aligned_cols=77 Identities=10% Similarity=0.047 Sum_probs=53.5
Q ss_pred eeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC---CCceeEEeeeecCceEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH---DNLVKFLGACKDPLMVIV 135 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~lv 135 (290)
+.-++.+|.|..+.||+.+. +|+.|++|+.......... .+.+|...|+.|.. -.++++++.. ..++|
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~-----~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~~~lv 88 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDG-----LFRAEALGLDWLGRSFGSPVPQVAGWD---DRTLA 88 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTT-----HHHHHHHHHHHHTCSTTCCSCCEEEEE---TTEEE
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhh-----HHHHHHHHHHHHHhhCCCCcceEEecc---CceEE
Confidence 45567899999999999987 5689999987654433221 26688888888852 2344455542 34789
Q ss_pred EEecCCCCH
Q 022903 136 TELLPGMSL 144 (290)
Q Consensus 136 ~e~~~~~~L 144 (290)
||++++...
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.03 E-value=2.5e-05 Score=66.34 Aligned_cols=74 Identities=16% Similarity=0.143 Sum_probs=55.9
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC---CCCceeEEeeeec-CceEEEEEe
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK---HDNLVKFLGACKD-PLMVIVTEL 138 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~-~~~~lv~e~ 138 (290)
.+.|+.|.+..+|+....++.+++|+..... . ..+.+|...|+.|. ...+++++..... +..++|||+
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~----~----~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERSY----R----SMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGGG----H----HHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCccc----H----HHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 4678999999999998888889999876431 1 24678888888874 2456777776653 468899999
Q ss_pred cCCCCH
Q 022903 139 LPGMSL 144 (290)
Q Consensus 139 ~~~~~L 144 (290)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.89 E-value=6.1e-05 Score=64.49 Aligned_cols=137 Identities=12% Similarity=0.121 Sum_probs=70.2
Q ss_pred ceecccccee-EEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC--CCceeEEeeeecCceEEEEEec
Q 022903 64 SKIGEGAHGK-VYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH--DNLVKFLGACKDPLMVIVTELL 139 (290)
Q Consensus 64 ~~lG~G~~g~-V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~lv~e~~ 139 (290)
+.|+.|.... +|+.... ++.+++|........ .+..|+.+++.+.. -.+.+++....+.. +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~~--------~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g-~ll~e~l 94 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEGG--------DTQPFVDLAQYLRNLDISAPEIYAEEHARG-LLLIEDL 94 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTTC--------CSHHHHHHHHHHHHTTCBCCCEEEEETTTT-EEEECCC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCCc--------cccHHHHHHHHHHhCCCCCCceeeecCCCC-EEEEeeC
Confidence 3465565554 6677654 677888876553211 13355666655532 22445665543333 7899999
Q ss_pred CCCCHHHHHHhcC---------------------C---CCCCHHHHH-------H-HH------------HHHHHHHHHH
Q 022903 140 PGMSLRKYLVSLR---------------------P---NKLDLHVAL-------N-FA------------LDIARAMDCL 175 (290)
Q Consensus 140 ~~~~L~~~~~~~~---------------------~---~~~~~~~~~-------~-i~------------~qi~~~l~~l 175 (290)
.+..+.+++.... . ..++..... . +. ..+...+..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 7766655443210 0 012221110 0 00 0111222233
Q ss_pred ------HHCCCeeecCCCCCEEEcCC---CCceEEeccccccc
Q 022903 176 ------HANGIIHRDLKPDNLLLTPD---QKSLKLADFGLARE 209 (290)
Q Consensus 176 ------H~~givH~Dikp~Nili~~~---~~~~kl~Dfg~~~~ 209 (290)
+...++|+|+.+.||+++.+ ...+.|+||+.+..
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 12469999999999999854 14589999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.89 E-value=4.3e-05 Score=64.53 Aligned_cols=71 Identities=11% Similarity=0.108 Sum_probs=43.7
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc-eeEEeeeecCceEEEEEec-C
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELL-P 140 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~lv~e~~-~ 140 (290)
++.|+.|....+|+. +.+++|+......... ...+|..+++.+...++ .+++.... ...+++++|+ +
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~------~r~~E~~~l~~l~~~g~~P~~~~~~~-~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYI------NRANEAVAAREAAKAGVSPEVLHVDP-ATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----CC------CHHHHHHHHHHHHHTTSSCCEEEECT-TTCCEEEECCTT
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcccee------CHHHHHHHHHHHHHcCCCCceEEEEC-CCCEEEEeecCC
Confidence 567889999999998 6788898765321100 12357777766643223 45555433 2457899999 6
Q ss_pred CCCH
Q 022903 141 GMSL 144 (290)
Q Consensus 141 ~~~L 144 (290)
|.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.83 E-value=6.5e-05 Score=63.88 Aligned_cols=139 Identities=22% Similarity=0.220 Sum_probs=75.7
Q ss_pred cceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC--ceeEEeee-------ecCceE
Q 022903 63 GSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LVKFLGAC-------KDPLMV 133 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~-------~~~~~~ 133 (290)
++.|+.|....+|+....+..+++|+........ .+..|..+++.|...+ +.+++... .++..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~~~-------~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKN-------DLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC---CC-------HHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCCCHH-------HHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 4567888889999998776689999987632111 2345666666664212 23333211 134568
Q ss_pred EEEEecCCCCHHH-----------H---HHhc-CC--CC----CC---HHHHHH------------HHHHHHHHHHHHHH
Q 022903 134 IVTELLPGMSLRK-----------Y---LVSL-RP--NK----LD---LHVALN------------FALDIARAMDCLHA 177 (290)
Q Consensus 134 lv~e~~~~~~L~~-----------~---~~~~-~~--~~----~~---~~~~~~------------i~~qi~~~l~~lH~ 177 (290)
+++++++|..+.. . +... .. .. .. +..... +...+...+..++.
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999998865311 0 1110 00 00 11 111000 00113344555552
Q ss_pred -------CCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 178 -------NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 178 -------~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.+++|+|+.|.||+++.+ ..+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 368999999999999844 4357999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00017 Score=62.99 Aligned_cols=137 Identities=15% Similarity=0.243 Sum_probs=78.2
Q ss_pred ceeccccceeEEEEEEC---------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC-ceeEEeeeecCceE
Q 022903 64 SKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN-LVKFLGACKDPLMV 133 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~ 133 (290)
+.|..|-...+|+.... ++.+++|+...... ... .+.+|..+++.|...+ ..++++.+.+ .
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~-~~~-----~~~rE~~vl~~L~~~gv~P~ll~~~~~---g 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ-GVD-----SLVLESVMFAILAERSLGPQLYGVFPE---G 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C-CHH-----HHHHHHHHHHHHHHTTSSCCEEEEETT---E
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc-hHH-----HHHHHHHHHHHHHhcCCCCeEEEEcCC---c
Confidence 56777888899998763 36899998643221 111 2458888888875322 3556766654 3
Q ss_pred EEEEecCCCCHHH--------------HHHhcCC------CCCC--HHHHHHHHHHHHH-------------------HH
Q 022903 134 IVTELLPGMSLRK--------------YLVSLRP------NKLD--LHVALNFALDIAR-------------------AM 172 (290)
Q Consensus 134 lv~e~~~~~~L~~--------------~~~~~~~------~~~~--~~~~~~i~~qi~~-------------------~l 172 (290)
+||||++|..|.. .+..... .... +.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998855421 1111111 1111 3445555544322 22
Q ss_pred HHHH----HC----CCeeecCCCCCEEEcCC---CCceEEeccccccc
Q 022903 173 DCLH----AN----GIIHRDLKPDNLLLTPD---QKSLKLADFGLARE 209 (290)
Q Consensus 173 ~~lH----~~----givH~Dikp~Nili~~~---~~~~kl~Dfg~~~~ 209 (290)
..|. .. .++|+|+.+.||+++.+ .+.+.++||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 22 58999999999999865 24689999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00064 Score=60.35 Aligned_cols=71 Identities=18% Similarity=0.262 Sum_probs=47.8
Q ss_pred cceeccccceeEEEEEEC---------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc-eeEEeeeecCce
Q 022903 63 GSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLM 132 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~ 132 (290)
++.|+.|....||+.... ++.+++|+....... . .+.+|..+++.|...++ .++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~-~------~li~E~~~l~~L~~~g~~P~l~~~~~~--- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-S------HLVAESVIFTLLSERHLGPKLYGIFSG--- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-H------HHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcH-H------HHHHHHHHHHHHHhCCCCCcEEEEeCC---
Confidence 467888999999999864 478999998542220 1 23478888888753334 556766543
Q ss_pred EEEEEecCCCC
Q 022903 133 VIVTELLPGMS 143 (290)
Q Consensus 133 ~lv~e~~~~~~ 143 (290)
.+|++|++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38899998643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00026 Score=61.50 Aligned_cols=71 Identities=14% Similarity=0.156 Sum_probs=42.2
Q ss_pred ceeccccceeEEEEEECC----------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC-ceeEEeeeecCce
Q 022903 64 SKIGEGAHGKVYEGRYGD----------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN-LVKFLGACKDPLM 132 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~ 132 (290)
..|+.|....+|+....+ +.+++|+........ . ....|..+++.+...+ +.++++... .
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~-----~~~~E~~~l~~L~~~g~~P~~~~~~~---~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-Y-----NTISEFEVYKTMSKYKIAPQLLNTFN---G 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-S-----CHHHHHHHHHHHHHTTSSCCEEEEET---T
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-e-----cHHHHHHHHHHHHhcCCCCceEEecC---C
Confidence 567888889999988754 689999875432110 0 1236777777775333 345665442 3
Q ss_pred EEEEEecCCCC
Q 022903 133 VIVTELLPGMS 143 (290)
Q Consensus 133 ~lv~e~~~~~~ 143 (290)
++||+|++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0012 Score=59.18 Aligned_cols=73 Identities=14% Similarity=0.080 Sum_probs=47.4
Q ss_pred cceeccccceeEEEEEECC--ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc-eeEEeeeecCceEEEEEec
Q 022903 63 GSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMVIVTELL 139 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~lv~e~~ 139 (290)
++.|+.|-...+|+....+ ..+++|+........ . ...+|..+++.|...++ .++++.+.+ .+||+|+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-i-----dR~~E~~vl~~L~~~gl~P~ll~~~~~---G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-I-----NREREKKISCILYNKNIAKKIYVFFTN---GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-S-----CHHHHHHHHHHHTTSSSBCCEEEEETT---EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-c-----CHHHHHHHHHHHHhcCCCCCEEEEeCC---eEEEEee
Confidence 4578889999999998876 889999875432111 0 01378888888865445 457776632 3599999
Q ss_pred CCCCH
Q 022903 140 PGMSL 144 (290)
Q Consensus 140 ~~~~L 144 (290)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0017 Score=55.13 Aligned_cols=73 Identities=11% Similarity=0.162 Sum_probs=44.1
Q ss_pred ceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC--ceeEEee-----e-ecCceEE
Q 022903 64 SKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN--LVKFLGA-----C-KDPLMVI 134 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~-----~-~~~~~~l 134 (290)
..|+ |....||+.... ++.+++|+......... .+..|..+++.|.... +++++.. . .++..++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~------~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTAD------QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHH------HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHH------HHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 3466 888899988764 55799999875432221 2456777776664222 3334332 0 1335578
Q ss_pred EEEecCCCC
Q 022903 135 VTELLPGMS 143 (290)
Q Consensus 135 v~e~~~~~~ 143 (290)
+|++++|..
T Consensus 105 l~~~i~G~~ 113 (328)
T 1zyl_A 105 VFPSVGGRQ 113 (328)
T ss_dssp EEECCCCEE
T ss_pred EEEecCCCC
Confidence 999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.012 Score=50.39 Aligned_cols=30 Identities=20% Similarity=0.366 Sum_probs=25.4
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 179 givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
.++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEE-SIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence 689999999999998543 489999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.79 E-value=0.062 Score=47.41 Aligned_cols=73 Identities=10% Similarity=0.085 Sum_probs=46.9
Q ss_pred cceeccccceeEEEEEEC---------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCC-ceeEEeeeecCce
Q 022903 63 GSKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN-LVKFLGACKDPLM 132 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~ 132 (290)
++.|..|-...+|+.... ++.+++|+........ . ...+|..+++.+...+ ..++++.+. .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-i-----dR~~E~~~l~~L~~~gi~P~l~~~~~---~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-Y-----DSKVELDVFRYLSNINIAPNIIADFP---E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-C-----CHHHHHHHHHHHHHTTSSCCEEEEET---T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-c-----CHHHHHHHHHHHHhcCCCCCEEEEcC---C
Confidence 456777888999999875 5889999975432110 0 1236777777775323 345665442 3
Q ss_pred EEEEEecCCCCH
Q 022903 133 VIVTELLPGMSL 144 (290)
Q Consensus 133 ~lv~e~~~~~~L 144 (290)
++||+|++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999998653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.27 E-value=0.1 Score=41.40 Aligned_cols=98 Identities=16% Similarity=0.149 Sum_probs=61.5
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCCceEEecccccccccccccccccC
Q 022903 142 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 220 (290)
Q Consensus 142 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 220 (290)
.+|.+.+.. ...++++++++.++.|.+.+|.-+-. +.-..+=+.|..|++..++. |-+.+ +.+. .
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~-V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA-VTLAP-AADD-----------A 98 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC-EEECC-C---------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc-eeccc-cccc-----------c
Confidence 479999887 46899999999999999999877622 22123334567788876654 54442 1110 1
Q ss_pred CCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh
Q 022903 221 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 262 (290)
Q Consensus 221 g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~ 262 (290)
....+.|||... ...+.+.=|||||+++|..+-
T Consensus 99 ~~~~~~~pe~~~---------~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 99 GEPPPVAGKLGY---------SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------CCSS---------SSSCHHHHHHHHHHHHHHHHT
T ss_pred cccCCCChhhcc---------ccchHHHHHHHHHHHHHHHhh
Confidence 223466888652 234678899999999998886
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.08 E-value=0.064 Score=46.91 Aligned_cols=30 Identities=30% Similarity=0.490 Sum_probs=24.5
Q ss_pred CeeecCCCCCEEEcC-----CCCceEEeccccccc
Q 022903 180 IIHRDLKPDNLLLTP-----DQKSLKLADFGLARE 209 (290)
Q Consensus 180 ivH~Dikp~Nili~~-----~~~~~kl~Dfg~~~~ 209 (290)
++|+|+.+.||++.+ +...+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 579999999999942 345699999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.13 E-value=0.047 Score=48.78 Aligned_cols=60 Identities=12% Similarity=0.051 Sum_probs=15.9
Q ss_pred eecceeccccceeEEEEEECC--ceEEE------EEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEee
Q 022903 61 FIGSKIGEGAHGKVYEGRYGD--RIVAI------KVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGA 126 (290)
Q Consensus 61 ~~~~~lG~G~~g~V~~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 126 (290)
.+.+.|| ||.||+|.+.+ .+||+ |.........+. ...+.+|..+++.++|||+++.++.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~---~~~~~rea~l~~~~~H~niv~~h~f 212 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKR---LTSLVRRATLKENEQIPKYEKIHNF 212 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC--------------------------------------CBCCCE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccc---cccccccccccccccccccCCCcce
Confidence 3456776 99999998754 47888 665443322221 1246788888888999999887654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.42 E-value=2.4 Score=33.33 Aligned_cols=83 Identities=14% Similarity=0.114 Sum_probs=53.5
Q ss_pred CCCCceeEEeeeecCceEEEEEecC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC
Q 022903 116 KHDNLVKFLGACKDPLMVIVTELLP-GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 194 (290)
Q Consensus 116 ~h~~iv~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~ 194 (290)
.||++++.--.-.++...+.++.-+ +.++.. + ...+....++++.+|+....++++ -+|=-+.|+|++++.
T Consensus 43 ~~~~Fl~~~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDAELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCEEEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECT
T ss_pred cCCcccceEEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcC
Confidence 4788887632223333434444432 222332 2 347888889999999887754443 488899999999996
Q ss_pred CCCceEEeccccc
Q 022903 195 DQKSLKLADFGLA 207 (290)
Q Consensus 195 ~~~~~kl~Dfg~~ 207 (290)
+. .+++.=.|+.
T Consensus 115 ~~-~p~i~~RGik 126 (215)
T 4ann_A 115 DG-LPIAKTRGLQ 126 (215)
T ss_dssp TS-CEEESCCEET
T ss_pred CC-CEEEEEccCc
Confidence 54 5888877664
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.00 E-value=2.6 Score=33.32 Aligned_cols=82 Identities=10% Similarity=0.056 Sum_probs=53.5
Q ss_pred CCCCceeEEeeeecCceEEEEEecCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHHHCCCeeecCCCCCEEEc
Q 022903 116 KHDNLVKFLGACKDPLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMD-CLHANGIIHRDLKPDNLLLT 193 (290)
Q Consensus 116 ~h~~iv~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~-~lH~~givH~Dikp~Nili~ 193 (290)
.||++ +.--...++.+.+.++.-+++ ++. .++ ..+....++++.+|+.... +++ .-+|--+.|+|++++
T Consensus 48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~-~i~-----~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFA-AIR-----KTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS-EEEEEECSSEEEEEEECCTTCEEHH-HHH-----TSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEEC
T ss_pred cCCCC-CeEEEEeCCEEEEEEEcCcccCcHH-HHH-----hcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEe
Confidence 57888 432223344444555554333 333 333 4788888899998887665 443 448888999999999
Q ss_pred CCCCceEEeccccc
Q 022903 194 PDQKSLKLADFGLA 207 (290)
Q Consensus 194 ~~~~~~kl~Dfg~~ 207 (290)
.+ ..+++.=.|+-
T Consensus 119 ~~-~~p~i~hRGi~ 131 (219)
T 4ano_A 119 RA-LEPFFLHVGVK 131 (219)
T ss_dssp TT-CCEEESCCEET
T ss_pred CC-CcEEEEEcCCc
Confidence 55 45898877764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 290 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-68 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-49 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-48 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-48 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-44 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-42 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-39 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-37 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-25 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (537), Expect = 4e-68
Identities = 75/228 (32%), Positives = 126/228 (55%), Gaps = 14/228 (6%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
+ + +G +IG G+ G VY+G++ VA+K+LN + + ++ F EV ++ +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQ---LQAFKNEVGVLRK 60
Query: 115 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+H N++ F+G P + IVT+ G SL +L + K ++ ++ A A+ MD
Sbjct: 61 TRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDY 119
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELY 231
LHA IIHRDLK +N+ L D ++K+ DFGLA + + +G+ WMAPE+
Sbjct: 120 LHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV- 177
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279
+R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N
Sbjct: 178 ----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM 221
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-59
Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG +G+G G VY R I+A+KVL + +E + REV + S ++H N
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG--VEHQLRREVEIQSHLRHPN 67
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ G D + ++ E P ++ + L + +K D + ++A A+ H+
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELANALSYCHSK 125
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
+IHRD+KP+NLLL LK+ADFG + + T GT ++ PE+
Sbjct: 126 RVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEG----- 178
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+ ++ KVD++S G++ +E L + PFE + +
Sbjct: 179 ---RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-59
Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 15/229 (6%)
Query: 55 VDPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNM 111
++P+ + I ++G+GA GKVY+ + + A KV++ S + ++ E+++
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-----DYMVEIDI 62
Query: 112 MSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
++ H N+VK L A + I+ E G ++ ++ L L
Sbjct: 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLD 121
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPE 229
A++ LH N IIHRDLK N+L T D +KLADFG++ + T T + + GT WMAPE
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+ T + + Y+ K DV+S GI L E+ P ++ ++
Sbjct: 181 VVMCETSKD---RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK 226
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-59
Identities = 51/227 (22%), Positives = 101/227 (44%), Gaps = 20/227 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
S++G G G V++ + ++A K+++ R + IRE+ ++
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN----QIIRELQVLHECNSPY 65
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-A 177
+V F GA + I E + G SL + L + ++ + ++ + + + L
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
+ I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE
Sbjct: 124 HKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQG---- 177
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQ 284
HY+ + D++S G+ L E+ R P + +V+
Sbjct: 178 ----THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-59
Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 24/231 (10%)
Query: 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
D + L +IG G+ VY+G VA L + RF E M+
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEMLK 63
Query: 114 RVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 168
++H N+V+F + + + +V+VTEL+ +L+ YL R + + V ++ I
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWCRQI 121
Query: 169 ARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 226
+ + LH IIHRDLK DN+ +T S+K+ D GLA + A GT +M
Sbjct: 122 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFM 180
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
APE+Y ++ Y+ VDVY+FG+ + E+ T+ P+ N Y
Sbjct: 181 APEMY---------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-58
Identities = 73/225 (32%), Positives = 114/225 (50%), Gaps = 19/225 (8%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
V + L + ++G G G+V+ G Y G VA+K L +GS S + F+ E N+M
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA------FLAEANLMK 63
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+++H LV+ + I+TE + SL +L + KL ++ L+ A IA M
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELY 231
+ IHRDL+ N+L+ D S K+ADFGLAR E+ +W APE
Sbjct: 124 FIEERNYIHRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA 275
+ + K DV+SFGI+L E++T+ R+P+ GM+N +
Sbjct: 183 NY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (471), Expect = 1e-57
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 17/227 (7%)
Query: 56 DPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DP+ LF +IG G+ G VY R +VAIK ++ I+EV +
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW--QDIIKEVRFL 69
Query: 113 SRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+++H N +++ G +V E G + V +P L +
Sbjct: 70 QKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQG 127
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
+ LH++ +IHRD+K N+LL+ +KL DFG A GT WMAPE+
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMAPEV- 182
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+ ++ Y+ KVDV+S GI EL + P M+ + A Y
Sbjct: 183 ----ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-57
Identities = 70/227 (30%), Positives = 111/227 (48%), Gaps = 21/227 (9%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
++ K L + IG+G G V G Y VA+K + +T+ F+ E ++M++
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ-------AFLAEASVMTQ 56
Query: 115 VKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++H NLV+ LG + + IVTE + SL YL S + L L F+LD+ AM
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
+ L N +HRDL N+L++ D K++DFGL +E + +W APE
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALR 173
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA 278
K ++ K DV+SFGI+LWE+ + R+P+ +
Sbjct: 174 E--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 183 bits (466), Expect = 1e-56
Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 18/217 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G GA G V+ A K + SD+ +E+ MS ++H
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-----TVRKEIQTMSVLRHPT 84
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
LV A +D MV++ E + G L + + NK+ A+ + + + + +H N
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 179 GIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
+H DLKP+N++ T + + LKL DFGL + + TGT + APE+
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG---- 199
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
K D++S G++ + LL+ PF G ++ +
Sbjct: 200 ----KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE 232
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-55
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 25/230 (10%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ IG G++G+ + R +I+ K L+ GS ++ + + EVN++ +KH N
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE---KQMLVSEVNLLRELKHPN 64
Query: 120 LVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDC 174
+V++ D + IV E G L + + LD L + A+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 175 LH-----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAP 228
H + ++HRDLKP N+ L Q ++KL DFGLAR T A GT +M+P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 229 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
E + YN K D++S G +L+EL PF S + A
Sbjct: 184 EQMNR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK 225
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (460), Expect = 1e-55
Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I ++G GA G V+ R+ K +N D+ E+++M+++ H
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY-----TVKNEISIMNQLHHPK 87
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
L+ A +D MV++ E L G L + + K+ +N+ + +H +
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 179 GIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
I+H D+KP+N++ + S+K+ DFGLA + E++ T T + APE+
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV------ 200
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+++ D+++ G++ + LL+ PF G +L+
Sbjct: 201 --DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN 239
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-55
Identities = 70/228 (30%), Positives = 108/228 (47%), Gaps = 22/228 (9%)
Query: 56 DPKLLF-IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
DPK + KIG+GA G VY + VAI+ +N + I E+ +M
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-----LIINEILVM 71
Query: 113 SRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
K+ N+V +L + + +V E L G SL + +D + +A
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQA 128
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPEL 230
++ LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT WMAPE+
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+ K Y KVD++S GI+ E++ P+ + L+A Y
Sbjct: 188 VTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-55
Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+DPK L ++G G G V G++ G VAIK++ GS S++ FI E +M
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE------FIEEAKVMM 54
Query: 114 RVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
+ H+ LV+ G C + I+TE + L YL ++ L D+ AM
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAM 113
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPEL 230
+ L + +HRDL N L+ +K++DFGL+R + RW PE+
Sbjct: 114 EYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV 172
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA 278
+++K D+++FG+++WE+ + ++P+E +N + A
Sbjct: 173 LMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-55
Identities = 58/242 (23%), Positives = 112/242 (46%), Gaps = 28/242 (11%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALL 101
+L + R LL ++G G G V +G Y VAIKVL +G+ +
Sbjct: 2 KLFLKRD-----NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE-- 54
Query: 102 EGRFIREVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 161
+RE +M ++ + +V+ +G C+ +++V E+ G L K+LV + ++ +
Sbjct: 55 --EMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNV 111
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMT 217
++ M L +HRDL N+LL K++DFGL++ +++ +
Sbjct: 112 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARS 170
Query: 218 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAA 276
A +W APE + + ++++ DV+S+G+ +WE L+ + P++ M +
Sbjct: 171 AGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222
Query: 277 YA 278
Sbjct: 223 AF 224
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 7e-55
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 20/223 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+ +GEGA+G+V + VA+K+++ D +E+ + + H+N
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE----NIKKEICINKMLNHEN 64
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+VKF G ++ + + E G L + + A F + + LH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVT 235
GI HRD+KP+NLLL +LK++DFGLA ++ GT ++APEL
Sbjct: 123 GITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-- 179
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
++ + VDV+S GIVL +L LP++ S+ Y+
Sbjct: 180 -----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 9e-55
Identities = 59/232 (25%), Positives = 108/232 (46%), Gaps = 24/232 (10%)
Query: 53 LLVDPKLLFIGSK-IGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIR 107
+ +D KLL + K +G G G V +G Y + VA+K+L + L+ +
Sbjct: 1 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA---LKDELLA 57
Query: 108 EVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
E N+M ++ + +V+ +G C+ ++V E+ L KYL + + +
Sbjct: 58 EANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQ--QNRHVKDKNIIELVHQ 115
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTY 223
++ M L + +HRDL N+LL K++DFGL++ +E + T
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+W APE + +++K DV+SFG+++WE + + P+ GM +
Sbjct: 175 KWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-53
Identities = 72/237 (30%), Positives = 105/237 (44%), Gaps = 22/237 (9%)
Query: 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFI 106
+ L+ K L + K+G+G+ G V G + VA+K L S A+ FI
Sbjct: 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM--DDFI 59
Query: 107 REVNMMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 166
REVN M + H NL++ G P M +VTEL P SL L L +A+
Sbjct: 60 REVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAV 118
Query: 167 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGT 222
+A M L + IHRDL NLLL +K+ DFGL R + M
Sbjct: 119 QVAEGMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 223 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA 278
+ W APE T + +++ D + FG+ LWE+ T + P+ G++ Q +
Sbjct: 178 FAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 1e-53
Identities = 40/217 (18%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +G G G V+ + K + T +E+++++ +H N
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL------VKKEISILNIARHRN 62
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
++ + + +V++ E + G+ + + + + +L+ +++ + A+ LH++
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 179 GIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 237
I H D++P+N++ + S +K+ +FG AR+ + + APE++
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH------ 175
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+ + D++S G +++ LL+ PF +N Q
Sbjct: 176 --QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-53
Identities = 70/228 (30%), Positives = 108/228 (47%), Gaps = 19/228 (8%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS 113
+ + L + K+G+G G+V+ G + G VAIK L G+ S E F++E +M
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA------FLQEAQVMK 67
Query: 114 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
+++H+ LV+ + + IVTE + SL +L L L ++ A IA M
Sbjct: 68 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELY 231
+ +HRDL+ N+L+ + K+ADFGLAR E+ +W APE
Sbjct: 128 YVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA 278
+ K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 187 LY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 226
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 171 bits (435), Expect = 9e-53
Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 13/221 (5%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGS----TSDERALLEGRFIREVNMMSRV 115
+G G V + + A+K+++ +++E L ++EV+++ +V
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 116 K-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
H N+++ + +V +L+ L YL L + +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRALLEVIC 124
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
LH I+HRDLKP+N+LL D +KL DFG + + E + GT ++APE+
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE- 182
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
Y +VD++S G++++ LL PF +
Sbjct: 183 -CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-52
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 19/219 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
G +GEG+ V R R AIK+L + E + RE ++MSR+ H
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP--YVTRERDVMSRLDHPF 69
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
VK +D + L KY+ + D + +I A++ LH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVT 235
GIIHRDLKP+N+LL D +++ DFG A+ E+ + GT ++++PEL +
Sbjct: 128 GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-- 184
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
K D+++ G ++++L+ PF +
Sbjct: 185 ------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 8e-52
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 20/228 (8%)
Query: 54 LVDPKLLFIGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
++DP L +IG G G V+ G + + VAIK + G+ S+E FI E +M
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED------FIEEAEVM 54
Query: 113 SRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
++ H LV+ G C + + +V E + L YL + + L LD+
Sbjct: 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEG 113
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPE 229
M L +IHRDL N L+ + + +K++DFG+ R + T +W +PE
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
++S Y++K DV+SFG+++WE+ + +
Sbjct: 173 VFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (426), Expect = 2e-51
Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 20/228 (8%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112
++ + + K+G G +G+VYEG + VA+K L + E F++E +M
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE------FLKEAAVM 67
Query: 113 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 171
+KH NLV+ LG C ++P I+TE + +L YL ++ V L A I+ A
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPE 229
M+ L IHRDL N L+ + +K+ADFGL+R +W APE
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 230 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
+ ++ K DV++FG++LWE+ T + +L Y
Sbjct: 187 SLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (425), Expect = 5e-51
Identities = 52/222 (23%), Positives = 98/222 (44%), Gaps = 19/222 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA +V ++VAIK + + + + E+ ++ ++KH N
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG----SMENEIAVLHKIKHPN 68
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V + + ++ +L+ G L +V A + A+ LH
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 179 GIIHRDLKPDNLLLTPDQKS--LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTL 236
GI+HRDLKP+NLL + + ++DFGL++ E +++ GT ++APE+ +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ--- 183
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
K Y+ VD +S G++ + LL PF ++ +
Sbjct: 184 -----KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (413), Expect = 2e-49
Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 22/227 (9%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G +G G +V+ R R VA+KVL D L RF RE + + H
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYL--RFRREAQNAAALNHPA 68
Query: 120 LVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
+V + PL IV E + G++LR + + A+ D +A++
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVIADACQALNF 126
Query: 175 LHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
H NGIIHRD+KP N++++ +A A GT ++++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
+ + DVYS G VL+E+LT PF G S + AY
Sbjct: 187 RG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 225
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-49
Identities = 63/225 (28%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
+G IGEG G V++G Y VAIK ++ R +F++E M +
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE----KFLQEALTMRQFD 66
Query: 117 HDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
H ++VK +G + + I+ EL LR +L R LDL + +A ++ A+ L
Sbjct: 67 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLE 125
Query: 177 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYSTV 234
+ +HRD+ N+L++ +KL DFGL+R E++ + +WMAPE +
Sbjct: 126 SKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF- 183
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA 278
+ + + DV+ FG+ +WE+L + PF+G+ N
Sbjct: 184 -------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 221
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-49
Identities = 73/267 (27%), Positives = 108/267 (40%), Gaps = 47/267 (17%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGR-------YGDRIVAIKVLNRGSTSDER 98
+ D + L G +G GA GKV VA+K+L + S ER
Sbjct: 25 EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 84
Query: 99 ALLEGRFIREVNMMSRV-KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP--- 153
+ E+ MM+++ H+N+V LGAC + ++ E L YL S R
Sbjct: 85 E----ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140
Query: 154 ------------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 195
N L L FA +A+ M+ L +HRDL N+L+T
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 200
Query: 196 QKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 252
K +K+ DFGLAR ++ + +WMAPE Y K DV+S
Sbjct: 201 -KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWS 251
Query: 253 FGIVLWELLTN-RLPFEGMSNLQAAYA 278
+GI+LWE+ + P+ G+ Y
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDANFYK 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-49
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 18/218 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHD 118
+ +G+G+ GKV+ + ++ AIK L + + + + E ++S +H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHP 63
Query: 119 NLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
L + + V E L G L ++ +K DL A +A +I + LH+
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTL 236
GI++RDLK DN+LL D K+ADFG+ +E GT ++APE+
Sbjct: 122 KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--- 177
Query: 237 RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+ YN+ VD +SFG++L+E+L + PF G +
Sbjct: 178 -----QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 5e-49
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 15/218 (6%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEG-RFIREVNMMSRVK-- 116
+G +G G G VY G + VAIK + + SD L G R EV ++ +V
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 117 HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+++ L + P V++ E + ++ L +A +F + A+
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHC 126
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 235
H G++HRD+K +N+L+ ++ LKL DFG T + T GT + PE
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-- 183
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 273
+++ V+S GI+L++++ +PFE +
Sbjct: 184 -----HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 162 bits (412), Expect = 6e-49
Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 18/220 (8%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
I +G G+ G+V+ R + R A+KVL + + + E M+S V H
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV--EHTNDERLMLSIVTHPF 65
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+++ G +D + ++ + + G L L + + VA +A ++ A++ LH+
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
II+RDLKP+N+LL + +K+ DFG A+ V ++ GT ++APE+ ST
Sbjct: 124 DIIYRDLKPENILLDKN-GHIKITDFGFAKY--VPDVTYTLCGTPDYIAPEVVST----- 175
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278
K YN +D +SFGI+++E+L PF + ++
Sbjct: 176 ---KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 212
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 7e-49
Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 30/234 (12%)
Query: 62 IGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLV 121
+ IG+G G+V+ G++ VA+K+ + E+ ++H+N++
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSW------FREAEIYQTVMLRHENIL 60
Query: 122 KFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 176
F+ A + +V++ SL Y L + + + AL A + LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDY---LNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 177 A--------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTY 223
I HRDLK N+L+ + + +AD GLA +T+ GT
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
R+MAPE+ + + + D+Y+ G+V WE+ + Q Y
Sbjct: 177 RYMAPEVLDDSINMKHFE--SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-48
Identities = 66/246 (26%), Positives = 104/246 (42%), Gaps = 28/246 (11%)
Query: 51 RSLLVDPKLLFI--GSKIGEGAHGKVYEGRYGDR-----IVAIKVLNRGSTSDERALLEG 103
+ +++ P L + IG G G VY G D A+K LNR + E +
Sbjct: 18 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS---- 73
Query: 104 RFIREVNMMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 161
+F+ E +M H N++ LG C + ++V + LR ++ + + +
Sbjct: 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDL 132
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMM 216
+ F L +A+ M L + +HRDL N +L +K+ADFGLAR E
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNK 191
Query: 217 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 276
T +WMA E T + + K DV+SFG++LWEL+T P N
Sbjct: 192 TGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 243
Query: 277 YAAAFK 282
+
Sbjct: 244 TVYLLQ 249
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-48
Identities = 58/238 (24%), Positives = 96/238 (40%), Gaps = 28/238 (11%)
Query: 61 FIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KH 117
+G G +GKV + A+K+L + REV + R +
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----------KARREVELHWRASQC 64
Query: 118 DNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++V+ + ++ ++IV E L G L + A I A+
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 173 DCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 230
LH+ I HRD+KP+NLL T LKL DFG A+E T +T T ++APE+
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288
+ Y+ D++S G++++ LL PF L + +++ Y
Sbjct: 185 LG--------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (408), Expect = 2e-48
Identities = 61/246 (24%), Positives = 102/246 (41%), Gaps = 27/246 (10%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERAL 100
+ + + +D + I IG G G+V G + VAIK L G T +R
Sbjct: 14 EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR- 72
Query: 101 LEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLH 159
F+ E ++M + H N++ G ++I+TE + SL +L + +
Sbjct: 73 ---DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVI 128
Query: 160 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR------EETVT 213
+ IA M L +HRDL N+L+ + K++DFGL+R +
Sbjct: 129 QLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTY 187
Query: 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 272
RW APE + + + DV+S+GIV+WE+++ P+ M+N
Sbjct: 188 TSALGGKIPIRWTAPEAIQY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239
Query: 273 LQAAYA 278
A
Sbjct: 240 QDVINA 245
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-48
Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 17/220 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGST-SDERALLEGRFIREVNMMSRVKHD 118
G ++G G V + R A K + + T S R + REV+++ ++H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 119 NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
N++ ++ ++++ EL+ G L +L L A F I + LH+
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHS 131
Query: 178 NGIIHRDLKPDNLLLTPD---QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 234
I H DLKP+N++L + +K+ DFGLA + GT ++APE+
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV--- 188
Query: 235 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+ + D++S G++ + LL+ PF G + +
Sbjct: 189 -----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 6e-47
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 14/214 (6%)
Query: 65 KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVK 122
+GEG VY+ R ++IVAIK + G S+ + + +RE+ ++ + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 123 FLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 181
L A + +V + + ++ L + L + ++ LH + I+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 182 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGE 240
HRDLKP+NLLL + LKLADFGLA+ T + T + APEL
Sbjct: 123 HRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG------- 174
Query: 241 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+ Y VD+++ G +L ELL G S+L
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 208
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 8e-47
Identities = 66/251 (26%), Positives = 107/251 (42%), Gaps = 47/251 (18%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
IGEGA G+V++ R +VA+K+L +++D +A F RE +M+
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA----DFQREAALMAE 72
Query: 115 VKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN------------------- 154
+ N+VK LG C M ++ E + L ++L S+ P+
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 155 ---KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--- 208
L L A +A M L +HRDL N L+ + +K+ADFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIY 191
Query: 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 267
+ + RWM PE Y + DV+++G+VLWE+ + P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 268 EGMSNLQAAYA 278
GM++ + Y
Sbjct: 244 YGMAHEEVIYY 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-46
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 34/234 (14%)
Query: 62 IGSKIGEGAHGKVYEGRYGD----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-K 116
IGEG G+V + R AIK + ++ D+ F E+ ++ ++
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR----DFAGELEVLCKLGH 69
Query: 117 HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYL--------------VSLRPNKLDLHVA 161
H N++ LGAC+ + + E P +L +L + + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 162 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 221
L+FA D+AR MD L IHRDL N+L+ + K+ADFGL+R + V T
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLSRGQEVYVKKTMGRL 188
Query: 222 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
RWMA E + Y DV+S+G++LWE+++ P+ GM+ +
Sbjct: 189 PVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-46
Identities = 63/236 (26%), Positives = 100/236 (42%), Gaps = 25/236 (10%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIRE 108
+ P + IG G G+VY+G VAIK L G T +R F+ E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV----DFLGE 59
Query: 109 VNMMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 167
+M + H N+++ G M+I+TE + +L K+L + + + +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRG 118
Query: 168 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTY 223
IA M L +HRDL N+L+ + K++DFGL+R + T +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 224 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279
RW APE S + + + DV+SFGIV+WE++T + A
Sbjct: 178 RWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA 225
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-46
Identities = 70/244 (28%), Positives = 111/244 (45%), Gaps = 33/244 (13%)
Query: 55 VDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIR 107
V + + + ++G+G+ G VYEG + VAIK +N ++ ER F+
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI----EFLN 72
Query: 108 EVNMMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP--------NKLDL 158
E ++M ++V+ LG + +++ EL+ L+ YL SLRP L
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 159 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEM 215
+ A +IA M L+AN +HRDL N ++ D ++K+ DFG+ R E
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRK 191
Query: 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 274
RWM+PE + DV+SFG+VLWE+ T P++G+SN Q
Sbjct: 192 GGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
Query: 275 AAYA 278
Sbjct: 244 VLRF 247
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-46
Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY---GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD 118
++IGEGA+GKV++ R G R VA+K + + + L R + + + +H
Sbjct: 11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70
Query: 119 NLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
N+V+ C + +V E + YL + + + + R +
Sbjct: 71 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
D LH++ ++HRDLKP N+L+T +KLADFGLAR + +T+ T + APE+
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 188
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
Y VD++S G + E+ + F G S++
Sbjct: 189 Q--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-46
Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 26/224 (11%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
S IGEGA+G V VAIK ++ R +RE+ ++ R +H+N
Sbjct: 12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ----RTLREIKILLRFRHEN 67
Query: 120 LVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
++ + P + V + L G L K L + L F I R +
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFLYQILRGLKY 124
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWMAPEL 230
+H+ ++HRDLKP NLLL LK+ DFGLAR + T +T T + APE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 231 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
K Y +D++S G +L E+L+NR F G L
Sbjct: 184 MLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-46
Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 26/226 (11%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG G+ G VY+ + D +VAIK + + RE+ +M ++ H N
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---------FKNRELQIMRKLDHCN 74
Query: 120 LVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARA 171
+V+ + +V + +P R R + L + + + R+
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 172 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 231
+ +H+ GI HRD+KP NLLL PD LKL DFG A++ E + + + APEL
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 232 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
Y + +DV+S G VL ELL + F G S +
Sbjct: 195 F-------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-45
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 62 IGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV 115
+G GA G VY+G + VAIK L ++ + E +M+ V
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK----EILDEAYVMASV 68
Query: 116 KHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+ ++ + LG C + ++T+L+P L Y+ + + LN+ + IA+ M+ L
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYS 232
++HRDL N+L+ + +K+ DFGLA+ E +WMA E
Sbjct: 128 EDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 274
+ Y ++ DV+S+G+ +WEL+T P++G+ +
Sbjct: 187 H--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-45
Identities = 71/260 (27%), Positives = 106/260 (40%), Gaps = 41/260 (15%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDER 98
QL D L G +G GA GKV E VA+K+L + ER
Sbjct: 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70
Query: 99 ALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-- 154
+ E+ ++S + H N+V LGAC +++TE L +L R +
Sbjct: 71 E----ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 155 --------------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
LDL L+F+ +A+ M L + IHRDL N+LLT + + K
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-K 185
Query: 201 LADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
+ DFGLAR ++ + +WMAPE Y + DV+S+GI L
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIFL 237
Query: 258 WELLTNRLPFEGMSNLQAAY 277
WEL + + + +
Sbjct: 238 WELFSLGSSPYPGMPVDSKF 257
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-45
Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 14/219 (6%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
KIGEG +G VY+ R +VA+K + + ++ + IRE++++ + H N
Sbjct: 6 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELNHPN 62
Query: 120 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
+VK L + + L+K++ + + L + ++ + + + H++
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQ 238
++HRDLKP NLL+ + ++KLADFGLAR V T E T + APE+
Sbjct: 123 VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL------ 175
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
K+Y+ VD++S G + E++T R F G S + +
Sbjct: 176 -GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (388), Expect = 6e-45
Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--- 116
+ IG G G+VY R D ++ A+K L++ ++ E + E M+S V
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGD 65
Query: 117 HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+V A P + + +L+ G L +L +A +I ++ +
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD--MRFYAAEIILGLEHM 123
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 235
H +++RDLKP N+LL + ++++D GLA + + A GT+ +MAPE+
Sbjct: 124 HNRFVVYRDLKPANILLD-EHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQK-- 179
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
Y++ D +S G +L++LL PF
Sbjct: 180 -----GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 17/217 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G+G GKV R R A+K+L + + + + E ++ +H
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA--HTVTESRVLQNTRHPF 66
Query: 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
L A + + V E G L +L R A + +I A++ LH+
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR 124
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELYSTVTLR 237
+++RD+K +NL+L D +K+ DFGL +E + M GT ++APE+
Sbjct: 125 DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED---- 179
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
Y VD + G+V++E++ RLPF + +
Sbjct: 180 ----NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 149 bits (377), Expect = 1e-43
Identities = 47/233 (20%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HD 118
+ K+G G + +V+E + V +K+L + RE+ ++ ++
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--------KIKREIKILENLRGGP 90
Query: 119 NLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
N++ KDP +V E + ++ L + + +I +A+D
Sbjct: 91 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYC 145
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT 235
H+ GI+HRD+KP N+++ + + L+L D+GLA + + + PEL
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV--- 202
Query: 236 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQESIY 288
+ + Y+ +D++S G +L ++ + PF + KV +
Sbjct: 203 ----DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-43
Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 29/229 (12%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+KIG+G G+V++ R+ + VA+K + +E+ +RE+ ++ +KH+N
Sbjct: 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLM---ENEKEGFPITALREIKILQLLKHEN 70
Query: 120 LVKFLGACKDP---------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
+V + C+ + +V + L K L +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLN 128
Query: 171 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRW 225
+ +H N I+HRD+K N+L+T D LKLADFGLAR + + T T +
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 226 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
PEL ++ Y +D++ G ++ E+ T +G +
Sbjct: 188 RPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 5e-43
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 16/216 (7%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120
KIGEG +G VY+ + A+K + + + IRE++++ +KH N+
Sbjct: 6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEG---IPSTTIREISILKELKHSNI 62
Query: 121 VKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG 179
VK +V+V E L + V L+ A +F L + + H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 180 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAPELYSTVTLRQ 238
++HRDLKP NLL+ + LK+ADFGLAR + W AP++
Sbjct: 121 VLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM------ 173
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
K Y+ +D++S G + E++ F G+S
Sbjct: 174 -GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 9e-42
Identities = 74/258 (28%), Positives = 115/258 (44%), Gaps = 42/258 (16%)
Query: 46 QLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY---------GDRIVAIKVLNRGSTSD 96
+L D + L +G +GEGA G+V VA+K+L +T
Sbjct: 1 ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 60
Query: 97 ERALLEGRFIREVNMMSRV-KHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRP- 153
+ + I E+ MM + KH N++ LGAC + ++ E +LR+YL + RP
Sbjct: 61 DLS----DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP 116
Query: 154 -------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 200
+L ++ A +AR M+ L + IHRDL N+L+T D K
Sbjct: 117 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-K 175
Query: 201 LADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 257
+ADFGLAR + T +WMAPE + Y ++ DV+SFG++L
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLL 227
Query: 258 WELLTN-RLPFEGMSNLQ 274
WE+ T P+ G+ +
Sbjct: 228 WEIFTLGGSPYPGVPVEE 245
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 2e-41
Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 18/216 (8%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G G+ G+V ++ A+K+L++ + + + E ++ V
Sbjct: 45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE--HTLNEKRILQAVNFPF 102
Query: 120 LVKFLGACKDPLMVI-VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
LVK + KD + V E + G + +L R + A +A I + LH+
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQ 238
+I+RDLKP+NLL+ +++ DFG A+ GT +APE+ +
Sbjct: 161 DLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILS----- 212
Query: 239 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
K YN VD ++ G++++E+ PF +Q
Sbjct: 213 ---KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 8e-41
Identities = 51/227 (22%), Positives = 98/227 (43%), Gaps = 17/227 (7%)
Query: 62 IGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
KIGEG +G V++ + IVA+K + + + +RE+ ++ +KH N
Sbjct: 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKN 62
Query: 120 LVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+V+ + +V E + + + + +F + + + H+
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE--IVKSFLFQLLKGLGFCHSR 120
Query: 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLR 237
++HRDLKP NLL+ + + KLA+FGLAR + +AE T + P++
Sbjct: 121 NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG---- 175
Query: 238 QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQ 284
K Y+ +D++S G + EL P +++ F++
Sbjct: 176 ---AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (355), Expect = 1e-40
Identities = 51/230 (22%), Positives = 85/230 (36%), Gaps = 31/230 (13%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G KIG G+ G +Y G VAIK+ + + E + ++
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGV 63
Query: 120 LVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 177
+ + C + V+V ELL + K L L A + ++ +H+
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 178 NGIIHRDLKPDNLLLTPDQKSLKL--ADFGLAR--------EETVTEMMTAETGTYRWMA 227
IHRD+KPDN L+ +K + DFGLA+ + TGT R+ +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 228 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277
+ + + D+ S G VL LP++G+
Sbjct: 182 INTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 8e-40
Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 19/234 (8%)
Query: 62 IGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK 116
+ +G GA+GKV+ R ++ A+KVL + + + E E ++ ++
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE-HTRTERQVLEHIR 86
Query: 117 H-DNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 174
LV A + + ++ + + G L +L + + H + +I A++
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEIVLALEH 144
Query: 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMAPELYS 232
LH GII+RD+K +N+LL + + L DFGL++E TE GT +MAP++
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV- 202
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQES 286
+G ++ VD +S G++++ELLT PF + + ++ +S
Sbjct: 203 -----RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (347), Expect = 1e-39
Identities = 45/228 (19%), Positives = 87/228 (38%), Gaps = 31/228 (13%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-D 118
+G +IGEG+ G ++EG ++ VAIK R S + + E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-------LRDEYRTYKLLAGCT 61
Query: 119 NLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN 178
+ ++ L ++ L G SL L K + A + + +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 179 GIIHRDLKPDNLLLT----PDQKSLKLADFGLAR--------EETVTEMMTAETGTYRWM 226
+++RD+KPDN L+ + + + DFG+ + + +GT R+M
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
+ + + + + D+ + G V L LP++G+
Sbjct: 181 SINTH--------LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-39
Identities = 66/244 (27%), Positives = 108/244 (44%), Gaps = 41/244 (16%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSR 114
+G +G GA G+V E R VA+K+L G+T E + E+ ++
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR----ALMSELKILIH 72
Query: 115 VKHD-NLVKFLGACKDP--LMVIVTELLPGMSLRKYLVS--------------LRPNKLD 157
+ H N+V LGAC P ++++ E +L YL S L + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 158 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTE 214
L + ++ +A+ M+ L + IHRDL N+LL+ +K+ DFGLAR ++
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYV 191
Query: 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 273
+WMAPE + Y + DV+SFG++LWE+ + P+ G+
Sbjct: 192 RKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 274 QAAY 277
+
Sbjct: 244 EEFC 247
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 9e-39
Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 62 IGSKIGEGAHGKVYEGRYGD--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
+G GA+G V G VAIK L R S+ R RE+ ++ ++H+N
Sbjct: 22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMRHEN 78
Query: 120 LVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ L +V + + ++ KL + + +
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL----MKHEKLGEDRIQFLVYQMLKGL 134
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
+HA GIIHRDLKP NL + D + K+ DFGLAR+ MT T + APE+
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
Y VD++S G ++ E++T + F+G +L
Sbjct: 192 -------NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-37
Identities = 63/222 (28%), Positives = 94/222 (42%), Gaps = 26/222 (11%)
Query: 62 IGSKIGEGAHGKVYEGRYG--DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
IG GA G V DR VAIK L+R + A R RE+ +M V H N
Sbjct: 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVNHKN 77
Query: 120 LVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 172
++ L + +V EL+ + +LD + +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQMLCGI 132
Query: 173 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 232
LH+ GIIHRDLKP N+++ D K+ DFGLAR + MMT T + APE+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 233 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
Y VD++S G ++ E++ +++ F G +
Sbjct: 192 --------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-37
Identities = 67/221 (30%), Positives = 95/221 (42%), Gaps = 24/221 (10%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDN 119
S +G GA+G V VA+K L+R S A R RE+ ++ +KH+N
Sbjct: 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMKHEN 78
Query: 120 LVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 173
++ L V + L G L + + KL I R +
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFLIYQILRGLK 135
Query: 174 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 233
+H+ IIHRDLKP NL + LK+ DFGLAR + MT T + APE+
Sbjct: 136 YIHSADIIHRDLKPSNLA-VNEDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML- 191
Query: 234 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274
HYN VD++S G ++ ELLT R F G ++
Sbjct: 192 ------NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 4e-30
Identities = 44/226 (19%), Positives = 86/226 (38%), Gaps = 23/226 (10%)
Query: 62 IGSKIGEGAHGKVYEGR--YGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK--- 116
+ K+G G V+ + + VA+K++ E A E + ++ VN K
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 117 --HDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 170
++++K L + + V++ + G +L + + L + +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 171 AMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWM 226
+D +H GIIH D+KP+N+L+ L +A E T T +
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 227 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272
+PE+ + D++S +++EL+T FE
Sbjct: 197 SPEVLLG--------APWGCGADIWSTACLIFELITGDFLFEPDEG 234
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.9 bits (243), Expect = 2e-25
Identities = 33/199 (16%), Positives = 62/199 (31%), Gaps = 26/199 (13%)
Query: 62 IGSKIGEGAHGKVYEGRYGD-RIVAIKVLNRGSTSDE-----RALLEGRFIREVNMMSRV 115
IG +GEG V+ +K G TS + R + F +R
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 116 KHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 175
+ L K G + V L + + + ++ + I +
Sbjct: 64 EFRALQKLQGLA----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 176 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY--ST 233
+ GI+H DL N+L++ + + + DF + E E+
Sbjct: 120 YHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVE------------VGEEGWREILERDV 165
Query: 234 VTLRQGEKKHYNNKVDVYS 252
+ + Y + D+ S
Sbjct: 166 RNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 290 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.6 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.12 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.06 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.52 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.31 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.16 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=357.25 Aligned_cols=210 Identities=33% Similarity=0.469 Sum_probs=181.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||+||+|++ +++.||||++........ ..+.+|+.+++.++||||+++++++.+. ..++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK-----ELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCH-----HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHH-----HHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence 4699999999999999999986 589999999876544332 2478999999999999999999999754 7889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 95 vmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTT
T ss_pred EEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-CcEeeccchhheeecccc
Confidence 9999999999998875 469999999999999999999999999999999999999965 46999999999865433
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhc
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQ 284 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~ 284 (290)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~ 233 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSS--------SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred ccccccccCCCccChhhhcC--------CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence 33455679999999999865 6789999999999999999999999999988887777765543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=356.12 Aligned_cols=219 Identities=34% Similarity=0.584 Sum_probs=181.3
Q ss_pred cccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCce
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM 132 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 132 (290)
+.++.++|.+++.||+|+||+||+|++.+ .||||+++........ ...|.+|+.++++++||||+++++++.++..
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~ 78 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQ---LQAFKNEVGVLRKTRHVNILLFMGYSTAPQL 78 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTH---HHHHHHHHHHHTTCCCTTBCCEEEEECSSSC
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHH---HHHHHHHHHHHHhCCCCCEeeeeEEEeccEE
Confidence 45677889999999999999999998765 5999999765443322 1358899999999999999999999988889
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+++....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEEECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SSEEECCCCCSCC---
T ss_pred EEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CCEEEccccceeeccc
Confidence 999999999999999975 34579999999999999999999999999999999999999955 5699999999976432
Q ss_pred c---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 213 T---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 213 ~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
. .......||+.|||||++... ....++.++|||||||++|||+||+.||.+.+..........+
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~ 224 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQ-----DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH
T ss_pred cCCcccccccccCcccCCHHHHhcc-----cCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 2 233455799999999998541 1245789999999999999999999999998877766655544
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=355.53 Aligned_cols=209 Identities=29% Similarity=0.427 Sum_probs=173.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||+||+|++ +++.||||++......... .++.+|+.++++++||||+++++++.++ ..++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~----~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP----ENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHH----HHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 4699999999999999999987 5789999999765433322 3578999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 81 vmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCC
Confidence 9999999999999864 46799999999999999999999999999999999999999554 5999999999864322
Q ss_pred --ccccccCCCccccCccccccccccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 214 --EMMTAETGTYRWMAPELYSTVTLRQGEKKH-YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 214 --~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~-~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
......+||+.|||||++.+ .. ++.++|||||||++|+|++|+.||.+.+.....+....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~ 220 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKR--------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHC--------SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH
T ss_pred ccccccceeeCcCccCHhHhcC--------CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 23345689999999999864 33 46789999999999999999999988766544444433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=350.69 Aligned_cols=208 Identities=29% Similarity=0.501 Sum_probs=176.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||+||+|++ +++.||+|++.+...... .....+.+|+.+++.++||||+++++++.++ ..++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA--GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT--TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccCh--HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 4699999999999999999987 578999999864322111 1123578999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 84 vmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS- 159 (263)
T ss_dssp EEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCCC-
T ss_pred EEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCCC-
Confidence 9999999999999986 35799999999999999999999999999999999999999554 5999999999865433
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
......||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i 216 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216 (263)
T ss_dssp CCEETTEEGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cccccCCCCcccCHHHHcC--------CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 3345689999999999865 66899999999999999999999999997766554443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=355.04 Aligned_cols=216 Identities=30% Similarity=0.459 Sum_probs=182.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
+.|++++.||+|+||+||+|++ +++.||+|++........ ..+.+|+.++++++||||+++++++.+ ...++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~-----~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL-----EDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGG-----GGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHH-----HHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence 3589999999999999999987 578999999976544332 247799999999999999999999975 47889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 87 vmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHH
T ss_pred EEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCc
Confidence 99999999999998653 46799999999999999999999999999999999999999654 5999999999764332
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKV 283 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~ 283 (290)
.......||+.|+|||++... ......++.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~---~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~ 231 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCE---TSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE 231 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTC---STTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC
T ss_pred ccccccccccccCCHHHHhhc---ccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 233456899999999987541 1123568999999999999999999999999998888777766543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=346.91 Aligned_cols=212 Identities=32% Similarity=0.536 Sum_probs=178.7
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec----
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 129 (290)
+.+.|++.++||+|+||+||+|++ +++.||+|++......... ..++.+|++++++++||||+++++++.+
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE---RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHH---HHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence 334567888999999999999987 4678999998765543332 2358899999999999999999999853
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCEEEcCCCCceEEecccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGL 206 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~g--ivH~Dikp~Nili~~~~~~~kl~Dfg~ 206 (290)
...++||||+++++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.+++.+||+|||+
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred CCEEEEEEeCCCCCcHHHHHhc--cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 247899999999999999976 357999999999999999999999998 999999999999975556799999999
Q ss_pred cccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 207 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 207 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
++.... .......||+.|||||++. ..++.++|||||||++|+|++|+.||.+..+...+++...+
T Consensus 162 a~~~~~-~~~~~~~GT~~Y~aPE~~~---------~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~ 227 (270)
T d1t4ha_ 162 ATLKRA-SFAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227 (270)
T ss_dssp GGGCCT-TSBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred ceeccC-CccCCcccCccccCHHHhC---------CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc
Confidence 976433 2334568999999999874 35899999999999999999999999988877777665544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-51 Score=352.21 Aligned_cols=215 Identities=28% Similarity=0.421 Sum_probs=182.9
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
.|..++.||+|+||+||+|++ +++.||||++.......... ...+.+|+.++++++|||||++++++.++ ..++|
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK--WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHH--HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHH--HHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 499999999999999999987 57899999998765544332 24588999999999999999999999754 78899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccccc
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 215 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~ 215 (290)
|||+.+++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 94 ~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp EECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---
T ss_pred EEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-CCEEEeecccccccCC---
Confidence 999999999877655 4679999999999999999999999999999999999999954 5699999999986433
Q ss_pred ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhccc
Q 022903 216 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQES 286 (290)
Q Consensus 216 ~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~~~ 286 (290)
.....||+.|||||++.+. ....++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 168 ~~~~~GT~~Y~APE~~~~~-----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~ 233 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA 233 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTT-----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred CCccccCccccCHHHHhcc-----CCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 2456899999999998642 12568899999999999999999999999999888877776654433
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-52 Score=353.83 Aligned_cols=210 Identities=25% Similarity=0.440 Sum_probs=163.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|++++.||+|+||+||+|++ +++.||||++......... ..+.+|+.+++.++||||+++++++.++ ..++
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE----GSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHH----HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4499999999999999999987 5789999999876544322 3577999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC--CCCceEEecccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAREETV 212 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~--~~~~~kl~Dfg~~~~~~~ 212 (290)
||||++|++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+|||+.. +++.+||+|||+++....
T Consensus 85 vmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999999975 467999999999999999999999999999999999999953 345699999999987666
Q ss_pred cccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 213 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 213 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.......+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 223 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 223 (307)
T ss_dssp ----------CTTSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred CCeeeeeeeCccccCcHHHcC--------CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 666667789999999999865 6789999999999999999999999999877665554443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-52 Score=347.15 Aligned_cols=213 Identities=30% Similarity=0.432 Sum_probs=170.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec---Cce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD---PLM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 132 (290)
++|++++.||+|+||+||+|++ +++.||+|++......... ...+.+|+.++++++||||+++++++.+ ...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE---KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHH---HHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHH---HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 5699999999999999999987 5789999999876554332 2358899999999999999999998854 357
Q ss_pred EEEEEecCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeecCCCCCEEEcCCCCceEEeccc
Q 022903 133 VIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANG-----IIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~g-----ivH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG 159 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFG 159 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeecc
Confidence 8999999999999998642 2457999999999999999999999976 9999999999999955 469999999
Q ss_pred ccccccccc-cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 206 LAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 206 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
+++...... ......||+.|||||++.. ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~ 229 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG 229 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcC--------CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 998654332 3345689999999999864 67899999999999999999999999998877665555443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=352.98 Aligned_cols=211 Identities=27% Similarity=0.426 Sum_probs=175.7
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
+++|++++.||+|+||+||+|++ +++.||||++......... ....+.+|+.++++++||||+++++++.+. ..+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHH--HHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 45699999999999999999987 5789999998653221111 123578999999999999999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||++||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 85 ivmEy~~gg~L~~~~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPE 161 (288)
T ss_dssp EEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC--
T ss_pred EEEEccCCCCHHHhhhc--cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccC
Confidence 99999999999999876 35799999999999999999999999999999999999999554 5999999999864332
Q ss_pred ---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 214 ---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++.
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 223 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223 (288)
T ss_dssp --------CCCCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CcccccccccCCccccCceeecc--------CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH
Confidence 23345679999999999865 678999999999999999999999999977666554443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=356.57 Aligned_cols=203 Identities=25% Similarity=0.412 Sum_probs=174.1
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ce
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LM 132 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 132 (290)
..++|++++.||+|+||+||+|++ +++.||+|+++........ .++.+|+.+++.++|||||++++++.++ ..
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR----NQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHH----HHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHH----HHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456799999999999999999987 5789999999865443322 3578999999999999999999999765 68
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCEEEcCCCCceEEeccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 211 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~ 211 (290)
++||||++|++|.+++.. .+.+++..+..++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|||+++...
T Consensus 80 ~iVmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEEECCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHH
T ss_pred EEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-CCEEEeeCCCccccC
Confidence 899999999999999976 35799999999999999999999975 99999999999999955 469999999998643
Q ss_pred ccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 212 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 212 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
. ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+
T Consensus 157 ~-~~~~~~~GT~~Y~APEvl~~--------~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 157 D-SMANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp H-HTC---CCSSCCCCHHHHHC--------SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred C-CccccccCCccccCchHHcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 2 23346689999999999875 679999999999999999999999998876443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-51 Score=356.21 Aligned_cols=209 Identities=27% Similarity=0.412 Sum_probs=181.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|.+++.||+|+||.||+|++ +++.||||++....... ...+.+|+.+++.++||||+++++++.+. ..++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-----KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH-----HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh-----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3699999999999999999987 58899999997654322 13578999999999999999999998754 7889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC-CCceEEeccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVT 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~-~~~~kl~Dfg~~~~~~~~ 213 (290)
||||++||+|.+++.. ....+++..+..++.||+.||.|||++|++||||||+|||++.+ ++.+||+|||+++.....
T Consensus 101 vmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp EECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999999999864 34579999999999999999999999999999999999999643 457999999999876666
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.......||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 238 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHT--------CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccceecCcccccCHHHHcC--------CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 66667789999999999865 668899999999999999999999999988776665554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-51 Score=355.74 Aligned_cols=210 Identities=25% Similarity=0.411 Sum_probs=182.7
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
+.|++++.||+|+||.||+|++ +++.||||++........ ..+.+|+.+++.++||||+++++++.++ ..++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK-----YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHH-----HHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHH-----HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3599999999999999999987 579999999976543322 3577999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC-CCCceEEeccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP-DQKSLKLADFGLAREETVT 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~-~~~~~kl~Dfg~~~~~~~~ 213 (290)
||||++||+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++. +.+.+||+|||++......
T Consensus 104 vmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999999987764 3457999999999999999999999999999999999999973 3457999999999887666
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 242 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred CceeeccCcccccCHHHHcC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 66667789999999999865 6689999999999999999999999999888776655543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=345.51 Aligned_cols=215 Identities=33% Similarity=0.529 Sum_probs=180.5
Q ss_pred ccccccCCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 50 DRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 50 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
++.+.++.++|++++.||+|+||+||+|++. ++.||||+++...... ..+.+|+.++++++|||||++++++.
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~------~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP------DAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH------HHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 4556677788999999999999999999985 5789999997655443 24789999999999999999999998
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
++..++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 79 ~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla~ 157 (272)
T d1qpca_ 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLAR 157 (272)
T ss_dssp SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCE
T ss_pred cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccceE
Confidence 8888999999999999998765444569999999999999999999999999999999999999955 569999999998
Q ss_pred cccccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022903 209 EETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 209 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~ 279 (290)
...... ......||+.|||||++.. ..++.++|||||||++|||+| |.+||.+.+..+....+
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i 223 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred EccCCccccccccCCcccccChHHHhC--------CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 654332 2334578999999999864 568899999999999999999 55666666655544443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-51 Score=345.59 Aligned_cols=216 Identities=31% Similarity=0.493 Sum_probs=181.1
Q ss_pred ccccCCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
.+.++.++|++.+.||+|+||+||+|.+ +++.||||+++...... +.+.+|+.++++++||||+++++++.+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------EEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCH------HHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchH------HHHHHHHHHHHhCCCCCEecCCccEee
Confidence 4567788899999999999999999987 57899999997655443 247899999999999999999999975
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
+ ..++||||+++|+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG~a~ 163 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSR 163 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCCTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-CcEEEcccccee
Confidence 4 78899999999999999987667789999999999999999999999999999999999999955 469999999998
Q ss_pred ccccccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 209 EETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 209 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
....... .....|++.|+|||++.. ..++.++|||||||++|||++|..||....+....+.+..+
T Consensus 164 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~ 231 (287)
T d1opja_ 164 LMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231 (287)
T ss_dssp TCCSSSSEEETTEEECGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred ecCCCCceeeccccccccccChHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc
Confidence 6543322 223357889999999865 67899999999999999999966665554555555555443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=344.48 Aligned_cols=214 Identities=27% Similarity=0.552 Sum_probs=179.2
Q ss_pred cccCCCceeecc-eeccccceeEEEEEE----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 53 LLVDPKLLFIGS-KIGEGAHGKVYEGRY----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 53 ~~~~~~~~~~~~-~lG~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
+....++|.+.+ +||+|+||+||+|.+ ++..||||+++........ .++.+|+.++++++|||||++++++
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~----~~~~~E~~il~~l~HpnIv~l~g~~ 78 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT----EEMMREAQIMHQLDNPYIVRLIGVC 78 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHH----HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHH----HHHHHHHHHHHhCCCCCEeeEeeee
Confidence 345556788888 499999999999975 2347999999876544332 3588999999999999999999999
Q ss_pred ecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 128 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 128 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
.++..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 79 ~~~~~~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla 156 (285)
T d1u59a_ 79 QAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLS 156 (285)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTC
T ss_pred ccCeEEEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cceeeccchhh
Confidence 88889999999999999999865 34679999999999999999999999999999999999999954 56999999999
Q ss_pred ccccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 208 REETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 208 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
+...... ......||+.|+|||++.. ..++.++|||||||++|||+| |..||.+.+..+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~ 226 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 226 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH
T ss_pred hcccccccccccccccccCccccChHHHhC--------CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 8643322 2234468899999999864 568999999999999999998 999999988766554443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=353.01 Aligned_cols=208 Identities=25% Similarity=0.379 Sum_probs=177.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|.+++.||+|+||.||+|++ +++.||||++.+....... ...++.+|+.+|+.++||||+++++++.+. ..++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~--~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHH--HHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 4699999999999999999987 6899999999754321111 123577999999999999999999999876 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc-c
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-T 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~-~ 213 (290)
||||++||+|.+++.. ...+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 83 v~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred ceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccCC
Confidence 9999999999999886 45799999999999999999999999999999999999999664 599999999986433 3
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~--------~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~ 216 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cccccceeCHHHhhhhhccC--------CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH
Confidence 34456789999999999865 6789999999999999999999999999776554433
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=338.59 Aligned_cols=211 Identities=31% Similarity=0.580 Sum_probs=170.3
Q ss_pred cCCCceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-Cce
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLM 132 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 132 (290)
+++++|.+++.||+|+||+||+|++ +++.||||+++......+ .+.+|+.++++++||||+++++++.+ +..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~------~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~ 75 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE------DFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 75 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHH------HHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHH------HHHHHHHHHHhcCCCCcccccceeccCCce
Confidence 5678899999999999999999988 467899999987554432 47899999999999999999999864 478
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+|||++.+ +.+||+|||+++....
T Consensus 76 ~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLD 153 (263)
T ss_dssp EEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-GCEEECSCC-------
T ss_pred EEEEEecCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-CCeEecccchheeccC
Confidence 899999999999999876 34678999999999999999999999999999999999999955 4699999999976433
Q ss_pred ccc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022903 213 TEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 213 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~ 281 (290)
... .....||+.|+|||++.. ..++.++|||||||++|||+| |.+||.+.+..+....+..
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~ 217 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217 (263)
T ss_dssp -----------CTTSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH
T ss_pred CCceeecceecCcccCChHHhcC--------CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh
Confidence 322 233568999999999865 678999999999999999999 6777877776655555444
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-51 Score=345.04 Aligned_cols=213 Identities=24% Similarity=0.394 Sum_probs=181.6
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHH-HHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
++|++++.||+|+||+||+|++ +++.||||++......... ......+.+|+.++++++||||+++++++.+. ..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4599999999999999999987 5789999998764432211 00123578999999999999999999999765 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCC---ceEEecccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREE 210 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~---~~kl~Dfg~~~~~ 210 (290)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++.++. .+||+|||++...
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999763 57999999999999999999999999999999999999985543 5999999999876
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
..........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 168 ~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 229 (293)
T d1jksa_ 168 DFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 229 (293)
T ss_dssp TTSCBCSCCCCCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCccccccCCCCcccCHHHHcC--------CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 66666667789999999999864 668999999999999999999999999988776655443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.7e-51 Score=348.59 Aligned_cols=209 Identities=29% Similarity=0.449 Sum_probs=178.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||+||+|++ +++.||||+++........ ...++.+|+.+++.++||||+++++++.++ ..++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK--QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHH--HHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 4699999999999999999987 4789999998653221111 123578999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||++|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 vmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 82 IMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD-- 156 (316)
T ss_dssp EECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--
T ss_pred EeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEecc--
Confidence 9999999999999886 46788999999999999999999999999999999999999654 699999999987543
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.....+||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...++..
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~--------~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 215 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred ccccccCcccccCHHHHcC--------CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 3345689999999999864 6689999999999999999999999999887766655543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=340.00 Aligned_cols=209 Identities=27% Similarity=0.533 Sum_probs=169.9
Q ss_pred Cceeec-ceeccccceeEEEEEEC----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecCce
Q 022903 58 KLLFIG-SKIGEGAHGKVYEGRYG----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDPLM 132 (290)
Q Consensus 58 ~~~~~~-~~lG~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 132 (290)
+.+.+. ++||+|+||+||+|.+. ++.||||+++....... ...++.+|+.++++++||||+++++++.++..
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~ 82 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA---LKDELLAEANVMQQLDNPYIVRMIGICEAESW 82 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CH---HHHHHHHHHHHHHTCCCTTBCCEEEEEESSSE
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHH---HHHHHHHHHHHHHhCCCCCCceEEEEeccCCE
Confidence 334443 46999999999999752 36799999976543322 22468899999999999999999999988888
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 212 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~ 212 (290)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 83 ~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRA 159 (277)
T ss_dssp EEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Ccccccchhhhhhccc
Confidence 999999999999999986 4579999999999999999999999999999999999999954 5699999999975332
Q ss_pred cc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 022903 213 TE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 213 ~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~ 280 (290)
.. ......||+.|||||++.. ..++.++|||||||++|||++ |+.||.+.+..+....+.
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~ 224 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred cccccccccccCCCceecCchhhcC--------CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH
Confidence 21 2233468999999998865 567899999999999999998 999999988776554443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=347.40 Aligned_cols=223 Identities=33% Similarity=0.493 Sum_probs=180.6
Q ss_pred ccccccccCCCceeecceeccccceeEEEEEEC--C-----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCC
Q 022903 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG--D-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDN 119 (290)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~--~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 119 (290)
..+..+.++.++|.+++.||+|+||+||+|++. + ..||+|.+......... ..+.+|+.++.++ +|||
T Consensus 27 ~~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~~Hpn 102 (325)
T d1rjba_ 27 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER----EALMSELKMMTQLGSHEN 102 (325)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------C----HHHHHHHHHHHHHCCCTT
T ss_pred CCCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHH----HHHHHHHHHHHHhcCCCc
Confidence 344455677788999999999999999999863 2 36999998765433322 3578999999998 8999
Q ss_pred ceeEEeeeecC-ceEEEEEecCCCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 022903 120 LVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP---------------------NKLDLHVALNFALDIARAMDCLHA 177 (290)
Q Consensus 120 iv~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~i~~qi~~~l~~lH~ 177 (290)
||++++++.+. ..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+
T Consensus 103 Iv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~ 182 (325)
T d1rjba_ 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 182 (325)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred EeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999999754 68899999999999999976432 348899999999999999999999
Q ss_pred CCCeeecCCCCCEEEcCCCCceEEeccccccccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHH
Q 022903 178 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 254 (290)
Q Consensus 178 ~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG 254 (290)
+||+||||||+|||++.+ +.+||+|||+++....... .....||+.|||||++.. ..++.++||||||
T Consensus 183 ~~IiHRDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DiwS~G 253 (325)
T d1rjba_ 183 KSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSYG 253 (325)
T ss_dssp TTEEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHH
T ss_pred CCeeeccCchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--------CCCCcceeccchh
Confidence 999999999999999955 5699999999976433322 223457999999998865 6789999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHHHhh
Q 022903 255 IVLWELLT-NRLPFEGMSNLQAAYAAAFKV 283 (290)
Q Consensus 255 ~~l~~~l~-g~~Pf~~~~~~~~~~~~~~~~ 283 (290)
|++|||++ |..||.+.+..+...++..+.
T Consensus 254 vil~emlt~g~~Pf~~~~~~~~~~~~~~~~ 283 (325)
T d1rjba_ 254 ILLWEIFSLGVNPYPGIPVDANFYKLIQNG 283 (325)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHTT
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 99999998 999999988777777665543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-50 Score=340.68 Aligned_cols=214 Identities=29% Similarity=0.487 Sum_probs=170.1
Q ss_pred cCCCceeecceeccccceeEEEEEEC--C---ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--D---RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD 129 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 129 (290)
++.+.|++.+.||+|+||+||+|++. + ..||||.+......... .+|.+|+.+|++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR----RDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHH----HHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHH----HHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 34567999999999999999999873 2 25899998766554433 358899999999999999999999965
Q ss_pred C-ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 P-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
+ ..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++|++||||||+|||++.+ +++||+|||+++
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGLSR 176 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC----
T ss_pred CCEEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-CcEEECCcccce
Confidence 4 78899999999999998875 34579999999999999999999999999999999999999955 569999999997
Q ss_pred ccccccc------ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022903 209 EETVTEM------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 209 ~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~ 281 (290)
....... .....+|+.|||||.+.. ..++.++|||||||++|||+| |..||.+.+..+....+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~ 248 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248 (299)
T ss_dssp -------------------CGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhc--------CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 6433221 112357899999998864 678999999999999999998 8999999988776665544
Q ss_pred h
Q 022903 282 K 282 (290)
Q Consensus 282 ~ 282 (290)
.
T Consensus 249 ~ 249 (299)
T d1jpaa_ 249 D 249 (299)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.3e-49 Score=333.29 Aligned_cols=219 Identities=23% Similarity=0.368 Sum_probs=185.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCCh----hHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeecC
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTS----DERALLEGRFIREVNMMSRVK-HDNLVKFLGACKDP 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 130 (290)
++|++++.||+|+||+||+|++ +++.||||++...... ........++.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999987 6799999998765432 223334557889999999997 99999999999865
Q ss_pred -ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 131 -LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 131 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
..++||||+++++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.+ +.+||+|||+++.
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~ 159 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQ 159 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred cceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-CCeEEccchheeE
Confidence 67899999999999999976 3579999999999999999999999999999999999999955 4599999999987
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
...........||+.|+|||.+.+... .....++.++||||+||++|+|++|+.||.+.+..+....+..
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~--~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCCceeeeeccCCCCCHHHhhcccc--ccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence 665555566789999999999865221 1234578899999999999999999999999887765555544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=332.30 Aligned_cols=210 Identities=30% Similarity=0.577 Sum_probs=180.1
Q ss_pred CCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
++++|++++.||+|+||+||+|++. ++.||||+++......+ .+.+|+.++++++||||+++++++.++ ..+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~------~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED------EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHH------HHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHH------HHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence 5678999999999999999999984 56899999987655432 378999999999999999999999754 788
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++|+|.+++.. ....+++..+..++.|++.||.|||++||+||||||+|||++.+ ..+||+|||+++.....
T Consensus 76 iv~Ey~~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 76 IITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EEEECCTTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSS
T ss_pred EEEEccCCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-CcEEECcchhheeccCC
Confidence 99999999999999765 34678999999999999999999999999999999999999955 46999999999754333
Q ss_pred cc--ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHH
Q 022903 214 EM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 214 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~ 281 (290)
.. .....+|+.|+|||.+.. ..++.++||||||+++|||+| |+.||.+.+..+....+..
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~--------~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~ 216 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred CceeecccCCCCCcCCcHHhcC--------CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh
Confidence 22 223568999999999865 678999999999999999998 8999999998776655543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-50 Score=348.21 Aligned_cols=209 Identities=24% Similarity=0.341 Sum_probs=177.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||.||+|++ +++.||||++......... ...++.+|+.+++.++||||+++++++.+. ..++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~--~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK--QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTT--CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHH--HHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 4699999999999999999987 5889999998643221111 113578999999999999999999999765 6789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+.+++|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 119 v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS--
T ss_pred ccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeeccc--
Confidence 99999999999999763 5799999999999999999999999999999999999999654 699999999987543
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
......||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 252 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252 (350)
T ss_dssp CBCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccccCccccCCHHHHcC--------CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc
Confidence 2345679999999999865 6689999999999999999999999999877666555543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=341.51 Aligned_cols=208 Identities=19% Similarity=0.351 Sum_probs=179.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-CceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD-PLMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l 134 (290)
++|.+++.||+|+||+||+|.+ +++.||+|+++...... ..+.+|+.+|+.++||||+++++++.+ ...++
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~------~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ------VLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH------HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH------HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 4599999999999999999987 57899999997654322 247799999999999999999999975 47889
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC-CCceEEeccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVT 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~-~~~~kl~Dfg~~~~~~~~ 213 (290)
||||++|++|.+++.. ....+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||++......
T Consensus 79 vmE~~~gg~L~~~i~~-~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp EECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999999999975 34579999999999999999999999999999999999999854 346999999999876655
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.......+|+.|+|||.+.. ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 158 ~~~~~~~~t~~y~ape~~~~--------~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~ 216 (321)
T d1tkia_ 158 DNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp CEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CcccccccccccccchhccC--------CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 55566689999999998764 568899999999999999999999999988766655543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-49 Score=334.09 Aligned_cols=212 Identities=31% Similarity=0.464 Sum_probs=174.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-----
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 130 (290)
++|++.+.||+|+||.||+|++ +++.||||+++......... ..++.+|+.+++.++||||+++++++.+.
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~--~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSF--YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHH--HHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHH--HHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 4599999999999999999987 58899999998765543332 24688999999999999999999988532
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||++|++|.+++... +.+++..++.++.||+.||.|||++|++||||||+|||++.++ .++|+|||.+...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhhhhhh
Confidence 378999999999999998763 5799999999999999999999999999999999999999554 5999999988643
Q ss_pred ccc----ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Q 022903 211 TVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 211 ~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~ 282 (290)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+...++...
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~ 229 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229 (277)
T ss_dssp C----------------TTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred ccccccccccccccCcccccCHHHHcC--------CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc
Confidence 222 23345579999999999864 66899999999999999999999999999888877776654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=332.76 Aligned_cols=215 Identities=29% Similarity=0.505 Sum_probs=172.3
Q ss_pred ccCCCceeecceeccccceeEEEEEEC-----CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG-----DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
.++.++|.+++.||+|+||.||+|++. +..||||.++........ ..+.+|+.++++++||||+++++++.
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~----~~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR----EKFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHH----HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHH----HHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 355678999999999999999999873 246889988765544332 35889999999999999999999998
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
++..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||++|++||||||+||+++.+ +.+||+|||+++
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSR 156 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC-----
T ss_pred cCeEEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchhhe
Confidence 8889999999999999998775 45679999999999999999999999999999999999999954 569999999998
Q ss_pred cccccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022903 209 EETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 209 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~~ 282 (290)
...... ......||+.|+|||++.. ..++.++|||||||++|||++ |.+||.+.+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~--------~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~ 225 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 225 (273)
T ss_dssp --------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred eccCCcceeccceecCcccchhhHhcc--------CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 643322 2334568899999999865 678999999999999999998 99999998887766555443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=334.26 Aligned_cols=215 Identities=32% Similarity=0.485 Sum_probs=175.0
Q ss_pred ccccCCCceeecceeccccceeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC
Q 022903 52 SLLVDPKLLFIGSKIGEGAHGKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP 130 (290)
Q Consensus 52 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 130 (290)
.+.++.++|++.+.||+|+||.||+|++. ++.||||+++...... ..|.+|+.++++++|||||++++++.+.
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~------~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP------EAFLQEAQVMKKLRHEKLVQLYAVVSEE 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH------HHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH------HHHHHHHHHHHhcccCCEeEEEEEEecC
Confidence 44566778999999999999999999884 4679999997655433 2478999999999999999999999888
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+++|+|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.+ +++||+|||+++..
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~ 163 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLI 163 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC--
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhhc
Confidence 89999999999999999876555679999999999999999999999999999999999999954 56999999999754
Q ss_pred cccc--cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHH
Q 022903 211 TVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 211 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g-~~Pf~~~~~~~~~~~~~~ 281 (290)
.... ......||+.|+|||.+.. ..++.++||||||+++|||++| .+||.+....+....+..
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~ 229 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229 (285)
T ss_dssp ------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred cCCCceeeccccccccccChHHHhC--------CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 3222 2234578999999999865 6789999999999999999995 555666665555544443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=339.34 Aligned_cols=211 Identities=29% Similarity=0.479 Sum_probs=175.3
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHh-hcCCCCceeEEeeeecC-ceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMS-RVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~-~~~ 133 (290)
++|.+++.||+|+||+||+|++ +++.||||++++........ ...+.+|..++. .++||||+++++++.++ ..+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~--~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD--VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTC--HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHH--HHHHHHHHHHHHHhCCCCcEEEEEEEEccCCcee
Confidence 4699999999999999999988 68999999997532111111 123556666654 68999999999999765 688
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.+ +.+||+|||+++.....
T Consensus 80 ivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred EEEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-Cceeccccchhhhcccc
Confidence 99999999999999986 3578999999999999999999999999999999999999955 46999999999864433
Q ss_pred -ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 214 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 214 -~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 217 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccccCCCCCcCCHHHHcC--------CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 33345689999999999875 6789999999999999999999999999887766555543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=344.89 Aligned_cols=199 Identities=29% Similarity=0.429 Sum_probs=170.4
Q ss_pred ceeecc-eeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeeec-----
Q 022903 59 LLFIGS-KIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACKD----- 129 (290)
Q Consensus 59 ~~~~~~-~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----- 129 (290)
+|.++. .||+|+||.||+|++ +++.||||+++.. ..+.+|+.++.++ +||||+++++++++
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 588775 599999999999987 5789999998642 1356899887655 79999999999864
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--CCceEEeccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLA 207 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~~~~kl~Dfg~~ 207 (290)
...++|||||+||+|.+++.......+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||++
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 357899999999999999987555679999999999999999999999999999999999999853 346999999999
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 275 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~ 275 (290)
+............||+.|||||++.+ ..++.++|||||||++|+|++|+.||.+.+....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~ 221 (335)
T d2ozaa1 162 KETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221 (335)
T ss_dssp EECCCCCCCCCCSCCCSSCCCCCCCG--------GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred eeccCCCccccccCCcccCCcHHHcC--------CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence 87666666667789999999999865 5689999999999999999999999988655433
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-49 Score=344.40 Aligned_cols=204 Identities=25% Similarity=0.363 Sum_probs=168.8
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHH-HHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDER-ALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~ 133 (290)
++|.+++.||+|+||.||+|++ +++.||||++.+....... .....+..+++.+++.++||||+++++++.+. ..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 4699999999999999999987 5789999998643321111 11111233457778888899999999999765 688
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 213 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~ 213 (290)
+||||++|++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||+++.....
T Consensus 84 ivmE~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHh--cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecCCC
Confidence 99999999999999976 35789999999999999999999999999999999999999554 5999999999865433
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
......||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+.
T Consensus 161 -~~~~~~GT~~y~APE~~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred -cccccccccccchhHHhhc-------CCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 3345689999999999853 25689999999999999999999999987643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=336.48 Aligned_cols=209 Identities=29% Similarity=0.385 Sum_probs=169.4
Q ss_pred cceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEEEEec
Q 022903 63 GSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
++.||+|+||+||+|++ +++.||||+++.............++.+|+.+++.++||||+++++++.+. ..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999987 578999999976554433333334688999999999999999999999754 788999999
Q ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-ccccc
Q 022903 140 PGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTA 218 (290)
Q Consensus 140 ~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 218 (290)
.++++..+.. ....+++..+..++.||+.||+|||++|++||||||+|||++.+ +.+||+|||+++..... .....
T Consensus 83 ~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 83 ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp SEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCCC
T ss_pred cchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-CccccccCccccccCCCcccccc
Confidence 8877665543 35679999999999999999999999999999999999999955 46999999999764433 23345
Q ss_pred cCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 219 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 219 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
..||+.|+|||++.. ...++.++|||||||++|+|++|.+||.+.++.+....+..
T Consensus 160 ~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~ 215 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215 (299)
T ss_dssp SCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eecChhhccHHHHcc-------CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHH
Confidence 679999999998754 25679999999999999999999999999998887776654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=327.00 Aligned_cols=211 Identities=31% Similarity=0.519 Sum_probs=167.5
Q ss_pred cCCCceeecceeccccceeEEEEEECC------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYGD------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
++++.|.+.+.||+|+||.||+|.+.+ ..||||++......... ..+.+|+.++++++|||||++++++.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~----~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR----VDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHH----HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHH----HHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 455678999999999999999997632 36999999765554432 35889999999999999999999996
Q ss_pred c-CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 129 D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 129 ~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
+ ...++||||+.++++.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.+ +.+||+|||++
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla 157 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLS 157 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC-
T ss_pred cCCceEEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-CeEEEcccchh
Confidence 5 477899999999999998876 45679999999999999999999999999999999999999955 56999999999
Q ss_pred ccccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHH
Q 022903 208 REETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAA 279 (290)
Q Consensus 208 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g-~~Pf~~~~~~~~~~~~ 279 (290)
+...... ......||+.|||||++.. ..++.++|||||||++|||++| .+||.+.+..+....+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i 226 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 226 (283)
T ss_dssp ----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH
T ss_pred hcccCCCccceEeccCCCCccccCHHHHcc--------CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH
Confidence 7643321 1223468999999998864 6789999999999999999995 5555555555444333
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=328.21 Aligned_cols=212 Identities=33% Similarity=0.562 Sum_probs=174.4
Q ss_pred cccCCCceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec--C
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--P 130 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 130 (290)
+.++.++|++++.||+|+||.||+|+++++.||||+++..... +.+.+|+.++++++||||+++++++.+ .
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~-------~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA-------QAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC---------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHH-------HHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4456778999999999999999999999999999999765432 247899999999999999999998853 3
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..++||||+++|+|.+++.......+++..++.++.||+.||.|||+++++||||||+|||++.+ +.+||+|||+++..
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA 153 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-CCEeecccccceec
Confidence 57899999999999999976544568999999999999999999999999999999999999955 46999999999864
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~~ 282 (290)
... .....++..|+|||.+.. ..++.++||||||+++|||+| |++||.+.+..+....+...
T Consensus 154 ~~~--~~~~~~~~~y~aPE~l~~--------~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~ 216 (262)
T d1byga_ 154 SST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 216 (262)
T ss_dssp ----------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred CCC--CccccccccCCChHHHhC--------CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 332 334568899999999864 678999999999999999998 89999998777666555443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=331.16 Aligned_cols=217 Identities=33% Similarity=0.523 Sum_probs=172.0
Q ss_pred ccCCCceeecceeccccceeEEEEEEC---C--ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRYG---D--RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
.++.++|++++.||+|+||.||+|++. + ..||||++......... ...+|.+|+.++++++||||+++++++.
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~--~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE--AMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CH--HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHH--HHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 456788999999999999999999762 2 36899998765543322 2246889999999999999999999998
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
++..++||||++++++.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++.+ ..+||+|||+++
T Consensus 82 ~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~~ 159 (273)
T d1u46a_ 82 TPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMR 159 (273)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCE
T ss_pred ecchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhhh
Confidence 88889999999999999988763 4579999999999999999999999999999999999999955 469999999998
Q ss_pred cccccc----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHh
Q 022903 209 EETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 209 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~~ 282 (290)
...... ......++..|+|||++.. ..++.++||||||+++|||+| |..||.+.+..+....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred hcccCCCcceecCccccCcccCCHHHHhC--------CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC
Confidence 643322 2233457889999999865 568899999999999999998 89999999888877666544
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=333.37 Aligned_cols=208 Identities=27% Similarity=0.528 Sum_probs=171.5
Q ss_pred cCCCceeecceeccccceeEEEEEEC--Cc----eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG--DR----IVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACK 128 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 128 (290)
+...+|++++.||+|+||+||+|++. ++ .||+|.+........ ...+.+|+.++++++||||+++++++.
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA----NKEILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CT----HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34467999999999999999999873 33 588998865433222 235889999999999999999999999
Q ss_pred cCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 129 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 129 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
++..+++++++.+++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 82 ~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~~kl~DFGla~ 159 (317)
T d1xkka_ 82 TSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAK 159 (317)
T ss_dssp SSSEEEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCCSHHH
T ss_pred cCCeeEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CCeEeeccccce
Confidence 8888999999999999998876 45679999999999999999999999999999999999999954 569999999998
Q ss_pred ccccccc---ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 022903 209 EETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 209 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~-g~~Pf~~~~~~~~~ 276 (290)
....... .....||+.|+|||++.. ..++.++|||||||++|||+| |.+||.+.+..+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~ 223 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH
T ss_pred ecccccccccccccccCccccChHHHhc--------CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 6433222 233468999999998865 678999999999999999998 89999998766543
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=329.57 Aligned_cols=212 Identities=30% Similarity=0.503 Sum_probs=175.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||+||+|++ +++.||||+++....... ...++.+|+.++++++||||+++++++.++ ..++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~---~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG---VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC----------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChH---HHHHHHHHHHHHHhCCCCcEEEeccccccccceeE
Confidence 4699999999999999999987 478999999965443221 123578999999999999999999999765 7789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccccccc-
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT- 213 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~- 213 (290)
||||+.+ ++..++.......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 79 v~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 79 VFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCS
T ss_pred EEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCc
Confidence 9999954 666666655667899999999999999999999999999999999999999654 6999999999764332
Q ss_pred ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 214 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 214 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
.......||+.|+|||.+.. ...++.++|||||||++|+|++|+.||.+.+..+..+.+..
T Consensus 157 ~~~~~~~gt~~y~apE~~~~-------~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccceeecccceeeehhhhcc-------ccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 33345579999999998754 24468899999999999999999999999988877776643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=324.90 Aligned_cols=233 Identities=33% Similarity=0.478 Sum_probs=193.9
Q ss_pred CCccCcccccccccccCCCceeecceeccccceeEEEEEE-------CCceEEEEEcccCCChhHHHHHHHHHHHHHHHH
Q 022903 40 GSITAPQLTIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRY-------GDRIVAIKVLNRGSTSDERALLEGRFIREVNMM 112 (290)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l 112 (290)
+...+.++..+..+.++.++|.+++.||+|+||.||+|++ .++.||||+++........ ..+.+|+.++
T Consensus 5 ~~~~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~E~~~~ 80 (311)
T d1t46a_ 5 VYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER----EALMSELKVL 80 (311)
T ss_dssp CCCCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHH----HHHHHHHHHH
T ss_pred eeeCcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHH----HHHHHHHHHH
Confidence 4566777888888888889999999999999999999975 2368999999876654433 3588999999
Q ss_pred hhc-CCCCceeEEeeeecC-ceEEEEEecCCCCHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHH
Q 022903 113 SRV-KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR----------------PNKLDLHVALNFALDIARAMDC 174 (290)
Q Consensus 113 ~~l-~h~~iv~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~i~~qi~~~l~~ 174 (290)
+.+ +||||+++++++.+. ..++||||+++++|.+++.... ...+++..+..++.||+.||.|
T Consensus 81 ~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~ 160 (311)
T d1t46a_ 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160 (311)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 999 699999999999765 6789999999999999997643 2258899999999999999999
Q ss_pred HHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhH
Q 022903 175 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 251 (290)
Q Consensus 175 lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~Diw 251 (290)
||++|++||||||+||+++.+ +.++|+|||+++...... ......||+.|+|||.+.. ..++.++|||
T Consensus 161 LH~~~ivHrDLKp~NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DIw 231 (311)
T d1t46a_ 161 LASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVW 231 (311)
T ss_dssp HHHTTCCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHH
T ss_pred HHhCCeeeccccccccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--------CCCCCccccc
Confidence 999999999999999999955 569999999998643322 2233468999999999865 6789999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHhhcc
Q 022903 252 SFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKVQE 285 (290)
Q Consensus 252 slG~~l~~~l~-g~~Pf~~~~~~~~~~~~~~~~~~ 285 (290)
|||+++|||+| |.+||.+.+..+...++..+..+
T Consensus 232 S~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~ 266 (311)
T d1t46a_ 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266 (311)
T ss_dssp HHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC
T ss_pred chHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 99999999998 78888888777777776655443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=326.55 Aligned_cols=212 Identities=28% Similarity=0.417 Sum_probs=174.3
Q ss_pred CCceeecceeccccceeEEEEEEC---CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc---CCCCceeEEeeeec-
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRYG---DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV---KHDNLVKFLGACKD- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~- 129 (290)
.++|++++.||+|+||+||+|++. ++.||||+++......... ..+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB---CTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH---HHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 357999999999999999999873 5679999986543222110 1244677776665 79999999998842
Q ss_pred -----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 130 -----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 130 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
...+++|||++++.+.... ......+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~df 160 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADF 160 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSC
T ss_pred ccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecch
Confidence 3578999999876665443 34567899999999999999999999999999999999999999554 5999999
Q ss_pred cccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 205 GLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 205 g~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
|++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~--------~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcC--------CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 99987666666677899999999999865 6789999999999999999999999999988877766644
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=323.14 Aligned_cols=217 Identities=31% Similarity=0.528 Sum_probs=167.6
Q ss_pred cccCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEE
Q 022903 53 LLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFL 124 (290)
Q Consensus 53 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 124 (290)
+.+..++|++++.||+|+||.||+|++. ++.||||+++........ ..+.+|..++.++ +|+||+.++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~----~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH----RALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHH----HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHH----HHHHHHHHHHHhhcCCCeEEEee
Confidence 3355678999999999999999999762 368999999765554433 2467788888777 689999999
Q ss_pred eeeecC--ceEEEEEecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q 022903 125 GACKDP--LMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 188 (290)
Q Consensus 125 ~~~~~~--~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~ 188 (290)
+++.+. ..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 987543 5789999999999999997532 235889999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC-C
Q 022903 189 NLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-R 264 (290)
Q Consensus 189 Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g-~ 264 (290)
|||++.+ +.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|||++| .
T Consensus 164 NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gvil~ellt~~~ 234 (299)
T d1ywna1 164 NILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGA 234 (299)
T ss_dssp GEEECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ceeECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhc--------CCCCcccceeehHHHHHHHHhCCC
Confidence 9999954 469999999997533222 2334578999999999865 6789999999999999999985 6
Q ss_pred CCCCCCCHHHHHHHHHHh
Q 022903 265 LPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 265 ~Pf~~~~~~~~~~~~~~~ 282 (290)
+||.+.+..+....+..+
T Consensus 235 ~p~~~~~~~~~~~~~~~~ 252 (299)
T d1ywna1 235 SPYPGVKIDEEFCRRLKE 252 (299)
T ss_dssp CSSTTCCCSHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhc
Confidence 789988766665555444
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-47 Score=322.85 Aligned_cols=215 Identities=30% Similarity=0.511 Sum_probs=177.5
Q ss_pred cCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeee
Q 022903 55 VDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGAC 127 (290)
Q Consensus 55 ~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 127 (290)
...++|.+++.||+|+||+||+|++. ++.||||++......... .++.+|+.+++.++||||+++++++
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ----ADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHH----HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHH----HHHHHHHHHHHhcCCCCcccceeee
Confidence 34567999999999999999999863 368999999876554332 3688999999999999999999998
Q ss_pred ecC-ceEEEEEecCCCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeec
Q 022903 128 KDP-LMVIVTELLPGMSLRKYLVSLR----------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRD 184 (290)
Q Consensus 128 ~~~-~~~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~D 184 (290)
.+. ..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||++|+||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 654 7889999999999999997532 22478889999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccccccccccc---ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHH
Q 022903 185 LKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 261 (290)
Q Consensus 185 ikp~Nili~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l 261 (290)
|||+|||++.+ +.+||+|||+++..... .......+++.|+|||.+.. ..++.++|||||||++|||+
T Consensus 166 lKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~t~ksDVwS~Gvvl~ell 236 (301)
T d1lufa_ 166 LATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIF 236 (301)
T ss_dssp CSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHH
T ss_pred EcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--------CCCChhhhhccchhhHHHHH
Confidence 99999999955 56999999998753222 22234568899999999865 67899999999999999999
Q ss_pred hCC-CCCCCCCHHHHHHHHHHh
Q 022903 262 TNR-LPFEGMSNLQAAYAAAFK 282 (290)
Q Consensus 262 ~g~-~Pf~~~~~~~~~~~~~~~ 282 (290)
+|. +||.+.+..+....+...
T Consensus 237 ~~~~~p~~~~~~~e~~~~v~~~ 258 (301)
T d1lufa_ 237 SYGLQPYYGMAHEEVIYYVRDG 258 (301)
T ss_dssp TTTCCTTTTSCHHHHHHHHHTT
T ss_pred ccCCCCCCCCCHHHHHHHHHcC
Confidence 985 789998888776665544
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=321.06 Aligned_cols=215 Identities=33% Similarity=0.569 Sum_probs=174.9
Q ss_pred cccccccCCCceeecceeccccceeEEEEEECC---------ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCC
Q 022903 49 IDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYGD---------RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHD 118 (290)
Q Consensus 49 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ 118 (290)
.+..+.++.++|.+++.||+|+||.||+|++.+ ..||||+++........ ..+.+|...+.++ +||
T Consensus 4 ~~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~----~~~~~e~~~l~~~~~Hp 79 (299)
T d1fgka_ 4 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL----SDLISEMEMMKMIGKHK 79 (299)
T ss_dssp CCTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHH----HHHHHHHHHHHHHCCCT
T ss_pred cCCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHH----HHHHHHHHHHHHhcCCC
Confidence 344566778899999999999999999997522 36999999876654443 3477888888888 799
Q ss_pred CceeEEeeeecC-ceEEEEEecCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeee
Q 022903 119 NLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGIIHR 183 (290)
Q Consensus 119 ~iv~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~ 183 (290)
||+++++++.++ ..++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++|+|||
T Consensus 80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr 159 (299)
T d1fgka_ 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159 (299)
T ss_dssp TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence 999999999754 6889999999999999997643 2458999999999999999999999999999
Q ss_pred cCCCCCEEEcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHH
Q 022903 184 DLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 260 (290)
Q Consensus 184 Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~ 260 (290)
||||+|||++.++ .+||+|||++....... ......+++.|+|||.+.. ..++.++||||||+++|||
T Consensus 160 DiKp~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--------~~y~~k~DiwS~Gvvl~el 230 (299)
T d1fgka_ 160 DLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEI 230 (299)
T ss_dssp CCSGGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred eecccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC--------CCCCchhhhHHhHHHHHHh
Confidence 9999999999654 59999999998643332 2334578999999998865 6799999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHH
Q 022903 261 LT-NRLPFEGMSNLQAA 276 (290)
Q Consensus 261 l~-g~~Pf~~~~~~~~~ 276 (290)
++ |.+||.+.+..+..
T Consensus 231 l~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 231 FTLGGSPYPGVPVEELF 247 (299)
T ss_dssp HTTSCCSSTTCCHHHHH
T ss_pred ccCCCCCCCCCCHHHHH
Confidence 98 79999987776543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=326.31 Aligned_cols=203 Identities=26% Similarity=0.417 Sum_probs=167.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHH-HHHHHHHHHHHHHhhcC--CCCceeEEeeeecC-c
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERA-LLEGRFIREVNMMSRVK--HDNLVKFLGACKDP-L 131 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~-~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~-~ 131 (290)
++|++++.||+|+||+||+|++ +++.||||++.......... ....++.+|+.++++++ ||||+++++++.++ .
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4699999999999999999987 57899999987543221000 00012568999999986 89999999999765 6
Q ss_pred eEEEEEecCC-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 132 MVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 132 ~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
.++||||+.+ +++.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+++.+||+|||+++..
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 7899999976 578888876 3579999999999999999999999999999999999999977677999999999764
Q ss_pred cccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 022903 211 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 270 (290)
Q Consensus 211 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~ 270 (290)
.. .......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cc-ccccccccCCCcCCHHHHcC-------CCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 33 23456689999999998864 133467899999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=327.46 Aligned_cols=207 Identities=29% Similarity=0.387 Sum_probs=174.5
Q ss_pred ceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-------
Q 022903 59 LLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------- 129 (290)
Q Consensus 59 ~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 129 (290)
+|+.++.||+|+||+||+|++ +++.||||++...... ..+|+.++++++||||+++++++..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 589999999999999999998 5789999999765432 3479999999999999999998842
Q ss_pred CceEEEEEecCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
...++||||++++.+..+... .....+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||++.
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 136899999976544433321 2356799999999999999999999999999999999999999777679999999998
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 281 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~ 281 (290)
............||+.|+|||.+.. ...++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~ 237 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred hccCCcccccccccccccChHHhhc-------ccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHH
Confidence 7666666667789999999998754 25689999999999999999999999999988777766643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.3e-47 Score=320.18 Aligned_cols=210 Identities=29% Similarity=0.418 Sum_probs=172.2
Q ss_pred CceeecceeccccceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVIV 135 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~lv 135 (290)
++|+++++||+|+||+||+|++ +++.||||++......... ..++.+|+.++++++||||+++++++.+. ..+++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGI---PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCC---CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHH---HHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 4699999999999999999987 5689999999765433211 13578999999999999999999999765 67899
Q ss_pred EEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc-
Q 022903 136 TELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 214 (290)
Q Consensus 136 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~- 214 (290)
|+++.++.+..+.. ..+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||.+.......
T Consensus 79 ~e~~~~~~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EECCSEEHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---
T ss_pred EEeehhhhHHHHHh--hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCcc
Confidence 99997766666554 357899999999999999999999999999999999999999654 59999999997643332
Q ss_pred cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 215 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 215 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
......+++.|+|||.+.. ...++.++|||||||++|+|++|+.||.+.+..+...++.
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-------~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~ 214 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214 (286)
T ss_dssp ------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccceecccchhhhHHHHhC-------CCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 2344468999999998864 2457899999999999999999999999988877766654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=322.14 Aligned_cols=207 Identities=32% Similarity=0.437 Sum_probs=170.1
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-----
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP----- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 130 (290)
.+|++++.||+|+||+||+|++ +++.||||++......... .++.+|+.+|+.++||||+++++++...
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~----~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC----QRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHH----HHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHH----HHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 4699999999999999999987 5899999999765543322 3578999999999999999999998543
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..+++++++.+++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~-~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVA 159 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred ceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC-CCEEEcccCceeec
Confidence 24566677779999999975 469999999999999999999999999999999999999955 46999999999764
Q ss_pred ccccc----ccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022903 211 TVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 279 (290)
Q Consensus 211 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~ 279 (290)
..... .....||+.|+|||++.. ...++.++||||+||++|+|++|+.||.+.+..+.....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~ 225 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTT-------BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCccceeeccccccceechHHHhhc-------CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH
Confidence 33322 344578999999998754 356789999999999999999999999998776555444
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-46 Score=318.22 Aligned_cols=221 Identities=31% Similarity=0.509 Sum_probs=183.0
Q ss_pred ccccccccCCCceeecceeccccceeEEEEEEC-------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc
Q 022903 48 TIDRSLLVDPKLLFIGSKIGEGAHGKVYEGRYG-------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL 120 (290)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 120 (290)
...+.+.++.++|.+++.||+|+||+||+|.+. +..||||+++........ ..+.+|+.++++++||||
T Consensus 10 ~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~----~~~~~E~~il~~l~h~nI 85 (308)
T d1p4oa_ 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER----IEFLNEASVMKEFNCHHV 85 (308)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHH----HHHHHHHHHGGGCCCTTB
T ss_pred cCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHH----HHHHHHHHHHHHcCCCCE
Confidence 344456778889999999999999999999763 368999999866544432 358899999999999999
Q ss_pred eeEEeeeec-CceEEEEEecCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEE
Q 022903 121 VKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR--------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 191 (290)
Q Consensus 121 v~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nil 191 (290)
+++++++.. ...++||||+.+|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 86 v~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 165 (308)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEE
T ss_pred eeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCcee
Confidence 999999864 47889999999999999986421 134688899999999999999999999999999999999
Q ss_pred EcCCCCceEEecccccccccccc---cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC-CCCC
Q 022903 192 LTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPF 267 (290)
Q Consensus 192 i~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g-~~Pf 267 (290)
++.+ .++||+|||+++...... ......+|+.|+|||.+.. ..++.++||||||+++|||++| .+||
T Consensus 166 ld~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--------~~~~~~~Dv~S~G~il~El~t~~~~p~ 236 (308)
T d1p4oa_ 166 VAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPY 236 (308)
T ss_dssp ECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred ecCC-ceEEEeecccceeccCCcceeeccceecccccCCHHHHcc--------CCCCcccccccHHHHHHHHHhCCCCCC
Confidence 9954 569999999997543322 2233468999999998865 6788999999999999999997 6899
Q ss_pred CCCCHHHHHHHHHH
Q 022903 268 EGMSNLQAAYAAAF 281 (290)
Q Consensus 268 ~~~~~~~~~~~~~~ 281 (290)
.+.+..+....+..
T Consensus 237 ~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 237 QGLSNEQVLRFVME 250 (308)
T ss_dssp TTSCHHHHHHHHHT
T ss_pred CCCCHHHHHHHHHh
Confidence 99888777665544
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=321.32 Aligned_cols=215 Identities=31% Similarity=0.510 Sum_probs=174.0
Q ss_pred ccCCCceeecceeccccceeEEEEEE--CCc--eEEEEEcccCCChhHHHHHHHHHHHHHHHHhhc-CCCCceeEEeeee
Q 022903 54 LVDPKLLFIGSKIGEGAHGKVYEGRY--GDR--IVAIKVLNRGSTSDERALLEGRFIREVNMMSRV-KHDNLVKFLGACK 128 (290)
Q Consensus 54 ~~~~~~~~~~~~lG~G~~g~V~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 128 (290)
.++.++|++.+.||+|+||+||+|++ ++. .||||.+......... ..+.+|+.+++++ +||||+++++++.
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH----RDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC----------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHH----HHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 35667899999999999999999976 443 5778887654433322 3588999999999 7999999999997
Q ss_pred cC-ceEEEEEecCCCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEc
Q 022903 129 DP-LMVIVTELLPGMSLRKYLVSL--------------RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 193 (290)
Q Consensus 129 ~~-~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~ 193 (290)
+. ..++||||+++|+|.+++... ....+++..+..++.||+.||.|||++|++||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEc
Confidence 54 688999999999999998653 235689999999999999999999999999999999999999
Q ss_pred CCCCceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCH
Q 022903 194 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN 272 (290)
Q Consensus 194 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g-~~Pf~~~~~ 272 (290)
.+ ..+||+|||+++............||..|+|||.+.. ..++.++||||||+++|||++| .+||.+.+.
T Consensus 162 ~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~ 232 (309)
T d1fvra_ 162 EN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 232 (309)
T ss_dssp GG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CC-CceEEccccccccccccccccceecCCcccchHHhcc--------CCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence 55 4699999999987655555555678999999999865 6789999999999999999995 568988877
Q ss_pred HHHHHHHHH
Q 022903 273 LQAAYAAAF 281 (290)
Q Consensus 273 ~~~~~~~~~ 281 (290)
.+....+..
T Consensus 233 ~~~~~~i~~ 241 (309)
T d1fvra_ 233 AELYEKLPQ 241 (309)
T ss_dssp HHHHHHGGG
T ss_pred HHHHHHHHh
Confidence 766555443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=321.26 Aligned_cols=207 Identities=30% Similarity=0.429 Sum_probs=170.0
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP---- 130 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 130 (290)
.++|++++.||+|+||+||+|.+ +++.||||+++........ ..++.+|+.+|+.++|||||++++++...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~---~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF---AKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHH---HHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHH---HHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 46799999999999999999987 4899999999865544332 24688999999999999999999998643
Q ss_pred ---ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccc
Q 022903 131 ---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 207 (290)
Q Consensus 131 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~ 207 (290)
..++||||+ +.+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a 168 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLA 168 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTC
T ss_pred ccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccce
Confidence 468999999 6788887764 5799999999999999999999999999999999999999654 5999999999
Q ss_pred ccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 208 REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 208 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
..... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 169 ~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~ 232 (346)
T d1cm8a_ 169 RQADS--EMTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 232 (346)
T ss_dssp EECCS--SCCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eccCC--ccccccccccccCHHHHcC-------CCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHH
Confidence 86543 3345689999999998864 2457899999999999999999999999988776655443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.9e-46 Score=319.71 Aligned_cols=197 Identities=22% Similarity=0.403 Sum_probs=170.9
Q ss_pred CCCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeeec---
Q 022903 56 DPKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACKD--- 129 (290)
Q Consensus 56 ~~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--- 129 (290)
..++|+++++||+|+||+||+|++ +++.||||+++.... .++.+|+.+|+.++ ||||+++++++..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~ 104 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--------KKIKREIKILENLRGGPNIITLADIVKDPVS 104 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH--------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH--------HHHHHHHHHHHhccCCCCCcEEEEEEEecCC
Confidence 345799999999999999999987 578999999875431 24779999999995 9999999999863
Q ss_pred CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 130 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 130 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
...++||||+.+++|..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++..+||+|||++..
T Consensus 105 ~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 105 RTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp CSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 3588999999999998753 46999999999999999999999999999999999999997776799999999987
Q ss_pred ccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCH
Q 022903 210 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 272 (290)
Q Consensus 210 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~ 272 (290)
...........+|+.|+|||.+.+ ...++.++|||||||++|+|++|..||....+
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccCCCcccccccCccccCcccccC-------CCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 665556667789999999998764 24578999999999999999999999987654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=313.74 Aligned_cols=209 Identities=31% Similarity=0.475 Sum_probs=165.1
Q ss_pred ecceeccccceeEEEEEECC-----ceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec--CceEE
Q 022903 62 IGSKIGEGAHGKVYEGRYGD-----RIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD--PLMVI 134 (290)
Q Consensus 62 ~~~~lG~G~~g~V~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~l 134 (290)
+.+.||+|+||+||+|++.+ ..||||+++........ .++.+|++++++++||||+++++++.+ ...++
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV----SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHH----HHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHH----HHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 35789999999999998732 35899999765443332 468899999999999999999998753 46789
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
||||+++++|.+++.. .....++..++.++.|++.||.|+|+++|+||||||+|||++.+ ..+||+|||+++......
T Consensus 107 v~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE 184 (311)
T ss_dssp EEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTT
T ss_pred EEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-CCEEEecccchhhccccc
Confidence 9999999999999875 45567888899999999999999999999999999999999954 569999999998643322
Q ss_pred -----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhc
Q 022903 215 -----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKVQ 284 (290)
Q Consensus 215 -----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~~~~~ 284 (290)
......||+.|+|||.+.. ..++.++||||||+++|||++|..||..............+.+
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~ 251 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR 251 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC
T ss_pred cccceecccccccccccChHHHhc--------CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 1223468899999998864 6789999999999999999997777766544433333333333
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-45 Score=311.84 Aligned_cols=203 Identities=26% Similarity=0.353 Sum_probs=161.9
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEe-eeec-CceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLG-ACKD-PLMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~-~~~~ 133 (290)
++|++++.||+|+||.||+|++ +++.||||++....... .+.+|+++++.++|++++..+. ++.+ ...+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC-------CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH-------HHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 4599999999999999999987 47899999987654332 2668999999998777665544 4443 4677
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCC--CCceEEeccccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREET 211 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~--~~~~kl~Dfg~~~~~~ 211 (290)
+||||+ +++|.+.+.. ....+++..+..++.|++.||+|||++||+||||||+|||++.. +..++|+|||+++...
T Consensus 80 ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 899999 6677776655 45689999999999999999999999999999999999998642 3469999999998643
Q ss_pred ccc--------cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 022903 212 VTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 277 (290)
Q Consensus 212 ~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~ 277 (290)
... ......||+.|||||++.+ ..++.++|||||||++|+|++|..||.+........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--------BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred ccccccceeccccCCcCCCccccCHHHHhC--------CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH
Confidence 221 2234579999999998865 668999999999999999999999999876554433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.8e-45 Score=310.34 Aligned_cols=197 Identities=24% Similarity=0.372 Sum_probs=165.5
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC-CCceeEEeeeecC-ceE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-DNLVKFLGACKDP-LMV 133 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~-~~~ 133 (290)
++|++++.||+|+||.||+|++ +++.||||++....... .+.+|+++++.|.| +|++.+++++.+. ..+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-------QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC-------CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH-------HHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 5699999999999999999987 57899999987654332 25678888888875 8999998888654 678
Q ss_pred EEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcC----CCCceEEeccccccc
Q 022903 134 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP----DQKSLKLADFGLARE 209 (290)
Q Consensus 134 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~----~~~~~kl~Dfg~~~~ 209 (290)
+||||+ +++|.+++.. ....++...+..++.|++.||+|||++||+||||||+|||++. ..+.++|+|||+++.
T Consensus 78 ~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 999998 7899998876 4567999999999999999999999999999999999999974 234699999999986
Q ss_pred cccc--------ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 210 ETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 210 ~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.... .......||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcC--------CCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 4322 12234579999999999865 678999999999999999999999998754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-45 Score=313.77 Aligned_cols=211 Identities=25% Similarity=0.352 Sum_probs=169.2
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 129 (290)
-++|+++++||+|+||+||+|++ +++.||||++......... ..++.+|+.+|+.++||||+++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF---PITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSS---CHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHH---HHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 36799999999999999999987 5789999998665433211 1347799999999999999999998743
Q ss_pred ----CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 130 ----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 130 ----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
...++||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg 162 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFG 162 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCT
T ss_pred cccCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC-CcEEeeecc
Confidence 24789999997766554433 35679999999999999999999999999999999999999965 469999999
Q ss_pred cccccccc-----ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 206 LAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 206 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
++...... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.++.+....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~ 235 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 235 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcC-------CCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence 99753322 12234579999999998764 2468899999999999999999999999987766655543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=315.09 Aligned_cols=200 Identities=26% Similarity=0.418 Sum_probs=159.1
Q ss_pred CceeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-----ce
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-----LM 132 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 132 (290)
++|.+.+.||+|+||.||+|+++++.||||+++.... .. .....|+..+..++||||+++++++.+. ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~---~~---~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE---RS---WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH---HH---HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch---hH---HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 3578889999999999999999999999999864321 11 1123466666788999999999998542 46
Q ss_pred EEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCeeecCCCCCEEEcCCCCceEEecc
Q 022903 133 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLADF 204 (290)
Q Consensus 133 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--------~givH~Dikp~Nili~~~~~~~kl~Df 204 (290)
++||||+++|+|.++++. ..+++..+..++.|++.||.|+|+ +||+||||||+|||++.+ +.+||+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~DF 152 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADL 152 (303)
T ss_dssp EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEECCC
T ss_pred EEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEEec
Confidence 899999999999999986 469999999999999999999996 599999999999999955 56999999
Q ss_pred cccccccccc-----cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 022903 205 GLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 269 (290)
Q Consensus 205 g~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~ 269 (290)
|+++...... ......||+.|+|||++.... ......++.++|||||||+||||+||..||..
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI--NMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCS--CTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccc--cccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 9997543222 223457999999999876411 00112356789999999999999999888743
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=316.79 Aligned_cols=208 Identities=33% Similarity=0.429 Sum_probs=172.4
Q ss_pred CCceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec-----
Q 022903 57 PKLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD----- 129 (290)
Q Consensus 57 ~~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 129 (290)
+++|+++++||+|+||+||+|++ +++.||||++.......... .++.+|+.+++.++||||+++++++..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~ 93 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHMKHENVIGLLDVFTPARSLE 93 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHH---HHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHH---HHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence 46799999999999999999987 58999999998765443332 357899999999999999999998842
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
...+++|+++.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|++|||++.
T Consensus 94 ~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~ 169 (348)
T d2gfsa1 94 EFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR 169 (348)
T ss_dssp TCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----
T ss_pred cCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhc
Confidence 245677888889999999864 5799999999999999999999999999999999999999654 59999999987
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
.... ......|++.|+|||.+.. ...++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 170 ~~~~--~~~~~~g~~~y~apE~~~~-------~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~ 232 (348)
T d2gfsa1 170 HTDD--EMTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232 (348)
T ss_dssp CCTG--GGSSSCHHHHTSCHHHHTT-------CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccCc--ccccccccccccCchhhcC-------CccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6433 3345678999999998654 2456899999999999999999999999988776665554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=315.36 Aligned_cols=206 Identities=32% Similarity=0.438 Sum_probs=163.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeec------
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKD------ 129 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 129 (290)
++|+++++||+|+||+||+|++ +++.||||++.......... .++.+|+.+++.++||||+++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~---~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA---KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHH---HHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHH---HHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 5699999999999999999988 48999999998766543332 368899999999999999999999842
Q ss_pred -CceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccc
Q 022903 130 -PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 208 (290)
Q Consensus 130 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~ 208 (290)
...++||||+.++ +.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .++++|||++.
T Consensus 94 ~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC--
T ss_pred CceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhhh
Confidence 3678999999665 444443 4689999999999999999999999999999999999999665 59999999988
Q ss_pred cccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q 022903 209 EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 280 (290)
Q Consensus 209 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~~~ 280 (290)
............+|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+.......+.
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~--------~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~ 231 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_dssp -------------CCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccChhhhcC--------CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 7666666667789999999999865 678999999999999999999999999988766655554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=304.26 Aligned_cols=208 Identities=25% Similarity=0.416 Sum_probs=172.3
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCceeEEeeeecC-ceEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNLVKFLGACKDP-LMVI 134 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~l 134 (290)
++|++++.||+|+||+||+|++ +++.||||+++........ ..++.+|+.+++.++||||+++++++.+. ..++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~---~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV---PSSALREICLLKELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTH---HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHH---HHHHHHHHHHHHhcCcCCEEeeccccccccceeE
Confidence 4699999999999999999987 5789999999765543322 24588999999999999999999999765 5679
Q ss_pred EEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccccccc
Q 022903 135 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 214 (290)
Q Consensus 135 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~~~~~ 214 (290)
+++++.+++|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||.+.......
T Consensus 79 v~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCC
T ss_pred Eeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCC
Confidence 9999999888887764 56889999999999999999999999999999999999999654 59999999998654433
Q ss_pred -cccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022903 215 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 278 (290)
Q Consensus 215 -~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~~~~~ 278 (290)
......+++.|+|||.+.. ...++.++|||||||++|+|++|+.||....+......
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~ 213 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred ccceeeccccchhhhhHhcc-------CCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH
Confidence 2334457788999998764 24568999999999999999999999765555444433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-46 Score=318.32 Aligned_cols=207 Identities=26% Similarity=0.389 Sum_probs=168.2
Q ss_pred CceeecceeccccceeEEEEEE-----CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCC-CCceeEEeeeecC-
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY-----GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKH-DNLVKFLGACKDP- 130 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~- 130 (290)
++|++++.||+|+||+||+|++ +++.||||+++......+.. ...++.+|+.++++++| |||+++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~-~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAK-TTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEES-SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchH-HHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 5699999999999999999976 46789999986543211100 01236789999999976 8999999999755
Q ss_pred ceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEecccccccc
Q 022903 131 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 210 (290)
Q Consensus 131 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg~~~~~ 210 (290)
..+++|||+.+++|.+++... ..+++..+..++.||+.||.|+|++|++||||||+|||++.+ +.+||+|||+++..
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEEC
T ss_pred ceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccchhhh
Confidence 678999999999999999863 567899999999999999999999999999999999999965 46999999999764
Q ss_pred ccc--ccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCHHH
Q 022903 211 TVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 274 (290)
Q Consensus 211 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~~~~ 274 (290)
... .......|++.|+|||.+.. ....++.++|||||||+||+|++|..||.+.+..+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~------~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred cccccccccccccccccchhHHhhc------CCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 332 23345679999999998864 22457889999999999999999999998875433
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.7e-38 Score=272.92 Aligned_cols=198 Identities=21% Similarity=0.310 Sum_probs=155.2
Q ss_pred CceeecceeccccceeEEEEEE--CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-----------CCCceeEE
Q 022903 58 KLLFIGSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-----------HDNLVKFL 124 (290)
Q Consensus 58 ~~~~~~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~ 124 (290)
.+|+++++||+|+||+||+|++ +++.||||+++...... ..+.+|+.+++.++ |+||++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~------~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT------EAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHH------HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccch------HHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 4599999999999999999987 58999999997643221 23567888877765 57899998
Q ss_pred eeeec---CceEEEEEecCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCEEEcCCCC--
Q 022903 125 GACKD---PLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQK-- 197 (290)
Q Consensus 125 ~~~~~---~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~givH~Dikp~Nili~~~~~-- 197 (290)
+++.. ...+++++++... .............+++..+..++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 88753 2445666665444 34444445456779999999999999999999998 89999999999999975432
Q ss_pred ---ceEEecccccccccccccccccCCCccccCccccccccccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 022903 198 ---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 271 (290)
Q Consensus 198 ---~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~~l~~~l~g~~Pf~~~~ 271 (290)
.++++|||.+..... ......||+.|+|||++.. ..++.++|||||||++++|++|+.||....
T Consensus 167 ~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccceeeEeeccccccccc--ccccccccccccChhhccc--------cCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 389999999876433 3345689999999998865 668999999999999999999999998653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=1.9e-28 Score=194.27 Aligned_cols=138 Identities=20% Similarity=0.184 Sum_probs=106.2
Q ss_pred eeecceeccccceeEEEEEE-CCceEEEEEcccCCCh-------------hHHHHHHHHHHHHHHHHhhcCCCCceeEEe
Q 022903 60 LFIGSKIGEGAHGKVYEGRY-GDRIVAIKVLNRGSTS-------------DERALLEGRFIREVNMMSRVKHDNLVKFLG 125 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~-------------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 125 (290)
+.++++||+|+||+||+|++ +++.||||+++..... ...........+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35678999999999999986 6789999987542211 011122234567889999999999998876
Q ss_pred eeecCceEEEEEecCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCEEEcCCCCceEEeccc
Q 022903 126 ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 205 (290)
Q Consensus 126 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~givH~Dikp~Nili~~~~~~~kl~Dfg 205 (290)
.. ..+++|||+++..+.+ ++...+..++.|++.+|.|||++|++||||||+|||++. ++ ++|+|||
T Consensus 82 ~~---~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~-~~-~~liDFG 147 (191)
T d1zara2 82 WE---GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE-EG-IWIIDFP 147 (191)
T ss_dssp EE---TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-TE-EEECCCT
T ss_pred ec---CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-CC-EEEEECC
Confidence 53 2479999998866543 344456789999999999999999999999999999994 33 8999999
Q ss_pred cccccc
Q 022903 206 LAREET 211 (290)
Q Consensus 206 ~~~~~~ 211 (290)
++....
T Consensus 148 ~a~~~~ 153 (191)
T d1zara2 148 QSVEVG 153 (191)
T ss_dssp TCEETT
T ss_pred CcccCC
Confidence 987643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.60 E-value=8.5e-08 Score=77.45 Aligned_cols=83 Identities=14% Similarity=0.041 Sum_probs=54.5
Q ss_pred eeecceeccccceeEEEEEECCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcC-CCCceeEEeeee-cCceEEEEE
Q 022903 60 LFIGSKIGEGAHGKVYEGRYGDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVK-HDNLVKFLGACK-DPLMVIVTE 137 (290)
Q Consensus 60 ~~~~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~lv~e 137 (290)
|++.+..+.++.+.||+...+++.+++|+.......... .+.+|...+..+. +-.+.+++.... ++..++||+
T Consensus 16 ~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~-----~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTY-----DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp SEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTT-----CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchh-----hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 455555444555789999888888889987654322211 2457777777664 323456666664 346789999
Q ss_pred ecCCCCHHHH
Q 022903 138 LLPGMSLRKY 147 (290)
Q Consensus 138 ~~~~~~L~~~ 147 (290)
+++|.++.+.
T Consensus 91 ~l~G~~~~~~ 100 (263)
T d1j7la_ 91 EADGVLCSEE 100 (263)
T ss_dssp CCSSEEHHHH
T ss_pred eccccccccc
Confidence 9999877553
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.12 E-value=5.6e-06 Score=66.03 Aligned_cols=72 Identities=14% Similarity=0.171 Sum_probs=47.1
Q ss_pred eeccccc-eeEEEEEEC-CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCC--CceeEEeeeecC-ceEEEEEec
Q 022903 65 KIGEGAH-GKVYEGRYG-DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHD--NLVKFLGACKDP-LMVIVTELL 139 (290)
Q Consensus 65 ~lG~G~~-g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~-~~~lv~e~~ 139 (290)
.+..|.. +.||+.... +..+++|......... +..|...++.+... .+.+++....++ ..++||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~--------l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNE--------LQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSC--------HHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHhH--------HHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence 3455554 578988764 5568889876554332 44677777766432 245567666544 678999999
Q ss_pred CCCCH
Q 022903 140 PGMSL 144 (290)
Q Consensus 140 ~~~~L 144 (290)
+|.++
T Consensus 89 ~G~~~ 93 (255)
T d1nd4a_ 89 PGQDL 93 (255)
T ss_dssp SSEET
T ss_pred ecccc
Confidence 88655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.06 E-value=2.2e-06 Score=73.30 Aligned_cols=80 Identities=21% Similarity=0.189 Sum_probs=45.8
Q ss_pred cceeccccceeEEEEEE--CCceEEEEEcccCC--ChhHHHHHHHHHHHHHHHHhhcC-C-C-CceeEEeeeecCceEEE
Q 022903 63 GSKIGEGAHGKVYEGRY--GDRIVAIKVLNRGS--TSDERALLEGRFIREVNMMSRVK-H-D-NLVKFLGACKDPLMVIV 135 (290)
Q Consensus 63 ~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~-h-~-~iv~~~~~~~~~~~~lv 135 (290)
.+.||.|....||+... +++.+++|...+.. ..........+...|...|+.+. + | .+++++.+ .....++|
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d~~~~~lv 109 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV 109 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-cCCCCEEE
Confidence 35689999999999865 46789999754310 00000000012446777776653 2 3 34455554 34466899
Q ss_pred EEecCCCC
Q 022903 136 TELLPGMS 143 (290)
Q Consensus 136 ~e~~~~~~ 143 (290)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.52 E-value=0.00012 Score=60.49 Aligned_cols=66 Identities=12% Similarity=0.170 Sum_probs=40.6
Q ss_pred ceeEEEEEE-CCceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc--eeEEee------eecCceEEEEEecCC
Q 022903 71 HGKVYEGRY-GDRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL--VKFLGA------CKDPLMVIVTELLPG 141 (290)
Q Consensus 71 ~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~------~~~~~~~lv~e~~~~ 141 (290)
--.||+++. +|+.|++|+.++.....+ .+..|...+..|...++ +..+.. ..++..+.+++++.|
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~------~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTAD------QILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHH------HHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHH------HHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 357999976 567899999876544332 25567777777653222 111111 124567788999876
Q ss_pred C
Q 022903 142 M 142 (290)
Q Consensus 142 ~ 142 (290)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.31 E-value=0.00064 Score=57.52 Aligned_cols=71 Identities=20% Similarity=0.303 Sum_probs=47.5
Q ss_pred ceeccccceeEEEEEEC---------CceEEEEEcccCCChhHHHHHHHHHHHHHHHHhhcCCCCc-eeEEeeeecCceE
Q 022903 64 SKIGEGAHGKVYEGRYG---------DRIVAIKVLNRGSTSDERALLEGRFIREVNMMSRVKHDNL-VKFLGACKDPLMV 133 (290)
Q Consensus 64 ~~lG~G~~g~V~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~ 133 (290)
+.|+.|-.-.+|++... .+.|++++.-...... ...+|..+++.+.-.++ .++++.+.+ .
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~i-------dr~~E~~i~~~ls~~gl~Pkll~~~~~---g 117 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETES-------HLVAESVIFTLLSERHLGPKLYGIFSG---G 117 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHH-------HHHHHHHHHHHHHHTTSSSCEEEEETT---E
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhh-------HHHHHHHHHHHHHhCCCCCeEEEEcCC---c
Confidence 57888999999998753 2467788765332221 13478888888753344 467777654 6
Q ss_pred EEEEecCCCCH
Q 022903 134 IVTELLPGMSL 144 (290)
Q Consensus 134 lv~e~~~~~~L 144 (290)
+|++|++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 88999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.16 E-value=0.0007 Score=55.27 Aligned_cols=30 Identities=40% Similarity=0.559 Sum_probs=25.5
Q ss_pred CCeeecCCCCCEEEcCCCCceEEeccccccc
Q 022903 179 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 209 (290)
Q Consensus 179 givH~Dikp~Nili~~~~~~~kl~Dfg~~~~ 209 (290)
|+||+|+.++|++++.+ ...-|+||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~-~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGD-ELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccc-cceeEeccccccc
Confidence 79999999999999954 4457999998864
|